"Keyword","Scopus","IFSMS"
"'DATE-RAPE' DRUGS",1,NA
"'ECSTASY'",1,NA
"'POST MORTEM' WHOLE BLOOD",1,NA
"'SPEED'",1,NA
"-141C INS/DEL",1,NA
"""""CHEMICAL FINGERPRINT""""",1,NA
"""""CHINESE HERBS""""",1,NA
"""""COUNTERFEIT DRUG"""" LABELLING WITHOUT AUTHORISATION, OF DRUG MANUFACTURERS",1,NA
"""""CRACK LUNG""""",1,NA
"""""DARE"""" (""""DRUG ABUSE RESISTANCE EDUCATION"""")",1,NA
"""""DATE-RAPE"""" DRUGS",1,NA
"""""DEATH IN THE MICROWAVE OVEN""""",1,NA
"""""GANGSTA""""/""""GANG-BANGER""""",1,NA
"""""GENERAL UNKNOWN SCREENING""""",1,NA
"""""KROKODIL"""" SYNTHESIS",1,NA
"""""LEGAL HIGHS""""",2,NA
"""""LIQUID ECSTASY""""",1,NA
"""""POPULAR"""" INTOXICATION",1,NA
"""""PSYCHOTIC EXPERIENCE""""",1,NA
"""""RESPONDEAT SUPERIOR"""" DOCTRINE",1,NA
"""""SEX-IN"""" AND """"BEAT-IN"""" GANG INITIATIONS",1,NA
"""""UFO""""",1,NA
"(-)-MENTHYLCHLOROFORMATE",1,NA
"(−)-TRANS-Δ9-TETRAHYDROCANNABINOL AND METABOLITES",1,NA
"( -)-DEPRENYL",1,NA
"(+)-N-METHYL-1-(1,3-BENZODIOXOL-5-YL)-2-BUTANAMINE",1,1
"(±)- EPHEDRINE",1,NA
"(±)-METHAMPHETAMINE",1,NA
"(±)-METHCATHINONE",1,NA
"(±)-PSEUDOEPHEDRINE",1,NA
"(1-(4-PENTENYL)-1H-INDOL-3-YL)(NAPHTHALEN-1-YL)METHANONE",1,1
"(1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE DERIVATIVES",1,1
"(2-METHOXYPHENYL)(1-PENTYL-1H-INDOL-3-YL)METHANONE",1,1
"(2″-OXO-PYRROLIDINO)VALEROPHENONE (2″-OXO- Α-PVP)",1,NA
"(4-ETHYL-1-NAPHTHALENYL)(2-METHYL-1-PENTYL-1H-INDOL-3-YL)METHANONE",1,1
"(4-METHOXYPHENYL)(1-PENTYL-1H-INDOL-3-YL)METHANONE",1,1
"(4-METHYLMETHCATHINONE, 4-MMC)",1,NA
"(4-METHYLPIPERAZIN-1-YL)(1-PENTYL- 1H-INDOL-3-YL)METHANONE (MEPIRAPIM)",1,NA
"(AMINOALKYL)INDOLE",1,1
"(BENZODIFURANYL)AMINOALKANES",1,1
"(BIO)SENSORS",1,1
"(BROMOMETHYL)NAPHTHALENE",1,NA
"(ESI-MS)",4,8
"(FTIR)",47,59
"(GC-MS)",567,304
"(HPLC)",161,170
"(HPTLC)",21,23
"(HUMAN SERUM)",1,NA
"(HUMAN URINE)",1,NA
"(ICP-MS)",23,20
"(LA-ICP-MS)",5,5
"(LC-GC/MS)",5,NA
"(LC-MS)",175,90
"(LC-MS/MS)",462,115
"(MALDI-MS)",2,2
"(MEKC)",8,20
"(PY-GC/MS)",2,2
"(R)-(+)-Α-METHOXY-Α-(TRIFLUROMETHYL) PHENYLACETIC ACID",1,NA
"(R)-MACROMERINE",1,1
"(R)-NORMACROMERINE",1,1
"(REAL-TIME PCR)",28,3
"(RFLP)",4,2
"(TETRAHYDROBENZODIFURANYL)AMINOALKANES",1,1
"(UHPLC)",19,19
"(UN)ACCOUNTABILITY",1,NA
"(UV)LASER-INDUCED FLUORESCENCE DETECTION",1,1
"(Z)-1,8-HEPTADECADIENE",1,NA
".",1,NA
"[ 35S]GTPΓS BINDING ASSAY",1,NA
"[1-(TETRAHYDROPYRAN-4-YLMETHYL)-1H-INDOL-3- YL]-(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE",1,1
"[35S]-GTPΓS",1,NA
"[CA2+] OSCILLATION",1,NA
"[INFRARED] SPECTROSCOPY",1,NA
"‘BATH SALTS’",2,1
"‘EXIT BAG’",1,NA
"‘LEGAL HIGHS’",2,NA
"‘POPPERS’",1,NA
"‘RESEARCH CHEMICALS’",1,NA
"‘TRIPLE CONTRAST’ METHOD",1,NA
"“CURED” PSYCHOTIC PATIENTS",1,NA
"“KROKODIL”",1,NA
"“LEGAL HIGHS”",1,NA
"“PER SE” LAW",1,NA
"“PINK COCAINE”",1,NA
"∆9-TETRAHYDROCANNABINOL",1,NA
"§ 24A STVG (TRAFFIC LAW)",1,NA
"§ 64 GERMAN PENAL CODE",1,NA
"§24A (2) STVG",1,NA
"§24A SEC. 2 STVG",1,NA
"06-MONOACETYLMORPHINE",1,NA
"1",1,NA
"1-(1,3-BENZODIOXOL-5-YL)-2-BUTANAMINE",1,1
"1-(2-PHENETHYL)-4-(N-PROPIONYLANILINO)PIPERIDINE ANALOGUE",1,NA
"1-(2-PHENETHYL)-4-N-PROPIONYLANILINOPIPERIDINE",1,1
"1-(2,3-DIHYDRO-1H-INDEN-5-YL)-2-(PYRROLIDIN-1-YL)BUTAN-1-ONE",1,1
"1-(2,3-DIHYDRO-1H-INDEN-5-YL)-2-PHENYL-2-(PYRROLIDIN-1-YL)-ETHANONE",1,1
"1-(3- TRIFLUOROMETHYLPHENYL)PIPERAZINE",1,1
"1-(3-CHLOROPHENYL) PIPERAZINE",2,NA
"1-(3-CHLOROPHENYL)PIPERAZINE",1,2
"1-(3-TRIFLUOROMETHYLPHENYL) PIPERAZINE",1,NA
"1-(3,4-METHYLENEDIOXYPHENYL)-2-(1-PYRROLIDINYL)-1-BUTANONE, MDPBP",1,NA
"1-（3,4-METHYLENEDIOXYPHENYL）-2-（DIMETHYLAMINO）BUTAN-1-ONE （DIBUTYLONE",1,NA
"1-(4-METHYLPHENYL)-2-(PROPYLAMINO)-1-BUTANONE",1,1
"1-[3-(TRIFLUOROMETHYL) PHENYL] PIPERAZINE",1,NA
"1-[3-TRIFLUOROMETHYLPHENYL]-PIPERAZINE",1,1
"1-[4-METHOXYPHENYL]-PIPERAZINE",1,1
"1-2-NAPTHOQUINONE-4-SULFONATE",1,NA
"1-BENZYL-3-METHYLNAPHTHALENE",1,1
"1-BENZYL-4-METHYLPIPERAZINE",1,1
"1-BENZYL-PIPERAZINE",1,1
"1-BUTYL-3-(2-METHOXYBENZOYL)INDOLE",1,1
"1-CHLOROBUTANE",1,NA
"1-CHLOROETHYL CHLOROFORMATE",1,NA
"1-HYDROXY-1-PHENYL-2-PROPANONE",1,1
"1-HYDROXYMETHYLTRIAZOLAM",1,NA
"1-METHYLNAPHTHALENE",1,NA
"1-OCTEN-3-OL",1,NA
"1-PENTYL-3-(1-NAPHTHOYL)INDOLE",1,1
"1-PENTYL-3-(2-IODOBENZOYL)INDOLE",1,1
"1-PENTYL-3-(2-METHOXYBENZOYL)INDOLE",1,1
"1-PENTYL-3-(2-METHOXYPHENYLACETYL)INDOLE",1,1
"1-PHENYL-1,2-PROPANEDIOL",1,1
"1-PHENYL-1,2-PROPANEDIONE",1,1
"1-PHENYL-2-(PYRROLIDIN-1-YL) PENTAN-1-OL (OH-Α-PVP)",1,NA
"1-PHENYL-2-(PYRROLIDIN-1-YL)OCTAN-1-ONE",2,NA
"1-PHENYL-2-(PYRROLIDIN-1-YL)PENTAN-1- OL (OH-Α-PVP)",1,NA
"1-PHENYL-2-PROPANOL",1,2
"1-PHENYL-2-PROPANONE",5,5
"1-PHENYLETHYLAMINE",1,1
"1-PHENYLPROPAN-2-ONE",1,NA
"1-PROPANOL",1,NA
"1-PROPANOYL-LYSERGIC ACID DIETHYLAMIDE (1P-LSD)",1,NA
"1-PYRENYLDIAZOMETHANE",1,NA
"1 H NMR",1,NA
"1,1-DIFLUOROETHANE",1,NA
"1,1′-CARBONYLDIIMIDAZOLE (CDI)",1,NA
"1,2-DIARYLETHYLAMINES",1,NA
"1,2-INDANEDIONE",19,NA
"1,2,4,-TRIAZINES",1,NA
"1,3 DIMETHYLAMYLAMINE (DMAA)",1,NA
"1,3,5-TRICHLORO-1,3,5-TRIAZINANE-2,4,6-TRIONE",1,NA
"1,4-BENZODIAZEPINE IDENTIFICATION",1,NA
"1,4-BENZODIAZEPINES",3,1
"1,4-BUTANEDIOL",7,3
"1,4-DIPHENYL-2(O)-ACETYL-BUTANE-2,3-DIOL",1,NA
"1,4-DIPHENYL-3-HYDROXY-2-BUTANO NE",1,NA
"1,4-DIPHENYLBUTANE-2,3-DIOL",1,NA
"1,8-DIAMINONAPHTHALENE",1,NA
"1,8-DIAZAFLUOREN-9-ONE (DFO)",17,NA
"1,8-DIAZAFLUOREN-9-ONE(DFO)",1,NA
"1,8-DIAZAFLUORENONE",1,NA
"1.4-BUTANEDIOL",1,NA
"10-HYDROXYCARBAZEPINE",1,NA
"10-HYDROXYOCTADECANOIC ACID",1,NA
"101-25-7",1,NA
"1064 NM",1,NA
"11- NOR-DELTA-9-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID",1,NA
"11- NOR-DELTA9-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID",1,NA
"11-CARBOXY-DELTA-9-TETRAHYDROCANNABINOL",1,NA
"11-HYDROXY-TETRAHYDROCANNABINOL",1,NA
"11-HYDROXY-Δ 9-TETRAHYDROCANNABINOL",1,NA
"11-HYDROXY-Δ9-TETRAHYDROCANNABINOL",1,NA
"11-HYDROXYLATION",1,NA
"11-NOR-9-CARBOXY-DELTA-TETRAHYDROCANNABINOL",1,NA
"11-NOR-9-CARBOXY-DELTA9-TETRAHYDROCANNABINOL",1,NA
"11-NOR-9-CARBOXY-TETRAHYDROCANNABINOL",2,NA
"11-NOR-9-CARBOXY-THC",1,1
"11-NOR-9-CARBOXY-Δ9- TETRAHYDROCANNABINOL",1,NA
"11-NOR-9-CARBOXY-Δ9-TETRAHYDROCANNABINOL",1,NA
"11-NOR-9-CARBOXY-Δ9-TETRAHYDROCANNABINOL (THCCOOH)",1,NA
"11-NOR-DELTA-9- TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID",1,NA
"11-NOR-DELTA-9-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID ETHYL ESTER",1,NA
"11-NOR-DELTA9-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID",1,NA
"11-NOR-Δ9-CARBOXY TETRAHYDROCANNABINOL GLUCURONIDE",1,NA
"11-NOR-Δ9-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID",1,NA
"11-NOR-Δ9-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID (THCA)",1,NA
"12 SAMPLES SIMULTANEOUS WITHIN LESS THAN 2 MINUTES",1,NA
"125I-LABELED METHAMPHETAMINE",1,NA
"137 BA",1,NA
"137 CS",1,NA
"13C-LABELLED INTERNAL STANDARDS",1,NA
"13C ISOTOPE CALIBRATION",1,NA
"13C4-SECOBARBITAL",1,1
"14-C BOMB SPIKE",1,1
"14C-HEXACHLOROBENZENE",1,NA
"16-O-DEMETHYLACONITINE",1,NA
"16-O-DEMETHYLHYPACONITINE",1,NA
"160TB AND 161TB",1,NA
"16S RRNA",2,NA
"16SRRNA GENE",1,NA
"16Β-HYDROXY STEROID",1,NA
"16Β-HYDROXYMESTANOLONE",1,NA
"17Α-ALKYL ANABOLIC STEROID",1,NA
"18FDG",1,NA
"19-NORTESTOSTERONE",1,1
"1D AND 2D NMR",1,1
"1H",2,3
"1H- NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (1H-NMR)",1,NA
"1H-NMR",2,6
"1H NMR",1,10
"1H NMR SPECTROSCOPY",1,NA
"2- AND 3-METHYLBUTYRIC ACID",1,NA
"2-(2-ETHYLAMINOPROPYL)BENZOFURAN (2-EAPB)",1,1
"2-(2-FL UOROPHENYL)-2-METHYLAMINO-CYCLOHEXANONE",1,NA
"2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL)ETHANAMINE",1,NA
"2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-[(2-METHOXYPHENYL)METHYL]ETHANAMINE, 25B-NBOME",1,NA
"2-(8-QUINOLYLAZO)-4,5-DI-P-TOLYLIMIDAZOLE (QTI)",1,NA
"2-(DIMETHYLAMINO)ETHYL-(1-HYDROXYCYCLOPENTYL)(PHENYL) ACETATE",1,NA
"2-(DIMETHYLAMINO)ETHYL-(1-HYDROXYCYCLOPENTYL)(PHENYL)ACETATE",1,NA
"2-(ETHYLAMINO)-1-(4-METHYLPHENYL)-1-PENTANONE",1,1
"2-ACETAMIDOPHENOL",1,NA
"2-AMINO-3-HYDROXY-5-BROMOBENZOYLPYRIDINE",1,NA
"2-AMINO-5-CHLOROPYRIDINE",2,1
"2-AMINO-N-ETHYL-1-PHENYLBUTANE",1,NA
"2-AMINOPROPYLINDOLE",1,1
"2-AMINOTHIAZOLINE-4-CARBOXYLIC ACID (ATCA)",2,NA
"2-BROMOHEXANOYLUREA",1,NA
"2-BUTANOL",1,NA
"2-BUTANONE",1,NA
"2-CHLORO-4,5-METHYLENEDIOXYAMPHETAMINE",1,1
"2-CHLORO-4,5-METHYLENEDIOXYMETHYLAMPHETAMINE",1,1
"2-CHLOROBENZALDEHYDE",1,NA
"2-CHLOROBENZALMALONONITRILE",1,NA
"2-DIMENSIONAL SENSING",1,NA
"2-DIMETHYLAMINO-1-(3,4-METHYLENEDIOXYPHENYL)PROPAN-1-ONE",1,1
"2-DPMP",2,NA
"2-ETHYL-5-METHYL-3,3-DIPHENYL-1-PYRROLINE",1,NA
"2-ETHYLAMINO-1-(3,4-METHYLENEDIOXYPHENYL) PROPAN-1-ONE",1,1
"2-ETHYLIDENE-1,5-DIMETHYL-3, 3-DIPHENYLPYRROLIDINE",1,NA
"2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE",1,NA
"2-ETHYLIDINE-1",1,NA
"2-FLUORODESCHLOROKETAMINE",1,NA
"2-FLUOROMETHAMPHETAMINE",1,2
"2-HYDROXY-1-PHENYL-1-PROPANONE",1,1
"2-HYDROXYBENZOYL-PALIPERIDONE",1,NA
"2-HYDROXYBENZOYL-RISPERIDONE",1,NA
"2-MAPB",1,1
"2-METHYL-3-O-TOLYL-4(3H)-QUINAZOLINONE",1,1
"2-METHYLAMINO-1-(3,4- METHYLENEDIOXYPHENYL)BUTAN-1-ONE",1,1
"2-METHYLFENTANYL",1,NA
"2-NBDG",1,NA
"2-OXO-3-HYDROXY-LSD",1,NA
"2-OXO-PCE",1,NA
"2-OXOQUAZEPAM",1,NA
"2-PROPANOL",1,NA
"2-ΜM SILICA GEL",1,NA
"2,2,2-TRICHLOROETHYL CHLOROFORMATE",1,NA
"2,2′-DIPYRIDYL",1,NA
"2,3-ISOMERS",1,1
"2,4-DECADIENAL",1,NA
"2,4-DICHLORO-6-NITROPHENOL",1,NA
"2,4-DICHLOROPHENOL (2,4-DCP)",1,NA
"2,4-DICHLOROPHENOXYACETIC ACID (2,4-D)",1,NA
"2,4-DIMETHYL-3,5-BIS(4'-METHOXYPHENYL) TETRAHYDROFURAN",1,1
"2,4-DINITROPHENOL",1,NA
"2,4-DINITROPHENOL (DNP)",2,NA
"2,4 DINITROTOLUENE (DNT)",4,NA
"2,4,6 TRINITROTOLUENE (TNT)",11,NA
"2,5-DIMETHOXY-4-BROMAMPHETAMINE (DOB)",1,NA
"2,5-DIMETHOXY-4-BROMOAMPHETAMINE",2,1
"2,5-DIMETHOXY-4-ETHYLTHIO-Β-PHENETHYLAMINE",1,NA
"2,5-DIMETHOXY-4-METHYLAMPHETAMINE",1,1
"2,5-DIMETHOXYAMPHETAMINE",1,NA
"2,5-DIMETHOXYAMPHETAMINE (DMA)",1,1
"2,5-DIMETHOXYPHENETHYLAMINE ANALOGUES",1,1
"2,5-PHENETHYLAMINES",1,NA
"2,5,-DIMETHOXY-4-BROMOAMPHETAMINE",1,1
"2,6-DIPN",1,1
"206PB/207PB",1,NA
"226RA",1,NA
"227AC",1,NA
"23 YEARS OF POST-MORTEM INTERVAL",1,NA
"230TH/234U AGE-DATING",1,NA
"231PA",2,NA
"233PA",1,NA
"233PA SPIKE",1,NA
"233U",1,NA
"234U/230TH",1,NA
"235U/231PA",1,NA
"241AM",3,NA
"241PU",1,NA
"243AM",2,NA
"244PU",1,NA
"25B-NBOME",4,4
"25C-NBOME",2,4
"25H-NBOME 3,4,5-TRIMETHOXYBENZYL ANALOG",1,NA
"25I-NBOH",5,5
"25I-NBOM.E.",1,NA
"25I-NBOME",5,7
"25X-NBOME",1,2
"28S",1,NA
"2C",1,2
"2C-B",12,7
"2C-C",1,4
"2C-I",5,7
"2C-I NBOM.E.",1,NA
"2C-N-NBOME",1,NA
"2C-P",1,NA
"2C-T-2",2,4
"2C-T-7",2,5
"2CB-AMINONITRILE (2C-B-AN)",1,NA
"2D-GC",1,NA
"2D CHROMATOGRAPHY",1,1
"2D7 ANTIBODY",1,NA
"2DE",1,NA
"2F-DCK",1,1
"2F-DESCHLOROKETAMINE",1,NA
"2F-MT-45",1,1
"2H3‐LORAZEPAM",1,NA
"2H5-SECOBARBITAL",1,1
"2ND DERIVATIVE",1,1
"3",1,1
"3-(2-PYRIDYL)-5,6-DIPHENYL-1,2,4-TRIAZINE",1,NA
"3-(2-PYRIDYL)-5,6-DIPHENYL-1,2,4-TRIAZINE (PDT)",2,NA
"3-CHLORO-L-TYROSINE",1,NA
"3-CMC",1,NA
"3-D STRUCTURE",1,NA
"3-DIMENSIONAL (3D) PRINTING",1,NA
"3-DIPHENYLPYRROLIDINE (EDDP)",1,NA
"3-FLUOROMETHCATHINONE",1,NA
"3-FLUOROPHENMETRAZINE",1,NA
"3-FPM",2,NA
"3-GALACTOSE",1,NA
"3-HO-PCP",1,NA
"3-HYDROXY-2-OXOQUAZEPAM",1,NA
"3-HYDROXYBROMAZEPAM",1,NA
"3-HYDROXYFLUNITRAZEPAM",1,NA
"3-IT",1,1
"3-MEO-PCE",1,1
"3-MEO-PCP",3,1
"3-METHOXYPHENCYCLIDINE",1,2
"3-METHOXYTYRAMINE",1,NA
"3-METHYL-4-NITROPHENOL",1,NA
"3-METHYL PENTANOIC ACID",1,NA
"3-METHYLCROTONYLFENTANYL",1,NA
"3-METHYLEPHEDRINE",1,NA
"3-METHYLFENTANYL",7,2
"3-METHYLFENTANYL ANALOG",1,1
"3-METHYLMETHCATHINONE",3,2
"3-METHYLNOREPHEDRINE",1,NA
"3-METHYLPHOSPHONICOACETIC ACID (MPPA)",1,NA
"3-MMC",2,1
"3-PHENOXYBENZOIC ACID",1,NA
"3 MEO-PCP",1,NA
"3, 4-METHYLENEDIOXY-N-METHYLCATHINONE",1,NA
"3,3,6,6,9,9-HEXAMETHYL-1,2,4,5,7,8-HEXOXONANE",2,NA
"3,4- DICHLORO-N-(2-(DIMETHYLAMINO)CYCLOHEXYL)-N-METHYLBENZAMIDE",1,NA
"3,4- METHYLENEDIOXYAMPHETAMINE",1,NA
"3,4-(METHYLENEDIOXY)AMPHETAMINE (MDA)",1,NA
"3,4-(METHYLENEDIOXY)METHAMPHETAMINE (MDMA)",1,NA
"3,4-DIMETHYLMETHCATHINONE",2,NA
"3,4-DIMETHYLMETHCATHINONE (3,4-DMMC)",2,NA
"3,4-MDMA",1,1
"3,4-MDP-2-P",1,1
"3,4-MDPHP",1,1
"3,4-METHYIENEDIOXYMETHAMPHETAMINE",2,2
"3,4-METHYLENEDIOXY-ALPHA-PHP",1,NA
"3,4-METHYLENEDIOXY-N- ISOPROPYLAMPHETAMINE (MDIP)",1,NA
"3,4-METHYLENEDIOXY-N-BENZYLAMPHETAMINE (MDBZ)",1,NA
"3,4-METHYLENEDIOXY-N-CYCLOPROPYLMETHYLAMPHETAMINE (MDCPM)",1,NA
"3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDEA)",5,5
"3,4-METHYLENEDIOXY-N-METHYLAMPHETAMINE (MDMA)",2,3
"3,4-METHYLENEDIOXY-N,N-DIMETHYL-AMPHETAMINE",1,NA
"3,4-METHYLENEDIOXY-U-47700",1,NA
"3,4-METHYLENEDIOXYAMPHETAMINE (MDA)",26,16
"3,4-METHYLENEDIOXYAMPHETAMINES (MDAS)",1,NA
"3,4-METHYLENEDIOXYETHYLAMPHETAMINE",2,NA
"3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA)",161,194
"3,4-METHYLENEDIOXYPHENYLACETONE",1,1
"3,4-METHYLENEDIOXYPYROVALERONE",2,NA
"3,4-METHYLENEDIOXYPYROVALERONE (MDPV)",1,1
"3,4,5-TRIMETHOXYAMPHETAMINE",1,NA
"3,5-DIMETHOXYPHENOL",2,NA
"3,5-DIMETHOXYPHENOL, AS A MARKER FOR TAXUS INGESTION",1,NA
"3,6-DIACETYLMORPHINE",2,2
"3,7- DINITROSO-1,3,5,7-TETRAAZABICYCLO[3.3.1]-NONANE",1,NA
"31P MRS",1,NA
"32P- PRELABEL",1,NA
"39 DRUGS",1,NA
"3D-DRAWING-PEN",1,NA
"3D-MORSE DESCRIPTORS",1,1
"3D MODELS",1,NA
"3D MOMENTS",1,NA
"3D ORGANS",1,NA
"3D PRINTING",5,2
"3D PRINTING FILAMENT",1,NA
"3D SCANNING",1,NA
"4'-CHLORODIAZEPAM",1,NA
"4- (4-METHOXYBENZYL)PYRIMIDINE",1,1
"4- CARBETHOXYHEXAFLUOROBUTYRYL",1,NA
"4- CARBETHOXYHEXAFLUOROBUTYRYL DERIVATIVE",1,NA
"4-(4-METHYLTHIOBENZYL)PYRIMIDINE",1,1
"4-(METHOXYPHENYL)(1-PENTYL-1H-INDOL-3-YL)METHANONE",1,1
"4-ACETAMIDOPHENOL",1,NA
"4-ACO-DMT",1,NA
"4-AMINOANTIPYRINE",1,NA
"4-ANILINOPIPERIDINE-T-BOC",1,1
"4-ANPP",2,NA
"4-BENZYLPYRIMIDINE",1,1
"4-BMC",1,NA
"4-BROMO-2,5-DIMETHOXYAMPHETAMINE",1,NA
"4-BROMO-2,5-DIMETHOXYAMPHETAMINE (DOB)",1,1
"4-BROMOMETHCATHINONE",1,1
"4-CHLOROMETHCATHINONE",2,1
"4-CHLOROTESTOSTERONE",1,NA
"4-CMC",2,NA
"4-DIMETHYLPHENYL-N-METHYL-FORMAMIDINE",1,NA
"4-EPITETRODOTOXIN",1,NA
"4-FLUOROAMPHETAMINE",4,NA
"4-FLUOROCYCLOPROPYLBENZYLFENTANYL",1,NA
"4-FLUOROMETHYLPHENIDATE",1,NA
"4-HO-MET",1,NA
"4-HYDROXY-3- METHOXYMETHAMPHETAMINE",1,NA
"4-HYDROXY-3-METHOXYMETHCATHINONE",1,NA
"4-HYDROXY-3-PHENOXYBENZOIC ACID",1,NA
"4-HYDROXYCYCLOHEXYLMETHYL AB-CHMINACA",1,NA
"4-HYDROXYLATION",1,NA
"4-HYDROXYMETHAMPHETAMINE-O-GLUCURONIDE",1,NA
"4-HYDROXYTRIAZOLAM",1,NA
"4-MEC",2,3
"4-METHOXY-Α-PVP",1,NA
"4-METHOXY PV8",1,NA
"4-METHOXYAMPHETAMINE",2,3
"4-METHOXYMETHAMPHETAMINE",2,2
"4-METHYL-5-(4-METHOXYPHENYL)PYRIMIDIN E",1,1
"4-METHYL-5-(4-METHYLTHIOPHENYL )PYRIMIDINE",1,1
"4-METHYL-5-PHENYLPYRIMIDINE",1,1
"4-METHYL GAMMA-HYDROXYBUTYRATE",1,1
"4-METHYL METHCATHINONE",1,NA
"4-METHYLAMINOANTIPYRINE",1,NA
"4-METHYLAMPHETAMINE",1,1
"4-METHYLBUPHEDRINE",1,1
"4-METHYLETHCATHINONE",1,NA
"4-METHYLHEXANE-2-AMINE",1,NA
"4-METHYLIMIDAZOLE",1,NA
"4-METHYLMETHCATHINONE",4,4
"4-METHYLPENTEDRONE",1,1
"4-METHYLPENTEDRONE (4-MPD)",1,NA
"4-METHYLTHIOAMPHETAMINE (4-MTA)",1,4
"4-METHYLTHIOPHENYLISOPROPYLAMINE",1,1
"4-OH-MET",1,NA
"4-PMP",1,NA
"4-S110T",1,NA
"4,4'-DMAR",1,1
"4,4′-DIMETHYLAMINOREX",1,NA
"4,9-ANHYDROTETRODOTOXIN",1,NA
"42-YEAR FOLLOW-UP",1,NA
"454 PYROSEQUENCING",1,NA
"497",1,NA
"4977 BP DELETION",1,NA
"4F-MDMB-BINACA",2,NA
"4F-MDMB-BUTINACA",1,NA
"4F-PBP",1,1
"4F-Α-PVP",1,NA
"4Π LIQUID SCINTILLATION-Γ COINCIDENCE COUNTING",1,NA
"4ΠΑ LIQUID SCINTILLATION",1,NA
"5-(2-AMINOPROPYL)INDOLE",1,1
"5-(4-NITROPHENYL)-2,4-PENTADIEN-1-AL (NPPD)",1,NA
"5-APB",3,NA
"5-DBFPV",1,1
"5-EAPB",1,NA
"5-FLUORO-AB-PINACA",1,3
"5-FLUORO-ADB",2,NA
"5-HT 2 A RECEPTOR AGONIST",1,1
"5-HT2A AND 5-HT2C RECEPTORS",1,NA
"5-HT2A RECEPTOR",1,3
"5-HT2A RECEPTOR AGONIST",1,NA
"5-HYDROXYINDOLEACETIC ACID",1,NA
"5-HYDROXYTRYPTOPHOL",2,NA
"5-HYDROXYTRYPTOPHOL GLUCURONIDE",1,NA
"5-IAI",1,1
"5-IODO-2-AMINOINDAN (5-IAI)",1,NA
"5-IT",2,2
"5-MAPB",2,NA
"5-MEO-DALT",2,NA
"5-MEO-DIPT",5,1
"5-MEO-IPT",1,NA
"5-MEO-MIPT",2,NA
"5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MEO-AMT)",1,NA
"5-METHOXY-N",1,1
"5-METHOXY-N,N-DI-N-PROPYLTRYPTAMINE",1,NA
"5-METHOXY-N,N-DIALKYLTRYPTAMINE",1,NA
"5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE",4,2
"5-METHOXYNINHYDRIN",1,NA
"5-METHYLTHIONINHYDRIN",4,NA
"5-MTN-L-ALANINE",1,NA
"5-OH-DIPT",1,NA
"5-PPDI",2,1
"5,6,11- TRIDEOXYTETRODOTOXIN",1,NA
"5DIMETHYL-3",1,NA
"5F-ADB",3,1
"5F-ADB-PINACA",1,NA
"5F-ADB AND ITS METHYL ESTER HYDROLYSIS METABOLITE",1,NA
"5F-AKB-48",1,1
"5F-AMB",1,1
"5F-AMB-PINACA/5F-AB-PINACA/5F-ADB",1,NA
"5F-APP-PICA",1,NA
"5F-CUMYL-P7AICA",1,1
"5F-CUMYL-PEGACLONE",1,1
"5F-CUMYL-PICA",1,NA
"5F-EMB-PINACA",1,NA
"5F-MDMB-PICA",2,NA
"5F-MDMB-PINACA",1,NA
"5F-PB-22",1,1
"5F-QUPIC",1,2
"5F-UR-144",1,1
"6- ACETYLMORPHINE",1,NA
"6-ACETYL-MORPHINE",1,NA
"6-ACETYLMORPHINE",10,1
"6-ACETYLMORPHINE (6-AM)",1,NA
"6-AM",1,NA
"6-AM SCREENING IN DUID",1,NA
"6-AM SCREENING IN WDT",1,NA
"6-HYDROXYBENTAZONE",1,NA
"6-MAM",1,NA
"6-MONACETYLOMORPHINE",1,NA
"6-MONOACETHYLMORPHINE",1,NA
"6-MONOACETYL MORPHINE",2,NA
"6-MONOACETYLMORPHINE",7,3
"6-单乙酰吗啡",1,NA
"6,7-DIHYDROXYNOSCAPINE",1,NA
"63NI IONIZATION",1,NA
"6AM",1,NA
"6Α-OXYCODOL",1,NA
"6Β-OXYCODOL",1,NA
"7-[125I]IODOCLONAZEPAM (PURIFICATION)",1,NA
"7-AMINOCLONAZEPAM",3,NA
"7-AMINOFLUNITRAZEPAM",5,NA
"7-AMINOFLUNITRAZEPAM (7-AMINOFM2)",1,NA
"7-AMINONIMETAZEPAM",1,NA
"7-AMINONITRAZEPAM",2,NA
"7-AZAINDOLESYNTHETIC CANNABINOIDSURINARY EXCRETION PATTERN",1,NA
"7-HYDROPEROXYCHOLESTEROL",1,NA
"7-HYDROXYMITRAGYNINE",3,4
"7-HYDROXYQUETIAPINE",1,NA
"7 AMINO FLUNITRAZEPAM",1,NA
"7,7,8,8-TETRACYANOQUINODIMETHANE",1,NA
"7.5% CO2",1,NA
"7’N-5F-ADB",1,NA
"72-KDA HEAT SHOCK PROTEIN",1,NA
"7BE",1,NA
"8-AMINOPYRENE-1,3,6-TRISULFONIC ACID",1,NA
"8-HYDROXY-ISO-HEXAHYDROCANNABINOL",1,NA
"8-HYDROXYBENTAZONE",1,NA
"8-HYDROXYCANNABINOL",1,NA
"8-OHDG",1,NA
"86RB METHOD",1,NA
"87SR/86SR",1,NA
"87SR/86SR RATIOS",1,NA
"9-CARBOXY-THC",1,NA
"9,10-DIHYDRO-LSD",1,1
"9,10-DIPHENYLANTHRACENE",1,NA
"90 SR",1,NA
"90SR",1,NA
"96-WELL FILTRATION PLATES",1,NA
"96-WELL ΜELUTION PLATE SOLID-PHASE EXTRACTION",1,NA
"96-WELL ΜELUTION SOLID-PHASE EXTRACTION PLATE",1,NA
"9Α- HYDROXYHEXAHYDROCANNABINOL",1,NA
"A-834,735",1,1
"A-834735",1,1
"A-836,339",1,1
"A NEW MIX DRUG SUBSTANCE",1,NA
"A SECTION ON DRUGS AND ALCOHOL IS ESSENTIAL",1,NA
"A SINGLE DOSE",1,NA
"A2",1,NA
"AAS",1,3
"AASS",1,NA
"AATF RNOME",1,NA
"AB- GLUCURONIDASE",1,NA
"AB-CHMINACA",3,4
"AB-CHMINACA METABOLITES",1,NA
"AB-FUBINACA",7,2
"AB-FUBINACA 2-FLUOROBENZYL ISOMER",1,NA
"AB-PINACA",2,NA
"AB INITIO CALCULATION",1,4
"ABACARD® HEMATRACE®",1,NA
"ABACAVIR",1,NA
"ABBREVIATED INJURY SCALE",2,NA
"ABCB1",6,NA
"ABDOMINAL X-RAY",1,NA
"ABERRANT DRUG-RELATED BEHAVIORS",1,NA
"ABERRANT DRUG RELATED BEHAVIORS",1,NA
"ABILITY",1,1
"ABILITY TO STAND TRIAL",1,NA
"ABNORMAL BEHAVIOR",1,NA
"ABNORMAL BODY POSITIONS",1,NA
"ABNORMALITIES OF NAILS",1,NA
"ABO",3,NA
"ABO BLOOD GROUP",1,NA
"ABO BLOOD GROUPING",1,NA
"ABO GENOTYPE",1,NA
"ABOLITION OF PRIVILEGING § 217 GERMAN CRIMINAL CODE",1,NA
"ABORIGINAL",1,NA
"ABORTION",2,NA
"ABS",1,NA
"ABSCONDING",2,NA
"ABSINTHE",1,1
"ABSOLUTE BIOAVAILABILITY/I.M",1,NA
"ABSOLUTE DISCHARGE",1,NA
"ABSORBANCE DERIVATE",1,NA
"ABSORPTION",2,NA
"ABSORPTION DIFFERENCE",1,NA
"ABSORPTION DURING CARDIOPULMONARY RESUSCITATION",2,NA
"ABSORPTION RATE",1,NA
"ABSORPTION/EMISSION SPECTROMETRY",1,1
"ABSTENTION",1,NA
"ABSTINENCE",2,NA
"ABSTINENCE CONTROL",9,NA
"ABSTINENCE MONITORING",3,NA
"ABSTINENCE TEST",1,NA
"ABSTINENCE TESTING",2,NA
"ABSTINENCE THERAPY",1,NA
"ABUNDANCE OF PRODUCT IONS",2,NA
"ABUSE",24,22
"ABUSE AND DEPENDENCE",1,NA
"ABUSE AND TOXIC COMPOUNDS",1,NA
"ABUSE DRUGS",6,NA
"ABUSE DRUGS ANALYSES",1,NA
"ABUSE EXCUSE",1,NA
"ABUSE LIABILITY",1,1
"ABUSE OF DRUGS",1,NA
"ABUSE OF THE DRUG",1,NA
"ABUSE, MORPHINE",1,NA
"ABUSED-DRUG TESTING",1,NA
"ABUSED DRUG",14,8
"ABUSED PHARMACEUTICALS",1,NA
"ABUSED PRESCRIPTION DRUG",1,NA
"ABUSED SUBSTANCES",1,NA
"ABUSED THINNER",1,NA
"ABUSER",1,NA
"ABUSERS",1,NA
"ACADEMIA",2,1
"ACADEMIC LIBRARIES",1,NA
"ACCELERANTS",4,1
"ACCELERATED AGING",1,NA
"ACCELERATED SOLVENT EXTRACTION",2,3
"ACCEPTANCE CRITERIA",1,1
"ACCESSORY SPLEEN",1,NA
"ACCI ENTAL DEATH",1,NA
"ACCIDENT",29,1
"ACCIDENT DEATHS",1,NA
"ACCIDENT DU TRAVAIL",1,NA
"ACCIDENT INVESTIGATION",1,NA
"ACCIDENT RISK",1,NA
"ACCIDENT STATISTIC IN MALAYSIA",1,NA
"ACCIDENTAL",5,NA
"ACCIDENTAL AUTOEROTIC DEATH",1,NA
"ACCIDENTAL CONTAMINATION",1,NA
"ACCIDENTAL DEATH",5,NA
"ACCIDENTAL DEATHS",3,NA
"ACCIDENTAL DOSIMETRY",1,NA
"ACCIDENTAL DRUG ADMINISTRATION",1,NA
"ACCIDENTAL INGESTION",2,NA
"ACCIDENTAL POISONING",1,NA
"ACCIDENTAL POISONINGS",1,NA
"ACCOUNTABILITY",2,NA
"ACCREDITATION",6,2
"ACCUMULATED DEGREE HOURS",1,NA
"ACCUMULATED DEGREE HOURS (ADH)",1,NA
"ACCUMULATION",2,NA
"ACCURACY",5,NA
"ACCURACY OF ANALYTICAL STEPS",1,NA
"ACCURACY PROFILE",1,1
"ACCURATE MASS",3,5
"ACCURATE MASS DATABASE",1,1
"ACCURATE MASS MASS SPECTROMETRY",1,1
"ACCURATE MASS SPECTRA LIBRARY",1,NA
"ACCURATE QUANTITATION",1,NA
"ACCUSED",1,NA
"ACCUTOF®",1,NA
"ACE INHIBITOR",1,NA
"ACE STUDY",1,NA
"ACEBUTOLOL",2,NA
"ACECLOFENAC",1,1
"ACEI INDUCED ANGIOEDEMA",1,NA
"ACEPHATE",3,NA
"ACEPROMAZINE",2,1
"ACETALDEHYDE",4,NA
"ACETALDEHYDE DEHYDROGENASE",1,NA
"ACETAMINOPHEN-INDUCED HEPATOTOXICITY",1,NA
"ACETAMINOPHEN-PROTEIN ADDUCTS",1,NA
"ACETAMINOPHEN—DIFFERENTIAL PULSE VOLTAMMETRIC ANALYSIS IN PLASMA",1,NA
"ACETAMINOPHEN (PARACETAMOL)",16,23
"ACETAMINOPHEN OVERDOSE",1,NA
"ACETANILIDE",1,1
"ACETATE",1,NA
"ACETATE SALT",1,NA
"ACETIC ACID DERIVATIVE",2,1
"ACETONE",3,2
"ACETONE CYANOHYDRIN",1,NA
"ACETONE PRECIPITATION",1,NA
"ACETYL FENTANYL",8,NA
"ACETYLATION",5,6
"ACETYLCHOLINE",3,NA
"ACETYLCHOLINE ESTERASE",1,NA
"ACETYLCHOLINE RECEPTORS",1,NA
"ACETYLCHOLINESTERASE",3,NA
"ACETYLCODEINE",2,2
"ACETYLFENTANYL",3,NA
"ACETYLMORPHINE",1,NA
"ACETYLSALICYLIC ACID",4,4
"ACHIRAL ANALYSIS METHODS",1,NA
"ACID",1,NA
"ACID-BASE INDICATOR",1,NA
"ACID-BASE INDICATOR (PH INDICATOR)",1,NA
"ACID-CATALYZED CYCLIZATION",1,NA
"ACID-FAST STAIN",1,NA
"ACID ALTERATION",1,NA
"ACID BLACK 1",1,NA
"ACID DIGESTION",1,NA
"ACID HYDROLYSIS",2,NA
"ACID INGESTION, EMERGENCY CARE",1,NA
"ACID INJURY",1,NA
"ACID PHOSPHATASE",2,NA
"ACID POISONING",1,NA
"ACID SOLUTION",1,NA
"ACID YELLOW 7",1,NA
"ACIDIC",1,NA
"ACIDIC AND BASIC DRUGS",1,NA
"ACIDIC AND NEUTRAL DRUGS",1,NA
"ACIDIC DRUGS",2,1
"ACIDIC EXTRACTION",1,NA
"ACIDIC HYDROLYSIS",1,NA
"ACIDIC POTASSIUM PERMANGANATE",1,4
"ACIDIFICATION",1,NA
"ACIDIFIED GOLD(III) CHLORIDE",1,1
"ACIDOSIS",2,NA
"ACIDS",1,1
"ACINETOBACTER",1,NA
"ACITVATING DRUGS",1,NA
"ACIVICIN",1,NA
"ACKEE",1,NA
"ACONITE",1,NA
"ACONITE POISONING",2,NA
"ACONITE ROOTS",3,NA
"ACONITE TINCTURE",1,NA
"ACONITINE",10,1
"ACONITINE ALKALOIDS",1,NA
"ACONITINE AND AMANITIN",1,NA
"ACONITINE POISONING",1,NA
"ACONITUM",2,NA
"ACONITUM ALKALOIDS",8,NA
"ACORUS CALAMUS",1,NA
"ACP",1,NA
"ACQUAINTANCE RAPE",1,NA
"ACQUIRED ANGIOEDEMA",1,NA
"ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)",1,NA
"ACQUIRED MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY",1,NA
"ACQUISITIVE CRIME",1,NA
"ACQUISITORY CRIME",1,NA
"ACRE",1,1
"ACROMIOCLAVICULAR FIXATION/SURGERY",1,NA
"ACRYLAMIDE",1,NA
"ACRYLFENTANYL",2,2
"ACRYLONITRILE-BUTADIENE-STYRENE",1,NA
"ACRYLONITRILE BUTADIENE STYRENE (ABS)",1,NA
"ACRYLOYLFENTANYL (ACRYLFENTANYL)",2,2
"ACT",1,NA
"ACT OF AGGRESSION",1,NA
"ACTBP2",1,NA
"ACTING OUT",1,NA
"ACTING PATTERN",1,NA
"ACTINIDE ANALYSIS",1,NA
"ACTINIDE DECAY SERIES",1,NA
"ACTINIUM",1,NA
"ACTIVATED CHARCOAL",1,NA
"ACTIVATED CHARCOAL HEMOPERFUSION",1,NA
"ACTIVATED CHARCOAL STRIP (ACS)",1,NA
"ACTIVE CARBON CARTRIDGE",1,NA
"ACTIVE COMPONENT",1,1
"ACTIVE METABOLITES OF FLUNITRAZEPAM",1,NA
"ACTIVE PHARMACEUTICAL INGREDIENT (API)",1,9
"ACTIVE WOUND DRESSINGS",1,NA
"ACTIVITY",1,2
"ACTIVITY-BASED",1,NA
"ACTIVITY CONCENTRATION",1,NA
"ACTIVITY LEVEL EVALUATION",1,NA
"ACTS",1,NA
"ACTUAL/RECENT DRUG ADMINISTRATION",1,NA
"ACUTE",1,NA
"ACUTE ABDOMINAL",1,NA
"ACUTE ABDOMINAL PAIN",1,NA
"ACUTE ADULT WARDS",1,NA
"ACUTE ALCOHOL-INDUCED DEATHS",1,NA
"ACUTE ALCOHOL INTAKE",1,NA
"ACUTE ALCOHOL POISONING",1,NA
"ACUTE AND CHRONIC WOUNDS",1,NA
"ACUTE BEHAVIOURAL DISTURBANCE",1,NA
"ACUTE CARBON MONOXIDE",1,NA
"ACUTE CO FATAL POISONING",1,NA
"ACUTE CORONARY SYNDROME",1,NA
"ACUTE CORONARY SYNDROMES",1,NA
"ACUTE CORONARY THROMBOSIS",1,NA
"ACUTE DEATH",1,NA
"ACUTE DELIRIUM",1,NA
"ACUTE DISTURBANCE",1,NA
"ACUTE DRUG POISONING",1,NA
"ACUTE ESOPHAGEAL NECROSIS",1,NA
"ACUTE ETHANOL TOXICITY",1,NA
"ACUTE EXPOSURES",1,NA
"ACUTE FATAL COMPLICATIONS DIABETES",1,NA
"ACUTE HEROIN FATALITIES",1,NA
"ACUTE INFECTIVE ENDOCARDITIS",1,NA
"ACUTE INTOXICATION",14,NA
"ACUTE INTOXICATIONS",1,NA
"ACUTE IRON TOXICITY",1,NA
"ACUTE ISCHEMIC STROKE",1,NA
"ACUTE KIDNEY INJURY",1,NA
"ACUTE LIVER FAILURE",1,NA
"ACUTE LUNG INJURY",1,NA
"ACUTE METHADONE TOXICITY",1,NA
"ACUTE MYOCARDIAL INFARCTION",2,NA
"ACUTE MYOCARDITIS",1,NA
"ACUTE OESOPHAGEAL NECROSIS",1,NA
"ACUTE ORGANIC PSYCHOSIS",1,NA
"ACUTE PAIN",1,1
"ACUTE POISONING",13,NA
"ACUTE PROMYELOCYTIC LEUKEMIA",1,NA
"ACUTE PSYCHIATRY",1,NA
"ACUTE PSYCHOSIS",1,NA
"ACUTE PULMONARY EDEMA",1,NA
"ACUTE REJECTION",1,NA
"ACUTE RENAL FAILURE",2,NA
"ACUTE SEVERE OR FATAL VIOLENCE",1,NA
"ACUTE SEXUAL ASSAULT",1,NA
"ACUTE STRESS DISORDER",1,NA
"ACUTE STRESS DISORDER (ASD)",1,NA
"ACUTE TOXIC HAEMORRHAGIC NEUROPATHY",1,NA
"ACUTE TOXICITY",4,1
"ACUTE TUBULAR NECROSIS",1,NA
"ACUTE TUBULO-NEPHROPATHY",1,NA
"ACUTE/CHRONIC INTOXICATION",1,NA
"ACYLATION",1,3
"ACYLCARNITINE",1,NA
"AD/HD",1,NA
"ADA",1,NA
"ADAMTS1",1,NA
"ADAMTS15",1,NA
"ADAMTS4",1,NA
"ADAMTS5",1,NA
"ADAMTS8",1,NA
"ADAMTS9",1,NA
"ADANA",1,NA
"ADAPTATION TO COLD",1,NA
"ADAPTION",1,NA
"ADAPTIVE SAMPLING",1,NA
"ADAPTIVE TREATMENT",1,NA
"ADB-CHMINACA",1,NA
"ADB-FUBINACA",2,NA
"ADD",1,NA
"ADDERALL",1,NA
"ADDICT",1,NA
"ADDICTED CRIMINAL OFFENDERS",1,NA
"ADDICTED OFFENDERS",2,NA
"ADDICTION",73,30
"ADDICTION HISTORY",1,NA
"ADDICTION OF ILLEGAL DRUGS",1,NA
"ADDICTION PATTERNS",2,NA
"ADDICTION SYNDROME",1,NA
"ADDICTION TO OPIATES",1,NA
"ADDICTION TREATMENT",4,NA
"ADDICTION TREATMENT ORDER",1,NA
"ADDICTION TREATMENTS",1,NA
"ADDICTIONS",2,NA
"ADDICTIVE BEHAVIOR",1,2
"ADDICTIVE DRUG",1,1
"ADDICTIVE DRUGS",1,NA
"ADDICTIVE POTENTIAL",1,NA
"ADDICTOVIGILANCE",1,3
"ADDICTS",1,NA
"ADDISON",1,NA
"ADDITIVE",1,3
"ADDITIVE EFFECT, DEXTROPROPOXYPHENE AND ALCOHOL",1,NA
"ADDITIVE MANUFACTURING",1,NA
"ADDITIVE MANUFACTURING (AM)",1,NA
"ADDITIVE MANUFACTURING PRINTING TECHNOLOGY",1,NA
"ADDUCT FORMATION",2,5
"ADDUCT FRAGMENTATION",1,2
"ADDUCT METABOLITES",1,NA
"ADDUCT QUANTIFICATION",1,NA
"ADENOSINE TRIPHOSPHATE (ATP)",1,NA
"ADH/REA METHOD",1,NA
"ADH1B",1,NA
"ADH1C",1,NA
"ADHD",8,NA
"ADHD CRIMINALITY",1,NA
"ADHERENCE",3,NA
"ADHERENCE THERAPY",1,NA
"ADHESION MOLECULE",1,NA
"ADHESION MOLECULES",1,NA
"ADHESIVE FOIL",1,NA
"ADHESIVE LIFTERS",1,1
"ADHESIVE TAPE",1,NA
"ADIPOCERE",11,NA
"ADIPOSE TISSUE",5,NA
"ADJACENCY MATRIX",1,1
"ADJUSTMENT",1,NA
"ADJUSTMENT DISORDER",1,NA
"ADJUSTMENT DISORDERS",1,NA
"ADME",1,1
"ADMINISTRATION",2,NA
"ADMINISTRATION STUDY",1,NA
"ADMINISTRATION WAY",1,NA
"ADMISSIBILITY",2,1
"ADMISSION FORM",1,NA
"ADMISSION OF EVIDENCE",1,NA
"ADNA",1,NA
"ADOLESCENT",64,13
"ADOLESCENT DEATHS",1,NA
"ADOLESCENT DEVELOPMENT",1,NA
"ADOLESCENT HEALTH",1,1
"ADOLESCENT MENTAL HEALTH",1,NA
"ADOLESCENT PROSTITUTES",1,NA
"ADOLESCENT SUBSTANCE ABUSE",1,NA
"ADOLESCENT SUICIDE",1,1
"ADRA2A",1,NA
"ADRAFINIL",4,NA
"ADRENAL GLAND",1,NA
"ADRENAL INSUFFICIENCY",1,NA
"ADRENALINE FOR AUTO-INJECTION",1,NA
"ADSORPTION",4,5
"ADSORPTION AN AXD",1,NA
"ADSORPTION ON XAD.",1,NA
"ADSORPTION TUBES",1,NA
"ADSORPTION, IN VITRO—PHENOBARBITAL ONTO ACTIVATED CHARCOAL, DESORPTION, BINDING",1,NA
"ADSORPTIONSVERFAHREN, BIOLOGISCHES MATERIAL",1,NA
"ADSORPTIVE MICRO-EXTRACTION (AΜE)",1,NA
"ADSORPTIVE STRIPPING VOLTAMMETRY",1,6
"ADULT",7,NA
"ADULT-ONSET",1,NA
"ADULT AGING",1,NA
"ADULT CRIME",1,NA
"ADULT INTENSIVE CARE",1,NA
"ADULT MENTAL HEALTH-CARE",1,NA
"ADULT OFFENDERS",2,NA
"ADULT PSYCHIATRY",1,NA
"ADULT SUDDEN DEATH",1,NA
"ADULT VEHICULAR HYPERTHERMIA",1,NA
"ADULTERA",2,NA
"ADULTERANT",46,56
"ADULTERANT ANALYSIS",1,1
"ADULTERANT IDENTIFICATION",1,NA
"ADULTERANTS IN SLIMMING PRODUCTS",1,NA
"ADULTERATED CAPSULE SHELL",1,1
"ADULTERATED COCAINE",1,1
"ADULTERATED COMMERCIAL BEVERAGE",1,1
"ADULTERATION",21,38
"ADULTERATIONS",1,NA
"ADULTERY",1,NA
"ADVANCED DECOMPOSITION",1,NA
"ADVANCES IN MASS SPECTROMETRY",1,NA
"ADVANTAGES AND DISADVANTAGES OF DRIED SPECIMENS",1,NA
"ADVANTAGES SHOWN NOT ONLY FOR DRUG ANALYSIS IN FORENSIC AND TOXICOLOGICAL LABS",1,NA
"ADVERSE ANALYTICAL FINDING",1,NA
"ADVERSE CHILDHOOD EXPERIENCES",1,NA
"ADVERSE DRUG EFFECTS",1,NA
"ADVERSE DRUG EVENTS",1,NA
"ADVERSE DRUG INTERACTION",1,NA
"ADVERSE DRUG REACTION",10,NA
"ADVERSE DRUG REACTION (ADR)",2,NA
"ADVERSE DRUG REACTIONS",6,1
"ADVERSE EFFECT",1,NA
"ADVERSE EFFECTS",14,5
"ADVERSE EFFECTS.",1,NA
"ADVERSE EVENT (AE)",1,NA
"ADVERSE EVENT ATTRIBUTABILITY",1,NA
"ADVERSE EVENTS",2,1
"ADVERSE REACTION",2,NA
"AERIAL FUMIGATION",1,NA
"AEROMEDICAL EXAMINATION",1,NA
"AEROSOL PAINT",1,NA
"AEROSOL PROPELLANT GAS INHALATION",1,NA
"AEROSPACE MEDICINE",1,NA
"AESTHETIC",1,NA
"AESTHETIC DRUG",1,NA
"AFB1-LYSINE ADDUCT",1,NA
"AFB1-N7-GUANINE ADDUCT",1,NA
"AFFECTIVE-INTERPERSONAL DIMENSION",1,NA
"AFFECTIVE DISORDERS",1,NA
"AFFECTIVE PSYCHOSIS",1,NA
"AFFINITY",1,NA
"AFFIRMATIVE DEFENSE DPD",1,NA
"AFGHAN",1,NA
"AFLATOXIN BIOMARKERS",1,NA
"AFLATOXINS",1,2
"AFLP",1,4
"AFM",1,1
"AFM1",1,NA
"AFRICA",2,1
"AFRICAN AMERICAN",1,NA
"AFRICAN CHERRY",1,NA
"AFTER-DRINK",1,NA
"AGE",7,NA
"AGE-APPROPRIATE",1,NA
"AGE-AT-DEATH",1,NA
"AGE-AT-DEATH ESTIMATION",2,NA
"AGE-DATING",8,NA
"AGE-GROUPS",1,NA
"AGE-RELATED",2,NA
"AGE AT ONSET",1,NA
"AGE DATING",6,NA
"AGE DETERMINATION",1,NA
"AGE DETERMINATION BY SKELETON",1,NA
"AGE ESTIMATION",8,NA
"AGE ESTIMATION FROM TEETH",1,NA
"AGE MEASUREMENT",1,NA
"AGE OF ONSET",2,NA
"AGE PREDICTION",2,NA
"AGE THE LIVING",1,NA
"AGED BONE DNA",1,NA
"AGED EXHUMATION TISSUES",1,NA
"AGEING",6,NA
"AGEING PARAMETERS",1,NA
"AGENCY",1,NA
"AGENT ORANGE",1,NA
"AGENT PEPPER SPRAY",1,NA
"AGGLOMERATIVE HIERARCHICAL CLUSTERING",1,NA
"AGGRECANASES",1,NA
"AGGREGATION",2,2
"AGGREGATION-INDUCED EMISSION",1,3
"AGGRESSION",49,NA
"AGGRESSION QUESTIONNAIRES",1,NA
"AGGRESSIVE",1,NA
"AGGRESSIVE BEHAVIOR",4,NA
"AGGRESSIVE BEHAVIOUR UNDER INFLUENCE OF METAMPHETAMINE",1,NA
"AGGRESSIVENESS",4,NA
"AGGRESSIVITY",1,NA
"AGING AND BALLPOINT INK",1,NA
"AGITATED DELIRIUM",4,NA
"AGITATION",4,NA
"AGLYCONS",1,NA
"AGM1",1,NA
"AGOMELATINE",1,NA
"AGONAL PHASE",1,NA
"AGONAL SITUATION",1,NA
"AGONIST OPIOID TREATMENT",1,NA
"AGONISTS ACTING ON BOTH CB1 AND CB2 RECEPTORS",1,1
"AGRANULOCYTOSIS",1,1
"AGRANULOCYTOSIS/DRUG THERAPY",1,NA
"AGRESSION",1,NA
"AGRESSIVE BEHAVIOUR",1,NA
"AGRICULTURAL BIOSECURITY",1,NA
"AGRICULTURAL CHEMICALS",3,NA
"AGRICULTURE",2,1
"AGROCHEMICALS",1,NA
"AH-7921",4,2
"AI",1,NA
"AID TO IDENTIFICATION IN UNKNOWN CADAVERS AND CADAVER PARTS",1,NA
"AIDS",7,NA
"AIDS DEATHS",1,NA
"AIDS DRUG COCKTAIL",1,1
"AIDS HIV",1,NA
"AIMS",1,NA
"AIR-AGITATED DISPERSIVE LIQUID",1,NA
"AIR EMBOLISM",3,NA
"AIR EXPIRÉ",1,NA
"AIR KERMA",1,NA
"AIR RIFLE",1,NA
"AIR SAMPLING",1,NA
"AIR TRAVEL",1,NA
"AIR WEAPON",2,NA
"AIRBORNE",1,NA
"AIRCRAFT",1,NA
"AIRCRAFT ACCIDENT INVESTIGATION",4,NA
"AIRCRAFT FATALITIES",1,NA
"AIRPORT MALARIA",1,NA
"AIRPORT SECURITY",1,1
"AIRWAY INFECTION",1,NA
"AIRWAY MANAGEMENT",1,NA
"AIRWAY OBSTRUCTION",8,NA
"AIRWAY REMODELING",1,NA
"AIS",1,NA
"AJMALINE",1,NA
"AJULEMIC ACID",1,NA
"AK",1,NA
"AKATHISIA",1,NA
"AKB-48",1,NA
"AKB48",2,1
"AKR7A2",1,NA
"ALABAMA",1,NA
"ALACHLOR",1,NA
"ALANGIUM CHINENSE",1,NA
"ALBERS SCHONBERG DISEASE",1,NA
"ALBERTA",1,NA
"ALBERTA OIL SANDS",2,NA
"ALBIZIA HARVEYI FOURN",1,NA
"ALBUMIN-ADDUCTS",2,NA
"ALCHEMY",1,NA
"ALCOHOL",190,8
"ALCOHOL- AND DRUG-DEPENDENT OFFENDERS",1,NA
"ALCOHOL-DRUG INTERACTIONS",1,NA
"ALCOHOL-RELATED ACCIDENTS",1,NA
"ALCOHOL-RELATED CASES",1,NA
"ALCOHOL-RELATED DEATHS",1,NA
"ALCOHOL-RELATED INJURIES",1,NA
"ALCOHOL-TRANQUILIZER APPLICATION",1,NA
"ALCOHOL ABSTINENCE",1,NA
"ALCOHOL ABSTINENCE MONITORING",1,NA
"ALCOHOL ABUSE",14,2
"ALCOHOL ABUSE ‐ MALE AND FEMALE PATIENTS ‐ MORTALITY ‐ CAUSES OF DEATH",1,NA
"ALCOHOL ABUSE BIOMARKER",1,NA
"ALCOHOL ABUSE BIOMARKERS",1,NA
"ALCOHOL AND DRUG ABUSE",1,NA
"ALCOHOL AND DRUG DEPENDENCY",1,NA
"ALCOHOL AND DRUGS",4,NA
"ALCOHOL AND DRUGS SERVICES",1,NA
"ALCOHOL AND SUBSTANCE MISUSE",1,NA
"ALCOHOL AUDIT",1,NA
"ALCOHOL BIOMARKER",4,NA
"ALCOHOL BIOMARKERS",3,NA
"ALCOHOL CONGENER ANALYSIS",1,NA
"ALCOHOL CONSUMPTION MARKER",1,NA
"ALCOHOL CONSUMPTION MARKERS",1,NA
"ALCOHOL DEHYDROGENASE",3,NA
"ALCOHOL DELINQUENCY",1,NA
"ALCOHOL DETOXIFICATION",1,NA
"ALCOHOL DRINKING",12,2
"ALCOHOL ESTIMATION",1,NA
"ALCOHOL INTOXICATION",8,NA
"ALCOHOL MARKER",8,NA
"ALCOHOL MARKERS",3,NA
"ALCOHOL MARKERS IN HAIR",2,NA
"ALCOHOL METABOLISM",1,NA
"ALCOHOL MISUSE",2,NA
"ALCOHOL OXIDASE",2,NA
"ALCOHOL PREFERENCE",1,NA
"ALCOHOL RESEARCH",2,NA
"ALCOHOL SCREENING",1,NA
"ALCOHOL SENSING",1,NA
"ALCOHOL SWABS",1,NA
"ALCOHOL TECHNICAL DEFENSE",1,NA
"ALCOHOL TEST, POSTMORTEM IN THE TESTICLE",1,NA
"ALCOHOL TESTING",1,NA
"ALCOHOL USE",5,NA
"ALCOHOL WIPES",2,NA
"ALCOHOL/DRUG ABUSE",2,NA
"ALCOHOL/DRUGS ABUSE",1,NA
"ALCOHOLIC",4,NA
"ALCOHOLIC BEVERAGES",5,4
"ALCOHOLIC CIRRHOSIS",1,NA
"ALCOHOLIC DRINK",1,1
"ALCOHOLIC SALIVA",1,NA
"ALCOHOLISM",36,NA
"ALCOHOLOGY",1,NA
"ALCOHOLS/EFFECTS",1,NA
"ALCOPOPS",1,NA
"ALDEHYDE DEHYDROGENASE",1,NA
"ALDEHYDES",2,2
"ALDH5A1",1,NA
"ALDO-KETO REDUCTASE 7A2",1,NA
"ALDRICHINA GRAHAMI",3,NA
"ALFENTANIL",2,1
"ALGEA",1,NA
"ALGORITHM",3,2
"ALGORITHM-BASED PHARMACOTHERAPY",1,NA
"ALIAS DETECTION",1,NA
"ALIGNMENT",1,1
"ALIPHATIC HYDROCARBON",1,NA
"ALIPHATIC HYDROCARBONS",1,NA
"ALIPHATIC PRIMARY AMINE",1,NA
"ALIPHATIC SECONDARY AMINE",1,NA
"ALKALI HALIDE",1,1
"ALKALINE FAST BLUE-B REAGENT",1,NA
"ALKALINE LYSIS",1,NA
"ALKALINE MOBILE PHASE",1,NA
"ALKALINE SOLUBILISATION METHOD",1,NA
"ALKALIS",1,NA
"ALKALOID ANALYSIS",1,1
"ALKALOID STABILITY",1,1
"ALKALOIDS",19,61
"ALKOXY CYANOACRYLATE",1,NA
"ALKYL CYANOACRYLATE",1,NA
"ALKYL NITRITE",1,NA
"ALKYL NITRITES",2,NA
"ALKYLATED PASH",1,NA
"ALKYLATION",4,7
"ALKYLINDOLES",1,1
"ALKYLPHOSPHONIC ACIDS",2,NA
"ALL-IN-ONE DEVICE",1,NA
"ALL-IN-ONE TUBES",1,NA
"ALLEGED DRINKING AFTER DRIVING",1,NA
"ALLEGED FATHER (AF)",1,NA
"ALLEGHENY COUNTY",1,NA
"ALLELE",1,NA
"ALLELE-SPECIFIC PCR",1,NA
"ALLELE FREQUENCY",1,NA
"ALLELE SPECIFIC PCR",1,NA
"ALLELES FREQUENCIES",1,NA
"ALLELIC DIVERSITY",1,NA
"ALLELIC DROPOUT",2,NA
"ALLELIC FREQUENCY",1,NA
"ALLERGENIC ACAROFAUNA",1,NA
"ALLERGIC REACTION",1,NA
"ALLERGIC REACTIONS",2,NA
"ALLERGY",7,NA
"ALLERGY CASE",1,NA
"ALLIANCE",1,NA
"ALLOPURINOL",2,NA
"ALLYLCHLORIDE",1,NA
"ALLYLIC HYDROXYLATION",1,NA
"ALLYLISOPROPYLACETYLUREA",1,NA
"ALOPECIA",1,NA
"ALPHA-2-HS-GLYCOPROTEIN",1,NA
"ALPHA-CHLORALOSE",1,NA
"ALPHA-GAL SYNDROME",1,NA
"ALPHA-GAMMA ANTICOINCIDENCE COUNTING",1,NA
"ALPHA-METHYLSTYRENE",1,1
"ALPHA-METHYLTRYPTAMINE",1,1
"ALPHA-PARTICLE EMISSION PROBABILITIES",1,NA
"ALPHA-PVP",2,1
"ALPHA-PYRROLIDINO-VALEROPHENONE (A-PVP)",1,NA
"ALPHA-PYRROLIDINOISOHEXANOPHENONE",1,NA
"ALPHA CHLORALOSE",1,NA
"ALPHA SPECTROMETRY",4,NA
"ALPHOID REPEATS OF HUMAN Y CHROMOSOME (DYZ3)",1,NA
"ALPRAZOLAM",19,14
"ALPRENOLOL",1,NA
"ALQ3",1,NA
"ALTEPLASE",1,NA
"ALTERANTIVE SPECIMEN",1,NA
"ALTERNATING LEAST SQUARE",1,NA
"ALTERNATIVE BIOLOGICAL MATERIALS",1,NA
"ALTERNATIVE BIOLOGICAL MATRICES",4,1
"ALTERNATIVE BIOSAMPLES",1,NA
"ALTERNATIVE DETECTION",1,NA
"ALTERNATIVE MATERIALS",2,NA
"ALTERNATIVE MATRICES",20,NA
"ALTERNATIVE MATRIX",2,NA
"ALTERNATIVE MEDICINE",2,NA
"ALTERNATIVE SAMPLES",3,NA
"ALTERNATIVE SPECIMEN",3,NA
"ALTERNATIVE SPECIMENS",7,1
"ALTERNATIVE SPLICING",1,1
"ALTERNATIVE TREATMENTS",1,NA
"ALTERNATIVES TO HRT",1,NA
"ALTERNATIVES TO INCARCERATION",1,NA
"ALTERNATIVES TO THE INSANITY DEFENSE",1,NA
"ALU",1,NA
"ALU ELEMENTS",2,NA
"ALUMINA",1,1
"ALUMINIUM PHOSPHIDE",5,NA
"ALUMINIUM PHOSPIDE",1,NA
"ALUMINUM PHOSPHATE",1,NA
"ALUMINUM PHOSPHIDE",2,NA
"ALVEOLAR BONE",1,NA
"ALVEOLAR MACROPHAGES",1,NA
"ALVEOLAR PNEUMONIA",1,NA
"ALZHEIMER'S DISEASE",1,NA
"ALZHEIMER DISEASE",1,NA
"ALZHEIMER TYPE DEMENTIA",1,NA
"ALZHEIMER’S DISEASE",2,NA
"AM-1220",2,2
"AM-1241",1,1
"AM-1248",1,1
"AM-2201",7,1
"AM-2201 BENZIMIDAZOLE ANALOG (FUBIMINA)",1,NA
"AM-2202",1,1
"AM-2233",1,1
"AM-694",3,2
"AM-694 METABOLITES",1,NA
"AM2201",2,NA
"AM679",1,NA
"AMANITA DATURA",1,NA
"AMANITA MUSCARIA",2,2
"AMANITA MUSHROOM POISONING",1,NA
"AMANITA PANTHERINA",2,1
"AMANITIN",1,NA
"AMATORIUM",2,NA
"AMATOXIN",2,2
"AMB-FUBINACA",3,1
"AMBERLITE XAD-2",1,NA
"AMBFUBINACA",1,NA
"AMBIEN",1,NA
"AMBIENT",1,1
"AMBIENT ANALYSIS",1,2
"AMBIENT DESORPTION IONIZATION",1,NA
"AMBIENT IONIZATION",19,15
"AMBIENT IONIZATION MASS SPECTROMETRY",3,1
"AMBIENT IONIZATION MASS SPECTROMETRY, TRACE DETECTION, GAS CHROMATOGRAPHY MASS SPECTROMETRY",1,NA
"AMBIENT MASS SPECTROMETRY",14,7
"AMBIENT MASS SPECTROMETRY/EASI-MS",1,1
"AMBIVALENCE",2,NA
"AMBULATORY",1,NA
"AMBULATORY MONITOR",1,NA
"AMC",1,NA
"AMDIS",1,4
"AMELOGENIN-Y (AMELY)",1,NA
"AMELOGENIN GENE",2,NA
"AMELOGLYPHICS",1,NA
"AMENDMENT",1,NA
"AMERICAN COLLEGE OF SURGEONS COMMITTEE ON TRAUMA",1,NA
"AMETHYSTIC",1,NA
"AMFEPRAMONE",1,1
"AMFETAMINE",1,NA
"AMFETAMINES",1,1
"AMI",1,NA
"AMIDO BLACK",2,NA
"AMINE",2,9
"AMINES, IN BLOOD SAMPLES",1,NA
"AMINO ACID",14,10
"AMINO ACID REAGENT",2,NA
"AMINO ACID REAGENTS",1,NA
"AMINOALKYLINDOLE",1,NA
"AMINOALKYLINDOLES",3,2
"AMINODINITROTOLUENES",1,NA
"AMINOHI PPURATE",1,NA
"AMINOINDANES",1,1
"AMINOMETHYL PHOSPHONIC ACID (AMPA)",1,NA
"AMINOMETHYLPHOSPHONIC ACID (AMPA)",1,NA
"AMINOPHENAZONE",1,NA
"AMINOPROPYLBENZOFURAN",1,NA
"AMINOPYRINE",1,2
"AMINOREX",5,3
"AMIODARONE",1,NA
"AMISULPRIDE",3,NA
"AMITRAZ",2,NA
"AMITRIPTY LINE",1,NA
"AMITRIPTYLINE",32,1
"AMITRIPTYLINE METABOLISM",1,NA
"AMITRIPTYLINE PHARMACOKINETICS",1,NA
"AMLODIPINE",3,NA
"AMMONIA",1,NA
"AMMONIUM ACETATE",1,NA
"AMMONIUM BIFLUORIDE",2,NA
"AMMONIUM NITRATE",1,NA
"AMMUNITION",2,1
"AMNESIA",5,NA
"AMNESIA.",1,NA
"AMNESTY",1,NA
"AMNIOTIC FLUID",2,NA
"AMOBARBITAL",2,NA
"AMOROUS JEALOUSY",1,NA
"AMOSPHERIC PRESSURE MATRIX-ASSISTED LASER DESORPTION/IONIZATION",1,1
"AMOXAPINE",2,NA
"AMPA",1,1
"AMPEROMETRIC DETECTION",1,3
"AMPEROMETRY",1,3
"AMPFℓSTR MINIFILER",1,NA
"AMPFℓSTR® IDENTIFILER PLUS",1,NA
"AMPFℓSTR® SGM PLUS®",1,NA
"AMPHETAMINE-LIKE DESIGNER DRUGS",1,NA
"AMPHETAMINE-LIKE DRUGS",1,1
"AMPHETAMINE-TYPE DRUGS",1,1
"AMPHETAMINE-TYPE STIMULANT",2,NA
"AMPHETAMINE-TYPE SUBSTANCES (ATS)",1,NA
"AMPHETAMINE ABUSE",1,NA
"AMPHETAMINE ADDICTION",1,NA
"AMPHETAMINE ANALOGUE",3,6
"AMPHETAMINE AND DERIVATIVES",250,210
"AMPHETAMINE AND METHAMPHETAMINE",1,1
"AMPHETAMINE DESIGNER DRUGS",1,1
"AMPHETAMINE SYNTHESIS WASTE",1,NA
"AMPHETAMINE TOXICITY",1,NA
"AMPHETAMINE TYPE STIMULANTS",4,3
"AMPHETAMINE, IN BODY MATERIAL",1,NA
"AMPHETAMINE, TOXICOLOGIC ANALYSIS",1,NA
"AMPHETAMINES AND CATHINONES",1,NA
"AMPHETAMINES IN HAIR",1,NA
"AMPHETAMINIC DRUGS",1,NA
"AMPHETAMINIL",1,NA
"AMPICILLIN",1,NA
"AMPLICON BASED BISULFITE SEQUENCING",1,NA
"AMPLICON LENGTH HETEROGENEITY",1,NA
"AMPLIFICATION",2,NA
"AMPLIFICATION FACILITATORS",1,NA
"AMPLIFIED FRAGMENT LENGTH POLYMORPHISM",2,3
"AMR",1,NA
"AMS",2,NA
"AMSTERDAM",1,NA
"AMT",1,2
"AMYGDALA",4,NA
"AMYGDALIN",1,1
"AMYGDALOHIPPOCAMPAL REGION",1,NA
"AMYL NITRITE",1,1
"AMYLOID PRECURSOR PROTEIN",1,NA
"AMYLOIDOSIS",1,NA
"AMYTAL",1,NA
"AN (AMMONIUM NITRATE)",1,NA
"ANABASINE",1,NA
"ANABOLIC-ANDROGENIC STEROIDS",2,1
"ANABOLIC-ANDROGENIC STEROIDS (AAS)",1,NA
"ANABOLIC ANDROGEN STEROIDS",1,NA
"ANABOLIC ANDROGENIC STEROIDS",13,6
"ANABOLIC STEROID ESTERS",1,2
"ANABOLIC STEROIDS",23,27
"ANABOLICS",2,2
"ANAESTHESIA",1,NA
"ANAESTHESIE",1,NA
"ANAESTHESIOLOGY",1,NA
"ANAESTHETIC",1,NA
"ANAESTHETIC DRUGS",1,NA
"ANAESTHETICS",3,1
"ANALGESIA",1,6
"ANALGESIC",7,15
"ANALGESIC ACTIVITY",1,3
"ANALGESIC DRUGS",2,3
"ANALGESICS-OPIOID",1,NA
"ANALGESICS—ACETAMINOPHEN, DIFFERENTIAL PULSE VOLTAMMETRIC ANALYSIS IN PLASMA",1,NA
"ANALGESICS/OPIOID/FENTANYL",1,NA
"ANALGESTICS, FORENSIC TOXICOLOGY",1,NA
"ANALGETIC",1,NA
"ANALOGUE",9,13
"ANALYSES TOXICOLOGIQUES",1,NA
"ANALYSIS",86,41
"ANALYSIS BY A UNIFIED HPLC METHOD",1,NA
"ANALYSIS OF 6-AM FOR CLINICAL AND FORENSIC PURPOSES",1,NA
"ANALYSIS OF ALVEOLAR AIR",1,NA
"ANALYSIS OF DRUGS",1,1
"ANALYSIS OF ETHANOL AND CONGENER ALCOHOLS IN SERUM AND BEVERAGES",1,NA
"ANALYSIS OF MOLECULAR VARIANCE",1,1
"ANALYSIS OF TRENDS",1,NA
"ANALYSIS OF VARIANCE",1,1
"ANALYSIS TOOLS",1,NA
"ANALYSIS, QUANTITATIVE",1,NA
"ANALYTE ENRICHMENT",1,NA
"ANALYTES",1,NA
"ANALYTES IN DRIED MATRIX",1,NA
"ANALYTICAL AND BIOANALYTICAL METHOD FOR NANOTECHNOLOGY",1,NA
"ANALYTICAL BACKDROPS",1,NA
"ANALYTICAL CHEMISTRY",19,16
"ANALYTICAL CHEMISTRY TECHNIQUES",1,NA
"ANALYTICAL CHROMATOGRAPHY",1,NA
"ANALYTICAL DATABASES",1,NA
"ANALYTICAL DETECTION",1,NA
"ANALYTICAL EVALUATION OF ACTIVE SUBSTANCES",1,NA
"ANALYTICAL FIGURES OF MERIT",1,NA
"ANALYTICAL FINDINGS",1,NA
"ANALYTICAL INSTRUMENTATION",2,NA
"ANALYTICAL LABORATORIES",1,NA
"ANALYTICAL METHOD",32,29
"ANALYTICAL METHOD VALIDATION",1,NA
"ANALYTICAL METHODOLOGIES",1,2
"ANALYTICAL PERFORMANCE",1,NA
"ANALYTICAL REAGENT",1,NA
"ANALYTICAL RESULTS",1,NA
"ANALYTICAL SCIENCE",1,NA
"ANALYTICAL SEPARATION TECHNIQUES",1,NA
"ANALYTICAL SEPARATIONS",1,NA
"ANALYTICAL SPECTROSCOPY",1,NA
"ANALYTICAL STRATEGIES",1,NA
"ANALYTICAL THRESHOLD",1,NA
"ANALYTICAL TOXICOLOGY",30,9
"ANALYTICAL VALIDATION",2,1
"ANALYTICS",1,NA
"ANALYTISCHE CHEMIE",1,NA
"ANALYZER",1,NA
"ANANDAMIDE",1,1
"ANAPHYLACTIC DEATH",1,NA
"ANAPHYLACTIC REACTION",1,NA
"ANAPHYLACTIC RESPONSE",1,NA
"ANAPHYLACTIC SHOCK",7,NA
"ANAPHYLAXIS",25,NA
"ANAPHYLAXIS, DIAGNOSIS",1,NA
"ANASTROZOLE",1,NA
"ANCESTRY",2,NA
"ANCESTRY-INFORMATIVE MARKERS (AIMS)",1,NA
"ANCESTRY INFORMATIVE MARKERS",1,NA
"ANCESTRY MARKER",1,NA
"ANCIENT DNA",5,1
"ANCIENT MEDICINE",1,NA
"AND JURISPRUDENCE",1,NA
"ANDROGEN ANABOLIC STEROIDS ANALYSIS",1,NA
"ANDROGEN RECEPTOR",1,NA
"ANDROGENIC-ANABOLIC STEROIDS",2,NA
"ANDROGENIC ANABOLIC STEROIDS (AAS)",1,NA
"ANDROID FORENSICS",1,NA
"ANESTHESIA",5,2
"ANESTHESIA ROBBERY CASE",1,NA
"ANESTHESIOLOGIST",1,NA
"ANESTHESIOLOGY",2,NA
"ANESTHETIC",1,2
"ANESTHETIC ACCIDENT",1,NA
"ANESTHETIC DEATH",1,NA
"ANESTHETIC DRUGS",1,1
"ANESTHETIC TOXICITY",1,NA
"ANESTHETICS",2,1
"ANESTHETISTS",1,1
"ANETHOLE",1,2
"ANEURYSM",3,NA
"ANFIS",1,NA
"ANFO",2,NA
"ANGER",2,NA
"ANGIOEDEMA",4,NA
"ANGIOEDEMA WORKUP IN FORENSIC PATHOLOGY",1,NA
"ANGIOFIL®",1,NA
"ANGIOGENESIS",1,NA
"ANGIOGRAPHY",3,NA
"ANGIONEUROTIC EDEMA",1,NA
"ANGIOSPERM",1,NA
"ANGIOTENSIN-II ANTAGONISTS",1,NA
"ANGIOTENSIN CONVERTING ENZYME INHIBITOR",1,NA
"ANGIOTENSIN II (ANG II)",1,NA
"ANGIOTENSIN II RECEPTOR ANTAGONISTS",1,NA
"ANGLE OF ATTACK",1,NA
"ANGRY AFFECT",1,NA
"ANHYDROECGONINE ETHYL ESTER",1,NA
"ANHYDROECGONINE METHYL ESTER",5,NA
"ANHYDROECGONINE METHYLESTER",1,NA
"ANILERIDINE, GAS CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"ANILINE SULPHATE",1,NA
"ANIMA L MODEL",1,NA
"ANIMAL",2,NA
"ANIMAL ABUSE",1,NA
"ANIMAL BUCCAL SWABS",1,NA
"ANIMAL CONSERVATION",1,NA
"ANIMAL CRUELTY",2,NA
"ANIMAL DEATH",1,NA
"ANIMAL DEPREDATION",1,NA
"ANIMAL ETHOLOGY",1,NA
"ANIMAL EXPERIMENT",2,1
"ANIMAL INTOXICATION",1,NA
"ANIMAL MODEL",11,1
"ANIMAL NEGLECT",1,NA
"ANIMAL POISONING",1,NA
"ANIMAL PREDATION",1,NA
"ANION",1,NA
"ANION ANALYSIS",1,NA
"ANION EXCHANGE CHROMATOGRAPHY",1,NA
"ANION EXCHANGE DISK",1,NA
"ANION IDENTIFICATION",1,1
"ANIONS",2,1
"ANISE OIL",1,2
"ANKARA",2,1
"ANKK1",1,NA
"ANKYRIN REPEAT DOMAIN 1",1,NA
"ANN",1,1
"ANNA KARENINA PRINCIPLE",1,NA
"ANNIVERSARY REACTION",1,NA
"ANNUAL REPORT/ACTIVITY REPORT",1,NA
"ANODIC STRIPPING VOLTAMMETRY",1,NA
"ANOGENITAL INJURIES",3,NA
"ANOGENITAL INJURY",2,NA
"ANOGENITAL WARTS",1,NA
"ANOMALOUS CORONARY ARTERY",1,NA
"ANONYMITY",2,NA
"ANONYMOUS POOLED URINE ANALYSIS",1,NA
"ANORECTIC DRUG",1,NA
"ANORECTICS",1,1
"ANOXIA",2,NA
"ANTACID",1,NA
"ANTE-MORTEM",1,NA
"ANTE-MORTEM BLOOD",1,NA
"ANTECEDENTS OF VIOLENCE",1,NA
"ANTEMORTEM",3,NA
"ANTEMORTEM BLOOD",1,NA
"ANTEMORTEM CONSUMPTION",1,NA
"ANTEMORTEM FACTORS",1,NA
"ANTEMORTEM INTERVAL",1,NA
"ANTEMORTEM SPECIMENS",1,NA
"ANTENNAE TRANSCRIPTOME",1,NA
"ANTERIOR DESCENDING ARTERY",1,NA
"ANTEROGRADE AMNESIA",2,NA
"ANTHRANILIC ACID DERIVATIVES",1,NA
"ANTHRAX",2,1
"ANTHROPOLOGY",2,NA
"ANTHROPOMETRY",2,NA
"ANTI-ANDROGENIC TREATMENT",1,NA
"ANTI-ANDROGENS",2,NA
"ANTI-CANCER DRUGS",1,1
"ANTI-COUNTERFEITING",1,1
"ANTI-DEPRESSANTS",2,NA
"ANTI-DIABETIC",1,1
"ANTI-DIABETICS",1,NA
"ANTI-DOPING",4,3
"ANTI-DOPING ANALYSIS",3,1
"ANTI-EPILEPTIC DRUGS",1,NA
"ANTI-ESTROGENS",1,NA
"ANTI-GOUT",1,NA
"ANTI-HISTAMINES",1,NA
"ANTI-HUMAN SPERM NO.5",1,NA
"ANTI-INFECTIVES",1,NA
"ANTI-INFLAMMATORY DRUGS",3,NA
"ANTI-OSTEOPOROSIS",1,NA
"ANTI-PSYCHOTICS",1,NA
"ANTI-SOCIAL BEHAVIOR",1,NA
"ANTI-STOKES MATERIALS",1,NA
"ANTI-TERRORISM",1,NA
"ANTI‐ANDROGEN",1,NA
"ANTI ARA H 2 ANTIBODIES",1,NA
"ANTI HBS LEVELS >10 MIU/ML",1,NA
"ANTIALLERGIC DRUGS",1,NA
"ANTIANDROGEN THERAPY (ADT)",1,NA
"ANTIANDROGENS",3,NA
"ANTIARRYTHMIC DRUG",1,NA
"ANTIBACTERIAL ACTIVITY",1,1
"ANTIBIOTIC",1,3
"ANTIBIOTICS",10,3
"ANTIBODIES",1,NA
"ANTIBODY",4,1
"ANTIBODY-ANTIGEN RECOGNITION",1,NA
"ANTIBODY DISPLACEMENT",1,1
"ANTIBODY IMMOBILIZATION",1,1
"ANTIBODY INHIBITION",1,NA
"ANTICANCER DRUG",1,NA
"ANTICHOLINERGIC MEDICATION",1,NA
"ANTICHOLINERGICS",1,1
"ANTICHOLINESTERASE PESTICIDES",1,NA
"ANTICOAGULANT",2,NA
"ANTICOAGULANT DRUGS",1,NA
"ANTICOAGULANT RODENTICIDE",1,NA
"ANTICOAGULANT RODENTICIDES",4,NA
"ANTICONVULSANT",1,NA
"ANTICONVULSANT DRUGS",1,NA
"ANTICONVULSANTS",3,NA
"ANTICOUNTERFEITING",2,NA
"ANTIDEMENTIA DRUGS",1,NA
"ANTIDEPRESSANT",12,1
"ANTIDEPRESSANT DISCONTINUATION SYNDROME",1,NA
"ANTIDEPRESSANT DRUG",1,NA
"ANTIDEPRESSANT DRUGS",4,2
"ANTIDEPRESSANT PRESCRIPTION",1,NA
"ANTIDEPRESSANT SSRIS",1,NA
"ANTIDEPRESSANTS",41,6
"ANTIDEPRESSANTS AND ANTIPSYCHOTICS",1,NA
"ANTIDEPRESSANTS, DRUG LEVELS, PATHOLOGY",1,NA
"ANTIDEPRESSIVE AGENTS",2,NA
"ANTIDEPRESSIVE DRUGS",1,NA
"ANTIDEPRESSIVES",1,NA
"ANTIDIABETES DRUGS",1,NA
"ANTIDIABETIC",1,NA
"ANTIDOPING",1,NA
"ANTIDOPING CONTROL",1,NA
"ANTIDOTES",3,NA
"ANTIDRUG PROGRAMS",1,NA
"ANTIEMETICS",1,NA
"ANTIEPILEPTIC",1,NA
"ANTIEPILEPTIC AND ANTIPSYCHOTICS DRUGS",1,NA
"ANTIEPILEPTIC DRUG (AED)",1,NA
"ANTIEPILEPTIC DRUGS",3,2
"ANTIEPILEPTIC DRUGS (AEDS)",2,NA
"ANTIEPILEPTICS",3,NA
"ANTIFREEZE",1,NA
"ANTIHISTAMINE",3,NA
"ANTIHISTAMINES",4,1
"ANTIHISTAMINICS",2,NA
"ANTIHYPERGLYCEMIC AGENTS",1,NA
"ANTIHYPERTENSIVE",1,1
"ANTILLEANS",1,NA
"ANTIMALARIAL",2,2
"ANTIMALARIAL TABLETS",1,NA
"ANTIMALARIALS",1,NA
"ANTIMICROBIAL RESISTANCE",3,NA
"ANTIMICROBIALS",1,NA
"ANTIMONY",1,NA
"ANTIMYCOTICS",1,NA
"ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)",1,NA
"ANTINOCICEPTIVE EFFECT",1,NA
"ANTIOXIDANT",4,16
"ANTIOXIDANT EFFICIENCIES",1,NA
"ANTIPARASITIC",1,NA
"ANTIPARKINSON DRUGS",1,NA
"ANTIPHOSPHOLIPID ANTIBODIES",1,NA
"ANTIPSYCHOTIC",16,NA
"ANTIPSYCHOTIC AGENT",1,NA
"ANTIPSYCHOTIC AGENTS",4,NA
"ANTIPSYCHOTIC AGENTS/ADMINISTRATION & DOSAGE/",1,NA
"ANTIPSYCHOTIC AUGMENTATION",1,NA
"ANTIPSYCHOTIC DRUG",1,NA
"ANTIPSYCHOTIC DRUGS",10,NA
"ANTIPSYCHOTIC MEDICATIONS",1,NA
"ANTIPSYCHOTIC POISONING",1,NA
"ANTIPSYCHOTIC TREATMENT",1,NA
"ANTIPSYCHOTICS",37,NA
"ANTIPYRETIC DRUGS",1,NA
"ANTIPYRETICS",1,NA
"ANTIPYRINE",1,NA
"ANTIRETROVIRAL DRUG RESISTANCE",1,NA
"ANTISEPTIC",1,NA
"ANTISERUM",2,NA
"ANTISOCIAL",8,NA
"ANTISOCIAL BEHAVIOR",4,NA
"ANTISOCIAL BEHAVIOUR",1,NA
"ANTISOCIAL BEHAVIOURS",1,NA
"ANTISOCIAL PERSONALITY",3,NA
"ANTISOCIAL PERSONALITY DISORDER",13,NA
"ANTISOCIAL/PSYCHOPATHY",1,NA
"ANTISPASMODICS",1,NA
"ANTITUMOR",1,NA
"ANTITUSSIVE",1,NA
"ANTIVENOM",1,NA
"ANTROPOLOGICAL LEGAL MEDICINE",1,NA
"ANTS",1,NA
"ANUCS301",1,2
"ANUCS302",1,2
"ANUCS303",1,2
"ANUCS304",1,2
"ANUCS305",1,2
"ANUCS501",1,2
"ANXIETY",4,NA
"ANXIETY DISORDERS",1,NA
"ANYTHING RELATED TO SEXUAL ASSAULT",1,NA
"AOD",1,NA
"AORTA",1,NA
"AORTIC ANEURYSM",1,NA
"AORTIC DISSECTION",4,NA
"AORTIC STENOSIS",1,NA
"APAAN",3,4
"APB",1,NA
"APCI",2,1
"APCI-MS",1,1
"APELIN-13",1,NA
"APHRODISIAC",1,NA
"APICA",1,NA
"APINAC",1,NA
"APLASTIC ANEMIA",1,NA
"APLD",1,1
"APNEA",1,NA
"APNEA MONITOR",1,NA
"APOCYNACEAE",2,NA
"APOLIPOPROTEIN(A)",1,NA
"APOPTOSIS",10,NA
"APP-CHMINACA",1,NA
"APPARENT PERMEABILITY",1,NA
"APPLICATION",7,NA
"APPLICATION IN FORENSIC TOXICOLOGY",1,NA
"APPLICATION PROGRAMMING INTERFACES (API)",2,5
"APPLICATIONS",7,1
"APPLICATIONS IN DRUG METABOLISM",1,NA
"APPLICATIONS OF CHEMISTRY",1,2
"APPLIED FORENSICS",1,NA
"APPLIED PSYCHOLOGY",2,NA
"APPREHENDED DRIVERS",1,NA
"APPROACH TO IN VITRO-IN VIVO SCALING",1,NA
"APS",1,NA
"APTAMER",6,23
"APTASENSORS",1,3
"AQ1 IMMUNOASSAYS",1,NA
"AQPS",1,NA
"AQUA",1,NA
"AQUACULTURE",1,NA
"AQUATIC-RIPARIAN LINKAGES",1,NA
"AQUATIC DECOMPOSITION",1,NA
"AQUATIC ENVIRONMENT",1,2
"AQUEOUS",1,NA
"AQUEOUS DERIVATISATION",1,NA
"AQUEOUS ELECTROLYTES",1,NA
"AQUEOUS EXTRACTION",1,NA
"AQUEOUS MATRIX",1,NA
"AQUEOUS MEDIA",1,NA
"AQUEOUS MEDIUM",1,NA
"AQUEOUS SAMPLES",1,NA
"AQUEOUS TWO-PHASE SYSTEMS",1,1
"AQUEOUS TWO PHASE EXTRACTION SYSTEM",1,NA
"ARA H 2",1,NA
"ARABIAN POPULATION",1,NA
"ARBITRARY PRIMER",1,NA
"ARCHAEOLOGICAL FEATURES",1,NA
"ARCHAEOLOGY",5,NA
"ARCHAIC DNA",1,NA
"ARCHITECTURAL PAINT",1,NA
"ARCHIVAL RESEARCH",1,NA
"AREA OF ORIGIN",1,NA
"ARGEMONE MEXICAN L.",1,NA
"ARGEMONE OIL",2,NA
"ARGON",1,NA
"ARGYREIA NERVOSA",3,2
"ARIPIPRAZOLE",4,NA
"ARISTOLOCHIA MANSHURIENSIS",1,NA
"ARISTOLOCHIC ACID",1,NA
"ARMANNI-EBSTEIN LESION",2,NA
"ARMODAFINIL",1,NA
"ARMS",1,NA
"AROMA COMPONENTS",1,NA
"AROMA COMPOUNDS IN BLOOD SAMPLES",1,NA
"AROMA DETECTION",1,NA
"AROMA LIQUID",1,NA
"AROMATIC STACKING",1,1
"AROUSALS",1,NA
"ARRAY",1,NA
"ARREST",1,NA
"ARREST-RELATED DEATH",1,NA
"ARREST RELATED DEATH",1,NA
"ARREST SCENARIO",1,NA
"ARRESTEE",2,NA
"ARRESTEES",2,NA
"ARRHYTHMIA",9,NA
"ARRHYTHMIA.",1,NA
"ARRHYTHMIAS",1,NA
"ARRHYTHMIC CARDIOMYOPATHY",1,NA
"ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY/DYSPLASIA",1,NA
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA",1,NA
"ARRYTHMIA",1,NA
"ARSENATE",1,NA
"ARSENIC",1,NA
"ARSENIC COMPOUNDS",1,NA
"ARSENIC POISONING",1,NA
"ARSENIC TRIOXIDE",1,NA
"ARSENITE",1,NA
"ARSON",9,NA
"ARSON INVESTIGATIONS",1,NA
"ART",1,NA
"ART 64 OF THE GERMAN PENAL CODE",1,NA
"ART HISTORY",1,NA
"ART. 64 OF THE GERMAN PENAL CODE",1,NA
"ARTEETHER",1,NA
"ARTEFACTS",1,NA
"ARTEMISIA ABSINTHIUM",2,1
"ARTERIOBRONCHIAL FISTULA",1,NA
"ARTERIOSCLEROSIS",1,NA
"ARTERIOVENOUS COMMUNICATION",1,NA
"ARTESUNATE",5,NA
"ARTICLES FOR METHAMPHETAMINE ABUSE",1,NA
"ARTIFACT",9,3
"ARTIFACT PRODUCTION",1,NA
"ARTIFICIAL DNA",1,NA
"ARTIFICIAL GASTRIC JUICE",1,NA
"ARTIFICIAL HUMAN BLOOD",1,1
"ARTIFICIAL INTELLIGENCE",1,2
"ARTIFICIAL NEURAL NETWORKS",4,6
"ARTIFICIAL SUBSTITUTE",1,NA
"ARTWORK",1,NA
"ARYL PIPERAZINES",1,1
"ARYLCYCLOALKYLAMINES",1,1
"ARYLCYCLOHEXYLAMINE",4,3
"ARYLCYCLOHEXYLAMINE DERIVATIVES",1,1
"ARYLCYCLOHEXYLMORPHOLINES",1,1
"ARZNEIMITTEL IN BLUT",1,NA
"ARZNEIMITTEL, NACHWEIS IN BIOLOGISCHEM MATERIAL",1,NA
"ASAP-MS/MS",1,NA
"ASCLEPIAS FRUTICOSA L.",1,NA
"ASCORBIC ACID",3,2
"ASE",1,NA
"ASENAPINE",1,NA
"ASENLIX",1,NA
"ASEPTIC URINE COLLECTION KIT",1,NA
"ASIA",3,1
"ASIALO-TF",1,NA
"ASIALO-TRANSFERRIN",1,NA
"ASP",1,1
"ASPD",2,NA
"ASPERGER",1,NA
"ASPERPHENAMATE",1,NA
"ASPHYXIA",37,NA
"ASPHYXIA BY ALIMENTARY BOLUS",1,NA
"ASPHYXIA DUE TO HANGING",1,NA
"ASPHYXIAL DEATH",1,NA
"ASPHYXIAL SUICIDE",2,NA
"ASPHYXIANT GAS",1,NA
"ASPHYXIATION",4,NA
"ASPIRATION",2,NA
"ASPIRIN",4,NA
"ASSASSINATION",1,NA
"ASSAULT",4,NA
"ASSAULT IN PRISON",1,NA
"ASSAULTS",1,NA
"ASSAY EVALUATION",1,NA
"ASSAY VALIDATION",1,NA
"ASSAYS",1,NA
"ASSESSMENT",23,1
"ASSESSMENT OF DANGEROUSNESS",1,NA
"ASSESSMENT OF SYMPTOMS",1,NA
"ASSISTANCE",1,NA
"ASSISTED SUICIDE",2,NA
"ASSOCIATION",4,NA
"ASSOCIATION STUDIES",1,NA
"ASSOCIATION STUDY",2,NA
"ASTERACEAE",1,NA
"ASTHMA",9,NA
"ASTHMA DEATH",2,NA
"ASTM",1,1
"ASTRAGALUS",1,NA
"ASTROCYTES",2,NA
"ASYLUM APPLICANTS",1,NA
"ASYLUM SEEKERS",1,NA
"ATAXIA, BAC",1,NA
"ATELECTASIS",1,NA
"ATENOLOL",4,NA
"ATENOLOL TABLETS",1,NA
"ATF3",1,NA
"ATHABASCA RIVER",1,NA
"ÄTHANOL- UND METHANOL-VERTEILUNG IM ZNS",1,NA
"ATHEROMA",1,NA
"ATHLETE",1,NA
"ATHLETE BIOLOGICAL PASSPORT",1,NA
"ATHLETES",2,1
"ATLS®",1,NA
"ATM",1,NA
"ATMOSPHERIC-PRESSURE CHEMICAL IONIZATION (APCI)",1,NA
"ATMOSPHERIC PRESSURE",1,NA
"ATMOSPHERIC PRESSURE CHEMICAL IONIZATION",8,7
"ATMOSPHERIC PRESSURE CHEMICAL IONIZATION (APCI)",1,NA
"ATMOSPHERIC PRESSURE CHEMICAL IONIZATION MASS SPECTROSCOPY",1,1
"ATMOSPHERIC PRESSURE DESORPTION/IONIZATION ON SILICON",1,1
"ATMOSPHERIC PRESSURE IONIZATION",2,NA
"ATMOSPHERIC SOLIDS ANALYSIS PROBE",1,1
"ATOMIC ABSORPTION",1,1
"ATOMIC ABSORPTION SPECTROMETRY",1,2
"ATOMIC ABSORPTION SPECTROSCOPY",1,1
"ATOMIC ABSORPTION/EMISSION SPECTROMETRY",1,1
"ATOMIC FLUORESCENCE SPECTROSCOPY",1,NA
"ATOMIC FORCE MICROSCOPY",1,NA
"ATOMIC FORCE MICROSCOPY (AFM)",1,NA
"ATOMOXETINE",1,NA
"ATOPIC DERMATITIS",1,NA
"ATP",1,NA
"ATP6 GENE",1,NA
"ATPASE 6",1,NA
"ATR",6,8
"ATR-FTIR",8,8
"ATR-FTIR DRUG PROFILING",1,NA
"ATR-FTIR SPECTROSCOPY",1,2
"ATR-IR SPECTROSCOPY",1,NA
"ATR INFRARED SPECTROSCOPY",1,NA
"ATR SAMPLING, SAMPLE PREPARATION BEING CONVENIENT",1,NA
"ATRACTYLOSIDE",2,NA
"ATRAZINE",2,NA
"ATRIA BLOOD SUPPLY",1,NA
"ATRIOVENTRICULAR NODE",1,NA
"ATROPINE",10,13
"ATROPINE, DRUG TRAFFICKING",1,1
"ATS",2,1
"ATS-RELATED DRUGS",1,NA
"ATS DRUG IDENTIFICATION",1,NA
"ATS DRUGS",3,NA
"ATTACK",1,NA
"ATTEMPTED MURDER",1,NA
"ATTEMPTED SUICIDE",1,NA
"ATTEMPTS OF SUICIDE",1,NA
"ATTENTION",1,NA
"ATTENTION-DEFICIT/HYPERACTIVITY DISORDER",3,NA
"ATTENTION DEFICIT",1,NA
"ATTENTION DEFICIT DISORDER",1,NA
"ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY",3,NA
"ATTENTION DEFICIT HYPERACTIVITY",1,NA
"ATTENTION DEFICIT HYPERACTIVITY DISORDER",2,NA
"ATTENUATED TOTAL INTERNAL REFLECTION",1,1
"ATTENUATED TOTAL REFLECTANCE",2,3
"ATTENUATED TOTAL REFLECTION",7,7
"ATTITUDE",1,NA
"ATTITUDE TOWARDS MEDICATION",1,NA
"ATTITUDES",5,1
"ATTOMOLE SENSITIVITY",1,NA
"ATTORNEY",1,NA
"ATTRIBUTION",1,1
"ATTRIBUTIONS",1,NA
"ATTRITION",3,NA
"ATYPICAL ADMINISTRATION",1,NA
"ATYPICAL ANTIPSYCHOTIC DRUGS",1,NA
"ATYPICAL MYOPATHY OF HORSES",1,NA
"AU NANOPARTICLE",1,NA
"AUC",1,NA
"AUDIT",10,NA
"AUDITING OF MLC",1,NA
"AUDITING OF POSTMORTEM EXAMINATION REPORTS",1,NA
"AUGMENTATION",2,NA
"AURICULAR ACUPUNCTURE",1,NA
"AUSTRALIA",4,12
"AUSTRALIAN FEDERAL POLICE (AFP)",1,NA
"AUSTRALIAN PERSPECTIVE",1,1
"AUSTRALIAN URANIUM ORE CONCENTRATES",1,NA
"AUSTRIA",2,NA
"AUTHENTIC HUMAN URINE AND BLOOD",1,NA
"AUTHENTIC HUMAN URINE SPECIMEN",1,NA
"AUTHENTIC SAMPLES",2,NA
"AUTHENTICATED STANDARD",1,NA
"AUTHENTICATION",1,4
"AUTHENTICITY",1,3
"AUTHENTICITY TESTING",1,1
"AUTHOR ATTRIBUTION",1,NA
"AUTHORITIES",1,NA
"AUTHORIZATION OF CHEMICALS",1,NA
"AUTHORSHIP ANALYSIS",1,NA
"AUTISM",3,NA
"AUTISM SPECTRUM DISORDER",4,NA
"AUTISM SPECTRUM DISORDERS",1,NA
"AUTISTIC SPECTRUM DISORDER",1,NA
"AUTO-BREWERY SYNDROME",1,NA
"AUTO-EXTRACTION",1,NA
"AUTO-IMMUNE THYROID DISEASE",1,NA
"AUTOEROTIC",2,NA
"AUTOEROTIC ACCIDENT",2,NA
"AUTOEROTIC ASPHYXIA",2,NA
"AUTOFLUORESCENCE",2,NA
"AUTOIMMUNE POLYGLANDULAR SYNDROMES",1,NA
"AUTOLITIC EPISODES",1,NA
"AUTOLOGOUS FAT TRANSFER",1,NA
"AUTOLYSIS",3,NA
"AUTOLYSIS/PUTREFACTION",1,NA
"AUTOMATED ANALYSIS",1,NA
"AUTOMATED ANALYSIS.",1,NA
"AUTOMATED DATABASE SEARCH",1,NA
"AUTOMATED DNA SEQUENCING",1,NA
"AUTOMATED EXTRACTION",1,NA
"AUTOMATED HONEYPOTS",1,NA
"AUTOMATED LIBRARY SEARCH",1,1
"AUTOMATED LIQUID HANDLING",1,NA
"AUTOMATED MINERAL ANALYSIS",1,NA
"AUTOMATED ON-LINE SYSTEM",1,NA
"AUTOMATED PARTICLE IMAGING",1,NA
"AUTOMATED SAMPLE PREPARATION",4,NA
"AUTOMATED SOLID-PHASE EXTRACTION",2,NA
"AUTOMATED SPE",2,NA
"AUTOMATED SUPPORTED LIQUID EXTRACTION (SLE)",1,NA
"AUTOMATED THERMAL DESORPTION (ATD)",1,NA
"AUTOMATIC DETECTION",1,NA
"AUTOMATING FIRE DEBRIS USING COMPUTER ALGORITHMS FOR ILR",1,NA
"AUTOMATION",7,3
"AUTOMATISM",2,NA
"AUTOMOBILE ACCIDENT INVESTIGATION",1,NA
"AUTOMOBILE DRIVING",49,NA
"AUTOMOBILE DRIVING LEGISLATION AND JURISPRUDENCE",1,NA
"AUTOMOBILE PAINT",1,NA
"AUTOMOTIVE PAINT",4,NA
"AUTOMOTIVE WHITE PAINT FRAGMENTS",1,NA
"AUTONOMIC DYSFUNCTION",1,NA
"AUTONOMY",4,NA
"AUTOOXIDATION",1,NA
"AUTOPHAGY",3,NA
"AUTOPSIED DRUG ADDICTS",2,NA
"AUTOPSIES MINIMAL REQUIREMENTS",1,NA
"AUTOPSY",447,8
"AUTOPSY BIOSAFETY",1,NA
"AUTOPSY CASE",2,NA
"AUTOPSY CASES",1,NA
"AUTOPSY CHECKLIST",1,NA
"AUTOPSY CLANDESTINE",1,1
"AUTOPSY FINDINGS",3,NA
"AUTOPSY METHODS",1,NA
"AUTOPSY PATHOLOGY",1,NA
"AUTOPSY POPULATION",1,NA
"AUTOPSY RATE",2,NA
"AUTOPSY RESULTS",1,NA
"AUTOPSY SAMPLE",1,NA
"AUTOPSY SAMPLES",2,NA
"AUTOPSY SERIES",1,NA
"AUTOPSY TECHNICIANS",1,NA
"AUTOPSY, FORENSIC PATHOLOGY",1,NA
"AUTOPTIC AND HISTOPATHOLOGICAL FINDINGS",1,NA
"AUTORADIOGRAPHY",1,NA
"AUTOSOMAL SNPS",1,NA
"AUTOSOMAL STR MARKERS",1,NA
"AUTOSOMAL STRS",2,NA
"AVERMECTIN",2,NA
"AVERSIVE AND TRAUMATIC EVENTS",1,NA
"AVERSIVE THERAPY",1,NA
"AVIAN SPECIES IDENTIFICATION",1,NA
"AVIATION",3,NA
"AVIATION ACCIDENT INVESTIGATION",4,NA
"AVIATION FORENSIC TOXICOLOGY",2,NA
"AVOIDABLE MORTALITY",1,NA
"AVOIDANCE LEARNING APPARATUS",1,NA
"AWAKE TRIGGERING",1,NA
"AWARENESS",1,NA
"AWTAR",1,NA
"AXIAL DIFFUSION",1,NA
"AXIAL MIGRATION",1,NA
"AXSIM",1,1
"AYAHUASCA",5,14
"AYAHUSACA",1,1
"AYURVEDA",1,NA
"AYURVEDIC AILMENT",1,NA
"AZAN-MALLORY STAIN",1,NA
"AZAPERONE",1,NA
"AZEPANE ISOMER",1,1
"AZEPANE ISOMERS OF AM-2233, AM-1220",1,3
"AZFC",2,NA
"AZFC DELETION",1,NA
"AZIDE DISTRIBUTION IN VIVO",1,NA
"AZIDE FATALITY",1,NA
"AZITHROMYCIN",1,NA
"AZOOSPERMY",1,NA
"B CELL CLUSTERS",1,NA
"B01-CANN1",1,2
"B02-CANN2",1,2
"B05-CANN1",1,2
"BABY BOOMERS",1,NA
"BABY FORMULA",1,NA
"BABYLON PROVINCE",1,NA
"BAC IN INJURED DRIVERS",1,NA
"BAC/BRAC QUOTIENT",1,NA
"BACILLI",1,NA
"BACILLUS ANTHRACIS",3,2
"BACILLUS CEREUS",1,NA
"BACK-CALCULATION",1,2
"BACK PAIN",1,NA
"BACKFLUSH",1,NA
"BACKGROUND",5,NA
"BACKGROUND DNA",1,NA
"BACKGROUND INTERFERENCES",1,NA
"BACKGROUND REMOVAL",1,2
"BACKGROUND SUBTRACTION",1,1
"BACKLOG",1,NA
"BACKLOGS",1,NA
"BACKSPATTER",3,NA
"BACLOFEN",3,2
"BACTERIA",5,1
"BACTERIA CULTURES",1,1
"BACTERIAL BIOSENSORS",1,NA
"BACTERIAL COMMUNITY",1,NA
"BACTERIAL DECOMPOSITION",2,NA
"BACTERIAL DEGRADATION",1,NA
"BACTERIAL DNA",1,NA
"BACTERIAL ENDOCARDITIS",1,NA
"BACTERIAL EVOLUTION",1,NA
"BACTERIAL MENINGITIS",1,NA
"BACTERIAL MODEL",1,NA
"BACTERIOLOGIEAL FINDINGS",1,NA
"BACULOVIRUS-INFECTED INSECT CELLS",1,NA
"BAD TRIP",1,NA
"BAG-OF-VISUAL-WORDS",1,NA
"BAGGING",1,NA
"BAKERY",1,NA
"BALCONING",1,NA
"BALKAN ENDEMIC NEPHROPATHY",1,NA
"BALLISTIC",10,2
"BALLISTIC FRACTURE",1,NA
"BALLISTIC GEL",1,NA
"BALLISTIC GELATIN",1,NA
"BALLISTIC MODIFIERS",1,NA
"BALLISTIC MORTAR",1,NA
"BALLISTIC PENETRATION",1,NA
"BALLISTIC WOUNDS",1,NA
"BALLISTICS GELATIN",1,NA
"BALLPOINT INK",1,NA
"BANGLADESH",1,NA
"BANK DYE",1,NA
"BANK INSTRUMENTS",1,NA
"BANK NOTES",1,2
"BANKNOTE",7,14
"BAR ADSORPTIVE MICRO-EXTRACTION (BAΜE)",1,NA
"BARBARIN",1,NA
"BARBITAL",2,2
"BARBITAL, AMOBARBITAL, PHENOBARBITAL AND SECOBARBITAL",1,NA
"BARBITAL, ANALYTICAL DATA",1,NA
"BARBITURATE DRUGS",1,NA
"BARBITURATE INTOXICATION",1,NA
"BARBITURATE POISONING",1,NA
"BARBITURATE TOLERANCE",1,NA
"BARBITURATES",36,29
"BARBITURATES IN HUMAN PLASMA",1,NA
"BARCODES",1,NA
"BARCODING",3,1
"BARIATRIC",1,NA
"BARIUM",2,NA
"BARIUM ISOTOPE RATIO",1,NA
"BARIUM SULFATE",1,NA
"BARK ANATOMY",1,NA
"BAROREFLEX",1,NA
"BARRATT IMPULSIVENESS SCALE-11",1,NA
"BARRATT IMPULSIVENESS SCALE-BRIEF",1,NA
"BARRATT IMPULSIVENESS SCALE VERSION 11",1,NA
"BARRATT IMPULSIVENESS SCALE VERSION 11 (BIS-11)",1,NA
"BARRIER MATERIAL",1,NA
"BARTONELLA SPP.",1,NA
"BARTONELLA SPP. ANTIBODIES",1,NA
"BASAL GANGLIA",2,NA
"BASE COMPOSITION",1,NA
"BASELINE",1,NA
"BASEMENT MEMBRANE DEFECTS",1,NA
"BASES",1,NA
"BASIC DRUG",1,9
"BASIC DYES",1,1
"BASIC FORENSIC HAIR ANALYSIS, COLOUR, IN SAMPLES SPANNING NO MORE THAN A YEAR",1,NA
"BASIC PHARMACEUTICAL",1,4
"BASIC PHARMACOLOGY",1,NA
"BASIC VIOLET 2",1,NA
"BASIC VIOLET 3",1,NA
"BASIC YELLOW 40",3,NA
"BASOPHIL ACTIVATION TEST (BAT)",1,NA
"BATCH",1,1
"BATCH INJECTION ANALYSIS (BIA)",1,1
"BATCH LINKS",1,1
"BATH",1,NA
"BATH-RELATED DEATH",2,NA
"BATH SALTS",27,17
"BATHING",1,NA
"BATHTUB",4,NA
"BATHWATER",1,NA
"BATON",1,NA
"BATTERED WOMAN SYNDROME",1,NA
"BATTERED WOMAN SYNDROME (BWS)",1,NA
"BAX PROTEIN",1,NA
"BAYES",1,NA
"BAYES' FACTOR",1,1
"BAYESIAN",1,NA
"BAYESIAN APPROACH",3,1
"BAYESIAN ESTIMATION",1,NA
"BAYESIAN INFERENCE",3,3
"BAYESIAN METHODS",1,NA
"BAYESIAN NETWORK",1,2
"BAYESIAN STATISTICS",1,1
"BB-22",1,NA
"BCG",1,NA
"BCHE-ADDUCTS",1,NA
"BCL-2 PROTEIN",1,NA
"BDD ELECTRODE",1,2
"BDNF",2,NA
"BDSM",2,NA
"BEAD-ASSISTED LIQUID-LIQUID EXTRACTION",1,NA
"BEADS BEAT",1,NA
"BEARD",1,NA
"BEATING",1,NA
"BECLIN-1",1,NA
"BECLIN 1",1,NA
"BECLOMETHASONE",1,NA
"BED USE",1,NA
"BEDEUTUNG FÜR DIE ALLG. WISSENSCHAFT",1,NA
"BEEF",1,NA
"BEER",4,2
"BEER-LAMBERT LAW",1,NA
"BEETLES",1,NA
"BEHAVIOR",3,NA
"BEHAVIOR ANALYSIS",1,NA
"BEHAVIOR DISORDERS",1,NA
"BEHAVIOR THERAPY",1,NA
"BEHAVIORAL ATTRIBUTES",1,NA
"BEHAVIORAL EFFECTS",2,NA
"BEHAVIORAL EMERGENCY",1,NA
"BEHAVIORAL EVIDENCE ANALYSIS",1,NA
"BEHAVIORAL HEALTH",1,NA
"BEHAVIORAL SCIENCE",1,NA
"BEHAVIORAL STUDIES",1,NA
"BEHAVIORAL TERATOGENECITY",1,NA
"BEHAVIORAL THEORY (CONDITIONINGS)",1,NA
"BEHAVIORISM",1,NA
"BEHAVIOUR",2,NA
"BEHAVIOURAL MANAGEMENT PLANS",1,NA
"BEHAVIOURAL NEUROLOGY",1,NA
"BELGIUM",2,1
"BELGRADE/SERBIA",1,NA
"BELIEFS",1,NA
"BEN",1,NA
"BENCHMARK DETECTION COMPARISON",1,NA
"BENCHMARKING AND FORESIGHT'S KPIS",1,NA
"BENCHTOP NMR",3,2
"BENCHTOP NMR SPECTROMETER",1,NA
"BENCHTOP RAMAN ANALYSIS, WELL-ESTABLISHED WITH RAPID IDENTIFICATION",1,NA
"BENCYCLANE",1,NA
"BENDECTIN",1,NA
"BENEVOLENCE",1,NA
"BENFORD",1,NA
"BENTAZEPAM",1,NA
"BENTAZONE",1,NA
"BENZALDEHYDE",1,4
"BENZALKONIUM CHLORIDE",1,NA
"BENZENE",1,1
"BENZHEXOL",2,NA
"BENZIDINE",1,NA
"BENZIMIDAZOLE",1,2
"BENZINE INJECTION",1,NA
"BENZINE INTOXICATION",1,NA
"BENZO FURY",1,NA
"BENZOCAINE",2,4
"BENZODIAZEPINE AND DERIVATIVES",199,92
"BENZODIAZEPINE DETECTION",1,NA
"BENZODIAZEPINE OVERDOSE",1,NA
"BENZODIAZEPINE TOXICITY",1,NA
"BENZODIAZEPINE WITHDRAWAL",1,NA
"BENZODIAZEPINE, CLOBAZAM",1,NA
"BENZODIAZEPINES WITH SHORT HALF-LIFE",1,NA
"BENZODIAZEPINES, ADVERSE REACTIONS",1,NA
"BENZODIAZEPINES: EXTRACTION FROM BLOOD",1,NA
"BENZODIFURANS",1,NA
"BENZOFURAN",1,5
"BENZOFURAN-7-OL",1,NA
"BENZOFURANOL",1,NA
"BENZOIC, 3-AND 4-METHYL-BENZOIC ACIDS",1,NA
"BENZOPHENANTHRIDINE",1,NA
"BENZOPHENONE",1,1
"BENZOPHENONE-DERIVATIVE UV FILTERS",1,NA
"BENZOPHENONES",1,NA
"BENZOYL ECGONINE",1,NA
"BENZOYLECGONINE",34,14
"BENZOYLMESACONINE",1,1
"BENZPHETAMINE",2,1
"BENZYDAMINE",1,NA
"BENZYL ALCOHOL",1,1
"BENZYLPIPERAZINE (BZP)",6,11
"BERBERINE",2,1
"BERLIN",1,NA
"BERRY ANEURYSM",1,NA
"BEST PRACTICE",1,NA
"BEST. VON ARSEN IN BIOLOG. MATERIAL",1,NA
"BEST. VON PARAQUAT IN SERUM, URIN",1,NA
"BESTIALITY",1,NA
"BESTIMMUNG",1,NA
"BETA-ADRENERGIC-RECEPTOR-ANTAGONISTS",1,NA
"BETA-AGONISTS",2,NA
"BETA-AMYLOID PRECURSOR PROTEIN (AΒPP)",1,NA
"BETA-APP",1,NA
"BETA-BLOCKER",1,NA
"BETA-BLOCKERS",6,1
"BETA-CARBOLINE ALKALOIDS",1,NA
"BETA-DISPERSION",1,NA
"BETA-GLUCURONIDASE",1,NA
"BETA-HYDROXYBUTYRATE",1,NA
"BETA-KETO",1,1
"BETA-KETO DESIGNER DRUGS",1,NA
"BETA-STIMULATING DRUG",1,NA
"BETA-TRACE PROTEIN (ΒTP)",1,NA
"BETA-TRYPTASE",1,NA
"BETA AGONISTS",1,NA
"BETA BLOCKERS",1,NA
"BETA KETO-PHENETHYLAMINES",1,1
"BETABINOMIAL DISTRIBUTION",1,NA
"BETAMETHASONE",2,NA
"BETANIDINE",1,NA
"BETANIN",1,NA
"BETMVV-EDI",1,NA
"BEVERAGE",10,16
"BEYOND TRAUMA",1,NA
"BGC",1,NA
"BIALAPHOS",1,NA
"BIAS",2,2
"BIAS-MINIMIZING PROCEDURE",1,NA
"BIASED SIGNALING",1,NA
"BIBLE",1,NA
"BIBLIOMETRICS",1,1
"BICYCLE",1,NA
"BICYCLIC",1,NA
"BICYCLING",1,NA
"BICYCLIST",1,NA
"BIG CITY ISSUE",1,NA
"BIG DATA",1,NA
"BIG FIVE",1,NA
"BIGUANIDES",1,NA
"BILASTINE",1,NA
"BILATERAL ADRENAL HEMORRHAGE",1,NA
"BILATERAL PNEUMOTHORAX",1,NA
"BILE",10,NA
"BILE PHYSIOLOGY",2,NA
"BILE SALT",1,NA
"BILL C-14",1,NA
"BIMODAL SEPARATIONS",1,NA
"BINARY MODEL",1,NA
"BINARY TREE",1,NA
"BINDER DISCRIMINATION",1,NA
"BINDING",1,NA
"BIO-MOLECULES",1,NA
"BIO-PSYCHO-SOCIAL MODEL",1,NA
"BIO-RELATED COMPOUND",1,NA
"BIO-THREAT ALERT SYSTEM",1,NA
"BIOACCUMULATION",2,1
"BIOACTIVE COMPOUNDS",1,5
"BIOANALYSIS",14,3
"BIOANALYSIS AND ANTIGOUT DRUG",1,NA
"BIOANALYTICAL",1,1
"BIOANALYTICAL APPLICATIONS",1,1
"BIOANALYTICAL METHODS",10,2
"BIOANALYTICAL VALIDATION",1,NA
"BIOANALYTICS",2,1
"BIOARCHAEOLOGY",1,NA
"BIOASSAY",3,1
"BIOASSAY-GUIDED FRACTIONATION",1,1
"BIOASSAYS",2,NA
"BIOAVAILABILITY",3,3
"BIOCHEMICAL ALTERATIONS",1,NA
"BIOCHEMICAL ANALYSIS",2,1
"BIOCHEMICAL CHARACTERISTICS OF BLOOD USED IN FORENSICS",1,NA
"BIOCHEMICAL MARKERS",2,NA
"BIOCHEMICAL PARAMETERS",1,NA
"BIOCHEMICAL TECHNIQUES",1,NA
"BIOCHEMICAL TOXICOLOGY",1,NA
"BIOCHEMISTRY",6,1
"BIOCHIP",1,NA
"BIOCHIP ARRAY TECHNOLOGY",1,NA
"BIOCOMPATIBILITY",2,NA
"BIOCOMPATIBLE",1,NA
"BIOCORROSION",1,NA
"BIOCRIMES",1,NA
"BIODEGRADABLE",1,NA
"BIODEGRADATION",2,3
"BIODEGRADATION STUDIES",1,NA
"BIODIESEL",1,1
"BIODISTRIBUTION",1,NA
"BIODIVERSITY",1,1
"BIODIVERSITY INFORMATICS",1,NA
"BIOELECTRONIC DEVICES",1,NA
"BIOENERGETICS",1,NA
"BIOFEEDBACK",1,NA
"BIOFILM",1,2
"BIOFLUIDS",3,NA
"BIOFORENSICS",1,NA
"BIOFUEL CELLS",1,NA
"BIOGENIC AMINES",1,2
"BIOGENIC ORGANIC COMPOUNDS (BOC)",2,NA
"BIOGEOGRAPHY",1,1
"BIOIMIMETIC SYSTEM",1,NA
"BIOINFORMATIC",1,NA
"BIOINFORMATICS",7,NA
"BIOINFORMATICS LEGAL ISSUES",1,NA
"BIOLOGIC FLUIDS",1,NA
"BIOLOGIC SAMPLES",1,NA
"BIOLOGICAL",1,NA
"BIOLOGICAL ACTIVITY",2,3
"BIOLOGICAL AGING",2,NA
"BIOLOGICAL AND NON-BIOLOGICAL MATERIALS",1,NA
"BIOLOGICAL AND NON-BIOLOGICAL SAMPLES",1,NA
"BIOLOGICAL ASSAY",1,NA
"BIOLOGICAL BIOMARKERS",1,NA
"BIOLOGICAL DISTRIBUTION",1,NA
"BIOLOGICAL DRUGS",1,NA
"BIOLOGICAL FINGERPRINTS",1,NA
"BIOLOGICAL FLUID",27,8
"BIOLOGICAL FORENSIC SAMPLES",1,NA
"BIOLOGICAL MARKER",4,NA
"BIOLOGICAL MATERIAL",8,2
"BIOLOGICAL MATERIALS",1,NA
"BIOLOGICAL MATRIX",7,3
"BIOLOGICAL PASSPORT",1,NA
"BIOLOGICAL PROFILE",1,NA
"BIOLOGICAL RISK",1,NA
"BIOLOGICAL SAMPLE",3,NA
"BIOLOGICAL SAMPLES",35,13
"BIOLOGICAL SENSORS",1,1
"BIOLOGICAL SPECIMEN",2,NA
"BIOLOGICAL SPECIMENS",10,NA
"BIOLOGICAL TISSUE",2,NA
"BIOLOGICAL TOXINS",1,1
"BIOLOGICAL TRACES",2,NA
"BIOLOGICAL WARFARE AGENTS",1,NA
"BIOLOGICAL WEAPONS",4,1
"BIOLOGICALLY ACTIVE COMPOUND",1,NA
"BIOLOGY",5,NA
"BIOLUMINESCENCE",1,NA
"BIOMARKER DISCOVERY",1,NA
"BIOMARKER DISCOVERY AND VALIDATION",1,NA
"BIOMARKERS",49,8
"BIOMARKERS OF EXPOSURE",1,NA
"BIOMARKERS OF SMOKING TOBACCO",1,NA
"BIOMATERIALS",2,1
"BIOMECHANICS",1,NA
"BIOMECHATRONICS",1,NA
"BIOMEDICAL",2,1
"BIOMEDICAL ANALYSIS",1,1
"BIOMEDICAL ANALYSIS, MASS SPECTROMETRY",1,NA
"BIOMEDICAL APPLICATIONS",1,NA
"BIOMEDICAL LASERS",1,NA
"BIOMEDICINE",1,NA
"BIOMEK® 2000",1,NA
"BIOMETRIC ANALYSIS",1,NA
"BIOMETRIC VERIFICATION",1,NA
"BIOMETRICS",4,NA
"BIOMIMETICS",2,1
"BIOMOLECULAR IMAGING",1,NA
"BIOMOLECULE",1,NA
"BIOMOLECULE EXTRACTION",1,NA
"BIOMOLECULES",2,NA
"BIOMONITORING",5,NA
"BIOPHARMACEUTICAL MANUFACTURING",1,NA
"BIOPHARMACY",1,NA
"BIOPOLYMER",1,1
"BIOPROCESS",1,NA
"BIOPSIES",1,NA
"BIOPSY",1,1
"BIOREACTOR",1,NA
"BIOSAMPLES",2,NA
"BIOSAMPLING",1,NA
"BIOSENSING",2,NA
"BIOSENSOR",14,15
"BIOSIMILARS",1,NA
"BIOTECHNOLOGICAL APPLICATIONS",1,NA
"BIOTERRORISM",2,NA
"BIOTRANSFORMATION",5,7
"BIOWARFARE AGENT DETECTION DEVICES SYSTEM",1,NA
"BIPERIDEN",1,NA
"BIPOLAR",1,NA
"BIPOLAR DEPRESSION",2,NA
"BIPOLAR DISORDER",11,NA
"BIPOLAR ELECTROCHEMICAL ETCHING",1,NA
"BIPOLAR MOOD DISORDER",1,NA
"BIRDS",1,NA
"BIREFRINGENCE",2,NA
"BIREFRINGENT MATERIAL",1,NA
"BIREFRINGENT PARTICLES",1,NA
"BIRTH DEFECTS",1,NA
"BIRTH INJURIES",1,NA
"BIRTH OUTCOMES",1,NA
"BIS-11",1,NA
"BISOPROLOL",1,NA
"BISULFITE CONVERSION",1,NA
"BITCOIN",2,NA
"BITCOIN CLIENT",1,NA
"BITCOIN CORE",1,NA
"BITCOIN FORENSICS",1,NA
"BITTER ALMONDS",1,NA
"BITUMEN",1,NA
"BIURET",1,NA
"BIZARRE DRUG OF ABUSE",1,NA
"BK-2C-B",1,1
"BK-IVP",1,1
"BK-MBDB",4,1
"BK-MDEA",3,1
"BK-MDMA",1,NA
"BK-MDPAS",1,1
"BK VIRUS",1,NA
"BLACK AND GREEN TEA",1,NA
"BLACK CORAL",1,NA
"BLACK ESOPHAGUS",1,NA
"BLACK HAIR",1,NA
"BLACK HAIRY TONGUE",1,NA
"BLACK LEAF 40 INSECTICIDE",1,NA
"BLACK MARKET",3,5
"BLACK POWDER",3,NA
"BLACK POWDER SUBSTITUTES",3,NA
"BLACK POWDERS",1,NA
"BLACK SPOTS",1,NA
"BLACK TAR HEROIN",1,NA
"BLACK TEA",1,NA
"BLACKENING",1,NA
"BLADDER FULLNESS",1,NA
"BLADDER RUPTURE",1,NA
"BLAMING THE VICTIM",1,NA
"BLANK MEMORY",1,NA
"BLAST INJURIES",2,NA
"BLAST LUNG INJURY",1,NA
"BLAST SEARCH",1,1
"BLEACH",3,NA
"BLEACHING",1,NA
"BLEEDING",3,NA
"BLENDS",1,NA
"BLIND FIELD TEST",1,NA
"BLIND PROFICIENCY TESTING",2,NA
"BLIND QUALITY CONTROL",1,1
"BLIND STICK",2,NA
"BLIND TESTING",1,1
"BLIND TESTS",1,NA
"BLIND VERIFICATION",1,1
"BLOG2.0",2,NA
"BLONANSERIN",1,NA
"BLOOD",199,9
"BLOOD-ALCOHOL CONCENTRATION (""""BAC"""")",1,NA
"BLOOD-AMPHETAMINE",1,NA
"BLOOD-BRAIN BARRIER",4,NA
"BLOOD-CONCENTRATION",4,NA
"BLOOD-DRUG CONCENTRATION",1,NA
"BLOOD-DRUG CONCENTRATIONS",1,NA
"BLOOD-PO2-VALUES",1,NA
"BLOOD-RETINAL BARRIER",2,NA
"BLOOD-SPECIFIC MARKERS",2,NA
"BLOOD-TO-“SERUM” RATIOS",1,NA
"BLOOD ALCOHOL",10,NA
"BLOOD ALCOHOL AND DRUGS",2,NA
"BLOOD ALCOHOL CONCENTRATION",24,NA
"BLOOD ALCOHOL MEASURING",1,NA
"BLOOD ALCOHOL STABILITY",2,NA
"BLOOD ANALYSIS",18,1
"BLOOD AND TISSUE LEVELS",1,NA
"BLOOD AND URINE",1,NA
"BLOOD BIOCHEMISTRY",2,NA
"BLOOD COLLECTION SITES",1,NA
"BLOOD CONCENTRATION",22,2
"BLOOD CONTAMINATION",2,NA
"BLOOD CYANIDE CONCENTRATIONS",1,NA
"BLOOD CYANIDE VALUES",1,NA
"BLOOD DEPOSITION TIME",1,NA
"BLOOD DOPING",1,NA
"BLOOD DRUG CONCENTRATION",3,NA
"BLOOD DRUG LEVEL",1,NA
"BLOOD ENHANCEMENT",1,NA
"BLOOD ETHANOL SAMPLES",1,NA
"BLOOD FRACTIONS",1,NA
"BLOOD FROM A LINE",1,NA
"BLOOD GLUCOSE CONCENTRATION",1,NA
"BLOOD GLUCOSE MONITORING",1,NA
"BLOOD GROUP ANTIGEN",1,NA
"BLOOD GROUPS",2,NA
"BLOOD IDENTIFICATION",3,NA
"BLOOD IMMUNOASSAYS",1,NA
"BLOOD ISLANDS",1,NA
"BLOOD LEVEL",3,NA
"BLOOD LEVEL OF METHADONE",1,NA
"BLOOD LEVELS",3,NA
"BLOOD LOSS",3,NA
"BLOOD PRESSURE",1,NA
"BLOOD SAMPLE ANALYSIS",2,NA
"BLOOD SAMPLES",13,1
"BLOOD SCREENING",2,NA
"BLOOD SCREENING ANALYSIS",1,NA
"BLOOD SERUM",3,NA
"BLOOD SPATTER",1,NA
"BLOOD SPECIMEN COLLECTION",1,NA
"BLOOD SPECIMEN CONTAMINATION",1,NA
"BLOOD SPOT",1,NA
"BLOOD STAIN",5,1
"BLOOD STAINED FINGERPRINTS",1,NA
"BLOOD TEST",1,NA
"BLOOD TEST EVIDENCE",1,NA
"BLOOD TESTING",1,NA
"BLOOD TO PLASMA RATIO",1,NA
"BLOOD TRANSFUSION",1,NA
"BLOOD TRANSFUSION NETWORK",1,NA
"BLOOD TYPING",1,NA
"BLOOD, URINE, BREATH ALCOHOL",1,NA
"BLOOD/SERUM-RATIO",1,NA
"BLOODMARKS",1,NA
"BLOODSTAIN",4,NA
"BLOODSTAIN AGE ESTIMATION",1,NA
"BLOODSTAIN PATTERN ANALYSIS",4,NA
"BLOODSTAINS INVESTIGATION",1,NA
"BLOODY FINGERMARKS",1,NA
"BLOODY IMPRESSION LIFTERS",1,NA
"BLOODY IMPRESSIONS",1,NA
"BLOTTER",1,1
"BLOTTER PAPER",5,12
"BLOTTER PAPER SAMPLES",1,1
"BLOTTERS",1,2
"BLOW",1,NA
"BLOW FIES",1,NA
"BLOW FLIES",2,NA
"BLOW FLY",5,NA
"BLOWFLIES",6,NA
"BLOWFLY",3,NA
"BLUE CRAB",1,NA
"BLUE LIGHT EMITTING DIODE",1,NA
"BLUE TONING",1,NA
"BLUE WRITING INK",1,NA
"BLUEBERRY SPICE",1,NA
"BLUESTAR® FORENSIC",1,NA
"BLUESTAR® MAGNUM",1,NA
"BLUNT ABDOMINAL TRAUMA",1,NA
"BLUNT FORCE",1,NA
"BLUNT FORCE HEAD INJURY",1,NA
"BLUNT FORCE INJURY",1,NA
"BLUNT FORCE TRAUMA",3,NA
"BLUNT HEAD TRAUMA",1,NA
"BLUNT INJURY",2,NA
"BLUNT TRAUM.A.",1,NA
"BLUNT TRAUMA",1,NA
"BLUTALKOHOL, RESORPTIONSDEFIZIT",1,NA
"BLUTALKOHOLBESTIMMUNG, DURCH COMPUTERGESTEUERTE GASCHROMATOGRAPHIE",1,NA
"BMI",1,NA
"BNP",1,NA
"BOATING FATALITIES, ACCIDENT PREVENTION",1,NA
"BODILY FLUIDS",1,NA
"BODY-PACKER",2,NA
"BODY-PACKER SYNDROME",1,NA
"BODY-PACKING",3,NA
"BODY ART",1,NA
"BODY COOLING",1,NA
"BODY DEPOSITION SITE",1,NA
"BODY FAT-FREE MASS",1,NA
"BODY FAT EXTRACTS",1,NA
"BODY FLUID",22,1
"BODY FLUID-SPECIFIC MARKERS",1,NA
"BODY FLUID IDENTIFICATION",43,NA
"BODY FLUID LEVELS OF LSD",1,NA
"BODY FLUID MARKERS",1,NA
"BODY FLUID TYPING",1,NA
"BODY FLUIDS IDENTIFICATION",1,NA
"BODY FLUIDS, TISSUE—PHENAGLYCODOL DETERMINATION",1,NA
"BODY HAIR",2,NA
"BODY MASS INDEX",4,NA
"BODY MATERIALS",1,NA
"BODY PACKER",12,NA
"BODY PACKER SYNDROME",1,NA
"BODY PACKERS",3,NA
"BODY PACKING",17,2
"BODY POSITION",1,NA
"BODY PUSHER",1,NA
"BODY PUSHING",2,1
"BODY SITES",1,NA
"BODY STUFFER",7,1
"BODY STUFFERS",1,NA
"BODY STUFFING",2,NA
"BODY TEMPERATURE",1,NA
"BODYBUILDER",1,NA
"BODYBUILDERS",1,NA
"BODYBUILDING",2,1
"BODYPACKING",1,NA
"BODYPUSHING",1,NA
"BODYSTUFFER SYNDROME",1,NA
"BODYSTUFFING",1,NA
"BOILING POINT",1,NA
"BOLAM TEST",1,NA
"BOLD-IDS",1,NA
"BOLDENONE",1,NA
"BOLDNESS",1,NA
"BOLUS DEATH",1,NA
"BOMB-CURVE",1,NA
"BOMB-PULSE",1,1
"BOMB DATING",1,1
"BOMBING CASE",1,NA
"BONE",26,NA
"BONE AEROSOL",1,NA
"BONE CEMENT IMPLANTATION SYNDROME",1,NA
"BONE CHEMISTRY",1,NA
"BONE DIAGENESIS",1,NA
"BONE FRAGMENTATION",1,NA
"BONE HISTOLOGY",1,NA
"BONE HISTOMORPHOMETRY",1,NA
"BONE MARROW",13,NA
"BONE MARROW ASPIRATE",1,NA
"BONE MARROW HISTOLOGY",1,NA
"BONE METABOLISM",1,NA
"BONE MINERAL DENSITY",1,NA
"BONE ONTOGENETIC VARIATION",1,NA
"BONE PROTEOMICS",2,NA
"BONE REMAIN",1,NA
"BONE REMAINS",1,NA
"BONE TOXICOLOGY",1,NA
"BONES CLEANING",1,NA
"BONGKREKIC ACID POISONING",1,NA
"BOOBY TRAP",1,NA
"BOOK REVIEW",1,NA
"BOOKER",1,NA
"BOOPHANE DISTICHA",1,NA
"BORATE",1,1
"BORATE FUSION",1,NA
"BORDER LENGTH MINIMIZATION PROBLEM (BMP)",1,NA
"BORDER SECURITY",1,NA
"BORDERLINE",1,NA
"BORDERLINE PERSONALITY DISORDER",6,NA
"BORDERLINE PRODUCTS",1,1
"BORON-DOPED DIAMOND ELECTRODE",2,8
"BOSNIA AND HERZEGOVINA",1,NA
"BOSTON MARATHON BOMBINGS",1,NA
"BOTANY",1,NA
"BOTEST MATRIX",1,NA
"BOTTOM-UP PROTEOMICS",1,NA
"BOTULINUM",1,NA
"BOTULINUM TOXIN",1,NA
"BOTULISM",1,NA
"BOWEL OBSTRUCTION",2,NA
"BOWFLY",1,NA
"BOX-BEHNKEN MODEL",1,NA
"BOX-BEHNKEN MODELING",1,NA
"BOX AND WHISKER PLOT",1,NA
"BOX SERIES",1,1
"BPAQ-SF",1,NA
"BR-DMEQ",1,1
"BRADFORD HILL CRITERIA",1,NA
"BRADY NOTICES",1,NA
"BRADYCARDIA",1,NA
"BRADYKININ",1,NA
"BRAGG ANGLE",1,NA
"BRAIN",22,3
"BRAIN-BLOOD RATIO",1,NA
"BRAIN-DERIVED NEUROTROPHIC FACTOR PRECURSOR (PRO-BDNF)",1,NA
"BRAIN AND POST-MORTEM BLOOD ANALYSIS",1,NA
"BRAIN CONCENTRATION",1,NA
"BRAIN CONTUSION",1,NA
"BRAIN DAMAGE",4,NA
"BRAIN DEATH",5,NA
"BRAIN DEATH, REDUCED METABOLISM IN BRAIN",1,NA
"BRAIN DISTRIBUTION",1,NA
"BRAIN EDEMA",2,NA
"BRAIN HEALTH",1,NA
"BRAIN HYPOXIA",1,NA
"BRAIN INJURIES",2,NA
"BRAIN INJURY",6,NA
"BRAIN MICROVASCULAR ENDOTHELIAL CELL",1,NA
"BRAIN SCINTIGRAPHY",1,NA
"BRAIN TISSUE",4,NA
"BRAIN TRAUMA",1,NA
"BRAIN, WOUNDS AND INJURIES",1,NA
"BRAINSTEM",1,NA
"BRAKE FLUID",2,NA
"BRAKE FLUID, FATAL POISONING",1,NA
"BRAKE SYSTEM TROUBLE?",1,NA
"BRAND DRUG",1,NA
"BRAND IDENTIFICATION",2,NA
"BRANDED DRUGS",1,NA
"BRANDY",1,NA
"BRASSICACEAE",1,NA
"BRAZIL",10,1
"BRAZILIAN BUTT LIFT",1,NA
"BREACHES OF STANDARDS",3,NA
"BREAK",1,NA
"BREAK ENTER AND DIE SYNDROME",1,NA
"BREAKDOWN",1,NA
"BREAST AND LUNG CANCER CELLS",1,NA
"BREAST CANCER",1,NA
"BREAST CANCER HISTORY",1,NA
"BREAST MILK",5,3
"BREAST NEOPLASMS, DRUG THERAPY",1,NA
"BREAST NEOPLASMS, HISTORY",1,NA
"BREASTFEEDING",1,NA
"BREASTMILK",1,NA
"BREATH",2,NA
"BREATH-ALCOHOL ANALYSIS",1,NA
"BREATH ALCOHOL",2,NA
"BREATH ALCOHOL CONCENTRATION",2,NA
"BREATH ALCOHOL MEASURING",1,NA
"BREATH ALCOHOL TESTING",2,NA
"BREATH ANALYSIS",1,1
"BREATH DEPRESSION",1,NA
"BREATH TESTS",1,NA
"BREPHEDRONE",1,NA
"BRESCIA (NORTHERN ITALY)",1,NA
"BREUER, JOSEF",1,NA
"BRIBERY",1,NA
"BRIDE BURNING",1,NA
"BRIEF PSYCHOSES",1,NA
"BRIJ-35",1,1
"BRITISH FIREARMS LEGISLATION",1,NA
"BRIVARACETAM",1,NA
"BROAD-RANGE PCR",1,NA
"BROADBAND",2,1
"BRODIFACOUM",8,1
"BROKEN HOME",1,NA
"BROMADIOLONE",5,NA
"BROMADOL",1,2
"BROMAZEPAM",4,3
"BROMID, IM KNOCHEN",1,NA
"BROMIDE",1,NA
"BROMINATED FLAME RETARDANTS",2,NA
"BROMISOVAL",1,NA
"BROMISOVALUM",4,NA
"BROMO-DMA",1,NA
"BROMO-DRAGONFLY",1,1
"BROMOAMPHETAMINE ANALOGS",1,1
"BROMOUREIDES",1,NA
"BROMPERIDOL",2,NA
"BROMUREIDE, NACHWEIS BEI SKELETFUNDEN",1,NA
"BROMUREIDES, IN CADAVER",1,NA
"BROMVALERYLUREA",5,1
"BRONCHI",1,NA
"BRONCHIAL ASTHMA",2,NA
"BRONCHIOLITIS OBLITERANS",2,NA
"BRORPHINE",2,2
"BROTIZOLAM",1,NA
"BROUGHT DEAD CASE",1,NA
"BROWARD COUNTY",1,NA
"BROWN HEROIN",1,1
"BRUCINE",4,NA
"BRUISING",1,NA
"BRUXISM",1,NA
"BRYDE'S WHALE (BALAENOPTERA EDENI)",1,NA
"BSA",1,NA
"BSI-25-F",1,NA
"BST DNA POLYMERASE",1,NA
"BT ALLELE",1,NA
"BTG2",1,NA
"BUFADIENOLIDES",1,1
"BUFALIN",2,1
"BUFFER GAS",1,NA
"BUFLOMÉDIL",1,NA
"BUFOTENINE",2,6
"BUILDING A THERAPEUTIC RELATIONSHIP",1,NA
"BUILT ENVIRONMENT",1,NA
"BULB FILAMENT EXAMINATION",1,NA
"BULK ISOTOPE RATIOS",1,2
"BULLET",1,NA
"BULLY VICTIMIZATION",1,NA
"BULLYING",2,NA
"BUPHANDRIN",1,NA
"BUPHANINE",1,NA
"BUPHEDRONE",2,2
"BUPHEDRONE DETECTION",1,NA
"BUPIVACAINE",3,1
"BUPIVACAINE TOXICITY",1,NA
"BUPRENORPHIN",1,NA
"BUPRENORPHINE",40,3
"BUPRENORPHINE MISUSE",1,NA
"BUPROPION",4,1
"BUPROPION METABOLITE",1,NA
"BURDEN OF DISEASE",1,NA
"BURDEN OF PROOF",1,NA
"BURGLARY",2,NA
"BURIAL",5,NA
"BURN",8,NA
"BURNED BODY",2,NA
"BURNED BONE FRAGMENTS",1,NA
"BURNED BONES",1,NA
"BURNING RATE",1,NA
"BURNOUT",1,NA
"BURNOUT SYNDROME",1,NA
"BURNS, PATHOLOGY AND BIOLOGY",1,NA
"BURNT BODIES",1,NA
"BUSH MEAT",1,NA
"BUSINESS RECORDS",1,NA
"BUSPIRONE",1,NA
"BUTALBITAL",2,NA
"BUTANAMINES",1,NA
"BUTANE",10,NA
"BUTANE-PROPANE POISONING",1,NA
"BUTHYRYLTHIOCHOLINE",1,NA
"BUTTER",1,NA
"BUTYL GLUCURONIDE",1,NA
"BUTYLSCOPOLAMINE BROMIDE",1,NA
"BUTYRFENTANYL",2,NA
"BUTYRFENTANYL POISONING",1,NA
"BUTYROPHENONES",1,NA
"BUTYROPHENONES, SEP-PAK C18 CARTRIDGES",1,NA
"BUTYRYL CHOLINESTERASE",1,NA
"BUTYRYLCHOLINESTERASE",1,NA
"BUTYRYLFENTANYL",1,1
"BY-40",1,NA
"BY-PRODUCT",2,7
"BY-PRODUCTS OF LEUCKART REACTION",1,NA
"BZ",1,NA
"BZP",3,3
"C-FOS",1,NA
"C-FOS PROTEIN",1,NA
"C-JUN",1,NA
"C-PEPTIDE",3,NA
"C-PTSD",1,NA
"C-REACTIVE PROTEIN",2,NA
"C. COLLINUS",1,NA
"C.COLLINUS",1,NA
"C/P RATIO",1,NA
"C1 ESTERASE INHIBITOR",1,NA
"C1 ESTERASE INHIBITOR DEFICIENCY",1,NA
"C11-CANN1",1,2
"C18 PIPETTE-TIP",1,NA
"C4D",2,2
"CA",1,1
"CA CHANNEL OF THE MEMBRANE",1,NA
"CA FIELD",1,NA
"CABERGOLINE",1,NA
"CABIN PARTICULATE SPECIATION",1,NA
"CABOHYDRATE CHEMISTRY",1,NA
"CACO-2 CELLS",1,NA
"CACTACEAE",2,NA
"CADAVER",6,NA
"CADAVER DECOMPOSITION",1,NA
"CADAVER DECOMPOSITION ISLAND",1,NA
"CADAVER IDENTIFICATION",1,NA
"CADAVER ODOR",1,NA
"CADAVERIC BLOOD",1,NA
"CADAVERIC ENTOMOTOXICOLOGY",1,NA
"CADAVERIC ORGAN TRANSPLANTATION",1,NA
"CADHERIN",1,NA
"CADMIUM",1,1
"CADMIUM CHLORIDE",1,NA
"CADMIUM POISONING",1,NA
"CADMIUM SULFIDE",1,NA
"CADMIUM TELLURIDE",1,NA
"CAESIUM 135",1,NA
"CAESIUM 137",1,NA
"CAFÉ CORONARY",1,NA
"CAFFEINATED DRINKS",1,NA
"CAFFEINE",31,28
"CAFFEINE-INTOXICATION",1,NA
"CAFFEINE INTOXICATION",1,NA
"CAFFEINE TOXICITY",1,NA
"CALCINEURIN A",1,NA
"CALCIUM-CHANNEL ANTAGONISTS",1,NA
"CALCIUM CHANNEL BLOCKER (CCB)",1,NA
"CALCIUM CHANNEL BLOCKER OVERDOSE",1,NA
"CALCIUM CHANNEL BLOCKERS",1,NA
"CALCIUM IMAGING",1,NA
"CALCIUM OXALATE",1,NA
"CALCULATIONS",1,1
"CALIBRATION",4,3
"CALIBRATION-LOCKING DATABASE",4,1
"CALIBRATION MATRIX",1,NA
"CALIBRATION MODELS",1,NA
"CALIBRATION STRATEGY",1,NA
"CALIBRATOR",1,NA
"CALIFORNIA",1,1
"CALIFORNIUM",1,NA
"CALLIHORIDAE",1,NA
"CALLILEPIS LAUREOLA",1,NA
"CALLIPHORA",2,NA
"CALLIPHORA AUGUR",1,NA
"CALLIPHORA STYGIA",2,NA
"CALLIPHORA VICINA",4,NA
"CALLIPHORA VOMITORIA",3,NA
"CALLIPHORIDAE",12,NA
"CALLOUS-UNEMOTIONAL TRAITS",1,NA
"CALMODULIN-BINDING PROTEINS",1,NA
"CALSEQUESTRIN",1,NA
"CALSEQUESTRIN 2",1,NA
"CAM",1,NA
"CAMEL",1,NA
"CAMELLIA SINENSIS",1,NA
"CAMK II Α",1,NA
"CAMPUS CRIME",1,NA
"CAMS",1,NA
"CANABINOL",1,NA
"CANADA",3,4
"CANAL DISTRICT",1,NA
"CANARY ISLANDS",1,1
"CANCELLOUS BONE",1,NA
"CANCER",4,NA
"CANCER THERAPY",2,NA
"CANCER TREATMENT",1,NA
"CANDIDA ALBICANS",1,NA
"CANDIDA RUGOSA LIPASE NANOCONJUGATES",1,NA
"CANFOR",1,NA
"CANINE",4,NA
"CANINE ACCURACY",1,1
"CANINE ALERT",1,NA
"CANINE DETECTION",4,2
"CANINE SCAVENGING",1,NA
"CANINE STR",1,NA
"CANINE TOXICOSIS",1,NA
"CANINE TRAINING AIDS",1,NA
"CANIS LUPUS VAR. FAMILIARIS",1,NA
"CANNABICHROMENE (CBC)",1,4
"CANNABICYCLOHEXANOL",2,2
"CANNABIDIOL (CBD)",25,65
"CANNABIGEROL (CBG)",1,4
"CANNABIMIMETIC",9,10
"CANNABIMIMETIC DRUG",1,1
"CANNABIMIMETIC INDOLE",4,4
"CANNABINOID-1 RECEPTOR",1,NA
"CANNABINOID ANTIBODIES",1,NA
"CANNABINOID CONTENT",1,2
"CANNABINOID GLUCURONIDE",1,NA
"CANNABINOID HYPEREMESIS SYNDROME",2,NA
"CANNABINOID IMMUNOGENS",1,NA
"CANNABINOID METABOLITES",2,NA
"CANNABINOID RECEPTOR",2,NA
"CANNABINOID RECEPTOR AGONISTS",1,NA
"CANNABINOIDE",1,NA
"CANNABINOIDS AND DERIVATIVES",254,239
"CANNABINOIDS COMPOSITION",1,1
"CANNABINOIDS EXTRACTION",1,2
"CANNABINOL (CBN)",1,1
"CANNABINOLS",1,NA
"CANNABIS ABUSE",1,NA
"CANNABIS AND DERIVATIVES",160,196
"CANNABIS CHEMOTYPE",1,1
"CANNABIS DEPENDENCE",1,NA
"CANNABIS EXPOSURE DIAGNOSIS",1,NA
"CANNABIS GENOME",1,NA
"CANNABIS INFLUENCE FACTOR",1,NA
"CANNABIS OIL",1,3
"CANNABIS ORIGIN",1,NA
"CANNABIS POTENCY",1,2
"CANNABIS PRICES",1,1
"CANNABIS PRODUCTS",2,1
"CANNABIS PROFILING",1,1
"CANNABIS RESIN",4,4
"CANNABIS SALIVA",1,NA
"CANNABIS SATIVA L.",25,110
"CANNABIS SATIVA/INDICA",1,NA
"CANNABIS SEIZURE",1,1
"CANNABIS USE DISORDER",1,NA
"CANNABIS/DRIVERS",1,NA
"CANNABISSP.",1,1
"CANNABOID RECEPTOR",1,NA
"CANNIBALISM",1,NA
"CANTHARIDES",1,NA
"CAOWU",1,NA
"CAPACITANCE",1,NA
"CAPACITIES",1,NA
"CAPACITY",4,1
"CAPACITY FOR CONTROL",1,NA
"CAPE TOWN",1,NA
"CAPILLARIES",2,NA
"CAPILLARY-ARRAY ELECTROPHORESIS",1,NA
"CAPILLARY BLOOD",1,NA
"CAPILLARY COLUMN",3,1
"CAPILLARY COLUMN GAS CHROMATOGRAPHY",1,NA
"CAPILLARY COLUMNS",1,NA
"CAPILLARY ELECTOPHORESIS",1,NA
"CAPILLARY ELECTROCHROMATOGRAPHY",5,19
"CAPILLARY ELECTROCHROMATROGRAPHY",1,NA
"CAPILLARY ELECTROMIGRATION TECHNIQUES",1,1
"CAPILLARY ELECTROPHORESIS",128,173
"CAPILLARY ELECTROPHORESIS-ELECTROSPRAY IONIZATION MASS SPECTROMETRY",1,1
"CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRY",6,6
"CAPILLARY ELECTROPHORESIS - MASS SPECTROMETRY",2,1
"CAPILLARY ELECTROPHORESIS AND CAPILLARY ELECTROCHROMATOGRAPHY",1,1
"CAPILLARY ELECTROPHORESIS IMMUNOASSAY (CEIA)",1,NA
"CAPILLARY GAS-CHROMATOGRAPHY",1,NA
"CAPILLARY GAS CHROMATOGRAPHY",5,3
"CAPILLARY GC",6,NA
"CAPILLARY GC ECD",1,NA
"CAPILLARY GC/NPD",1,NA
"CAPILLARY GLC ANALYSIS",1,NA
"CAPILLARY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY",2,1
"CAPILLARY HPLC",2,1
"CAPILLARY ION ELECTROPHORESIS",2,NA
"CAPILLARY LIQUID CHROMATOGRAPHY",1,NA
"CAPILLARY MICROEXTRACTION (CME)",1,NA
"CAPILLARY MICROEXTRACTION OF VOLATILES",1,NA
"CAPILLARY MICROSAMPLING",1,NA
"CAPILLARY ZONE ELECTROPHORESIS",10,21
"CAPITAL EXPENSE",1,NA
"CAPITAL PUNISHMENT",1,NA
"CAPSAICIN",2,NA
"CAPSAICINOIDS",2,NA
"CAPSULE",2,4
"CAPTAGON FENETHYLLINE, COUNTERFEIT DRUGS",1,1
"CAR COATING",1,NA
"CAR DRIVERS",2,NA
"CAR EXHAUSTS",1,NA
"CAR PAINTS",2,NA
"CARBACHOL",1,NA
"CARBAMATE",2,NA
"CARBAMATE PESTICIDES",1,NA
"CARBAMATES",1,NA
"CARBAMAZEPINE",10,2
"CARBAMAZEPINE-10,11-EPOXIDE",1,NA
"CARBAMAZEPINE, DETERMINATION IN BLOOD",1,NA
"CARBAMIDE PEROXIDE",1,NA
"CARBAZOLE DERIVATIVE",1,NA
"CARBIDE",1,NA
"CARBIMAZOLE",1,NA
"CARBOFURAN",4,NA
"CARBOFURAN METABOLITES",1,NA
"CARBOHYDRATE-DEFICIENT TRANSFERRIN",2,NA
"CARBOHYDRATE CROSS-REACTIVE DETERMINANTS (CCDS)",1,NA
"CARBOHYDRATE DEFICIENT TRANSFERRIN",1,NA
"CARBOHYDRATE DEFICIENT TRANSFERRIN (CDT)",1,NA
"CARBOHYDRATES",1,3
"CARBON",1,2
"CARBON-13",1,1
"CARBON-BASED BLACK GEL INK",2,NA
"CARBON-BASED ELECTRODES",1,NA
"CARBON-BASED SENSOR",1,NA
"CARBON-BASED SUBSTRATES",1,NA
"CARBON COATED MAGNETIC NANOPARTICLES",1,NA
"CARBON DIOXIDE",2,1
"CARBON DIOXIDE POISONING",1,NA
"CARBON DOTS",2,5
"CARBON ELECTRODE",3,NA
"CARBON FILM RING-DISK ELECTRODE",1,NA
"CARBON ISOTOPE RATIO",2,3
"CARBON ISOTOPES",1,1
"CARBON MONOXIDE",15,NA
"CARBON MONOXIDE INTOXICATION",1,NA
"CARBON MONOXIDE POISONING",5,NA
"CARBON MONOXIDE SATURATION",1,NA
"CARBON NANO PARTICLES",1,NA
"CARBON NANOTUBE",3,11
"CARBON QUANTUM DOTS",1,1
"CARBON TETRACHLORIDE-POISONING-ORAL INGESTION- DISTRIBUTION",1,NA
"CARBONACEOUS NANOMATERIALS",1,NA
"CARBONATE",1,NA
"CARBONIC ANHYDRASE INHIBITORS",1,NA
"CARBONIZATION",1,NA
"CARBONYL SOURCE",1,NA
"CARBOPHENOTHION",1,NA
"CARBOSULFAN",4,NA
"CARBOXAMIDE-TYPE SYNTHETIC CANNABINOID",1,NA
"CARBOXYATRACTYLOSIDE",1,NA
"CARBOXYHEMOGLOBIN",6,NA
"CARBOXYHEMOGLOBIN CONCENTRATIONS",1,NA
"CARBOXYL DERIVATIZATION",1,NA
"CARBOXYLATED MAGNETIC NANOPARTICLES",1,NA
"CARBOXYLESTERASE",2,NA
"CARBOXYLESTERASES",1,NA
"CARBROMAL",1,NA
"CARDARINE",1,NA
"CARDENOLIDES",1,NA
"CARDIAC",4,NA
"CARDIAC-SPECIFIC",1,NA
"CARDIAC AGLYCONES",1,NA
"CARDIAC ARREST",2,NA
"CARDIAC ARRHYTHMIA",6,NA
"CARDIAC ARRHYTHMIAS",1,NA
"CARDIAC BLOOD",3,NA
"CARDIAC CHANGES",1,NA
"CARDIAC CHANNELOPATHIES",1,NA
"CARDIAC CONDUCTION SYSTEM",1,NA
"CARDIAC CONGESTION",1,NA
"CARDIAC CONTUSION",1,NA
"CARDIAC DAMAGE",1,NA
"CARDIAC DEATH",2,NA
"CARDIAC DEATHS",1,NA
"CARDIAC DISEASE, SERUM LEVELS OF DIGOXIN",1,NA
"CARDIAC DYSFUNCTION",1,NA
"CARDIAC FLOW",1,NA
"CARDIAC FUNCTION",1,NA
"CARDIAC GLYCOSIDES",4,NA
"CARDIAC HISTOPATHOLOGY",1,NA
"CARDIAC ISCHEMIA",1,NA
"CARDIAC MARKER",1,NA
"CARDIAC RHABDOMYOMA",1,NA
"CARDIAC SAFETY SIMULATOR",1,NA
"CARDIAC SODIUM CHANNEL",1,NA
"CARDIAC SUDDEN DEATH",1,NA
"CARDIAC SURGERY",1,NA
"CARDIAC TAMPONADE",3,NA
"CARDIAC TISSUE",2,NA
"CARDIAC TOXICITY",2,NA
"CARDIAC TROPONIN I",2,NA
"CARDIAC TROPONIN INHIBITOR (CTNI)",1,NA
"CARDIAC TROPONIN T",1,NA
"CARDIAC TROPONINS",1,NA
"CARDIAC VALVULOPATHY",1,NA
"CARDIO-TOXICITY",2,NA
"CARDIOACTIVE SUBSTANCES",1,NA
"CARDIOGENETICS",1,NA
"CARDIOLOGICAL GUIDELINES",1,NA
"CARDIOMYOPATHY",6,NA
"CARDIOPULMONARY RESUSCITATION",5,NA
"CARDIORESPIRATORY FUNCTION",1,NA
"CARDIOTHORACIC RATIO",1,NA
"CARDIOTONIC GLYCOSIDES",1,NA
"CARDIOTOXICITY",4,NA
"CARDIOTOXICITY UHPLC-MS/MS",1,NA
"CARDIOTROPONIN T",1,NA
"CARDIOVASCULAR",3,NA
"CARDIOVASCULAR AGENTS",2,NA
"CARDIOVASCULAR DEATH",2,NA
"CARDIOVASCULAR DISEASE",13,NA
"CARDIOVASCULAR DISEASES",3,NA
"CARDIOVASCULAR DISORDER",1,NA
"CARDIOVASCULAR DRUGS",2,NA
"CARDIOVASCULAR EFFECTS",1,NA
"CARDIOVASCULAR RISK",1,NA
"CARDIOVASCULAR SIDE EFFECTS",1,NA
"CARDIOVASCULAR TOXICITY",2,NA
"CARE",1,NA
"CARE-PROVIDING AUTHORITIES",1,NA
"CARE ETHICS",1,NA
"CARE IN CUSTODY",1,NA
"CARE PATHWAY",1,NA
"CARFENTANIL",14,12
"CARFENTANYL",1,NA
"CARIES",1,NA
"CARIOPULMONARY RESUSCITATION",1,NA
"CARISOPRODOL",8,1
"CARL AUER VON WELSBACH",1,NA
"CARNITINE",1,1
"CARNITINE PALMITOYLTRANSFERASE II",3,NA
"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY",1,NA
"CARNIVORE SCAVENGING",1,NA
"CAROTENOIDS",1,2
"CAROTID",1,NA
"CAROTID BODY HYPERPLASIA",1,NA
"CARPET FIBERS",1,NA
"CARPROFEN",1,NA
"CARRIER-FREE",1,NA
"CARRIER GAS",1,1
"CARRION FLY",1,NA
"CARTAP",1,NA
"CARTRIDGE CASE",2,NA
"CARTRIDGE CASES",1,NA
"CAS REGISTRY",1,1
"CASE",1,NA
"CASE-CONTROL",1,NA
"CASE-CONTROL STUDIES",1,NA
"CASE-CONTROL STUDY",1,NA
"CASE-CROSSOVER",1,NA
"CASE-LOAD CHARACTERISTICS",1,NA
"CASE-STUDY",1,NA
"CASE ANALYSIS",3,NA
"CASE ASSESSMENT",1,NA
"CASE ATTRITION",1,NA
"CASE CONTROL STUDIES",1,NA
"CASE CONTROL STUDY",1,NA
"CASE DEFINITIONS",1,NA
"CASE FORMULATION BASED ON THOROUGH ASSESSMENT - OF PROBLEM BEHAVIORS, FUNCTIONAL ANALYSES OF BEHAVIORS",1,NA
"CASE HISTORIES",3,NA
"CASE HISTORY",1,NA
"CASE LAW",2,NA
"CASE MANAGEMENT",2,NA
"CASE PROFILING",2,NA
"CASE RECORDS",1,NA
"CASE REPORT",18,2
"CASE SERIES",1,NA
"CASE STRATEGY",1,NA
"CASE STUDY",6,2
"CASES' MANAGEMENT",1,NA
"CASES ANALYSIS",3,NA
"CASES STUDY",1,NA
"CASEWORK",4,NA
"CASEWORK SAMPLES",1,NA
"CASPASE-3",3,NA
"CASPASE-9",1,NA
"CASS",1,NA
"CASSIA ITALICA LAM. EX.",1,NA
"CAST IRON ENGINE BLOCK",1,NA
"CASTOR BEAN",1,NA
"CASTRATION",2,NA
"CASUALTIES",1,NA
"CATACHOLAMINES",1,NA
"CATALASE-LIKE ACTIVITY",1,NA
"CATALEPSY",1,NA
"CATALYST",2,NA
"CATATONIA",1,NA
"CATECHOL",1,NA
"CATECHOL-O-METHYLTRANSFERASE",1,NA
"CATECHOLAMINE",3,NA
"CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA",1,NA
"CATECHOLAMINES",2,NA
"CATEGORICAL DIAGNOSES",1,NA
"CATHA EDULIS",4,19
"CATHEPSIN D",1,NA
"CATHINE",7,15
"CATHINE (D-NORPSEUDOEPHEDRINE)",1,NA
"CATHINONE",62,92
"CATHINONE ANALOGS",1,2
"CATHINONE ANALOGUES",1,NA
"CATHINONE DERIVATIVE",11,8
"CATHINONE DRUG",1,NA
"CATHINONES SYNTHESIS",1,NA
"CATHODICALLY PRE-TREATED BDD ELECTRODE",1,NA
"CATION",1,3
"CATION-EXCHANGE",1,4
"CATOPIDAE",1,NA
"CATTLE",4,NA
"CATTLE GENOTYPING",1,NA
"CAUDAL VEIN",1,NA
"CAUDATE",1,NA
"CAUSAL CHAIN",1,NA
"CAUSAL CONNECTION",1,NA
"CAUSALGIA",1,NA
"CAUSALITY",3,1
"CAUSATION",1,NA
"CAUSATIVE POTENCY",1,NA
"CAUSE",1,NA
"CAUSE-OF-DEATH CERTIFICATION",1,NA
"CAUSE-OF-DEATH CODING",2,NA
"CAUSE-OF-DEATH RECORDING",1,NA
"CAUSE-OF-DEATH STATISTICS",1,NA
"CAUSE AND MANNER OF DEATH",3,NA
"CAUSE OF DEATH",82,1
"CAUSE OF DEATH DETERMINATION",1,NA
"CAUSE OF DEATH INVESTIGATION",1,NA
"CAUSE, TIME OF ORIGIN AND FORENSIC DIFFERENTIAL DIAGNOSIS",1,NA
"CAUSES",1,NA
"CAUSTIC SUBSTANCES",1,NA
"CAVUM SEPTUM PELLUCIDUM",1,NA
"CAVY HAIR",1,NA
"CB 2-SELECTIVE AGONIST",1,1
"CB1 ACTIVITY",1,NA
"CB1 AGONIST",1,NA
"CB1 RECEPTOR",2,NA
"CB1 RECEPTORS",2,NA
"CB1/CB2 RECEPTOR AGONIST",1,NA
"CBD TO THC CONVERSION",1,NA
"CBD TRANSFORMATION",1,NA
"CBDA SYNTHASE",1,2
"CBDAS",2,2
"CBG",1,3
"CBIR",2,NA
"CBN",1,4
"CBRN DEFENSE",1,NA
"CCK-8",1,NA
"CCK RECEPTOR ANTAGONISTS",2,NA
"CCL4-INTOXICATION",1,NA
"CCL4 INTOXICATION",1,NA
"CD (II) COMPLEX",1,NA
"CD15",1,NA
"CD52",1,NA
"CDC SCREENING GUIDELINES",1,NA
"CDNA SCREENING",1,NA
"CDSN",1,NA
"CDT",3,NA
"CE(IV)",1,1
"CEC",2,4
"CEDIA",3,NA
"CEFACLOR",1,NA
"CEFAZOLIN",1,NA
"CEFEPIME",1,NA
"CEFOPERAZONE",1,NA
"CEFTRIAXONE",2,NA
"CEFUROXIME AXETIL",1,NA
"CELEBRITY DEATHS",1,NA
"CELITE",1,NA
"CELL-FREE DNA",1,NA
"CELL-FREE FETAL DNA",3,NA
"CELL-FREE NUCLEIC ACIDS (CNAS)",1,NA
"CELL ADHESION",1,NA
"CELL AUTOLYSIS",1,NA
"CELL COUNTING",1,NA
"CELL CYCLE",1,NA
"CELL ELUTION",1,NA
"CELL FREE DNA",1,NA
"CELL FREE NUCLEIC ACIDS (CNAS)",1,NA
"CELL IMAGING",1,NA
"CELL LINE IDENTIFICATION",1,NA
"CELL MEMBRANE",1,NA
"CELL PHONES",1,NA
"CELL PROLIFERATION",1,NA
"CELL SEPARATION",2,NA
"CELL SIGNALING ASSAYS",1,NA
"CELL SORTING",1,NA
"CELLULAR MECHANISMS",1,NA
"CELLULOSE",1,3
"CELLULOSE ACETATE MEMBRANE",1,NA
"CELLULOSIC SAMPLES",1,NA
"CEMENTED ARTHROPLASTY",1,NA
"CEMENTUM ENAMEL JUNCTION",1,NA
"CEMETERY",1,NA
"CENSUS",1,NA
"CENTER OF GRAVITY ALGORITHM",1,1
"CENTERS FOR DISEASE CONTROL AND PREVENTION",1,NA
"CENTRAL BLOOD",6,NA
"CENTRAL GREECE",1,NA
"CENTRAL METABOLISM",1,NA
"CENTRAL NERVOUS AGENTS",1,NA
"CENTRAL NERVOUS SYSTEM",2,2
"CENTRAL NERVOUS SYSTEM (CNS)",1,NA
"CENTRAL NERVOUS SYSTEM DEPRESSION",1,NA
"CENTRAL NERVOUS SYSTEM STIMULANTS",1,NA
"CENTRAL PONTINE MYELINOLYSIS",1,NA
"CENTRAL STIMULANTS",1,1
"CENTRAL VENOUS CATHETER",1,NA
"CENTRALLY ADMINISTERED DRUGS",1,NA
"CENTRALLY MEDIATED",1,NA
"CENTRALLY STIMULATING AMINES",1,NA
"CENTRE OF PORTUGAL",1,NA
"CENTRIFUGAL DEVICES",1,NA
"CENTRIFUGATION",1,NA
"CENTRILOBULAR",1,NA
"CENTRO NAZIONALE DIPENDENZE E DOPING",1,NA
"CEO2-CB NANOCOMPOSITE",1,NA
"CEPHAELINE",1,NA
"CEPHALOSPORINS",3,NA
"CERA",1,NA
"CERBERA MANGHAS L.",1,NA
"CERBERA ODOLLAM",1,NA
"CERBERIN",1,NA
"CEREBELLAR CORTEX",1,NA
"CEREBELLAR INFARCTION",1,NA
"CEREBELLUM",1,NA
"CEREBRAL ANEURYSM",1,NA
"CEREBRAL ARTERIES",1,NA
"CEREBRAL BLOOD FLOW",1,NA
"CEREBRAL CORTEX",1,NA
"CEREBRAL DEATH SYNDROME",1,NA
"CEREBRAL HEMORRHAGE",2,NA
"CEREBRAL HYPOXIA",1,NA
"CEREBRAL INFARCTS",1,NA
"CEREBRAL MALARIA",1,NA
"CEREBRAL PALSY",1,NA
"CEREBRAL REGIONS RELATED TO MORPHINE DEPENDENCE",1,NA
"CEREBRAL VENOUS THROMBOSIS",1,NA
"CEREBROSPINAL FLUID",8,NA
"CEREBROVASCULAR ACCIDENTS",1,NA
"CEREBROVASCULAR DISEASE",1,NA
"CERTIFICATION",4,1
"CERTIFICATION OF DEATH",1,NA
"CERTIFIED REFERENCE MATERIAL",1,1
"CERTIFIED REFERENCE MATERIAL (CRM)",2,NA
"CERTIFIED REFERENCE MATERIALS",2,NA
"CERUMEN",3,NA
"CERVI CORNU PANTOTRICHUM",1,NA
"CERVICAL DYSTONIA",1,NA
"CERVICAL NECROTIZING FASCIITIS",1,NA
"CESIUM-133",1,NA
"CESIUM-135",1,NA
"CESIUM-137",2,NA
"CESIUM ISOTOPE RATIO",1,NA
"CETACEANS",1,NA
"CETUXIMAB",1,NA
"CETYLTRIMETHYLAMMONIUM BROMIDE (CTAB)",1,NA
"CFDNA",2,NA
"CGC",1,NA
"CHAGAS DISEASE - TRYPANOSOMA CRUZI",1,NA
"CHAID",1,NA
"CHAIN OF CUSTODY",3,NA
"CHAIN SAW",2,NA
"CHAINSAW",1,NA
"CHALLENGES",1,NA
"CHAN SU",2,1
"CHANGED COMPOUNDS",1,NA
"CHANGES DURING THE POSTMORTEM INTERVAL",1,NA
"CHANGES IN DRUG CONSUMPTION",1,NA
"CHANGES IN PATTERNS OF DRUG USE",1,NA
"CHANGING TRENDS",1,NA
"CHANNELOPATHIES",1,NA
"CHANNELOPATHY",2,NA
"CHANSU",1,NA
"CHAOSHAN GROUP",1,NA
"CHARACTERISATION",1,2
"CHARACTERISATION (NMR, FT-IR)",2,2
"CHARACTERISATION OF DRUGS IN CT",1,NA
"CHARACTERISTIC COMPOUNDS",1,NA
"CHARACTERISTIC FEATURES",1,NA
"CHARACTERISTIC FRAGMENT ION",1,NA
"CHARACTERISTIC FRAGMENTATION",1,1
"CHARACTERISTIC IONS",1,NA
"CHARACTERISTIC PEAK METHOD",2,3
"CHARACTERISTICS",1,1
"CHARACTERIZATION",3,8
"CHARACTERIZATION OF NANOPARTICLES",1,NA
"CHARACTERIZATION OF SYNTHETIC GLASSES",1,NA
"CHARACTERIZATION, FENTALOGS, FENTANYL, GC-EI-MS, SYNTHETIC OPIOIDS, TRIAGE",1,NA
"CHARCOAL BURNING",1,NA
"CHARGED AEROSOL DETECTOR",1,3
"CHARGED PARTICLE",1,NA
"CHARRED DOCUMENTS",1,NA
"CHARRING",1,NA
"CHCA",1,1
"CHD GENE",1,NA
"CHEESE",1,NA
"CHEILOSCOPY",3,NA
"CHELATE",1,NA
"CHELATE FORMATION",1,NA
"CHELATES",1,NA
"CHELATING AGENTS",1,NA
"CHELEX",1,NA
"CHELEX 100",1,NA
"CHEMICAL",3,3
"CHEMICAL-CLINICAL CORRELATIONS",1,NA
"CHEMICAL-TOXICOLOGICAL ANALYSIS OF MUNICIPAL SEWAGE",1,NA
"CHEMICAL-TOXICOLOGICAL EXAMINATION",1,NA
"CHEMICAL ABSTRACTS SERVICE",1,1
"CHEMICAL ADDICTION",1,NA
"CHEMICAL ADULTERANTS",1,1
"CHEMICAL ANALYSIS",10,9
"CHEMICAL AND BIOLOGICAL MATERIALS",1,NA
"CHEMICAL AND BIOLOGICAL WEAPONS",1,NA
"CHEMICAL ATTACK",1,NA
"CHEMICAL ATTRIBUTE SIGNATURES",1,NA
"CHEMICAL ATTRIBUTION SIGNATURE",1,NA
"CHEMICAL ATTRIBUTION SIGNATURES",2,NA
"CHEMICAL BODY CONCEALMENT",1,NA
"CHEMICAL BURNS",1,NA
"CHEMICAL CHARACTERIZATION",1,6
"CHEMICAL CLASSIFICATION",1,1
"CHEMICAL COMPOSITION",4,6
"CHEMICAL CONTAMINANT",1,NA
"CHEMICAL DERIVATIZATION",2,4
"CHEMICAL DESTRUCTION",1,NA
"CHEMICAL DETECTION",1,NA
"CHEMICAL DISTRIBUTION IN TISSUES",1,1
"CHEMICAL ETCHING",1,NA
"CHEMICAL FINGERPRINT",5,2
"CHEMICAL FORCE MICROSCOPY",1,NA
"CHEMICAL FORENSICS",6,1
"CHEMICAL FRACTIONATION",1,NA
"CHEMICAL FUNCTIONAL ANALYSIS OF LABELS, AND SUSPECT, VISUAL, FROM SLM",1,1
"CHEMICAL HAZARDS",1,1
"CHEMICAL HYDROLYSIS",1,NA
"CHEMICAL IDENTIFICATION",1,5
"CHEMICAL IMAGE",1,1
"CHEMICAL IMAGING",8,4
"CHEMICAL IMPURITY PROFILING",1,1
"CHEMICAL IONIZATION",8,9
"CHEMICAL LINK",1,NA
"CHEMICAL LINKS",1,NA
"CHEMICAL MAPPING",1,1
"CHEMICAL PRINTER",1,NA
"CHEMICAL PROFILE",4,5
"CHEMICAL PROFILES",1,NA
"CHEMICAL PROFILING",12,14
"CHEMICAL RISK",1,NA
"CHEMICAL SENSORS",1,4
"CHEMICAL SEPARATION",1,NA
"CHEMICAL SEPARATIONS",1,NA
"CHEMICAL SPECIATION",1,NA
"CHEMICAL SPOT TEST",1,1
"CHEMICAL STABILITY",1,NA
"CHEMICAL STRUCTURE",1,NA
"CHEMICAL SUBMISSION",14,3
"CHEMICAL SYNTHESIS",2,4
"CHEMICAL TERRORISM",1,NA
"CHEMICAL THREAT AGENTS",1,NA
"CHEMICAL TOXICOLOGICAL ANALYSIS",2,NA
"CHEMICAL TOXICOLOGICAL INVESTIGATIONS",1,NA
"CHEMICAL TOXICOLOGY",1,NA
"CHEMICAL TRACERS",1,1
"CHEMICAL TRACKING",1,NA
"CHEMICAL VULNERABILITY",1,NA
"CHEMICAL WARFARE AGENTS (CWAS)",12,6
"CHEMICAL WEAPONS",2,NA
"CHEMICALLY DISPERSED OIL",1,NA
"CHEMICALLY MASKED",1,NA
"CHEMICALLY MODIFIED CAPILLARY",1,2
"CHEMICALLY MODIFIED ELECTRODE",1,5
"CHEMICALS",2,1
"CHEMICALS POISONING",1,NA
"CHEMICALS WEAPONS CONVENTION",1,NA
"CHEMICALTOXICOLOGICAL ANALYSIS",1,NA
"CHEMIINFORMATICS",1,NA
"CHEMILUMINESCENCE",10,20
"CHEMILUMINESCENCE DETECTION",2,7
"CHEMILUMINESCENCE IMMUNOCHEMICAL ASSAY",1,NA
"CHEMILUMINESCENCE NITROGEN DETECTION",1,2
"CHEMIOVARIANTS",1,NA
"CHEMISTRY",16,23
"CHEMO-BRAIN",1,NA
"CHEMO-FOG",1,NA
"CHEMO-TOXICOLOGICAL ANALYSIS",2,NA
"CHEMOGRAPHIC DETECTION METHODS",1,NA
"CHEMOKINES",1,NA
"CHEMOMETRIC METHOD APPLICATION IN DRUG PURITY DETERMINATION BY CE",1,NA
"CHEMOMETRIC METHODS IN DRUG PURITY DETERMINATION",1,NA
"CHEMOMETRIC PROCEDURES",1,1
"CHEMOMETRICS",50,86
"CHEMORE",2,NA
"CHEMOSELECTIVITY",1,1
"CHEMOSENSOR",1,NA
"CHEMOSENSOR FOR PARAQUAT",1,NA
"CHEMOTAXONOMY",1,3
"CHEMOTHERAPEUTIC DRUGS",1,NA
"CHEMOTHERAPY",1,1
"CHEMOTHERAPY-INDUCED COGNITIVE IMPAIRMENT",1,NA
"CHEMOTYPE",3,15
"CHEMSEX",4,1
"CHEMSPIDER",1,1
"CHEMSTATION® MACRO PROGRAMMING",1,NA
"CHEN-KAO TEST",1,1
"CHENNAI",1,NA
"CHEST HAIR",1,NA
"CHEST WALL RIGIDITY",1,NA
"CHEVEUX",1,NA
"CHEWING-GUM ASPIRATION",1,NA
"CHI-SQUARED TESTS",1,NA
"CHICAGO",1,NA
"CHICKEN FEED",1,NA
"CHIEN-VALIA- DIFFUSION CHAMBER",1,NA
"CHIEN-VALIA DIFFUSION CHAMBER",1,NA
"CHILD",45,1
"CHILD ABUSE",23,1
"CHILD ABUSERS",1,NA
"CHILD ADVOCACY CENTERS",1,NA
"CHILD AND ADOLESCENT PSYCHIATRY",2,NA
"CHILD AND ADOLESCENT SUICIDE",1,NA
"CHILD BEHAVIOR DISORDERS",1,NA
"CHILD DEVELOPMENT",1,NA
"CHILD FORENSIC MEDICINE",1,NA
"CHILD FORENSIC PSYCHIATRY",1,NA
"CHILD HOMICIDE",2,NA
"CHILD MALTREATMENT",1,NA
"CHILD NEGLECT",1,NA
"CHILD PATIENT",1,NA
"CHILD PROTECTION",2,1
"CHILD PROTECTIVE SERVICES",1,NA
"CHILD PSYCHOPATHY SCALE",1,NA
"CHILD SEXUAL ABUSE",6,NA
"CHILD SEXUAL EXPLOITATION",1,NA
"CHILD VICTIMIZATION",1,NA
"CHILD WELFARE",1,NA
"CHILDHOOD",3,NA
"CHILDHOOD ABUSE",1,NA
"CHILDHOOD ACCIDENTS",1,NA
"CHILDHOOD ADVERSITY",1,NA
"CHILDHOOD AND ADOLESCENCE",1,NA
"CHILDHOOD AND ADOLESCENT TAXON SCALE (CATS)",1,NA
"CHILDHOOD DEATHS",1,NA
"CHILDHOOD EXPERIENCES",1,NA
"CHILDHOOD FATALITIES",1,NA
"CHILDHOOD MALTREATMENT",1,NA
"CHILDHOOD TRAUMA",1,NA
"CHILDREN'S HAIR",3,NA
"CHILDREN AND YOUNG PEOPLE",1,NA
"CHILDREN ANDROID APPLICATIONS (APPS)",1,NA
"CHILDREN DEATH",1,NA
"CHILDREN HAIR",1,NA
"CHILE",1,NA
"CHIMERIC MICE",1,NA
"CHINA",3,9
"CHINA: JAPAN: KOREA: TAIWAN",1,NA
"CHINESE BAI ETHNIC GROUP",1,NA
"CHINESE DIET PRODUCTS",1,NA
"CHINESE HERB NEPHROPATHY",1,NA
"CHINESE HERBAL DRUG",1,NA
"CHINESE HERBS",1,NA
"CHINESE MEDICINE",1,4
"CHIP",1,1
"CHIRAL",4,8
"CHIRAL 2D LC",1,NA
"CHIRAL AMINE DRUG",1,NA
"CHIRAL ANALYSIS",11,8
"CHIRAL CAPILLARY ELECTROPHORESIS",1,2
"CHIRAL CE",1,NA
"CHIRAL CHROMATOGRAPHY",3,7
"CHIRAL COLUMN",1,2
"CHIRAL CROWN ETHER COLUMN",1,1
"CHIRAL DERIVATIZATION",4,4
"CHIRAL DERIVATIZATION AGENTS",2,2
"CHIRAL DERIVATIZATION REAGENT",1,NA
"CHIRAL DRUG",2,10
"CHIRAL DRUG ANALYSIS",1,1
"CHIRAL DRUGS ANALYSIS",1,1
"CHIRAL FORENSIC",1,NA
"CHIRAL LC-MS/MS",3,NA
"CHIRAL LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",1,NA
"CHIRAL LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY/MASS SPECTROMETRY",1,NA
"CHIRAL MEASUREMENT",1,NA
"CHIRAL PHARMACEUTICAL",2,3
"CHIRAL RESOLUTION",1,2
"CHIRAL SELECTOR",2,7
"CHIRAL SENSING",1,NA
"CHIRAL SENSORS",1,NA
"CHIRAL SEPARATION",20,52
"CHIRAL STATIONARY PHASE",7,17
"CHIRALITY",6,10
"CHIRALITY OF METHAMPHETAMINE",1,NA
"CHIRALPAK IB",1,1
"CHIROPTICAL SPECTROSCOPY",1,4
"CHITIN",1,NA
"CHITOSAN",5,1
"CHITOSAN-TRIPOLYPHOSPHATE MICROPARTICLES",1,NA
"CHLORAL HYDRATE",1,3
"CHLORALHYDRATE",1,NA
"CHLORAMINE",1,NA
"CHLORANTHUS SERRATUS",1,NA
"CHLORATE",2,NA
"CHLORATE POISONING",1,NA
"CHLORDESMETHYLDIAZEPAM",1,NA
"CHLORDIAZEPOXIDE",2,7
"CHLORDIAZEPOXIDE—AND DESMETHYL METABOLITE, DERIVATIZATION AND GLC ANALYSES, BULK DRUG",1,NA
"CHLORHEXIDINE",1,NA
"CHLORIDE",1,NA
"CHLORIMIPRAMINE",1,NA
"CHLORINATED COPPER PHTHALOCYANINE",1,NA
"CHLORINATED HYDROCARBONS",1,NA
"CHLORINATED POLYSACCHARIDE-BASED STATIONARY PHASE",1,1
"CHLORINATED WATER",1,NA
"CHLORINE GAS",1,NA
"CHLORINE POISONING",1,NA
"CHLORMETHIAZOLE",2,NA
"CHLORMETHIAZOLE, METABOLITES",1,NA
"CHLORO-N,N-DIMETHYLCATHINONE",1,1
"CHLORO QUINE",1,NA
"CHLOROACETOPHENONE",1,NA
"CHLOROAMPHETAMINE ANALOGS",1,1
"CHLORODIFLUOROMETHANE",1,NA
"CHLOROETHANE",2,NA
"CHLOROETHCATHINONE",1,1
"CHLOROFORM",5,NA
"CHLOROFORMATE",1,NA
"CHLOROFORMATE DERIVATIZATION",1,NA
"CHLOROFORMATES",1,1
"CHLOROHEROIN",1,1
"CHLOROPENTAFLUOROETHANE",1,NA
"CHLOROPHACINONE",2,NA
"CHLOROPHENYLPIPERAZINE",1,1
"CHLOROPHYLL",1,NA
"CHLOROPLAST",3,2
"CHLOROPLAST DNA",2,5
"CHLOROPLAST DNA BARCODING",1,NA
"CHLOROPLAST GENOME",2,4
"CHLOROQUINE",7,1
"CHLOROQUINE POISONING",1,NA
"CHLOROQUINE POISONING, TOXICOLOGICAL DETECTION",1,NA
"CHLOROQUINE SULPHATE",1,NA
"CHLOROQUINE, INTOXICATION",1,NA
"CHLORPHENIRAMINE",6,6
"CHLORPROMAZINE",11,1
"CHLORPYRIFOS- METHYL",1,NA
"CHLORSUCCILLIN",1,NA
"CHOCOLATE",1,NA
"CHOKING",3,NA
"CHOLECYSTOKININ",2,NA
"CHOLESTEROL",2,1
"CHOLESTEROL SCREENING",1,NA
"CHOLESTEROLIC STATIONARY PHASE",1,NA
"CHOLINE",2,NA
"CHOLINERGIC RECEPTORS",1,NA
"CHOLINESTERASE",1,NA
"CHOLINESTERASE ESTIMATION",1,NA
"CHOLINESTERASE INHIBITION",1,NA
"CHOLINESTERASE, E 605-VERGIFTUNG",1,NA
"CHOLINESTERASEAKTIVITÄT, PHOSPHORSÄUREESTER UND ALKOHOL",1,NA
"CHOROIDAL LYMPHOMA",1,NA
"CHRISTA KOHLER",1,NA
"CHROMALYNX XS",1,NA
"CHROMATE",1,NA
"CHROMATES",1,NA
"CHROMATOBAR",1,NA
"CHROMATOGRA PHIC ANALYSIS",1,NA
"CHROMATOGRAM",1,NA
"CHROMATOGRAM LIBRARY",1,NA
"CHROMATOGRAPHIC ANALYSES",1,2
"CHROMATOGRAPHIC DETERMINATION",1,1
"CHROMATOGRAPHIC SEPARATION",2,2
"CHROMATOGRAPHIC SIGNATURE ANALYSIS",2,2
"CHROMATOGRAPHIC TECHNIQUES",2,2
"CHROMATOGRAPHY",75,34
"CHROMATOGRAPHY-MASS SPECTROMETRIC ANALYSIS",1,NA
"CHROMATOGRAPHY ANALYSIS",1,NA
"CHROMATOGRAPHY LIQUID",1,NA
"CHROMATOGRAPHY MASS SPECTROMETRY",1,NA
"CHROME TITANATE",1,NA
"CHROMIUM",1,2
"CHROMIUM(VI) DETECTION",1,NA
"CHROMOGENIC REAGENT",2,2
"CHROMOGENIC SPRAY REAGENT",3,NA
"CHROMOSOME COUNTS",1,1
"CHROMOSOME Y",1,NA
"CHROMOTROPIC ACID",1,1
"CHRONIC",1,NA
"CHRONIC ABUSE",2,NA
"CHRONIC ALCOHOL INTAKE",1,NA
"CHRONIC ALCOHOL INTOXICATION",1,NA
"CHRONIC ALCOHOL USE MARKERS",1,NA
"CHRONIC ALCOHOLISM",1,NA
"CHRONIC DISEASE",1,NA
"CHRONIC DOSAGE",1,NA
"CHRONIC DRUG DEPENDENCE",1,NA
"CHRONIC DRUG INTOXICATION",1,NA
"CHRONIC DRUG USE",1,NA
"CHRONIC ETHANOL POISONING",1,NA
"CHRONIC EXCESSIVE ALCOHOL USE",1,NA
"CHRONIC HEALTH",1,NA
"CHRONIC HYPOXIA",1,NA
"CHRONIC HYPOXIC CHANGES",1,NA
"CHRONIC ILLNESS",1,NA
"CHRONIC KIDNEY DISEASE",1,NA
"CHRONIC MYOCARDIAL ISCHEMIA",1,NA
"CHRONIC OPIOID ANALGESIC THERAPY",3,NA
"CHRONIC PAIN",10,1
"CHRONIC TOXICITY",1,NA
"CHRONIC USE",3,NA
"CHRONOLOGICAL AGE",1,NA
"CHRONOMETRY",3,NA
"CHRONOTYPE",1,NA
"CHRYSOMYA ALBICEPS",1,NA
"CHRYSOMYA MEGACEPHALA",8,NA
"CHRYSOMYA PUTORIA AND CHRYSOMYA ALBICEPS",1,NA
"CHUANWU",1,NA
"CHYMASE",1,NA
"CHYMOTRYPSIN",1,1
"CI",1,NA
"CI-MASS SPECTRA",1,NA
"CIALIS",1,2
"CIALIS®",2,NA
"CICHLID",1,NA
"CID",1,2
"CID MASS SPECTRA LIBRARY",1,NA
"CIEMAT/NIST (CNET) METHOD",1,NA
"CIGARETTE BURN",1,NA
"CIGARETTE SMOKING",2,NA
"CIGARETTES",2,1
"CIGARETTES WASTE",1,NA
"CIGUATERA",2,NA
"CIGUATOXIN",2,NA
"CIMBI-5",1,NA
"CIMDL",1,NA
"CIMETIDINE",1,NA
"CINNAMYL/GUAIACYL RATIO",1,NA
"CINNARIZINE",1,NA
"CINOB UFAGIN",1,1
"CINOBUFAGIN",1,NA
"CINOBUFOTALIN",1,NA
"CIPROFLOXACIN",1,NA
"CIRCADIAN",2,NA
"CIRCADIAN CLOCK GENES",1,NA
"CIRCADIAN HORMONES",1,NA
"CIRCADIAN PACEMAKER",1,NA
"CIRCADIAN RHYTHM",1,NA
"CIRCRNAS",2,NA
"CIRCUIT ENCRYPTION",1,NA
"CIRCULAR DICHROISM",3,3
"CIRCULAR SAW",1,NA
"CIRCULARE TECHNIQUE IN ADSORPTION AND REVERSED PHASE MODE",1,NA
"CIRCULATING CELL-FREE DNA (CCF DNA)",1,NA
"CIRCULATING MIRNAS",1,NA
"CIRCULATION OF MEDICINES",1,NA
"CIRCULATORY BLOOD",1,NA
"CIRCUMSTANCES",3,NA
"CIRCUMSTANCES OF DEATH",1,NA
"CIS-12-OCTADECENOIC ACID",1,NA
"CIS-6-HYDROXYNORKETAMINE",1,NA
"CISAPRIDE",1,NA
"CISORDINOL®",1,NA
"CISPA",1,NA
"CISPLATIN",1,NA
"CIST BURIAL",1,NA
"CITALOPRAM",21,1
"CITALOPRAM ENANTIOMERS",1,NA
"CITALOPRAM INTOXICATION",1,NA
"CITATION ANALYSIS",1,NA
"CITES",2,NA
"CITRATE BUFFER",1,NA
"CITRIC ACID/ACETIC ANHYDRIDE REAGENT",1,1
"CITY",1,NA
"CITY AND COUNTY OF SAN FRANCISCO",1,NA
"CIVIL AVIATION ACCIDENT INVESTIGATION",1,NA
"CIVIL COMMITMENT",6,NA
"CIVIL COURT",1,NA
"CIVIL LIABILITY",2,NA
"CIVIL LIABILITY LAWSUITS",1,NA
"CIVIL PSYCHIATRIC PATIENTS",1,NA
"CIVIL PSYCHIATRY",1,NA
"CIVIL SOCIETY",1,NA
"CL CYCLING",1,NA
"CLAIM",1,NA
"CLAIMED",1,NA
"CLANDESTINE",1,1
"CLANDESTINE BURIAL",1,NA
"CLANDESTINE DRUG LABORATORY",1,4
"CLANDESTINE LABORATORY",12,20
"CLANDESTINE LABORATORY PREPARATIONS",1,NA
"CLANDESTINE RECORDS",1,NA
"CLANDESTINE SPIRITS",1,NA
"CLANDESTINE TABLET",1,2
"CLASSIC DRUGS OF ABUSE",1,NA
"CLASSIFICATION",19,24
"CLASSIFICATION MODELS",1,NA
"CLASSIFICATION OF DRUGS",1,1
"CLASSIFICATION OF VEGETABLE OILS",1,1
"CLASSIFICATION SYSTEM",2,NA
"CLASSIFICATION TREE",1,NA
"CLAVICLE",1,NA
"CLAVULANIC ACID",1,NA
"CLDN5",1,NA
"CLEAN-UP",1,NA
"CLEAN-UP PROTOCOL",1,NA
"CLEAN REAGENTS",1,NA
"CLEANSING SHAMPOO",1,NA
"CLEANUP",1,NA
"CLEAR COAT",1,NA
"CLEARANCE",4,NA
"CLEARCOATS",1,NA
"CLEFT PALATE FIBROBLASTS",1,NA
"CLEISTANTHIN",1,NA
"CLENBUTEROL",4,7
"CLEPHEDRONE",1,1
"CLIENT-COUNSELOR RAPPORT",1,NA
"CLIMATE CHANGE",1,1
"CLINIC",2,NA
"CLINICAL",14,12
"CLINICAL ADVANCES",1,NA
"CLINICAL ANALYSIS",8,5
"CLINICAL AND DIAGNOSTIC APPLICATIONS",1,NA
"CLINICAL AND FORENSIC ASPECTS",1,NA
"CLINICAL AND FORENSIC DIAGNOSIS",1,NA
"CLINICAL AND FORENSIC TOXICOLOGY",4,4
"CLINICAL APPLICATION",1,NA
"CLINICAL APPLICATIONS",4,NA
"CLINICAL ASPECTS",1,NA
"CLINICAL ASSESSMENT",1,NA
"CLINICAL AUDIT",1,NA
"CLINICAL CASE",1,NA
"CLINICAL CHARACTERISTICS",1,NA
"CLINICAL CHEMISTRY",1,NA
"CLINICAL DEATH TIME",1,NA
"CLINICAL DIAGNOSIS",4,NA
"CLINICAL DIAGNOSTICS",3,NA
"CLINICAL DRUG RESEARCH",1,NA
"CLINICAL DRUG SCREENING",1,NA
"CLINICAL DRUG TRIALS",1,NA
"CLINICAL EFFECTS",1,1
"CLINICAL EPIDEMIOLOGY < EPIDEMIOLOGY",1,NA
"CLINICAL ETHICS",1,NA
"CLINICAL ETHICS SUPPORT",1,NA
"CLINICAL EXAMINATION",1,NA
"CLINICAL FEATURES",1,NA
"CLINICAL FORENSIC MEDICINE",5,NA
"CLINICAL FORENSIC MEDICINE UNIT",1,NA
"CLINICAL INDICATORS",1,NA
"CLINICAL INSIGHT",1,NA
"CLINICAL LABORATORY",3,2
"CLINICAL LABORATORY IMPROVEMENT ACT",1,NA
"CLINICAL LABORATORY TECHNIQUES",1,NA
"CLINICAL LABORATORY TOXICOLOGY",1,NA
"CLINICAL LEGAL MEDICINE",1,NA
"CLINICAL MANIFESTATIONS",1,NA
"CLINICAL MEDICINE",1,NA
"CLINICAL MISMANAGEMENT",1,NA
"CLINICAL PHARMACISTS",1,NA
"CLINICAL PHARMACOLOGY",2,NA
"CLINICAL PHARMACY SERVICES",1,NA
"CLINICAL PHENOTYPES",1,NA
"CLINICAL PHENOTYPING",1,NA
"CLINICAL PHYSIOLOGY",1,NA
"CLINICAL PREDICTION",1,NA
"CLINICAL PROFILES",1,NA
"CLINICAL PSYCHOLOGY",1,NA
"CLINICAL RESEARCH",2,NA
"CLINICAL RISK MANAGEMENT",2,NA
"CLINICAL SAMPLES",1,1
"CLINICAL SAMPLES, FORENSIC SAMPLES",1,NA
"CLINICAL SETTING",1,NA
"CLINICAL STUDIES",1,NA
"CLINICAL STUDY",1,NA
"CLINICAL SUPERVISION",1,NA
"CLINICAL SYMPTOMS",1,1
"CLINICAL TEST FOR IMPAIRMENT",1,NA
"CLINICAL TEST OF IMPAIRMENT",2,NA
"CLINICAL TESTING",1,NA
"CLINICAL TOXICOLOGY",41,3
"CLINICAL TOXICOLOGY < TOXICOLOGY",1,NA
"CLINICAL TOXICOLOGY.3",1,NA
"CLINICAL TREATMENT",1,NA
"CLINICAL TRIAL",2,1
"CLINICAL USE",1,NA
"CLINICAL/BIOMEDICAL ANALYSIS",3,1
"CLIPPINGS",1,NA
"CLOBAZAM",1,2
"CLOBAZAM, DETECTION",1,NA
"CLOBENZOREX",2,NA
"CLOBUTINOL",1,NA
"CLOCAPRAMINE",1,NA
"CLOMETHIAZOL INTOXICATION, CHEMICAL ANALYSIS",1,NA
"CLOMETHIAZOLE, DETECTION IN URINE",1,NA
"CLOMIPRAMINE",1,NA
"CLONALITY TESTING",1,NA
"CLONAZEPAM",17,7
"CLONAZOLAM",2,1
"CLONIDINE",1,NA
"CLONIDINE HYDROCHLORIDE",1,NA
"CLONIPRAZEPAM",1,NA
"CLORAZEPATE",1,NA
"CLOSED-SET IDENTIFICATION",1,NA
"CLOSED HEAD INJURY",2,NA
"CLOSED PRISON",1,NA
"CLOSTEBOL",1,NA
"CLOSTRIDIUM",2,NA
"CLOTHIAPINE",1,NA
"CLOTHING",5,1
"CLOTHING AND OTHER FABRICS",1,1
"CLOTHS",1,NA
"CLOTIAPINE",1,NA
"CLOUD FORENSIC",1,NA
"CLOUD POINT EXTRACTION",3,5
"CLOUD STORAGE APPLICATION FORENSICS",1,NA
"CLOUDS",1,NA
"CLOZAPIN",1,NA
"CLOZAPINE",40,NA
"CLOZAPINE-N-OXIDE",2,NA
"CLOZAPINE TOXICITY: NAÏVE SUBJECTS",1,NA
"CLOZAPINE.",1,NA
"CLOZAPINE/",1,NA
"CLOZAPINE: POST MORTEM TOXICOLOGY",1,NA
"CLOZAPINE: SUDDEN DEATH",1,NA
"CLP",1,NA
"CLUB DRUGS",7,9
"CLUSTER",2,2
"CLUSTER ANALYSIS",12,12
"CLUSTER B PERSONALITY DISORDERS",1,NA
"CLUSTER OF NODES",1,NA
"CLUSTERED PROTOCADHERINS",1,NA
"CLUSTERIN",1,NA
"CLUSTERING",5,1
"CLUSTERING ALGORITHMS",1,NA
"CLUSTERS",2,NA
"CMX-4",2,NA
"CMX-5",1,NA
"CN STATIONARY PHASE",1,1
"CN YELLOW CRYSTALS",1,NA
"CNS",2,2
"CNS PATHOLOGY",1,NA
"CNS STIMULANT MEDICINE",1,NA
"CNS STIMULANTS",1,NA
"CNS TOXICITY",1,NA
"CNV",1,NA
"CNVS",1,NA
"CO-ADMINISTRATION",1,NA
"CO-CRYSTALS",1,1
"CO-EXPOSURE",1,NA
"CO-EXTRACTION",1,NA
"CO-HB SATURATION LEVEL",1,NA
"CO-MEDICATION",1,NA
"CO-MORBIDITY",8,NA
"CO-OCCURRENCE",1,NA
"CO-OCCURRENCES",1,1
"CO-OCCURRING DISORDERS",1,NA
"CO-OPERATION",1,NA
"CO-OXIMETRY",1,NA
"CO I",1,NA
"CO II",1,NA
"CO INTOXICATION",1,NA
"CO1 GENE",1,NA
"COADMINISTERED DRUGS",1,NA
"COAGULATION",1,NA
"COAGULATION TEST",1,NA
"COAGULOPATHY",1,NA
"COAMPLIFICATION",1,NA
"COATED CAPILLARIES",1,1
"COATING",1,NA
"COBALT-CYANIDE COMPLEXES",1,NA
"COBALT CHLORIDE",1,NA
"COBALT HEXACYANOFERRATE",1,1
"COBALT THIOCYANATE",3,4
"COC",1,NA
"COCA ALKALOIDS",1,2
"COCA CHEWER",1,NA
"COCA CHEWING",2,2
"COCA LEAF",1,6
"COCA SEEDS",1,1
"COCA TEA",1,NA
"COCAETHYLENE",18,4
"COCAETHYLENE FORMATION",1,NA
"COCAINE-RELATED CASES",1,NA
"COCAINE-RELATED DISORDERS",1,NA
"COCAINE ABUSE",3,1
"COCAINE ADULTERANTS",1,NA
"COCAINE ANALYSIS",1,NA
"COCAINE AND ALCOHOL",1,NA
"COCAINE AND DERIVATIVES",350,273
"COCAINE AND METABOLITES",2,1
"COCAINE BASE",2,3
"COCAINE BODY PACKER",1,NA
"COCAINE CARDIOTOXICITY",1,NA
"COCAINE CONGENERS",1,NA
"COCAINE CONSUMPTION",1,1
"COCAINE DEATHS",2,NA
"COCAINE DERIVATIVES",1,NA
"COCAINE HYDROCHLORIDE",5,13
"COCAINE IDENTIFICATION",1,1
"COCAINE IMPREGNATED TEXTILES",1,1
"COCAINE IMPURITIES",1,2
"COCAINE INTOXICATION",1,NA
"COCAINE MARKERS",2,1
"COCAINE METABOLITE",2,1
"COCAINE METABOLITES",9,NA
"COCAINE POISONING",1,NA
"COCAINE PSYCHOSIS",1,NA
"COCAINE PURITY",1,NA
"COCAINE SALT",1,2
"COCAINE SIGNATURES",1,1
"COCAINE TOXICITY",2,NA
"COCAINE USE",2,NA
"COCAINE, GAS CHROMATOGRAPHY/MASS SPECTROMETRY",1,NA
"COCAINE, OPIATES",1,NA
"COCAINE/CRACK",1,1
"COCAINICS",1,NA
"COCHLIOMYIA HOMINIVORAX",1,NA
"CODAMINE",1,1
"CODEINE",50,53
"CODEINE-RELATED DEATH",1,NA
"CODEINE DEMETHYLATION",1,NA
"CODEINE TOXICITY",1,NA
"CODEINE, EXAMINATION IN BLOOD SAMPLES",1,NA
"CODING",1,NA
"CODING REGION SNPS (CSNPS)",1,NA
"CODIS MARKERS",1,NA
"COERCED DRUG TREATMENT",1,NA
"COERCED TREATMENT FOR OFFENDERS",1,NA
"COERCION",10,NA
"COERCIVE CARE",1,NA
"COERCIVE MEASURES",3,NA
"COERCIVE TREATMENT",2,NA
"COFFEE",1,1
"COGNITION",3,1
"COGNITIVE-BEHAVIORAL THERAPY",1,NA
"COGNITIVE AND EMOTION REGULATION",1,NA
"COGNITIVE AND VOLITIONAL DEFICITS",1,NA
"COGNITIVE BEHAVIORAL THERAPY (CBT)",1,NA
"COGNITIVE BEHAVIOURAL THERAPY",1,NA
"COGNITIVE BIAS",2,NA
"COGNITIVE EFFECTS",1,NA
"COGNITIVE ENHANCEMENT",3,NA
"COGNITIVE FUNCTION",3,NA
"COGNITIVE IMPAIRMENT",1,NA
"COGNITIVE LOAD",1,NA
"COGNITIVE MODULE",1,NA
"COGNITIVE PERFORMANCE",2,NA
"COGNITIVE PSYCHOLOGY",1,NA
"COGNITIVE SKILLS",1,NA
"COGNITIVE THERAPY",1,NA
"COHB",1,NA
"COHORT STUDIES",2,NA
"COHORT STUDY",3,NA
"COI",3,NA
"COINGREDIENTS",1,1
"COINTOXICANT",1,NA
"COITAL DEATH",1,NA
"COL3A1 GENE",1,NA
"COLATYPE DRINKS",1,NA
"COLCHICINE",9,NA
"COLCHICINE POISONING",1,NA
"COLCHICINE POISONING, SERUM LEVELS",1,NA
"COLCHICUM AUTUMNALE",2,NA
"COLD-EI",1,NA
"COLD CASES",1,NA
"COLD DRINKS",1,NA
"COLD ELECTRON IONIZATION",2,NA
"COLD ELECTRON IONIZATION MASS SPECTROMETRIC DETECTION",1,1
"COLD EXPOSURE",1,NA
"COLD TOLERANCE, DIAZEPAM",1,NA
"COLEOPTERA",4,NA
"COLGATE",1,NA
"COLLABORATIVE MATERIALS EXERCISE (CMX)",1,NA
"COLLABORATIVE STUDY",1,NA
"COLLAGEN",1,NA
"COLLAGEN DEGRADATION",1,NA
"COLLATERAL CONSEQUENCES",1,NA
"COLLATERAL VICTIMS",1,NA
"COLLECTING AND INSTRUMENTAL TECHNIQUES",1,NA
"COLLECTING ORGANS AND TISSUES",1,NA
"COLLECTION",1,NA
"COLLECTION DEVICES",1,NA
"COLLECTION OF SALIVA",1,NA
"COLLECTION PROTOCOLS",1,NA
"COLLECTION TIME",1,NA
"COLLECTION TUBES",1,NA
"COLLEGE-AGE",1,NA
"COLLISION-INDUCED DISSOCIATION",3,8
"COLLOID",2,NA
"COLLOIDAL ASSEMBLY",1,1
"COLLOIDAL GOLD",3,1
"COLLOIDAL NANOPARTICLES",1,NA
"COLLOIDAL SUSPENSIONS",1,NA
"COLOCYNTH (BITTER APPLE)",1,NA
"COLOMBIA",1,2
"COLOMBIAN ARMED CONFLICT",1,NA
"COLONIC PERFORATION",1,NA
"COLONIZATION",1,NA
"COLOR MEASUREMENT",1,NA
"COLOR REACTION",2,1
"COLOR SPOT TEST",1,1
"COLOR STABILITY",1,NA
"COLOR TEST",10,9
"COLOR TEST ETC",1,NA
"COLORASSIST®",1,NA
"COLORECTAL CANCER",1,NA
"COLORED SILICONE INJECTION",1,NA
"COLORIMETRIC",4,1
"COLORIMETRIC ASSAY",1,2
"COLORIMETRIC DETECTION",4,6
"COLORIMETRIC NANOARRAY",1,1
"COLORIMETRIC PAPER-BASED DEVICES",1,NA
"COLORIMETRIC SENSOR",2,2
"COLORIMETRIC SENSOR ARRAY",1,NA
"COLORIMETRIC TEST",5,3
"COLORIMETRY",3,9
"COLOUR",3,4
"COLOUR EXAMINATION",1,NA
"COLOUR SPOT TEST",1,NA
"COLOUR TEST ETC",1,NA
"COLOUR TESTS",2,NA
"COLUMN",1,NA
"COLUMN-SWITCHING CHROMATOGRAPHY",1,1
"COLUMN-SWITCHING LC-MS",1,NA
"COLUMN-SWITCHING SOLID-PHASE EXTRACTION",1,NA
"COLUMN CHROMATOGRAPHY",1,1
"COLUMN COMPARISON",1,NA
"COLUMN EXTRACTION",1,NA
"COLUMN ION CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"COLUMN LIQUID CHROMATOGRAPHY",4,22
"COLUMN LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY",1,1
"COLUMN SWITCHING",7,6
"COLUMN SWITCHING HPLC",1,NA
"COLUMN TECHNOLOGY",1,NA
"COLUMNAR THIN FILM (CTF)",1,NA
"COMA BLISTER",1,NA
"COMA BLISTERS",2,NA
"COMA DÉPASSÉ",1,NA
"COMATOSE",1,NA
"COMBINATION ANTIPSYCHOTICS",1,NA
"COMBINATION DEPOT",1,NA
"COMBINATION OF LABORATORY PARAMETERS",1,NA
"COMBINED CLUSTER AND DISCRIMINANT ANALYSIS",1,NA
"COMBINED CONCENTRATION",1,NA
"COMBINED METHODS",1,NA
"COMBINED PATERNITY INDEX",1,NA
"COMBINED POISONING",1,NA
"COMBINED RADIONUCLIDE ANALYSIS",1,NA
"COMBINED TREATMENT",1,NA
"COMBINED VALUE (GLUCOSE/LACTATE) IN BLOOD",1,NA
"COMBUSTION PRODUCTS OF FIBERS",1,NA
"COMMAND HALLUCINATIONS",1,NA
"COMMEMORATIVE",1,NA
"COMMENTARY",1,NA
"COMMERCIAL OFF-THE-SHELF",1,1
"COMMERCIAL RODENTICIDE",1,NA
"COMMERCIAL VEHICLE AIR MONITORING",1,NA
"COMMERCIALIZATION",1,NA
"COMMITMENT",2,NA
"COMMITMENT IN AN INSTITUTION FOR DRUG TREATMENT",1,NA
"COMMITMENT LAW",1,NA
"COMMITMENT OF MENTALLY ILL",1,NA
"COMMITMENT OF THE MENTALLY ILL",1,NA
"COMMITMENT TO MENTAL HOSPITAL",1,NA
"COMMON BATCH",1,1
"COMMON FACTORS",1,NA
"COMMOTIO",1,NA
"COMMOTIO CORDIS",1,NA
"COMMUNICATION",2,1
"COMMUNICATION APPS",1,NA
"COMMUNITY",2,NA
"COMMUNITY-BASED MENTAL HEALTH",1,NA
"COMMUNITY-BASED MENTAL HEALTH CARE",1,NA
"COMMUNITY CORRECTIONS",1,NA
"COMMUNITY CRIME",1,NA
"COMMUNITY DENTISTRY",1,NA
"COMMUNITY FORENSIC SERVICE",1,NA
"COMMUNITY FORENSIC TEAM",2,NA
"COMMUNITY MENTAL HEALTH",3,NA
"COMMUNITY POLICING",1,NA
"COMMUNITY PSYCHIATRY",2,NA
"COMMUNITY SEX OFFENDER TREATMENT",1,NA
"COMMUNITY STUDIES",1,NA
"COMMUNITY TEAMS",1,NA
"COMMUNITY TREATMENT",1,NA
"COMORBID",1,NA
"COMORBID SUBSTANCE MISUSE",1,NA
"COMORBIDITIES",2,NA
"COMORBIDITY",19,NA
"COMORBIDITY AND CRIME",1,NA
"COMORBIDITY WITH PERSONALITY DISORDER",1,NA
"COMPACT MASS SPECTROMETRY",1,1
"COMPARATIVE CRIMINOLOGY",1,NA
"COMPARATIVE EVALUATION",2,NA
"COMPARATIVE SEQUENCING",1,NA
"COMPARATIVE STUDY",9,7
"COMPARED TO OTHER COUNTRIES",1,NA
"COMPARING NORDIC COUNTRIES",1,NA
"COMPARISON",6,7
"COMPARISON METRICS",1,NA
"COMPARISON OF SEIZURES",1,1
"COMPARISON PROCESS",1,1
"COMPARISON SAMPLES",1,NA
"COMPARTMENT",1,NA
"COMPARTMENT SYNDROME",1,NA
"COMPENSATION AND REDRESS",2,NA
"COMPENSATION NEUROSIS",1,NA
"COMPETENCE",1,NA
"COMPETENCE TO STAND TRIAL",1,NA
"COMPETENCY",3,NA
"COMPETENT AUTHORITIES",1,NA
"COMPETING RISKS",1,NA
"COMPETITIVE ENZYME IMMUNOASSAY",1,NA
"COMPETITIVE IMMUNOASSAY",1,1
"COMPLEMENT",1,NA
"COMPLETE ANTIGEN",1,NA
"COMPLETE INTOXICATION",1,NA
"COMPLETED SUICIDE",2,NA
"COMPLEX BEHAVIOUR",1,NA
"COMPLEX MATRICES",2,NA
"COMPLEX MIXTURE",2,NA
"COMPLEX MIXTURES",1,1
"COMPLEX NETWORKS",1,NA
"COMPLEX POISONINGS",1,NA
"COMPLEX REGIONAL PAIN SYNDROME",1,NA
"COMPLEX SAMPLE",1,NA
"COMPLEX SUICIDE",6,NA
"COMPLEX SUICIDE, UNPLANNED",1,NA
"COMPLEX TRAITS",1,NA
"COMPLEXATION",1,1
"COMPLIANCE",9,1
"COMPLIANCE MONITORING",2,NA
"COMPLIANCE TESTING",1,NA
"COMPLIANCE TESTING, IMPAIRMENT AND EMPLOYMENT TESTING",1,NA
"COMPLIANCE WITH ANTIHYPERTENSIVE TREATMENT",1,NA
"COMPLICATED SUICIDE",1,NA
"COMPLICATION",4,NA
"COMPLICATION/ERROR",1,NA
"COMPLICATIONS",2,2
"COMPLICATIONS TUMESCENCE",1,NA
"COMPONENT ANALYSIS",4,1
"COMPONENT RECOGNITION",1,NA
"COMPORTEMENT VIOLENT",1,NA
"COMPOSITE",1,1
"COMPOSITE PROPELLANTS",1,NA
"COMPOSITE SAMPLING",1,NA
"COMPOSITION BY NUMBER",1,NA
"COMPOSITION C-4",1,NA
"COMPOSITIONAL ANALYSIS",1,NA
"COMPOUND-SPECIFIC ISOTOPE ANALYSIS",1,1
"COMPOUND-SPECIFIC ISOTOPE RATIOS",1,2
"COMPOUND CROSSBOW",1,NA
"COMPOUND DATABASE",1,NA
"COMPOUND FLUORESCENCE RT-PCR",1,NA
"COMPOUND GENETIC MARKER",1,NA
"COMPOUND IDENTIFICATION",3,1
"COMPOUND SPECIFIC ISOTOPE RATIO MASS SPECTROMETRY",1,NA
"COMPOUNDS",2,NA
"COMPOUNDS IDENTIFICATION",1,NA
"COMPREHENSIVE ANALYTICAL CHARACTERISTICS",1,NA
"COMPREHENSIVE GC",1,NA
"COMPREHENSIVE INVESTIGATION",1,NA
"COMPREHENSIVE TOXICOLOGICAL AND FORENSIC DRUG SCREENING",1,1
"COMPREHENSIVE TWO-DIMENSIONAL GAS CHROMATOGRAPHY",4,9
"COMPREHENSIVE TWO-DIMENSIONAL GAS CHROMATOGRAPHY-TIME-OF-FLIGHT MASS SPECTROMETRY",1,1
"COMPREHENSIVE TWO DIMENSIONAL GC",1,NA
"COMPRESSION",2,2
"COMPRESSION GAIN",1,NA
"COMPRESSION RATIO",1,NA
"COMPULSARY DRUG TREATMENT",1,NA
"COMPULSION",1,NA
"COMPULSION TO USE",1,NA
"COMPULSIVE CHARACTER",1,NA
"COMPULSIVE SEXUAL BEHAVIOUR",1,NA
"COMPULSORY ADDICTION TREATMENT",1,NA
"COMPULSORY ADMISSION",3,NA
"COMPULSORY CARE",1,NA
"COMPULSORY COMMITMENT TO CARE",3,NA
"COMPULSORY COMMUNITY TREATMENT",1,NA
"COMPULSORY MEASURES",2,NA
"COMPULSORY TREATMENT",7,NA
"COMPUTATION",1,NA
"COMPUTATIONAL",1,NA
"COMPUTATIONAL BIOLOGY",2,1
"COMPUTATIONAL MODELLING",1,NA
"COMPUTED TOMOGRAPHY",15,NA
"COMPUTED TOMOGRAPHY (CT)",1,NA
"COMPUTED TOMOGRAPHY IMAGING",1,NA
"COMPUTER-AUTOMATED EXTRACTION",1,NA
"COMPUTER AID",1,1
"COMPUTER AIDED DESIGN (CAD)",1,NA
"COMPUTER CRIME",1,NA
"COMPUTER INFORMATION",1,NA
"COMPUTER RECORD LINKAGE",1,NA
"COMPUTER RETRIEVAL",1,NA
"COMPUTER SIMULATIONS",1,NA
"COMPUTER STORAGE",1,NA
"COMPUTER TOMOGRAPHY",2,NA
"COMPUTER, ANALYTIC TOXICOLOGY",2,NA
"COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEM",1,NA
"COMPUTERIZED TOMOGRAPHY",1,1
"COMPUTERS",1,NA
"COMPUTING",1,NA
"COMQUOL",1,NA
"COMT",1,NA
"CONCEALMENT LOCATIONS",1,NA
"CONCEALMENT TECHNIQUES",1,1
"CONCENTRATION",5,3
"CONCENTRATION-SYNCHRONOUS-MATRIX-FLUORESCENCE (CSMF)",1,NA
"CONCENTRATION DISTRIBUTION",1,NA
"CONCENTRATION IN BLOOD",1,NA
"CONCENTRATION MEASUREMENT",1,NA
"CONCENTRATION PER SE LIMITS",1,NA
"CONCENTRATION RATIO",1,NA
"CONCENTRATION, BODY FLUIDS",1,NA
"CONCENTRATIONS",8,NA
"CONCENTRATIONS OF DRUGS IN MUSCLES",1,NA
"CONCENTRATIONS OF THCCOOH",1,NA
"CONCEPT DETECTION",1,NA
"CONCEPT OF MENTAL HEALTH",1,NA
"CONCEPTUAL ANALYSIS",1,NA
"CONCEPTUAL GEOLOGICAL MODEL (CGM)",1,NA
"CONCLUSIVE TESTS",1,NA
"CONCOMITANT DRUG USE",1,NA
"CONCORDANCE",1,NA
"CONCURRENT VALIDITY",1,NA
"CONCUSSION INJURY",1,NA
"CONDEMNED PERSON",1,NA
"CONDENSED PHASE",1,1
"CONDITIONAL DISCHARGE",3,NA
"CONDITIONAL PLACE PREFERENCE (CPP)",1,NA
"CONDITIONAL REDUCED MOBILITY",1,NA
"CONDOM",1,NA
"CONDOMS",3,NA
"CONDUCT DISORDER",6,NA
"CONDUCT PROBLEM",1,NA
"CONDUCTED ELECTRICAL WEAPON",2,NA
"CONDUCTED ENERGY DEVICE",1,NA
"CONDUCTED ENERGY WEAPON",4,NA
"CONDUCTING POLYMER THIN FILMS",1,NA
"CONDUCTING POLYMERS",2,5
"CONDUCTION",1,NA
"CONDUCTIVE POLYMER",1,1
"CONDUCTIVE POLYMERS",1,NA
"CONDUCTIVITY",1,NA
"CONDUCTIVITY METHOD",1,NA
"CONDUCTOMETRIC TITRATION",1,NA
"CONDYLOMA ACUMINATA",1,NA
"CONE BEAM COMPUTED TOMOGRAPHY",1,NA
"CONFESSIONS",1,NA
"CONFIDENCE INTERVAL",2,1
"CONFIDENCE INTERVALS",2,NA
"CONFIDENTIAL PHYSICAL EXAMINATION",1,NA
"CONFIDENTIALITY",1,NA
"CONFIRMATION",6,5
"CONFIRMATION ANALYSIS",1,NA
"CONFIRMATION ASSAY",1,NA
"CONFIRMATION CRITERIA",1,NA
"CONFIRMATION METHOD",2,NA
"CONFIRMATION TESTING",2,NA
"CONFIRMATION TESTS",3,NA
"CONFIRMATORY ANALYSIS",1,NA
"CONFIRMATORY EVIDENCES",1,NA
"CONFIRMATORY TESTS",2,1
"CONFISCATED DRUG",1,2
"CONFOCAL LASER SCANNING MICROSCOPE",1,NA
"CONFOCAL MICROSCOPY",1,NA
"CONFOCAL RAMAN MICROSCOPY",2,3
"CONFOCAL RAMAN MICROSCOPY, DRUGS IN FINGERPRINTS, CYANOACRYLATE-FUMED FINGERPRINTS",1,NA
"CONFORMATION",1,3
"CONFORMATIONAL ENANTIOMERS",1,2
"CONFORMERS",1,NA
"CONFOUNDING",1,NA
"CONFUSION",1,NA
"CONFUSIONAL AROUSALS",1,NA
"CONGENER ALCOHOLS",1,NA
"CONGENER ANALYSIS",2,NA
"CONGENER SUBSTANCES IN ALCOHOLIC BEVERAGES",1,NA
"CONGENERS",1,NA
"CONGENITAL ANOMALY",1,NA
"CONGENITAL HEART DISEASE",1,NA
"CONGENITAL TOXOPLASMOSIS",1,NA
"CONGESTIVE CARDIOMYOPATHY",1,NA
"CONJUGATE METABOLITE",1,NA
"CONJUGATED POLYMER NANOPARTICLES",1,NA
"CONJUGATED STEROIDS",1,NA
"CONJUGATION",1,NA
"CONNEXIN 43 (CX43)",1,NA
"CONSCIOUS SEDATION",1,NA
"CONSCRIPTION CANDIDATES",1,NA
"CONSENSUAL INTERCOURSE",1,NA
"CONSENSUS",2,NA
"CONSENSUS GUIDELINES",3,NA
"CONSENSUS GUIDELINES, DRUG ANALYSIS",1,NA
"CONSENT",5,NA
"CONSIDERATION OF CLOSE CHILD CONTACTS",1,NA
"CONSTITUTIONAL BASIS OF RIGHT TO REFUSE PSYCHOLOGICAL TREATMENT, INVOLUNTARILY COMMITTED PSYCHIATRIC PATIENTS",1,NA
"CONSTITUTIONAL DESCRIPTORS",2,2
"CONSTRICTED FIELDS",1,NA
"CONSTRUCTED WETLAND TREATMENT SYSTEM",1,NA
"CONSULTATION",1,NA
"CONSULTATION/LIAISON SERVICE",1,NA
"CONSULTATIONS",1,NA
"CONSUMER",1,NA
"CONSUMER BEHAVIOUR",1,NA
"CONSUMER FIREWORK",1,NA
"CONSUMER FIREWORKS",1,NA
"CONSUMER RECOVERY",1,NA
"CONSUMPTION",2,7
"CONSUMPTION FREQUENCY",1,NA
"CONSUMPTION MARKER",1,1
"CONSUMPTION MONITORING",1,NA
"CONSUMPTION PATTERNS",1,NA
"CONSUMPTION TIME",1,NA
"CONTACT TRACES",2,NA
"CONTACTLESS",1,NA
"CONTACTLESS CONDUCTIVITY DETECTION",4,6
"CONTACTLESS DISTRIBUTION SCHEMES",1,NA
"CONTAINERS",1,NA
"CONTAMINANT",3,6
"CONTAMINATED HEPARIN",1,NA
"CONTAMINATED SITES",1,NA
"CONTAMINATION",27,10
"CONTAMINATION OF CURRENCY",1,1
"CONTAMINATION SOURCES CHARACTERIZATION",1,NA
"CONTENT-BASED IMAGE RETRIEVAL (CBIR)",1,NA
"CONTENT FORENSICS",1,NA
"CONTENT IN INTERNAL ORGANS",1,NA
"CONTENT INSPECTION",1,NA
"CONTENTS BASED INFORMATION RETRIEVAL",1,NA
"CONTEXT",1,NA
"CONTEXTUAL BIAS",2,1
"CONTEXTUAL INFORMATION",1,NA
"CONTEXTUALIZATION",1,NA
"CONTINGENCY MANAGEMENT",2,NA
"CONTINUING EDUCATION",1,NA
"CONTINUITY OF HEALTHCARE",1,NA
"CONTINUOUS MODEL",1,NA
"CONTINUOUS MODELS",1,NA
"CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP)",1,NA
"CONTINUOUS SUBCUTANEOUS INSULIN INFUSION",1,NA
"CONTINUUM OF CONVENTIONALITY",1,NA
"CONTOUR-SHAPE",1,NA
"CONTOUR ANGLE",1,NA
"CONTRACEPTION",1,NA
"CONTRACTION BAND NECROSIS",3,NA
"CONTRAINDICATIONS",1,NA
"CONTRAST AGENTS",1,NA
"CONTRAST MATERIAL",2,NA
"CONTRAST MEDIA",1,NA
"CONTRAST MEDIUM",1,NA
"CONTRIBUTION",1,NA
"CONTROL",2,1
"CONTROL CHECK OF FORENSIC WORK",1,NA
"CONTROL REGION",1,NA
"CONTROL SAMPLE",1,NA
"CONTROL WITH X-RAYS",1,NA
"CONTROLLED ADMINISTRATION",2,NA
"CONTROLLED DANGEROUS SUBSTANCES (""""CDS"""")",1,NA
"CONTROLLED DOSING",1,NA
"CONTROLLED DRUGS",5,2
"CONTROLLED MEDICATION SUBSTANCES",1,NA
"CONTROLLED ODOR MIMIC PERMEATION SYSTEM",1,NA
"CONTROLLED PRESCRIPTION DRUG ABUSE",1,NA
"CONTROLLED SUBSTANCES",30,26
"CONTROLLED TRIALS",1,NA
"CONTROVERSY",1,NA
"CONTUSED SKELETAL MUSCLE",1,NA
"CONTUSIO CORDIS",1,NA
"CONTUSIONS",1,NA
"CONVERSION",1,1
"CONVERSION FACTOR",1,NA
"CONVERTION FACTOR",1,NA
"CONVICTION",1,NA
"COOK COUNTY",1,1
"COOLING DATA",1,NA
"COOMASSIE BRILLIANT BLUE",1,NA
"COOPERATION",1,NA
"COORDINATOR",1,NA
"COPING",1,NA
"COPING ABILITY",1,NA
"COPING BEHAVIOR",1,NA
"COPING STRATEGIES",1,NA
"COPING STYLES",1,NA
"COPPER",2,1
"COPPER PHTHALOCYANINE",1,NA
"COPY NUMBER VARIANTS (CNV)",1,NA
"CORE-SHELL COLUMN",1,NA
"CORE COMPETENCIES",1,NA
"CORE CONTENT",1,NA
"CORHYDRON",2,NA
"CORICIDIN",1,NA
"CORN OIL INJECTIONS",1,NA
"CORNEAL THICKNESS",1,NA
"CORNEOCYTES",1,NA
"CORNEODESMOSIN",1,NA
"CORONA CHARGED AEROSOL DETECTION",2,NA
"CORONA VIRUS DISEASE 2019",1,NA
"CORONARY ANGIOGRAPHY",1,NA
"CORONARY ARTERY",5,NA
"CORONARY ARTERY DISEASE",2,NA
"CORONARY ATHEROSCLEROSIS",1,NA
"CORONARY DISEASE",1,NA
"CORONARY SCLEROSIS",1,NA
"CORONARY THROMBOSIS",3,NA
"CORONER",7,NA
"CORONER'S COURT",1,NA
"CORONER'S INQUIRY",1,NA
"CORONER'S VERDICT",1,NA
"CORONER AND MEDICAL EXAMINER",1,NA
"CORONER RECORDS",1,NA
"CORONERS",2,NA
"CORONERS ACT 2006 (NZ)",1,NA
"CORONERS AND MEDICAL EXAMINERS",5,NA
"CORONIAL AUTOPSY",2,NA
"CORPORATE LOGOS",1,NA
"CORPSE",1,NA
"CORPSE DECOMPOSITION",1,NA
"CORPUS LINGUISTICS",1,NA
"CORRECTED R(F)-VALUE",1,NA
"CORRECTION METHOD",1,NA
"CORRECTIONAL ADAPTATION",1,NA
"CORRECTIONAL CENTRES",1,NA
"CORRECTIONAL FACILITIES",1,NA
"CORRECTIONAL HEALTHCARE",1,NA
"CORRECTIONAL INSTITUTIONS",1,NA
"CORRECTIONAL MENTAL HEALTH CARE",1,NA
"CORRECTIONAL NURSING",1,NA
"CORRECTIONAL PSYCHIATRY",2,NA
"CORRECTIONAL PSYCHOLOGY",2,NA
"CORRECTIONS",6,NA
"CORRELATION",3,2
"CORRELATION ALGORITHMS",1,NA
"CORRELATION ANALYSIS",2,NA
"CORRELATION COEFFICIENT",3,3
"CORRELATION OPTIMIZED WARPING",1,NA
"CORRELATION STUDY",1,NA
"CORRESPONDENCES ANALYSES",1,NA
"CORROSION",1,NA
"CORROSION CAST METHOD",1,NA
"CORROSION CASTS",1,NA
"CORROSIVE ACIDS",1,NA
"CORROSIVE AGENTS",1,NA
"CORROSIVE BURNS",1,1
"CORROSIVE INJURY",1,NA
"CORROSIVE POISON",1,NA
"CORROSIVES",2,NA
"CORRUPTION",1,NA
"CORRUPTION OFFENSES",1,NA
"CORRUPTION OFFENSES INVESTIGATION",1,NA
"CORSICA (FRANCE)",1,NA
"CORTICAL RESPONSE AUDIOMETRY",1,NA
"CORTICAL TEARS",1,NA
"CORTICOSTEROID",2,NA
"CORTICOSTEROIDS",3,3
"CORTISOL",1,NA
"CORYPHANTHA MACROMERIS",1,1
"COSINE AND PEARSON CORRELATION",1,1
"COSMETIC HAIR TREATMENT",3,NA
"COSMETIC INJECTIONS",1,NA
"COSMETIC PRODUCTS",1,NA
"COSMETIC TREATMENT",5,1
"COSMETICS",3,1
"COST",1,NA
"COST ANALYSIS",1,NA
"COST REDUCTION",2,NA
"COTININE",6,NA
"COTTON",2,NA
"COTTON FIBRES",1,NA
"COUGH SUPPRESSANT",1,NA
"COUMARIN DERIVATIVES",1,NA
"COUNSEL",1,NA
"COUNTER-FORENSICS",1,NA
"COUNTER-IMPROVISED EXPLOSIVE DEVICES (IEDS)",1,NA
"COUNTERFEIT",8,28
"COUNTERFEIT ANTI-MALARIALS",1,NA
"COUNTERFEIT BILL",1,NA
"COUNTERFEIT CONTACT LENS",1,NA
"COUNTERFEIT DRUGS",8,16
"COUNTERFEIT LIPITOR® LABELS, USING SMITHS DETECTION ILLUMINATIR™ FT-IR, WITH ATR",1,NA
"COUNTERFEIT MEDICINES",8,20
"COUNTERFEIT PACKAGING ANALYSIS, SLM ANALYSIS OF PRINTING ON SUSPECT LABELS",1,1
"COUNTERFEIT PHARMACEUTICAL PRODUCTS",1,NA
"COUNTERFEIT PHARMACEUTICAL, WITH LIGHT MICROSCOPY, MOLECULAR SPECTROSCOPY",1,1
"COUNTERFEIT PHARMACEUTICALS",5,4
"COUNTERFEIT PHARMACEUTICALS, CORRECT, WRONG INGREDIENTS, INCORRECT APIS, FAKE PACKAGING",1,1
"COUNTERFEIT WEIGHT LOSS FORMULATIONS",1,NA
"COUNTERFEITING",5,7
"COUNTERFEITING OF PHARMACEUTICAL DRUGS, THE US AND FDA AND OTHERS",1,1
"COUNTERING DRUG BUSINESS",1,NA
"COUNTERMEASURES",1,NA
"COUNTERTERRORISM",1,NA
"COUPLED CHROMATOGRAPHY",1,NA
"COURT",4,1
"COURT-ORDERED THERAPY",1,NA
"COURT ASSIGNMENT",1,NA
"COURT DECISION",1,NA
"COURT ORDERS",1,NA
"COURT TESTIMONY",2,NA
"COURTROOM EVIDENCE",1,NA
"COVALENT ATTACHMENT",1,NA
"COVERT DRUG ADMINISTRATION",2,NA
"COVERT RECORDINGS",1,NA
"COVERT VIDEO SURVEILLANCE",1,NA
"COVID",1,NA
"COVID-19",13,1
"COVID-19 PANDEMIC",1,NA
"COX REGRESSION",1,NA
"COZART DDS",1,NA
"COZART® RAPISCAN SYSTEM",1,NA
"CP-47,497",2,4
"CP 47",1,NA
"CP 47,497, HU-210",1,NA
"CP47,497",1,NA
"CPDNA",1,2
"CPG ISLANDS",1,NA
"CPG METHYLATION",1,NA
"CPGS",1,NA
"CPI",1,NA
"CRACK",7,10
"CRACK-COCAINE",1,NA
"CRACK COCAINE",1,2
"CRANE",1,NA
"CRANIAL BONE",1,NA
"CRANIAL SUTURES",1,NA
"CRANIOCEREBRAL TRAUMA",3,NA
"CRANIOFACIAL RECONSTRUCTION",2,NA
"CRANIOMETRIC MEASUREMENTS",1,NA
"CRASH CHARACTERISTICS",1,NA
"CRASH CULPABILITY",1,NA
"CRASH RISK",2,NA
"CRASH STATISTICS",1,NA
"CRAVING",4,NA
"CRAZE",1,NA
"CREAM BISCUITS",1,NA
"CREATINE KINASE",2,NA
"CREATINE KINASE ACTIVITY",1,NA
"CREATINE KINASE MB",1,NA
"CREATINE PHOSPHOKINASE",1,NA
"CREATININE",11,3
"CREMAINS",1,NA
"CREMATION",1,NA
"CRESOL",2,NA
"CRESYL VIOLET",1,NA
"CRETE",1,NA
"CRIME",38,1
"CRIME-SCENE PRESENCE",1,NA
"CRIME ANALYSIS",2,1
"CRIME AND PUNISHMENT (SCOTLAND) ACT 1997",1,NA
"CRIME CASEWORK",1,NA
"CRIME CAUSALITY NETWORK",1,NA
"CRIME LAB",2,NA
"CRIME LAB DIRECTORS",1,NA
"CRIME LABORATORIES",2,1
"CRIME LABORATORY",1,NA
"CRIME PREVENTION",1,NA
"CRIME RECONSTRUCTION",1,NA
"CRIME SCENE",3,NA
"CRIME SCENE ANALYSIS",1,NA
"CRIME SCENE IMAGES",1,NA
"CRIME SCENE INVESTIGATION",9,2
"CRIME SCENES",2,NA
"CRIME VICTIM",1,1
"CRIME VICTIMS",2,NA
"CRIMINAL",2,NA
"CRIMINAL-THINKING STYLES",1,NA
"CRIMINAL ACTS",1,NA
"CRIMINAL BEHAVIOR",8,NA
"CRIMINAL BEHAVIOUR",1,NA
"CRIMINAL CAREER",4,NA
"CRIMINAL CASE",1,NA
"CRIMINAL CASES",1,NA
"CRIMINAL COD E IN HUNGARY",1,NA
"CRIMINAL CODE",1,NA
"CRIMINAL COMMUNITIES",1,NA
"CRIMINAL COURT",1,NA
"CRIMINAL CULPABILITY",1,NA
"CRIMINAL EQUITY SYSTEM",1,NA
"CRIMINAL FORENSIC ANALYSIS",1,NA
"CRIMINAL FORENSIC SETTING",1,NA
"CRIMINAL INJURY CASE",1,NA
"CRIMINAL INSANITY",2,NA
"CRIMINAL INTENT",1,NA
"CRIMINAL INTOXICATIONS",1,NA
"CRIMINAL INVESTIGATION",10,1
"CRIMINAL JUSTICE",9,NA
"CRIMINAL JUSTICE INVOLVEMENT",1,NA
"CRIMINAL JUSTICE REFORM",1,NA
"CRIMINAL JUSTICE SYSTEM",4,NA
"CRIMINAL JUSTICE SYSTEM (CJS)",1,NA
"CRIMINAL LAW",7,NA
"CRIMINAL LIABILITY",2,NA
"CRIMINAL MARKET",2,2
"CRIMINAL OFFENCE",1,NA
"CRIMINAL OFFENDERS",3,NA
"CRIMINAL OFFENDING",1,NA
"CRIMINAL POISONING",1,NA
"CRIMINAL PROCEDURE",1,NA
"CRIMINAL PROCEEDING",1,NA
"CRIMINAL PROCEEDINGS",2,NA
"CRIMINAL PROFILING",2,NA
"CRIMINAL RECIDIVISM",4,NA
"CRIMINAL RECORD",1,NA
"CRIMINAL REGISTER",1,NA
"CRIMINAL RESPONSIBILITY",18,NA
"CRIMINAL RISK REDUCTION",1,NA
"CRIMINAL SCENES",1,NA
"CRIMINAL STATE",1,NA
"CRIMINAL THINKING",4,NA
"CRIMINAL VIOLENCE",1,NA
"CRIMINALISTIC AND FORENSIC ASPECTS",1,NA
"CRIMINALISTIC TOXICOLOGY",1,NA
"CRIMINALISTICS",38,22
"CRIMINALISTICS CHARACTERISTIC OF THE CRIMINAL ACTS",1,NA
"CRIMINALISTICS SAMPLING",1,1
"CRIMINALISTICS, ETHICS AS CENTRAL TO ORGANIZATION'S VALUES",1,NA
"CRIMINALISTICS, THE BEDROCK OF FORENSIC SCIENCE",1,NA
"CRIMINALITY",9,NA
"CRIMINALITY DIRECT AND INDIRECT",1,NA
"CRIMINALIZATION",1,NA
"CRIMINOGENIC NEED",1,NA
"CRIMINOGENIC NEEDS",1,NA
"CRIMINOLOGICAL FEATURES",1,NA
"CRIMINOLOGICAL LITERATURE",1,NA
"CRIMINOLOGY",6,NA
"CRISP2",1,NA
"CRITERIA",1,1
"CRITICAL CARE",3,NA
"CRITICAL CARE MEDICINE",1,NA
"CRITICAL CONDITIONS",1,NA
"CRITICAL POLICY ANALYSIS",1,NA
"CRITICAL REVIEW",1,NA
"CRITICAL THOUGHT",1,1
"CRL-40,940",1,NA
"CRL-40,941",1,NA
"CROATIA",1,1
"CROATIAN EXPERIENCE",1,NA
"CROHN'S DISEASE",2,NA
"CRONE ETHER",1,NA
"CROP THRASHER",1,NA
"CROSPOVIDONE",2,1
"CROSS- REACTIVITIES",1,NA
"CROSS-BORDER",1,NA
"CROSS-CHECK",1,1
"CROSS-CONTAMINATION",1,1
"CROSS-CONTRIBUTION",2,3
"CROSS-COUPLING REACTION",1,NA
"CROSS-COUPLING REACTIONS",1,NA
"CROSS-CULTURAL STUDY",1,1
"CROSS-DISCIPLINARY RELATIONSHIPS",1,NA
"CROSS-DOCKING",1,NA
"CROSS-LINKED PEPTIDES",1,NA
"CROSS-REACTION",1,NA
"CROSS-REACTIVITY",8,5
"CROSS-SECTIONAL STUDIES",1,NA
"CROSS-VALIDATION",3,NA
"CROSS CONTRIBUTION",1,NA
"CROSS REACTION",1,NA
"CROSS SECTIONAL STUDY",1,NA
"CROSSED POLARIZING FILTERS",1,NA
"CROSSING INK LINES",1,NA
"CROSSLINKING",1,NA
"CROSSMATCH",1,NA
"CROSSREACTIVITY",1,NA
"CROTON TIGLIUM (JAMALGOTA)",1,NA
"CROTONYLFENTANYL",3,3
"CROWD CONTROL AGENT",1,NA
"CROWDSOURCING",1,NA
"CROWN-OF-THORNS STARFISH",1,NA
"CRUDE DRUGS",1,NA
"CRUDE OIL",2,NA
"CRUM BROWN, ALEXANDER",1,NA
"CRUSH",1,NA
"CRUSH ASPHYXIA",2,NA
"CRUSHED PILLS",1,NA
"CRYOGENIC",1,NA
"CRYPTANALYSIS",1,NA
"CRYPTOCURRENCY FORENSICS",1,NA
"CRYPTOGRAPHY",1,NA
"CRYPTOMARKETS",5,14
"CRYSTAL",1,1
"CRYSTAL METH",3,2
"CRYSTAL MORPHOLOGY",1,1
"CRYSTAL STRUCTURE",2,9
"CRYSTALLOGRAPHY",3,2
"CRYSTALLURIA",1,NA
"CS",1,NA
"CS ALGORITHM",1,NA
"CSEI-SWEEP-MEKC",4,NA
"CSF1PO",2,NA
"CSFPO",1,NA
"CSIA",1,NA
"CSR",1,NA
"CT",5,NA
"CT GUIDE",1,NA
"CT SPECTROSCOPY",1,NA
"CTAB",1,2
"CTX",1,NA
"CTX3C",1,NA
"CU NANOPARTICLE",1,NA
"CUCURBIT[7]URIL",1,2
"CUE EXPOSURE TRAINING",1,NA
"CUKUROVA REGION",1,NA
"CULPABILITY",3,NA
"CULTIGEN",1,1
"CULTIVATED SILK",1,NA
"CULTIVATION",1,7
"CULTURAL COMPETENCE",1,NA
"CULTURAL DEFENSE",1,NA
"CULTURAL NORMALISATION",1,NA
"CUMYL-4CN-BINACA",1,1
"CUMYL-5F-P7AICA",1,NA
"CUMYL-5F-PICA",1,1
"CUMYL-BICA",1,1
"CUMYL-PEGACLONE",1,1
"CUMYL-PICA",1,NA
"CUMYL CARBOXAMIDE-TYPE",1,1
"CUNNINGHAMELLA ELEGANS",1,NA
"CUPRIC FERROCYANIDE REAGENT",1,NA
"CURARE-LIKE SUBSTANCES",1,NA
"CURATION",1,1
"CURCUMIN",1,NA
"CURIE POINT PYROLYZER",1,NA
"CURIUM ISOTOPES",1,NA
"CURRENCY",3,2
"CURRENCY CONTAMINATION",1,NA
"CURRENT FORENSIC CAPABILITIES",1,NA
"CURRICULA",2,1
"CURRICULUM DEVELOPMENT",1,NA
"CUSCOHYGRINE",1,4
"CUSTODIAL DEATHS",2,NA
"CUSTODIAL MEASURES",1,NA
"CUSTODY",6,NA
"CUSTODY CARE",1,NA
"CUSTODY DETAINEES",1,NA
"CUSTODY MEDICINE",1,NA
"CUSTODY NURSE",1,NA
"CUSTOM-TAILORED APTAMERS",1,NA
"CUSTOMS",1,2
"CUSTOMS BORDER",1,NA
"CUT-OFF",9,NA
"CUT-OFF REFERENCE VALUES",1,NA
"CUT-OFF VALUE",2,NA
"CUT-OFF VALUES",2,NA
"CUT-OFFS",4,NA
"CUT-THROAT",1,NA
"CUT OFF LEVEL FOR EXOGENOUS ADMINISTRATION OF GHB",1,NA
"CUT VS. PULVERIZING",1,NA
"CUT WOUND",1,NA
"CUTANEOUS BLISTERS",1,NA
"CUTICULAR HYDROCARBONS",2,NA
"CUTOFF",1,1
"CUTOFF CONCENTRATIONS",1,NA
"CUTOFF VALUE",1,NA
"CUTOFFS",2,NA
"CUTTING-AGENTS",1,NA
"CUTTING AGENTS",9,9
"CVD",1,NA
"CWAS",1,NA
"CYAMEMAZINE",1,NA
"CYANAMIDE",1,NA
"CYANIDE",14,1
"CYANIDE EXPOSURE",1,NA
"CYANIDE POISONING",2,NA
"CYANIDE QUANTITATION",1,NA
"CYANOACRYLATE",11,NA
"CYANOACRYLATE (SUPERGLUE) FUMING",1,NA
"CYANOACRYLATE FUMING",4,1
"CYANOACRYLATE STAINS",1,NA
"CYANOBLOOM UV",1,NA
"CYANOBOROHYDRIDE",1,1
"CYANOGENIC COMPOUNDS",1,NA
"CYANOPHOS",1,NA
"CYANURIC ACID",1,NA
"CYBER",1,NA
"CYBER-VIGILANTES",1,NA
"CYBER CRIME",4,3
"CYBERPHYSICAL SYSTEMS",1,NA
"CYBERSUICIDE",1,NA
"CYCLIC ANTIDEPRESSANT",1,NA
"CYCLIC INDENE",1,1
"CYCLIC NEUTRON ACTIVATION ANALYSIS",1,NA
"CYCLIC OLEFIN COPOLYMER",1,NA
"CYCLIC VOLTAMMETRY (CV)",1,13
"CYCLIN-DEPENDENT KINASE 5",1,NA
"CYCLIZINE",1,NA
"CYCLOBENZAPRINE",1,NA
"CYCLODEXTRINS",6,41
"CYCLOFRUCTAN",1,NA
"CYCLOHEXYL NITRITE",1,1
"CYCLOOXYGENASE",1,NA
"CYCLOPROP-2-ENE CARBOXYLIC ACID",1,NA
"CYCLOPROPYLCARBONYLINDOLES",1,1
"CYCLOPROPYLFENTANYL",5,3
"CYCLOPYRROLONES",1,NA
"CYCLOSPORIN A",1,NA
"CYCLOTETRAMETHYLENE TRETRANITRAMINE",1,NA
"CYCLOTRIMETHYLENE-TRINITRAMINE (RDX)",5,NA
"CYCLOTRIMETHYLENETRINITRAMINE DINITROTOLUENE",1,NA
"CYNEGETIC SPECIES",1,NA
"CYP",3,NA
"CYP 2C19",1,NA
"CYP 2D6",3,NA
"CYP ENZYMES",1,NA
"CYP ISOENZYMES",1,NA
"CYP ISOFORMS",1,NA
"CYP POLYMORPHISM",1,NA
"CYP1A2",1,NA
"CYP2A6",1,NA
"CYP2B6",2,NA
"CYP2C19",7,NA
"CYP2C19 GENE",1,NA
"CYP2C9",3,NA
"CYP2D6",17,1
"CYP2D6 GENE",2,NA
"CYP2D6 PHARMACOGENETICS",1,NA
"CYP2D6 POLYMORPHISM",2,NA
"CYP3A4",2,NA
"CYP3A4 CYP2D6",1,NA
"CYP450",3,NA
"CYP450 ENZYMES",1,NA
"CYP450 SYSTEM",1,NA
"CYP4A11",1,NA
"CYPROHEPTADINE",1,1
"CYPROTERONE ACETATE",4,NA
"CYSTEINE DISULFIDE-ADDUCTS",1,NA
"CYTISINE",1,NA
"CYTISINE EXTRACTION",1,NA
"CYTOCHOROME P450 2D6",1,NA
"CYTOCHROME B",3,NA
"CYTOCHROME B GENE (CYT B)",1,NA
"CYTOCHROME C OXIDASE I",2,NA
"CYTOCHROME C OXIDASE I (COI)",1,NA
"CYTOCHROME C OXIDASE SUBUNIT 1",1,NA
"CYTOCHROME C OXIDASE SUBUNIT I",1,NA
"CYTOCHROME OXIDASE",1,NA
"CYTOCHROME OXIDASE I",1,NA
"CYTOCHROME OXIDASE I (COI)",1,NA
"CYTOCHROME OXIDASE I GENE (COI)",1,NA
"CYTOCHROME OXIDASE SUBUNIT ONE (COI)",1,NA
"CYTOCHROME P-450",1,NA
"CYTOCHROME P-450 CYP2D6",1,NA
"CYTOCHROME P-450 ENZYME SYSTEM",3,NA
"CYTOCHROME P450",19,NA
"CYTOCHROME P450 (CYP450)",1,NA
"CYTOCHROME P450 2C19",1,NA
"CYTOCHROME P450 2D6",1,NA
"CYTOCHROME P450 2E1",1,NA
"CYTOCHROME P450 3A",1,NA
"CYTOCHROME P450 ISOFORMS",1,NA
"CYTOKINES",1,NA
"CYTOLOGY",1,NA
"CYTOSOLIC FRACTIONS",2,NA
"CYTOTOXICITY",2,5
"CYTOTOXICITY ASSAYS",1,NA
"CYTOTOXICITY TEST",1,NA
"CZE",2,6
"CZE/MEKC",1,1
"D-AMPHETAMINE",1,1
"D-FENFLURAMINE",1,NA
"D-LYSERGIC ACID DIETHYLAMIDE",1,1
"D-METAMPHETAMINE",1,NA
"D‑ASPARTIC ACID",1,NA
"D 600-INDUCED BLOCKADE OF THE CA CHANNEL",1,NA
"D,L-AMPHETAMINE",1,NA
"D,L-METHAMPHETAMINE",1,NA
"D13S317",2,NA
"D14S299",1,NA
"D16S539",2,NA
"D18S51",1,NA
"D21S11",1,NA
"D2S1338",1,NA
"D7S8",3,NA
"D7S820",2,NA
"DA:DOPAMINE",1,NA
"DACT",1,NA
"DACTYLOSCOPY",2,NA
"DAD",1,1
"DADP",2,NA
"DAILY MEDIUM DOSAGE SCREENINGS",1,NA
"DAIRY",1,NA
"DAKIN-WEST",1,1
"DAKTARIN",1,NA
"DALT",1,1
"DAMAGE COMPENSATION",1,NA
"DAMAGES",1,NA
"DAME JANET SMITH",1,NA
"DAMIANA",1,1
"DANDELION",1,NA
"DANGER",1,NA
"DANGEROUS",1,NA
"DANGEROUS ADULTERANTS",1,NA
"DANGEROUS DRUGS",1,NA
"DANGEROUSNESS",7,NA
"DAOISM",1,NA
"DAPP-IMS",1,NA
"DAR ES SALAAM",1,NA
"DARBEPOETIN ALFA",1,NA
"DARK",1,NA
"DARK NET",7,4
"DARK TRIAD",1,NA
"DARK WEB",3,3
"DARKNET MARKETS",2,2
"DART",3,4
"DART-HRMS",3,2
"DART-MS",9,13
"DART-MS/MS",1,NA
"DART-TOF",1,2
"DART-TOF-MS",2,2
"DARTTM (DIRECT ANALYSIS IN REAL TIME)",1,NA
"DATA",1,NA
"DATA-DEPENDENT ACQUISITION",2,1
"DATA-DEPENDENT ANALYSIS",1,NA
"DATA-INDEPENDENT ACQUISITION",2,NA
"DATA-MANAGEMENT, IDENTIFICATION",1,NA
"DATA ANALYSIS",5,3
"DATA CLASSIFICATION",1,NA
"DATA DEPENDENT ACQUISITION (DDA)",1,NA
"DATA EVALUATION",2,1
"DATA HANDLING",2,NA
"DATA INDEPENDENT ACQUISITION",1,NA
"DATA INDEPENDENT ACQUISITION (DIA)",1,NA
"DATA INTERPRETATION",2,1
"DATA MANAGEMENT SYSTEM",1,NA
"DATA MANAGEMENT, IDENTIFICATION",1,NA
"DATA MINING",7,2
"DATA NORMALISATION",1,NA
"DATA PROVIDING A """"SPECTROSCOPIC FINGERPRINT""""",1,NA
"DATA QUALITY",1,NA
"DATA RAPE",1,NA
"DATA SCRAPING",1,1
"DATA SECURITY",1,NA
"DATA VALIDATION",1,1
"DATABANK",1,NA
"DATABASE",14,7
"DATABASE RESEARCH",1,NA
"DATABASE RETRIEVAL",1,NA
"DATABASE SCREENING",1,NA
"DATABASE SEARCH",4,NA
"DATABASING",1,1
"DATAMINING",2,NA
"DATASET",1,1
"DATASET PREPARATION",2,NA
"DATE-RAPE",2,1
"DATE-RAPE DRUG TESTS",1,NA
"DATE-RAPE DRUGS",18,16
"DATE RAPE",8,1
"DATING APP",1,NA
"DATING OF DOCUMENTS",1,NA
"DATING OF INKPAD SEALS",1,NA
"DATURA",5,1
"DATURA SEEDS",1,NA
"DATURA STRAMONIUM",4,5
"DAUBERT",2,NA
"DAUBERT CASE",1,NA
"DAVIES-GRAY",1,NA
"DAY OF DEATH",1,NA
"DBS",3,1
"DDPCR",1,NA
"DDT",1,NA
"DDVP",1,NA
"DE-ACTIVATED FIREARMS",1,NA
"DE-ESCALATION",1,NA
"DE NOVO",1,NA
"DE NOVO ASSEMBLY",1,NA
"DE NOVO CRIME",1,NA
"DEA",2,2
"DEACETYLDILTIAZEM",1,NA
"DEAD-TIME",1,NA
"DEAL",1,NA
"DEALING",1,NA
"DEALKYLATION",1,2
"DEATH",160,2
"DEATH BY DROWNING",1,NA
"DEATH CAP MUSHROOM",1,NA
"DEATH CERTIFICATE",1,NA
"DEATH CERTIFICATES",3,NA
"DEATH CERTIFICATES/CORNER AUTOPSIES",1,NA
"DEATH CERTIFICATION",14,NA
"DEATH CLASSIFICATION",1,NA
"DEATH DUE TO FIRE",1,NA
"DEATH DUE TO PESTICIDE POISONING",1,NA
"DEATH FROM FIRE",1,NA
"DEATH IDENTIFICATION",1,NA
"DEATH IN CUSTODY",6,NA
"DEATH IN POLICE CUSTODY",1,NA
"DEATH INQUEST",1,NA
"DEATH INVESTIGATION",15,NA
"DEATH MECHANISM",1,NA
"DEATH PENALTY",1,NA
"DEATH PROCESS",1,NA
"DEATH RATE",1,NA
"DEATH SCENE INVESTIGATION",6,NA
"DEATH SUDDEN",1,NA
"DEATH TIME",1,NA
"DEATH TIME DIAGNOSIS",1,NA
"DEATH TIME ESTIMATION",1,NA
"DEATH, SUDDEN",1,NA
"DEATHS",13,NA
"DEATHS IN CUSTODY",5,NA
"DEATHS IN PRISONS",1,NA
"DECAETHYLENE GLYCOL MONODODECYL ETHER (DGME)",1,NA
"DECALCIFICATION",1,NA
"DECAPITATION",2,NA
"DECARBOXYLATION",1,5
"DECAY",1,1
"DECAY DATA",2,NA
"DECEASED DRUG ADDICTS",1,NA
"DECEDENTS",1,NA
"DECEPTION",1,NA
"DÉCÈS",1,NA
"DECISION LIMITS",1,NA
"DECISION MAKING",5,1
"DECISION SUPPORT SYSTEMS",1,NA
"DECISION THEORY",1,1
"DECISION TREE",2,NA
"DECOMPOSED BODY",1,NA
"DECOMPOSED CADAVERS",1,NA
"DECOMPOSERS",1,NA
"DECOMPOSING TISSUE",1,NA
"DECOMPOSITION",16,NA
"DECOMPOSITION BY A FOX",1,NA
"DECOMPOSITION CHEMISTRY",1,NA
"DECOMPOSITION ODOUR PROFILING",1,NA
"DECOMPOSITION OF HEROIN",1,1
"DECOMPOSITION RATE",1,NA
"DECOMPOSITION STAGES",2,NA
"DECOMPOSITIONAL CHANGES",1,NA
"DECOMPOSITIONAL PROCESS",1,NA
"DECOMPRESSION",1,NA
"DECONGESTANT TABLET",1,NA
"DECONJUGATION",1,NA
"DECONTAMINATION",8,NA
"DECONTAMINATION PROCEDURES",1,NA
"DECONVOLUTION",3,1
"DECORATIVE CONTACT LENS",1,NA
"DECREASE DURING ABSTINENCE",1,NA
"DECRIMINALIZATION",1,1
"DECRYPTION",1,NA
"DECUBITUS",1,NA
"DEEP-SEA",1,NA
"DEEP LEARNING",1,2
"DEEP SEDATION",1,NA
"DEEP VEIN THROMBOSIS",1,NA
"DEEP VENOUS THROMBOSIS",1,NA
"DEEP WEB",2,NA
"DEEPWATER HORIZON",2,NA
"DEFAMATION",1,NA
"DEFENSE",2,NA
"DEFENSE WOUND",1,NA
"DEFENSIVE RESPONDING",1,NA
"DEFENSIVE SEARCH",1,NA
"DEFICIENCY SYMPTOMS",1,NA
"DEFINED DAILY DOSE (DDD)",1,2
"DEFINITION",2,1
"DEGENERATE OLIGONUCLEOTIDE-PRIMED PCR",1,NA
"DEGLUTITION",1,1
"DEGRADATION",16,12
"DEGRADATION KINETICS",1,NA
"DEGRADATION PATHWAY",1,1
"DEGRADATION PRODUCT",2,6
"DEGRADING TREATMENT",1,NA
"DEGREE DAYS",1,NA
"DEHYDRONORKETAMINE",1,2
"DEIFICATION OF THE VICTIM",1,NA
"DEINSTITUTIONALIZATION",3,NA
"DEKOMPRESSIONSKRANKHEIT",1,NA
"DÉLAI POST MORTEM",1,NA
"DELAYED CLEARANCE IN VIVO",1,NA
"DELAYED COMPLICATIONS",1,NA
"DELAYED DEATH",1,NA
"DELAYED GAMMA",1,NA
"DELAYED NEUTRON ACTIVATION ANALYSIS",1,NA
"DELAYED NEUTRON COUNTING",1,NA
"DELAYED PACING LEAD MIGRATION",1,NA
"DELETION",1,NA
"DELIBERATE-SELF HARM",1,NA
"DELIBERATE SELF-HARM",1,NA
"DELIBERATE SELF-INFLICTED BURNS",1,NA
"DELIBERATE TEAM INTOXICATION",1,NA
"DELICTS",1,NA
"DELINQUENCY",10,NA
"DELINQUENCY TYPE",1,NA
"DELINQUENT",1,NA
"DELINQUENT CAREER",1,NA
"DELINQUENT WOMEN",1,NA
"DELINQUENTS",2,NA
"DELIQUENCY",2,NA
"DELIRIUM",3,1
"DELIRIUM TREMENS",1,NA
"DELIVERY OF HEALTH CARE",2,NA
"DELORAZEPAM",2,NA
"DELPHI-STUDY",1,NA
"DELTA-9- TETRAHYDROCANNABINOLIC ACID",1,1
"DELTA-9-TETRAHYDROCANNABINOL (D-9-THC)",41,51
"DELTA-9-TETRAHYDROCANNABINOLIC ACID A",1,NA
"DELTA-9-THC (DELTA-9-TETRAHYDROCANNABIOL)",1,NA
"DELTA SIGNATURES",1,1
"DELTA(9)-THC",1,NA
"DELTA9-TETRAHYDROCANNABINOL",1,NA
"DELUSION",1,NA
"DELUSIONS",3,NA
"DEMAND REDUCTION",1,NA
"DEMENTIA",4,NA
"DEMETHYLATION",1,3
"DEMETHYLENATION",1,NA
"DEMOBILIZATION",1,NA
"DEMOGRAPHIC",2,1
"DEMOGRAPHIC DATA",3,NA
"DEMOGRAPHIC DEVELOPMENT",1,NA
"DEMOGRAPHIC VARIABLES",1,NA
"DEMOGRAPHICS",4,1
"DENDROCHRONOLOGY",1,NA
"DENGUE VIRUS",1,NA
"DENMARK",3,2
"DENSITOMETRY",3,5
"DENSITY",1,NA
"DENSITY-BASED SEPARATION",1,NA
"DENSITY FUNCTIONAL THEORY (DFT)",3,29
"DENSITY FUNCTIONAL THEORY METHODS",1,NA
"DENTAL AGE ESTIMATION",1,NA
"DENTAL ANTHROPOLOGY",1,NA
"DENTAL CALCULUS",1,NA
"DENTAL DEVELOPMENT",1,NA
"DENTAL ETHICS",1,NA
"DENTAL FLUOROSIS",1,NA
"DENTAL HEALTH",1,NA
"DENTAL IDENTIFICATION",1,NA
"DENTAL MATERIALS",2,NA
"DENTAL PULP",2,NA
"DENTAL TISSUE",1,NA
"DENTATE GYRUS",2,NA
"DENTINE",1,NA
"DENTISTRY",2,NA
"DENTITION",1,NA
"DEONTIC REASONING",1,NA
"DEONTOLOGY",1,NA
"DEOXYRIBONUCLEASE I",1,NA
"DEPARAFFINIZATION",1,NA
"DEPARTURES",1,NA
"DEPENDENCE ON PSYCHOACTIVE SUBSTANCES",1,NA
"DEPENDENCE SYNDROME",1,NA
"DEPENDENCE SYNDROMES",1,NA
"DEPENDENT PERSONALITY",1,NA
"DEPENDENT PERSONALITY DISORDER",1,NA
"DEPO-PROVERA",1,NA
"DEPOSITION TIME",1,NA
"DEPOT",2,NA
"DEPOT ANTIPSYCHOTICS",1,NA
"DEPOT FORMULATION",1,NA
"DEPOT NEUROLEPTICS",1,NA
"DEPRENYL",2,1
"DEPRESSION",19,6
"DEPRESSIVE DISORDER",1,NA
"DEPRESSIVE SYMPTOMS",1,NA
"DEPRIVATION",1,NA
"DEPROTONATION",1,1
"DERELICTION",1,NA
"DERIVATISATION AGENT",1,1
"DERIVATISATION, GC",1,NA
"DERIVATIVE",4,2
"DERIVATIVES OF INDOLE-3-CARBOXYLIC ACID",1,1
"DERIVATIZATION",26,32
"DERIVATIZATION STEP",1,NA
"DERIVATIZATION, GC",3,NA
"DERIVATIZATION, LC",2,1
"DERMAL",1,NA
"DERMAL EXPOSURE",1,NA
"DERMAL INJURY",1,NA
"DERMCIDIN",1,NA
"DERMESTES FRISCHI",1,NA
"DERMESTES HAEMORRHOIDALIS",1,NA
"DERMESTES MACULATUS",2,NA
"DERMIS",1,NA
"DESALKYLFLURAZEPAM",1,1
"DESB30 INSULIN",1,NA
"DESCENDING NECROTIZING MEDIASTINITIS",1,NA
"DESCHLORO-N-ETHYL-KETAMINE",1,NA
"DESCHLOROETIZOLAM",1,1
"DESCHLOROKETAMINE",1,1
"DESCHLOROKETAMINE (DCK)",1,1
"DESCRIPTIVE EPIDEMIOLOGY",1,NA
"DESCRIPTIVE STUDY",2,NA
"DESETHYLAMIODARONE",1,NA
"DESI",6,1
"DESI-MSI",1,NA
"DESIGN OF EXPERIMENTS",4,5
"DESIGNATED SUBSTANCE",1,3
"DESIGNER",1,NA
"DESIGNER BENZODIAZEPINES",14,4
"DESIGNER DRUGS",147,161
"DESIGNER DRUGS OF ABUSE",1,NA
"DESIGNER OPIOIDS",2,1
"DESIGNER STIMULANTS",1,1
"DESIPRAMINE",9,NA
"DESIRES",1,NA
"DESISTANCE",1,NA
"DESMETHYL-SILDENAFIL",1,NA
"DESMETHYL CITALOPRAM",1,NA
"DESMETHYLCLOZAPINE",1,NA
"DESMETHYLDIAZEPAM",1,NA
"DESMETHYLLOPERAMIDE",1,NA
"DESMETHYLMIRTAZAPINE",1,NA
"DESMETHYLSELEGILINE",1,NA
"DESMOCOLLIN 1",1,NA
"DESMOPRESSIN",1,NA
"DESOMORPHINE",4,5
"DESORPTION",4,NA
"DESORPTION AND THEN IONIZATION",1,1
"DESORPTION ATMOSPHERIC PRESSURE PHOTOIONIZATION",3,1
"DESORPTION ELECTROSPRAY IONIOZATION",1,NA
"DESORPTION ELECTROSPRAY IONISATION-MASS SPECTROMETRY (DESI-MS)",1,NA
"DESORPTION ELECTROSPRAY IONISATION (DESI)",1,NA
"DESORPTION ELECTROSPRAY IONISATION DESI",1,NA
"DESORPTION ELECTROSPRAY IONISATION MASS SPECTROMETRY (DESI-MS)",1,2
"DESORPTION ELECTROSPRAY IONIZATION (DESI)",6,5
"DESORPTION/IONIZATION",2,2
"DESORPTION/IONIZATION PROCESS",1,NA
"DESOXYPIPRADROL",2,NA
"DESTRUCTION",1,NA
"DETAINEE",2,NA
"DETAINEES",6,NA
"DETECTABILITY OF POISONS",1,NA
"DETECTING LATENT FINGERPRINTS",1,NA
"DETECTION",36,23
"DETECTION AND QUANTIFICATION ANALYSES",1,1
"DETECTION CANINES",3,3
"DETECTION DOG",1,NA
"DETECTION DOGS",1,NA
"DETECTION EFFECTIVENESS",1,NA
"DETECTION LIMITS",2,3
"DETECTION METHOD",4,1
"DETECTION OF DRUGS IN AUTOLYTIC BRAIN TISSUE",1,NA
"DETECTION OF POISONS",1,NA
"DETECTION SEQUENCES",1,NA
"DETECTION SYSTEMS",1,1
"DETECTION TECHNIQUE",1,1
"DETECTION TECHNIQUES",1,NA
"DETECTION TECHNIQUES AND FALSE POSITIVE RATE, ON HOW OFTEN A SUBSTANCE TESTS POSITIVE",1,NA
"DETECTION WINDOW",3,1
"DETECTIVES",1,NA
"DETECTOR FLAME",1,NA
"DETECTOR RESPONSE",1,NA
"DETENTION",10,NA
"DETENTION IN A PSYCHIATRIC HOSPITAL",1,NA
"DETERGENT",1,NA
"DETERGENT MACERATION",1,NA
"DETERGENTS",2,NA
"DETERMINATION",17,18
"DETERMINATION CHIP",1,NA
"DETERMINATION IN AUTOPSY MATERIAL",1,NA
"DETERMINATION IN URINE WITH LC-MS/MS",1,1
"DETERMINATION METHODS",1,NA
"DETERMINATION OF",1,NA
"DETERMINATION OF BAC, ADH/REA METHOD",1,NA
"DETERMINATION OF BROMINE",1,NA
"DETERMINATION OF ETHANOL",1,NA
"DETERMINATION OF SEVERITY",1,NA
"DETERMINATIONS",1,NA
"DETERMINISTIC APPROACH",1,1
"DETOX AGENTS",1,NA
"DETOXICATION",2,NA
"DETOXIFICATION",4,1
"DEUTERATION",2,3
"DEUTERIUM",2,3
"DEUTERIUM-LABELED INTERNAL STANDARD",1,NA
"DEUTERIUM EXCHANGE",1,NA
"DEVELOPING COUNTRIES",1,1
"DEVELOPING ECONOMIES",1,NA
"DEVELOPING WORLD",2,NA
"DEVELOPMENT",6,1
"DEVELOPMENT CYCLE",1,NA
"DEVELOPMENT DRUGS",1,NA
"DEVELOPMENT RATE",2,NA
"DEVELOPMENT RATES",2,NA
"DEVELOPMENT TREND",1,NA
"DEVELOPMENTAL DISABILITY",3,NA
"DEVELOPMENTAL DURATION",1,NA
"DEVELOPMENTAL PSYCHOLOGY",1,NA
"DEVELOPMENTAL PSYCHOPATHOLOGY",1,NA
"DEVELOPMENTAL TRANSCRIPTOME",1,NA
"DEVELOPMENTAL VALIDATION",1,NA
"DEVICE DEBRIS",1,NA
"DEXAMETHASONE",4,1
"DEXAMETHASONE AND TRIAMCINOLONE ACETONIDE",1,NA
"DEXFENFLURAMINE",1,1
"DEXMEDETOMIDINE",1,NA
"DEXTROMETHORPHAN",11,12
"DEXTROMORAMIDE",1,1
"DEXTROPROPOXYPHENE",8,NA
"DEXTROPROPOXYPHENE (DXP)",2,NA
"DEXTROPROPOXYPHENE ADDICTION",1,NA
"DEXTROPROPOXYPHENE, DEATHS",1,NA
"DEXTROPROPOXYPHENE, FATAL POISONINGS",1,NA
"DEXTRORPHAN",1,1
"DEXTROSE MONOHYDRATE",1,NA
"DFC",3,NA
"DFSA",10,NA
"DFT CALCULATIONS",2,4
"DFTPP",1,NA
"DGGE",1,NA
"DHPLC",1,NA
"DIABETES",15,NA
"DIABETES MELLITUS",6,NA
"DIABETIC",1,NA
"DIABETIC ARTEFACTS IN FORENSIC PRACTICE",1,NA
"DIABETIC BLISTERS",1,NA
"DIABETIC COMA",2,NA
"DIABETIC KETOACIDOSIS",2,NA
"DIABETIC KETOSIS",1,NA
"DIACETYL",1,NA
"DIACETYLMORPHINE",6,7
"DIACETYLMORPHINE (HEROIN)",1,NA
"DIAGNOSIS",24,1
"DIAGNOSIS OF CANCER AND RHEUMATOID ARTHRITIS",1,NA
"DIAGNOSIS PER EXCLUSIONEM",1,NA
"DIAGNOSTIC",6,3
"DIAGNOSTIC BIOMARKER",3,NA
"DIAGNOSTIC CRITERIA",3,NA
"DIAGNOSTIC NUCLEOTIDES",2,NA
"DIAGNOSTIC PCR",1,NA
"DIAGNOSTIC PERFORMANCE",1,NA
"DIAGNOSTIC RATIOS",1,1
"DIAGNOSTIC TESTS",1,NA
"DIAGNOSTIC TOOL",1,NA
"DIAGNOSTIC TOOLS",1,NA
"DIALOG",1,NA
"DIALYSIS",1,NA
"DIAMAGNETIC SUSCEPTIBILITY AND ELECTRON IONIZATION CROSS-SECTIONS",1,1
"DIAMOND ANVIL CELL",1,NA
"DIAMOND CELL",1,NA
"DIAMOND DYE",1,NA
"DIAMOND™ NUCLEIC ACID DYE",1,NA
"DIAPER",1,NA
"DIAPHORESIS",1,NA
"DIASTEREOISOMERS",1,NA
"DIASTEREOMERS",2,2
"DIATOM",1,NA
"DIATOM NANOTECHNOLOGY",1,NA
"DIATOM TEST",3,NA
"DIATOMACEOUS EARTH COLUMN",1,NA
"DIATOMS",3,NA
"DIAZAFLUORENONE",1,NA
"DIAZEPAM",33,27
"DIAZEPAM & METHYLPHENIDATE, VALIDITY OF POLYGRAPH DETECTION OF GUILT, 19-28 YR OLD COLLEGE STUDENTS",1,NA
"DIAZEPAM GLUCURONIDES",1,NA
"DIAZEPAM, COLD TOLERANCE",1,NA
"DIAZEPAM, FREQUENCY IN LEGAL-MEDICINE AUTOPSIES",1,NA
"DIAZINON",2,NA
"DIAZO COUPLING",1,NA
"DIAZOPROPANE",1,NA
"DIBENZEPINE",1,NA
"DIBENZOXAZEPINE",1,NA
"DIBUCAINE",2,NA
"DICARBOXYLIC ACID CONJUGATES",1,NA
"DICHLOROMETHANE",1,2
"DICHLORVOS",5,NA
"DICLAZEPAM",3,1
"DICLOFENAC",1,5
"DICLOFENSINE",1,1
"DICOBALT EDTA",1,NA
"DICTATED DISCHARGE SUMMARY",1,NA
"DIDESMETHYL CITALOPRAM",1,NA
"DIELECTRIC",1,NA
"DIELECTRIC-BARRIER DISCHARGE",1,2
"DIELECTRIC BARRIER DISCHARGE IONIZATION",2,NA
"DIENESTROL",1,NA
"DIESEL FUEL",1,1
"DIESEL OIL SPILLS",1,NA
"DIETARY HABITS",1,NA
"DIETARY SUPPLEMENTS",9,53
"DIETFRIED MÜLLER-HEGEMANN",1,NA
"DIETHYL ETHER",3,NA
"DIETHYLDITHIOCARBAMATE",4,NA
"DIETHYLENE GLYCOL",2,NA
"DIETHYLNITROSAMINE",1,NA
"DIFENIDOL",1,NA
"DIFFERENCES AMONG EXPERTS",2,NA
"DIFFERENT CLASSES OF DRUGS",1,NA
"DIFFERENT TYPES OF DELINQUENCY",1,NA
"DIFFERENTIAL",1,1
"DIFFERENTIAL DIAGNOSIS",4,NA
"DIFFERENTIAL DISPLAY PCR",1,NA
"DIFFERENTIAL EXPRESSION",1,NA
"DIFFERENTIAL EXTRACTION",3,NA
"DIFFERENTIAL GENE EXPRESSION",1,NA
"DIFFERENTIAL INHIBITION",1,NA
"DIFFERENTIAL MOBILITY SPECTROMETRY",1,3
"DIFFERENTIAL MOBILITY SPECTROMETRY-MASS SPECTROMETRY",1,1
"DIFFERENTIAL MOBILITY SPECTROMETRY - MASS SPECTROMETRY",1,NA
"DIFFERENTIAL PULSE POLAROGRAPHY",1,NA
"DIFFERENTIAL PULSE VOLTAMMETRY—ANALYSIS, ACETAMINOPHEN IN PLASMA",1,NA
"DIFFERENTIAL SCANNING CALORIMETRY (DSC)",5,4
"DIFFERENTIAL THERAPY",1,NA
"DIFFERENTIAL THERMAL",1,NA
"DIFFERENTIAL THERMAL ANALYSIS",1,NA
"DIFFERENTIAL TRANSFER",1,NA
"DIFFERENTIATION",4,3
"DIFFERENTIATION ENDOGENOUS/EXOGENOUS",1,NA
"DIFFERENTIATION OF ABSORPTION",1,NA
"DIFFERENTIATION OF MORPHINE FROM CODEINE ABUSE",1,NA
"DIFFERENTLY EXPRESSED",1,NA
"DIFFICULT PATIENT",1,NA
"DIFFRACTION",1,NA
"DIFFUSE AXONAL INJURY",4,NA
"DIFFUSE CEREBRAL EDEMA",1,NA
"DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINCE CELL HYPERPLASIA",1,NA
"DIFFUSE LIGHT",1,1
"DIFFUSE REFLECTANCE",1,1
"DIFFUSE REFLECTANCE INFRARED FOURIER TRANSFORM SPECTROSCOPY (DRIFTS)",1,NA
"DIFFUSION",4,NA
"DIFFUSION PATHWAYS IN HUMAN HAIR FIBERS",1,NA
"DIFFUSION PERCENTAGE",1,NA
"DIFLUNISAL",1,NA
"DIFLUOROETHANE",4,NA
"DIGESTION",1,NA
"DIGESTIVE PERFORATION",1,NA
"DIGGABILITY",1,NA
"DIGITAL AUTOPSY",1,NA
"DIGITAL EVIDENCE",2,NA
"DIGITAL EVIDENCE ANALYSIS",1,NA
"DIGITAL FORENSIC",10,NA
"DIGITAL FORENSIC EVIDENCE",1,1
"DIGITAL IMAGE",2,2
"DIGITAL IMAGE COLORIMETRY",1,NA
"DIGITAL INFORMATION TECHNOLOGY",1,NA
"DIGITAL INVESTIGATION",1,1
"DIGITAL LIGHT PROCESSING",1,NA
"DIGITAL MENTAL HEALTH",1,NA
"DIGITAL MICROFLUIDIC BIOCHIP",1,NA
"DIGITAL MICROFLUIDICS",1,NA
"DIGITAL PATHOLOGY",1,NA
"DIGITAL TRACE",2,2
"DIGITAL VAGINAL PENETRATION",1,NA
"DIGITALIS PURPUREA",1,NA
"DIGITOXIN",1,NA
"DIGITOXIN POISONING",1,NA
"DIGLYCOLAMIDE RESIN",1,NA
"DIGOXIN",7,NA
"DIGOXIN AND ITS ANALOGUES",1,NA
"DIGOXIN INTOXICATION",1,NA
"DIGOXIN POISONING",2,NA
"DIGOXIN POISONING, TISSUE LEVELS, MORPHOLOGICAL FINDINGS",1,NA
"DIGOXIN, IN PERSONS WITH ISCHEMIC HEART DISEASE",1,NA
"DIGOXIN, INTOXICATION",1,NA
"DIHYDROCODEINE",9,1
"DIHYDROMORPHINE",1,2
"DIHYDROMORPHINE-3-GLUCURONIDE HUMANS",1,NA
"DIHYDROMORPHINE DIHYDROMORPHINE-6- GLUCURONIDE",1,NA
"DIHYDROPYRIDINE (DHP)",1,NA
"DIHYDROXY BUTYRIC ACIDS",1,1
"DILATED CARDIOMYOPATHY",2,NA
"DILATED CARDIOPATHY, MOLECULAR AUTOPSY",1,NA
"DILATED PUPILS",1,NA
"DILTIAZEM",2,3
"DILUANTS",1,NA
"DILUENTS",4,6
"DILUTE-AND-SHOOT",1,1
"DILUTED BLOOD",1,NA
"DILUTION",3,NA
"DIMENHYDRINATE",1,NA
"DIMENSIONAL FRAMEWORK",1,NA
"DIMER FORMATION",1,NA
"DIMETHENAMID-P",1,NA
"DIMETHOATE",1,NA
"DIMETHOXYBENZOYL-N-METHYLPIPERAZINES",1,1
"DIMETHOXYPHENYL-N-[(2-METHOXYPHENYL)METHYL]ETHANAMINE",1,1
"DIMETHOXYPHENYLPIPERAZINE",1,1
"DIMETHYL SULFONE",2,2
"DIMETHYL TRISULFIDE",1,NA
"DIMETHYLAMINOCINNAMALDEHYDE",1,NA
"DIMETHYLAMINOETHANOL",1,NA
"DIMETHYLAMPHETAMI NE",1,NA
"DIMETHYLAMPHETARNINE",1,1
"DIMETHYLARSINIC ACID",1,NA
"DIMETHYLNITROSAMINE",1,NA
"DIMETHYLPHOSPHATE",1,NA
"DIMETHYLPOLYSILOXANE PHASE DB™-1",1,NA
"DIMETHYLTRYPTAMINE (DMT)",4,5
"DIMINISHED CAPACITY",1,NA
"DIMINISHED RESPONSIBILITY",3,NA
"DIN 32645",1,NA
"DINITROPHENOLS",1,NA
"DINITROSOPENTAMETHYLENETETRAMINE",1,NA
"DINUCLEOTIDE REPEAT MARKER",1,NA
"DIODE-ARRAY DETECTION",3,6
"DIODE-ARRAY DETECTOR",1,1
"DIODE-ARRAY TLC",1,1
"DIODE ARRAY DETECTOR",1,3
"DIODEARRAY ULTRAVIOLET DETECTION",1,1
"DIOL",1,1
"DIOSCORIDES",1,NA
"DIOXINS",1,NA
"DIPHACINONE AND RODENTICIDE IN ANIMAL LIVER",1,NA
"DIPHENHYDRAMINE",10,5
"DIPHENHYDRAMINE POISONINGS",1,NA
"DIPHENHYDRAMINE, BLOOD AND TISSUE LEVELS",1,NA
"DIPHENHYDRAMINE, FATAL INTOXICATION",1,NA
"DIPHENIDINE",5,4
"DIPHENIDINE, KETAMINE ANALOGS",1,NA
"DIPHENIDOL",1,NA
"DIPHENIDOL HYDROCHLORIDE",1,NA
"DIPHENLYAMINE (DPA)",1,NA
"DIPHENOXYLATE",1,NA
"DIPHENYLAMINE",1,NA
"DIPHENYLMETHANE ANTIHISTAMINICS",1,NA
"DIPHTHERIA",1,NA
"DIPNECH",1,NA
"DIPRIVAN",1,NA
"DIPTERA",4,NA
"DIPTERA LARVAE",1,NA
"DIPTEROCARPACEAE",1,NA
"DIPYRONE",2,NA
"DIQUAT",4,NA
"DIRECT-ACTING ANTIVIRALS",1,NA
"DIRECT-FLOW INJECTION",4,NA
"DIRECT ALCOHOL MARKER",1,NA
"DIRECT ANALYSIS",6,4
"DIRECT ANALYSIS IN REAL-TIME",1,1
"DIRECT ANALYSIS IN REAL-TIME MASS SPECTROMETRY",1,1
"DIRECT ANALYSIS IN REAL TIME-MASS SPECTROMETRY",1,NA
"DIRECT ANALYSIS IN REAL TIME (DART)",17,11
"DIRECT ANALYSIS IN REAL TIME MASS SPECTROMETRY",2,2
"DIRECT ANALYTE-PROBED NANOEXTRACTION",2,1
"DIRECT CAUSE",1,NA
"DIRECT COST",1,NA
"DIRECT EI LC-MS INTERFACE",1,1
"DIRECT ELISA",1,NA
"DIRECT EXPOSURE PROBE",1,NA
"DIRECT HPLC/ESI-MS",1,NA
"DIRECT HPTLC-FTIR MEASUREMENT",1,NA
"DIRECT INFUSION MASS SPECTROMETRY, HIGH-THROUGHPUT ANALYSIS",1,NA
"DIRECT INJECTION",8,6
"DIRECT INLET MASS SPECTROMETRY",1,NA
"DIRECT IONIZATION",1,1
"DIRECT LASER PROCESSING",1,NA
"DIRECT MASS SPECTROMETRY",1,NA
"DIRECT MEASUREMENT",1,NA
"DIRECT MS",1,NA
"DIRECT ORAL ANTICOAGULANT",1,NA
"DIRECT PCR",4,NA
"DIRECT SAMPLE ANALYSIS",2,2
"DIRECT SAMPLE INJECTION.",1,NA
"DIRECT SAMPLING MASS SPECTROMETRY",1,NA
"DIRECTANALYSISINREALTIME",1,1
"DISABILITY",2,NA
"DISABILITY-ADJUSTED LIFE YEARS",1,NA
"DISABILITY AND TRAUMA",1,NA
"DISACCHARIDES",1,NA
"DISAPPEARING INK",1,NA
"DISASTER",1,NA
"DISASTER VICTIM IDENTIFICATION",2,NA
"DISASTER VICTIM IDENTIFICATION (DVI)",1,NA
"DISCERNMENT",1,NA
"DISCHARGE",3,NA
"DISCHARGE SUMMARY",1,NA
"DISCIPLINARY MISCONDUCTS",1,NA
"DISCONTINUATION",1,NA
"DISCOURSE",1,NA
"DISCOURSE ANALYSIS",1,NA
"DISCOVERY",2,NA
"DISCOVERY-BASED ANALYSIS",1,NA
"DISCRIMINANT ANALYSIS",6,6
"DISCRIMINANT FUNCTION",1,NA
"DISCRIMINANT FUNCTION ANALYSIS",1,1
"DISCRIMINATE ANALYSIS",1,NA
"DISCRIMINATING DETECTION",1,NA
"DISCRIMINATING POWER",1,NA
"DISCRIMINATION",14,13
"DISCRIMINATION POWER",1,NA
"DISCRIMINATION TEST",1,NA
"DISEASE",1,NA
"DISEASE DIAGNOSIS",2,NA
"DISEASE OF THE MIND",1,NA
"DISEASE PREVALENCE",1,NA
"DISEASE PREVENTION",1,NA
"DISEASE SURVEILLANCE",1,NA
"DISEASE TREATMENT",1,NA
"DISEASES",4,NA
"DISGUISED SUICIDE",1,NA
"DISGUISED TABLETS",1,1
"DISINFECTANT",4,NA
"DISINFECTANTS",1,NA
"DISINHIBITION",3,NA
"DISINHIBITORY PSYCHOPATHOLOGY",1,NA
"DISK SOLID-PHASE EXTRACTION",1,NA
"DISK SOLID PHASE EXTRACTION",1,NA
"DISMEMBERMENT",1,NA
"DISOCIAL PERSONALITY",1,NA
"DISOPYRAMIDE",1,NA
"DISORDERS",1,NA
"DISORDERS OF PERSONALITY",1,NA
"DISORGANIZATION CAN",1,NA
"DISPENSARY",1,2
"DISPENSED PRESCRIPTION",1,NA
"DISPERSANT EFFECT",1,NA
"DISPERSE DYES",1,1
"DISPERSION",1,2
"DISPERSION LIQUID-LIQUID MICROEXTRACTION",1,NA
"DISPERSIVE LIQUID-LIQUID MICRO-EXTRACTION",1,NA
"DISPERSIVE LIQUID-LIQUID MICROEXTRACTION (DLLME)",9,4
"DISPERSIVE LIQUID-PHASE MICRO-EXTRACTION",1,NA
"DISPERSIVE LIQUID-PHASE MICROEXTRACTION",1,1
"DISPERSIVE LIQUID LIQUID MICROEXTRACTION",1,NA
"DISPERSIVE NEAR-IR RAMAN",1,NA
"DISPERSIVE SOLID-PHASE EXTRACTION",2,1
"DISPERSIVE SOLID PHASE EXTRACTION",1,NA
"DISPERSIVE SPE",1,NA
"DISPOSABLE CHARCOAL BARBEQUES",1,NA
"DISPOSABLE DIAPER",1,NA
"DISPOSABLE NEEDLES",1,NA
"DISPOSABLE PIPETTE EXTRACTION",2,NA
"DISPOSABLE PIPETTE EXTRACTION (DPX)",1,NA
"DISPOSAL",1,NA
"DISPOSITION",3,NA
"DISPOSITION IN RATS",1,NA
"DISRUPTIVE BEHAVIOUR",1,NA
"DISSECTION/CLAMPING",2,NA
"DISSEMINATED INTRAVASCULAR COAGULATION",1,NA
"DISSEMINATION",1,NA
"DISSOCIAL",1,NA
"DISSOCIATION ENERGY",1,NA
"DISSOCIATION REACTIVITY",1,NA
"DISSOCIATIVE AMNESIA",1,NA
"DISSOCIATIVE ANAESTHESIA",1,NA
"DISSOCIATIVE ANESTHETICS",1,4
"DISSOCIATIVE DISORDERS",1,1
"DISSOCIATIVE DRUGS",2,1
"DISSOCIATIVES",3,1
"DISSOLUTION",4,4
"DISSOLUTION-DIFFUSION METHOD",1,NA
"DISSOLUTION MONITORING",1,NA
"DISSOLVED OXYGEN",1,1
"DISSOLVING METAL REDUCTION METHOD",1,1
"DISTANCE METRICS",1,NA
"DISTILLATION",1,1
"DISTRANEURIN",1,NA
"DISTRANEURIN, DETECTION",1,NA
"DISTRESS",1,NA
"DISTRIBUTION",21,3
"DISTRIBUTION IN HUMAN ORGANS",1,NA
"DISTRIBUTION IN ORGANS",1,NA
"DISTRIBUTION IN THE ORGANISM",2,NA
"DISTRIBUTION IN TISSUES",1,NA
"DISTRIBUTION MAPS",1,1
"DISUBSTITUTED PIPERAZINES",1,NA
"DISULFIRAM",2,NA
"DISULFIRAM (ANTABUSE)",1,NA
"DITALIMFOS",1,NA
"DITRAN",1,NA
"DIURETIC",1,NA
"DIURETICS",3,1
"DIVERSION",4,6
"DIVERTED MEDICINES",1,NA
"DIVINER'S SAGE",1,2
"DIVORCE",1,NA
"DIVORCE AND CHILD CUSTODY PROCEEDINGS",1,NA
"DIZOCILPINE",1,NA
"DLG4",1,NA
"DLLME",5,3
"DLLME-SFO",1,NA
"DMAC",1,NA
"DMBZMPS",1,1
"DMFC",1,NA
"DMMP",1,NA
"DMS",3,2
"DMS-MS",1,NA
"DNA",37,8
"DNA-AGNCS PROBES",1,NA
"DNA-BASED IDENTIFICATION",1,1
"DNA-BASED METHOD",1,NA
"DNA-BASED METHODS",1,NA
"DNA-BASED PREDICTION",1,NA
"DNA-FREE",1,NA
"DNA-MIXTURES",1,NA
"DNA ACT",1,NA
"DNA ADDUCTS",1,NA
"DNA ANALYSIS",12,5
"DNA ARRAY",1,NA
"DNA ARRAYS",1,NA
"DNA AUTHENTICATION",1,NA
"DNA BARCODE",4,1
"DNA BARCODING",12,6
"DNA BREAKTHROUGH, QUANTIFICATION OF EXTRACTED DNA",1,NA
"DNA CHIP",1,NA
"DNA CHIPS",1,NA
"DNA CHROMATOGRAPHY",1,1
"DNA COMPUTING",1,NA
"DNA DAMAGE",2,NA
"DNA DAMAGE TOLERANCE",1,NA
"DNA DATABANK",1,NA
"DNA DATABASE",4,1
"DNA DATABASES",1,NA
"DNA DATABASES IN SEXUAL CRIMES",1,NA
"DNA DEGRADATION",7,NA
"DNA DEGRADATION ASSESSMENT",1,NA
"DNA DETECTION",2,NA
"DNA DETECTION DISCRIMINATION",1,NA
"DNA DEVICES",1,NA
"DNA DIAGNOSTICS",1,NA
"DNA ELUATES",1,NA
"DNA EXTRACTION",17,4
"DNA EXTRACTION KIT",1,1
"DNA FINGERPRINTING",3,3
"DNA FORENSICS",1,NA
"DNA FOUR-WAY JUNCTION",1,NA
"DNA FRAGMENTS",1,NA
"DNA FROM NAILS",1,NA
"DNA HYBRIDIZATION",1,NA
"DNA IDENTIFICATION",1,1
"DNA INTERNAL STANDARD",1,NA
"DNA IQ™",1,NA
"DNA IQ™ SYSTEM",1,NA
"DNA ISOLATION",2,NA
"DNA MARKER",1,NA
"DNA MARKERS",1,1
"DNA METABARCODING",1,NA
"DNA METHYLATION",13,NA
"DNA METHYLATION AGE",1,NA
"DNA METHYLATION MARKERS",2,NA
"DNA MICROCHIPS",1,NA
"DNA MIXTURE",2,NA
"DNA MIXTURES",5,NA
"DNA OXIDATION",1,NA
"DNA POLYMORPHISMS",1,NA
"DNA PREDICTION",1,NA
"DNA PROFILING",8,1
"DNA PURIFICATION",1,1
"DNA QUALIFICATION",1,NA
"DNA QUANTIFICATION",3,NA
"DNA REPAIR",1,NA
"DNA SAMPLE",1,NA
"DNA SAMPLE PREPARATION",1,NA
"DNA SAMPLE SEPARATION",1,NA
"DNA SEQUENCE",1,1
"DNA SEQUENCING",1,NA
"DNA SIZING",1,NA
"DNA STORAGE",2,NA
"DNA STRAND BREAKAGE",1,NA
"DNA TECHNOLOGY",1,NA
"DNA TYPING",15,12
"DNA TYPING/PROFILING",1,NA
"DNA, PLANT",1,NA
"DNA/RNA RE-EXTRACTION",1,NA
"DNAPL",2,NA
"DNAZYME",1,NA
"DOA",1,NA
"DOA DETECTION TECHNIQUE",1,NA
"DOB",4,5
"DOCK",1,NA
"DOCKING",1,1
"DOCOSAHEXAENOIC ACIDS",1,NA
"DOCTOR-PATIENT DISAGREEMENT",1,NA
"DOCTOR OF PHARMACY",1,NA
"DOCTOR SHOPPING",1,NA
"DOCUMENT",2,NA
"DOCUMENT ANALYSIS",1,NA
"DOCUMENT EXAMINATION",6,1
"DOCUMENT FRAUD",1,NA
"DOCUMENTARY EVIDENCE",1,NA
"DOCUMENTATION",1,NA
"DOCUMENTATION ABOUT SUICIDE",2,NA
"DOCUMENTOSCOPY",1,1
"DOCUMENTS AND WRITING",1,NA
"DODAF",1,NA
"DOFS",1,NA
"DOG",2,NA
"DOG ATTACKS",1,NA
"DOG BITES",1,NA
"DOG IDENTIFICATION",1,NA
"DOG REPELLENT",1,NA
"DOGS",3,2
"DOI",1,1
"DOKUMENTATION, FORENSISCH-TOXIKOLOGISCHE DATEN-MASCHINENLOCHKARTEN",1,NA
"DOLL RE-ENACTMENT",1,NA
"DOLOMITE",1,NA
"DOMEPP",1,1
"DOMESTIC-SETTING CORPSE",1,NA
"DOMESTIC CAT",1,NA
"DOMESTIC CONFLICT",1,NA
"DOMESTIC DOGS",1,NA
"DOMESTIC HOMICIDE",1,NA
"DOMESTIC MITES",1,NA
"DOMESTIC POISON",1,NA
"DOMESTIC PREPAREDNESS",1,NA
"DOMESTIC SEWAGE",1,NA
"DOMESTIC VIOLENCE",16,NA
"DOMESTIC WASTEWATER TREATMENT PLANT",1,NA
"DONEPEZIL",2,NA
"DONOR‐SPECIFIC ANTIBODIES",1,NA
"DONOR DNA",1,NA
"DONOR INDEPENDENT",1,NA
"DONOR SCREENING",1,NA
"DOP-PCR",1,NA
"DOPALACZE (LEGAL HIGHS)",1,NA
"DOPAMINE",11,7
"DOPAMINE AGONIST",2,NA
"DOPAMINE AGONIST TREATMENT",1,NA
"DOPAMINE AGONISTS",1,NA
"DOPAMINE ANTAGONISTS",2,NA
"DOPAMINE D2 RECEPTOR",1,NA
"DOPAMINE MANIPULATION",1,NA
"DOPAMINE RECEPTORS",2,NA
"DOPAMINERGIC MARKERS",1,NA
"DOPAMINERGIC TERMINAL MARKERS",1,NA
"DOPANT",2,1
"DOPE TESTING",1,NA
"DOPING",42,18
"DOPING AGENTS",3,NA
"DOPING ANALYSIS",4,4
"DOPING CONTROL",19,18
"DOPING IN SPORT",3,NA
"DOPING IN SPORTS",2,1
"DOPING SUBSTANCES",1,NA
"DOSAGE CALCULATION UNCERTAINTY",1,NA
"DOSAGE FORMS",1,3
"DOSE",3,1
"DOSE-CONCENTRATION RELATIONSHIP",3,NA
"DOSE-EFFECT RELATIONSHIP",1,NA
"DOSE-RELATED REFERENCE RANGE",1,NA
"DOSE-RESPONSE",2,NA
"DOSE REDUCTION",1,NA
"DOSES",1,NA
"DOSIMETRY",1,NA
"DOSING ERRORS",1,NA
"DOSULEPINE",1,NA
"DOSY NMR",1,2
"DOTHIEPIN",2,NA
"DOUBLE BASE PROPELLANTS",1,NA
"DOUBLE ENDONUCLEASES DIGESTION",1,NA
"DOUBLE JEOPARDY",1,NA
"DOUBLE PARRICIDE",2,NA
"DOUBLE SUICIDE",1,NA
"DOUBLY COATED CAPILLARY",1,1
"DOWN-STREAM ANALYSES",1,NA
"DOWNERDRUGS",1,NA
"DOXEPIN",5,NA
"DOXYLAMINE",3,NA
"DOXYLAMINE SUCCINATE",1,NA
"DPP4 INHIBITORS",1,NA
"DPX",2,1
"DQA1 AND PM MARKERS",1,NA
"DR. """"X"""" CASE",1,NA
"DRAGONFLY",1,1
"DRAM SHOP LIABILITY",1,NA
"DRAMATIZATION",1,NA
"DRBA",1,NA
"DRD2",1,NA
"DRD2/ANKK1",1,NA
"DRE",2,NA
"DREAM MARKET",1,NA
"DRESDEN REGION",1,NA
"DRIED AGAROSE FILM OVERLAY",1,NA
"DRIED BIOLOGICAL MATRICES",1,NA
"DRIED BLOOD ANALYSIS",1,NA
"DRIED BLOOD SPOT",6,3
"DRIED BLOOD SPOT (DBS)",5,NA
"DRIED BLOOD SPOTS",15,NA
"DRIED BLOOD SPOTS (DBS)",1,NA
"DRIED BLOOD STAIN SAMPLE",1,NA
"DRIED BLOOD STORAGE",1,NA
"DRIED MATRIX SPOT",1,1
"DRIED MATRIX SPOTS",2,NA
"DRIED ORAL FLUID SPOT",1,NA
"DRIED ORAL FLUID SPOTS",1,NA
"DRIED PLASMA SPOT",1,NA
"DRIED SALIVA SPOTS",1,NA
"DRIED SPECIMEN APPLICATIONS",1,NA
"DRIED URINE SPOTS",3,NA
"DRIFT",1,NA
"DRINK-DRIVE LIMIT",1,NA
"DRINK-SPIKING",3,NA
"DRINK SPIKING",2,2
"DRINKING BEHAVIOUR",1,NA
"DRINKING DRIVER",1,NA
"DRINKING DRIVERS",1,NA
"DRINKING DRIVERS, DRUGS IN URINE",1,NA
"DRIVE CLASSIFICATION",1,NA
"DRIVER",26,NA
"DRIVER'S LICENCE REGRANTING",1,NA
"DRIVER'S LICENSE",2,NA
"DRIVER'S LICENSE REGRANTING",1,NA
"DRIVER-RELATED DEATHS",1,NA
"DRIVER FATALITIES",1,NA
"DRIVING ABILITY",4,NA
"DRIVING ABILITY DIAGNOSTICS",1,NA
"DRIVING BEHAVIOR",1,NA
"DRIVING FITNESS",1,NA
"DRIVING IMPAIRMENT",11,NA
"DRIVING INABILITY",1,NA
"DRIVING LICENCE",4,NA
"DRIVING LICENCE RE-GRANTING",2,NA
"DRIVING LICENCE RE-GRANTING GUIDELINES",1,NA
"DRIVING LICENSE",1,NA
"DRIVING LICENSE REVIEW",1,NA
"DRIVING PEOPLE",1,NA
"DRIVING PERFORMANCE",2,NA
"DRIVING SAFETY",1,NA
"DRIVING SIMULATOR",1,NA
"DRIVING SKILLS",1,NA
"DRIVING UNDER THE INFLUENCE LAWS",1,NA
"DRIVING UNDER THE INFLUENCE OF DRUGS (DUID)",132,6
"DROGENTOD",1,NA
"DRONE",1,NA
"DRONE FORENSICS",2,NA
"DROP-IN",2,NA
"DROP-ON-DEMAND INKJET PRINTING",1,NA
"DROP-OUT",4,NA
"DROP MODEL",1,NA
"DROPLET TRAVERSAL",1,NA
"DROPLETS",1,NA
"DROPOUT",2,NA
"DROSPIRENONE",1,NA
"DROWNING",39,NA
"DROWNING DIAGNOSIS",1,NA
"DROWNING INDEX",1,NA
"DROWSY DRIVING",1,NA
"DRUG",365,104
"DRUG- AND ALCOHOL-DEPENDENT OFFENDERS",1,NA
"DRUG-ADDICTION",2,NA
"DRUG-ALCOHOL INTERACTIONS",2,NA
"DRUG-ANALYSIS",1,NA
"DRUG-ASSISTED SUBMISSION",1,NA
"DRUG-ASSOCIATED FATAL ASPIRATION",1,NA
"DRUG-BLOOD-LEVEL",1,NA
"DRUG-CHECKING",1,NA
"DRUG-DRUG COMBINATIONS",1,NA
"DRUG-DRUG INTERACTION",6,1
"DRUG-DRUG INTERACTIONS",2,NA
"DRUG-ELUTING STENT",1,NA
"DRUG-FACILITATE SEXUAL ASSAULT",1,NA
"DRUG-FACILITATED",6,NA
"DRUG-FACILITATED ASSAULT",2,NA
"DRUG-FACILITATED CRIME",22,2
"DRUG-FACILITATED CRIMES",19,5
"DRUG-FACILITATED CRIMES (DFC)",1,NA
"DRUG-FACILITATED SEDATION",1,NA
"DRUG-FACILITATED SEXUAL ASSAULT (DFSA)",81,13
"DRUG-FACILITATED SEXUAL ASSAULTS",2,NA
"DRUG-FACILITATED SEXUAL ASSAULTS (DFSA)",1,NA
"DRUG-GLUCURONIDES OF CODEINE, P-NITROPHENOL AND 2-PHENYL-L-PROPANOL",1,NA
"DRUG-INDUCED",1,NA
"DRUG-INDUCED ANAPHYLACTIC DEATH",1,NA
"DRUG-INDUCED ARRHYTHMIA",1,NA
"DRUG-INDUCED BLISTERS",1,NA
"DRUG-INDUCED COMA",1,NA
"DRUG-INDUCED DEATHS",1,NA
"DRUG-INDUCED HISTOPATHOLOGY",2,NA
"DRUG-INDUCED LIVER TOXICITY",1,NA
"DRUG-INDUCED MENTAL DISORDERS",1,NA
"DRUG-INTERACTIONS",1,NA
"DRUG-INVOLVED OFFENDERS",2,NA
"DRUG-MELANIN BINDING",1,NA
"DRUG-METABOLIZING ENZYMES",1,NA
"DRUG-ONLY POISONINGS",1,NA
"DRUG-RELATED DEATH",39,3
"DRUG-RELATED DEATHS, CIRCUMSTANCES SURROUNDING DEATH",1,NA
"DRUG-RELATED EMERGENCIES",1,NA
"DRUG-RELATED FATAL ANAPHYLAXIS",1,NA
"DRUG-RELATED FATALITIES",2,NA
"DRUG-RELATED FATALITIES OF MORPHINE-ADDICTS",1,NA
"DRUG-RELATED FATALITY",2,NA
"DRUG-RELATED MORTALITY",2,NA
"DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS",3,NA
"DRUG-SCREENING TESTS",1,NA
"DRUG-SMUGGLING",1,NA
"DRUG-THERAPY INDUCED LAMINITIS",1,NA
"DRUG-TOXICITY",1,NA
"DRUG-TYPE",1,NA
"DRUG-TYPE CANNABIS",2,NA
"DRUG-VIOLENCE",1,NA
"DRUG ABSORPTION",1,NA
"DRUG ABSTINENCE",1,NA
"DRUG ABUSE-RELATED DEATH",1,NA
"DRUG ABUSE-RELATED FATALITIES",1,NA
"DRUG ABUSE DEATH",1,NA
"DRUG ABUSE IN DENMARK",1,NA
"DRUG ABUSE PATTERN IN ROMANIA",1,NA
"DRUG ABUSE TESTING",1,NA
"DRUG ABUSE, CONTEMPORARY TRENDS IN LONDON",1,NA
"DRUG ABUSE, RAPID SCREENING",1,NA
"DRUG ABUSER",1,NA
"DRUG ABUSERS",5,NA
"DRUG ACTION TEAM (DAT)",1,NA
"DRUG ADDICT",2,NA
"DRUG ADDICT ACQUIRED DISEASES",1,NA
"DRUG ADDICT DEATHS",2,NA
"DRUG ADDICTION",35,1
"DRUG ADDICTION THERAPY",1,NA
"DRUG ADDICTION TREATMENT",1,NA
"DRUG ADDICTS",12,NA
"DRUG ADDITIVES",1,NA
"DRUG ADMINISTRATION",2,NA
"DRUG ADMINISTRATION ERROR",1,NA
"DRUG ADMINISTRATION ROUTES",1,2
"DRUG ADVERSE EFFECT",1,NA
"DRUG ALLERGY",2,NA
"DRUG ANALOG",2,3
"DRUG ANALYSIS",73,37
"DRUG ANALYSIS-EXTERNAL CONTAMINATION-LOSS OF DRUG SUBSTANCES",1,NA
"DRUG ANALYSIS BY SOLID-PHASE MICROEXTRACTION",1,NA
"DRUG ANALYSIS IN HAIR",1,NA
"DRUG ANALYSIS IN ORAL FLUID",1,NA
"DRUG ANALYSIS SYSTEM",1,NA
"DRUG ANAPHYLAXIS",1,NA
"DRUG AND CRIME FRAMEWORK",1,NA
"DRUG AND PHARMACEUTICAL ANALYSIS",1,NA
"DRUG ASSOCIATIONS",1,NA
"DRUG ATTITUDE",2,NA
"DRUG ATTITUDE INVENTORY-30",1,NA
"DRUG BILE CONCENTRATION",1,NA
"DRUG BIOMARKER",1,NA
"DRUG BLOOD CONCENTRATION",2,NA
"DRUG BLOOD LEVEL",1,NA
"DRUG CAREER",2,NA
"DRUG CHANNELLING",1,NA
"DRUG CHECKING",3,18
"DRUG CHEMISTRY",4,3
"DRUG COCKTAIL",1,NA
"DRUG COMBINATION",1,NA
"DRUG CONCEALMENT",1,NA
"DRUG CONCENTRATION",7,NA
"DRUG CONCENTRATIONS",7,1
"DRUG CONCENTRATIONS IN HAIR",1,NA
"DRUG CONFIRMATION",1,1
"DRUG CONSUMPTION",2,4
"DRUG CONTAMINATION",2,NA
"DRUG CONTENT",1,NA
"DRUG CONTRAINDICATIONS",1,NA
"DRUG CONTROL",2,3
"DRUG COUNTERFEITING",1,NA
"DRUG COURIER",1,NA
"DRUG COURT",14,NA
"DRUG COURT COMPONENTS QUESTIONNAIRE",1,NA
"DRUG COURT TREATMENT",1,NA
"DRUG COURTS",6,NA
"DRUG CRAVING",1,NA
"DRUG CRIMES",1,NA
"DRUG DEALERS",1,NA
"DRUG DEATH",5,NA
"DRUG DEATHS",15,NA
"DRUG DEATHS - EPIDEMIOLOGY - HIV-PREVALENCE",1,NA
"DRUG DEGRADATION",1,1
"DRUG DELINQUENCY",1,NA
"DRUG DELIVERY",8,1
"DRUG DELIVERY DEVICES",1,NA
"DRUG DELIVERY ROUTE",1,NA
"DRUG DEPENDENCY",1,NA
"DRUG DETECTING CANINES",1,1
"DRUG DETECTION",18,17
"DRUG DETERMINATION",2,1
"DRUG DETOXIFICATION",1,NA
"DRUG DISCOVERY",4,6
"DRUG DISCRIMINATION",2,3
"DRUG DISPENSING",1,NA
"DRUG DISPOSITION",2,NA
"DRUG DISTRIBUTION",9,NA
"DRUG DIVERSION",1,2
"DRUG DIVERSION TREATMENT",1,NA
"DRUG EARLY WARNING SYSTEM",1,NA
"DRUG EFFECT",2,NA
"DRUG EFFICACY",1,NA
"DRUG ELIMINATION",3,NA
"DRUG ENANTIOMERS",1,NA
"DRUG ENDANGERED CHILDREN",2,NA
"DRUG EVALUATION",1,NA
"DRUG EVALUATION AND CLASSIFICATION PROGRAM",1,NA
"DRUG EVIDENCE",2,NA
"DRUG EXHIBITS",1,NA
"DRUG EXPOSURE",4,NA
"DRUG EXPOSURES",1,1
"DRUG EXTRACTION",4,2
"DRUG FACILITATED",1,NA
"DRUG FACILITATED ASSAULT",2,2
"DRUG FACILITATED CRIME",3,NA
"DRUG FACILITATED CRIME (DFC)",1,NA
"DRUG FACILITATED CRIME AND DATE-RAPE",1,1
"DRUG FACILITATED SEXUAL ASSAULT (DFSA), FORENSIC TOXICOLOGY",1,NA
"DRUG FACILITATED SEXUAL ASSAULTS",1,NA
"DRUG FACILITATED SEXUAL ASSAULTS (DFSA)",1,NA
"DRUG FATALITIES",4,NA
"DRUG FATALITY",2,NA
"DRUG FILES",1,NA
"DRUG FRAUD",1,NA
"DRUG HABITS BEHAVIOURAL STRUCTURES",1,NA
"DRUG HAIR ANALYSIS",1,NA
"DRUG HISTORY",3,NA
"DRUG HYPERSENSITIVITY",1,NA
"DRUG IDENTIFICATION",17,10
"DRUG IMPAIRMENT",2,NA
"DRUG IMPURITY PROFILE",1,1
"DRUG INCORPORATION",6,NA
"DRUG INCORPORATION RATES",1,NA
"DRUG INDUCED ANGIOEDEMA",1,NA
"DRUG INDUCED DEATH",1,NA
"DRUG INDUCED IMPAIRMENT",1,NA
"DRUG INGESTION",1,NA
"DRUG INJURIES",1,NA
"DRUG INSTABILITY",1,NA
"DRUG INTELLIGENCE",12,15
"DRUG INTERACTION",14,NA
"DRUG INTERACTIONS",14,1
"DRUG INTERVENTIONS PROGRAMME (DIP)",1,NA
"DRUG INTOXICATION",9,NA
"DRUG INVESTIGATIONS",1,NA
"DRUG ISOMERS",1,NA
"DRUG LAW",1,1
"DRUG LAWS",1,NA
"DRUG LEGISLATION",1,NA
"DRUG LEVELS AFTER DEATH",1,NA
"DRUG MANAGEMENT",1,1
"DRUG MARKETS",1,7
"DRUG MEASUREMENT",1,NA
"DRUG METABOLISM",12,1
"DRUG METABOLITE",4,NA
"DRUG METABOLITE QUANTIFICATION",2,NA
"DRUG MISUSE",7,1
"DRUG MISUSE AND ABUSE",1,NA
"DRUG MISUSER",1,NA
"DRUG MIXTURES",3,3
"DRUG MONITORING",20,4
"DRUG MONITORING SYSTEMS",1,1
"DRUG MONITORING/DRUG SCREENING",9,2
"DRUG MORTALITY",2,NA
"DRUG MULE",1,NA
"DRUG OF ABUSE",274,114
"DRUG OF ABUSE TESTING",1,1
"DRUG OF POISONING",1,NA
"DRUG OFFENDER",1,NA
"DRUG OFFENDERS",1,NA
"DRUG OVERDOSE",33,2
"DRUG OVERDOSE FATALITIES",1,NA
"DRUG PACKAGE WRAPPING",1,NA
"DRUG PACKAGES",1,NA
"DRUG PACKAGING",6,3
"DRUG PACKAGING MATERIAL",1,NA
"DRUG PACKERS",1,NA
"DRUG PARAPHERNALIA",2,NA
"DRUG POISONING",3,NA
"DRUG POLICY",3,17
"DRUG POSSESSION",1,NA
"DRUG PRESCRIPTION",1,NA
"DRUG PREVALENCE",1,2
"DRUG PROFICIENCY TESTS",1,1
"DRUG PROFILING",25,37
"DRUG PURITY",2,5
"DRUG RAPE",4,1
"DRUG REACTION",1,NA
"DRUG REACTIONS",1,NA
"DRUG RECIDIVISM",1,NA
"DRUG RECOGNITION EVALUATOR",1,NA
"DRUG RECOGNITION EXPERT",5,NA
"DRUG RECOGNITION EXPERT (DRE)",1,NA
"DRUG RECORDS",1,NA
"DRUG RECOVERY",1,NA
"DRUG REDISTRIBUTION",2,NA
"DRUG REGULATION",1,NA
"DRUG REHABILITATION PROGRAMS",1,NA
"DRUG RELATED CRIME",1,NA
"DRUG RELATED DEATH",3,NA
"DRUG RELATED DEATHS",6,NA
"DRUG RELATED DEATHS IN ROMANIA",1,NA
"DRUG RELATED FATALITY",1,NA
"DRUG RELEASE AND REDISTRIBUTION",1,NA
"DRUG RESERVOIRS",2,NA
"DRUG RESIDUE",1,NA
"DRUG RESIDUES",1,1
"DRUG RESISTANCE",1,1
"DRUG SALES",1,1
"DRUG SAMPLE DIFFERENTIATION",1,1
"DRUG SAMPLING",4,4
"DRUG SCENE",1,NA
"DRUG SCREENING",64,11
"DRUG SCREENING CONFIRMATION",1,NA
"DRUG SCREENING TEST",1,NA
"DRUG SEIZURE",6,13
"DRUG SELLING",2,NA
"DRUG SENSING",2,NA
"DRUG SMUGGLING",7,3
"DRUG SOURCING",2,3
"DRUG SPECIFIC MEDICATION",1,NA
"DRUG STABILITY",6,1
"DRUG STABILITY AND RECOVERY",1,NA
"DRUG STREET SEIZURES",1,1
"DRUG SUBSTITUTION",2,NA
"DRUG SWALLOWERS",1,NA
"DRUG SYNTHESIS",1,2
"DRUG TAMPERING",1,1
"DRUG TARGETING",1,NA
"DRUG TEST",2,1
"DRUG TEST ADULTERATION",1,NA
"DRUG TESTING",43,7
"DRUG TESTING, FORENSIC TOXICOLOGY, FUB-AMB, MASS SPECTROMETRY, SYNTHETIC CANNABINOIDS, UHPLC",1,NA
"DRUG THERAPIES",1,NA
"DRUG THERAPY",4,NA
"DRUG THERAPY MANAGEMENT",2,NA
"DRUG TOILETS",1,NA
"DRUG TOXICITY",10,NA
"DRUG TRAFFIC",1,NA
"DRUG TRAFFIC ORGANIZATION",1,NA
"DRUG TRAFFICKING",11,13
"DRUG TRANSPORT",1,NA
"DRUG TREATMENT",5,NA
"DRUG TRENDS",5,3
"DRUG UNIT WEIGHT",1,1
"DRUG USE",65,17
"DRUG USE 'VULNERABILITY'",1,NA
"DRUG USE AND NAILS",1,NA
"DRUG USE DISORDER",1,NA
"DRUG USE PREVALENCE",2,NA
"DRUG USE TESTING",1,NA
"DRUG USER",2,NA
"DRUG USERS",6,2
"DRUG UTILISATION",1,3
"DRUG VICTIMS",1,NA
"DRUG VICTIMS, POST-MORTEM HEPATITIS-SEROLOGY",1,NA
"DRUG, ADVERSE REACTION",1,NA
"DRUG/NARCOTIC",1,NA
"DRUGFACILITATED CRIME",1,NA
"DRUGGED DRIVERS",1,NA
"DRUGMAN",1,NA
"DRUGMETABOLISMANDDISPOSITION",1,NA
"DRUGS-OF-ABUSE",2,1
"DRUGS-OF-ABUSE TESTING",1,NA
"DRUGS ADDICTION",1,NA
"DRUGS AFFECTING THE NERVOUS SYSTEM",1,NA
"DRUGS ANALYSIS",2,3
"DRUGS AND ALCOHOL",1,NA
"DRUGS AND ALCOHOL USE",1,NA
"DRUGS AND BEHAVIOR",1,NA
"DRUGS AND CHEMICALS IN HEMATOMAS",1,NA
"DRUGS AND DRIVERS",1,1
"DRUGS AND EXPLOSIVES",1,NA
"DRUGS AND METABOLITES",2,1
"DRUGS AND MOTOR CYCLE ACCIDENTS",1,NA
"DRUGS AND PHARMACEUTICAL COMPOUNDS",1,NA
"DRUGS AND POISONS",3,NA
"DRUGS AND TOXINS INTERACTING WITH A DEVELOPING INSECTS",1,NA
"DRUGS CLAIMS",1,NA
"DRUGS CRIMINAL USE",1,NA
"DRUGS DETECTION",1,1
"DRUGS IDENTIFICATION",1,NA
"DRUGS IDENTIFICATION AND ANALYSIS",2,NA
"DRUGS IN BLOOD",1,NA
"DRUGS IN BODY FLUIDS",1,NA
"DRUGS IN DRIVING",1,NA
"DRUGS IN HAIR",3,NA
"DRUGS IN HUMAN MILK",1,NA
"DRUGS IN SPORTS",1,NA
"DRUGS IN TRAFFIC ACCIDENT VICTIMS",1,NA
"DRUGS IN UTERO",1,NA
"DRUGS INTELLIGENCE PROGRAM",1,NA
"DRUGS OF ABUSE ANALYSIS",1,NA
"DRUGS OF ABUSE IN ILLICIT SALE",1,NA
"DRUGS OF ABUSE IN URINE",1,NA
"DRUGS OF ABUSE TESTING",2,NA
"DRUGS OF ABUSE, UNIQUE, INFORMATION-RICH VIBRATIONAL SPECTRA",1,NA
"DRUGS OF ADDICTION",1,1
"DRUGS OF ATRIX",1,NA
"DRUGS OF SMALL MOLECULAR MASS",1,4
"DRUGS SCREENING",3,NA
"DRUGS TABLETS",1,NA
"DRUGS TRAFFICKING",1,NA
"DRUGS&POSTMORTEM",1,NA
"DRUGS, AND DRUGS OF ABUSE IN BULK MATERIALS, TRACE DETECTION",1,NA
"DRUGS, FORENSIC",1,NA
"DRUGS, GASTRIC CONTENTS",1,NA
"DRUGS, IN BIOLOGICAL SAMPLES",1,NA
"DRUGS/ADULTERANT COMPOSITIONS",1,NA
"DRUGS/DRIVERS",1,NA
"DRUGS/PHARMACEUTICALS",8,3
"DRUGSTORES",1,NA
"DRUGWIPE",1,NA
"DRUID",1,NA
"DRUNG NATIONALITY",1,NA
"DRUNK DRIVERS",1,NA
"DRUNKEN DRIVERS",1,NA
"DRUNKEN DRIVING",2,NA
"DRY",1,NA
"DRY BONE",1,NA
"DRY COUPLING",1,NA
"DRY STAIN",1,NA
"DRYING DROPLET",1,NA
"DRYLAB®",1,NA
"DSA Α COUNTING",1,NA
"DSC",2,6
"DSG2",1,NA
"DSM",1,NA
"DSM DPD CASES",1,NA
"DSSP",1,NA
"DT50",1,NA
"DTP VACCINE",1,NA
"DUAL-ANALYSIS",1,1
"DUAL-ENERGY",2,NA
"DUAL-LABEL TIME-RESOLVED FLUOROIMMUNOASSAY",1,NA
"DUAL ACTION",1,NA
"DUAL ACTION REAGENTS",1,NA
"DUAL CAPILLARY COLUMNS IN SERIES",1,1
"DUAL DETECTION",1,1
"DUAL DIAGNOSIS",9,NA
"DUAL DISORDERS",1,NA
"DUAL FINGERPRINT REAGENTS",1,NA
"DUAL ON-COLUMN UV DETECTION",1,1
"DUAL PATHOLOGY",1,NA
"DUAL PROCESS MODELS",1,NA
"DUCTAL PROLIFERATION",1,NA
"DULOXETINE",4,NA
"DUMPING",1,NA
"DUNDRUM",1,NA
"DUNDRUM-1",1,NA
"DUODENAL MUCOSA",1,NA
"DUPING AGENT",1,1
"DUPLEX-SPECIFIC NUCLEASE",1,NA
"DUPLICATION",1,NA
"DUPUYTREN'S CONTRACTURE",1,NA
"DURAGESIC®",1,NA
"DURAL SINUS THROMBOSIS",1,NA
"DURATION OF MONITORING",1,NA
"DURING ARREST",1,NA
"DUROGESIC PAIN PATCH",1,NA
"DUSP-1",3,NA
"DUTCH ANTILLES",1,NA
"DUTY",1,NA
"DUTY OF CARE",1,NA
"DUTY TO REPORT REACTIONS",1,NA
"DVI",3,NA
"DYADIC DEATH",1,NA
"DYE",13,NA
"DYE-TRAPS",1,NA
"DYE DEGRADATION",1,NA
"DYEING",1,NA
"DYNAMIC",1,NA
"DYNAMIC BACKGROUND SUBTRACTION",1,NA
"DYNAMIC COATING",1,3
"DYNAMIC DOUBLY COATED CAPILLARIES",1,NA
"DYNAMIC HEADSPACE",1,2
"DYNAMIC HEADSPACE CONCENTRATION",1,NA
"DYNAMIC LIGHT SCATTERING",1,NA
"DYNAMIC MRM",1,1
"DYNAMIC PH-JUNCTION",1,NA
"DYNAMIC RISK FACTORS",1,NA
"DYNAMIC SIGNATURE",1,NA
"DYNAMICALLY COATED CAPILLARIES",2,3
"DYNAMITE",1,NA
"DYS19",1,NA
"DYS385",1,NA
"DYS389",1,NA
"DYS390",1,NA
"DYS448",1,NA
"DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR",1,NA
"DYSFUNCTIONAL BEHAVIOR",1,NA
"DYSLIPIDEMIA",1,NA
"DYSMENORRHEA",1,NA
"DYSOSMA VERSIPELLIS",1,NA
"DYSPLASIA",1,NA
"E-605-EXHUMIERUNG, NACHWEIS VON E 605",1,NA
"E-CIGARETTES",1,5
"E-LIQUID",1,4
"E-MAIL FORENSICS",1,NA
"E-MAIL SOCIAL NETWORKS",1,NA
"E-SELECTIN",1,NA
"E 605-VERGIFTUNG",1,NA
"E 605-VERGIFTUNG, SERUM-CHOLINESTERASEAKTIVITÄT IN LEICHENBLUT",1,NA
"E 605 - GIFTBEIBRINGUNG",1,NA
"E 605 - INSEKTIZIDE",1,NA
"E. COLI",1,NA
"EA-IRMS",1,2
"EA1 PROTEINASE",1,NA
"EAAT2",1,NA
"EAD-ACTIVE COMPOUNDS",1,NA
"EADESI",1,NA
"EAM-2201",1,NA
"EAP",1,NA
"EAR PRINTS",1,NA
"EARLY-ONSET ALCOHOL ABUSE",1,NA
"EARLY-WARNING",1,NA
"EARLY ALCOHOL ABUSE",1,NA
"EARLY EVIDENCE",1,NA
"EARLY INTERVENTION",2,NA
"EARLY ONSET",1,NA
"EARLY PHASE OF PSYCHOTIC DISORDERS",1,NA
"EARLY POSTMORTEM INTERVAL",1,NA
"EARLY PSYCHOSIS",2,NA
"EARLY PSYCHOSIS INTERVENTION",2,NA
"EARLY TWENTIETH CENTURY",1,NA
"EARLY WARNING",1,1
"EARLY WARNING SYSTEM",1,2
"EARWAX",1,NA
"EASI",1,1
"EASI-MS",4,2
"EASILY DIAGNOSED CASES",1,NA
"EAST GERMANY",1,1
"EASTERN EUROPE",1,NA
"EATING DISORDERS",1,NA
"EB VIRUS",2,NA
"EBDB",1,NA
"EC50",1,NA
"EC50 VALUES",1,1
"ECCRINE GLAND",1,NA
"ECCRINE SECRETION",1,NA
"ECDYSTERONE",1,NA
"ECGONINE",2,3
"ECGONINE METHYL ESTER",8,1
"ECGONINE METHYLESTER",1,NA
"ECL",1,1
"ECM PROTEINS",1,NA
"ECO-FRIENDLY SAMPLE PREPARATION TECHNIQUE",1,NA
"ECOCIDE",1,NA
"ECOLOGY",3,3
"ECONOMICS",2,2
"ECONOMIES OF SCALE",1,NA
"ECOPHARMACOGNOSY",1,NA
"ECOSYSTEM",1,NA
"ECOTOXICOLOGICAL EVALUATION OF SEDIMENTS",1,NA
"ECOTOXICOLOGY",2,NA
"ECSTASY-LIKE SAMPLES",1,1
"ECSTASY (XTC)",2,1
"ECSTASY AND CATHINONE",1,1
"ECSTASY DEATHS",1,NA
"ECSTASY OFFENDERS",1,NA
"ECSTASY PREVALENCE OF USE",1,NA
"ECSTASY PRICE",1,NA
"ECSTASY SEIZURES",1,NA
"ECT",2,NA
"ECTOPIC PREGNANCY",1,NA
"EDDP",2,4
"EDEN DEATH",1,NA
"EDIBLE MUSTARD OIL",1,NA
"EDNAP EXERCISE",1,NA
"EDS ANALYSIS",2,NA
"EDTA",1,NA
"EDUCATION",5,5
"EDUCATIONAL AUTOPSY",1,NA
"EDUCATIONAL REQUIREMENTS",1,NA
"EDX",1,NA
"EDXRD",1,NA
"EDXRF",2,NA
"EEG LEARNING",1,NA
"EESI-MS",1,NA
"EFAVIRENZ",1,NA
"EFFECT-BASED BIOMARKERS",1,NA
"EFFECT OF DRUGS",1,NA
"EFFECT OF LIGHT",1,NA
"EFFECT OF PUTREFACTION",1,NA
"EFFECT ON DIFFERENTIATING AND SELF-CONTROL CAPACITY",1,NA
"EFFECT VARIABILITY",1,NA
"EFFECTIVE CARBON NUMBER (ECN)",1,2
"EFFECTIVENESS",1,NA
"EFFECTS ON THE HUMAN CENTRAL NERVOUS SYSTEM",1,NA
"EFFICACY",1,1
"EFFICIENCY",1,2
"EFFICIENT EXTRACTION",1,NA
"EFFORT",1,NA
"EGDN",2,NA
"EGFR",1,NA
"EGREGIOUS BEHAVIORS",1,NA
"EGYPT",1,NA
"EHLERS-DANLOS SYNDROME",1,NA
"EHRLICH REACTION",1,1
"EI",1,NA
"EI-GC-MSD",1,NA
"EI-HRMS",1,1
"EI-MASS SPECTRA",1,NA
"EI LIBRARY SEARCHING",1,NA
"EIA",1,1
"EICOSAPENTAENOIC ACID",1,NA
"EL MASS SPECTROMETRY",1,NA
"ELASMOBRANCHS",1,NA
"ELDER ABUSE",2,NA
"ELDERLY",11,NA
"ELDERLY ACCIDENT",2,NA
"ELDERLY ALCOHOLICS",1,NA
"ELDERLY INDIVIDUALS",1,NA
"ELDERLY PEOPLE",3,NA
"ELDERLY PERSONS",1,NA
"ELDERLY SUICIDE",2,NA
"ELECTRIC INJURY",1,NA
"ELECTRIC SHOCKING DEVICE",1,NA
"ELECTRIC STIMULATION",1,NA
"ELECTRIC VIBRATORY SAW",1,NA
"ELECTRICAL-ACCELERATED HOLLOW FIBER-SOLID-PHASE MICROEXTRACTION (EAHF-SPME)",1,NA
"ELECTRICAL DETECTION",1,NA
"ELECTRICAL RESISTIVITY TOMOGRAPHY",1,NA
"ELECTRO-MUSCULAR DISRUPTION",1,NA
"ELECTROANALYSIS",3,7
"ELECTROCHEMICAL",2,5
"ELECTROCHEMICAL ANALYSIS",2,NA
"ELECTROCHEMICAL BIOSENSOR",1,1
"ELECTROCHEMICAL BIOSENSORS",2,NA
"ELECTROCHEMICAL DERIVATIZATION",1,NA
"ELECTROCHEMICAL DETECTION",8,10
"ELECTROCHEMICAL DETECTOR (ECD)",1,NA
"ELECTROCHEMICAL DETERMINATION",1,NA
"ELECTROCHEMICAL DNA SENSOR",1,NA
"ELECTROCHEMICAL FINGERPRINT",1,NA
"ELECTROCHEMICAL FINGERPRINTING",1,NA
"ELECTROCHEMICAL MECHANISM",1,NA
"ELECTROCHEMICAL PROFILE",2,3
"ELECTROCHEMICAL SENSING",1,NA
"ELECTROCHEMICAL SENSOR",12,33
"ELECTROCHEMICAL SYNTHESIS",2,NA
"ELECTROCHEMICALLY ENHANCED SOLID PHASE MICROEXTRACTION",1,NA
"ELECTROCHEMILUMINESCENCE (ECL)",4,11
"ELECTROCHEMISTRY",13,15
"ELECTROCONVULSIVE THERAPY",2,NA
"ELECTROCUTION",5,NA
"ELECTROENCEPHALOGRAM",1,NA
"ELECTROENCEPHALOGRAPHIC LEARNING",1,NA
"ELECTROENCEPHALOGRAPHY/EFFECT OF DRUGS ON",1,NA
"ELECTROKINETIC CHROMATOGRAPHY (EKC)",2,5
"ELECTROKINETICS",1,1
"ELECTROLYTE IMBALANCE",1,NA
"ELECTROLYTES",1,NA
"ELECTROMEMBRANE EXTRACTION",2,NA
"ELECTROMEMBRANE EXTRACTION (EME)",1,NA
"ELECTROMYOGRAPHY",1,NA
"ELECTRON CAPTURE DETECTION",2,1
"ELECTRON CAPTURE DETECTOR",1,NA
"ELECTRON IONIZATION",2,3
"ELECTRON IONIZATION-TRIPLE QUADRUPOLE MASS SPECTROMETRY",1,NA
"ELECTRON IONIZATION MASS SPECTROMETRY",1,1
"ELECTRON MEDIATOR",1,NA
"ELECTRON MICROSCOPY",1,NA
"ELECTRON SPIN RESONANCE",1,NA
"ELECTRON TRANSFER",1,NA
"ELECTRONIC",1,1
"ELECTRONIC CONTROL DEVICE",2,NA
"ELECTRONIC DANCE MUSIC FESTIVALS",1,NA
"ELECTRONIC DATA PROCESSING",1,NA
"ELECTRONIC DESIGN AUTOMATION",1,NA
"ELECTRONIC DISCHARGE SUMMARY",1,NA
"ELECTRONIC ENVIRONMENTS",1,1
"ELECTRONIC EVIDENCE",1,NA
"ELECTRONIC MEDICAL RECORDS",1,NA
"ELECTRONIC MESSAGES",1,NA
"ELECTRONIC NOSE",1,1
"ELECTRONIC NOSE AND TONGUE",1,NA
"ELECTRONIC SCREENING",1,NA
"ELECTRONIC WEAPONS",1,NA
"ELECTROPHORESIS",2,2
"ELECTROPHORETIC IMMUNOASSAY",1,1
"ELECTROPHORETIC MOBILITY SCALE",1,1
"ELECTROPHOTOGRAPHY",1,NA
"ELECTROPOLYMERIZATION",2,8
"ELECTROSPRAY",7,10
"ELECTROSPRAY-IONIZATION",1,NA
"ELECTROSPRAY INTERFACE",1,NA
"ELECTROSPRAY IONISATION MASS SPECTROMETRY (ESI-MS)",3,8
"ELECTROSPRAY IONIZATION (ESI)",20,18
"ELECTROSPRAY IONIZATION (ESI), FORENSIC SCIENCES. FORMIC ACID",1,NA
"ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY",1,NA
"ELECTROSPUN FIBER",1,NA
"ELECTROSTATIC LIFT",1,1
"ELECTRUM FORENSICS",1,NA
"ELEMENT",1,1
"ELEMENTAL ANALYSIS",4,4
"ELEMENTAL COMPOSITION",4,4
"ELEMENTAL IMPURITIES",1,NA
"ELEMENTAL PROFILING",1,1
"ELEPHANT IVORY",1,NA
"ELEPHANT SPECIES",1,NA
"ELEVATED PRESSURE",1,1
"ELEVATOR",1,NA
"ELIMINATION",2,NA
"ELIMINATION HALF-LIFE",1,NA
"ELIMINATION KINETICS",1,NA
"ELIMINATION RATE",2,NA
"ELISA",24,9
"ELISA TEST",1,NA
"ELOPEMENT",1,NA
"ELOVL2",2,NA
"ELUTION",2,1
"ELVANSE®",1,NA
"EMAMECTIN BENZOATE",2,NA
"EMB-FUBINACA",1,NA
"EMBALMED",1,NA
"EMBALMING",1,NA
"EMBOLIZATION",2,NA
"EMBRYO CULTURE",1,NA
"EMBRYOFETAL ALCOHOL SYNDROME",1,NA
"EMBRYOFETAL PERIOD",1,NA
"EMBUTRAMIDE",2,NA
"EMCDDA",1,NA
"EMDP",1,1
"EMERGENCIES",1,NA
"EMERGENCY",6,NA
"EMERGENCY AND AUTOPSY CASES",1,NA
"EMERGENCY CONTRACEPTION",2,NA
"EMERGENCY DEPARTMENT",10,2
"EMERGENCY FORENSIC UNIT",1,NA
"EMERGENCY MEDICAL CARE",1,NA
"EMERGENCY MEDICAL SERVICE",1,NA
"EMERGENCY MEDICINE",12,NA
"EMERGENCY MENTAL HEALTH",1,NA
"EMERGENCY NURSING",1,NA
"EMERGENCY PSYCHIATRY",2,NA
"EMERGENCY RESPONSE",1,NA
"EMERGENCY ROOM",1,1
"EMERGENCY SCREENING",1,NA
"EMERGENCY SERVICE",2,NA
"EMERGENCY SERVICES",1,NA
"EMERGENCY TOXICOLOGY",1,NA
"EMERGENCY TREATMENT",3,NA
"EMERGENCY TREATMENT FOR DRUG OVERDOSE",1,NA
"EMERGING CONTAMINANTS",5,8
"EMERGING DRUGS",2,1
"EMERGING POLLUTANTS",1,NA
"EMESIS",1,NA
"EMETICS",2,1
"EMETINE",1,NA
"EMISSION COMPUTED TOMOGRAPHY",1,NA
"EMISSION SCANNING ELECTRON MICROSCOPY (FE-SEM)",1,NA
"EMIT",5,1
"EMIT-GLC COMPARISON",1,NA
"EMIT II",1,1
"EMIT II IMMUNOASSAY",1,NA
"EMIT ST",1,NA
"EMIT®",2,NA
"EMOTION",1,NA
"EMOTIONAL CONTROL PROGRAM",1,NA
"EMOTIONAL DISTRESS",1,NA
"EMOTIONAL DYSREGULATION",1,NA
"EMOTIONAL INSECURITY",1,NA
"EMOTIONAL INTELLIGENCE",1,NA
"EMOTIONAL MEMORY",1,NA
"EMOTIONS",1,NA
"EMPATHY",2,NA
"EMPIRICAL STUDY",1,NA
"EMPIRICALLY-SUPPORTED TOOLS",1,NA
"EMPIRICALLY ESTABLISHED FACTS",1,NA
"EMPLOYEE DRUG TESTING",1,NA
"EMPLOYMENT APPLICANT DRUG TESTING",1,NA
"EMPTY PUPARIA",1,NA
"EMPTY PUPARIAL CASE",1,NA
"EMULSIFIERS",1,NA
"EMULSION EXPLOSIVES",1,NA
"ENAMEL",1,NA
"ENAMEL PEPTIDE",1,NA
"ENAMEL PROTEOME",1,NA
"ENAMEL ROD END PATTERNS",1,NA
"ENANTIO-SELECTIVE ANALYSIS",1,NA
"ENANTIOMER",27,25
"ENANTIOMER ANALYSIS",1,NA
"ENANTIOMER DISCRIMINATION",1,NA
"ENANTIOMER SEPARATION",13,77
"ENANTIOMER SEPARATIONS",1,NA
"ENANTIOMERIC ANALYSIS",1,2
"ENANTIOMERIC COMPOSITION",1,2
"ENANTIOMERIC DIFFERENCE IN ACTIVITY",1,NA
"ENANTIOMERIC EXCESS",1,1
"ENANTIOMERIC EXCESS DETERMINATION",1,NA
"ENANTIOMERIC FRACTION",1,1
"ENANTIOMERIC RATIO",4,2
"ENANTIOMERIC SCREENING",1,NA
"ENANTIOMERIZATION",1,NA
"ENANTIOSELECTIVE",1,1
"ENANTIOSELECTIVE CAPILLARY ELECTROPHORESIS",1,NA
"ENANTIOSELECTIVE METABOLISM",2,NA
"ENANTIOSELECTIVE RAMAN SPECTROSCOPY (ESR)",1,NA
"ENANTIOSELECTIVE SEPARATION",1,2
"ENCRYPTION",1,NA
"ENDANGERED SPECIES",2,NA
"ENDOCAN",2,NA
"ENDOCANNABINOID",1,NA
"ENDOCANNABINOID SYSTEM",2,NA
"ENDOCANNABINOIDS",1,4
"ENDOCARDIAL FIBROELASTOSIS",1,NA
"ENDOCARDITIS",1,1
"ENDOCRINE-DISRUPTING COMPOUNDS",1,NA
"ENDOCRINE DISRUPTOR",1,3
"ENDOCRINE ORGAN",1,NA
"ENDOCRINE ORGANS",1,NA
"ENDOCRINOLOGY",1,NA
"ENDOGENOUS",7,2
"ENDOGENOUS AND POST-MORTEM BEHAVIOUR",2,NA
"ENDOGENOUS CONTROL",2,NA
"ENDOGENOUS ETHANOL",1,NA
"ENDOGENOUS GHB",1,NA
"ENDOGENOUS LEVEL",1,NA
"ENDOGENOUS MORPHINE",1,NA
"ENDOGENOUS ORGANIC COMPOUNDS",1,NA
"ENDOGENOUS REFERENCES",2,NA
"ENDOGENOUS SUBSTANCE",1,NA
"ENDOGENOUS VALUES",2,NA
"ENDOPHTHALMITIS",1,NA
"ENDOPLASMIC RETICULUM",1,NA
"ENDOSCOPY",1,NA
"ENDOSPORES",2,1
"ENDOSULFAN ISOMERS/METABOLITES",1,NA
"ENDOTHELIUM",2,NA
"ENDOTRACHEAL INTUBATION",7,NA
"ENDPOINT PCR",1,NA
"ENDRIN",2,NA
"ENEMA INTOXICATION",1,NA
"ENERGETIC COMPOUNDS",1,NA
"ENERGETIC MATERIAL",1,NA
"ENERGY-DISPERSIVE X-RAY SPECTROSCOPY (EDX)",1,NA
"ENERGY-RESOLVED MASS SPECTROMETRY",1,NA
"ENERGY DISPERSIVE X-RAY (EDX)",1,NA
"ENERGY DISPERSIVE X-RAY ANALYSIS",1,NA
"ENERGY DISPERSIVE X-RAY FLUORESCENT SPECTROMETRY (EDXRF)",1,NA
"ENERGY DISPERSIVE X-RAY SPECTRAL ANALYSIS",1,NA
"ENERGY DISPERSIVE X-RAY SPECTROSCOPY",1,NA
"ENERGY DISPERSIVE XRF",1,NA
"ENERGY DRINKS",2,NA
"ENERGY LEVELS",1,NA
"ENERGY STORAGE",1,NA
"ENFLURANE",2,NA
"ENFORCED TREATMENT",1,NA
"ENFORCEMENT",1,1
"ENFORCEMENT OF DISCIPLINARY PROCEEDINGS",1,NA
"ENFSI",1,1
"ENGAGEMENT",1,NA
"ENGINE STARTING FLUID",1,NA
"ENHANCED FTIR",1,NA
"ENHANCED POLYMER COLUMN",2,1
"ENHANCED RISK",1,NA
"ENHANCED SENSITIVITY",1,1
"ENHANCEMENT",4,NA
"ENHANCEMENT OF COLOUR REACTION",1,NA
"ENRICHMENT",1,1
"ENSEMBLE FEATURE SELECTION",1,NA
"ENTACTOGEN",3,4
"ENTELLAN NEW",1,NA
"ENTER",1,NA
"ENTERO-HEPATIC CIRCULATION",1,NA
"ENTEROBACTERIACEAE",1,NA
"ENTEROHEPATIC CIRCLE",1,NA
"ENTEROHEPATIC RECIRCULATION",1,NA
"ENTHEOGENS",1,NA
"ENTOMOLOGICAL TECHNIQUES",1,NA
"ENTOMOLOGY",8,NA
"ENTOMOTOXICOLOGY",48,NA
"ENTOMOTOXICOLOGY, DRUGS AND TOXINS INTERACTING WITH A DEVELOPING INSECT",1,NA
"ENTRY WOUND",1,NA
"ENVENOMATION",1,NA
"ENVIRONMENT",8,5
"ENVIRONMENTAL",1,3
"ENVIRONMENTAL ANALYSIS",10,7
"ENVIRONMENTAL ASSAY",1,NA
"ENVIRONMENTAL CHEMISTRY",1,NA
"ENVIRONMENTAL CHEMISTY",1,1
"ENVIRONMENTAL COLD EXPOSURE",1,NA
"ENVIRONMENTAL CONDITIONS",1,NA
"ENVIRONMENTAL CONTAMINATION",2,NA
"ENVIRONMENTAL CORRELATIONS",1,NA
"ENVIRONMENTAL DESIGNS",1,NA
"ENVIRONMENTAL DRUG EXPOSURE",1,NA
"ENVIRONMENTAL EXPOSURE",2,NA
"ENVIRONMENTAL FATE",1,NA
"ENVIRONMENTAL FATE OF ORGANICS",1,NA
"ENVIRONMENTAL FORENSICS",22,5
"ENVIRONMENTAL IMPACT",1,1
"ENVIRONMENTAL MASS SPECTROMETRY",1,NA
"ENVIRONMENTAL MATRICES",1,NA
"ENVIRONMENTAL MEDICINE",1,NA
"ENVIRONMENTAL MONITORING",6,1
"ENVIRONMENTAL OESTROGENS",1,NA
"ENVIRONMENTAL POLLUTANTS",1,NA
"ENVIRONMENTAL POLLUTION",1,1
"ENVIRONMENTAL PROTECTION AGENCY (EPA)",1,NA
"ENVIRONMENTAL PROTECTION AND LAW",1,NA
"ENVIRONMENTAL RELEASE",1,NA
"ENVIRONMENTAL SCANNING ELECTRON MICROSCOPE",1,NA
"ENVIRONMENTAL SCANNING ELECTRON MICROSCOPE (ESEM)",1,NA
"ENVIRONMENTAL STABILITY",1,NA
"ENVIRONMENTAL TEMPERATURE",1,NA
"ENVIRONMENTAL VIOLENCE",1,NA
"ENVIRONMENTAL/FORENSIC/ANALYTICAL TOXICOLOGY",1,NA
"ENZYMATIC",2,NA
"ENZYMATIC AND NON-ENZYMATIC DMFC",1,NA
"ENZYMATIC ASSAYS",1,NA
"ENZYMATIC CATALYSIS",1,NA
"ENZYMATIC DIGESTION",1,NA
"ENZYMATIC DIGESTION, LIVER TISSUE",1,NA
"ENZYMATIC HYDROLYSIS",6,NA
"ENZYMATIC MACERATION",1,NA
"ENZYMATIC METHODS",1,NA
"ENZYMATIC TREATMENT",1,NA
"ENZYME",1,NA
"ENZYME-ASSISTED SYNTHESIS",1,NA
"ENZYME-LINKED IMMUNOASSAY",1,NA
"ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)",3,3
"ENZYME CONJUGATE",1,NA
"ENZYME IMMUNOASSAY",11,2
"ENZYME IMMUNOASSAY, CANNABINOIDS",1,NA
"ENZYME INDUCTION",1,NA
"ENZYME LINKED IMMUNOSORBENT ASSAY",1,NA
"ENZYME MULTIPLIED IMMUNOASSAY (EMIT)",1,NA
"ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE",1,NA
"ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE (EMIT)",1,NA
"ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE (EMIT®)",1,NA
"ENZYMIC DIGESTION",3,NA
"ENZYMIC PARACETAMOL ASSAY",1,NA
"EOSIN Y",1,1
"EOSINOPHIL CATIONIC PROTEIN",1,NA
"EOSINOPHILIC",1,NA
"EOSINOPHILIC GRANULOCYTE",1,NA
"EOSINOPHILIC INFILTRATION",1,NA
"EOSINOPHILIC PNEUMONIA",1,NA
"EOSINOPHILS",2,NA
"EPAD",1,NA
"EPHEDRA",1,16
"EPHEDRA PLANT",1,3
"EPHEDRINE",33,107
"EPHEDRONE",1,NA
"EPHELIDES",1,NA
"EPIC PRIVACY BROWSER",1,NA
"EPIDEMIC",2,1
"EPIDEMIOLGY",1,NA
"EPIDEMIOLOGICAL APPROACH",1,NA
"EPIDEMIOLOGICAL DATA",1,NA
"EPIDEMIOLOGICAL EVIDENCE",1,NA
"EPIDEMIOLOGICAL METHODS",1,NA
"EPIDEMIOLOGICAL SAFETY OF MEDICAL ACTIVITY",1,NA
"EPIDEMIOLOGICAL STUDIES",1,NA
"EPIDEMIOLOGICAL STUDY",1,NA
"EPIDÉMIOLOGIE",1,NA
"EPIDEMIOLOGY",84,13
"EPIDERMAL PATCHES",1,NA
"EPIDERMOLYSIS",1,NA
"EPIDURAL ANESTHESIA",1,NA
"EPIDURAL HEMATOMAS",1,NA
"EPIGENETIC",6,NA
"EPIGENETIC DRIFT",1,NA
"EPIGENETICS",2,NA
"EPIGENOME",1,NA
"EPILEPSIA",1,NA
"EPILEPSY",22,NA
"EPILEPSY MORTALITY",1,NA
"EPILEPSY, POST-TRAUMATIC",1,NA
"EPILEPTIC PATIENTS",1,NA
"EPINECROTIC",1,NA
"EPISODIC DYSCONTROL SYNDROME",2,NA
"EPISTAXIS",1,NA
"EPITAXIAL GRAPHENE",1,1
"EPITHELIAL CELL",1,NA
"EPITHELIAL CELLS",2,NA
"EPITOPE",1,NA
"EPITOPE MAPPING",1,NA
"EPITYPER®",1,NA
"EPO",2,1
"EPOXY RESIN",1,NA
"EPQ(R) EYSENCK PERSONALITY QUESTIONNAIRE",1,NA
"EPSTEIN-BARR VIRUS INFECTION",1,NA
"EQUESTRIAN SPORTS",1,NA
"EQUILIBRIUM DIALYSIS",1,NA
"EQUINE",1,NA
"EQUINE FORENSIC CHEMISTRY",1,NA
"EQUINE PHARMACOLOGY",1,NA
"EQUINE PLASMA",1,NA
"EQUINE TESTING",1,NA
"ERBB4",1,NA
"ERECTILE DYSFUNCTION",5,3
"ERECTILE DYSFUNCTION FORENSIC MEDICINE",1,NA
"EREG",1,NA
"ERGINE",2,2
"ERGOMETRINE",1,2
"ERGONOVINE",1,1
"ERGOPEPTIDES",1,1
"ERGOT",1,6
"ERGOT ALKALOIDS",1,40
"ERIK WIDMARK",1,NA
"ERROR-RELATED NEGATIVITY",1,NA
"ERROR POSITIVITY",1,NA
"ERROR PROCESSING",1,NA
"ERRORS",2,NA
"ERYTHROPOIETIN",1,NA
"ERYTHROXYLUM",1,7
"ESCAPE",1,NA
"ESCHERICHIA COLI",1,NA
"ESCITALOPRAM",2,1
"ESCITALORAM",1,NA
"ESCULENTOSIDE",1,NA
"ESDA",1,NA
"ESEM",1,NA
"ESI",1,2
"ESI-FT-ICR MS",2,1
"ESI-HR-MS/MS",1,1
"ESI-HRMS",1,NA
"ESI-LC-MS/MS",2,NA
"ESI-QQQ-MS",1,NA
"ESI-QTOFMS",1,NA
"ESI-TOF",1,NA
"ESMOLOL",1,NA
"ESSENCES",1,NA
"ESSENTIAL MEDICINE",1,NA
"ESSENTIAL OIL",2,9
"ESTAZOLAM",10,1
"ESTERASES",1,NA
"ESTERS",1,NA
"ESTIMATE THE CAUSE OF DEATH",1,NA
"ESTIMATED WEIGHT",1,1
"ESTIMATION OF CONSUMPTION",1,NA
"ESTIMATION OF PMI",1,NA
"ESTIMATION OF THE TIME OF DEATH",1,NA
"ESTIMATION OF THE TIME SINCE DEATH",1,NA
"ESTROGEN",2,6
"ESZOPICLONE",2,4
"ETAQUALONE",1,NA
"ETAZENE",1,1
"ETC",1,NA
"ETG",9,NA
"ETHACRIDINE",1,NA
"ETHANOL",113,3
"ETHANOL ABSORPTION FROM INSPIRED AIR",1,NA
"ETHANOL ANALYSIS",1,NA
"ETHANOL AND DRUGS",1,NA
"ETHANOL AND DRUGS OF ABUSE",1,NA
"ETHANOL BIOMARKERS",1,NA
"ETHANOL IN AIRWAYS AND LUNGS",1,NA
"ETHANOL IN CADAVERS",1,NA
"ETHANOL IN PHARMACEUTICALS BY DMFC",1,NA
"ETHANOL IN RESPIRED AIR",1,NA
"ETHANOL KINETICS",1,NA
"ETHANOL LEVEL, IN THE TESTICLE",1,NA
"ETHANOL MARKERS",3,NA
"ETHANOL METABOLISM",3,NA
"ETHANOL METABOLITE",1,NA
"ETHANOL METABOLITES",2,NA
"ETHANOL PHARMACOKINETICS",2,NA
"ETHANOL STABILITY",1,NA
"ETHANOL TESTING",1,NA
"ETHCATHINONE",1,1
"ETHER",2,NA
"ETHICAL DILEMMA",1,NA
"ETHICAL DILEMMAS",1,NA
"ETHICAL PROBLEMS",1,NA
"ETHICS",12,2
"ETHICS COMMITTEE",1,NA
"ETHICS CONSULTATION",1,NA
"ETHILIC ALCOHOL",1,NA
"ETHINYLESTRADIOL",1,1
"ETHNIC BIAS",1,NA
"ETHNIC DETERMINATION",1,NA
"ETHNIC MINORITIES",2,NA
"ETHNICITY",4,NA
"ETHNO BOTANICAL SUBSTANCES",1,NA
"ETHNOBOTANY",1,3
"ETHNOGRAPHY",1,2
"ETHNOLOGY",1,NA
"ETHYL",1,NA
"ETHYL-GAMMA-HYDROXYBUTYRATE",1,1
"ETHYL-GLUCURONIDE",1,NA
"ETHYL-VINYL ACETATE",1,NA
"ETHYL 1-PENTYL-(1H-INDOLE) -3-CARBOXYLATE",1,NA
"ETHYL CENTRALITE",2,NA
"ETHYL CENTRALITE (EC)",1,NA
"ETHYL CHLORIDE",4,NA
"ETHYL GLUCORONIDE POINT OF CARE TEST",1,NA
"ETHYL GLUCURONIDE",62,NA
"ETHYL GLUCURONIDE (ETG)",1,NA
"ETHYL SULFATE",15,2
"ETHYL SULPHATE",3,NA
"ETHYLAMPHETAMINE",2,NA
"ETHYLCHLOROFORMATE",1,NA
"ETHYLECGONIDINE",1,NA
"ETHYLENE",1,NA
"ETHYLENE GLYCOL",9,NA
"ETHYLENE GLYCOL DINITRATE",3,NA
"ETHYLENE OXIDE",1,NA
"ETHYLENEGLYCOL",1,NA
"ETHYLGLUCURONIDE",3,NA
"ETHYLMORPHINE",3,1
"ETHYLONE",5,4
"ETHYLPARAQUAT",1,NA
"ETHYLPHENIDATE",3,NA
"ETHYLVANILLIN",1,NA
"ETHYMORPHINE",1,NA
"ETIOLOGY",1,NA
"ETIOLOGY OF SEPSIS IN LEGAL MEDICINE",1,NA
"ETIZOLAM",4,7
"ETOMIDATE",3,NA
"ETOPOSIDE",1,NA
"ETORPHINE",1,NA
"ETS",2,NA
"EU LAW",1,NA
"EU PROJECT ROSITA",1,NA
"EU3+-DOPED SRTIO3",1,NA
"EULER TOUR",1,NA
"EULERIAN ROUTE",1,NA
"EUREYE",1,NA
"EUROPE",2,3
"EUROPEAN AGRICULTURAL HEMP CULTIVAR",1,NA
"EUROPEAN COMPARISONS",1,NA
"EUROPEAN COURT OF HUMAN RIGHTS",1,NA
"EUROPEAN SOILS",1,NA
"EUROPEAN UNION",1,3
"EUROPEAN YEW (TAXUS BACCATA)",1,NA
"EUROPIUM",2,NA
"EUTHANASIA",4,NA
"EUTHANSIA",1,NA
"EUTTAPHEN",1,NA
"EUTYLONE",1,NA
"EVALUATION",2,1
"EVALUATION MODEL",1,NA
"EVALUATIVE REPORTING",1,1
"EVALUATOR RECOMMENDATIONS",1,NA
"EVAPORATION",2,1
"EVC",1,NA
"EVENING TYPE",1,NA
"EVENT-RELATED POTENTIALS",1,NA
"EVENT DETECTION",1,NA
"EVIDENCE",19,10
"EVIDENCE-BASED GUIDANCE",1,NA
"EVIDENCE-BASED HEALTH-CARE MANAGEMENT",1,NA
"EVIDENCE-BASED MEDICINE",1,NA
"EVIDENCE COLLECTION",2,NA
"EVIDENCE CONTAINER",1,NA
"EVIDENCE DATA ANALYSIS",1,NA
"EVIDENCE IDENTIFICATION",1,NA
"EVIDENCE INTERPRETATION",1,1
"EVIDENTIAL MATERIAL",1,NA
"EVIDENTIARY STANDARDS",1,1
"EVISCERATION",1,NA
"EVOKED POTENTIALS",1,NA
"EVOLUTION MARKET",1,1
"EVOLUTION OVER TIME",1,NA
"EVOLUTIONAL ANALYSIS",1,NA
"EX-ARMED FORCES PERSONNEL",1,NA
"EX-COMBATANTS",1,NA
"EX-PATIENT",1,NA
"EXACT MASS DATABASE",1,NA
"EXACT MOLECULAR FORMULA",1,NA
"EXAMINATION",2,NA
"EXAMINATION OF COUNTERFEIT PHARMACEUTICAL LABELS",1,1
"EXAMINATION OF SAMPLES OF BONES",1,NA
"EXCEL",1,NA
"EXCESSIVE VIOLENCE",1,NA
"EXCHANGE OF S FOR O",1,NA
"EXCIMER",1,NA
"EXCIPIENT LUNG DISEASE",1,NA
"EXCIPIENTS",1,7
"EXCISION REPAIR CROSS-COMPLEMENTATION GROUP 1 (ERCC1)",1,NA
"EXCISIONAL WOUND",1,NA
"EXCITATION",1,NA
"EXCITATION-EMISSION MATRIX FLUORESCENCE",1,NA
"EXCITATION PROFILES",1,1
"EXCITATION WAVELENGTH",1,NA
"EXCITED DELERIUM SYNDROME",1,NA
"EXCITED DELIRIUM",17,1
"EXCITED DELIRIUM SYNDROME",4,NA
"EXCLUSION",1,NA
"EXCLUSION CRITERIA",1,NA
"EXCRETION",6,NA
"EXCRETION HALF-LIFE",1,NA
"EXCRETION PROFILE",2,NA
"EXCRETION TIME",1,NA
"EXECUTIVE FUNCTION",1,NA
"EXECUTIVE FUNCTIONING",1,NA
"EXERCISE",1,NA
"EXFOLIATED EPIDERMAL CELLS",1,NA
"EXFOLIATED EPITHELIAL CELL",1,NA
"EXHALED BREATH",4,NA
"EXHALED BREATH CONDENSATE",1,NA
"EXHAUSTION",2,NA
"EXHAUSTIVE MANIA",1,NA
"EXHIBITIONISM",2,NA
"EXHUMATION",16,NA
"EXHUMATION, DETECTION OF E605",1,NA
"EXHUMED BODY",1,NA
"EXHUMED CORPSE",1,NA
"EXHUMED HAIR",1,NA
"EXIT BAG",1,NA
"EXIT PROBLEM",1,NA
"EXIT WOUND",1,NA
"EXOFFENDER",1,NA
"EXOGENIC HYPERINSULINISM",1,NA
"EXOGENOUS",2,NA
"EXOGENOUS EMBOLISM",1,NA
"EXOGENOUS SUBSTANCE",1,NA
"EXOME",1,NA
"EXPANDED DYNAMIC RANGE",1,NA
"EXPANDED NEWBORN SCREENING",1,NA
"EXPERIENCE-BASED KNOWLEDGE",1,NA
"EXPERIENCE BASED KNOWLEDGE",1,NA
"EXPERIMENTAL",2,NA
"EXPERIMENTAL DESIGN",9,15
"EXPERIMENTAL METHOD",1,NA
"EXPERIMENTAL MODELS",1,NA
"EXPERIMENTAL MYOCARDIAL INFARCTION",1,NA
"EXPERIMENTAL SET-UP",1,1
"EXPERIMENTAL TESTING",1,NA
"EXPERIMENTATION",1,NA
"EXPERT",1,NA
"EXPERT ASSESSMENT",1,NA
"EXPERT COURT WITNESS",1,NA
"EXPERT EVIDENCE",3,NA
"EXPERT OPINION",2,NA
"EXPERT REPORT",2,NA
"EXPERT REPORTS",1,NA
"EXPERT REVIEW OF FITNESS TO DRIVE",1,NA
"EXPERT SYSTEM",2,2
"EXPERT SYSTEMS",1,NA
"EXPERT TESTIMONY",6,1
"EXPERT WITNESS",7,NA
"EXPERT WITNESSES",1,NA
"EXPERTISE",2,1
"EXPLETIVES",1,NA
"EXPLOSION",2,NA
"EXPLOSION-RELATED DEATH",1,NA
"EXPLOSIVE",81,29
"EXPLOSIVE-RELATED COMPOUNDS",1,NA
"EXPLOSIVE ANALYSIS",3,NA
"EXPLOSIVE CONTAMINATION",1,NA
"EXPLOSIVE DETECTION",7,4
"EXPLOSIVE IDENTIFICATION",1,NA
"EXPLOSIVE MARKER",1,NA
"EXPLOSIVE RESIDUE",1,NA
"EXPLOSIVE RESIDUES",3,NA
"EXPLOSIVE SCREENING",1,NA
"EXPLOSIVE SORPTION",3,NA
"EXPLOSIVE TAGGANT",1,NA
"EXPLOSIVE VAPOR",3,NA
"EXPLOSIVES ANALYSIS",1,1
"EXPLOSIVES RESIDUES",1,NA
"EXPLOSIVES TRACES",2,NA
"EXPONENTIAL CURVE",1,NA
"EXPOSURE",7,4
"EXPOSURE-BASED BIOMARKERS",1,NA
"EXPRESSION PATTERN",1,NA
"EXPRESSIONAL STABILITY",1,NA
"EXPULSIVE HEMORRHAGE",1,NA
"EXSANGUINATION",2,NA
"EXTENDED SUICIDE",2,NA
"EXTENSIVE DRUGS AND POISONS",1,NA
"EXTENSIVE METABOLIZER",1,NA
"EXTERNAL",1,NA
"EXTERNAL CAVITY QUANTUM CASCADE LASER",1,1
"EXTERNAL CONTAMINATION",8,1
"EXTERNAL DRUG CONTAMINATION",2,NA
"EXTERNAL EXAMINATION",1,NA
"EXTERNAL EXAMINATION OF A CORPSE",1,NA
"EXTERNAL PROFICIENCY TESTING",2,NA
"EXTERNAL QUALITY ASSESSMENT SCHEME",1,NA
"EXTERNAL QUALITY ASSURANCE",1,NA
"EXTERNAL QUALITY CONTROL",1,NA
"EXTERNALIZING",2,NA
"EXTERNALIZING BEHAVIOUR",1,NA
"EXTERNALIZING BEHAVIOUR PROBLEMS",1,NA
"EXTERNALIZING DISORDERS",1,NA
"EXTERNALIZING PSYCHOPATHOLOGY",1,NA
"EXTERNALLY VISIBLE CHARACTERISTICS",2,NA
"EXTERNALLY VISIBLE TRAITS",1,NA
"EXTORTION",1,NA
"EXTRA DOMAIN A",1,NA
"EXTRA LARGE OFF-LADDER",1,NA
"EXTRACELLULAR DNA",3,NA
"EXTRACTION",37,19
"EXTRACTION CHROMATOGRAPHY",4,NA
"EXTRACTION EFFICIENCY",2,NA
"EXTRACTION OPTIMIZATION",1,1
"EXTRACTION REAGENT",1,NA
"EXTRACTION RECOVERY PREDICTION",1,NA
"EXTRACTION TECHNOLOGY",1,NA
"EXTRACTIVE ACYLATION",1,NA
"EXTRACTIVE ELECTROSPRAY IONIZATION MASS SPECTROMETRY",1,NA
"EXTRACTIVE FREEZING-OUT",1,NA
"EXTRAMEDULLARY HAEMATOPOIESIS",1,NA
"EXTRAMURAL FACTORS",1,NA
"EXTRAPOLATION",1,NA
"EXTRAVASATION",1,NA
"EXTRELUT",1,NA
"EXTRELUT ® COLUMN",1,NA
"EXTRELUT® EXTRACTION",1,NA
"EXTREME CONTROL",1,NA
"EXTREMELY AGED SEMINAL STAIN",1,NA
"EXXON VALDEZ OIL",1,NA
"EYE COLOUR",3,NA
"EYE COLOUR PREDICTION",1,NA
"EYE LESIONS",1,NA
"EYE MOVEMENTS",2,NA
"EYELINER",1,NA
"EYES",1,NA
"EYESHADOW",1,NA
"EYEWEAR FORENSICS",1,NA
"EYEWITNESS MEMORY",1,NA
"EYEWITNESS REPORTS",1,NA
"F-108 POLYMER",1,NA
"F AAS",1,NA
"F13A01",1,NA
"F3A",1,NA
"FAB-MS",1,NA
"FAB (FAST ATOM BOMBARDMENT)-MS",1,NA
"FABRIC MORPHOLOGY",1,NA
"FABRIC PHASE SORPTIVE EXTRACTION",2,NA
"FABRICATION",1,NA
"FABRICS",2,NA
"FACE-TO FACE INTERVIEW",1,NA
"FACE RECOGNITION",1,NA
"FACETS OF VIOLENCE",1,NA
"FACIAL EXPRESSIONS",1,NA
"FACIAL PETECHIAE",1,NA
"FACTITIOUS DISORDER",2,NA
"FACTITIOUS DISORDER BY PROXY",1,NA
"FACTITIOUS HYPOGLYCAEMIA",2,NA
"FACTITIOUS ILLNESS",1,NA
"FACTOR ANALYSIS",3,1
"FACTOR STRUCTURE",2,NA
"FACTORIAL DESIGN",1,3
"FACTORS OF BIAS",1,NA
"FACTORS OF JUVENILE DELINQUENCY",1,NA
"FAD",1,1
"FAEE",2,NA
"FAHR'S DISEASE",1,NA
"FAILED ROMANTIC RELATIONSHIPS",1,NA
"FAIMS",3,2
"FAKE",2,NA
"FAKE DRUG CASE",1,NA
"FAKE DRUGS",2,1
"FAKE HEROIN",1,NA
"FAKE MEDICINE",1,NA
"FALISIFIED MEDICINE",1,NA
"FALL",2,NA
"FALL ACCIDENT",1,NA
"FALL AND FALL DOWN",1,NA
"FALL FROM HEIGHT",1,NA
"FALL FROM THE HEIGHT",1,NA
"FALL INVOLVING STAIRS",1,NA
"FALL/JUMP FROM HEIGHT - ADDICTIVE SUBSTANCES - ETHANOL - AUTOPSY - TOXICOLOGICAL ANALYSIS.",1,NA
"FALLOUT",1,NA
"FALLS AND DESCENT FROM HEIGHT",1,NA
"FALLS AND DESCENTS FROM HEIGHT",1,NA
"FALLS FROM HEIGHT",1,NA
"FALSE-NEGATIVE DETECTION",2,NA
"FALSE-NEGATIVE RESULTS",1,NA
"FALSE-POSITIVE",5,NA
"FALSE-POSITIVES",1,NA
"FALSE ADMISSION",1,NA
"FALSE MEMORY",1,NA
"FALSE NEGATIVE",1,NA
"FALSE NEGATIVE HIV TEST",1,NA
"FALSE NEGATIVES",1,NA
"FALSE POSITIVE",9,4
"FALSE POSITIVE RESPONSES",1,NA
"FALSE REPORTS",1,NA
"FALSIFIED ‘XANAX’",1,1
"FALSIFIED DRUGS",1,1
"FALSIFIED MEDICINES",1,1
"FALSIFIED PHARMACEUTICALS",1,NA
"FALSIFIED STEROIDS",1,1
"FAMILIAL ENVIRONMENT",1,NA
"FAMILIAL SEARCHING",1,NA
"FAMILICIDE",1,NA
"FAMILY",1,NA
"FAMILY ADVERSITY",1,NA
"FAMILY AND PRIVATE LIFE",1,NA
"FAMILY CARE",1,NA
"FAMILY COURT",1,NA
"FAMILY MEDICINE",3,NA
"FAMILY PURPOSE DOCTRINE",1,NA
"FAMILY VIOLENCE",1,NA
"FAMILY VIOLENCE HOMICIDE",1,NA
"FAMOUS CRIMINAL POISONING CASES",1,NA
"FAMPROFAZONE",2,NA
"FANG MUK",1,NA
"FANNIA LEUCOSTICTA",1,NA
"FANNIIDAE",2,NA
"FANTASY",1,1
"FAR-INFRARED",1,NA
"FARMER",1,NA
"FAS",1,NA
"FASERHANF",1,NA
"FASS",1,NA
"FAST ANALYSIS",1,1
"FAST ATOM BOMBARDMENT-MASS SPECTROMETRY",2,NA
"FAST ATOM BOMBARDMENT (FAB)",2,NA
"FAST BLACK K SALT",1,NA
"FAST BLUE B",1,1
"FAST BLUE BB SALT",1,NA
"FAST CHROMATOGRAPHY",1,NA
"FAST FORENSIC ANALYSIS",1,1
"FAST GAS-CHROMATOGRAPHY",1,NA
"FAST GAS CHROMATOGRAPHY",2,4
"FAST GAS CHROMATOGRAPHY/MASS SPECTROMETRY",1,1
"FAST GC",4,NA
"FAST GC-MS",1,NA
"FAST GC-MS SCREENING",1,NA
"FAST METABOLIZER",1,NA
"FAST SAMPLE PREPARATION",1,NA
"FAST SCREEN",1,NA
"FAST SCREENING",2,2
"FASTQ",1,NA
"FAT EMBOLISM",4,NA
"FAT EMBOLISM SYNDROME",2,NA
"FATAL ACUTE",1,NA
"FATAL ALCOHOL POISONINGS",1,NA
"FATAL ANAPHYLAXIS",1,NA
"FATAL AND NONFATAL INTOXICATION",1,NA
"FATAL ASTHMA",2,NA
"FATAL AVIATION ACCIDENT INVESTIGATION",1,NA
"FATAL BLOOD LEVELS",1,NA
"FATAL CASE",3,NA
"FATAL CASES",3,NA
"FATAL CODEINE INTOXICATION",1,NA
"FATAL COMPLICATION",1,NA
"FATAL CRASH",1,NA
"FATAL DIABETIC KETOACIDOSIS",1,NA
"FATAL DROWNINGS",1,NA
"FATAL DRUG ADDICTION",4,NA
"FATAL DRUG ADDICTIONS",1,NA
"FATAL DRUG LEVELS",1,NA
"FATAL DRUG POISONINGS",1,NA
"FATAL FALL",1,NA
"FATAL FIREARM CASES",1,NA
"FATAL FIREARM INJURY",1,NA
"FATAL FORENSIC CASES ANALYSIS",1,NA
"FATAL HEMORRHAGE",2,NA
"FATAL HYDROPERICARDIUM",1,NA
"FATAL HYPOTHERMIA",1,NA
"FATAL INFECTIONS",1,NA
"FATAL INTOXICATION",33,2
"FATAL INTOXICATIONS",4,NA
"FATAL INTRAVENOUS INJECTION",1,NA
"FATAL LEVEL",1,NA
"FATAL MARINE POISONING",1,NA
"FATAL METHAMPHETAMINE INTOXICATION",1,NA
"FATAL MOTORCYCLE CRASH",1,NA
"FATAL OUTCOME",7,NA
"FATAL OVERDOSAGE",1,NA
"FATAL OVERDOSE",2,NA
"FATAL OVERDOSE CONCENTRATION",1,NA
"FATAL POISONING",44,1
"FATAL POISONING - CHILDREN",1,NA
"FATAL POISONING CASE",1,NA
"FATAL POISONING: CLOZAPINE",1,NA
"FATAL POISONING: INTERPRETATION OF RESULTS",1,NA
"FATAL POISONINGS",7,NA
"FATAL PULMONARY EMBOLISM",1,NA
"FATAL SHOCK",1,NA
"FATAL TOXICITY",1,NA
"FATAL TOXICITY INDEX",1,NA
"FATAL TRAFFIC ACCIDENT",1,NA
"FATAL TRAFFIC ACCIDENTS",1,NA
"FATAL TRAUMA",1,NA
"FATALITY",117,6
"FATHERS",2,NA
"FATIGUE",1,NA
"FATTY",1,NA
"FATTY ACID DERIVATIZATION",1,NA
"FATTY ACID ETHYL ESTER",1,NA
"FATTY ACID ETHYL ESTERS",10,NA
"FATTY ACID ETHYL ESTERS (FAEE)",2,NA
"FATTY ACID METHYL ESTERS",1,1
"FATTY ACID TRANSPORT PROTEIN",1,NA
"FATTY ACIDS",4,10
"FATTY FISH CONSUMPTION",1,NA
"FATTY INFILTRATION OF THE LIVER",1,NA
"FATTY LIVER",1,NA
"FATTY TISSUES",1,NA
"FAULTY INTRAARTERIAL INJECTIONS",1,NA
"FBI GENERAL RIFLING CHARACTERISTICS FILES (GRC) ANOMALIES",1,NA
"FBT",1,NA
"FCΕRIΑ",1,NA
"FDA",1,1
"FDA APPROVAL",1,NA
"FDDM",1,NA
"FDP",1,NA
"FE3O4 MAGNETIC NANOPARTICLES",1,NA
"FE65",1,NA
"FEARLESS DOMINANCE",2,NA
"FEASIBILITY OUTCOMES",1,NA
"FEATURE-BASED MODELS",1,NA
"FEATURES",2,1
"FECUNDITY",1,NA
"FEDERAL AVIATION ADMINISTRATION",3,NA
"FEDERAL OFFENDERS",1,NA
"FEDERAL RULES OF EVIDENCE",1,NA
"FEDERAL SENTENCING",1,NA
"FEDERAL SENTENCING GUIDELINES",4,NA
"FEDERAL STATE MEDICAL BOARD MODEL GUIDELINES",1,NA
"FEDERATION OF STATE MEDICAL BOARD MODEL POLICY",1,NA
"FEDRATINIB",1,NA
"FEES, MEDICAL",1,NA
"FELINE",1,NA
"FEMALE",17,NA
"FEMALE ADOLESCENT RAPE VICTIM",1,NA
"FEMALE ADOLESCENTS",2,NA
"FEMALE EX-OFFENDERS",1,NA
"FEMALE JUVENILE DELINQUENCY",1,NA
"FEMALE JUVENILE DELINQUENTS",1,NA
"FEMALE OFFENDERS",2,NA
"FEMALE PATIENT",1,NA
"FEMALE SAME GENDER STALKING",1,NA
"FEMALE SEXUAL OFFENDERS",1,NA
"FEMALE STALKER",1,NA
"FEMALE STALKING",1,NA
"FEMALE SUICIDE",1,NA
"FEMALE URINARY INCONTINENCE",1,NA
"FEMICIDE",1,NA
"FEMINIST THEORY",1,NA
"FEMORAL ARTERY",1,NA
"FEMORAL BLOOD",7,NA
"FEMORAL BLOOD VESSELS",1,NA
"FEMORAL CATHETERIZATION",1,NA
"FEMORAL PSEUDO-ANEURYSM",1,NA
"FEMORAL VEIN BLOOD",1,NA
"FEMORAL VEIN EROSION",1,NA
"FEMORAL VENOUS BLOOD DRUG CONCENTRATIONS",1,NA
"FEMTOSECOND LASER IONIZATION",1,NA
"FEMTOSECOND LASER PULSES",1,NA
"FEMUR",2,NA
"FENCAMINE",1,NA
"FENETHYLLINE",1,2
"FENETYLLIN INTOXICATION, COMA DÉPASSÉ",1,NA
"FENFLURAMINE",3,1
"FENITROTHION",2,NA
"FENITROTHION METABOLITES",1,NA
"FENOTEROL",2,NA
"FENOTIAZINES",1,NA
"FENPROPOREX",4,1
"FENPROPOREX AND METHYLPHENIDATE",1,1
"FENTALOGS",1,NA
"FENTANYL ANALOGUES",14,13
"FENTANYL AND ANALOGS",1,NA
"FENTANYL AND DERIVATIVES",121,94
"FENTANYL AND ITS ANALOGUES",2,1
"FENTANYL INTOXICATION",1,1
"FENTANYL METABOLITE",1,NA
"FENTANYL PATCH",1,NA
"FENTANYL VOLTAMMETRIC DETERMINATION",1,1
"FERMENTATION",1,1
"FERRIC CHLORIDE",1,1
"FERRIC HYDROXAMATE TEST",1,1
"FERRIHEXACYANOFERRATE (II)",1,NA
"FERROPRINT™",2,NA
"FERROTRACE™",2,NA
"FERTILITY",1,NA
"FERTILIZER",1,NA
"FESFPS",1,NA
"FESTIVALS",1,2
"FETAL",1,NA
"FETAL ALCOHOL SPECTRUM DISORDERS",1,NA
"FETAL ALCOHOL SYNDROME",1,NA
"FETAL DNA",1,NA
"FETAL DRUGS",1,NA
"FETAL EFFECT",1,NA
"FETAL EXPOSURE",1,NA
"FETAL FRACTION",1,NA
"FETAL TRAUMA",1,NA
"FETTEMBOLIE, LIPIDCHEMISCHE UNTERSUCHUNGEN",1,NA
"FETUS FLUIDS",1,NA
"FETUS TISSUES",1,NA
"FETUSES",1,NA
"FFPE TISSUE",1,NA
"FGA",1,NA
"FGA LOCUS",1,NA
"FGF2",1,NA
"FHL2",1,NA
"FIBER-ENHANCED RAMAN SPECTROSCOPY (FERS)",1,NA
"FIBER-TYPE CANNABIS",1,NA
"FIBER OPTIC PROBES",1,NA
"FIBER OPTICS",1,1
"FIBER SOLID-PHASE MICROEXTRACTION",1,NA
"FIBRE",11,7
"FIBRE CANNABIS",1,1
"FIBRE HEMP",1,1
"FIBRE OPTIC PROBES OR DIRECT LASER EXCITATION, SPECTRA FOR DRUG SAMPLES",1,NA
"FIBRINOID",1,NA
"FIBRINOLYSIS",1,NA
"FIBRONECTIN",1,NA
"FIBROUS EXTRACTION MEDIUM",1,NA
"FIELD-AMPLIFIED SAMPLE STACKING",1,1
"FIELD-ENHANCED SAMPLE STACKING",1,NA
"FIELD-PORTABLE INSTRUMENTS",1,NA
"FIELD-PORTABLE MASS SPECTROMETERS",1,1
"FIELD AMPLIFIED SAMPLE INJECTION",1,1
"FIELD ASSAY",1,1
"FIELD FORENSICS",1,1
"FIELD GC-MS ANALYSIS",1,NA
"FIELD KIT",2,NA
"FIELD SCREENING TECHNIQUE",1,NA
"FIELD SOBRIETY TESTS",1,NA
"FIELD TEST",2,2
"FIELD TRIALS",1,NA
"FIELDABLE MASS SPECTROMETRY",2,1
"FILICIDE",4,NA
"FILICIDE-SUICIDE",3,NA
"FILTER- EMBEDDED FEATURE RANKING TECHNIQUES (FEFR)",1,NA
"FILTER CONE SPRAY IONIZATION",1,NA
"FILTER PAPER",4,NA
"FILTRATION",2,1
"FIN EROSION",1,NA
"FINANCING OF PSYCHIATRIC HEALTH CARE",4,NA
"FINDING OF BODY",1,NA
"FINE BEAM X-RAY FLUORESCENCE ANALYSIS",1,NA
"FINE LINE",1,NA
"FINGEMAIL",1,NA
"FINGER NAIL ANALYSIS",1,NA
"FINGER/FOOTWEAR MARK ENHANCEMENT",1,NA
"FINGERMARK DETECTION",4,NA
"FINGERMARK DEVELOPMENT",1,NA
"FINGERMARK ENHANCEMENT",1,NA
"FINGERMARK POWDERS",1,NA
"FINGERMARK REAGENTS",1,NA
"FINGERMARKS DEVELOPMENT",1,NA
"FINGERNAIL",1,NA
"FINGERNAILS",1,NA
"FINGERPRINT",72,14
"FINGERPRINT ANALYSIS",1,2
"FINGERPRINT DETECTION",1,NA
"FINGERPRINT DEVELOPMENT",4,NA
"FINGERPRINT FOR DRUG TESTING",1,NA
"FINGERPRINT POWDER",1,NA
"FINGERPRINT POWDERS",1,NA
"FINGERPRINT REAGENT",2,NA
"FINGERPRINT REAGENTS",1,NA
"FINGERPRINT RESIDUE",1,NA
"FINGERPRINT VISUALIZATION TECHNIQUES",1,NA
"FINGERPRINTING",5,8
"FINITE CONSIGNMENT",1,NA
"FINITE ELEMENT ANALYSIS",2,NA
"FINITE ELEMENT MODELING",1,NA
"FINITE POPULATION",1,1
"FINLAND",2,NA
"FIRE",5,NA
"FIRE-SETTING",1,NA
"FIRE AND ARSON INVESTIGATION",1,NA
"FIRE DEATHS",1,NA
"FIRE DEATHS, HOMICIDE",1,NA
"FIRE DEBRIS",11,2
"FIRE DEBRIS ANALYSIS",5,NA
"FIRE FATALITIES",2,NA
"FIRE INVESTIGATION",1,NA
"FIRE VICTIMS",1,NA
"FIREARM",22,2
"FIREARM-RELATED DEATHS",1,NA
"FIREARM DISCHARGE RESIDUE",1,NA
"FIREARM DISCHARGE RESIDUES",2,NA
"FIREARM FATALITIES",1,NA
"FIREARM HANDLING",1,NA
"FIREARM INJURIES",1,NA
"FIREARMS DISCHARGE RESIDUE",1,NA
"FIREARMS PROPELLANT ANALYSIS",1,NA
"FIRECRACKER",1,NA
"FIRED CARTRIDGE CASINGS",1,NA
"FIREFIGHTER",1,NA
"FIRES AND EXPLOSIONS",1,NA
"FIRESETTING",1,NA
"FIREWORKS",2,NA
"FIRING DISTANCE",1,NA
"FIRST-EPISODE",1,NA
"FIRST-EPISODE PSYCHOSIS",2,NA
"FIRST-PASS METABOLISM",1,NA
"FIRST-TIME INMATES",2,NA
"FIRST-YEAR UNDERGRADUATE/GENERAL",3,3
"FIRST DIGIT LAW",1,NA
"FIRST EPISODE",1,NA
"FIRST RESPONDER",1,NA
"FIRST RESPONDERS",1,2
"FISH",2,NA
"FISHER DISCRIMINANT ANALYSIS",1,1
"FISHER TRANSFORM",1,1
"FISHER TROPSCH",1,NA
"FISSION AND ACTIVATION PRODUCTS",2,NA
"FISSION FOIL",1,NA
"FISSION PRODUCT",2,NA
"FISSION PRODUCTS",3,NA
"FISSION XE",1,NA
"FISTING",1,NA
"FIT FOR PURPOSE",1,NA
"FITNESS FOR DETENTION",2,NA
"FITNESS FOR IMPRISONMENT",1,NA
"FITNESS FOR INTERVIEW",1,NA
"FITNESS TO DRIVE",8,NA
"FITNESS TO HOLD A DRIVING LICENSE",1,NA
"FIXATION",2,NA
"FIXATION PROCESS",1,NA
"FIXATIVE",1,NA
"FIXATIVES",1,NA
"FIXED EFFECTS MODEL",1,NA
"FLAKKA",2,3
"FLAME-THERMIONIC DETECTOR",1,NA
"FLAME IONISATION DETECTOR",1,1
"FLAME IONIZATION DETECTION",1,2
"FLAME PHOTOMETRIC DETECTOR",1,NA
"FLAME THERMIONIC DETECTION",1,NA
"FLAMELESS AAS",1,NA
"FLANKING REGION MUTATION",1,NA
"FLASH CHROMATOGRAPHY",1,3
"FLASH DERIVATIZATION",1,NA
"FLASHBACK",2,NA
"FLAT CAPILLARY TUBES",1,1
"FLAVIN",1,NA
"FLECAINIDE",1,NA
"FLESH FLIES",2,NA
"FLESH FLY",1,NA
"FLG",1,NA
"FLIGHT LOGS",1,NA
"FLIGHT OR FIGHT",1,NA
"FLINDERS TECHNOLOGY ASSOCIATES CARD",1,NA
"FLOCOUMAFEN",2,NA
"FLOOD",1,NA
"FLORENCE IODINE",1,NA
"FLORIDA MEDICAL EXAMINERS COMMISSION",1,NA
"FLOSEAL",1,NA
"FLOTATION TANK",1,NA
"FLOURENS, JEAN PIERRE",1,NA
"FLOW ASSURANCE",1,NA
"FLOW CYTOMETRY",1,NA
"FLOW INJECTION",1,5
"FLOW INJECTION ANALYSIS (FIA)",4,13
"FLOW PROGRAM",1,1
"FLOWER BUDS",1,1
"FLUALPRAZOLAM",5,NA
"FLUBROMAZOLAM",3,1
"FLUCONAZOLE",2,NA
"FLUFENOXURON",1,NA
"FLUID FROM ORAL CAVITY",1,NA
"FLUID MIXTURE",1,NA
"FLUMAZENIL",1,1
"FLUMETHASONE",1,NA
"FLUNITRAZEPAM",33,17
"FLUNITRAZEPAM - ETHANOL - PAROXETINE - GAS CHROMATOGRAPHY MASS SPECTROMETRY (GC/MS).",1,NA
"FLUNITRAZEPAM ABUSE",1,NA
"FLUNITRAZEPAM DETERMINATION",1,NA
"FLUNITRAZEPAM METABOLITES",1,NA
"FLUORESCENCE",20,17
"FLUORESCENCE-BASED MULTIPLEX STR GENOTYPING",1,NA
"FLUORESCENCE ANALYSIS",1,1
"FLUORESCENCE CORRELATION",1,NA
"FLUORESCENCE DETECTION (FLD)",8,8
"FLUORESCENCE GENOSENSOR",1,NA
"FLUORESCENCE IMMUNOCHROMATOGRAPHIC ASSAY",1,NA
"FLUORESCENCE IN SITU HYBRIDISATION",1,NA
"FLUORESCENCE IN SITU HYBRIDIZATION (FISH)",1,NA
"FLUORESCENCE MICROSCOPE",1,NA
"FLUORESCENCE MICROSCOPY",4,NA
"FLUORESCENCE POLARIZATION IMMUNOASSAY",3,NA
"FLUORESCENCE POLARIZATION IMMUNOASSAY (FPIA)",1,NA
"FLUORESCENCE PROBE",1,2
"FLUORESCENCE REJECTION",1,1
"FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)",1,3
"FLUORESCENCE SPECTROPHOTOMETER",1,NA
"FLUORESCENCE SPECTROSCOPY",1,1
"FLUORESCENT",1,1
"FLUORESCENT DERIVATIVE",1,1
"FLUORESCENT DETECTION",1,NA
"FLUORESCENT DEVELOPMENT",1,NA
"FLUORESCENT DYES",1,NA
"FLUORESCENT LABELING",1,NA
"FLUORESCENT MARKER",1,NA
"FLUORESCENT MICROSCOPY",1,NA
"FLUORESCENT POWDER",1,NA
"FLUORESCENT PROBE",1,NA
"FLUORESCENT SENSOR",2,NA
"FLUORESCENT X-RAY ANALYSIS",1,NA
"FLUORIDE",4,1
"FLUORIDE IONS",1,NA
"FLUORIDE REACTIVATION",2,NA
"FLUORIMETRIC ASSAY",1,1
"FLUORIMETRIC DETERMINATION",1,NA
"FLUORINATION",1,NA
"FLUORO-DESCHLOROKETAMINE (FDCK)",1,1
"FLUORO-METHOXYAMPHETAMINES",1,1
"FLUORO-Α-PYRROLIDINOPROPIOPHENONES",1,1
"FLUOROACETAMIDE",2,NA
"FLUOROACETIC ACID",1,NA
"FLUOROAMPHETAMINE",4,4
"FLUOROAMPHETAMINE ANALOGS",1,1
"FLUOROBENZYL INDOLE",2,NA
"FLUOROBENZYL INDOLES",1,1
"FLUOROFURANYLFENTANYL",1,NA
"FLUOROGENIC",2,NA
"FLUOROGENIC SUBSTRATE",1,NA
"FLUOROIMMUNOASSAY",1,NA
"FLUOROKETAMINE",1,NA
"FLUOROMETHCATHINONE",1,1
"FLUOROMETRY",1,NA
"FLUOROPHENMETRAZINE",1,1
"FLUOROPHENYLALKYLAMINES",1,1
"FLUOROPHORE",2,2
"FLUOROPYROLIDINOBUTYROPHENONE",1,1
"FLUOROQUINOLONES",1,NA
"FLUOROTROPACOCAINE",1,NA
"FLUOXETINE",10,4
"FLURAZEPAM",2,1
"FLUROQUINOLONES ANTIBIOTICS",1,NA
"FLUROXYPYR",1,NA
"FLUROXYPYR-MEPTYL",1,NA
"FLUVOXAMINE",5,NA
"FLY",1,1
"FLY LARVA",1,NA
"FME",2,NA
"FMRI",1,NA
"FOCUS COLUMN",1,NA
"FOCUS™",1,NA
"FOLIE À DEUX",1,NA
"FOLIN’S REAGENT",1,NA
"FOLK REMEDY",1,NA
"FOLLOW-UP OF DETOXIFICATION PROGRAMS",1,NA
"FOLLOW-UP STUDIES",1,NA
"FOLLOW-UP STUDY",1,NA
"FOLLOW UP",5,NA
"FOLLOW UP SURVEY",1,NA
"FOLPET",1,NA
"FONAZEPAM",1,1
"FOOD",14,4
"FOOD-CONTROL LABORATORY",1,NA
"FOOD-SCARE",1,NA
"FOOD ADDITIVES",1,NA
"FOOD ALLERGY",1,NA
"FOOD ANALYSIS",7,6
"FOOD AND BEVERAGE",1,NA
"FOOD AND PLANT ANALYSIS",1,NA
"FOOD ASPHYXIA",1,NA
"FOOD AUTHENTICATION",1,1
"FOOD AUTHENTICITY",1,1
"FOOD CHEMISTRY",1,1
"FOOD CONTAMINANTS",1,2
"FOOD CONTROL",1,NA
"FOOD FORENSICS",2,NA
"FOOD LEGISLATION",1,NA
"FOOD SAFETY",1,6
"FOOD STUFF",1,4
"FOOD TAMPERING",1,NA
"FOOD TESTING",1,NA
"FOOD WEB",1,NA
"FOOT DROP",1,NA
"FOOTPRINT CAST",1,NA
"FOOTWEAR",2,1
"FOOTWEAR IMPRESSIONS",2,NA
"FORCE",1,NA
"FORCE MAPPING",1,NA
"FORCE SPECTROSCOPY",1,NA
"FORCED DEGRADATION STUDY",1,NA
"FORCED DIURESIS, PERICARDIUM-TAMPONADE",1,NA
"FORCED MEDICATION",4,NA
"FORCED SEX",1,NA
"FORCES",1,NA
"FORECASTING",1,NA
"FOREIGN BODIES",3,NA
"FOREIGN BODIES INGESTION",1,NA
"FOREIGN BODY",4,NA
"FOREIGN BODY EMBOLIZATION",1,NA
"FOREIGN BODY INGESTION",1,NA
"FOREIGN CITIZENS",1,NA
"FOREIGN MATERIALS",1,NA
"FOREIGN NATIONAL EX-PRISONERS",1,NA
"FOREIGN OBJECTS",1,NA
"FOREIGN ORGANIC COMPOUNDS",1,NA
"FOREIGN PARTICLE EMBOLIZATION",1,NA
"FOREIGN SUBSTANCES",2,NA
"FORENSEQ DNA SIGNATURE PREP KIT",1,NA
"FORENSIC",412,90
"FORENSIC-TOXICOLOGICAL ANALYSES",2,NA
"FORENSIC-TOXICOLOGICAL INTERPRETATION",1,NA
"FORENSIC ACAROLOGY",2,NA
"FORENSIC ACCOUNTING",1,NA
"FORENSIC ACCREDITATION",2,NA
"FORENSIC ADDICTION TREATMENT",4,NA
"FORENSIC AFTERCARE",1,NA
"FORENSIC ANALYSIS",141,76
"FORENSIC ANALYSIS OF HAIR BY INFRARED SPECTROSCOPY",1,NA
"FORENSIC ANALYSIS OF STOMACH CONTENTS",1,NA
"FORENSIC ANALYTICAL",1,1
"FORENSIC ANALYTICAL CHEMISTRY",2,NA
"FORENSIC ANALYZIS",1,NA
"FORENSIC AND ARCHAEOLOGICAL IDENTIFICATION",1,NA
"FORENSIC AND CLINICAL ANALYSIS",1,NA
"FORENSIC AND CLINICAL ASPECTS",1,1
"FORENSIC AND CLINICAL TOXICOLOGY",3,NA
"FORENSIC AND LEGAL ASSESSMEN",1,NA
"FORENSIC AND STATE MEDICINE",1,NA
"FORENSIC AND TOXICOLOGICAL INVESTIGATION",1,NA
"FORENSIC ANTHROPOLOGISTS",1,NA
"FORENSIC ANTHROPOLOGY",20,NA
"FORENSIC ANTHROPOLOGY POPULATION DATA",1,NA
"FORENSIC ANTHROPOPULATION DATA",1,NA
"FORENSIC ANTIEPILEPTIC DRUG LEVELS",1,NA
"FORENSIC APPLICATIONS",11,5
"FORENSIC APPLICATIONS AND SORS, ILLICIT SUBSTANCE DETECTION IN POSTAL ENVELOPES",1,NA
"FORENSIC APPLICATIONS.",1,NA
"FORENSIC APPRAISAL",1,NA
"FORENSIC ASPECT",1,NA
"FORENSIC ASPECTS",2,NA
"FORENSIC ASPECTS AND PRACTICE",1,NA
"FORENSIC ASPECTS OF HYPOGLYCEMIA",1,NA
"FORENSIC ASSERTIVE COMMUNITY TREATMENT",2,NA
"FORENSIC ASSESSMENT",6,NA
"FORENSIC ATTRIBUTION",1,NA
"FORENSIC AUTOPSIES",1,NA
"FORENSIC AUTOPSY",57,NA
"FORENSIC AUTOPSY CASE",1,NA
"FORENSIC AUTOPSY CASES",2,NA
"FORENSIC AUTOPSY SPECIMENS",1,NA
"FORENSIC AUTOPSY TISSUES",1,NA
"FORENSIC BALLISTICS",1,NA
"FORENSIC BIOCHEMISTRY",2,NA
"FORENSIC BIOINFORMATICS",1,NA
"FORENSIC BIOLOGICAL EVIDENCE",11,NA
"FORENSIC BIOLOGY",3,NA
"FORENSIC BIOMARKER",2,NA
"FORENSIC BLOOD ANALYSIS",1,NA
"FORENSIC BLOOD SAMPLES",1,NA
"FORENSIC BLOOD SUBSTITUTES",1,NA
"FORENSIC BOTANY",6,3
"FORENSIC CARE",1,NA
"FORENSIC CASE",2,NA
"FORENSIC CASE FORMULATION - SUBSTANCE ABUSE DISORDERS AND ANGER",1,NA
"FORENSIC CASE REPORTS",1,NA
"FORENSIC CASEWORK",3,NA
"FORENSIC CAUSALITY",1,NA
"FORENSIC CHEMICAL ANALYSIS",1,NA
"FORENSIC CHEMICAL ANALYSIS.",1,NA
"FORENSIC CHEMICAL PROFILING",1,NA
"FORENSIC CHEMIST",1,NA
"FORENSIC CHEMISTRY",107,75
"FÒRENSIC CHEMISTRY",1,NA
"FORENSIC CHEMISTRY IN RELATION TO COCAINE",1,NA
"FORENSIC CHIRAL ANALYSIS",1,NA
"FORENSIC CLIENT",1,NA
"FORENSIC CLINIC",1,NA
"FORENSIC CONFIRMATION TEST",1,1
"FORENSIC CONSIDERATIONS",1,NA
"FORENSIC COUNSELING",5,NA
"FORENSIC DATABASE",1,NA
"FORENSIC DENTISTRY",5,NA
"FORENSIC DETECTION",2,2
"FORENSIC DETECTION METHODS, MOLECULAR CRYSTALS",1,NA
"FORENSIC DETENTION",1,NA
"FORENSIC DIAGNOSIS",2,NA
"FORENSIC DIAGNOSTI",1,NA
"FORENSIC DNA",10,3
"FORENSIC DNA ANALYSIS",7,1
"FORENSIC DNA INTERPRETATION",1,NA
"FORENSIC DNA PHENOTYPING",3,NA
"FORENSIC DNA TYPING",2,1
"FORENSIC DNA/MIRNA ANALYSIS",1,NA
"FORENSIC DOCTORS",1,NA
"FORENSIC DOCUMENT EXAMINATION",1,NA
"FORENSIC DRUG",2,NA
"FORENSIC DRUG ANALYSIS",10,2
"FORENSIC DRUG CHEMISTRY",1,1
"FORENSIC DRUG IDENTIFICATION",1,1
"FORENSIC DRUG PROFILING",1,NA
"FORENSIC DRUG SCREENING",3,1
"FORENSIC DRUG TESTING",3,NA
"FORENSIC DRUGS",2,1
"FORENSIC EDUCATION",1,NA
"FORENSIC ELECTROANALYSIS",3,2
"FORENSIC ELECTROCHEMISTRY",2,3
"FORENSIC ENETICS",1,NA
"FORENSIC ENGINEERING",1,NA
"FORENSIC ENTOMOLOGY",65,NA
"FORENSIC ENTOMOLOGY, ENTOMOLOGICAL EVIDENCE IN MEDICOLEGAL INVESTIGATIONS",1,NA
"FORENSIC ENTOMOTOXICOLOGY",1,NA
"FORENSIC ENZYME HISTOCHEMISTRY",1,NA
"FORENSIC EPIDEMIOLOGY",4,NA
"FORENSIC EPIGENETICS",2,NA
"FORENSIC EVALUATION",11,NA
"FORENSIC EVALUATIONS",1,NA
"FORENSIC EVIDENCE",9,2
"FORENSIC EVIDENCE COLLECTION",1,NA
"FORENSIC EVIDENCE RECOVERY",1,NA
"FORENSIC EXAMINATION",11,1
"FORENSIC EXPERT ANALYSIS",1,NA
"FORENSIC EXPERT REPORT",2,NA
"FORENSIC EXPERT TESTIMONY",1,NA
"FORENSIC EXPERTISE",3,NA
"FORENSIC EXPERTISES",1,NA
"FORENSIC EXPLOSIVES ANALYSIS",1,NA
"FORENSIC FIRE INVESTIGATION",1,NA
"FORENSIC GENETICS",28,3
"FORENSIC GENOMICS",1,NA
"FORENSIC GEOLOGY",2,NA
"FORENSIC GEOSCIENCE",2,1
"FORENSIC GLASS COMPARISON",1,NA
"FORENSIC HAIR ANALYSIS",1,NA
"FORENSIC HAIR DRUG TESTING",1,NA
"FORENSIC HAIR TESTING",1,NA
"FORENSIC HANDWRITING EXAMINATION",1,NA
"FORENSIC HISTOPATHOLOGY",3,NA
"FORENSIC HISTORY",1,NA
"FORENSIC HOSPITALS",1,NA
"FORENSIC IDENTIFICATION",12,3
"FORENSIC ILLICIT-DRUG ANALYSIS",1,2
"FORENSIC IMAGING",8,NA
"FORENSIC IMMUNOHISTOCHEMISTRY",1,NA
"FORENSIC IMPORTANCE",1,NA
"FORENSIC IN-PATIENT TREATMENT",1,NA
"FORENSIC INDICATORS",1,NA
"FORENSIC INDIVIDUALIZATION",1,NA
"FORENSIC INK ANALYSIS",1,NA
"FORENSIC INPATIENT SETTINGS",1,NA
"FORENSIC INPATIENT SUBSTANCE ABUSE TREATMENT",1,NA
"FORENSIC INPATIENTS",4,NA
"FORENSIC INTEGRITY",1,NA
"FORENSIC INTELLIGENCE",30,11
"FORENSIC INTERPRETATION",2,NA
"FORENSIC INTERPRETATION/EVALUATION",1,NA
"FORENSIC INTERVIEWING",1,NA
"FORENSIC INTERVIEWS WITH ADOLESCENTS",1,NA
"FORENSIC INTOXICATION",2,NA
"FORENSIC INVESTIGATION",9,2
"FORENSIC IONS",1,1
"FORENSIC ISSUES",1,NA
"FORENSIC LABORATORIES",1,1
"FORENSIC LABORATORY",2,NA
"FORENSIC LAW",2,NA
"FORENSIC LEXICOLOGICAL ANALYSIS",1,NA
"FORENSIC LIGHT SOURCE",1,NA
"FORENSIC LINGUISTICS",1,NA
"FORENSIC MASS SPECTROMETRY",1,1
"FORENSIC MATERIAL",2,NA
"FORENSIC MATRICES",1,NA
"FORENSIC MEDICAL EXAMINATION",2,NA
"FORENSIC MEDICAL EXAMINER",3,NA
"FORENSIC MEDICAL EXAMS",1,NA
"FORENSIC MEDICAL EXPERT OPINING",1,NA
"FORENSIC MEDICAL EXPERTISE",1,NA
"FORENSIC MEDICAL EXPERTISE OF MATERIAL EVIDENCES",1,NA
"FORENSIC MEDICAL EXPERTISE OF THE CORPSES",1,NA
"FORENSIC MEDICINE",171,3
"FORENSIC MEDICINE DEPARTMENT",1,NA
"FORENSIC MEDICINE EXPERT",1,NA
"FORENSIC MEDICINE IN PANDEMIC",1,NA
"FORENSIC MEDICINE/SCIENCE",1,NA
"FORENSIC MENTAL",1,NA
"FORENSIC MENTAL HEALTH",15,NA
"FORENSIC MENTAL HEALTH CARE",1,NA
"FORENSIC MENTAL HEALTH NURSING",1,NA
"FORENSIC MENTAL HEALTH PATIENTS",1,NA
"FORENSIC MENTAL HEALTH SERVICES",1,NA
"FORENSIC MENTAL HEALTH SERVICES.",1,NA
"FORENSIC METEOROLOGY",1,NA
"FORENSIC METHOD",1,1
"FORENSIC MICROBIOLOGY",7,NA
"FORENSIC MICROSCOPY",1,NA
"FORENSIC MIXTURE",1,NA
"FORENSIC MOLECULAR PATHOLOGY",3,NA
"FORENSIC NANOTECHNOLOGY",1,NA
"FORENSIC NETWORK",1,NA
"FORENSIC NEUROLOGY",1,NA
"FORENSIC NEUROPATHOLOGY",4,NA
"FORENSIC NEUROPSYCHOLOGY",2,NA
"FORENSIC NEUROSCIENCE",1,NA
"FORENSIC NGS",1,NA
"FORENSIC NURSE",1,NA
"FORENSIC NURSING",11,NA
"FORENSIC ODONTOLOGY",7,NA
"FORENSIC ODONTOLOGY (OR FORENSIC DENTISTRY)",1,NA
"FORENSIC OFFENDERS",1,NA
"FORENSIC ONYCHOLOGY",1,NA
"FORENSIC OPTOMETRY",1,NA
"FORENSIC ORAL FLUID",1,NA
"FORENSIC ORIGIN",1,NA
"FORENSIC OUTPATIENT CARE",1,NA
"FORENSIC OUTPATIENT CLINIC",1,NA
"FORENSIC PALYNOLOGY",3,1
"FORENSIC PARAMETERS",1,NA
"FORENSIC PATHOLOGISTS",1,NA
"FORENSIC PATHOLOGY",401,2
"FORENSIC PATHOLOGY AND CLINICS",1,NA
"FORENSIC PATHOPHYSIOLOGY",4,NA
"FORENSIC PATIENTS",11,NA
"FORENSIC PHARMACEUTICAL EXPERTISE",1,NA
"FORENSIC PHARMACOGENETICS",1,NA
"FORENSIC PHARMACOGNOSY",1,NA
"FORENSIC PHARMACOLOGY",2,NA
"FORENSIC PHARMACOVIGILLANCE",1,NA
"FORENSIC PHARMACY",3,NA
"FORENSIC PHENOTYPING",1,NA
"FORENSIC PHONETICS",1,NA
"FORENSIC PHYSICIAN",11,NA
"FORENSIC PHYSICIANS",3,NA
"FORENSIC PLANT IDENTIFICATION",1,2
"FORENSIC PLANT SCIENCE",7,6
"FORENSIC POPULATION",2,NA
"FORENSIC POSTMORTEM TOXICOLOGY, ANALYZING DRUGS, POISONS IN BIOLOGICAL FLUIDS",1,NA
"FORENSIC POSTQUALIFYING SOCIAL WORK EDUCATION",1,NA
"FORENSIC PREVENTATIVE PATHOLOGY",1,NA
"FORENSIC PROCESS",1,NA
"FORENSIC PROFILE",1,NA
"FORENSIC PROFILING",3,2
"FORENSIC PROGNOSIS",2,NA
"FORENSIC PROTEINS",1,1
"FORENSIC PROTEOMICS",4,NA
"FORENSIC PROVENANCING",2,NA
"FORENSIC PSYCHIATRIC ASSESSMENT",1,NA
"FORENSIC PSYCHIATRIC COMMITTEE",1,NA
"FORENSIC PSYCHIATRIC EVALUATION",2,NA
"FORENSIC PSYCHIATRIC EXAMINATION",2,NA
"FORENSIC PSYCHIATRIC HOSPITAL",1,NA
"FORENSIC PSYCHIATRIC HOSPITALS",1,NA
"FORENSIC PSYCHIATRIC INPATIENTS",1,NA
"FORENSIC PSYCHIATRIC INSTITUTE",1,NA
"FORENSIC PSYCHIATRIC OBSERVATION",1,NA
"FORENSIC PSYCHIATRIC PATIENT",1,NA
"FORENSIC PSYCHIATRIC PATIENTS",3,NA
"FORENSIC PSYCHIATRIC TREATMENT",1,NA
"FORENSIC PSYCHIATRISTS",1,NA
"FORENSIC PSYCHIATRY",184,NA
"FORENSIC PSYCHIATRY AND PSYCHOLOGY",1,NA
"FORENSIC PSYCHIATRY/LEGAL ISSUES",1,NA
"FORENSIC PSYCHOLOGISTS",1,NA
"FORENSIC PSYCHOLOGY",14,NA
"FORENSIC PSYCHOTHERAPY",6,NA
"FORENSIC PSYCHOTIC PATIENTS",1,NA
"FORENSIC PUBLICATIONS",1,NA
"FORENSIC RADIOGRAPHY",1,NA
"FORENSIC RADIOLOGY",19,NA
"FORENSIC RECONSTRUCTION",1,NA
"FORENSIC REHABILITATION",1,NA
"FORENSIC RELEVANCE",1,NA
"FORENSIC RESEARCH",4,1
"FORENSIC RULES",1,NA
"FORENSIC SAMPLE",8,2
"FORENSIC SCHIZOPHRENIC PATIENTS",1,NA
"FORENSIC SCIENCE",1379,347
"FORENSIC SCIENCE CRIMINALISTICS",1,1
"FORENSIC SCIENCE INTERNATIONAL",1,NA
"FORENSIC SCIENCE LABORATORIES",2,NA
"FORENSIC SCIENCE LABORATORY",1,NA
"FORENSIC SCIENCE PROVIDER",1,NA
"FORENSIC SCIENCE SERVICES",1,NA
"FORENSIC SCIENCE TOXICOLOGY",1,1
"FORENSIC SCIENCE, FORENSIC TOXICOLOGY",1,NA
"FORENSIC SCREENING",2,1
"FORENSIC SEROLOGY",2,NA
"FORENSIC SERVICE",1,NA
"FORENSIC SERVICE PROVIDER",1,1
"FORENSIC SERVICES",3,NA
"FORENSIC SETTING",2,NA
"FORENSIC SETTINGS",1,NA
"FORENSIC SLEEP MEDICINE/PARASOMNIA PSEUDO-SUICIDE",1,NA
"FORENSIC SOCIAL WORK",2,NA
"FORENSIC SOFTWARE",1,NA
"FORENSIC SOURCE DIFFERENTIATION",1,NA
"FORENSIC SPECIALIST",1,NA
"FORENSIC SPECIES IDENTIFICATION",1,NA
"FORENSIC STANDARDS",1,NA
"FORENSIC STATISTICS",4,NA
"FORENSIC STUDIES",1,1
"FORENSIC STUDY",1,NA
"FORENSIC SUMMER SCHOOL",1,NA
"FORENSIC TAPHONOMY",6,NA
"FORENSIC TAXONOMY",1,NA
"FORENSIC TEST",2,1
"FORENSIC TESTIMONY",1,NA
"FORENSIC TESTING",2,NA
"FORENSIC TESTS",1,NA
"FORENSIC TEXT COMPARISON",1,NA
"FORENSIC TIME ESTIMATION",1,NA
"FORENSIC TISSUE TYPING",1,NA
"FORENSIC TOPOLOGICAL ANALYSIS",1,NA
"FORENSIC TOXICANT ANALYSIS",1,NA
"FORENSIC TOXICANTS ANALYSIS",1,NA
"FORENSIC TOXICOLOGCAL ANALYSIS",1,NA
"FORENSIC TOXICOLOGIC ANALYSIS",1,NA
"FORENSIC TOXICOLOGICAL ANALISIS",1,NA
"FORENSIC TOXICOLOGICAL APPROACH",1,NA
"FORENSIC TOXICOLOGICAL LIBRARY",1,NA
"FORENSIC TOXICOLOGICAL SCREENING",2,NA
"FORENSIC TOXICOLOGIST",2,NA
"FORENSIC TOXICOLOGY",921,50
"FORENSIC TOXICOLOGY ANALYSIS",27,NA
"FORENSIC TOXICOLOGY AND APPLICATION OF TOXICOLOGY",1,NA
"FORENSIC TOXICOLOGY BUILT ON SUB-DISCIPLINES, FOR VALIDITY OF ANALYSIS",1,NA
"FORENSIC TOXICOLOGY PHENMETRAZINE",1,NA
"FORENSIC TOXICOLOGY SCREENING",1,NA
"FORENSIC TOXICOLOGY < TOXICOLOGY",1,NA
"FORENSIC TOXICOLOGY, AS KEY PART OF DEATH INVESTIGATION",1,NA
"FORENSIC TOXICOLOGY, SCOPE, CHALLENGES, FUTURE DIRECTIONS/NEEDS",1,NA
"FORENSIC TOXIEOLOGIEAL ANALYSIS",1,NA
"FORENSIC TRACE ANALYSIS",1,NA
"FORENSIC TRAINING",1,NA
"FORENSIC TREATMENT",4,NA
"FORENSIC TURNING INTO COMMODITY, TRACE EVIDENCE AND AN UNCERTAIN FUTURE",1,NA
"FORENSIC TYPOLOGIES",1,NA
"FORENSIC UNIT",1,NA
"FORENSIC URINE DRUG TESTING",1,NA
"FORENSIC VALIDATION",1,NA
"FORENSIC VALUE",1,NA
"FORENSIC WARDS",1,NA
"FORENSIC YOUTH",1,NA
"FORENSIC, ISOMERS",1,NA
"FORENSICS AND HOMELAND SECURITY",1,1
"FORENSICS IN DERMATOLOGY",1,NA
"FOREST REPRODUCTIVE MATERIAL",1,NA
"FORGERY",1,NA
"FORMALDEHYDE",2,1
"FORMALDEHYDE-FIXED",1,NA
"FORMALDEHYDE DERIVATIZATION",1,1
"FORMALDEHYDE, STABILITY",1,NA
"FORMALIN",6,1
"FORMALIN-FIXED AUTOPSY MATERIAL, IDENTIFICATION OF DRUGS",1,NA
"FORMALIN-FIXED ORGAN TISSUE",1,NA
"FORMALIN-FIXED PLACENTA",1,NA
"FORMALIN-FIXED TISSUE",1,NA
"FORMALIN-FIXED TISSUES",4,NA
"FORMALIN-FREE",1,NA
"FORMALIN SOLUTION",2,NA
"FORMAMIDINE PESTICIDES",1,NA
"FORMAMIDINES",1,NA
"FORMATE",1,NA
"FORMATION",1,1
"FORMIC ACID",3,NA
"FORMING",1,NA
"FORMS OF PSYCHIC ABNORMALITY",1,NA
"FORMULATION",3,6
"FORMULATION ENGINEERING",1,NA
"FORTIFICATION",1,NA
"FORTRAL",1,NA
"FOS",1,NA
"FOS-B",1,NA
"FOS-RELATED ANTIGEN-1",1,NA
"FOUNTAIN PEN",1,NA
"FOURIER-TRANSFORM INFRARED SPECTROMETRY",1,NA
"FOURIER TRANSFORM",1,NA
"FOURIER TRANSFORM - INFRARED SPECTROSCOPY",1,NA
"FOURIER TRANSFORM INFRA-RED",1,1
"FOURIER TRANSFORM INFRARED MICROSCOPY",1,NA
"FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR)",2,1
"FOURIER TRANSFORM INFRARED SPECTRUM (FTIR)",1,NA
"FOURIER TRANSFORM ION CYCLOTRON RESONANCE",1,1
"FOURIER TRANSFORM RAMAN SPECTROSCOPY",1,2
"FOURTH-GENERATION ANTIDEPRESSANTS",1,NA
"FOURTH AMENDMENT",1,NA
"FOXY",2,1
"FPIA",2,NA
"FPSE-HPLC-PDA",1,NA
"FRACTION OF FEMORAL NECK, CAUSED BY MUSCLE TRACTION",1,NA
"FRACTIONAL FACTORIAL DESIGN",1,2
"FRACTIONAL MASS FILTER",1,1
"FRACTIONATION",2,3
"FRACTOGRAPHY",1,NA
"FRACTURE FIT",1,NA
"FRACTURE MATCH",1,NA
"FRACTURE MORPHOLOGY",1,NA
"FRACTURE PATTERN",1,NA
"FRAGILE X SYNDROME",1,NA
"FRAGMENT ANALYSIS",1,NA
"FRAGMENT SIMULATING PROJECTILE",1,NA
"FRAGMENTATION",8,13
"FRAGMENTATION PATHWAY",6,2
"FRAGMENTATION PATTERN",2,6
"FRAGMENTED DNA",1,NA
"FRANCE",2,1
"FRANK PSYCHOSIS",1,NA
"FRAUD",2,NA
"FRAUDS",1,1
"FRAUDSTER PROFILING",1,NA
"FRECKLES",2,NA
"FRED METHOD",1,NA
"FREE-MORPHINE",1,NA
"FREE-RECALL",1,NA
"FREE DRUGS",1,NA
"FREE FATTY ACID",1,NA
"FREE FATTY ACIDS",2,NA
"FREE MORPHINE",3,NA
"FREE TESTOSTERONE",1,NA
"FREE WILL",1,NA
"FREEDOM DEPRIVATION",1,NA
"FREEDOM OF LIBERTY",1,NA
"FREEDOM TO ILLNESS",1,NA
"FREEZE GRINDING",1,NA
"FRENCH GUIANA",1,NA
"FRENCH LEGISLATION",1,NA
"FREON",4,NA
"FREQUENCY",3,1
"FREQUENCY-MULTIPLIED DIODE-PUMPED SOLID-STATE LASER",1,1
"FREQUENCY OF SUICIDES",1,NA
"FREQUENCY TABLES",1,NA
"FREQUENT DRUG DETECTION",1,NA
"FREQUENT USERS",1,NA
"FRESH BLOOD CALIBRATION CURVE",1,NA
"FRESH WATER",1,NA
"FRET",1,2
"FRIXION INK",1,NA
"FRONTAL CORTEX",1,NA
"FRONTAL LOBE",1,NA
"FRONTAL OSTEOMYLITIS",1,NA
"FROSTBITE",1,NA
"FROZEN TISSUES",1,NA
"FRUIT",2,NA
"FRUIT SPIRITS",1,NA
"FRY'S ETCHING REAGENTS",1,NA
"FRYE",2,NA
"FT-ICR",1,1
"FT-ICR-MS",2,NA
"FT-ICR MS",1,1
"FT-IR MICROSCOPY IN FORENSIC LABORATORIES",1,NA
"FT-IR SPECTROSCOPIC IMAGING",1,1
"FT-IR/MICROSCOPY",1,NA
"FTA CARDS",1,1
"FTI",1,NA
"FTICR",1,NA
"FTIR-ATR",2,2
"FTIR-ATR AND BENZODIAZEPINES",1,1
"FTIR MICRO-SPECTROSCOPY",1,NA
"FTIR MICRO SPECTROSCOPY",1,NA
"FTIR MICROSCOPY",1,NA
"FUB-AMB",2,NA
"FUBINACA",1,1
"FUCOSYLTRANSFERASE VI",1,NA
"FUEL DATING",1,NA
"FUJIWARA REACTION",1,NA
"FULL-BODY RADIOGRAPHY",1,NA
"FULL-FACE DIVING MASK",1,NA
"FULL FUNCTIONALITY FIELD PORTABLE MASS SPECTROMETRY",1,NA
"FULLY AUTOMATED ANALYSIS",1,NA
"FULMINANT INFECTIOUS MONONUCLEOSIS",1,NA
"FULMINANT STREPTOCOCCAL INFECTION",1,NA
"FUMIGANT",1,2
"FUMIGANTS",1,NA
"FUNCTIONAL ANALYSIS",1,NA
"FUNCTIONAL GENOMICS",1,2
"FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI)",1,NA
"FUNDAMENTALS",1,NA
"FUNGI",3,4
"FUNGI METABOLITES",1,NA
"FUNGICIDE",1,NA
"FURADAN",1,NA
"FURADAN POISONING",1,NA
"FURANS",1,NA
"FURANYL-FENTANYL",1,NA
"FURANYL FENTANYL",2,NA
"FURANYLBENZYLFENTANYL",1,NA
"FURANYLFENTANYL",4,1
"FURFENORE X",1,NA
"FUROSEMIDE",1,NA
"FURTHER HARMONISATION IN EUROPE",1,NA
"FUSED-SILICA CAPILLARY COLUMN",1,NA
"FUSED DEPOSITION MODELING",2,2
"FUSED DEPOSITION MODELING (FDM)",1,NA
"FUSED SILICA",1,NA
"FUSED SILICA CAPILLARY COLUMN",1,NA
"FUSED SILICA CAPILLARY SYSTEM",1,NA
"FUSION 6C",1,NA
"FUSION NEUTRON",1,NA
"FUSION TABLES",1,NA
"FUTURE DIRECTIONS",1,1
"G-PROTEIN COUPLED RECEPTOR",1,NA
"G-TYPE NERVE AGENTS",1,NA
"G.S. KIT",1,NA
"GABA",5,2
"GABA RECEPTOR",1,1
"GABAA RECEPTOR",1,1
"GABAPENTIN",11,1
"GABAPENTINOIDS",2,NA
"GABOR WAVELET ANALYSIS",1,NA
"GABRB3",1,NA
"GAD",1,NA
"GADOLINIUM-BASED CONTRAST AGENTS",1,NA
"GADOTERIDOL",2,NA
"GAGGING",1,NA
"GAIT ANALYSIS, BLOOD ALCOHOL CONCENTRATION",1,NA
"GALACTOSE-Α-1",1,NA
"GALEN",1,NA
"GAMBLING FRAUD",1,NA
"GAMBLING PROBLEMS",1,NA
"GAMMA-AMINOBUTYRIC ACID",2,NA
"GAMMA-BUTYROLACTONE (GBL)",20,19
"GAMMA-GAMMA COINCIDENCE",1,NA
"GAMMA-HYDROXY BUTYRATE",1,NA
"GAMMA-HYDROXYBUTYRATE (GHB)",1,NA
"GAMMA-HYDROXYBUTYRATE ACID",1,NA
"GAMMA-HYDROXYBUTYRATYRIC ACID (GHB)",1,NA
"GAMMA-HYDROXYBUTYRIC ACID (GHB)",93,45
"GAMMA-HYDROXYBUTYRIC ACID GLUCURONIDE",1,NA
"GAMMA-HYDROXYVALERATE",1,1
"GAMMA-VALEROLACTONE",1,NA
"GAMMA (Γ)-HYDROXYBUTYRIC ACID",1,NA
"GAMMA COUNTER",1,NA
"GAMMA HYDROXY BUTYRATE (GHB)",1,1
"GAMMA HYDROXYBUTYRATE",1,NA
"GAMMA HYDROXYBUTYRIC ACID",1,NA
"GAMMA RADIATION",1,NA
"GAMMA SPECTROMETRY",3,NA
"GAMMA SPECTROSCOPY",2,NA
"GAMMABUTYROLACTONE",2,NA
"GAMMAHYDROXYBUTRATE",1,NA
"GAMMARUS PULEX",1,NA
"GANCICLOVER",1,NA
"GANG MEMBERSHIP",1,NA
"GANG RAPE",1,NA
"GANGS",5,NA
"GARMENTS",1,NA
"GAS",2,NA
"GAS-CHROMATOGRAPHY-MASS SPECTROMETRY",1,2
"GAS-PHASE IR SPECTROSCOPY",1,1
"GAS ANALYSIS",3,NA
"GAS CHROMATOGRAPH-MASS SPECTROMETRY",1,NA
"GAS CHROMATOGRAPH/NITROGEN PHOSPHORUS DETECTOR (GC/NPD)",1,NA
"GAS CHROMATOGRAPH?MASS SPECTROME-TRY (GC-MS)",1,NA
"GAS CHROMATOGRAPHY-ELECTRON IONIZATION-MASS SPECTROMETRY",1,NA
"GAS CHROMATOGRAPHY-ELECTRON IONIZATION MASS SPECTROMETRY (GC-EI-MS)",1,NA
"GAS CHROMATOGRAPHY-FLAME IONISATION DETECTION",1,NA
"GAS CHROMATOGRAPHY-FLAME IONIZATION DETECTION-MASS SPECTROMETRY",1,1
"GAS CHROMATOGRAPHY-FLAME IONIZATION DETECTION (GC-FID)",9,15
"GAS CHROMATOGRAPHY-FOURIER TRANSFORM INFRARED",1,NA
"GAS CHROMATOGRAPHY-INFRARED",1,1
"GAS CHROMATOGRAPHY-INFRARED DETECTION (GC-IRD)",2,13
"GAS CHROMATOGRAPHY-INFRARED SPECTROSCOPY",2,1
"GAS CHROMATOGRAPHY-ION TRAP MASS SPECTROMETRY",1,NA
"GAS CHROMATOGRAPHY-ION TRAP TANDEM MASS SPECTROMETRY",1,NA
"GAS CHROMATOGRAPHY-ISOTOPE RATIO MASS SPECTROMETRY",1,1
"GAS CHROMATOGRAPHY-MASS SPECTROMETRY, LIQUID-CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"GAS CHROMATOGRAPHY-NITROGEN-PHOSPHORUS DETECTOR",1,NA
"GAS CHROMATOGRAPHY-QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRY(GC-QTOF-MS)",1,NA
"GAS CHROMATOGRAPHY-TANDEM MASS SPECTROMETER",1,NA
"GAS CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",3,3
"GAS CHROMATOGRAPHY - MASS SPECTROMETRY (GC-MS)",1,NA
"GAS CHROMATOGRAPHY (AP GC)",1,NA
"GAS CHROMATOGRAPHY (GC)",175,103
"GAS CHROMATOGRAPHY DETECTOR",1,1
"GAS CHROMATOGRAPHY TANDEM MASS SPECTROMETRY",1,NA
"GAS CHROMATOGRAPHY, COMPREHENSIVE TWO-DIMENSIONAL",1,NA
"GAS CHROMATOGRAPHY/MASS SPECTROMETER",1,NA
"GAS CHROMATOGRAPHY/MS SPECTROMETRY",1,NA
"GAS CHROMATOGRAPHY/NITROGEN-PHOSPHORUS DETECTOR",1,NA
"GAS CHROMATOGRAPHY: HIGH RESOLUTION",1,NA
"GAS EMBOLISM",1,NA
"GAS GANGRENE",1,NA
"GAS LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY ANALYSIS",1,NA
"GAS MASK",1,NA
"GAS PHASE",1,2
"GAS PHASE ABSORPTION",1,1
"GAS POISONING",1,NA
"GAS SENSOR",2,3
"GAS/LIQUID CHROMATOGRAPHY",1,NA
"GASCHROMATOGRAPHIE, ALKOHOLBESTIMMUNG",1,NA
"GASCHROMATOGRAPHIE, DERIVATISIERUNG",1,NA
"GASCHROMATOGRAPHY MASS SPECTROMETRY",1,NA
"GASEOUS BIOLOGICAL MATRICES",1,NA
"GASEOUS SUFFOCATION",1,NA
"GASES AND VOLATILE AGENTS",1,NA
"GASOLINE",1,NA
"GASOLINE IDENTIFICATION",1,NA
"GASOLINE SNIFFING",1,NA
"GASPING",1,NA
"GASS-M",1,NA
"GASTRIC BIOMARKERS",1,NA
"GASTRIC BYPASS",1,NA
"GASTRIC CONTENT",2,NA
"GASTRIC CONTENTS",2,NA
"GASTRIC EXCRETION",1,NA
"GASTRIC FIRST PASS EFFECT",1,NA
"GASTRIC JUICE",1,NA
"GASTRIC LAVAGE",1,NA
"GASTRIC MUCOSA",3,NA
"GASTRIC PERFORATION",1,NA
"GASTRIC RESIDUE",1,NA
"GASTROINTESTINAL",1,NA
"GASTROINTESTINAL HEMORRHAGE",1,NA
"GASTROINTESTINAL NECROSIS",1,NA
"GASTROINTESTINAL OCCLUSION",1,NA
"GASTROINTESTINAL TRACT",2,NA
"GASTROMALACIA",1,NA
"GATED DETECTION",1,1
"GATED SPECT",1,NA
"GC-C-IRMS",1,NA
"GC-CI-MS",1,NA
"GC-EI-MS",5,3
"GC-EI-MS-MS",1,2
"GC-EI-MS/MS",1,NA
"GC-EI/MS",2,1
"GC-EI/MS ANALYSIS",1,NA
"GC-FTIR",7,9
"GC-HRMS",1,3
"GC-INSTRUMENT CONVERSION",1,NA
"GC-IR",2,3
"GC-IRMS",1,2
"GC-LC/MS ANALYSIS",1,NA
"GC-MS-ECD",1,NA
"GC-MS-EI",1,NA
"GC-MS-MS",4,NA
"GC-MS-NCI",1,NA
"GC-MS ANALYSIS",1,1
"GC-MS CLINICAL AND FORENSIC PURPOSES",1,NA
"GC-MS CONFIRMATION",1,NA
"GC-MS DETERMINATION",1,1
"GC-MS SCREEN",1,1
"GC-MS WITH COLD EI",1,NA
"GC-MS/MS",28,8
"GC-NCI-MS/MS",1,NA
"GC-NPD",5,2
"GC-QTOF-MS",1,NA
"GC-TCD",1,NA
"GC-TID(N)",1,NA
"GC-TMS",1,NA
"GC-VUV",4,1
"GC‐MS",1,NA
"GC × GC",3,NA
"GC × GC",1,NA
"GC × GC-MS",2,NA
"GC AND GC-MS ANALYSES",1,NA
"GC RETENTION INDEX",1,NA
"GC × GC",1,NA
"GC/C/IRMS, Δ13C VALUES",1,NA
"GC/FID",3,3
"GC/FT-IR",1,NA
"GC/FTIR",1,NA
"GC/MS-MS",1,NA
"GC/MS (EI)",1,NA
"GC/MS (GAS CHROMATOGRAPH/MASS SPECTROMETRY)",1,NA
"GC/MS ANALYSIS IN DUID",1,NA
"GC/MS/MS",4,3
"GC/MS/NICI",1,NA
"GC/NICI/MS/MS",1,NA
"GC/NPD",6,1
"GC×GC",2,NA
"GC×GC TOFMS",1,NA
"GC×GC/MS",1,NA
"GCD ANALYSIS",2,2
"GCMS-MS",1,NA
"GCMSMS",1,NA
"GCXGC",1,NA
"GCXGC-TOFMS",1,NA
"GDNF",1,NA
"GEHIRNALKOHOL",1,NA
"GEL",1,NA
"GEL OVERLAY TECHNIQUE",1,NA
"GEL PEN INK",1,NA
"GEL PEN INKS",1,NA
"GEL SEPARATOR TUBES",1,NA
"GELATIN",2,NA
"GELATINE LIFTING",1,NA
"GELFOAM",1,NA
"GEM",1,NA
"GEMMOLOGY",1,NA
"GEMS",1,NA
"GEMSTONE",1,1
"GEMSTONES",1,NA
"GENBANK",1,NA
"GENDER",27,NA
"GENDER-BASED VIOLENCE",1,NA
"GENDER-BASED VIOLENCEADOLESCENTS (MESH)",1,NA
"GENDER-RESPONSIVE TREATMENT",1,NA
"GENDER DETERMINATION",1,NA
"GENDER RESPONSIVE PROGRAMMING",1,NA
"GENDER SPECIFIC",1,NA
"GENDER VIOLENCE",1,NA
"GENDERS",1,NA
"GENE",3,NA
"GENE-EXPRESSION",1,NA
"GENE DETECTION",1,NA
"GENE DOPING",1,NA
"GENE DRUG DELIVERY",1,NA
"GENE EXPRESSION",8,2
"GENE EXPRESSION PATTERNS",1,NA
"GENE LOCUS",1,NA
"GENE POLYMORPHISM",1,NA
"GENE PROBES, DNA",1,NA
"GENE SEQUENCES",1,NA
"GENE THERAPY",1,NA
"GENERAL ANAESTHESIA",1,NA
"GENERAL CAUSATION",1,NA
"GENERAL HEALTH QUESTIONNAIRE-28",1,NA
"GENERAL HOSPITAL PSYCHIATRIC UNIT",1,NA
"GENERAL HOSPITALS",1,NA
"GENERAL INTENT",1,NA
"GENERAL POPULATION",1,NA
"GENERAL PRACTICE",1,NA
"GENERAL PSYCHIATRY",2,NA
"GENERAL PUBLIC",2,2
"GENERAL TOXICOLOGICAL SCREENING",1,NA
"GENERAL UNKNOWN ANALYSIS",1,NA
"GENERAL UNKNOWN SCREENING",8,2
"GENERAL VIOLENCE",1,NA
"GENERALROAD SAFETY",1,NA
"GENERATION COHORT",1,NA
"GENERIC DRUG",1,1
"GENERIC DRUGS",1,NA
"GENERIC SUBSTITUTION",1,NA
"GENES",1,NA
"GENESCAN",1,NA
"GENETIC ALGORITHM",1,3
"GENETIC ANALYSIS",1,1
"GENETIC CORRELATIONS",1,NA
"GENETIC DIVERSITY",2,6
"GENETIC ENGINEERING",1,NA
"GENETIC FINGERPRINT",1,NA
"GENETIC MARKER",4,4
"GENETIC POLYMORPHISM",11,2
"GENETIC PREDICTION",1,NA
"GENETIC PREDICTION OF CHEMOTYPES",1,NA
"GENETIC RESEQUENCING",1,NA
"GENETIC SCREENING",1,NA
"GENETIC SEGREGATION",1,1
"GENETIC STUDIES",1,NA
"GENETIC STUDY",1,NA
"GENETIC SUSCEPTIBILITY",2,NA
"GENETIC SUSCEPTIBILITY TO DISEASE",1,NA
"GENETIC TESTING",4,NA
"GENETIC TYPING",1,NA
"GENETIC VARIANTS",1,NA
"GENETICALLY VARIABLE PEPTIDES",1,NA
"GENETICALLY VARIANT PEPTIDES",5,NA
"GENETICS",11,NA
"GENEVA",6,NA
"GENIPIN",5,NA
"GENITAL BEADS",1,NA
"GENITAL INJURIES",1,NA
"GENITAL INJURY",3,NA
"GENITOURINARY MEDICINE",1,NA
"GENOME",3,1
"GENOME DIVERSITY",1,1
"GENOME SCREENING",1,NA
"GENOME, MICROBIAL",1,NA
"GENOMIC DNA",2,NA
"GENOMIC REARRANGEMENT",1,NA
"GENOMICS",4,1
"GENORM",2,NA
"GENOTOXICITY",1,2
"GENOTYPE",4,7
"GENOTYPE DATABASE",1,1
"GENOTYPIC VARIATIONS",1,NA
"GENOTYPING",9,NA
"GEOCHEMISTRY",4,1
"GEOGRAPHIC AFFILIATION",1,NA
"GEOGRAPHIC INFORMATION SYSTEM",1,NA
"GEOGRAPHIC ORIGIN",2,5
"GEOGRAPHICAL ANALYSIS",1,NA
"GEOGRAPHICAL CLASSIFICATION",1,1
"GEOGRAPHICAL IDENTIFICATION",2,NA
"GEOGRAPHICAL INFORMATION SYSTEMS",1,NA
"GEOLOCATION",1,NA
"GEOPHYSICS",1,NA
"GEOSCIENCE",1,1
"GEOSPATIAL INFORMATION SYSTEMS AND MAPPING",1,NA
"GERIATRIC",3,NA
"GERIATRIC MEDICINE",1,NA
"GERIATRIC NURSING",1,NA
"GERIATRIC SUICIDE",1,NA
"GERMAN-SPEAKING EQUINE HOSPITALS",1,NA
"GERMAN LEGAL PROCEDURES",1,NA
"GERMAN MIGRANTS FROM THE FORMER SOVIET UNION",1,NA
"GERMAN PENAL CODE §64",1,NA
"GERMAN SHEPHERD DOGS",1,NA
"GERMANIUM",3,NA
"GERMANY",6,2
"GERONTOLOGICAL PATIENTS",1,NA
"GFAP",1,NA
"GGT",1,NA
"GH-MS.",1,NA
"GHB-4-SULFATE",1,NA
"GHB-GLUC",1,NA
"GHB-GLUCURONIDE",2,NA
"GHB-Β-O-GLUCURONIDE",1,NA
"GHB CUT-OFF",1,NA
"GHB EXPOSURE",1,NA
"GHB GLUCURONIDE",2,NA
"GHB GLUCURONIDE (GHB-GLUC)",1,NA
"GHB IN BLOOD AND URINE",1,NA
"GHB INTOXICATION",1,NA
"GHB POST-MORTEM PRODUCTION",1,NA
"GHB STABILITY AND FORMATION",1,NA
"GHB, BLOOD LEVELS",1,NA
"GHB, CENTRAL NERVOUS SYSTEM DEPRESSANT, EUPHORIC, APHRODISIAC EFFECTS",1,NA
"GHV",1,1
"GI DECONTAMINATION",1,NA
"GI ENDOSCOPY",1,NA
"GINSENG",1,NA
"GIRLS",1,NA
"GISCIENCE",1,NA
"GITC",1,1
"GLARGINE",1,NA
"GLASS",3,7
"GLASS-CONTAINING GUNSHOT RESIDUE (GGSR)",1,NA
"GLASS CAPILLARY GC",1,NA
"GLASS FRICTIONATOR",1,NA
"GLASS MATRIX",1,NA
"GLASSY CARBON ELECTRODE",1,8
"GLAUCINE",1,1
"GLAUCOMA",1,NA
"GLAZING INCIDENCE X-RAY FLUORESCENCE ANALYSIS",1,NA
"GLC—ANALYSES, CHLORDIAZEPOXIDE AND DESMETHYL METABOLITE, BULK DRUG",1,NA
"GLC—ANALYSIS, PYRITHYLDIONE IN PUTRIFIED BRAIN AND INTESTINE",1,NA
"GLIAL CELLS",1,NA
"GLIAL FIBRILLARY ACIDIC PROTEIN",1,NA
"GLIBENCLAMID",1,NA
"GLIBENCLAMIDE",3,NA
"GLICLAZIDE",1,NA
"GLIOBLASTOMA MULTIFORME",1,NA
"GLIOMA",1,NA
"GLIPIZIDE",1,NA
"GLIQUIDONE",1,NA
"GLOBAL ALARM AND ANXIETY",1,NA
"GLOBAL CHARACTERIZATION",1,NA
"GLOBAL HEALTH",1,1
"GLOBAL PANDEMIC",1,NA
"GLOBALFILER",2,NA
"GLOBIN CHAINS",1,NA
"GLOBUS PALLIDUS",1,NA
"GLOBUS PALLIDUS INJURY",1,NA
"GLOBUS PALLIDUS NECROSIS",1,NA
"GLOMERULONEPHRITIS",2,NA
"GLOMUS CAROTICUM, VERÄNDERUNGEN NACH E 605-VERGIF-TUNGEN",1,NA
"GLORIOSA SUPERBA",1,NA
"GLOVE SENSOR",1,NA
"GLOVE SENSORS",1,NA
"GLP-1 RECEPTOR AGONISTS",1,NA
"GLT-1",1,NA
"GLUCOCORTICOIDS",1,1
"GLUCOSE",3,NA
"GLUCOSE METABOLISM",1,NA
"GLUCOSE SENSING",1,NA
"GLUCOSE/SODIUM CHLORIDE COMPLEX",1,NA
"GLUCURONATES",2,NA
"GLUCURONIC ACID-CONJUGATED METABOLITE",1,NA
"GLUCURONIC ACID CONJUGATE",1,NA
"GLUCURONIDASE",2,NA
"GLUCURONIDATION",2,NA
"GLUCURONIDE",8,2
"GLUCURONIDE CONJUGATE",1,NA
"GLUCURONIDE CONJUGATES",1,NA
"GLUCURONIDE METABOLITES",3,NA
"GLUCURONIDES",5,NA
"GLUCURONOSYL TRANSFERASE",1,NA
"GLUE",2,NA
"GLUE FORMATION",1,NA
"GLUE SNIFFING",1,NA
"GLUFOSINATE",3,NA
"GLUTAMATE TRANSPORTER",1,NA
"GLUTAMIC ACID DECARBOXYLASE",1,NA
"GLUTARALDEHYDE",1,NA
"GLUTEAL INJECTION",1,NA
"GLUTEAL INTRAMUSCULAR INJECTION",1,NA
"GLUTEAL VARICES",1,NA
"GLUTETHIMIDE",1,NA
"GLUTETHIMIDE—METABOLITES IDENTIFIED IN HUMAN URINE, SYNTHESIZED",1,NA
"GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE",1,NA
"GLYCERIN",1,NA
"GLYCERYL DINITRATES",1,NA
"GLYCERYL TRINITRATE",1,NA
"GLYCIDYL ESTER",1,1
"GLYCINEXYLIDIDE",1,NA
"GLYCOALKALOID",1,NA
"GLYCOLIC ACID",3,NA
"GLYCOLS",1,1
"GLYCOLS IN BLOOD OF HEALTHY SUBJECTS",1,NA
"GLYCOPHOLIN",1,NA
"GLYCOSIDE LOCALIZATION, TOPO-OPTICAL REACTION",1,NA
"GLYCOSIDE POISONING",1,NA
"GLYCOSYL HYDROLASE",1,NA
"GLYCYRRHETIC ACID",1,NA
"GLYPHOSATE",9,3
"GMC - WE OWE OUR PATIENTS A DUTY OF CARE",1,NA
"GMETHADONE-ASSOCIATED DEATHS",1,NA
"GNRH-AGONISTS",2,NA
"GNRH-ANALOGUES",1,NA
"GNRH AGONIST",1,NA
"GO-ALONG",1,NA
"GOETHE, JOHANN WOLFGANG VON",1,NA
"GOLD",1,NA
"GOLD-PLATINUM CORESHELL NANOPARTICLES",1,NA
"GOLD MONITOR",1,NA
"GOLD NANOPARTICLES (GNPS)",8,14
"GOLD NANOROD ARRAYS",1,NA
"GOLD NANORODS",2,NA
"GOLD STANDARD",1,NA
"GOLD SUBSTRATES",1,NA
"GOLD(III)",1,NA
"GOLDENSEAL ROOT",1,NA
"GONADOTROPIN-RELEASING HORMONE AGONIST",1,NA
"GONORRHOEAE",1,NA
"GOOD CLINICAL PRACTICE",1,NA
"GOOD LABORATORY PRACTICES",1,NA
"GOOD NIGHT CINDERELLA POINT-OF-NEED",1,NA
"GOSSYPIBOMA",1,NA
"GOT-AKTIVITÄT",1,NA
"GOVERNANCE",1,NA
"GOVERNMENT GENERAL HOSPITAL",1,NA
"GOVERNMENT REGULATIONS",1,NA
"GPR18",1,NA
"GPR55",1,NA
"GPS/NAVIGATIONAL LOGS",1,NA
"GPT-AKTIVITÄT",1,NA
"GPX4",1,NA
"GRABA",1,1
"GRADIENT",1,NA
"GRADIENT ELUENT GENERATOR",1,NA
"GRADIENT ELUTION",1,NA
"GRADIENT ELUTION HPLC",1,1
"GRADIENT ELUTION LC",1,1
"GRADUATE EDUCATION/RESEARCH",1,NA
"GRADUATED SANCTIONS",1,NA
"GRAFFITI",2,NA
"GRAIN SIZE",1,1
"GRAM-NEGATIVE SEPSIS",1,NA
"GRAMOXONE",2,NA
"GRAND-NATIONAL REGISTER OF ESSENTIAL DRUGS",1,NA
"GRANULARITY",1,1
"GRANULATED MATERIALS",1,1
"GRANULOCYTE-COLONY-STIMULATING FACTOR/",1,NA
"GRANULOMA",1,NA
"GRANULOMATOUS INFLAMMATION",1,NA
"GRAPH THEORY",1,NA
"GRAPHENE",1,5
"GRAPHENE OXIDE",5,8
"GRAPHITE CARBON",1,1
"GRAPHITE FURNACE",1,NA
"GRAPHITE FURNACE ATOMIC ABSORPTION SPECTROMETRY",1,1
"GRAPHITIC CARBON NITRIDE",1,NA
"GRAPHITROHRKÜVETTE, HYDRIDTECHNIK",1,NA
"GRAVE",1,NA
"GRAVE SOILS",1,NA
"GRAVE WAX",1,NA
"GRAVES' DISEASE",2,NA
"GRAVESOIL",1,NA
"GRAVIMETRIC",1,1
"GRAVIMETRIC ANALYSIS",1,NA
"GRAYANOTOXIN",1,NA
"GREASE CONTAMINATION",1,NA
"GREASES",1,NA
"GREECE",7,2
"GREEN ANALYSIS",2,NA
"GREEN ANALYTICAL CHEMISTRY",3,3
"GREEN ANALYTICAL METHOD",1,1
"GREEN ANALYTICAL TOXICOLOGY (GAT)",1,NA
"GREEN BOTTLE FLY",1,NA
"GREEN CHEMISTRY",4,4
"GREEN CHROMATOGRAPHY",1,2
"GREEN EYED MONSTER",1,NA
"GREEN TEA",1,NA
"GREENISH-BLUE DISCOLORATION",1,NA
"GREENLAND",1,NA
"GREYHOUND URINE",1,NA
"GROIN ABSCESS",1,NA
"GROIN NODES",1,NA
"GROSS FINDINGS",1,NA
"GROSSING",1,NA
"GROUND BEEF",1,NA
"GROUND PENETRATING RADAR (GPR)",3,NA
"GROUNDED THEORY",1,NA
"GROUP-BASED TRAJECTORY MODELING",1,NA
"GROUP-SPECIFIC COMPONENT",1,NA
"GROUP-TYPE ANALYSIS",1,NA
"GROUP A STREPTOCOCCUS",1,NA
"GROUP COUNSELING, DURABILITY OF EFFECTS ON CONNOTATIVE MEANINGS TO CONCEPTS OF FATHER & MOTHER & SELF & PEERS, FEMALE DELINQUENTS, 1-YR FOLLOW-UP STUDY",1,NA
"GROUP PROGRAMME",1,NA
"GROUP PSYCHOLOGICAL INTERVENTIONS",1,NA
"GROUP THERAPY",1,NA
"GROUP WORK",1,NA
"GROWTH CONDITIONS",1,1
"GROWTH FACTORS",1,NA
"GROWTH HORMONE",2,3
"GROWTH MEDIUM",1,NA
"GROWTH PROMOTER",1,NA
"GROWTH PROMOTERS",2,NA
"GROWTH, DEVELOPMENT AND AGING",1,NA
"GS/MS",1,NA
"GSR",2,1
"GSR STUBS",1,NA
"GUAIFENESIN",1,4
"GUANMU TONG",1,NA
"GUARDIANSHIP",1,NA
"GUARDIANSHIP LAW",1,NA
"GUATEMALA",1,NA
"GUIDELINE",2,NA
"GUIDELINES",7,NA
"GUIDELINES AND PROTOCOLS",1,NA
"GUILT",1,NA
"GUINEA PIG",1,NA
"GUINEA PIGS",1,NA
"GUINEA PIGS AND MONKEYS",1,NA
"GUJARAT",1,NA
"GUN BLUE",1,NA
"GUNPOWDER",2,NA
"GUNSHOT",7,NA
"GUNSHOT ENERGY",1,NA
"GUNSHOT INJURY",11,NA
"GUNSHOT RESIDUE",9,NA
"GUNSHOT RESIDUE (GSR)",6,2
"GUNSHOT RESIDUES",7,NA
"GUT CONTENTS",1,NA
"GUT MICROBIOME",3,NA
"GW1516",1,1
"GWAS",2,NA
"GYNECOLOGY",1,NA
"GYNECOMASTIA",1,NA
"GYPA",3,NA
"GΑI SIGNALING",1,NA
"H PROBABILITY OF CAUSATION",1,NA
"H. PYLORI",1,NA
"HABITUAL OFFENDERS",1,NA
"HACK",1,NA
"HACKER ATTACK",1,NA
"HAEMODIALYSIS",1,NA
"HAEMOLYSIS",1,NA
"HAEMOLYTIC TRANSFUSION REACTION",1,NA
"HAEMORRHAGE",1,NA
"HAF MRNA",1,NA
"HAHN MOMENTS",1,NA
"HAIR",273,9
"HAIR ANALYSIS",239,11
"HAIR ANALYSIS BY GC/MS/MS",1,NA
"HAIR ANALYSIS FOR CANNABINOIDS",1,NA
"HAIR ANALYSIS FOR DRUGS",1,NA
"HAIR ANALYSIS VALIDITY",1,NA
"HAIR ANALYSIS, GC-MS",1,NA
"HAIR ANALYSISPOSTMORTEM HAIR CONCENTRATION",1,NA
"HAIR AND NAILS",1,NA
"HAIR AND SERUM",1,NA
"HAIR BIOMARKER",1,NA
"HAIR CARE PRODUCT",1,NA
"HAIR CARE PRODUCTS",2,NA
"HAIR COLOR",1,NA
"HAIR COLORS",1,NA
"HAIR CONTAMINATION",1,NA
"HAIR CREAM",1,NA
"HAIR DAMAGE COSMETIC TREATMENT",1,NA
"HAIR DECONTAMINATION PROCEDURES",1,NA
"HAIR DETECTION",1,NA
"HAIR DRUG TESTING",2,NA
"HAIR DYE",1,NA
"HAIR EXAMINATION",1,NA
"HAIR FOLLICLES",1,NA
"HAIR GROWTH RATE",2,NA
"HAIR IMAGING",1,NA
"HAIR IN CHEMICAL ANALYSIS, AND TIMELINE OF CHEMICAL INFLUENCES ON THE BODY",1,NA
"HAIR LENGTH",1,NA
"HAIR LIQUID",1,NA
"HAIR LOCK",1,NA
"HAIR MICROTOMING",1,NA
"HAIR OF THE HEAD, MORPHINE",1,NA
"HAIR PIGMENTATION",5,NA
"HAIR POROSITY",2,NA
"HAIR PREPARATION AND WASHING",1,NA
"HAIR PROTEOMICS",1,NA
"HAIR RINSE",1,NA
"HAIR ROOT",1,NA
"HAIR ROOT SHEATHS",1,NA
"HAIR SAMPLE",2,NA
"HAIR SEGMENTAL ANALYSIS",1,NA
"HAIR SHAFTS",2,NA
"HAIR SHAMPOO",1,NA
"HAIR STRUCTURE AND FORMATION",1,NA
"HAIR TEST",1,NA
"HAIR TESTS",1,NA
"HAIR TONIC",2,NA
"HAIR TOXICOLOGY",1,NA
"HAIR TREATMENT",1,NA
"HAIR TREATMENT (WASHING, STRAIGHTENING, PROTECTION)",1,NA
"HAIR TYPES",1,NA
"HAIRANALYSIS",1,NA
"HAIRSPRAYS",1,NA
"HALAL FORENSIC",1,NA
"HALAZEPAM",1,NA
"HALF-LIFE",7,1
"HALLOYSITE NANOTUBE",2,NA
"HALLOYSITE NANOTUBES (HNTS)",1,NA
"HALLUCINATION",1,NA
"HALLUCINATIONS",6,NA
"HALLUCINOGEN",27,48
"HALLUCINOGEN, ENDOGENOUS",1,NA
"HALLUCINOGENIC",1,NA
"HALLUCINOGENIC MUSHROOM",2,11
"HALLUCINOGENIC PLANT",3,2
"HALLUCINOGENIC TRYPTAMINES",2,1
"HALOGEN",1,NA
"HALOGEN BULB",1,NA
"HALOGENATED HYDROCARBON",1,NA
"HALOPERIDOL",6,NA
"HALOPERIDOL INTOXICATION",1,NA
"HALOPERIDOL METABOLITES",1,NA
"HALOTHANBLUTSPIEGEL",1,NA
"HALOTHANE",1,NA
"HALOTHANE TOXICITY",1,NA
"HALOXAZOLAM",1,NA
"HALSTEAD REITAN BATTERY",1,NA
"HAMIRPUR ETC",1,NA
"HAMMER AND CHISEL",1,NA
"HAND",2,NA
"HAND-WRIST BONES",1,NA
"HAND HYGIENE",1,NA
"HAND ODOR",1,NA
"HANDGUN",1,NA
"HANDHELD",1,NA
"HANDHELD NIR",1,1
"HANDHELD RAMAN SPECTROMETERS",1,1
"HANDHELD RAMAN SPECTROSCOPY",1,1
"HANDPRINT",1,NA
"HANDS-ON LEARNING",1,1
"HANDS-ON LEARNING/MANIPULATIVES",8,4
"HANDWRITING AND SIGNATURE EXAMINATION",1,NA
"HANFLEBENSMITTEL",1,NA
"HANGING",21,NA
"HANGING, SUICIDAL",1,NA
"HANNAH MESZAROS MARTIN",1,NA
"HAPLOGROUP ASSIGNMENT",1,NA
"HAPLOGROUPS",1,NA
"HAPLOTYPE",5,2
"HAPLOTYPE ANALYSIS",1,NA
"HAPLOTYPE DIVERSITY",1,NA
"HAPLOTYPE FREQUENCIES",1,NA
"HAPTEN",2,NA
"HAPTEN SYNTHESIS",1,NA
"HAPTENS",1,NA
"HAPTOGLOBIN",1,NA
"HARD DRUGS",1,NA
"HARM-FV",1,NA
"HARM-REDUCTION",1,NA
"HARM PRINCIPLE",1,NA
"HARM REDUCTION",9,22
"HARMALA ALKALOIDS",1,3
"HARMALINE",1,2
"HARMINE",1,2
"HARMING BEHAVIOUR",1,NA
"HARMOMED®",1,NA
"HARMONISATION",1,1
"HARMONIZATION",1,1
"HAROLD SHIPMAN",1,NA
"HARTREE-FOCK THEORY",1,NA
"HASHIMOTO'S DISEASE",1,NA
"HASHISH",3,13
"HASHISH SAMPLES",1,1
"HATE CRIME",1,NA
"HAWAII",1,1
"HAWAIIAN BABY WOODROSE",2,1
"HAY",1,NA
"HAYES ABILITY SCREENING INDEX",1,NA
"HAZARA",1,NA
"HAZARD",1,NA
"HAZARDOUS",1,NA
"HAZARDOUS DRINKING",1,NA
"HAZARDOUS JOBS",1,NA
"HAZARDOUS MATERIAL",1,NA
"HAZARDOUS MATERIALS",1,NA
"HAZARDOUS SUBSTANCES",1,NA
"HBB",1,NA
"HBCDS",1,NA
"HBGG",3,NA
"HBOC",1,NA
"HBV",2,NA
"HCA",1,5
"HCN GENE",1,NA
"HCR-20",4,NA
"HCV",3,NA
"HDL CHOLESTEROL",1,NA
"HEAD",1,NA
"HEAD-SPACE",1,NA
"HEAD-SPACE ANALYSIS",1,NA
"HEAD AND NECK",1,NA
"HEAD HAIR",2,NA
"HEAD INJURY",7,NA
"HEAD SPACE",1,NA
"HEAD TRAUMA",4,NA
"HEAD WOUND",1,NA
"HEADACHE",1,NA
"HEADSPACE",9,5
"HEADSPACE-GAS CHROMATOGRAPHY/MASS SPECTROMETRY",1,NA
"HEADSPACE-GC/MS",1,NA
"HEADSPACE-MASS SPECTROSCOPY ELECTRONIC NOSE",1,NA
"HEADSPACE—R-MATRIX",1,NA
"HEADSPACE ANALYSIS",7,9
"HEADSPACE EXTRACTION",3,NA
"HEADSPACE GAS CHROMATOGRAPHY",3,NA
"HEADSPACE GAS CHROMATOGRAPHY/MASS SPECTROMETRY",1,NA
"HEADSPACE GAS EXTRACTION",2,NA
"HEADSPACE GC",1,NA
"HEADSPACE METHOD",3,NA
"HEADSPACE METHOD CAPILLARY GAS CHROMATOGRAPHY",1,NA
"HEADSPACE SAMPLING",1,NA
"HEADSPACE SOLID-PHASE MICROEXTRACTION (HS-SPME)",2,11
"HEADSPACE SOLID PHASE MICROEXTRACTION (HS-SPME)",1,NA
"HEALTH",6,1
"HEALTH-CARE DATA AND MANAGEMENT",1,NA
"HEALTH-CARE USE",1,NA
"HEALTH AND LIFE INSURANCE",1,NA
"HEALTH BEHAVIOUR",1,NA
"HEALTH CARE PROFESSION",1,NA
"HEALTH CARE PROFESSIONAL",1,NA
"HEALTH CARE REFORM",1,NA
"HEALTH CONSEQUENCES",3,NA
"HEALTH HAZARD",1,1
"HEALTH INFORMATION TECHNOLOGY",1,NA
"HEALTH LITERACY",1,NA
"HEALTH MANAGEMENT",1,NA
"HEALTH POLICY",1,NA
"HEALTH PROFESSIONS EDUCATION",1,NA
"HEALTH PROMOTION",1,NA
"HEALTH PSYCHOLOGY",1,NA
"HEALTH RISK",4,3
"HEALTH SCREENING",1,NA
"HEALTH SERVICE RESEARCH",2,NA
"HEALTH SERVICES",3,NA
"HEALTH STATUS",1,NA
"HEALTH STATUS DISPARITIES",1,NA
"HEALTH/JUSTICE INTERFACE",1,NA
"HEALTHCARE",2,NA
"HEALTHCARE ACCESS",1,NA
"HEALTHCARE PROFESSIONALS",1,NA
"HEALTHCARE REFORM",1,NA
"HEALTHCARE SURVEILLANCE AUTHORITY",1,NA
"HEALTHCARE SYSTEM RESILIENCE",1,NA
"HEALTHY",1,NA
"HEARSAY EVIDENCE",1,NA
"HEART",14,NA
"HEART ARREST",1,NA
"HEART BLOCK",1,NA
"HEART BLOOD",2,NA
"HEART CONDUCTION SYSTEM",2,NA
"HEART DISEASE",2,NA
"HEART FAILURE",3,NA
"HEART RATE",1,NA
"HEART RUPTURE",1,NA
"HEART TRANSPLANTATION",1,NA
"HEART WEIGHT",2,NA
"HEAT",3,1
"HEAT-RELATED DEATH",2,NA
"HEAT-RELATED ILLNESS",1,NA
"HEAT CRAMP",1,NA
"HEAT DAMAGE",1,NA
"HEAT EXHAUSTION",1,NA
"HEAT SHOCK PROTEIN",1,NA
"HEAT SHOCK PROTEIN (HSP)",1,NA
"HEAT SHOCK PROTEIN 27",1,NA
"HEAT SHOCK PROTEIN 70",2,NA
"HEAT STROKE",2,NA
"HEAT TRANSPORT IN HUMAN BODY",1,NA
"HEATSTROKE",1,NA
"HEATWAVE",1,NA
"HEAVY-TAILED",1,NA
"HEAVY ISOTOPES",1,1
"HEAVY METAL",5,5
"HEAVY METAL POISONING",1,NA
"HEAVY MINERAL FRACTION",1,NA
"HEAVY USE",1,NA
"HEIA",1,NA
"HEIGHT",1,NA
"HEK293T",1,NA
"HELIUM",9,NA
"HELLP SYNDROME",1,NA
"HELMHOLTZ, HERMANN VON",1,NA
"HELMINTHES",1,NA
"HELPING WOMEN RECOVER",1,NA
"HEMANGIOSARCOMA",1,NA
"HEMASTIX",1,NA
"HEMATIN",4,NA
"HEMATOMA",1,NA
"HEMATOXYLIN",1,NA
"HEME OXYGENASE-1",1,NA
"HEMIN",1,NA
"HEMOCHROMOGEN",1,NA
"HEMODIALYSIS DEATH",1,NA
"HEMOGLOBIN",10,1
"HEMOGLOBIN A1C",1,NA
"HEMOGLOBIN BETA",2,NA
"HEMOGLOBIN TEST",1,NA
"HEMOLYMPH",1,NA
"HEMOLYZED BLOOD",1,NA
"HEMOPERICARDIUM",1,NA
"HEMOPHAGOCYTOSIS",2,NA
"HEMORRHAGE",8,NA
"HEMORRHAGE IN THE CEREBRAL VENTRICLES",1,NA
"HEMORRHAGIC",2,NA
"HEMORRHAGIC INFARCTION",1,NA
"HEMORRHAGIC PANCREATITIS",2,NA
"HEMORRHAGIC SHOCK",1,NA
"HEMORRHAGIC STROKE",1,NA
"HEMOSTATIC AGENTS",1,NA
"HEMOTHORAX",1,NA
"HEMP",12,52
"HEMP ANALYSIS",1,NA
"HEMP BEVERAGES",1,1
"HEMP FOOD",2,2
"HEMP OIL CONTAINING CREMES",1,NA
"HEMP SEED OIL",1,8
"HEMP SEEDS",1,NA
"HENNA",1,NA
"HEPARG",3,NA
"HEPARIN-INDUCED-THROMBOCYTOPENIA",1,NA
"HEPATIC ENCEPHALOPATHY",1,NA
"HEPATIC FAILURE",2,NA
"HEPATIC HEMORRHAGE",1,NA
"HEPATIC INJURY",1,NA
"HEPATIC NECROSIS",1,NA
"HEPATIC STEATOSIS",2,NA
"HEPATIC TOXICITY",1,NA
"HEPATITIS",8,NA
"HEPATITIS B",4,NA
"HEPATITIS B IN DRUG VICTIMS",1,NA
"HEPATITIS C",6,NA
"HEPATITIS C PREVALENCE",1,NA
"HEPATITIS C VIRUS",3,NA
"HEPATOCYTE",1,1
"HEPATOCYTE INCUBATION",2,NA
"HEPATOCYTE METABOLISM",5,NA
"HEPATOCYTES",5,NA
"HEPATOTOXICITY",5,3
"HEPG2",2,NA
"HEPG2 CELL LINES",1,NA
"HEPPAR 1",1,NA
"HEPTAFLUOROBUTYRIC ACID (HFBA)",1,NA
"HEPTAFLUOROBUTYRIC ANHYDRIDE (HFBA)",1,1
"HERBACEOUS AGENT",7,10
"HERBAL",3,2
"HERBAL BLEND",3,8
"HERBAL CANNABIS",1,1
"HERBAL COMPONENTS",1,NA
"HERBAL DRUGS",4,1
"HERBAL HIGHS",6,9
"HERBAL INCENSE",1,2
"HERBAL MARIJUANA",1,1
"HERBAL MEDICATIONS",1,NA
"HERBAL MIXTURE",1,1
"HERBAL MIXTURES",3,2
"HERBAL PREPARATIONS",1,NA
"HERBAL PRODUCT",5,12
"HERBAL SMOKING BLENDS",1,NA
"HERBAL SMOKING MIXTURES",1,NA
"HERBICIDE",4,1
"HERBS",1,1
"HERC2−OCA2 GENES VARIATION",1,NA
"HERERODUPLEX",1,NA
"HERKINORIN",1,1
"HERNIA",1,NA
"HEROIN",174,137
"HEROIN-ASSOCIATED NEPHROPATHY (HAN)",1,NA
"HEROIN-RELATED DEATH",1,NA
"HEROIN-RELATED DEATHS",1,1
"HEROIN-RELATED EMERGENCIES",1,1
"HEROIN (DIACETYLMORPHINE)",1,NA
"HEROIN (DIACETYLMORPHINE, DAM)",1,1
"HEROIN ABUSE",1,NA
"HEROIN ADDICTION",4,NA
"HEROIN ADDICTS",4,NA
"HEROIN ADULTERANTS",1,1
"HEROIN AND COCAINE ANALYSIS",1,1
"HEROIN AND ETHANOL",1,NA
"HEROIN AND MORPHINE IDENTIFICATION",1,NA
"HEROIN AND MORPHINE QUANTIFICATION",1,NA
"HEROIN AND MYCOTIC PROFILE",1,NA
"HEROIN BACTERIA",1,1
"HEROIN BODY PACKER",1,NA
"HEROIN COMBINATIONS",1,1
"HEROIN COMPARISON",1,1
"HEROIN CONSUMPTION",1,NA
"HEROIN DEATH",2,NA
"HEROIN DEATHS",2,NA
"HEROIN DEPENDENCE",7,NA
"HEROIN DETECTION",1,1
"HEROIN DILUENTS",1,1
"HEROIN HYDROCHLORIDE",1,1
"HEROIN INTOXICATION",4,NA
"HEROIN MAINTENANCE",1,NA
"HEROIN MARKET MONITORING",1,1
"HEROIN METABOLITE",2,NA
"HEROIN METABOLITES",1,NA
"HEROIN MYCOFLORA",1,NA
"HEROIN OVERDOSE",3,2
"HEROIN OVERDOSE AND BLOODLETTING",1,NA
"HEROIN PACKETS",1,NA
"HEROIN PARTICLE PARTICLE SIZE DISTRIBUTION",1,1
"HEROIN POISONING",2,NA
"HEROIN PROFILING",3,6
"HEROIN PURITY",1,1
"HEROIN RELATED COMPOUNDS",1,NA
"HEROIN SEIZURES",3,3
"HEROIN SIGNATURE",1,1
"HEROIN SIGNATURE PROGRAM",1,4
"HEROIN TOXICITY",2,1
"HEROIN USE",2,NA
"HEROIN USERS",1,NA
"HEROIN, FUNGI",1,NA
"HEROIN/FLUNITRAZEPAM COMBINATION",1,NA
"HEROIN/MORPHINE",2,NA
"HETEROCYCLE",1,1
"HETEROCYCLES",2,3
"HETEROCYCLIC IMPURITIES",1,1
"HETEROGENEITY",2,2
"HETEROGENEOUS MATRIX",1,NA
"HETEROPHIL-LYMPHOCYTE RATIO",1,NA
"HETEROPLASMY",1,NA
"HETEROSTRUCTURE",1,NA
"HETEROZYGOSITY",1,2
"HETEROZYGOTE BALANCE",1,NA
"HEVAY METAL ION DETECTION",1,NA
"HEX-EN",2,NA
"HEXACYANOFERRATES",1,NA
"HEXAFLUOROACETYLACETONE",1,NA
"HEXAMETHYLPROPYLENEAMINE OXIME",1,NA
"HEXOBARBITAL",1,NA
"HEXYL-CHLOROFORMATE DERIVATIZATION",1,1
"HEXYL CHLOROFORMATE",1,NA
"HFBA-DERIVATIZATION",1,NA
"HFBA DERIVATISATION",1,1
"HFC-152A",2,NA
"HFE7100",1,NA
"HGH",1,NA
"HGN",1,NA
"HHV-6/7",1,NA
"HI-FLOW COLUMN",1,NA
"HIDE BEETLES",1,NA
"HIERARCHICAL CLASSIFICATION",1,NA
"HIERARCHICAL CLUSTER ANALYSIS",4,8
"HIERARCHICAL CLUSTERING",1,NA
"HIERARCHICAL CLUSTERING (HCA)",1,1
"HIERARCHICAL CLUSTERS ANALYSIS",1,NA
"HIF-1",1,NA
"HIGH-AMBIENT TEMPERATURE",1,NA
"HIGH-DIMENSIONAL CLASSIFICATION",1,NA
"HIGH-DOSE",1,NA
"HIGH-DOSE BUPRENORPHINE",1,NA
"HIGH-DOSES",1,NA
"HIGH-ENERGY SYNCHROTRON RADIATION X-RAY FLUORESCENCE SPECTROMETRY",1,NA
"HIGH-FIELD STRENGTH ELEMENTS",1,NA
"HIGH-FLOW SOLID-PHASE EXTRACTIONL COCAINE",1,NA
"HIGH-GRADE DECUBITUS ULCERS",1,NA
"HIGH-HERFORMANCE LIQUID CHROMATOGRAPHY",1,NA
"HIGH-INTENSITY DRUG TRAFFICKING AREA",1,NA
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-DIODE ARRAY",1,NA
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-DIODE ARRAY DETECTION",2,1
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-ELECTROCHEMISTRY",1,NA
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY",2,4
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTRUM (HPLC/MS)",1,NA
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",2,NA
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (LC-MS/MS)",1,NA
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY ANALYSIS",1,NA
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY (LC/MS)",1,NA
"HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY-MASS SPECTROMETRY (HPTLC-MS)",1,NA
"HIGH-POTENCY NEUROLEPTICS",1,NA
"HIGH-PRESSURE LIQUID",1,NA
"HIGH-PRESSURE LIQUID CHROMATOGRAPHY-ATMOSPHERIC PRESSURE CHEMICAL IONISATION-MASS SPECTROMETRY",1,NA
"HIGH-PRESSURE LIQUID CHROMATOGRAPHY-ULTRAVIOLET DETECTION",1,NA
"HIGH-QUALITY COMPOUNDING PHARMACIES",1,NA
"HIGH-RESOLUTION",2,NA
"HIGH-RESOLUTION ACCURATE TANDEM MASS SPECTROMETRY",1,NA
"HIGH-RESOLUTION ANALYTICAL TECHNIQUE IN CHEMICAL, BIOMEDICAL, FORENSIC AND FOOD SCIENCES",1,NA
"HIGH-RESOLUTION MASS SPECTROMETRY (HRMS)",81,48
"HIGH-RESOLUTION MELT",1,1
"HIGH-RESOLUTION MELT (HRM)",2,1
"HIGH-RESOLUTION MELTING (HRM)",1,1
"HIGH-RESOLUTION MELTING ANALYSIS",1,NA
"HIGH-RESOLUTION MS",1,NA
"HIGH-RISK BEHAVIOURS",1,NA
"HIGH-SECURE HOSPITAL",1,NA
"HIGH-SENSITIVITY TROPONIN T",1,NA
"HIGH-SPEED ANALYSIS",1,1
"HIGH-SPEED CENTRIFUGATION",1,NA
"HIGH-SPEED GRINDING",1,NA
"HIGH-TEMPERATURE GAS CHROMATOGRAPHY/MASS SPECTROMETRY",1,NA
"HIGH-THROUGHPUT",4,3
"HIGH-THROUGHPUT ANALYSIS",1,2
"HIGH-THROUGHPUT ASSAY",2,NA
"HIGH-THROUGHPUT GENERATION SEQUENCING",1,NA
"HIGH-THROUGHPUT GENOTYPING METHODS",1,NA
"HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING",1,NA
"HIGH-THROUGHPUT SCREENING",3,NA
"HIGH-THROUGHPUT TECHNIQUE",1,NA
"HIGH CONTENT SCREENING ASSAY (HCSA)",1,NA
"HIGH COST DRUGS",1,NA
"HIGH DOSAGE",1,NA
"HIGH DOSE",1,NA
"HIGH DOSE INSULIN THERAPY",1,NA
"HIGH DOSES",1,NA
"HIGH ENERGY MATERIALS",1,NA
"HIGH EXPLOSIVES",1,NA
"HIGH FIELD NMR SPECTROSCOPY",1,NA
"HIGH LETHALITY SUICIDE METHOD",1,NA
"HIGH ORDER MIXTURES",1,NA
"HIGH PERFORMANCE ANION EXCHANGE CHROMATOGRAPHY",1,NA
"HIGH PERFORMANCE GAS CHROMATOGRAPHY",1,NA
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-ATMOSPHERIC PRESSURE IONIZATION-MASS SPECTROMETRY",1,NA
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-DIODE ARRAY DETECTION (HPLC-DAD)",21,18
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY",2,NA
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (HPLC-MS)",10,6
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",1,1
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (HPLC-MS/MS)",2,NA
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TIME OF FLIGHT MASS SPECTROMETRY",1,NA
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-ULTRAVIOLET DETECTION",2,1
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)",1,1
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)/MASS SPECTROMETRY(MS)",1,NA
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY ANALYSIS",1,NA
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY",1,NA
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY/QUANTITATIVE ANALYSIS",1,1
"HIGH PERFORMANCE THIN-LAYER CHROMATOGRAPHY",1,NA
"HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY (HPTLC)",1,2
"HIGH PH MOBILE PHASE",3,NA
"HIGH PRESSURE LIQUID",1,NA
"HIGH PURITY ISOTOPES",1,NA
"HIGH RESOLUTION",2,NA
"HIGH RESOLUTION-MASS SPECTROMETRY",1,NA
"HIGH RESOLUTION ACCURATE MASS",1,NA
"HIGH RESOLUTION IMAGING",1,NA
"HIGH RESOLUTION MASS SPECTROMETRY (HRMS)",1,NA
"HIGH RESOLUTION MELT ANALYSIS",1,NA
"HIGH RESOLUTION MELT CURVES",1,1
"HIGH RESOLUTION MELTING ANALYSIS",1,1
"HIGH RESOLUTION MS/MS SPECTRAL LIBRARY",1,NA
"HIGH RISK BEHAVIOR",5,1
"HIGH RISK SITUATION",1,NA
"HIGH SECURE",1,NA
"HIGH SECURE PSYCHIATRIC CARE",1,NA
"HIGH SECURITY",2,NA
"HIGH SECURITY HOSPITAL",2,NA
"HIGH SENSITIVE-SELECTIVE SCREENING",1,NA
"HIGH SPEED VAPOR SAMPLING",1,NA
"HIGH THROUGHPUT",6,5
"HIGH THROUGHPUT LABORATORY",1,NA
"HIGH THROUGHPUT SCREENING",1,NA
"HIGH THROUGHPUT SEQUENCING",3,NA
"HIGH X-RAY ABSORPTION",1,NA
"HIGH/THROUGHPUT SCREENING",1,NA
"HIGHER ALCOHOLS",1,NA
"HIGHER DERIVATIVE SPECTROSCOPY",1,NA
"HIGHLY HYDROPHILIC BASIC COMPOUNDS",1,1
"HIGHLY SENSITIVE",1,NA
"HIGHWAY CODE",1,NA
"HILIC",4,4
"HILL CRITERIA",1,NA
"HIMALAYAN BLACK BEAR",1,NA
"HIP-FLASK DEFENCE",2,NA
"HIP FRACTURE",1,NA
"HIPPOCAMPAL AGENESIS",1,NA
"HIPPOCAMPUS",3,NA
"HIPPURIC ACID",2,NA
"HISPANICS",1,NA
"HISTAMINE",1,NA
"HISTAMINE ANTAGONISTS",1,NA
"HISTATIN",1,NA
"HISTOCHEMICAL INVESTIGATION",1,NA
"HISTOCHEMISTRY",2,NA
"HISTOGRAM",1,NA
"HISTOLOGIC STAINING METHODS",1,NA
"HISTOLOGICAL ANALYSIS",2,NA
"HISTOLOGICAL EXAMINATION",1,NA
"HISTOLOGICAL PATTERN",1,NA
"HISTOLOGICAL TECHNIQUE",1,NA
"HISTOLOGICAL TECHNIQUES",2,NA
"HISTOLOGY",15,NA
"HISTOLOGY OF SKIN",1,NA
"HISTOLOGY, QUALITY STANDARD",1,NA
"HISTOMORPHOLOGY",1,NA
"HISTONE MODIFICATION",1,NA
"HISTOPATHOLOGIC",1,NA
"HISTOPATHOLOGICAL EXAMINATION",2,NA
"HISTOPATHOLOGICAL FEATURES",1,NA
"HISTOPATHOLOGICAL FINDINGS SURVIVAL PERIOD",1,NA
"HISTOPATHOLOGICAL QUALITY STANDARDS",1,NA
"HISTOPATHOLOGICAL TIME ESTIMATION",2,NA
"HISTOPATHOLOGY",7,NA
"HISTOPATHOLOGY AFTER EXHUMATION",1,NA
"HISTOPATHOLOGY AND SUDDEN DEATH",1,NA
"HISTOPATHOLOGY OF DRUG ABUSE",1,NA
"HISTORIC EXPOSURE",1,NA
"HISTORICAL DEVELOPMENTS OF DRUG TESTING",1,NA
"HISTORICAL STUDY",1,1
"HISTORY",17,4
"HISTORY OF ADDICTION MEDICINE",1,NA
"HISTORY OF DRUG USAGE",1,NA
"HISTORY OF FORENSIC MEDICINE",1,NA
"HISTORY OF FORENSIC TOXICOLOGY",1,NA
"HISTORY OF PSYCHIATRY",2,NA
"HISTORY OF SCIENCE",1,NA
"HISTORY/PHILOSOPHY",1,1
"HIT-AND-RUN",1,NA
"HIT AND RUN ACCIDENT",1,NA
"HIV",13,1
"HIV-1",2,NA
"HIV-1-PREVALENCE",1,NA
"HIV-1 INFECTION",2,NA
"HIV-1 PREVALENCE",2,NA
"HIV-1 SEROPOSITIVITY",1,NA
"HIV-ASSOCIATED CONDITIONS",1,NA
"HIV-INFECTION",1,NA
"HIV-INFECTION (AUTOPSY CASES)",1,NA
"HIV-PRÄVALENCE",1,NA
"HIV-PREVALENCE",1,NA
"HIV ANTIBODIES",1,NA
"HIV INFECTION",5,NA
"HIV INFECTIONS",1,NA
"HIV PREVALENCE",2,NA
"HIV PROPHYLAXIS",1,NA
"HKT-30",1,NA
"HL-1CELLS",1,NA
"HLA-A",1,NA
"HLA-B",1,NA
"HLA-C",1,NA
"HLA-CW",1,NA
"HLA-DQA1",3,NA
"HLA-DQB1",1,NA
"HLM",1,1
"HLMS",1,NA
"HMTD",3,NA
"HOARDING",1,NA
"HOAT1",1,NA
"HOFMANN DEGRADATION",1,1
"HOFMANN REARRANGEMENT",1,1
"HOG-TYING",1,NA
"HOGTYING",1,NA
"HOLE",1,NA
"HOLLOW-CORE PHOTONIC CRYSTAL FIBER",1,NA
"HOLLOW-FIBER LIQUID-PHASE MICROEXTRACTION",1,NA
"HOLLOW-FIBER LIQUID-PHASE MICROEXTRACTION (HF-LPME)",1,NA
"HOLLOW BULLETS",1,NA
"HOLLOW FIBER-BASED SOLID-PHASE MICROEXTRACTION",1,NA
"HOLLOW FIBER-LIQUID PHASE MICROEXTRACTION",1,NA
"HOLLOW FIBER-LIQUID PHASE MICROEXTRACTION (HF-LPME)",1,NA
"HOLLOW FIBER-SOLID PHASE MICROEXTRACTION (HF-SPME)",1,NA
"HOLLOW FIBER LIQUID PHASE MICROEXTRACTION",3,1
"HOLOGRAMS",1,NA
"HOLTER MONITOR",1,NA
"HOLY TRINITY",1,NA
"HOME-MADE EXPLOSIVE",1,NA
"HOME ABORTION",1,NA
"HOME ACCIDENTS",1,NA
"HOMELAND SECURITY",3,1
"HOMELESS",3,NA
"HOMELESS PERSONS",1,NA
"HOMELESSNESS",2,NA
"HOMER PROTEINS",1,NA
"HOMICID",1,NA
"HOMICID.E.",1,NA
"HOMICIDAL",1,NA
"HOMICIDAL IDEATION",1,NA
"HOMICIDAL POISONING",3,NA
"HOMICIDAL PROTEST",1,NA
"HOMICIDE",122,NA
"HOMICIDE-SUICIDE",3,NA
"HOMICIDE DEATHS",1,NA
"HOMICIDE RATE",1,NA
"HOMICIDE, FIRE DEATHS",1,NA
"HOMICIDE/SUICIDE",1,NA
"HOMICIDE/SUICIDE PAIRS",1,NA
"HOMICIDE/SUICIDE/ACCIDENTS",1,NA
"HOMOGENEITY",3,3
"HOMOGENEOUS IMMUNOASSAY",1,NA
"HOMOGENIZATION",2,3
"HOMOSEXUALITY",2,NA
"HOMOSILDENAFIL",1,2
"HONG KONG",3,1
"HONGDENAFIL",1,NA
"HORIZONTAL GAZE NYSTAGMUS",1,NA
"HORIZONTAL POLYACRYLAMIDE GEL ELECTROPHORESIS",1,NA
"HORMONAL THERAPY",1,NA
"HORMONE",6,7
"HORMONE REPLACEMENT THERAPY",3,NA
"HORMONE REPLACEMENT THERAPY, RISK PATIENTS",1,NA
"HORMONE THERAPY",1,NA
"HORSE",3,NA
"HORSE BLOOD",2,NA
"HORSERADISH PEROXIDASE",2,NA
"HORSES",2,NA
"HOSPITAL",8,NA
"HOSPITAL CARE",1,NA
"HOSPITAL DATA",2,NA
"HOSPITAL DIRECTION",1,NA
"HOSPITAL READMISSION",2,NA
"HOSPITAL SYSTEM",1,NA
"HOSPITAL TRANSFER",1,NA
"HOSPITAL TREATMENT",1,NA
"HOSPITALISATION",1,NA
"HOSPITALIZATION",5,1
"HOSPITALIZATION INDICATION",1,NA
"HOSPITALIZATION RATES",1,NA
"HOSPITALS",1,NA
"HOSPITALS, PSYCHIATRIC",1,NA
"HOST-PATHOGEN RESPONSE",1,NA
"HOST LIABILITY",1,NA
"HOSTILITY",6,NA
"HOT BATH",2,NA
"HOUSE-DUST-MITE ATOPY",1,NA
"HOUSE CROWS",1,NA
"HOUSE DUST MITES",1,NA
"HOUSEHOLD CHEMICALS",2,NA
"HOUSEHOLD CLEANSERS",1,NA
"HOUSEKEEPING GENES",1,NA
"HOUSTON COCKTAIL",1,NA
"HPCL",1,NA
"HPLC- FLUORESCENCE",1,1
"HPLC- PDA",1,NA
"HPLC-APCI-MS",1,1
"HPLC-CHEMILUMINESCENCE",2,NA
"HPLC-CL",1,NA
"HPLC-DAD ANALYSIS",1,NA
"HPLC-ESI-MS/MS",3,NA
"HPLC-ESI +-MS/MS",1,NA
"HPLC-FD",1,NA
"HPLC-HRMS",2,NA
"HPLC-HRMS/MS",1,NA
"HPLC-IDA-HR-MS/MS",1,NA
"HPLC-MS ANALYSIS",1,NA
"HPLC-PDA",2,NA
"HPLC-QTOF-MS",1,NA
"HPLC-UV",2,4
"HPLC DETERMINATION",1,1
"HPLC SYSTEM",1,NA
"HPLC UV-VIS",1,NA
"HPLC WITH MULTI-WAVE DETECTION",1,NA
"HPLC, RETENTION INDICES",1,NA
"HPLC/DAD SEPARATION",1,NA
"HPLC/DAD/MSD",1,NA
"HPLC/MS/MS",4,NA
"HPLC/PDA",1,NA
"HPLCMS/MS",1,NA
"HPTLC-MS",1,NA
"HPTLC ANALYSIS",1,NA
"HR-MS",3,NA
"HR-MS/MS",1,2
"HRGS",1,NA
"HRLM",1,NA
"HRM ANALYSIS",1,NA
"HRT",2,NA
"HS-GC-MS",1,NA
"HS-GC/MS",1,1
"HS-SPME",5,2
"HS/GC-MS",1,NA
"HSA",1,NA
"HSP70 FAMILY",1,NA
"HSSP",1,NA
"HSSP-BLOSUM62",1,NA
"HTLV- I/II",1,NA
"HTRB1",1,NA
"HU-210",2,3
"HU210",1,NA
"HUFFING",1,NA
"HUMAN",21,4
"HUMAN-LIKE EXPERIMENTAL MODEL",1,NA
"HUMAN-PERFORMANCE FORENSIC TOXICOLOGY",1,NA
"HUMAN AND CIVIL RIGHTS",1,NA
"HUMAN BEHAVIOR",1,NA
"HUMAN BIOLOGICAL SPECIMENS",1,NA
"HUMAN BLOOD",7,NA
"HUMAN BLOOD AND BONE MARROW",1,NA
"HUMAN BLOOD AND URINE",1,2
"HUMAN BLOOD SERUM",1,NA
"HUMAN BODY FLUIDS",1,NA
"HUMAN BODY ODOR",2,NA
"HUMAN BONE",5,NA
"HUMAN BONE MARROW",1,NA
"HUMAN BRAIN",9,NA
"HUMAN BRAIN MICROSOMES",1,NA
"HUMAN BRAIN TISSUE",1,NA
"HUMAN BREAST MILK",1,NA
"HUMAN CADAVER",1,NA
"HUMAN CARDIAC SODIUM CHANNEL",1,NA
"HUMAN CEREBRAL CORTEX",1,NA
"HUMAN DECAY",1,NA
"HUMAN DECOMPOSITION",2,NA
"HUMAN DIGESTOME",1,NA
"HUMAN ENAMEL",1,NA
"HUMAN EXPOSURE",1,NA
"HUMAN FACTORS",1,NA
"HUMAN FATAL CASE",1,NA
"HUMAN FATALITY",1,NA
"HUMAN GAMMA-GLOBULIN",1,1
"HUMAN GENETICS",1,NA
"HUMAN GENOME",1,NA
"HUMAN GROWTH HORMONE",1,1
"HUMAN HAIR",11,NA
"HUMAN HAIR ANALYSIS",1,NA
"HUMAN HAIR COMPLEXITIES, AND THE ANAGEN, CATAGEN, TELOGEN PHASES",1,NA
"HUMAN HAIR SAMPLE",1,NA
"HUMAN HAIR SHAFT PROTEINS",1,NA
"HUMAN HAIR, DETERMINATION OF COCAINE",1,NA
"HUMAN HEALTH",1,NA
"HUMAN HEMOGLOBIN",1,NA
"HUMAN HEPATIC MICROSOMES",1,NA
"HUMAN HEPATOCYTES",3,NA
"HUMAN IDENTIFICATION",7,NA
"HUMAN IMMUNODEFI CIENCY VIRUS",1,NA
"HUMAN IMMUNODEFICIENCY VIRUS",1,NA
"HUMAN IMMUNODEFICIENCY VIRUS (HIV)",1,NA
"HUMAN INSULIN",2,NA
"HUMAN INTOXICATION",1,NA
"HUMAN KINETIC PROFILES",1,NA
"HUMAN LEUKOCYTE ANTIGEN",1,NA
"HUMAN LEUKOCYTE ANTIGENS",1,NA
"HUMAN LIVER MICROSOMES",14,NA
"HUMAN LIVER PREPARATION",1,NA
"HUMAN LIVER PREPARATIONS",1,NA
"HUMAN MEDULLA OBLONGATA",1,NA
"HUMAN METABOLISM",2,NA
"HUMAN METABOLITES",1,NA
"HUMAN METHANOL ELIMINATION",1,NA
"HUMAN MIDBRAIN",1,NA
"HUMAN MYIASIS",1,NA
"HUMAN NAIL",1,NA
"HUMAN PARASITES",1,NA
"HUMAN PERFORMANCE",1,NA
"HUMAN PERFORMANCE FORENSIC TOXICOLOGY",1,NA
"HUMAN PERFORMANCE TOXICOLOGY",4,NA
"HUMAN PERFORMANCE TOXICOLOGY, AND ALCOHOL/DRUG USE ON BEHAVIOR",1,NA
"HUMAN PITUITARY",1,NA
"HUMAN PLASMA",11,6
"HUMAN POPULATIONS",1,NA
"HUMAN PROVENANCE",1,NA
"HUMAN PSOAS",1,NA
"HUMAN REMAINS",5,1
"HUMAN RIGHTS",6,NA
"HUMAN SCENT",5,1
"HUMAN SCENT ANALYSIS",1,NA
"HUMAN SCENT SIGNATURE",1,NA
"HUMAN SERUM",9,2
"HUMAN SERUM ALBUMIN",1,NA
"HUMAN SERUM SAMPLES",1,NA
"HUMAN SKELETAL REMAINS",2,NA
"HUMAN SKIN",1,NA
"HUMAN SPECIFIC MARKER",1,NA
"HUMAN SPECIMEN",1,NA
"HUMAN SUBJECTS",1,NA
"HUMAN SURROGATE",1,NA
"HUMAN TEETH",1,1
"HUMAN THERMOREGULATION",1,NA
"HUMAN TISSUE",2,NA
"HUMAN TISSUE ACT 2008 (NZ)",1,NA
"HUMAN TORSO",1,NA
"HUMAN TOXICOLOGY",3,1
"HUMAN TRAFFICKING",2,NA
"HUMAN URINE",14,6
"HUMAN WHOLE BLOOD",5,NA
"HUMAN WHOLE BLOOD AND URINE",2,NA
"HUMANE URINE",1,NA
"HUMANITARIAN GIS",1,NA
"HUMIC ACID",5,NA
"HUMOR/PUZZLES/GAMES",1,NA
"HUNAN PROVINCE",1,NA
"HUNGARIAN RED",1,NA
"HUNGARY",1,NA
"HUNGER STRIKE",1,NA
"HUOXIANG ZHENGQI LIQUID",1,NA
"HV2",1,NA
"HVS-I",1,NA
"HVS-II",1,NA
"HYBRID-SPE-PRECIPITATION",1,NA
"HYBRID HIGH-RESOLUTION QUADRUPOLE-TIME-OF-FLIGHT MASS SPECTROMETRY",1,NA
"HYBRID LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"HYBRID ORDER",1,NA
"HYBRID TECHNIQUES",1,NA
"HYBRIDIZATION PROBING",1,NA
"HYBRIDOMA",1,NA
"HYDERABAD",1,NA
"HYDRASTINE",1,NA
"HYDRASTIS CANADENSIS L.",1,NA
"HYDRATED MAGNESIUM SILICATE",1,NA
"HYDRAZOIC ACID",1,NA
"HYDRIODIC ACID",2,1
"HYDRIODINE SALT",1,1
"HYDROCARBON",2,1
"HYDROCHLORIC ACID",1,NA
"HYDROCHLORIDE SALT",1,1
"HYDROCODONE",10,7
"HYDROCORTISONE",3,NA
"HYDROCYANIC ACID, PRODUCED DURING COMBUSTION",1,NA
"HYDRODYNAMIC MASS TRANSPORT",1,NA
"HYDROFLUORIC ACID",1,NA
"HYDROGELS",1,NA
"HYDROGEN",1,1
"HYDROGEN CYANIDE",1,NA
"HYDROGEN CYANIDE (HCN)",1,NA
"HYDROGEN CYANIDE POISONING",1,NA
"HYDROGEN ISOTOPES",1,1
"HYDROGEN PEROXIDE",4,NA
"HYDROGEN PEROXIDE, INTOXICATION",1,NA
"HYDROGEN SULFIDE",3,NA
"HYDROGENATED MORPHAMQUAT",1,NA
"HYDROGENATION",1,3
"HYDROGÈNE SULFURÉ",1,NA
"HYDROLYSIS",5,5
"HYDROLYTIC DEGRADATION",1,NA
"HYDROMORPHONE",4,3
"HYDROMORPHONE-3-GLUCURONIDE",1,NA
"HYDROPHILIC INTERACTION CHROMATOGRAPHY (HILIC)",1,NA
"HYDROPHILIC INTERACTION LC-MS-MS",1,NA
"HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (HILIC-MS/MS)",1,NA
"HYDROPHILIC POLYMER COLUMN",1,NA
"HYDROPHOBIC COMPOUNDS",1,1
"HYDROTHERMAL SYNTHESIS",1,NA
"HYDROXOCOBALAMIN",1,NA
"HYDROXONIUM CATION",1,1
"HYDROXY-1-(3-TRIFLUOROMETHYLPHENYL) PIPERAZINE",1,1
"HYDROXY-N-BENZYLPIPERAZINE",1,1
"HYDROXY-N,N-DIMETHYLTRYPTAMINE (HO-DMT)",1,1
"HYDROXY METABOLITES",1,NA
"HYDROXYCHLOROQUINE, SENSORS.",1,NA
"HYDROXYCOCAINES",1,NA
"HYDROXYETHOXY METABOLITE",1,NA
"HYDROXYETHYLFLURAZEPAM",1,1
"HYDROXYHOMOSILDENAFIL",1,NA
"HYDROXYLATION",1,NA
"HYDROXYLIMINE",1,NA
"HYDROXYPROPYL-Β-CYCLODEXTRIN",1,NA
"HYDROXYTHIOHOMOSILDENAFIL",1,NA
"HYDROXYVARDENAFIL",1,NA
"HYDROXYZINE",3,NA
"HYGIENE",2,NA
"HYGRINE",1,4
"HYOSCINE",13,19
"HYPERACTIVITY",3,NA
"HYPERCARB COLUMN",1,NA
"HYPEREOSINOPHILIC SYNDROME",1,NA
"HYPERGEOMETRIC DISTRIBUTION",2,1
"HYPERGLYCEMIA",2,NA
"HYPERHYDRATION",1,NA
"HYPERKALEMIA",2,NA
"HYPERKINESIS",1,NA
"HYPERKINETIC DISORDER",1,NA
"HYPERMAGNESEMIA",1,NA
"HYPEROSMOLALITY",1,NA
"HYPERPREXIA",1,NA
"HYPERREACTIVITY",1,NA
"HYPERSENSITIVE REACTION",1,NA
"HYPERSENSITIVITY",3,NA
"HYPERSENSITIVITY REACTION",1,NA
"HYPERSEXUALITY",2,NA
"HYPERSPECTRAL IMAGING",7,3
"HYPERTENSION",1,NA
"HYPERTHEMIA, FOLLOWING NEAR HANGING",1,NA
"HYPERTHERMAL LESIVITY",1,NA
"HYPERTHERMIA",18,NA
"HYPERTHYROIDISM",1,NA
"HYPERTROPHIC CARDIOMYOPATHY",5,NA
"HYPERVARIABLE REGION HV1",1,NA
"HYPERVARIABLE REGIONS",1,NA
"HYPERVENTILATION THERAPY",1,NA
"HYPHENATED CHROMATOGRAPHY",1,1
"HYPHENATED CONFIGURATION",1,NA
"HYPHENATED TECHNIQUE",2,NA
"HYPHENATED TECHNIQUES",3,5
"HYPHENATION",4,2
"HYPNOSIS",1,NA
"HYPNOTHERAPY",1,NA
"HYPNOTIC-SEDATIVE DRUG",1,NA
"HYPNOTIC AGENTS",1,NA
"HYPNOTIC SEDATIVE DRUGS",1,NA
"HYPNOTICS",13,3
"HYPNOTICS AND SEDATIVES",2,NA
"HYPOGLYCAEMIA",4,NA
"HYPOGLYCEMIA",4,NA
"HYPOGLYCEMIC DRUG",2,NA
"HYPOGLYCEMIC SULFONYLUREA",1,NA
"HYPOGLYCIN-A",1,NA
"HYPOGLYCINE A",1,NA
"HYPOGONADISM",1,1
"HYPOKALEMIA",3,NA
"HYPOLIPIDEMIC",1,NA
"HYPOLIPIDEMIC DRUGS",1,NA
"HYPONATREMIA",1,NA
"HYPOPERFUSION",1,NA
"HYPOPHOSPHITE",1,1
"HYPOPHOSPHOROUS ACID",1,1
"HYPOPHOSPHOROUS ROUTE",1,1
"HYPOPOTASSEMIA",1,NA
"HYPOSENSITIZATION",1,NA
"HYPOTENSION",2,NA
"HYPOTHALAMO-HYPOPHYSEAL SYSTEM",1,NA
"HYPOTHALAMUS",1,NA
"HYPOTHERMIA",15,NA
"HYPOTHERMIA DEATH",1,NA
"HYPOTHERMIA, FATAL",1,NA
"HYPOTHESIS-BASED RESEARCH",1,NA
"HYPOTHESIS BASED RESEARCH",1,NA
"HYPOTHESIS TEST",1,NA
"HYPOXEMIA",1,NA
"HYPOXIA",4,NA
"HYPOXIA-ISCHEMIA",1,NA
"HYPOXIA MARKERS",1,NA
"HYPOXIA RELATED ANTIGENS",1,NA
"HYPOXIC-ISCHEMIC ENCEPHALOPATHY",1,NA
"HYPOXIC BRAIN DAMAGE",1,NA
"HYPOXIC ENCEPHALOPATHY",1,NA
"HYPOXIC ISCHEMIC ENCEPHALOPATHY",1,NA
"HYPOXIC RECREATION PRACTICE",1,NA
"HYPOXIC/ISCHAEMIC BRAIN DAMAGE",1,NA
"I.V. DRUG ABUSE",1,NA
"IACS",1,NA
"IATROGENESIS",1,NA
"IATROGENIC",3,NA
"IATROGENIC ADDICTION",1,NA
"IATROGENIC DAMAGE -SUDDEN AND UNEXPECTED DEATH FROM NATURAL CAUSES",1,NA
"IATROGENIC DEATH",1,NA
"IATROGENIC FATALITY",1,NA
"IATROGENIC HISTOLOGICAL ORGAN CHANGES",1,NA
"IATROGENIC INJECTION THERAPY",1,NA
"IATROGENIC LAMINITIS",1,NA
"IATROGENIC LEAD INTOXICATION",1,NA
"IATROGENIC VASCULAR INJURY",1,NA
"IBERIAN PENINSULA",1,NA
"IBOGA",1,1
"IBOGA AND RAUWOLFIA",1,NA
"IBOGAINE",4,3
"IBOTENIC ACID",3,2
"IBUPROFEN",4,5
"IC-MS/MS",1,NA
"ICAL-GC-MS",1,NA
"ICAM-1",1,NA
"ICD-10",1,NA
"ICE",2,NA
"ICELAND",1,1
"ICG",1,NA
"ICHTHYOSIS",1,NA
"ICP-AES",1,3
"ICP-OES",1,1
"ICP OES",1,2
"ICPC",1,NA
"ICU ADMISSION",1,NA
"IDENTIFICATION",54,37
"IDENTIFICATION AND QUANTIFICATION",1,2
"IDENTIFICATION BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"IDENTIFICATION CERTAINTY",1,NA
"IDENTIFICATION CRITERIA",2,1
"IDENTIFICATION OF DRUGS ORIGINS",1,NA
"IDENTIFICATION OF DRUGS, IN AUTOPSY MATERIAL",1,NA
"IDENTIFICATION OF ECSTASY",1,1
"IDENTIFICATION OF HAZARDOUS MATERIALS",1,NA
"IDENTIFICATION OF ILLICIT DRUGS",1,NA
"IDENTIFICATION OF ILLICIT ECSTASY SAMPLES",1,1
"IDENTIFICATION OF NEWLY EMERGED PSYCHOTROPIC DRUGS",1,1
"IDENTIFICATION OF NPS",1,NA
"IDENTIFICATION OF PERSON",1,NA
"IDENTIFICATION OF RE-ACTIVATED FIREARMS",1,NA
"IDENTIFICATION REQUIREMENT",1,NA
"IDENTIFICATION SUCCESS",1,NA
"IDENTIFICATION SYSTEM",1,2
"IDENTIFIERS",1,NA
"IDENTIFILER",1,NA
"IDENTIFILER PLUS",1,NA
"IDENTIFILER™",1,NA
"IDENTITY CONCEALMENT",1,NA
"IDENTITY DETERMINATION",1,NA
"IDENTITY DOCUMENTS",1,1
"IDENTITY THEFT",1,NA
"IDMS",2,NA
"IDU",1,NA
"IGE",1,NA
"IGNITABLE LIQUID (IL)",9,2
"IGNITABLE LIQUID RESIDUE (ILR)",4,NA
"IGNITABLELIQUID RESIDUES",1,NA
"IL",1,1
"IL-15",1,NA
"ILEUS",1,NA
"ILLEGAL ABORTION",2,NA
"ILLEGAL ACTIVITY",2,NA
"ILLEGAL ACTS",1,NA
"ILLEGAL BEHAVIOR",1,NA
"ILLEGAL CIRCULATION",1,NA
"ILLEGAL DRUG",2,2
"ILLEGAL DRUG ABUSE",1,NA
"ILLEGAL DRUG MARKETS",1,2
"ILLEGAL DRUG USE",1,NA
"ILLEGAL KETAMINE USE",1,1
"ILLEGAL LOOTING",1,NA
"ILLEGAL PEPTIDE",1,NA
"ILLEGAL PHARMACEUTICAL PRODUCTS",2,NA
"ILLEGAL PRODUCT",2,5
"ILLEGAL SUBSTANCES",1,NA
"ILLEGAL TRADE",2,NA
"ILLEGAL TRADE MONITORING",1,NA
"ILLICIT",2,3
"ILLICIT-DRUG ANALYSIS",1,1
"ILLICIT AMPHETAMINE",1,1
"ILLICIT AND MEDICINAL DRUGS",1,NA
"ILLICIT COCAINE",2,3
"ILLICIT COCAINE IMPURITIES",2,2
"ILLICIT CULTIVATION",1,1
"ILLICIT DIAMORPHINE PREPARATION",1,NA
"ILLICIT DRUG",175,218
"ILLICIT DRUG ABUSE",5,NA
"ILLICIT DRUG ADDICTS",1,NA
"ILLICIT DRUG ANALYSIS",5,6
"ILLICIT DRUG ANALYSIS, ACTIVE AREAS IN FORENSIC SCIENCE",1,NA
"ILLICIT DRUG CHEMICAL PROFILING",1,NA
"ILLICIT DRUG CONSUMPTION",1,1
"ILLICIT DRUG IDENTIFICATION",2,2
"ILLICIT DRUG MANUFACTURE",1,1
"ILLICIT DRUG MARKET",2,2
"ILLICIT DRUG PROFILING",4,3
"ILLICIT DRUG SAMPLES",1,2
"ILLICIT DRUG SEIZURES",1,1
"ILLICIT DRUG USE",3,1
"ILLICIT DRUGS CONSUMPTION",1,1
"ILLICIT DRUGS DETECTION",1,NA
"ILLICIT HEROIN",6,4
"ILLICIT HEROIN CHARACTERISATION",1,NA
"ILLICIT HEROIN IMPURITIES",1,1
"ILLICIT HEROIN, STREET SAMPLES",1,NA
"ILLICIT LABORATORIES",1,NA
"ILLICIT MANUFACTURE",1,NA
"ILLICIT METHAMPHETAMINE",1,1
"ILLICIT METHAQUALONE TABLET FORMULATIONS",1,1
"ILLICIT POWDERS",1,2
"ILLICIT PREPARATIONS",2,1
"ILLICIT PSYCHOTROPIC DRUGS",1,NA
"ILLICIT SAMPLES",3,3
"ILLICIT SMALL ARMS TRAFFIC",1,NA
"ILLICIT STIMULANTS",1,2
"ILLICIT STREET DRUGS",1,1
"ILLICIT SUBSTANCES",1,1
"ILLICIT SYNTHESIS",2,3
"ILLICIT TABLETS",4,2
"ILLICIT TRAFFIC IN NARCOTIC DRUGS",1,NA
"ILLICIT TRAFFICKING",1,NA
"ILLICITE DRUGS",1,NA
"ILLICITLY MANUFACTURED FENTANYL",1,NA
"ILLUMINA",1,NA
"IM-NAA",1,NA
"IMAGE",2,NA
"IMAGE- AND PERFORMANCE-ENHANCING DRUGS",1,NA
"IMAGE-GUIDED SURGERY",1,NA
"IMAGE ANALYSIS",2,3
"IMAGE AND PERFORMANCE ENHANCING DRUGS (IPEDS)",1,NA
"IMAGE CLASSIFICATION",1,NA
"IMAGE CLASSIFIER",1,NA
"IMAGE DATABASES",2,NA
"IMAGE FORENSIC ANALYSIS",1,NA
"IMAGE PROCESSING",3,4
"IMAGE RECOGNITION",1,NA
"IMAGE RESTORATION",1,NA
"IMAGE SOURCE IDENTIFICATION",1,NA
"IMAGE TAMPERING DETECTION",1,NA
"IMAGEJ",1,NA
"IMAGES",2,NA
"IMAGING",10,9
"IMAGING (NMR MICROSCOPY | ELECTRON MICROSCOPY)",1,NA
"IMAGING AUTOPSY",1,NA
"IMAGING ELLIPSOMETRY",1,1
"IMAGING FLOW CYTOMETRY",1,NA
"IMAGING MASS CYTOMETRY (IMC)",1,NA
"IMAGING MASS SPECTROMETRY",4,2
"IMAGING MS",1,NA
"IMAGING SOFTWARE",1,NA
"IMAGING SURFACE PLASMON RESONANCE",1,1
"IMIDACLOPRID",1,NA
"IMIDAZO[1,2-A]PYRIDINE",1,NA
"IMIDAZOLINE",2,NA
"IMIDAZOLIUM",1,1
"IMINOSTILBENE",1,NA
"IMIPENEM TEST",1,NA
"IMIPRAMINE",10,1
"IMMEDIATE EARLY GENE",1,NA
"IMMEDIATE EARLY GENE (IEG)",1,NA
"IMMEDIATE INSPECTION",1,NA
"IMMEDIATE MEDICAL AFTERCARE",1,NA
"IMMERSION",2,NA
"IMMIGRANTS",2,NA
"IMMIGRATION",1,NA
"IMMOBILISATION",1,NA
"IMMOBILIZED ENZYME",1,NA
"IMMOBILON(®)",1,NA
"IMMOLATION",1,NA
"IMMUNE FUNCTION",1,NA
"IMMUNE RESPONSE",1,NA
"IMMUNE SYSTEM",2,NA
"IMMUNIZATION",1,NA
"IMMUNOAFFINITY",1,1
"IMMUNOAFFINITY EXTRACTION",1,NA
"IMMUNOAFINITY",1,NA
"IMMUNOANALYSIS",1,NA
"IMMUNOASSAY",85,12
"IMMUNOASSAY FOR NARCOTICS",1,NA
"IMMUNOASSAY SCREENING",1,1
"IMMUNOASSAY SEMINAL VESICLE SPECIFIC ANTIGEN",1,NA
"IMMUNOASSAY TEST",1,NA
"IMMUNOBLASTS",1,NA
"IMMUNOBLOT",1,NA
"IMMUNOBLOTTING",3,NA
"IMMUNOCHEMICAL ANALYSES",1,NA
"IMMUNOCHROMATOGRAPHIC MEMBRANE TEST",1,NA
"IMMUNOCHROMATOGRAPHIC TEST",1,NA
"IMMUNOCHROMATOGRAPHY",4,4
"IMMUNOCYTOCHEMISTRY",1,NA
"IMMUNODEFICIENCY",1,NA
"IMMUNOGEN",2,NA
"IMMUNOGENIC",1,NA
"IMMUNOGLOBULIN E",2,NA
"IMMUNOHAEMATOLOGY",1,NA
"IMMUNOHISTOCHEMICAL ANALYSES",1,NA
"IMMUNOHISTOCHEMICAL ASSAY",1,NA
"IMMUNOHISTOCHEMICAL STAINING",1,NA
"IMMUNOHISTOCHEMISTRY",52,NA
"IMMUNOHISTOCHEMISTRY (IHC)",1,NA
"IMMUNOHISTOCHEMUISTRY",1,NA
"IMMUNOLABELING",2,NA
"IMMUNOLOGICAL CHARACTERISTICS",1,NA
"IMMUNOLOGICAL METHODS",1,NA
"IMMUNOLOGICAL METHODS, BENZODIAZEPINES",1,NA
"IMMUNOLOGICAL SCREENING",1,NA
"IMMUNOLOGICAL TESTS AND IDENTIFICATION",1,NA
"IMMUNOLOGICALLY MEDIATED TESTS",1,NA
"IMMUNOLOGY",4,NA
"IMMUNOMAGNETIC SEPARATION",1,NA
"IMMUNOMETHODS",1,NA
"IMMUNOREACTION",2,NA
"IMMUNOSENSOR",2,2
"IMMUNOSTAINING",2,NA
"IMMUNOSUPPRESSION",2,NA
"IMMUNOTHERAPY/ADVERSE EFFECTS",1,NA
"IMPACT INDEX",1,NA
"IMPACT OF CHILD‐REARING",1,NA
"IMPACT ON SUICIDE RATES",1,NA
"IMPACT PATTERN",1,NA
"IMPAIRED",3,NA
"IMPAIRED DRIVERS",4,NA
"IMPAIRED PERFORMANCE",1,NA
"IMPAIRMENT",34,1
"IMPAIRMENT SYMPTOMS",1,NA
"IMPERIOUS HALLUCINATIONS",1,NA
"IMPLICIT ASSOCIATION TEST",1,NA
"IMPORTANCE OF SPECIES ANALYSIS",1,NA
"IMPORTATION",1,3
"IMPOTENCE",1,NA
"IMPREGNATED CLOTHING",1,1
"IMPREGNATED TEXTILES",1,1
"IMPRINTING",1,NA
"IMPRISONED",1,NA
"IMPRISONMENT",5,NA
"IMPROVED COGNITIVE AND SOCIAL FUNCTIONING",1,NA
"IMPROVED NONDESTRUCTIVE METHOD",1,NA
"IMPROVED SENSITIVITY OF SORS, IDENTITY TESTING OF ILLICIT DRUGS",1,1
"IMPROVEMENT OF MEDICAL CARE",1,NA
"IMPROVISED EXPLOSIVE DEVICE (IED)",9,NA
"IMPROVISED FIREARMS",1,NA
"IMPROVIZED EXPLOSIVES",1,NA
"IMPULSE CONTROL DISORDER",1,NA
"IMPULSE CONTROL DISORDERS",2,NA
"IMPULSIVE AGGRESSION",1,NA
"IMPULSIVE STEALING",1,NA
"IMPULSIVENESS",2,NA
"IMPULSIVITY",17,NA
"IMPURITIES",15,51
"IMPURITIES PROFILE",1,1
"IMPURITY ANALYSIS",1,1
"IMPURITY CHARACTERIZATION",1,1
"IMPURITY PROFILING",27,57
"IMPUTABILITÉ",1,NA
"IMPUTABILITY",2,NA
"IMS-MS(/MS)",1,1
"IN-COLUMN HIGH-PRESSURE NEBULIZER",1,NA
"IN-CUSTODY DEATH",2,NA
"IN-FIELD DETECTION",1,1
"IN-HOUSE VALIDATION",1,1
"IN-LINE SOLID PHASE EXTRACTION",1,NA
"IN-LINE SPE-LC-MS/MS",1,NA
"IN-PATIENT",1,NA
"IN-PATIENT WARD",1,NA
"IN-SITU ANALYSIS",1,1
"IN-SITU FTIR MEASUREMENT",1,NA
"IN-SOURCE CID",2,2
"IN-SOURCE DECAY",1,NA
"IN-TUBE DERIVATISATION",1,NA
"IN-TUBE SOLID-PHASE MICROEXTRACTION",5,1
"IN-TUBE SPME",1,NA
"IN-VIAL STANDARD LOADING APPROACH",1,NA
"IN-VITRO METABOLISM",1,NA
"IN SILICO PREDICTION",1,NA
"IN SITU ANALYSIS",2,4
"IN SITU ANALYZES",1,NA
"IN SITU CRIME SCENE ANALYSIS",1,NA
"IN SITU DETECTION",1,1
"IN SITU PREPARATION",1,NA
"IN SITU REPEATABLE ANALYSIS",1,1
"IN SITU STABLE LABELED ISOTOPE GENERATION",1,NA
"IN SITU TESTING",1,NA
"IN UTERO EXPOSURE",4,NA
"IN VITRO",2,1
"IN VITRO-IN VIVO EXTRAPOLATION",1,NA
"IN VITRO AND IN VIVO METABOLISM",1,NA
"IN VITRO AND IN VIVO METABOLISM STUDIES",1,NA
"IN VITRO BIOTRANSFORMATION",2,NA
"IN VITRO EXPERIMENTS",2,NA
"IN VITRO METABOLISM",7,NA
"IN VITRO MODELS",1,NA
"IN VITRO PRODUCTION",1,NA
"IN VITRO STUDIES",1,NA
"IN VITRO TOXICOLOGY",1,NA
"IN VIVO AND IN VITRO MODELS",1,NA
"IN VIVO HUMAN METABOLISM",1,NA
"IN VIVO IMAGING",1,NA
"IN VIVO METABOLISM",3,NA
"IN VIVO STUDIES",1,NA
"IN VIVO TOXICOLOGY",1,NA
"IN VIVO TRAINING OF ATTENTION AND GOAL-DIRECTED BEHAVIOR",1,NA
"IN VIVO TRANSFECTION",1,NA
"IN VIVO, PHENCYCLIDINE",1,NA
"INABILITY TO DRIVE",1,NA
"INAPPROPRIATE CONTENTS",1,NA
"INAPPROPRIATE PRESCRIBING",2,NA
"INATTENTION",1,NA
"INBORN ERROR",1,NA
"INBORN ERRORS OF METABOLISM",1,NA
"INCANDESCENT LIGHT",1,NA
"INCAPACITATED",1,NA
"INCARCERATED",1,NA
"INCARCERATED ADULTS",1,NA
"INCARCERATED FEMALE JUVENILE DELINQUENTS",1,NA
"INCARCERATED YOUTH",1,NA
"INCARCERATION",7,NA
"INCEST",2,NA
"INCIDENCE",2,NA
"INCIDENCE RATE",1,NA
"INCIDENT DURING DESENSITIZATION, PENAL AND CIVIL LAW",1,NA
"INCIDENT RATE",1,NA
"INCIDENT REPORTING",1,NA
"INCIDENTAL FINDING",1,NA
"INCINERATED TEETH",1,NA
"INCISED WOUND",1,NA
"INCLUSION PROBABILITY",1,NA
"INCOMPATIBILITY REACTIONS",1,NA
"INCOMPETENCE TO STAND TRIAL",1,NA
"INCONTINENCE",1,NA
"INCORPORATION",2,NA
"INCREASE IN DRUG-LIKE SUBSTANCES",1,NA
"INCREASED DRUGGED DRIVING IN NORWAY",1,NA
"INCREASED PULMONARY CAPILLARY PRESSURE",1,NA
"INCREMENTAL SAMPLING",1,1
"INCRETINS",1,NA
"INCUBATION",1,NA
"INCUBATION METHANOLIC",1,NA
"IND",1,NA
"IND-ZN",1,NA
"INDANDIONE RODENTICIDE",1,NA
"INDANEDIONE-ZINC",1,NA
"INDANEDIONE ZINC",1,NA
"INDAPYROPHENIDONE",1,1
"INDAZOLE 7N POSITIONAL ISOMER",1,1
"INDAZOLE DERIVATIVE",1,1
"INDAZOLES",1,NA
"INDEL POLYMORPHISM",1,NA
"INDEMNITY",1,NA
"INDEMNITY PAYMENT",1,NA
"INDEX TERMS—DESIGN AUTOMATION, MICROFLUIDIC LAB-ON-CHIP",1,NA
"INDIA",1,1
"INDIAN SCENARIO",1,NA
"INDIAN YELLOW",1,NA
"INDICATIONS",2,NA
"INDICATIVE TESTING",1,2
"INDICATORS AND REAGENTS",1,NA
"INDIGO",1,NA
"INDIRECT",1,NA
"INDIRECT CHIRAL SEPARATION",1,2
"INDIRECT COMPETITIVE ELISA",1,NA
"INDIRECT FLUORESCENCE",1,1
"INDIRECT PATHWAY",1,NA
"INDIRECT SCREENING",1,NA
"INDIRECT TRANSFER",1,NA
"INDIRECT UV DETECTION",2,1
"INDIVIDUAL AGE",1,NA
"INDIVIDUAL IDENTIFICATION",1,NA
"INDIVIDUAL VARIABILITY",1,NA
"INDIVIDUALIZATION",1,1
"INDIVIDUALIZATION PARADIGM",1,NA
"INDIVIDUALIZED DOSAGE",1,NA
"INDOLE",2,7
"INDOLE COMPOUNDS",1,NA
"INDOLE DERIVATIVES",4,6
"INDOLEALKYLAMINES",1,NA
"INDOLEAMINE, METHYLATED",1,NA
"INDOOR CHEMISTRY",1,NA
"INDOOR MITES",1,NA
"INDUC-2R",1,NA
"INDUCED PSYCHOTIC DISORDER",1,NA
"INDUCEMENT",1,NA
"INDUCTION",1,NA
"INDUCTION DOSE",2,NA
"INDUCTIVELY COUPLED PLASMA ANALYSIS-MS",1,NA
"INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION SPECTROMETRY",1,2
"INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION SPECTROMETRY",1,1
"INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY",1,NA
"INDUSTRIAL ACCIDENT",1,NA
"INDUSTRIAL CLEANSERS",1,NA
"INEBRIATION PRIOR TO DEATH",1,NA
"INEQUALITIES",1,NA
"INEQUALITY",1,NA
"INFANCY",1,NA
"INFANCY INTOXICATIONS",1,NA
"INFANT",12,1
"INFANT DEATH",1,NA
"INFANT DEATHS",3,NA
"INFANT URINE",1,NA
"INFANTICIDE",6,NA
"INFANTS",3,NA
"INFANTS HAIR",1,NA
"INFECTION",4,NA
"INFECTIONS",1,NA
"INFECTIOSITY",1,NA
"INFECTIOUS DISEASE",1,NA
"INFECTIOUS DISEASES",3,NA
"INFECTIOUS MONONUCLEOSIS",1,NA
"INFECTIVE ENDOCARDITIS",2,NA
"INFERTILITY",1,NA
"INFESTATION",1,NA
"INFINITE ELUTION RANGE",1,1
"INFLAMMATION",3,1
"INFLAMMATORY CELLS",1,NA
"INFLAMMATORY CYTOKINE",1,NA
"INFLAMMATORY CYTOKINES",1,NA
"INFLUENCE FACTORS",1,NA
"INFLUENCE OF ALCOHOL, BOATING FATALITIES",1,NA
"INFLUENCING FACTORS",1,NA
"INFLUENZA A VIRUS",1,NA
"INFORMATION",2,NA
"INFORMATION-DEPENDENT ACQUISITION CONTROL",1,NA
"INFORMATION-INDEPENDENT ACQUISITION CONTROL",1,NA
"INFORMATION PROCESSING",1,NA
"INFORMATION RETRIEVAL",1,NA
"INFORMATION SPECIALISTS",1,NA
"INFORMATION SYSTEMS",2,NA
"INFORMATION TECHNOLOGY",1,NA
"INFORMATION THEORY",1,1
"INFORMED CONSENT",10,1
"INFORMERS",1,NA
"INFORMING PATIENTS",1,NA
"INFRARED ABSORPTION SPECTROSCOPY",1,1
"INFRARED AND RAMAN",1,NA
"INFRARED IMAGING",2,1
"INFRARED MICROSCOPE",1,NA
"INFRARED MICROSCOPIC TECHNIQUE",1,NA
"INFRARED MICROSCOPY",1,1
"INFRARED MICROSPECTROSCOPY",1,NA
"INFRARED PUPILLOGRAPHY",2,NA
"INFRARED RADIATION",9,1
"INFRARED RAMAN",1,1
"INFRARED RAYS",1,NA
"INFRARED SPECTRA",1,1
"INFRARED SPECTROSCOPIC HAIR ROOT ANALYSIS, IN GENETIC DISEASE DIAGNOSIS",1,NA
"INFRARED SPECTROSCOPIC IMAGING",1,1
"INFRARED SPECTROSCOPY (IR)",38,42
"INFRARED SPECTROSCOPY DEVELOPMENT, IN FORENSIC ANALYSIS",1,NA
"INFRARED SPECTROSCOPY, WITH ATR, TRANSMISSION, MICROSCOPY, AND IMAGING",1,NA
"INFRARED SPECTRUM",2,NA
"INFUSED PAPERS",1,NA
"INFUSION SET",1,NA
"INGAAS",1,NA
"INGESTION",4,NA
"INGREDIENT CONGENER",2,NA
"INGREDIENTS",1,1
"INHALANT",2,NA
"INHALANT ABUSE",3,NA
"INHALANTS",1,1
"INHALATION",4,2
"INHALATION ANAESTHETIC",1,NA
"INHALATION DRUG ABUSE",1,NA
"INHALATION OF FIRE FUMES",1,NA
"INHALERS",1,NA
"INHIBITION",5,NA
"INHIBITION IMMUNOASSAY",1,NA
"INHIBITOR",1,NA
"INHIBITORS",1,NA
"INHUMATION IN WATER",1,NA
"INITIAL CERTIFICATE",1,NA
"INITIAL TESTING",1,NA
"INITIAL TESTS",4,NA
"INITIATION TIME",1,NA
"INJECTABLE(S)",1,NA
"INJECTED",1,NA
"INJECTED DRUG ABUSE",1,NA
"INJECTING",1,1
"INJECTING DRUG ABUSE",1,NA
"INJECTING DRUG USE (IDU)",1,7
"INJECTING DRUG USER",1,NA
"INJECTING DRUG USERS",1,1
"INJECTION",4,1
"INJECTION-PORT DERIVATIZATION",2,NA
"INJECTION DRUG ABUSE",1,NA
"INJECTION DRUG USE ENDOCARDITIS",1,NA
"INJECTION DRUG USE INFECTIVE ENDOCARDITIS",1,NA
"INJECTION MARK",2,NA
"INJECTION MARKS",1,NA
"INJECTION MARKS (SECTIONS FROM)",1,NA
"INJECTION SITE",1,NA
"INJECTIONAL ANTHRAX",1,1
"INJURED DRIVERS",3,NA
"INJURY",13,NA
"INJURY AGE ESTIMATION",1,NA
"INJURY CASES",1,NA
"INJURY PATTERNS",1,NA
"INJURY PREVENTION",1,NA
"INJURY SEVERITY",2,NA
"INJURY SEVERITY SCORE",2,NA
"INJURY TIME",1,NA
"INJUSTICE",1,NA
"INK",8,3
"INK AGING",1,NA
"INK ANALYSIS",4,1
"INK DATING",3,NA
"INKJET",1,NA
"INKJET INK",1,NA
"INKPAD SEAL",1,NA
"INKS ANALYSIS",1,NA
"INMATE",1,NA
"INMATE BEHAVIORS",1,NA
"INMATE MISCONDUCT",1,NA
"INMATE RULE INFRACTIONS",1,NA
"INMATES",2,NA
"INNER STANDARD",1,NA
"INORGANIC CONSTITUENTS",1,NA
"INORGANIC EXPLOSIVES",2,NA
"INORGANIC GSR (IGSR)",1,NA
"INORGANIC IMPURITY",1,2
"INORGANIC OXIDIZERS",1,NA
"INORGANIC RESIDUES",2,NA
"INPATIENT",9,NA
"INPATIENT CARE FACILITIES",1,NA
"INPATIENT MANAGEMENT",1,NA
"INPATIENT MENTAL HEALTH TREATMENT",1,NA
"INPATIENT TREATMENT",1,NA
"INPATIENTS",6,NA
"INQUEST",1,NA
"INQUESTS",1,NA
"INQUIRIES",1,NA
"INQUIRY-BASED/DISCOVERY LEARNING",2,1
"INRUD INDICATORS",1,NA
"INSANITY",9,NA
"INSANITY DEFENCE",2,NA
"INSANITY DEFENSE",2,NA
"INSECT BEHAVIOR",1,NA
"INSECT BIOLOGY AND BEHAVIOR, LIMITING APPLICATIONS IN FORENSIC INVESTIGATIONS",1,NA
"INSECT DEVELOPMENT",3,NA
"INSECT GROWTH RATES",2,NA
"INSECT IDENTIFICATION",1,NA
"INSECT PHYSIOLOGY",1,NA
"INSECT SUCCESSION",4,NA
"INSECTICIDE",3,NA
"INSECTICIDES",5,NA
"INSECTIDES",1,NA
"INSECTS",5,NA
"INSECTS IN CANNABIS",1,NA
"INSEKTIZIDE, NACHWEIS IN EXHUMIERTEN LEICHEN",1,NA
"INSERTION/DELETION",1,NA
"INSIGHT",4,NA
"INSIGHT INTO ILLNESS",1,NA
"INSOMNIA",2,4
"INSTAGRAM MESSAGING",1,NA
"INSTAGRAM TV (IGTV)",1,NA
"INSTANT-VIEW™",1,NA
"INSTANT DETECTION",2,NA
"INSTANT URINE TESTS",1,NA
"INSTARS",1,NA
"INSTENT RESTENOSIS",1,NA
"INSTITUTE",1,NA
"INSTITUTION",1,NA
"INSTITUTIONAL CARE",1,NA
"INSTITUTIONAL MISCONDUCT",1,NA
"INSTITUTIONALIZATION",3,NA
"INSTRUMENT FOR FORENSIC TREATMENT EVALUATION (IFTE)",1,NA
"INSTRUMENT MALFUNCTION",1,NA
"INSTRUMENTAL ANALYSIS",3,NA
"INSTRUMENTAL METHODS",1,2
"INSTRUMENTAL NEUTRON ACTIVATION ANALYSIS",1,NA
"INSTRUMENTAL TECHNIQUES",1,1
"INSTRUMENTATION",3,NA
"INSUFFICIENT TEST EFFORT",1,NA
"INSUFFLATION",3,NA
"INSULA",1,NA
"INSULIN",18,NA
"INSULIN ACCIDENTS",1,NA
"INSULIN ANALOGUE",1,NA
"INSULIN ANALOGUES",1,NA
"INSULIN ANALYSIS",1,NA
"INSULIN IN POST-MORTEM BLOOD",1,NA
"INSULIN INFUSION SET",1,NA
"INSULIN OVERDOSE",1,NA
"INSULIN PUMP",1,NA
"INSULIN THERAPY",1,NA
"INSURANCE",2,NA
"INSURANCE MEDICINE",1,NA
"INSURER'S LIABILITY",1,NA
"INTACT POLAR LIPIDS",1,NA
"INTAKE ASSESSMENT",1,NA
"INTEGRATED",1,NA
"INTEGRATED ELECTROSPRAY IONIZATION SOURCE",1,NA
"INTEGRATED FORENSIC APPROACH",2,NA
"INTEGRATED FORENSIC PLATFORM",1,1
"INTEGRATED MANAGEMENT",1,NA
"INTEGRATED PLATFORMS",1,NA
"INTEGRATED PULSED AMPEROMETRY",1,NA
"INTEGRATED SERVICE MODEL",1,NA
"INTEGRATED TREATMENT",1,NA
"INTEGRATION",5,1
"INTEGRATION OF MICROELEMENTS",1,NA
"INTEGRINS",1,NA
"INTELLECTUAL DISABILITIES",1,NA
"INTELLECTUAL DISABILITY",11,NA
"INTELLECTUAL DISABILITY (ID)",1,NA
"INTELLECTUAL DISABILITY/MENTAL RETARDATION",1,NA
"INTELLECTUAL PROPERTY RIGHTS",1,NA
"INTELLIGENCE",11,5
"INTELLIGENCE-LED APPROACH",1,NA
"INTELLIGENCE-LED POLICING",1,NA
"INTELLIGENCE ARTIFICIELLE",1,NA
"INTELLIGENCE LED POLICING",1,1
"INTELLIGENT FOOD PACKAGING",1,NA
"INTENSITY",1,NA
"INTENSIVE CARE",2,1
"INTENSIVE INSULIN TREATMENT",1,NA
"INTENT",2,NA
"INTENTIONAL ACTS",1,NA
"INTENTIONAL INGESTION",1,NA
"INTENTIONAL INJURY",1,NA
"INTENTIONAL OVERDOSES",1,NA
"INTENTIONAL POISONING",1,NA
"INTENTIONAL SELF-INJURY",1,NA
"INTENTIONAL SELF-POISONING",1,NA
"INTER-AGENCY COMMUNICATION",1,NA
"INTER-INDIVIDUAL VARIATION",1,NA
"INTER-LABORATORY COMPARISON",2,2
"INTER-LABORATORY REPRODUCIBILITY",1,NA
"INTER-LABORATORY VARIATION",1,1
"INTER-SAMPLE CORRELATION",1,2
"INTER-VARIABILITY",1,NA
"INTERACTION",7,NA
"INTERACTIONS",3,1
"INTERACTIONS IN METABOLISM",1,NA
"INTERACTIONS, ETHANOL-BENZODIAZEPINE",1,NA
"INTERACTIVE FEEDBACK LOOP",1,NA
"INTERCALATING DYE",1,NA
"INTERCEPT",2,NA
"INTERCEPT I2",1,NA
"INTERCONVERSION",1,5
"INTERDISCIPLINARITY",1,NA
"INTERDISCIPLINARY",1,1
"INTERDISCIPLINARY CO-OPERATION",2,NA
"INTERDISCIPLINARY/ MULTIDISCIPLINARY",1,1
"INTERDISCIPLINARY/MULTIDISCIPLINARY",3,1
"INTERFACE",2,NA
"INTERFACES",2,1
"INTERFERENCE",8,2
"INTERFERENCE FROM LACTIC ACID WHEN USING AN ENZYMATIC BLOOD ALCOHOL METHOD",1,NA
"INTERFERENCE REMOVAL",1,NA
"INTERFERENTS",1,NA
"INTERFERING FLUORESCENCE ON SPECTRA, MID-IR SPECTROSCOPY MORE DESIRABLE",1,NA
"INTERFERON-Β-1B",1,NA
"INTERLABORATORY COMPARISON",2,NA
"INTERLABORATORY STUDIES",1,NA
"INTERLABORATORY VARIABILITY",1,NA
"INTERLEUKIN-17",1,NA
"INTERLEUKIN (IL)-8",1,NA
"INTERMAXILLARY FIXATION",1,NA
"INTERMEDIATE-POTENCY NEUROLEPTICS",1,NA
"INTERMEDIATE CYTOTROPHOBLAST",1,NA
"INTERMEDIN",2,NA
"INTERMITTENT EXPLOSIVE DISORDER",1,NA
"INTERNAL AMPLIFICATION CONTROL",1,NA
"INTERNAL AMPLIFICATION CONTROLS",1,NA
"INTERNAL CONCEALMENT",1,NA
"INTERNAL CONTROLS",1,NA
"INTERNAL INVESTIGATION",1,NA
"INTERNAL ORGANS",1,NA
"INTERNAL REFLECTION ELEMENT",1,1
"INTERNAL REFLECTION SPECTROSCOPY",2,2
"INTERNAL STANDARD METHOD",2,NA
"INTERNAL TRANSCRIBED SPACER",2,1
"INTERNAL TRANSCRIBED SPACER (ITS)",1,2
"INTERNAL TRANSCRIBED SPACER II (ITS2)",1,1
"INTERNAL USE",1,NA
"INTERNALIZATION",1,1
"INTERNATIONAL",1,NA
"INTERNATIONAL AGREEMENT",1,NA
"INTERNATIONAL ATOMIC ENERGY AGENCY",1,NA
"INTERNATIONAL CASE LAW",1,NA
"INTERNATIONAL CLASSIFICATION OF DISEASES",1,NA
"INTERNATIONAL CLASSIFICATION OF DISEASES: FATAL POISONING",1,NA
"INTERNATIONAL COMPARISON",1,NA
"INTERNATIONAL COOPERATION",1,NA
"INTERNATIONAL GUIDELINES",1,NA
"INTERNATIONAL OLYMPIC COMMITTEE",1,NA
"INTERNATIONAL TRENDS",1,NA
"INTERNET",10,23
"INTERNET OF THING (IOT)",2,NA
"INTERNET OF THINGS",1,1
"INTERNET TRACES",1,1
"INTERNET, INSTRUCTIONS FOR COMMITTING SUICIDE",1,NA
"INTERNET/WEB-BASED LEARNING",1,1
"INTERPERSONAL PSYCHOTHERAPY",1,NA
"INTERPERSONAL VIOLENCE",2,NA
"INTERPOL",2,NA
"INTERPRETATION",30,1
"INTERPRETATION OF ANALYTICAL RESULTS",1,NA
"INTERPRETATION OF POSTMORTEM FINDINGS, INCREASINGLY COMPLEX",1,NA
"INTERPRETATION OF POSTMORTEM RESULTS",1,NA
"INTERPRETATION OF RESULTS",1,NA
"INTERPRETATION OF THE RESULTS",1,NA
"INTERPRETATION OF TOXICOLOGICAL RESULTS",1,NA
"INTERPRETING",1,NA
"INTERPRETIVE TOXICOLOGY NEEDING STRENGTHENED SUPPORT FOR RELIABILITY",1,NA
"INTERROGATIONS",1,NA
"INTERRUPTION OF PREGNANCY",1,NA
"INTERSECTING LINES",1,NA
"INTERSECTIONALITY",1,NA
"INTERSPECIFIC VARIABILITY",1,NA
"INTERVENTION",6,1
"INTERVENTIONS",3,NA
"INTERVIEW",3,NA
"INTESTINAL ABSORPTION",1,NA
"INTESTINAL GLYCOBIOLOGY",1,NA
"INTESTINAL OBSTRUCTION",1,NA
"INTESTINAL PERFORATION",1,NA
"INTIMATE PARTNER",2,NA
"INTIMATE PARTNER HOMICIDE",1,NA
"INTIMATE PARTNER VIOLENCE",6,NA
"INTOXICANTS",1,NA
"INTOXICATED",1,NA
"INTOXICATION",159,16
"INTOXICATION BY METAMPHETAMINE",1,NA
"INTOXICATION DEATHS",1,NA
"INTOXICATION DEFENCE",1,NA
"INTOXICATION IN A CHILD",1,NA
"INTOXICATION WITH DRUGS, DISTRIBUTIONS IN ORGANS",1,NA
"INTOXICATION WITH PYRROLIDINOVALEROPHENONE",1,NA
"INTOXICATION, CHLOROQUINE",1,NA
"INTOXICATION, HYDROGEN PEROXIDE",1,NA
"INTOXICATION, PIPECURONIUM BROMIDE",1,NA
"INTOXICATION, PRAJMALIUM-BITARTRATE",1,NA
"INTOXICATION, TRICHLOROETHYLENE",1,NA
"INTRA- AND EXTRA-FAMILIAL",1,NA
"INTRA-ABDOMINAL",1,NA
"INTRA-GROUP HOMOGENEITY",1,NA
"INTRA-INTESTINAL",1,NA
"INTRA-LUMINAL",1,NA
"INTRA-VARIABILITY",1,NA
"INTRACEREBRAL AND PERIPHERIC HEMORRHAGES",1,NA
"INTRACEREBRAL HEMATOMA",2,NA
"INTRACEREBRAL HEMORRHAGE",4,NA
"INTRACORPOREAL",1,NA
"INTRACORPOREAL CHANNEL",1,NA
"INTRACRANIAL HEMATOMAS",1,NA
"INTRACRANIAL HEMORRHAGE",1,NA
"INTRACRANIAL STAB WOUND",1,NA
"INTRACTABLE PAIN",3,NA
"INTRALABORATORY COMPARISON",1,1
"INTRALABORATORY PROFICIENCY",1,1
"INTRALABORATORY TESTING",1,1
"INTRAMUSCULAR BLEEDING OF THE TONGUE",1,NA
"INTRAMUSCULAR INJECTION",4,NA
"INTRANASAL",1,1
"INTRANASAL APPLICATION",1,NA
"INTRAOCULAR FOREIGN BODIES",1,NA
"INTRAOCULAR LYMPHOMA",1,NA
"INTRAOCULAR TENSION",1,NA
"INTRAOSSEOUS INFUSION",1,NA
"INTRAPARENCHYMAL",1,NA
"INTRAPERITONEAL HEMORRHAGE",2,NA
"INTRASPECIFIC VARIABILITY",1,NA
"INTRATHECAL",2,NA
"INTRATRACHEAL TOXICOKINETIC STUDY",1,NA
"INTRAUTERINE",1,NA
"INTRAUTERINE EXPOSURE",1,NA
"INTRAVAGINAL ABSORPTION",1,NA
"INTRAVASCULAR CATHETER",1,NA
"INTRAVENONS APPLICATION",1,NA
"INTRAVENOUS",2,NA
"INTRAVENOUS (IV)",1,NA
"INTRAVENOUS ADDICTS",1,NA
"INTRAVENOUS ADMINISTRATION",3,NA
"INTRAVENOUS BAGS",1,NA
"INTRAVENOUS DRUG ABUSE",3,NA
"INTRAVENOUS DRUG ABUSER",1,NA
"INTRAVENOUS DRUG ADDICTION",1,NA
"INTRAVENOUS DRUG USE",2,NA
"INTRAVENOUS DRUG USE (IVDU)",1,NA
"INTRAVENOUS DRUG USER",1,NA
"INTRAVENOUS DRUG USERS",1,NA
"INTRAVENOUS FLUIDS",1,NA
"INTRAVENOUS INJECTION",10,NA
"INTRAVENOUS MISUSE",1,NA
"INTRAVITREAL INJECTION",1,NA
"INTRAVITREAL RITUXIMAB",1,NA
"INVERSE METHODS",1,NA
"INVESTIGATE",1,NA
"INVESTIGATING AUTHORITY",1,NA
"INVESTIGATING TOOL",3,NA
"INVESTIGATION OF CAUSE OF DEATH, FORENSIC MEDICINE CRITICS",1,NA
"INVESTIGATION OF DRUG CRIMES",1,NA
"INVESTIGATIONS",10,NA
"INVESTIGATIVE",1,NA
"INVESTIGATIVE ACTIONS",1,NA
"INVESTIGATIVE FORENSIC TOXICOLOGY",1,NA
"INVESTIGATIVE GENETICS",1,NA
"INVESTIGATIVE INFORMATION",1,NA
"INVESTIGATIVE TECHNIQUES",1,NA
"INVESTIGATOR 24PLEX",1,NA
"INVISIBLE INK",1,NA
"INVOLUNTARY",3,NA
"INVOLUNTARY ADMISSION",2,NA
"INVOLUNTARY ADMISSION OF THE MENTALLY ILL",1,NA
"INVOLUNTARY CARE",1,NA
"INVOLUNTARY CIVIL COMMITMENT",1,NA
"INVOLUNTARY COMMITMENT",3,NA
"INVOLUNTARY HOLD",4,NA
"INVOLUNTARY HOSPITALISATION",1,NA
"INVOLUNTARY HOSPITALIZATION",5,NA
"INVOLUNTARY MEDICATION",3,NA
"INVOLUNTARY PSYCHIATRIC CARE",1,NA
"INVOLUNTARY PSYCHIATRIC EXAMINATION",1,NA
"INVOLUNTARY TREATMENT",4,NA
"INVOLVEMENT SYSTEM",1,NA
"IODIDE",1,NA
"IODINATION",1,NA
"IODINE",2,NA
"IODINE-NAPHTHOFLAVONE",1,NA
"IODINE RADIOISOTOPES",1,NA
"ION-EXCHANGE",1,2
"ION-EXCHANGE CHROMATOGRAPHY",2,2
"ION-MOBILITY SPECTROMETRY",1,NA
"ION-PAIR CHROMATOGRAPHY",1,NA
"ION-PAIRING EXTRACTION",1,NA
"ION-PAIRING SOLID-PHASE EXTRACTION",1,NA
"ION-SELECTIVE ELECTRODE",1,1
"ION-SELECTIVE ELECTRODES",1,NA
"ION-TRAP",5,3
"ION-TRAP DETECTION",1,NA
"ION ANALYSIS",1,1
"ION ASSOCIATION",1,NA
"ION BEAM ANALYSIS",1,NA
"ION CHANNEL",1,NA
"ION CHANNELS",3,NA
"ION CHROMATOGRAPHY",7,2
"ION CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"ION CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",1,NA
"ION ENHANCEMENT",1,NA
"ION MOBILITY",2,3
"ION MOBILITY SPECTROMETRY (IMS)",17,37
"ION PGM™ SYSTEM",1,NA
"ION SUPPRESSION",6,1
"ION TORRENT PGM",1,NA
"ION TORRENT™ HID STR 10-PLEX",1,NA
"ION TRAP-MASS SPECTROMETRY",1,4
"ION TRAP GAS CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"ION TRAP GAS CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",1,NA
"ION TRAP GC-MS/MS",1,NA
"ION TRAP, GC- MS",1,NA
"IONBOOSTER™",1,NA
"IONIC GELATION",1,NA
"IONIC LIQUID",5,9
"IONIC LIQUIDS",5,4
"IONIC MATRICES",1,NA
"IONIZATION",4,4
"IONIZATION SOURCE",1,1
"IONIZATION TECHNIQUES",1,NA
"IONPAIR EXTRACTION",1,NA
"IONS",3,1
"IONSCAN® SWAB",1,NA
"IONTRAP",1,NA
"IOS FORENSICS",1,NA
"IP3R1",1,NA
"IPECAC",1,NA
"IPH",1,NA
"IPH CHARACTERISTICS",1,NA
"IPH PERPETRATOR CHARACTERISTICS",1,NA
"IPH PERPETRATORS",1,NA
"IPH RISK",1,NA
"IPH RISK FACTORS",1,NA
"IPOMOEA",1,2
"IPOMOEA PURPUREA",1,1
"IPSC",1,NA
"IPV",2,NA
"IR AND RAMAN SPECTROSCOPY, CHARACTERISING AUTHENTIC PHARMACEUTICAL LABELS",1,1
"IR AND RAMAN SPECTROSCOPY, EVIDENCE IN PHARMACEUTICAL FORENSIC CASES",1,1
"IR AND RAMAN SPECTROSCOPY, FORENSIC ANALYSIS OF DRUGS, EXPLOSIVES",1,NA
"IR AND RAMAN VIBRATIONAL SPECTROSCOPIC, EVIDENTIARY ROLE IN CRIMINAL CASES",1,NA
"IR SPECTRAL IMAGING, IN BICOMPONENT FIBRE ANALYSIS",1,NA
"IR SPECTROMETRY",1,NA
"IR SPECTROPHOTOMETRY",1,1
"IR SPECTROPHOTOMETRY—ANALYSIS",1,NA
"IR SPECTROSCOPIC ANALYSIS, AND GENERAL POLYMER ANALYSIS",1,NA
"IR SPECTROSCOPY, LEVEL OF MATURITY IN FORENSIC, RAMAN SPECTROSCOPY, A BEGINNING",1,NA
"IRAN",16,3
"IRE",1,1
"IRELAND",3,1
"IRISH PRISON SYSTEM",1,NA
"IRISH TRAVELLERS",1,NA
"IRISPLEX",2,NA
"IRM-13C NMR",1,NA
"IRON",1,1
"IRON COMPLEXATION",2,NA
"IRON DETERMINATION",1,NA
"IRON ENCRUSTATION",1,NA
"IRON GALL INK",1,NA
"IRON IMPURITY",1,NA
"IRON OVERDOSE",1,NA
"IRON(II)",1,NA
"IRREGULARITY OF HEART RATE",1,NA
"IRRIGATION SYSTEMS",1,NA
"IRRITATION",1,NA
"IRTD-DART-MS",1,NA
"ISAS SCALE",1,NA
"ISCHAEMIC HEART DISEASE",3,NA
"ISCHEMIA",3,NA
"ISCHEMIA-REPERFUSION INJURY",1,NA
"ISCHEMIA MODIFIED ALBUMIN",1,NA
"ISCHEMIC",2,NA
"ISCHEMIC HEART DISEASE",2,NA
"ISO-BUTYL NITRITE",1,NA
"ISO-LSD",1,1
"ISO-PENTYL NITRITE",1,NA
"ISO-Α-ACIDS",2,NA
"ISO 5725",1,NA
"ISO GUIDE 34",1,NA
"ISO/IEC 17025",1,1
"ISOBARIC",1,1
"ISOBUTANE",2,NA
"ISOELECTRIC BUFFERS",1,NA
"ISOELECTRIC FOCUSING",3,1
"ISOLATED DEATH",1,NA
"ISOLATION",8,13
"ISOLATION UNITS",1,NA
"ISOMER",11,7
"ISOMER DIFFERENTIATION",2,1
"ISOMERIC DIFFERENTIATION",1,1
"ISOMERIC DRUGS",1,1
"ISOMERIC SEPARATION",1,NA
"ISOMETHEPTENE",1,NA
"ISOOCTANE",1,NA
"ISOPAR H",1,NA
"ISOPROPANOL",1,NA
"ISOPROPYL-U-47700",1,NA
"ISOPROPYL ALCOHOL",1,NA
"ISOPROPYL PARAQUAT",1,NA
"ISOPROPYLBENZYLAMINE",1,1
"ISOPROTEIN",1,NA
"ISOSCAPE",3,2
"ISOTACHOPHORESIS",2,NA
"ISOTHERMAL AMPLIFICATION",1,2
"ISOTONITAZENE",1,1
"ISOTOPE DILUTION",7,2
"ISOTOPE DILUTION MASS SPECTROMETRY",3,1
"ISOTOPE DILUTION MASS SPECTROMETRY (IDMS)",1,NA
"ISOTOPE DILUTION MC-ICP-MS",1,NA
"ISOTOPE ENRICHMENT",1,NA
"ISOTOPE FRACTIONATION",1,1
"ISOTOPE GEOCHEMISTRY",1,NA
"ISOTOPE PURIFICATION",1,NA
"ISOTOPE RATIO",9,9
"ISOTOPE RATIO ANALYSIS",1,NA
"ISOTOPE RATIO MASS SPECTROMETRY (IRMS)",28,36
"ISOTOPE SIGNATURE",1,1
"ISOTOPES",7,4
"ISOTOPIC ABUNDANCES",1,1
"ISOTOPIC ANALYSIS",3,3
"ISOTOPIC COMPOSITION",2,1
"ISOTOPIC COMPOSITION OF URANIUM",1,NA
"ISOTOPIC COMPOSITION OF URANIUM PARTICLES",1,NA
"ISOTOPIC DILUTION",1,NA
"ISOTOPIC FRACTIONATION",1,2
"ISOTOPIC LANDSCAPE",1,NA
"ISOTOPIC PROFILE",1,NA
"ISOTOPIC PROFILING",1,2
"ISOTOPIC RATIO",1,NA
"ISOTOPIC SIGNATURE",1,1
"ISOTOPIC SIGNATURES",1,NA
"ISOTOPOLOGUE",1,1
"ISOZYME",3,NA
"ISOZYME MAPPING",1,NA
"ISRAEL",2,2
"ISSUE 116",1,1
"ISSUE 132",1,NA
"ISSUE 85",1,NA
"ITALIAN LAW",1,NA
"ITALY",3,3
"ITALY/EPIDEMIOLOGY",1,NA
"ITEM RESPONSE MODEL",1,NA
"ITEMS OF RECOVERY",1,NA
"ITERATIVE ALGORITHM",1,NA
"ITS",1,2
"ITS1",1,1
"ITS2",1,3
"IUCN RED LIST",1,NA
"IV DRUG USERS",1,NA
"IVABRADINE",1,NA
"IVABRADINE HYDROCHLORIDE",1,NA
"IVDA",1,NA
"IVERMECTIN",1,NA
"IVF",1,NA
"IVORY",1,NA
"IVORY DATING",1,NA
"JAIL",6,NA
"JAIL DIVERSION",1,NA
"JAIL INMATES",1,NA
"JAIL SUICIDE",1,NA
"JAILS",1,NA
"JAK-STAT SIGNALING PATHWAY",1,NA
"JAMAICA",1,NA
"JAMAICAN VOMITING SICKNESS",2,NA
"JAMNAGAR",1,NA
"JAPAN",1,3
"JAPANESE",2,NA
"JAPANESE MACAQUE",1,NA
"JAPANESE PATTERN OF POISONING",1,NA
"JAPANESE POPULATION",1,NA
"JATROPHA SEINERI PAX",1,NA
"JC VIRUS",1,NA
"JCAHO",1,NA
"JESNESS INVENTORY",1,NA
"JEWELLERY",1,NA
"JIEYANG HAN POPULATION",1,NA
"JIMSONWEED",1,2
"JOB SATISFACTION ENVIRONMENTAL FACTORS",1,NA
"JORDAN",7,NA
"JOULLIÉ'S PINK",1,NA
"JUDGE",1,NA
"JUDGE IN CHARGE OF APPLYING SENTENCES (JUDGE OF PROBATION)",1,NA
"JUDGEMENT",1,NA
"JUDICIAL ACCEPTANCE",1,NA
"JUDICIAL CHALLENGES",1,NA
"JUDICIAL DEATHS",1,NA
"JUDICIAL EXPERTISE",1,NA
"JUDICIAL INVESTIGATION",1,NA
"JUDICIAL SUPERVISION",1,NA
"JUDICIAL TRIALS",1,NA
"JUDICIALIZATION OF HEALTH",1,NA
"JUDICIOUS AUTOPSY",1,NA
"JUICES",1,NA
"JUMP FROM HEIGHT",1,NA
"JUMPING",1,NA
"JUNK SCIENCE",1,NA
"JURISDICTION",1,NA
"JURISPRUDENCE",7,NA
"JURY",2,NA
"JURY DECISION MAKING",1,1
"JUSTICE",4,NA
"JUSTICE SYSTEM",1,NA
"JUSTIFIED OFF-LABEL DRUG USE",1,NA
"JUVENILE",2,NA
"JUVENILE ASSESSMENT",1,NA
"JUVENILE CRIME",1,NA
"JUVENILE DELINQUENCY",9,NA
"JUVENILE DELINQUENTS",3,NA
"JUVENILE DETAINEES",1,NA
"JUVENILE DRUG CENTRES",1,NA
"JUVENILE JUSTICE",2,NA
"JUVENILE JUSTICE SYSTEM",1,NA
"JUVENILE OFFENDER",3,NA
"JUVENILE OFFENDERS",2,NA
"JUVENILE PSYCHOLOGICAL FUNCTIONING",1,NA
"JUVENILES",1,NA
"JWH",3,2
"JWH- 018",1,NA
"JWH-015",1,1
"JWH-018",20,17
"JWH-018 N-(3-HYDROXYPENTYL) METABOLITE",1,NA
"JWH-019",1,1
"JWH-073",7,7
"JWH-081",3,5
"JWH-122",8,4
"JWH-122 METABOLITES",1,NA
"JWH-133",1,NA
"JWH-200",2,1
"JWH-203",1,1
"JWH-210",3,2
"JWH-210 AND UR-144",1,NA
"JWH-213",1,1
"JWH-250",1,4
"JWH-251",1,1
"JWH-412",1,1
"JWH, AKB48",1,1
"K-10",1,NA
"K-12 EDUCATION",1,NA
"K-NEAREST NEIGHBORS",1,1
"K-NEAREST NEIGHBOUR (K-NN)",2,4
"K IN HAIR",1,NA
"K NEAREST NEIGHBOR ALGORITHM",1,1
"K P",1,NA
"K0-INAA",1,NA
"K2",5,2
"K2 TOXICITY",1,NA
"K2P DISTANCE",1,NA
"KAMBO",1,NA
"KANGRA",1,NA
"KANNA",1,1
"KAPOSI SARCOMA",1,NA
"KAROLINSKA SCALES OF PERSONALITY",1,NA
"KASTLE-MEYER",1,NA
"KASTLE-MEYER TEST",1,NA
"KATAMNESIS",1,NA
"KAVA",2,NA
"KAVALACTONES",1,NA
"KAYAKING",1,NA
"KAYEXALATE",1,NA
"KBR-FTIR",1,1
"KCNE",1,NA
"KCNH2",1,NA
"KCNQ1",1,NA
"KENYA",2,1
"KERALA POPULATION",1,NA
"KERATIN",3,1
"KERATINIZED MATRICES",1,NA
"KERATINIZED MATRIX",2,NA
"KERATINOUS BIOLOGICAL MATERIAL",1,NA
"KERATINS",1,NA
"KERNEL BASED-METHODS",1,NA
"KERNEL METHODS",1,1
"KEROSENE",2,NA
"KETALS",1,1
"KETAMINE",82,45
"KETAMINE .A SINGLE DOSE",1,NA
"KETAMINE ANALOGUE",2,NA
"KETAMINE HYDROCHLORIDE",1,NA
"KETOACIDOSIS",6,NA
"KETOBEMIDONE",1,NA
"KETONE",1,3
"KETONE BODIES",2,NA
"KETOPROFEN",1,NA
"KETOROLAC",1,NA
"KETOTIFEN",1,NA
"KETUM",1,2
"KETUM DRINK",1,1
"KETUM EXTRACTS",1,1
"KEY WORDS CARDIOMYOPATHY",1,NA
"KEYWORDS",1,NA
"KHAT",6,22
"KICKING",1,NA
"KIDNAPPING",1,NA
"KIDNEY",6,NA
"KIDNEY ACCUMULATION",1,NA
"KIDNEY BIOPSY",1,NA
"KIDNEY INJURY",1,NA
"KIDNEY TRANSPLANT",2,NA
"KIDNEY TRANSPLANTATION",1,NA
"KIDNEYS",2,NA
"KILLING IN OLD AGE",1,NA
"KINESISKOP",1,NA
"KINETIC DETERMINATION",1,1
"KINETIC INTERACTION OF MICROPARTICLES IN SOLUTION (KIMS) SCREENING",1,NA
"KINETIC PARAMETERS",2,1
"KINETICS",6,5
"KINGSTON",1,NA
"KINSHIP ANALYSIS",1,NA
"KINSHIP INVESTIGATION",1,NA
"KLANG VALLEY",1,NA
"KLEBSIELLA PNEUMONIAE",1,NA
"KLEBSIELLA QUASIPNEUMONIAE SUBSP. SIMILIPNEUMONIAE",1,NA
"KLEINE-LEVIN SYNDROME",1,NA
"KLEPTOMANIA",1,NA
"KLF14",1,NA
"KM-X1",1,NA
"KM TEST",1,NA
"KNEE INJURY",1,NA
"KNEE JOINT SYNOVIAL FLUID",1,NA
"KNOCKOUT DRUGS",1,NA
"KNOWN NON-CONTRIBUTOR",1,NA
"KNOWN UNKNOWNS",1,1
"KOLMOGOROV-SMIRNOV TEST",1,1
"KOR",1,NA
"KOREA",1,1
"KOREAN",1,NA
"KOREAN POPULATION",1,NA
"KOREANS",2,NA
"KOVÁTS RETENTION INDEX.",1,NA
"KRATOM",13,34
"KRATOM DEATHS",1,NA
"KREISCHER MANSION HOMICIDE",1,NA
"KROKODIL",1,4
"KRYPTON",2,NA
"KSP",1,NA
"KUBELKA-MUNK",1,NA
"KULLU",1,NA
"KUWAIT",5,1
"L-CYSTEINE",1,1
"L-DOPA",1,NA
"L-LYSINE",1,1
"L-METHAMPHETAMINE",1,NA
"L-TPC",1,3
"L374F",1,NA
"LABEL-FREE",1,2
"LABELLED",1,NA
"LABELLING",1,2
"LABETALOL",1,NA
"LABILE ANALYTE",1,NA
"LABORATORIES, FORENSIC",1,NA
"LABORATORY",7,2
"LABORATORY-ON-A-CHIP",1,NA
"LABORATORY ACCREDITATION",1,NA
"LABORATORY AUTOMATION",3,1
"LABORATORY DIAGNOSTIC",1,NA
"LABORATORY EQUIPMENT/APPARATUS",1,NA
"LABORATORY ERRORS",1,NA
"LABORATORY INSTRUCTION",8,5
"LABORATORY ORGANIZATION",1,NA
"LABORATORY STAFF",1,NA
"LABORATORY STANDARDS",1,NA
"LABORATORY TEST",2,NA
"LABORATORY TESTS",1,NA
"LABORTARY TESTING",1,NA
"LABOUR CAMPS",1,NA
"LACCIFER LACCA",1,NA
"LACERATION",1,NA
"LACK OF ALCOHOLISATION AND DRUG-INFLUENCE",1,NA
"LACK OF CONCURRENT AND PREDICTIVE VALIDITY",1,NA
"LACK OF EFFICACY",1,NA
"LACOSAMIDE",2,NA
"LACTATE",1,NA
"LACTATE DEHYDROGENASE (LDH)",1,NA
"LACTIC ACIDOSIS",2,NA
"LACTOFERRIN",1,NA
"LACTOSE",1,2
"LACUNAR AMNESIA",1,NA
"LADME PRINCIPLE",1,NA
"LAHORE",1,NA
"LAHORE GENERAL HOSPITAL",1,NA
"LAKES",1,1
"LAMA (LEFT AGAINST MEDICAL ADVICE)",1,NA
"LAMIACEAE",1,2
"LAMINECTOMY",1,NA
"LAMINITIS",1,NA
"LAMIVUDINE",1,NA
"LAMIVUDINE + ABACAVIR",1,NA
"LAMOTRIGINE",4,NA
"LAMP",2,1
"LANDMINES",1,NA
"LANGENDORFF-HEART",1,NA
"LANGUAGE POLICY",1,NA
"LANTHANIDE",2,NA
"LANTHANIDES",3,NA
"LANTHANUM NITRATE",1,1
"LAP-BAND",1,NA
"LAP SEAT BELT",1,NA
"LAPAROSCOPIC ADJUSTABLE BAND",1,NA
"LAPAROTOMY",1,NA
"LARGE-VOLUME INJECTION",2,NA
"LARGE-VOLUME PROGRAMMED-TEMPERATURE VAPORISER INJECTION",1,NA
"LARGE SAMPLES",1,NA
"LARGE VOLUME INJECTION-GAS CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"LARGE VOLUME WATER",1,NA
"LARVAE",11,NA
"LARVAL AGE",2,NA
"LARVAL DISPERSION",1,NA
"LARVAL EXCRETION/SECRETION",1,NA
"LARVAL GROWTH RATE",1,NA
"LARVAL STAGES",1,NA
"LARVAL THERAPY",1,NA
"LARYNGEAL OBSTRUCTION",1,NA
"LARYNGEAL POLYP",1,NA
"LARYNX",1,NA
"LAS VEGAS",1,NA
"LASER",5,1
"LASER-INDUCED FLUORESCENCE (LIF)",3,6
"LASER-INDUCED NATIVE FLUORESCENCE",1,NA
"LASER ABLATION",5,3
"LASER ABLATION-ICP-MS",1,NA
"LASER ABLATION INDUCTIVELY COUPLED PLASMA (LA-ICP)",1,NA
"LASER DESORPTION",1,NA
"LASER DESORPTION AND IONIZATION",1,NA
"LASER DESORPTION IONIZATION",2,NA
"LASER DESORPTION IONIZATION MASS SPECTROMETRY",1,1
"LASER DESORPTION MASS SPECTROMETRY",3,NA
"LASER EXCITATION WAVELENGTH",1,1
"LASER INDUCED FLUORESCENCE (LIF)",1,NA
"LASER MASS SPECTROMETRY",1,NA
"LASER MELTING",1,NA
"LASER MICROSCOPY, PHARMACOKINETICS OF DRUG INCORPORATION INTO HAIR",1,NA
"LASER POST-IONIZATION",1,NA
"LAST DRUG USE",1,NA
"LAST MEAL IDENTIFICATION",1,NA
"LAST WILL",1,NA
"LATE SEQUELAE",1,NA
"LATENT",3,NA
"LATENT CLASS ANALYSIS",2,1
"LATENT CLASSES",1,NA
"LATENT DIRICHLET ALLOCATION",2,NA
"LATENT DNA",1,NA
"LATENT FINGERMARK DEVELOPMENT",1,NA
"LATENT FINGERMARKS",9,NA
"LATENT FINGERPRINT DEVELOPMENT",1,NA
"LATENT FINGERPRINTS",24,3
"LATENT FINGERPRINTS ENHANCEMENT",1,NA
"LATENT FOOTWEAR MARKS",1,NA
"LATENT GROWTH CURVE ANALYSIS",1,NA
"LATENT GROWTH MODELS",2,NA
"LATENT IMPRINTS",1,NA
"LATENT PRINT",1,NA
"LATENT PRINT DETECTION",1,NA
"LATENT PRINT DEVELOPMENT",1,NA
"LATENT PRINT PROCESSING",1,NA
"LATENT PRINTS",1,NA
"LATENT PRINTS DEVELOPMENT",1,NA
"LATENT PROFILE ANALYSIS",3,NA
"LATERAL FLOW ASSAY",1,1
"LATERAL FLOW IMMUNOASSAY",3,5
"LATERAL FLOW STRIP",1,NA
"LATERAL FLOW STRIP TEST",1,NA
"LATEX AGGLUTINATION INHIBITION REACTION TEST",2,NA
"LATEX PARTICLES",1,NA
"LATIN AMERICA",1,1
"LATITUDE",1,NA
"LATTICE",1,NA
"LAUDANINE",1,2
"LAUDANOSINE",1,1
"LAUNDERED BLOODSTAIN",1,NA
"LAW",16,1
"LAW ENFORCEMENT",11,8
"LAW ENFORCEMENT AGENCIES",1,NA
"LAW ENFORCEMENT OFFICERS",2,1
"LAW ENFORCEMENT PERSONNEL",1,NA
"LAW INFRINGEMENT",1,NA
"LAW ON NARCOTIC DRUGS",1,NA
"LAWS ON HELP AND DETENTION OF THE MENTALLY ILL",1,NA
"LAWSONE",2,NA
"LAWSONE (2-HYDROXY-1,4-NAPHTHOQUINONE)",1,NA
"LAWSUIT",1,NA
"LAWYER",1,NA
"LAXATIVE",1,NA
"LAY BELIEFS",1,NA
"LAYER-SPECIFIC PROTEINS",1,NA
"LC-(HR)-MSN",1,NA
"LC-APCI-MS",2,NA
"LC-APCI-MS-MS",2,NA
"LC-CLND",1,NA
"LC-DAD",3,1
"LC-DAD-ORBITRAP MS",1,NA
"LC-ELECTROLYTE EFFECTS",1,NA
"LC-ES-MS/MS",1,NA
"LC-ESI",1,NA
"LC-ESI-IT-TOF-MS",1,NA
"LC-ESI-MS",8,4
"LC-ESI-MS-MS",2,NA
"LC-ESI-MS (/MS)",1,NA
"LC-ESI-MS/MS",7,2
"LC-ESI-QTOF",1,NA
"LC-ESI-QTOF-MS",1,1
"LC-HR-MS",1,NA
"LC-HR-MS N",1,NA
"LC-HR-MS/MS",4,1
"LC-HR-MSN",1,NA
"LC-HRMS",16,5
"LC-HRMS/MS",7,NA
"LC-ICP-MS",1,NA
"LC-ION TRAP MS",1,NA
"LC-MC ETC.",1,NA
"LC-MS ANALYSIS",2,NA
"LC-MS, HIGH-RESOLUTION MASS SPECTROMETRY",1,NA
"LC-MS/APCI METHODS",1,NA
"LC-MS/MS ANALYSIS",2,NA
"LC-MS/MS ION TRAP",1,NA
"LC-MS/MS LIBRARY OF DRUGS",1,NA
"LC-MS/MS SCREENING",1,NA
"LC-MS/MS TRIPLE QUADRUPOLE",1,NA
"LC-MS/MS/MS",1,NA
"LC-NMR",1,2
"LC-Q-TOF-MS",2,NA
"LC-Q-TOF-MS/MS",2,NA
"LC-Q-TOF/MS",1,NA
"LC-Q/TOF-MS",5,NA
"LC-QE",1,NA
"LC-QQQ-MS",3,NA
"LC-QTOF",1,1
"LC-QTOF-MS",8,NA
"LC-QTOF-MS/MS",1,NA
"LC-TOF-MS",3,2
"LC-TOFMS",1,NA
"LC-TRIPLE TOF",1,NA
"LC-UV",1,5
"LC-UV ANALYSIS",1,1
"LC−HRMS/MS",2,NA
"LC−MS/MS",1,NA
"LC - MS/MS",2,NA
"LC MS",1,NA
"LC MS/MS",1,1
"LC/APCI/MS",1,NA
"LC/APCI/MS/MS ANALYSIS",1,NA
"LC/ES/MS",1,NA
"LC/ESI-MS/MS",1,3
"LC/ESI/MS",1,NA
"LC/MS-APCI",1,NA
"LC/MS-TOF",1,NA
"LC/MS (APCI)",1,NA
"LC/MS/MS, LOCAL ANESTHETIC, ANALYSIS, SOLID PHASE EXTRACTION",1,NA
"LC/MSMS",1,NA
"LC/MSN",1,NA
"LC/Q-TOFMS",1,NA
"LC/TOF-MS",1,NA
"LC/TOF-MS SCREENING FOR DESIGNER DRUGS IN SEIZED SAMPLES",1,1
"LC/TOFMS",1,NA
"LC3",1,NA
"LC3B",1,NA
"LCE1C",1,NA
"LCGREEN PLUS®",1,NA
"LCV",2,NA
"LD50",1,NA
"LDA",1,3
"LDLR",3,NA
"LEAD",6,2
"LEAD (II) ACETATE",1,1
"LEAD INTOXICATION",1,NA
"LEAD ISOTOPIC RATIO",2,NA
"LEAD POISONING",1,NA
"LEADERSHIP",1,NA
"LEAN COCKTAIL",1,1
"LEARNING",1,NA
"LEARNING DISABILITY",6,NA
"LEARNING DISORDERS",1,NA
"LEAST SQUARE SUPPORT VECTOR REGRESSION(LSSVR)",1,NA
"LEBANON",1,NA
"LEBER'S HEREDITARY OPTIC NEUROPATHY",1,NA
"LECTIN",2,NA
"LECTIN AS ANTINUTRIENTS",1,NA
"LECTINS",1,NA
"LEDGERS",1,NA
"LEFT HEART BLOOD",1,NA
"LEFT ILIAC VESSELS",1,NA
"LEFT VENTRICULAR PRESSURE",1,NA
"LEGAL",6,2
"LEGAL-MEDICAL COLLUSION AND COLLISION WITH CODE OF CRIMINAL PROCEDURE",1,NA
"LEGAL ASPECTS",1,NA
"LEGAL ASSISTANCE",1,NA
"LEGAL AWARENESS",1,NA
"LEGAL BRIEFS",1,NA
"LEGAL CASE",1,NA
"LEGAL CHARACTERISTICS",1,NA
"LEGAL CONSIDERATIONS",1,NA
"LEGAL CULPABILITY",1,NA
"LEGAL DOCUMENTATION",1,NA
"LEGAL DRUG ALTERNATIVES",1,2
"LEGAL FRAMEWORK",3,NA
"LEGAL HIGHS",46,55
"LEGAL HISTORY",1,NA
"LEGAL IMPLICATION",1,NA
"LEGAL IMPLICATIONS",1,NA
"LEGAL INCAPACITY",1,NA
"LEGAL INSANITY",3,NA
"LEGAL INTERVENTION",1,NA
"LEGAL ISSUES",2,1
"LEGAL LEVERAGE",1,NA
"LEGAL LIABILITY",2,NA
"LEGAL LIABILITY: THIRD-PARTY LIABILITY",1,NA
"LEGAL LIMITS",3,NA
"LEGAL MEDICINE",23,NA
"LEGAL METHODS OF SUICIDE",1,NA
"LEGAL OUTCOMES",1,NA
"LEGAL PERMISSIBILITY",1,NA
"LEGAL PROCESS",1,NA
"LEGAL REACTION",1,NA
"LEGAL REGULATION",1,NA
"LEGAL REGULATIONS",1,NA
"LEGAL RELEVANCE",1,NA
"LEGAL REPRESENTATIVE",1,NA
"LEGAL RESPONSIBILITY",1,NA
"LEGAL SITUATION",2,NA
"LEGAL STATUS",3,4
"LEGAL SYSTEM",1,NA
"LEGAL THRESHOLD",1,NA
"LEGAL WORK",1,NA
"LEGAL/ILLEGAL USE",1,NA
"LEGISLATION AND JURISPRUDENCE",21,10
"LEGISLATION FOR APPLICATION OF DRUGS",1,NA
"LEGISLATIVE LIMITS",3,NA
"LEIGONGTENG",1,NA
"LENGTH OF HOSPITALIZATION STAY",1,NA
"LENGTH OF STAY",3,NA
"LEPONEX®",1,NA
"LEPTIN",1,NA
"LETHAL",6,NA
"LETHAL BLOOD-LEVELS",1,NA
"LETHAL COMPLICATION",1,NA
"LETHAL CONCENTRATION",1,NA
"LETHAL CONCENTRATIONS",1,NA
"LETHAL DESIGNER DRUG INTOXICATION",1,NA
"LETHAL DOSE 50",1,NA
"LETHAL DRUG INTERACTION",1,NA
"LETHAL ETHANOL INTOXICATION",1,NA
"LETHAL FENTANYL INTOXICATION",1,NA
"LETHAL HEMORRHAGE",1,NA
"LETHAL HYPOGLYCAEMIA",1,NA
"LETHAL INJECTION",1,NA
"LETHAL INTOXICATION",10,NA
"LETHAL INTOXICATIONS, CODEINE, MORPHINE",1,NA
"LETHAL ISSUE",1,NA
"LETHAL MEANS",1,NA
"LETHAL POISONING",2,NA
"LETHAL POISONING BY E-605 INTRAVENOUS APPLICATION POISONING, E-605",1,NA
"LETHAL POISONING BY OPIATES",1,NA
"LETHAL VIOLENCE",1,NA
"LETHALITY",2,NA
"LETROZOLE",1,NA
"LEUCHOMALAQUITE GREEN",1,NA
"LEUCKARDT METHOD",1,1
"LEUCKARDT REACTION",1,1
"LEUCKART",1,1
"LEUCKART'S METHOD",1,NA
"LEUCKART SYNTHESIS",2,4
"LEUCOCRYSTAL VIOLET",2,NA
"LEUCOCRYSTAL VIOLET (LCV)",1,NA
"LEUCOMALACHITE GREEN",1,NA
"LEUKAEMIA",1,NA
"LEUKOCYTE",2,NA
"LEUKOCYTES",1,NA
"LEUKOCYTOCLASTIC VASCULITIS",1,NA
"LEVAMISOLE",15,10
"LEVAMISOLE ADULTERATION",1,NA
"LEVEL",1,NA
"LEVEL OF LC/TOF-MS PERFORMANCE REQUIRED FOR SCREENING",1,1
"LEVELS OF COCAINE",1,NA
"LEVELS STORAGE",1,NA
"LEVETIRACETAM",3,NA
"LEVITRA",1,1
"LEVOMEDETOMIDINE",1,NA
"LEVOMEPROMAZINE",1,NA
"LEVOMETHADONE",1,NA
"LEVOMETHORPHAN",2,3
"LEWISITES",1,NA
"LEX CORNELIA DE VENEFICIS",2,NA
"LEXPOSURE",1,NA
"LFIA",1,NA
"LGBT",1,NA
"LH",1,NA
"LH-RH AGONISTS",1,NA
"LHRH-AGONIST",1,NA
"LHRH-AGONISTS",1,NA
"LHRH AGONISTS",2,NA
"LIABILITY",8,NA
"LIABILITY TO INJURY",1,NA
"LIABILITY, LEGAL",1,NA
"LIBERTY",1,NA
"LIBRARIES, MS",1,1
"LIBRARY",3,4
"LIBRARY SEARCH",2,5
"LIBRARY SEARCHING",2,1
"LIBRIUM",1,NA
"LICENSED INDICATIONS",1,NA
"LICIT AND ILLICIT DRUGS",1,NA
"LICIT DRUGS",2,NA
"LIDA",1,NA
"LIDOCA INE",1,NA
"LIDOCAINE",25,3
"LIDOCAINE/TOXICITY",1,NA
"LIE-DETECTOR",1,NA
"LIE DETECTION",2,NA
"LIES",1,NA
"LIF",1,NA
"LIFE-THREATENING INJURIES",1,NA
"LIFE COURSE",1,NA
"LIFE HISTORY OF AGGRESSION",1,NA
"LIFE HISTORY PARAMETER",1,NA
"LIFE INSURANCE",1,NA
"LIFE SENTENCE",1,NA
"LIFT",1,1
"LIFTING",1,NA
"LIGAND",1,NA
"LIGAND FIELD",1,NA
"LIGAND FLEXIBILITY",1,NA
"LIGATURE",2,NA
"LIGATURE MARK",1,NA
"LIGATURE MARKS",1,NA
"LIGATURE STRANGULATION",1,NA
"LIGHT AIRCRAFT",1,NA
"LIGHT EXPOSURE",1,NA
"LIGHT MINERAL FRACTION",1,NA
"LIGHT VOLATILE ORGANIC COMPONENTS",1,NA
"LIGNAN GLYCOSIDE",1,NA
"LIGNIN",1,1
"LIGNOCAINE",2,NA
"LIKELIHOOD PARADIGM",1,NA
"LIKELIHOOD RATIO",19,11
"LIKELIHOOD RATIO DISTRIBUTIONS",1,NA
"LIMB LESION",1,NA
"LIMBIC SYSTEM",2,NA
"LIMIT OF DETECTION (LOD)",3,4
"LIMIT OF QUANTITATION",2,NA
"LIMIT VALUES",1,NA
"LIMITED AUTOPSY",1,NA
"LIMITED SAMPLE VOLUME",1,NA
"LIMS",1,1
"LINCOMYCIN",1,NA
"LINEAR DISCRIMINANT ANALYSIS",3,5
"LINEAR DISCRIMINANT ANALYSIS (LDA)",1,NA
"LINEAR ION TRAP",1,1
"LINEAR ION TRAP MASS SPECTROMETRY",1,NA
"LINEAR RANGE",1,NA
"LINEAR REGRESSION",1,NA
"LINEAR TRANSFORMATIONS",1,1
"LINGUISTIC STRUCTURE",1,NA
"LINK ANALYSIS",1,NA
"LINKAGE",1,1
"LINKAGE DISEQUILIBRIUM",1,NA
"LINKED SCANNING",1,NA
"LINKING SAMPLES",1,NA
"LINKS WITH THE AGGRESSOR",1,NA
"LIP PRINTS",3,NA
"LIPEMIA",1,NA
"LIPID",1,1
"LIPID-PEROXIDATION",1,NA
"LIPID METABOLISM",1,NA
"LIPID PEROXIDATION",1,NA
"LIPID REAGENTS",1,NA
"LIPIDOMICS",3,1
"LIPIDS BIOMARKERS",1,NA
"LIPOAMINO ACID",1,NA
"LIPOID PNEUMONIA",1,NA
"LIPOLYTIC BACTERIA",1,NA
"LIPOMATOSIS",1,NA
"LIPOMATOUS HYPERTROPHY",1,NA
"LIPOPHAGY",1,NA
"LIPOPHILICITY",1,5
"LIPOPHORIN",1,NA
"LIPOPOLYSACCHA-RIDES",1,NA
"LIPOSOME",1,NA
"LIPOSUCTION",3,NA
"LIPOXIN",1,NA
"LIQUID",3,NA
"LIQUID-CHROMATOGRAPHY-QUADRUPOLE-TIME-OF-FLIGHT-MASS SPECTROMETRY (LC-QTOF-MS)",1,NA
"LIQUID-CHROMATOGRAPHY ELECTROSPRAY IONISATION QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRY (LC-ESI-QTOF-MS)",1,NA
"LIQUID-LIQUID MICRO-EXTRACTION (LLME)",1,NA
"LIQUID-LIQUID MICROEXTRACTION (LLME)",1,2
"LIQUID-LIQUID PHASE EXTRACTION",1,NA
"LIQUID-PHASE MICROEXTRACTION",3,3
"LIQUID-SOLID CHROMATOGRAPHY",1,NA
"LIQUID CHROMATOGRAPHIC- MASS PECTROMETRIC(LC/MS)",1,NA
"LIQUID CHROMATOGRAPHY-ELECTROSPRAY-MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION LINEAR ION TRAP MASS SPECTROMETRY (LC-ESI-LIT-MS)",1,NA
"LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION MASS SPECTROMETRY (ΜHPLC-ESI-MS/MS)",1,NA
"LIQUID CHROMATOGRAPHY-HIGH-RESOLUTION MASS SPECTROMETRY",1,1
"LIQUID CHROMATOGRAPHY-HIGH-RESOLUTION TANDEM MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPEC-TROMETRY",1,NA
"LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY-HIGH RESOLUTION TANDEM MASS SPECTROMETRY WITH QUADRUPOLE TIME-OF-FLIGHT ANALYZER (LC-QTOF-MS/MS)",1,NA
"LIQUID CHROMATOGRAPHY-ION TRAP MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (LCMS)",1,NA
"LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY/MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY-QUADRUPOLE-ORBITRAP MASS SPECTROMETER (LC-Q-ORBITRAP MS)",1,NA
"LIQUID CHROMATOGRAPHY-QUADRUPOLE/ORBITRAP MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY-ULTRAVIOLET DETECTION/FLUORESCENCE DETECTION",1,NA
"LIQUID CHROMATOGRAPHY - HIGH RESOLUTION MASS SPECTROMETRY (LC-HRMS)",1,1
"LIQUID CHROMATOGRAPHY (LC)",70,61
"LIQUID CHROMATOGRAPHY HYBRID TRIPLE QUADRUPOLE LINEAR ION TRAP (QTRAP) MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY ION TRAP MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY QUADRUPOLE-TIME OF FLIGHT MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRY",1,1
"LIQUID CHROMATOGRAPHY TANDEM-MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY TIME OF FLIGHT MASS SPECTROMETRY",1,1
"LIQUID CHROMATOGRAPHY WITH ELECTROSPRAY IONIZATION AND TANDEM MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY/ TANDEM MASS SPECTROMETRY (LC/MS/MS)",1,NA
"LIQUID CHROMATOGRAPHY/ TIME-OF-FLIGHT MASS SPECTROMETRY",1,NA
"LIQUID CHROMATOGRAPHY/QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRY (LC/Q-TOFMS)",2,3
"LIQUID ECSTASY INTOXICATION",1,NA
"LIQUID EXTRACTION SURFACE ANALYSIS (LESA)",1,NA
"LIQUID HANDLER INSTRUMENT",1,NA
"LIQUID LIQUID EXTRACTION",34,10
"LIQUID MICROEXTRACTION (AADLLME)",1,NA
"LIQUID PHASE MICROEXTRACTION",3,1
"LIQUID SCINTILLATION COUNTER",1,NA
"LIQUID SCINTILLATION COUNTING",1,1
"LIQUORICE",1,NA
"LIST-MODE DATA ACQUISITION",1,NA
"LITERATURE REVIEW",1,1
"LITHICS",1,NA
"LITHIUM",5,NA
"LITHIUM/",1,NA
"LITIGATION",2,NA
"LIVE-STRANDING",1,NA
"LIVE DATA FORENSICS",1,NA
"LIVE/DEAD",1,NA
"LIVER",37,NA
"LIVER CHANGES",1,NA
"LIVER DAMAGE",1,NA
"LIVER DISEASE",5,NA
"LIVER DISEASES",2,NA
"LIVER ENZYMES",1,NA
"LIVER FAILURE",2,NA
"LIVER FUNCTION DAMAGE",1,NA
"LIVER FUNCTIONTESTS",1,NA
"LIVER MATRIX",1,NA
"LIVER MICROSOMES",1,NA
"LIVER NECROSIS",1,NA
"LIVER NECROSIS, ORPHENADRINE INTOXICATION",1,NA
"LIVER PATHOLOGY",1,NA
"LIVER REJECTION",1,NA
"LIVER SPECIMEN",1,NA
"LIVER STEATOSIS",1,NA
"LIVER TISSUE",2,NA
"LIVER TRANSPLANTATION",1,NA
"LIVING WILL",1,NA
"LIVOR MORTIS",1,NA
"LLE",6,1
"LMG",1,NA
"LN RESIN",1,NA
"LOAEL",1,NA
"LOAN SHARKING",1,NA
"LOC",2,NA
"LOCAL ANAESTHETIC DRUG",1,NA
"LOCAL ANAESTHETICS",1,NA
"LOCAL ANESTHETIC",1,NA
"LOCAL ANESTHETICS",4,2
"LOCALIZED SURFACE PLASMON RESONANCE",2,NA
"LOCALIZER",1,NA
"LOCARD'S INFLUENCE ON TRACE EVIDENCE AND THE EXCHANGE PRINCIPLE",1,NA
"LOCATION OF SAMPLING",1,NA
"LOCKDOWN",1,NA
"LOCOMOTOR ACTIVITY",1,NA
"LOCUS B GENOTYPE",1,NA
"LOD",2,1
"LOFEPRAMINE",1,NA
"LOG-LIKELIHOOD-RATIO COST",1,NA
"LOGISTIC MODEL",1,NA
"LOGISTIC REGRESSION",2,1
"LOGO",1,NA
"LOGP",1,1
"LOITERING",1,NA
"LOLÓ",1,1
"LONDON",1,NA
"LONDONDERRY",1,NA
"LONE ACTOR TERRORIST",1,NA
"LONG-ACTING ANTICOAGULANT RODENTICIDE",1,NA
"LONG-ACTING ANTIPSYCHOTICS",2,NA
"LONG-ACTING INJECTABLE",1,NA
"LONG-ACTING INJECTABLE ANTIPSYCHOTIC",3,NA
"LONG-ACTING INJECTION",1,NA
"LONG-ACTING RISPERIDONE INJECTION",1,NA
"LONG-READ DNA SEQUENCING",1,NA
"LONG-RELEASE MEDICATION",1,NA
"LONG-TERM ADVERSE EFFECTS",1,NA
"LONG-TERM CARE",1,NA
"LONG-TERM DRUG HISTORY",1,NA
"LONG-TERM FOLLOW-UP",2,NA
"LONG-TERM FORENSIC PSYCHIATRIC CARE",1,NA
"LONG-TERM SEGREGATION",1,NA
"LONG-TERM STABILITY",4,NA
"LONG-TERM TREATMENT WITH MEDICATION",1,NA
"LONG DISTANT GUNSHOT",1,NA
"LONG DREADLOCKS",1,NA
"LONG QT SYNDROME",5,NA
"LONG TERM STABILITY",1,NA
"LONG TERM SURVIVAL",1,NA
"LONGITUDE",1,NA
"LONGITUDINAL",2,NA
"LONGITUDINAL ANALYSIS",1,NA
"LONGITUDINAL SECTIONING",1,NA
"LONGITUDINAL STUDIES",1,NA
"LONGITUDINAL STUDY",1,NA
"LOOK-ALIKE DRUGS",1,NA
"LOPERAMIDE",3,NA
"LOPERAMIDE HYDROCHLORIDE",1,NA
"LOPHOPHORA WILLIAMSII",1,1
"LOQ",1,NA
"LORAZEPAM",11,5
"LORAZEPAM-GLUCURONIDE",1,NA
"LORMETAZEPAM",1,NA
"LOSARTAN",1,NA
"LOSS DURING SOLVENT EVAPORATION",1,1
"LOSS FUNCTION",1,1
"LOVE STONE",1,1
"LOW-BOILING ACCELERANTS",1,NA
"LOW-DOSE ALCOHOL INTAKE",1,NA
"LOW-DOSE EXPOSURE",1,NA
"LOW-ENERGY GAMMA RAY SPECTROMETRY",1,NA
"LOW-FIELD NMR",1,3
"LOW-LEVEL RADIATION DETECTION",1,NA
"LOW-POTENCY NEUROLEPTICS",1,NA
"LOW-POWER SENSOR",1,NA
"LOW BINDING TUBES",1,NA
"LOW DENSITY CONCRETE",1,NA
"LOW DENSITY ORGANIC SOLVENTS",1,NA
"LOW DENSITY SOLVENT DISPERSIVE LIQUID-LIQUID MICROEXTRACTION",1,NA
"LOW DOSE",1,NA
"LOW ENERGY EI",1,NA
"LOW INTELLIGENCE",1,NA
"LOW MOLECULAR WEIGHT HEPARIN",1,NA
"LOW PRESSURE DEVELOPMENT",1,NA
"LOW RESOLUTION ION TRAPS",1,NA
"LOW SECURE SERVICES",1,NA
"LOW TEMPERATURE DYNAMIC CHROMATOGRAPHY",1,NA
"LOW TEMPLATE",1,NA
"LOW TEMPLATE DNA (LT-DNA)",3,NA
"LOW TEMPLATE DNA EXTRACTION",1,NA
"LOW THRESHOLD",1,NA
"LOWER AIRWAYS",1,NA
"LOWER URINARY TRACT SYMPTOMS",1,NA
"LPG",1,NA
"LPME",2,NA
"LQTS",2,NA
"LR DISTRIBUTION",1,NA
"LR SYSTEM",1,NA
"LRMIX",1,NA
"LRMIX STUDIO",1,NA
"LSA",1,3
"LSD DERIVATIVES",1,1
"LSD METABOLISM",1,NA
"LSD METABOLITES",1,1
"LSD/DETECTION",1,1
"LSPR GAS SENSOR",1,NA
"LSTM",1,NA
"LUBRICANT",1,NA
"LUC7L",1,NA
"LUCIFENSIN",1,NA
"LUCILIA",1,NA
"LUCILIA CUPRINA",3,NA
"LUCILIA SERICATA",9,NA
"LUCILIA SERICATA (DIPTERA: CALLIPHORIDAE)",1,NA
"LUCILIA SPEC.",1,NA
"LUCY-N-NATE",1,NA
"LUDWIG VAN BEETHOVEN",1,NA
"LUFTEMBOLIE",1,NA
"LUMBAR SURGERY",1,NA
"LUMICYANO",1,NA
"LUMICYANO™",1,NA
"LUMIKIT™",1,NA
"LUMINESCENCE",8,2
"LUMINESCENCE DETECTION",1,NA
"LUMINESCENCE TECHNIQUE",1,NA
"LUMINESCENT IMMUNOASSAY",1,NA
"LUMINESCENT LANTHANIDE NANOPARTICLES",1,NA
"LUMINESCENT NANOMATERIAL",1,NA
"LUMINESCENT TAGGANT",1,NA
"LUMINOL",6,1
"LUMINOL CHEMILUMINESCENCE",1,NA
"LUNG",11,1
"LUNG AIR CONTENT",1,NA
"LUNG AND HEART SECTIONS",1,NA
"LUNG COLLAPSE",1,NA
"LUNG EPITHELIAL CELLS",1,NA
"LUNG LESIONS",1,NA
"LUNG MICROSOMES",1,NA
"LUNG MORPHOLOGICAL CHANGES",1,NA
"LUNG PATHOLOGY",2,NA
"LUNG TISSUE",1,NA
"LUNG WEIGHT",1,NA
"LUNG WEIGHTS",1,NA
"LUNG: HEART WEIGHT RATIO",1,NA
"LUNGS",1,NA
"LUPUS",1,NA
"LYCOPODIUM CLAVATUM",1,NA
"LYE",1,NA
"LYELL SYNDROME",2,NA
"LYING",1,NA
"LYMPH-NODE AND THYMUS SECTIONS",1,NA
"LYMPH NODE HISTOLOGY",1,NA
"LYMPH NODES",1,NA
"LYMPHADENOPATHY SYNDROME",1,NA
"LYMPHANGIOGENESIS",1,NA
"LYMPHOCYTIC ENCEPHALITIS",1,NA
"LYMPHOID ORGANS",1,NA
"LYSERGAMIDE",2,1
"LYSERGAMIDES",2,3
"LYSERGIC ACID AMIDE (LSA)",1,5
"LYSERGIC ACID AMIDE/LSA",1,NA
"LYSERGIC ACID DIETHYLAMIDE (LSD)",40,32
"M-1",1,NA
"M ETHYLENEDIOXYAM PHETAMINE",1,NA
"M(I)RNA",1,NA
"M. SCALARIS",1,NA
"M3G",3,NA
"M6G",1,NA
"MAAQ",1,NA
"MAB-CHMINACA",3,1
"MACAW",1,NA
"MACERATION",1,NA
"MACH, ERNST",1,NA
"MACHINE LEARNING",17,8
"MACHINE LEARNING ALGORITHM",1,NA
"MACLEAYA CORDATA",1,NA
"MACRO",1,NA
"MACROCYCLIC GLYCOPEPTIDE",1,NA
"MACROETCHANTS",1,NA
"MACROHAPLOTYPE",1,NA
"MACROLIDE ANTIBIOTICS",1,NA
"MAD HONEY",1,NA
"MADAR AND MUSHROOMS",1,NA
"MADRID",1,NA
"MAE",1,NA
"MAGGOT",1,NA
"MAGGOT DEBRIDEMENT THERAPY",1,NA
"MAGGOTS",4,NA
"MAGIC GOLD",1,NA
"MAGIC MUSHROOMS",3,7
"MAGNETIC ADSORBENT",1,NA
"MAGNETIC BEAD METHOD",1,NA
"MAGNETIC BEADS",1,NA
"MAGNETIC COLUMN",1,NA
"MAGNETIC NANOMATERIAL",1,NA
"MAGNETIC NANOPARTICLES",2,2
"MAGNETIC PARTICLES",1,NA
"MAGNETIC POWDERS",1,NA
"MAGNETIC RESONANCE IMAGING",4,NA
"MAGNETIC SEPARATION",1,1
"MAGNETIC SOLID-PHASE EXTRACTION",2,2
"MAGNETIC SOLID PHASE EXTRACTION",3,2
"MAGNETIC SUSCEPTIBILITY",1,NA
"MAGNETITE NANOPARTICLES",1,NA
"MAGNETO-ARCHIMEDES LEVITATION",1,NA
"MAGNETRON SPUTTERING",1,NA
"MAHARASHTRA POPULATION",1,NA
"MAHOMET ALLUM",1,NA
"MAIN INTOXICANT",1,NA
"MAINTENANCE",4,NA
"MAINTENANCE THERAPY",2,NA
"MAINTENANCE TREATMENT",3,NA
"MAJOR COMPONENTS",1,1
"MAJOR DRUGS",1,NA
"MAJOR MENTAL DISORDER",1,NA
"MAJOR MENTAL DISORDERS",1,NA
"MAJOR METABOLITE",1,NA
"MAJOR METABOLITES",1,NA
"MAJOR TRAUMA",2,NA
"MAKGONATSOTLHE",1,NA
"MALARIA",10,NA
"MALARIA DIAGNOSIS",1,NA
"MALARIA ENDEMIC REGION",1,NA
"MALARIA PREVENTION",1,NA
"MALATHION",2,NA
"MALAYAN BOX TURTLE",1,NA
"MALAYSIA",2,1
"MALDI",8,8
"MALDI-FTMS",1,NA
"MALDI-MSI",2,1
"MALDI-Q-TOF MASS SPECTROMETRY",1,NA
"MALDI-QTOF-MASS SPECTROMETRY",1,1
"MALDI-TOF",1,1
"MALDI-TOF-MASS SPECTROMETRY",1,NA
"MALDI-TOF MASS SPECTROMETRY",3,2
"MALDI-TOF MS",2,NA
"MALDI-TOF/TOF",1,NA
"MALDI IMAGING",1,NA
"MALDI MSI",1,NA
"MALE",6,NA
"MALE BATTERERS",1,NA
"MALE DNA DETECTION",2,NA
"MALE FERTILITY",1,NA
"MALE GENITAL ORNAMENTS",1,NA
"MALE HOMOSEXUALITY",1,NA
"MALE PATIENT",1,NA
"MALE RAPE VICTIM",1,NA
"MALE VICTIMS",1,NA
"MALFORMATIONS OF THE BRAIN",1,NA
"MALIGNANT FIBROUS HISTIOCYTOMA",1,NA
"MALIGNANT HYPERPYREXIA",1,NA
"MALIGNANT HYPERTHERMIA",2,NA
"MALINGERING",5,NA
"MALNUTRITION",1,NA
"MALONDIALDEHYDE",2,NA
"MALPIGHIAN TUBULE",1,NA
"MALPRACTICE",9,NA
"MALPRACTICE ISSUES",1,NA
"MALPRACTICE MEDICAL",1,NA
"MALTREATMENT",1,NA
"MAM-2201",4,1
"MAMILLARY BODY",1,NA
"MANAGED CARE",2,NA
"MANAGEMENT",4,1
"MANDATE",2,NA
"MANDATORY CARE",2,NA
"MANDATORY MINIMUM PENALTIES",1,NA
"MANDELIC ACID",1,NA
"MANDIBULAR FRACTURE",1,NA
"MANIA",4,NA
"MANIPULATIONS",1,NA
"MANNER OF DEATH",22,NA
"MANNITOL",2,2
"MANNITOL HEXAACETATE",1,1
"MANUFACTURAL LOT",1,NA
"MANUFACTURE",3,2
"MANUFACTURED GAS PLANT",1,NA
"MANUFACTURING MARKS",2,NA
"MANURE",1,1
"MAO-I",1,NA
"MAP",1,NA
"MAP SCREENING",1,NA
"MAPP",1,NA
"MAPPING",1,3
"MAPRO",1,NA
"MAPROBAMATE",1,NA
"MAPROTILINE",2,NA
"MARATHON",1,NA
"MARIHUANA SMOKING",1,NA
"MARIJUANA ABUSE/DETECTION",1,NA
"MARIJUANA DETECTION",1,NA
"MARIJUANA SMOKING",2,1
"MARINE DANGEROUS ANIMAL",1,NA
"MARINE NEUROTOXIN",1,NA
"MARITIME ACCIDENT",1,NA
"MARITIME ANTARCTICA",1,NA
"MARKER",5,5
"MARKER OF OPIATE PRODUCT USE",1,NA
"MARKERS OF ILLICIT DRUGS",1,NA
"MARKET STUDY",1,NA
"MARKOV",1,NA
"MARKOV RANDOM WALK MODEL",1,NA
"MARKS COMPARISON",1,NA
"MARQUIS TEST",1,1
"MARQUIS TEST ETC",1,NA
"MARROW",3,NA
"MARYLAND",1,NA
"MASCULINITY",1,NA
"MASS-FATALITY INCIDENT",1,NA
"MASS-SCREENING",1,NA
"MASS-SPECTRAL LIBRARY",1,1
"MASS ANALYSIS",1,1
"MASS CHROMATOGRAPHY",1,NA
"MASS DEFECT FILTER",1,1
"MASS DETECTOR",1,NA
"MASS DISASTER",3,NA
"MASS FATALITIES",1,NA
"MASS FATALITY",1,NA
"MASS FRAGMENTATIONS",1,NA
"MASS FRAGMENTOGRAPHY",4,NA
"MASS IMAGING",1,NA
"MASS MICROSCOPY",1,NA
"MASS MURDER",2,NA
"MASS POISONING",2,NA
"MASS REDUCTION",1,2
"MASS SELECTIVE DETECTOR",3,NA
"MASS SPECTRA LIBRARIES",1,NA
"MASS SPECTRA LIBRARY",1,NA
"MASS SPECTRAL DATABASE",1,1
"MASS SPECTRAL LIBRARY",4,3
"MASS SPECTROMETRIC CONFIRMATION",1,NA
"MASS SPECTROMETRIC DETECTOR",1,NA
"MASS SPECTROMETRIC IMAGING",2,NA
"MASS SPECTROMETRY (MS)",298,240
"MASS SPECTROMETRY IMAGING",6,2
"MASS SPECTROMETRY IMAGING (MALDI)",1,NA
"MASS SPECTROMETRY PLASMA MASS SPECTROMETRY",1,1
"MASS SPECTROMETRY, CHLORMETHIAZOLE",1,NA
"MASS SPECTROMETRY, THC METABOLITE",1,NA
"MASS SPECTROMETRY/ICP-MS",1,NA
"MASS SPECTRUM",4,2
"MASSACHUSETTS",1,NA
"MASSIVE INTOXICATION",1,NA
"MASSIVE NECROSIS",1,NA
"MASSIVE PARALLEL SEQUENCING",2,NA
"MASSIVELY PARALLEL SEQUENCING",6,1
"MASSLIB",1,NA
"MAST-CELL TRYPTASE",1,NA
"MAST CELL",3,NA
"MAST CELL CARBOXYPEPTIDASE A",1,NA
"MAST CELL TRYPTASE",2,NA
"MAST CELLS",3,NA
"MASTER OF PHARMACY (PHARMACY PRACTICE)",1,NA
"MATCHED CONTROL SAMPLE",1,NA
"MATCHING COEFFICIENT VALUE",1,1
"MATE CRIMI",1,NA
"MATERIA MEDICA",1,NA
"MATERIAL """"FINGERPRINT""""",1,NA
"MATERIAL COMPOSITION",1,NA
"MATERIALS PROVENANCING",1,NA
"MATERIALS SCIENCE",1,2
"MATERNAL ABUSE",1,NA
"MATERNAL BEHAVIOR",1,NA
"MATERNAL DRUG ABUSE",2,NA
"MATERNAL PLASMA",2,NA
"MATERNAL/PATERNAL FILICIDE-SUICIDE",1,NA
"MATHEMATICAL MODEL",4,1
"MATHEMATICAL MODELLING",2,2
"MATHEMATICAL PREDICTION",1,NA
"MATHEMATICALLY MANIPULATION",1,NA
"MATRICIDE",6,NA
"MATRIX",1,NA
"MATRIX-ASSISTED LASER-DESORPTION/IONIZATION",1,NA
"MATRIX-ASSISTED LASER DESORPTION",2,1
"MATRIX-ASSISTED LASER DESORPTION/IONIZATION",2,NA
"MATRIX-ASSISTED LASER DESORPTION/IONIZATION IMAGING",1,NA
"MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY-MSN",1,NA
"MATRIX-MATCHED CALIBRATION METHOD",1,NA
"MATRIX DENSITY",1,NA
"MATRIX EFFECTS",16,14
"MATRIX NORMALIZATION FACTOR (MNF)",1,NA
"MATRIX PATCHES",1,NA
"MATRIX SUBLIMATION",1,NA
"MATTER OF DEATH",1,NA
"MATURITY GAP",1,NA
"MATURITY RATING",1,NA
"MAURITIUS",1,NA
"MAXILLOFACIAL INJURY",1,NA
"MAXIMAL RESTRAINT",1,NA
"MAXIMUM SECURITY",2,NA
"MAXQ-NMR",1,1
"MAYSI-2",1,NA
"MBCA",1,NA
"MBDB",3,4
"MBDB ECSTASY",1,NA
"MBTFA",1,1
"MC-ICP-MS",2,NA
"MC ICP-MS",1,NA
"MCAD DEFICIENCY",1,NA
"MCF",1,NA
"MCNAUGHTON RULES",1,NA
"MCNP",1,NA
"MCPA",1,NA
"MCPP",5,3
"MCR-ALS",1,3
"MCX",1,NA
"MDA DRUGS",1,NA
"MDAI",4,3
"MDDA",1,NA
"MDDM",1,NA
"MDE",1,1
"MDEA ('EVE')",1,NA
"MDMA-INTOXICATION",1,NA
"MDMA-RELATED DEATHS",1,NA
"MDMA ('ECSTASY', 'ADAM')",1,NA
"MDMA METABOLITES",1,1
"MDMA USERS",1,NA
"MDMB-2201",1,NA
"MDMB-4EN-PINACA",2,NA
"MDMB-CHMICA",1,3
"MDMB-CHMINACA",1,1
"MDMB-FUBINACA",1,NA
"MDMB(N)-073F",1,NA
"MDOS",1,NA
"MDPHP",1,NA
"MDPPP",1,NA
"MDPV",11,6
"MEANING OF THE PUNISHMENT",1,NA
"MEANNESS",1,NA
"MEANS OF AVOIDING FLUORESCENCE, CHANGING EXCITATION WAVELENGTH",1,NA
"MEASUREMENT",1,2
"MEASUREMENT INVARIANCE",1,NA
"MEASUREMENT STANDARDS",1,1
"MEASUREMENT UNCERTAINTY",7,3
"MEASURES & STATISTICS",1,NA
"MEASURES OF REHABILITATION AND INCAPACITATION",1,NA
"MEASURES OF REHABILITATION AND INCAPACITATION (§§ 63, 64, 66, 66A STGB)",1,NA
"MEAT PRODUCTION",1,NA
"MEBEZONIUM IODIDE.",1,NA
"MECC",1,2
"MECHANICAL ANTIDOTE",1,NA
"MECHANICAL ASPHYXIA",3,NA
"MECHANICAL PROPERTIES",1,2
"MECHANICAL PULVERIZATION",1,NA
"MECHANICAL RESTRAINT",1,NA
"MECHANISM",1,4
"MECHANISM OF ACTION",4,NA
"MECHANISM OF ADDICTION",1,NA
"MECHANISM OF DEATH",2,NA
"MECHANISM OF HEAD INJURY",1,NA
"MECHANISMS",1,1
"MECHANISMS OF ACTION",1,NA
"MECHANISTIC PHARMACOKINETIC SIMULATION",1,NA
"MECONIN",1,NA
"MECONIUM",11,1
"MECONIUM DRUG TESTING",1,NA
"MECONIUM ILEUS",1,NA
"MECONIUM IN UTERO EXPOSURE",1,NA
"MECONIUM PLUG SYNDROME",1,NA
"MEDETOMIDINE",1,1
"MEDIA ACTIVITY",1,NA
"MEDICAL",4,NA
"MEDICAL-LEGAL",2,NA
"MEDICAL-LEGAL AUTOPSY",1,NA
"MEDICAL-LEGAL INVESTIGATIONS",1,NA
"MEDICAL ABORTION",1,NA
"MEDICAL AID IN DYING",1,NA
"MEDICAL AND NONMEDICAL USE",1,1
"MEDICAL AND SCIENTIFIC EVIDENCE",1,NA
"MEDICAL ASSISTANCE IN DYING",1,NA
"MEDICAL AUDIT",1,NA
"MEDICAL BOARD",1,NA
"MEDICAL CANNABIS",1,3
"MEDICAL CARE",2,NA
"MEDICAL CHILD ABUSE",1,NA
"MEDICAL CONDITION",1,NA
"MEDICAL CONDITIONS",1,NA
"MEDICAL CRIMINAL LAW",1,NA
"MEDICAL DAMAGE",1,NA
"MEDICAL DIAGNOSTICS",1,NA
"MEDICAL DRUG-TESTING",1,NA
"MEDICAL DRUGS",2,NA
"MEDICAL EDUCATION",1,NA
"MEDICAL ERROR",3,NA
"MEDICAL ETHICS",1,NA
"MEDICAL EVIDENCE",1,NA
"MEDICAL EXAMINATION",3,NA
"MEDICAL EXAMINATIONS",1,NA
"MEDICAL EXAMINER",9,NA
"MEDICAL EXAMINER CASE MANAGEMENT",1,NA
"MEDICAL EXAMINER TOXICOLOGY",1,NA
"MEDICAL EXAMINERS",2,NA
"MEDICAL EXPERT",2,NA
"MEDICAL FORENSIC EXAMINATION",1,NA
"MEDICAL GENETICS",1,NA
"MEDICAL HYPERSPECTRAL IMAGE",1,NA
"MEDICAL INCAPACITATION WHEN DRIVING",1,NA
"MEDICAL INVESTIGATOR",1,NA
"MEDICAL LAW",3,NA
"MEDICAL LEGAL INSTITUTE",1,NA
"MEDICAL LEGISLATION",1,1
"MEDICAL LIABILITY",2,NA
"MEDICAL MALPRACTICE",8,NA
"MEDICAL MALPRACTICE ALLEGATIONS",1,NA
"MEDICAL MALPRACTICE PLLEGATIONS",1,NA
"MEDICAL MISADVENTURE",2,NA
"MEDICAL NEGLIGENCE",5,NA
"MEDICAL ORGANIZATION",1,NA
"MEDICAL OUTCOMES",1,NA
"MEDICAL PERSONNEL",1,NA
"MEDICAL PRESCRIPTION",1,NA
"MEDICAL PSYCHOLOGICAL ASSESSMENT (MPA)",1,NA
"MEDICAL PSYCHOLOGICAL EXAMINATION",1,NA
"MEDICAL RECORDS",4,NA
"MEDICAL REHABILITATION",1,NA
"MEDICAL REPORT",1,NA
"MEDICAL REVIEW OFFICER",2,NA
"MEDICAL SCREENING",1,NA
"MEDICAL SIMULATORS",1,NA
"MEDICAL SWAB",2,1
"MEDICAL TANGLE",1,NA
"MEDICAL TOXICOLOGY",5,NA
"MEDICAL TREATMENT",2,NA
"MEDICAL TREATMENT (OBLIGATION OF)",1,NA
"MEDICAL TREATMENT AND SUPERVISION ACT",1,NA
"MEDICAL/TOXIC SUBSTANCES",2,NA
"MEDICALIZATION",1,NA
"MEDICAMENT",1,NA
"MEDICAMENTS",1,NA
"MEDICATION",13,NA
"MEDICATION-INDUCED VIOLENCE",1,NA
"MEDICATION ADHERENCE",3,NA
"MEDICATION DISCONTINUATION PROGRAM",1,NA
"MEDICATION ERROR",3,NA
"MEDICATION ERRORS",1,NA
"MEDICATION MISUSE",1,NA
"MEDICATION NONCOMPLIANCE",1,NA
"MEDICATIONS",2,NA
"MEDICINAL CHEMISTRY",1,5
"MEDICINAL DRUGS",8,NA
"MEDICINAL PLANT",3,7
"MEDICINAL PRODUCTS",1,NA
"MEDICINE",13,2
"MEDICINE BOTTLES",1,NA
"MEDICINE COUNTERFEITING",1,2
"MEDICINE COUNTERFEITS",1,1
"MEDICINE HYPERSPECTRAL IMAGE ANALYSIS",1,NA
"MEDICINE IN LITERATURE",1,NA
"MEDICINES",4,2
"MEDICINES MANAGEMENT",1,NA
"MEDICINES SAFETY",1,NA
"MEDICO-LEGAL",8,NA
"MEDICO-LEGAL ASCERTAINMENT",1,NA
"MEDICO-LEGAL AUTOPSIES",1,NA
"MEDICO-LEGAL AUTOPSY",8,NA
"MEDICO-LEGAL CASES",2,NA
"MEDICO-LEGAL CAUSE-OF-DEATH DETERMINATION",1,NA
"MEDICO-LEGAL EVALUATION",2,NA
"MEDICO-LEGAL EXAMINATION",1,NA
"MEDICO-LEGAL EXAMINATIONS",1,NA
"MEDICO-LEGAL IMPLICATIONS",1,NA
"MEDICO-LEGAL ISSUES",1,NA
"MEDICO-LEGAL MEDICINE",1,NA
"MEDICO-LEGAL RELEVANCE",1,NA
"MEDICO-LEGAL REPORTS",1,NA
"MEDICO-LEGAL SPECIMEN",1,NA
"MEDICO-LEGAL TOXICOLOGY",1,NA
"MEDICO-PSYCHOLOGICAL ASSESSMENT",1,NA
"MEDICO‐LEGAL AUTOPSY",1,NA
"MEDICO LEGAL ADVICE",1,NA
"MEDICO LEGAL AUTOPSY",1,NA
"MEDICO LEGAL WORK",1,NA
"MEDICOLEGAL",12,NA
"MEDICOLEGAL ASPECTS",1,NA
"MEDICOLEGAL AUTOPSY",2,NA
"MEDICOLEGAL DEATH INVESTIGATION",5,NA
"MEDICOLEGAL DEATH INVESTIGATORS",1,NA
"MEDICOLEGAL EXPERT",1,NA
"MEDICOLEGAL IMPLICATIONS",1,NA
"MEDICOLEGAL INVESTIGATION",2,NA
"MEDICOLEGAL ISSUES",1,NA
"MEDICOLEGAL MANAGEMENT",1,NA
"MEDICOLEGAL OPINION",1,NA
"MEDICOLEGAL PROBLEMS",2,NA
"MEDITERRANEAN MARSHLANDS",2,1
"MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY",1,NA
"MEDIUM-SECURE UNITS",1,NA
"MEDIUM SECURE UNIT",2,NA
"MEDIUM SECURITY",4,NA
"MEDROXYPROGESTERONE ACETATE",1,NA
"MEDROXYPROGESTERONE ACETATE (MPA)",1,NA
"MEDULLA OBLONGATA",1,NA
"MEETING REPORT",1,NA
"MEFENOREX",1,NA
"MEFENTANYL",1,1
"MEFLOQUINE",2,NA
"MEGA-NUMTS",1,NA
"MEIZITANG",1,NA
"MEKC",7,8
"MEKC-LIF",1,1
"MELAMINE CYANURATE",1,1
"MELANIN",7,NA
"MELANIN DEGRADATION",2,NA
"MELANONYCHIA",1,NA
"MELANOTAN II BREMELANOTIDE",1,NA
"MELATONIN",1,NA
"MELATONIN RECEPTOR AGONISTS",1,NA
"MELITRACEN",1,NA
"MELOXICAM",1,NA
"MELT GLASS",2,NA
"MELTING CURVE ANALYSIS",2,1
"MEMBRANE-ASSOCIATED TRANSPORTER PROTEIN",1,NA
"MEMBRANE-BASED MICROEXTRACTION",1,NA
"MEMBRANE EXTRACTION",1,NA
"MEMBRANE INLET MASS SPECTROMETRY",1,NA
"MEMBRANE PERMEABILITY",1,1
"MEMORIES",1,NA
"MEMORY",7,NA
"MEMORY FORENSICS",2,NA
"MEN",5,NA
"MEN1 SYNDROME",1,NA
"MENA",1,1
"MENS REA",1,NA
"MENSTRUAL BLOOD",4,NA
"MENSTRUAL BLOOD IDENTIFICATION",2,NA
"MENSTRUAL CYCLE",1,NA
"MENSTRUAL FLUID",1,NA
"MENTAL CAPACITY",1,NA
"MENTAL COMPETENCY",1,NA
"MENTAL DISORDER",14,NA
"MENTAL DISORDERS",21,NA
"MENTAL DISTRESS",1,NA
"MENTAL HEALTH",54,1
"MENTAL HEALTH ACT",2,NA
"MENTAL HEALTH AFFIRMATIVE DEFENSE",1,NA
"MENTAL HEALTH CARE",3,NA
"MENTAL HEALTH COURT",1,NA
"MENTAL HEALTH COURTS",3,NA
"MENTAL HEALTH DISORDER",1,NA
"MENTAL HEALTH ETHICS",1,NA
"MENTAL HEALTH LAW",2,NA
"MENTAL HEALTH LEGISLATION",1,NA
"MENTAL HEALTH NURSING",1,NA
"MENTAL HEALTH POLICY",1,NA
"MENTAL HEALTH PROBLEMS",1,NA
"MENTAL HEALTH REVIEW TRIBUNAL",1,NA
"MENTAL HEALTH SERVICES",4,NA
"MENTAL HOSPITAL",2,NA
"MENTAL ILL OFFENDERS",1,NA
"MENTAL ILLNESS",24,NA
"MENTAL ILLNESS AND ADDICTION",1,NA
"MENTAL IMPAIRMENT",1,NA
"MENTAL INSANITY",1,NA
"MENTAL PATIENTS",1,NA
"MENTAL RETARDATION",3,NA
"MENTAL STATE AT THE TIME OF THE OFFENSE",1,NA
"MENTAL STATUS",1,NA
"MENTAL WELL-BEING",1,NA
"MENTALLY DISORDERED OFFENDER",5,NA
"MENTALLY DISORDERED OFFENDERS",10,NA
"MENTALLY HANDICAPPED INDIVIDUALS",1,NA
"MENTALLY ILL",1,NA
"MENTALLY ILL AND DISABLED PERSONS",1,NA
"MENTALLY ILL OFFENDER",1,NA
"MENTALLY ILL OFFENDERS",7,NA
"MENTALLY ILL PERSONS",3,NA
"MENTALLY ILL PRISONERS",1,NA
"MENTORING",1,NA
"MEPERIDINE",2,NA
"MEPHEDRONE",28,21
"MEPHENESIN",1,1
"MEPIQUAT CHLORIDE",2,NA
"MEPIVACAINE",4,NA
"MEPROBAMATE",10,NA
"MEPS",7,3
"MEPS EXTRACTION",1,1
"MERCHANT SEAFARERS",1,NA
"MERCURIC CHLORIDE",1,NA
"MERCURIC CHLORIDE-SUICIDE, INTRAVENOUS INJECTION",1,NA
"MERCURY",1,1
"MERCURY INTOXICATION",1,NA
"MERCURY POISONING",3,NA
"MERCURY SPECIATION",2,NA
"MERCY KILLING",1,NA
"MERE SUSPICION",1,NA
"MERLA",1,NA
"MERREMIA TUBEROSA",1,NA
"MESCALINE",5,4
"MESEMBRINE ALKALOIDS",1,NA
"MESO-OCTAMETHYLCALIX(4)PYRROLE",1,1
"MESOCARB",1,NA
"MESOPOROUS GERMANIUM",1,NA
"MESSENGER RNA (MRNA)",20,NA
"MESSENGERRNA (MRNAS)",1,NA
"META-ANALYSIS",5,3
"META-CHLOROPHENYLPIPERAZINE",1,1
"META-CHLOROPHENYLPIPERAZINE (MCPP)",1,NA
"META-HYDROXY-BENZOYLECGONINE",1,NA
"META-RESPONSIBILITY",1,NA
"META-SIMS",1,NA
"METABOLIC AUTOPSY",2,NA
"METABOLIC CAPACITY",1,NA
"METABOLIC COMPONENTS",1,NA
"METABOLIC DEGRADATION",1,NA
"METABOLIC DISEASE",1,NA
"METABOLIC DISTURBANCES",1,NA
"METABOLIC EFFECTS",1,NA
"METABOLIC FUNCTIONS",1,NA
"METABOLIC INHIBITORS",1,NA
"METABOLIC PATHWAY",1,NA
"METABOLIC PROFILE",1,NA
"METABOLIC PROFILING",3,1
"METABOLIC RATIO",1,NA
"METABOLIC SIDE EFFECTS",1,NA
"METABOLIC STABILITY",1,NA
"METABOLIC SYNDROME",2,NA
"METABOLISM",121,35
"METABOLISM STUDY",1,NA
"METABOLITE",92,25
"METABOLITE-TO-DRUG CONCENTRATION RATIO",1,NA
"METABOLITE-TO-DRUG RATIO",1,NA
"METABOLITE-TO-PARENT DRUG RATIO",3,NA
"METABOLITE IDENTIFICATION",7,2
"METABOLITE RATIO",1,NA
"METABOLITE RATIOS",2,NA
"METABOLITE TARGET ANALYSIS",1,NA
"METABOLITES—OF GLUTETHIMIDE, IDENTIFIED IN HUMAN URINE, SYNTHESIZED",1,NA
"METABOLITES ANALYSIS",1,NA
"METABOLITES OF DIPHENHYDRAMINE",1,NA
"METABOLITES OF TOLUENE, XYLENE, STYRENE",1,NA
"METABOLIZE",2,NA
"METABOLOME PROFILING",1,NA
"METABOLOMICS",24,17
"METABONOMICS",1,4
"METADATA",1,NA
"METAGENOME",1,NA
"METAGENOMICS",2,NA
"METAL",6,6
"METAL-SHOCK INTERACTIONS",1,NA
"METAL AEROSOLS",1,NA
"METAL COMPLEXES",1,1
"METAL ION ADDUCTS, SENSITIVITY, TOF",1,NA
"METAL IONS",1,NA
"METAL NANOMATERIALS",1,NA
"METAL ORGANIC FRAMEWORK (MOF)",2,3
"METAL OXIDE NPS",1,NA
"METAL PHOSPHIDES",1,NA
"METAL TENT STAKE",1,NA
"METAL UNDERLAYER ATR SPECTROSCOPY",1,NA
"METALDEHYDE",1,NA
"METALIZATION CHEMISTRY",1,NA
"METALLIC MERCURY",1,NA
"METALLIC POISON",1,NA
"METALLIC POISONS",1,NA
"METALLIC SPECIES",1,1
"METALLIC SURFACES",1,NA
"METALLICS CONTAMINANTS",1,1
"METALLOINTERCALATORS",1,NA
"METALLOPROTEASES",1,NA
"METALLOPROTEINS",1,1
"METALLOTHIONEIN",2,NA
"METALLURGY",1,NA
"METALS/HEAVY METALS",2,1
"METAMATERIAL",1,NA
"METAMORPHOSIS",1,NA
"METAMPHETAMINE",3,2
"METAMPHETAMINE DEPENDENCE",1,NA
"METAMPHETAMINE INDUCED MENTAL DISORDERS",1,NA
"METAPHEDRONE",1,2
"METAPHYSICS",1,NA
"METAPROTEOMICS",1,NA
"METASTABLE EPIALLELES",1,NA
"METASYSTOX®",1,NA
"METAXALONE",2,NA
"METFORMIN",6,NA
"METH",1,NA
"METH: METHAMPHETAMINE",1,NA
"METHACRYLIC ACID-ETHYLENE GLYCOL DIMATHACRYLATE CO-POLYMER",1,NA
"METHADONE",95,15
"MÉTHADONE",1,NA
"METHADONE-ASSOCIATED DEATHS",1,NA
"METHADONE-LIKE POWDER",1,NA
"METHADONE-RELATED DEATH",1,NA
"METHADONE-RELATED DEATHS",1,NA
"METHADONE-RELATED FATALITIES",1,NA
"METHADONE DEATHS",1,NA
"METHADONE INTOXICATION",2,NA
"METHADONE INTOXICATIONS, AUTOPSY VALUES",1,NA
"METHADONE MAINTENANCE",4,NA
"METHADONE MAINTENANCE THERAPY",1,NA
"METHADONE MAINTENANCE TREATMENT (MMT)",5,2
"METHADONE METABOLITES",1,NA
"METHADONE OVERDOSE",1,NA
"METHADONE POISONING",1,NA
"METHADONE PROGRAMME",1,NA
"METHADONE SUBSTITUTION",1,NA
"METHADONE THERAPY",2,NA
"METHADONE TO EDDP RATIO",1,NA
"METHADONE TOXICITY",2,NA
"METHADONE TREATMENT PROGRAMME",1,NA
"METHAEMOGLOBINAEMIA",3,NA
"METHAMAPHETAMINE",1,NA
"METHAMIDOPHOS",3,NA
"METHAMIDOPHOS (MP)",1,NA
"METHAMPHETAMIN",1,NA
"METHAMPHETAMINE",228,181
"METHAMPHETAMINE-DEPENDENT SUBJECTS",1,NA
"METHAMPHETAMINE (METH)",1,NA
"METHAMPHETAMINE ABUSE",7,NA
"METHAMPHETAMINE ANTIBODY",1,NA
"METHAMPHETAMINE CHRONIC TOXICITY",1,NA
"METHAMPHETAMINE CONTAMINATION",2,1
"METHAMPHETAMINE DETECTION KIT",1,NA
"METHAMPHETAMINE FATALITIES",1,NA
"METHAMPHETAMINE HYDROCHLORIDE",1,2
"METHAMPHETAMINE IMPURITY PROFILING",1,2
"METHAMPHETAMINE INTOXICATION",2,NA
"METHAMPHETAMINE LABORATORY",1,1
"METHAMPHETAMINE LYSERGIC ACID DIETHYLAMIDE",1,1
"METHAMPHETAMINE MANUFACTURE",2,2
"METHAMPHETAMINE MANUFACTURING",1,1
"METHAMPHETAMINE METABOLITES",1,NA
"METHAMPHETAMINE POISONING",1,NA
"METHAMPHETAMINE POISONING-RELATED DEATH",1,NA
"METHAMPHETAMINE PROFILING",2,3
"METHAMPHETAMINE PSYCHOSIS",1,NA
"METHAMPHETAMINE SCREENING CHIP",1,NA
"METHAMPHETAMINE SCREENING METHOD",1,NA
"METHAMPHETAMINE SMOKING",1,NA
"METHAMPHETAMINE TABLET",1,2
"METHAMPHETAMINE TESTING",1,NA
"METHAMPHETAMINE USE HISTORY",1,NA
"METHAMPHETAMINE USE PATTERNS",1,NA
"METHAMPHETAMINE USERS",1,NA
"METHAMPHETAMINE, TOXICOLOGICAL ANALYSIS",1,NA
"METHAMPHETAMINE, TOXICOLOGICAL ANALYSIS IN BIOLOGICAL MATERIAL",1,NA
"METHANANDAMIDE",1,1
"METHANE",1,NA
"METHANOL",12,2
"METHANOL ULTRASONICATION",1,NA
"METHANOL, VERTEILUNG IM ZNS BEI MISCHUNG MIT ÄTHANOL",1,NA
"METHAQUALON",1,NA
"METHARBITAL",1,NA
"METHCATHINONE (EPHEDRONE)",9,10
"METHCATHINONE ANALOGUES",2,2
"METHEMOGLOBIN",3,NA
"METHEMOGLOBINEMIA",2,NA
"METHIMAZOLE",1,NA
"METHIONYL SULFONIUM",1,NA
"METHIOPROPAMINE",3,1
"METHOD ATTRIBUTION",1,NA
"METHOD DEVELOPMENT AND VALIDATION",1,NA
"METHOD EVALUATION",1,NA
"METHOD OF SUICIDE",1,NA
"METHOD RESTRICTION",1,NA
"METHOD VALIDATION",27,24
"METHOD VALIDATION PARAMETERS",1,NA
"METHODOLOGICAL FRAMEWORK",1,1
"METHODOLOGY",21,14
"METHODOLOGY IN TRAFFIC MEDICINE",1,NA
"METHODS OF ANALYSIS",1,NA
"METHODS OF DETERMINATION",1,1
"METHODS OF PRODUCTION",1,NA
"METHODS OF SUICIDE",2,NA
"METHODS STORAGE",1,NA
"METHOMYL",4,NA
"METHOMYL POISONING",1,NA
"METHOTREXATE",2,NA
"METHOTRIMEPRAZINE",1,NA
"METHOXETAMINE",6,9
"METHOXPHENIDINE",1,1
"METHOXPROPAMINE (MXPR)",1,1
"METHOXY METHYL PHENYLACETONES",1,1
"METHOXYDIMETHYLAMPHETAMINE",1,1
"METHOXYETHYLAMPHETAMINE",1,1
"METHOXYPHENAMINE",1,1
"METHOXYPHENYLPIPERAZINOPROPANONES",1,1
"METHYL-AMPHETAMINE",1,NA
"METHYL-GAMMA-HYDROXYBUTYRATE",1,1
"METHYL 1-PENTYL-(1H-INDOLE)-3-CARBOXYLATE",1,NA
"METHYL ACETYLENE",1,NA
"METHYL BENZOATE",2,1
"METHYL CENTRALITE (MC)",1,NA
"METHYL CHLOROFORMATE",1,NA
"METHYL GLUCURONIDE",1,NA
"METHYL INDOLE-3-CARBOXYLATE",1,NA
"METHYL SULFONE",1,1
"METHYL VIOLET",2,NA
"METHYLAMMONIUM NITRATE",1,NA
"METHYLAMPHETAMINE",16,25
"METHYLAMPHETAMINE (L-PHENYL-2-AMINOMETHYLPROPANE)",1,NA
"METHYLAMPHETAMINE DIMER",1,1
"METHYLAMPHETAMINE ISOMER",1,1
"METHYLATION",2,2
"METHYLATION-SPECIFIC PCR",1,NA
"METHYLATION ANALYSIS",2,NA
"METHYLATION PATTERNS",1,NA
"METHYLECGONIDINE",1,NA
"METHYLENDIOXYAMPHETAMINE",1,NA
"METHYLENE BLUE",3,1
"METHYLENECYCLOPROPYL ACETATE",1,NA
"METHYLENEDIOXY DERIVATIVES",1,NA
"METHYLENEDIOXY NPS",1,NA
"METHYLENEDIOXYETHYLAMPHETAMINE",2,1
"METHYLENEDIOXYETHYLAMPHETAMINE P-METHOXYAMPHETAMINE",1,NA
"METHYLENEDIOXYLATED AMPHETAMINES",1,2
"METHYLENEDIOXYMETHAMPH ETAMINE",1,NA
"METHYLENEDIOXYMETHAMPHETAMINE (MDMA)",1,NA
"METHYLENEDIOXYMETHYLAMPHETAMINE",2,1
"METHYLENEDIOXYMETHYLAMPHETAMINE HYDROCHLORIDE MONOHYDRATE",1,NA
"METHYLENEDIOXYPHENYLALKYLAMINES",1,NA
"METHYLENEDIOXYPHENYLPIPERAZINOPROPANES",1,1
"METHYLENEDIOXYPYROVALERONE",6,1
"METHYLENEDIOXYPYROVALERONE (MDPV)",1,NA
"METHYLEPHEDRINE",2,5
"METHYLETHCATHINONE (MEC)",1,1
"METHYLMETHCATHINONE (MMC)",1,1
"METHYLONE",12,7
"METHYLPHENIDATE",11,4
"METHYSERGIDE",1,NA
"METILDIGOXIN",1,NA
"METIZOLAM",1,NA
"METOMIDATE",1,NA
"METOPROLOL",3,NA
"METRIFONATE",1,NA
"METROLOGICAL CHARACTERISTICS",1,NA
"METROLOGY",1,3
"METRONIDAZOLE",1,1
"METRONIDAZOLE (FLAGYL)",1,NA
"MEXAZOLAM",1,NA
"MEXICO",2,2
"MH17",1,NA
"MHC CLASS I",1,NA
"MHEALTH",1,NA
"MHS-5",1,NA
"MHS-5-ELISA",1,NA
"MI",1,NA
"MIANSERIN",5,NA
"MIANSERINE",1,NA
"MICE",13,NA
"MICELLAR",1,NA
"MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY",6,6
"MICELLAR ELECTROKINETIC CAPILLARY ELECTROPHORESIS",1,1
"MICELLAR ELECTROKINETIC CAPILLARY ELECTROPHORESIS (MECC)",1,NA
"MICELLAR ELECTROKINETIC CHROMATOGRAPHY (MEKC)",1,4
"MICELLAR LIQUID CHROMATOGRAPHY",2,4
"MICHEL PÊCHEUX",1,NA
"MICRO-CHIP CHROMATOGRAPHY",1,1
"MICRO-DERIVATIZATION",2,NA
"MICRO-FLUIDIC",1,NA
"MICRO-HAPLOTYPES",1,NA
"MICRO-ORGANISMS",1,NA
"MICRO-PLANAR CHROMATOGRAPHY (MICRO-TLC)",1,1
"MICRO-PLATE ENZYME IMMUNOASSAY",1,NA
"MICRO-PULVERIZED EXTRACTION",1,NA
"MICRO-RNA",4,NA
"MICRO-SAMPLE",1,NA
"MICRO-SEGMENTAL ANALYSIS",3,NA
"MICRO-SOLID-PHASE",1,NA
"MICRO-SOLID PHASE EXTRACTION",1,1
"MICRO DEVICES",1,NA
"MICRO FLUIDIC PAPER-BASED ANALYTICAL DEVICE (EΜPAD)",1,NA
"MICRO LIQUID CHROMATOGRAPHY",1,1
"MICRO RNA",2,NA
"MICRO TOTAL ANALYSIS SYSTEMS (ΜTAS)",1,NA
"MICRO VASCULAR LESIONS",1,NA
"MICROARRAY",5,3
"MICROARRAY EXPRESSION PROFILE",1,NA
"MICROARRAYS",4,NA
"MICROBEAM X-RAY FLUORESCENCE SPECTROMETRY",1,NA
"MICROBIAL ANALYSIS",1,NA
"MICROBIAL CARBON DIOXIDE RESPIRATION",1,NA
"MICROBIAL COMMUNITY",2,NA
"MICROBIAL DEGRADATION",3,2
"MICROBIAL FORENSICS",1,NA
"MICROBIAL KERATITIS",1,NA
"MICROBIOLOGY",3,NA
"MICROBIOME",3,1
"MICROBIOME METHODS",1,NA
"MICROBORE COLUMN",1,NA
"MICROCHANNELS",1,NA
"MICROCHEMICAL",1,NA
"MICROCHIMERISM",1,NA
"MICROCHIP",1,8
"MICROCHIP ELECTROPHORESIS",4,4
"MICROCOLUMN AGGLUTINATION",1,NA
"MICROCRYSTAL TEST",5,5
"MICROCRYSTALLINE CELLULOSE",2,NA
"MICROCRYSTALLINE TEST",4,5
"MICROCRYSTALLINE TESTS",2,1
"MICRODIALYSIS",1,NA
"MICRODROPLET",1,NA
"MICROELISA",1,NA
"MICROEXTRACTION",12,4
"MICROEXTRACTION-BASED TECHNIQUES",1,NA
"MICROEXTRACTION APPROACHES",1,NA
"MICROEXTRACTION BY PACKED SORBENT",4,NA
"MICROEXTRACTION MEPS",1,NA
"MICROEXTRACTION ON PACKED SORBENT",1,NA
"MICROEXTRACTION SPME",1,NA
"MICROEXTRACTION TECHNIQUES",1,1
"MICROEXTRACTIONS",1,NA
"MICROEXTRATION",1,NA
"MICROFABRICATION",5,NA
"MICROFIBRE",1,NA
"MICROFL UIDIC LC-MS/MS",1,NA
"MICROFLOW LC-MS/MS",2,1
"MICROFLOWMETER",1,NA
"MICROFLUIDIC",2,2
"MICROFLUIDIC CHIPS",1,1
"MICROFLUIDIC DEVICE",9,4
"MICROFLUIDIC PAPER-BASED ANALYTICAL DEVICE (ΜPAD)",1,NA
"MICROFLUIDIC PAPER-BASED ANALYTICAL DEVICES",1,NA
"MICROFLUIDIC PAPER-BASED ANALYTICAL DEVICES (ΜPADS)",1,NA
"MICROFLUIDICS",12,5
"MICROGLIA",4,NA
"MICROHAPLOTYPE",1,NA
"MICROHAPLOTYPES",1,NA
"MICROHARDNESS KNOOP",1,NA
"MICROLC-ESI-SMRM",1,NA
"MICROMANIPULATION",1,1
"MICROMORPHOLOGICAL CHANGES",1,NA
"MICRON-NANOPARTICULATE ANALYSIS",1,NA
"MICRONEEDLE SENSORS",1,NA
"MICROORGANISM",1,NA
"MICROORGANISMS",1,NA
"MICROPARTICLES",1,NA
"MICROPLASTIC",1,NA
"MICROPLATE IMMUNOASSAY",1,NA
"MICROPOLARITIES",1,NA
"MICROPOLLUTANTS",1,2
"MICROPSYCHOSES",1,NA
"MICROPULVERIZATION",1,NA
"MICROPULVERIZED EXTRACTION",3,NA
"MICRORAMAN SPECTROSCOPY",1,1
"MICROREACTOR",1,NA
"MICROREADER 40Y ID SYSTEM",1,NA
"MICRORNA",21,1
"MICRORNA (MIRNA)",1,NA
"MICRORNA MARKERS",1,NA
"MICRORNAS",8,NA
"MICRORNAS (MIRNAS)",1,NA
"MICROSAMPLING",3,1
"MICROSATELLITE",5,2
"MICROSATELLITE DNA",3,8
"MICROSCALE",1,NA
"MICROSCOPIC EXAMINATION",1,1
"MICROSCOPIC MATCHING, DNA TESTING AND CHEMICAL ANALYSIS",1,NA
"MICROSCOPY",12,4
"MICROSOFT VISUAL BASIC®",1,NA
"MICROSOME",2,NA
"MICROSOMES",2,NA
"MICROSPECTROSCOPY",4,3
"MICROSTAMPING",1,NA
"MICROSTRUCTURE",1,NA
"MICROSYSTEMS",1,NA
"MICROTHROMBI",1,NA
"MICROTITER PLATE",1,NA
"MICROTITER PLATE ASSAY",1,NA
"MICROTOF-Q",1,NA
"MICROTRACES",1,NA
"MICROVESICULAR STEATOSIS",1,NA
"MICROVESSELS",1,NA
"MICROWAVE",6,6
"MICROWAVE-ASSISTED DERIVATISATION (MAD)",1,NA
"MICROWAVE-ASSISTED DERIVATIZATION",1,2
"MICROWAVE-ASSISTED EXTRACTION (MAE)",6,9
"MICROWAVE-ASSISTED MICELLAR EXTRACTION",1,1
"MICROWAVE ASSISTED EXTRACTION",3,NA
"MICROWAVE DERIVATIZATION",1,NA
"MICROWAVE DIELECTRIC HEATING",1,1
"MICROWAVE FAST DERIVATIZATION",1,NA
"MICROWAVE IRRADIATION",1,2
"MID-INFRARED",1,3
"MIDAZOLAM",9,3
"MIDDLE-AGED ADULTS",1,NA
"MIDDLE EAST",1,NA
"MIDDLE INFRARED MICROSPECTROSCOPY",1,1
"MIDLINE DESTRUCTIVE LESION",1,NA
"MIDRIN",1,NA
"MIFEPRISTONE",1,NA
"MIGRAINE",1,NA
"MIGRANTS",1,1
"MIGRATION PATHWAYS TO DUST",1,NA
"MIGRATION PATTERN",1,NA
"MIGRATION SHIFTS",1,NA
"MILIEU BIOLOGIQUE",1,NA
"MILITARY",1,NA
"MILITARY AIRCRAFT FATALITIES",1,NA
"MILITARY ETHICS",1,NA
"MILK TEA",1,NA
"MILLON",1,NA
"MILNACIPRAN",2,NA
"MINDFULNESS",1,NA
"MINERAL OIL",1,NA
"MINERALOGY",1,NA
"MINERALS",2,1
"MINI-BARCODE",1,NA
"MINI-QUECHERS",1,NA
"MINI-YSTR",1,NA
"MINI SHORT TANDEM REPEAT",1,NA
"MINIATURE RAMAN INSTRUMENTS",1,1
"MINIATURIZATION",2,5
"MINICOMPUTERS",1,NA
"MINIMAL DETECTABLE DOSAGE",1,NA
"MINIMALISTIC SAMPLE PREPARATION",1,NA
"MINIMALLY INVASIVE AUTOPSY",1,NA
"MINIMALLY INVASIVE SAMPLING",1,NA
"MINIMISING EFFECT OF FLUORESCENCE, USE OF NIR LASER EXCITATION WAVELENGTHS",1,1
"MINIMUM POST-MORTEM INTERVAL",2,NA
"MINIMUM STANDARDS",1,NA
"MINING PRODUCTS",1,NA
"MINISTR",1,NA
"MINNESOTA MULTIPHASIC PERSONALITY INVENTORY-2 RESTRUCTURED FORM",1,NA
"MINOR ALKALOIDS",1,NA
"MINOR METABOLITES",1,NA
"MINORITY-RESISTANT VARIANTS",1,NA
"MINOXIDIL",1,NA
"MIP",1,NA
"MIPS",2,NA
"MIR",1,1
"MIR-133A",1,NA
"MIR-208B",1,NA
"MIR-499",1,NA
"MIRNA",7,NA
"MIRNA-3185",1,NA
"MIRNA DYSREGULATION",1,NA
"MIRNA PCR ARRAY",1,NA
"MIRNA PROFILING",5,NA
"MIRNAS",2,NA
"MIRRNA",1,NA
"MIRTAZAPINE",9,NA
"MISCARRIAGE",1,NA
"MISCELLANEOUS",1,NA
"MISCONCEPTIONS, AS PHYSICAL EVIDENCE BEST BY CRIME TECHNICIAN",1,NA
"MISCONDUCT",3,NA
"MISDIAGNOSIS",1,NA
"MISEQ FGX",1,NA
"MISER",1,NA
"MISIDENTIFICATION",1,1
"MISLEADING EVIDENCE",1,NA
"MISMATCHED PCR",1,NA
"MISOPROSTOL",2,NA
"MISOPROSTOL ACID",1,NA
"MISPE",1,NA
"MISSING DATA",1,1
"MISTAKE",1,NA
"MISTAKES",1,NA
"MISUSE",6,6
"MISUSED CONTENT",1,1
"MITIGATION",1,NA
"MITIGATION EVALUATIONS",1,NA
"MITIGATION EVIDENCE",1,NA
"MITIGATION RESPONSIBILITY",1,NA
"MITOCHONDRIA",2,NA
"MITOCHONDRIAL",1,1
"MITOCHONDRIAL CYTOCHROME B GENE",1,NA
"MITOCHONDRIAL DNA (MTDNA)",21,1
"MITOCHONDRIAL DNA SEQUENCING",1,NA
"MITOCHONDRIAL GENE",1,NA
"MITOCHONDRIAL MEMBRANE POTENTIAL",1,NA
"MITOCHONDRIAL TOXIN",1,NA
"MITOCHONDRIOPATHY",1,NA
"MITOGENOME",1,NA
"MITOTIC ARREST",1,NA
"MITOXPRESS",1,NA
"MITRAGYNA SPECIOSA",11,18
"MITRAGYNINE",15,23
"MITRAGYNINE TOXICITY",1,NA
"MIX-MODE",1,NA
"MIXED-DRUG FATALITY",1,NA
"MIXED-DRUG INTOXICATION",2,NA
"MIXED-MODE",1,1
"MIXED-MODE ANION-EXCHANGE COLUMN",1,NA
"MIXED-MODE C-C 18 MONOLITHIC SPIN-COLUMN",1,NA
"MIXED CELL-FOLLICLE",1,NA
"MIXED CHUG FATALITIES",1,NA
"MIXED DISTRIBUTIONS",1,1
"MIXED DRUG INTOXICATION",1,NA
"MIXED HEMIMICELLES",1,NA
"MIXED METHODOLOGY",1,NA
"MIXED PROTEIN PARTICLES",1,NA
"MIXED SUBSTANCE ABUSE",1,NA
"MIXTURE",1,NA
"MIXTURE ANALYSIS",1,1
"MIXTURE COMPARISON",1,NA
"MIXTURE INTERPRETATION",3,NA
"MIXTURE OF CITRIC ACID WITH BAKING SODA",1,NA
"MIXTURE PROPORTION",1,NA
"MIXTURE SEPARATION",1,NA
"MIXTURES",1,1
"MK-801",1,NA
"MMB-CHMICA",1,NA
"MMB-CHMINACA",1,NA
"MMD",1,NA
"MMDPPA",1,1
"MMP-7",1,NA
"MMPI-2",1,NA
"MMPI-2-RF",2,NA
"MMPS",1,NA
"MMXE",1,1
"MN BLOOD GROUP",1,NA
"MN NANOPARTICLE",1,NA
"MNEMIC DISTURBANCE",1,NA
"MOBILE",2,NA
"MOBILE-PHASE COMPOSITION",1,6
"MOBILE DEVICE ANALYSIS",2,NA
"MOBILE FORENSICS",5,NA
"MOBILE PHASE",3,1
"MOBILE PHONES",1,NA
"MOCLOBEMIDE",6,NA
"MODAFIENDZ",1,NA
"MODAFINIC ACID",1,NA
"MODAFINIL",5,NA
"MODAFINILIC ACID",1,NA
"MODE OF DEATH",1,NA
"MODEL OF TREATMENT OF VIOLENT OFFENDERS",1,NA
"MODEL RANDOM EFFECTS",1,NA
"MODELLING",4,2
"MODELS",3,1
"MODELS OF CARE",1,NA
"MODERN DRUG SCENE",1,NA
"MODERN HUMAN HAIR",1,NA
"MODERN METHODS",1,NA
"MODERN TIMES",1,NA
"MODIFICATION EFFECT",1,NA
"MODIFIED CARBON-PASTE ELECTRODES",1,NA
"MODIFIED ELECTRODE",2,11
"MODIFIED QUECHERS METHOD",1,NA
"MODIFIED WORKING ELECTRODE",1,NA
"MODULAR ION SOURCES",1,NA
"MODUS OPERANDI",2,NA
"MOISTENING AGENT",1,NA
"MOISTURE",1,NA
"MOLAR HYPOMINERALIZATION",1,NA
"MOLD",1,NA
"MOLDING",1,NA
"MOLECULAR-GENETIC RESEARCHES",1,NA
"MOLECULAR AUTOPSY",7,NA
"MOLECULAR BALLISTICS",1,NA
"MOLECULAR BASIS",1,NA
"MOLECULAR BEACON",1,NA
"MOLECULAR BIOLOGICAL APPROACHES",1,NA
"MOLECULAR BIOLOGY",2,NA
"MOLECULAR CHARACTERIZATION",1,NA
"MOLECULAR COMPOSITION OF HUMAN SCENT",1,NA
"MOLECULAR DESCRIPTORS",1,1
"MOLECULAR DIAGNOSIS",1,NA
"MOLECULAR DIAGNOSTICS",2,NA
"MOLECULAR DISTRIBUTION",1,NA
"MOLECULAR DOCKING",1,4
"MOLECULAR EVOLUTION",1,NA
"MOLECULAR FORENSICS",1,NA
"MOLECULAR FORMULA",1,1
"MOLECULAR GENETICS",1,NA
"MOLECULAR HISTOLOGY",1,NA
"MOLECULAR IMAGING",1,3
"MOLECULAR IMPRINTED POLYMER (MIP)",1,6
"MOLECULAR IMPRINTED TECHNOLOGY (MIT)",1,1
"MOLECULAR IMPRINTING",1,6
"MOLECULAR IMPRINTING TECHNIQUE",1,NA
"MOLECULAR IMPRINTING TECHNIQUE (MIT)",1,NA
"MOLECULAR MARKER",2,4
"MOLECULAR MECHANISMS",1,NA
"MOLECULAR MODELLING",1,7
"MOLECULAR NETWORKING",1,3
"MOLECULAR NETWORKING ANALYSIS",1,NA
"MOLECULAR ORBITAL",1,2
"MOLECULAR PATHOLOGY",3,NA
"MOLECULAR PATHWAYS",1,NA
"MOLECULAR PEAK ENHANCEMENT",1,NA
"MOLECULAR PHARMACOGNOSY",1,NA
"MOLECULAR PHARMACOLOGY",1,NA
"MOLECULAR POLARIZABILITY",1,1
"MOLECULAR PROBES",1,NA
"MOLECULAR PROPERTIES",1,NA
"MOLECULAR RECEPTORS",1,NA
"MOLECULAR RECOGNITION",1,3
"MOLECULAR SENSING",1,NA
"MOLECULAR SIMILARITY",1,NA
"MOLECULAR SIMULATION",1,NA
"MOLECULAR STRUCTURE",1,3
"MOLECULAR STRUCTURE REPRESENTATION",3,NA
"MOLECULAR TECHNIQUES",1,NA
"MOLECULAR TECHNOLOGIES",1,NA
"MOLECULAR WEIGHT",1,1
"MOLECULARLY IMPRINTED NANOPARTICLES",1,NA
"MOLECULARLY IMPRINTED POLYMER",9,31
"MOLECULARLY IMPRINTED POLYMERS (MIPS)",1,NA
"MOLECULARLY IMPRINTED SOLID PHASE EXTRACTION",2,1
"MOLECULARLY IMPRINTED SORBENTS",1,NA
"MOLECULARLY IMPRINTING",1,NA
"MOLLUSCICIDE",1,NA
"MONITORING",14,4
"MONITORING PROGRAM",1,NA
"MONO-DRUG FATALITIES",1,NA
"MONOAMINE METABOLISM",1,NA
"MONOAMINE METABOLITES",1,NA
"MONOAMINE OXIDASE A",1,NA
"MONOAMINE OXIDASE A INHIBITOR",1,NA
"MONOAMINE OXIDASE INHIBITOR",1,2
"MONOAMINE TRANSPORTER",1,NA
"MONOAMINE TRANSPORTERS",3,2
"MONOCLONAL ANTI-Α2-SEMINOGLYCOPROTEIN",1,NA
"MONOCLONAL ANTIBODY",8,8
"MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE",1,NA
"MONOCYTE",1,NA
"MONOETHYLGLYCINEXYLIDIDE",2,NA
"MONOETHYLGLYCINEXYLIDIDE (MEGX)",1,NA
"MONOFLUROACETATE",1,NA
"MONOISOTOPIC MASS",1,1
"MONOLITHIC C 18 SPE SPINTIP",1,NA
"MONOLITHIC COLUMN",5,6
"MONOLITHIC EXTRACTION PHASES",1,NA
"MONOLITHIC POLYMER",1,NA
"MONOLITHIC SILICA",3,NA
"MONOLITHIC SILICA SOLID-PHASE EXTRACTION",1,NA
"MONOLITHIC SUPPORT",1,1
"MONONITROTOLUENE",2,NA
"MONONUCLEAR PHAGOCYTIC SYSTEM",1,NA
"MONOOXYGENASE",1,1
"MONOZYGOTIC TWIN DISCORDANCE",1,NA
"MONOZYGOTIC TWIN PAIRS",1,NA
"MONOZYGOTIC TWINS",2,NA
"MONTE CARLO",1,1
"MONTE CARLO METHODS",1,NA
"MONTE CARLO SIMULATION",1,2
"MOOD",1,NA
"MOOD RATING",1,NA
"MOOD STABILIZERS",1,NA
"MOPERONE",1,NA
"MOR",1,NA
"MORAL DECISION-MAKING",1,NA
"MORBIDITY",2,NA
"MORNING-GLORY",1,NA
"MORNINGNESS-EVENINGNESS",1,NA
"MORPHAMQUAT",1,NA
"MORPHIA TABLETS",1,NA
"MORPHINE",149,111
"MORPHINE- 6-GLUCURONIDE",1,NA
"MORPHINE- GLUCURONIDES",1,NA
"MORPHINE-3-D GLUCURONIDE (M3DG)",1,NA
"MORPHINE-3-GLUCORONIDE",1,NA
"MORPHINE-3-GLUCURONIDE",1,NA
"MORPHINE-6- GLUCURONIDE",1,NA
"MORPHINE-6-GLUCURONIDE",2,1
"MORPHINE-GLUCURONIDE",1,NA
"MORPHINE-GLUCURONIDES",1,NA
"MORPHINE-INVOLVED DEATHS",1,NA
"MORPHINE 3-GLUCURONIDE",1,NA
"MORPHINE 3-O-GLUCURONIDE",1,1
"MORPHINE 6 ACETATE",1,1
"MORPHINE AND BENZODIAZEPINE DETECTION",1,NA
"MORPHINE CONCENTRATIONS",1,NA
"MORPHINE DETERMINATION",1,NA
"MORPHINE ETHERIAL SULFATE",1,NA
"MORPHINE GLUCURONIDE",1,NA
"MORPHINE GLUCURONIDES",3,NA
"MORPHINE HAIR PROFILE",1,NA
"MORPHINE METABOLISM",1,NA
"MORPHINE METABOLITES",1,1
"MORPHINE PLASMA DETERMINATION",1,NA
"MORPHINE TO CODEINE RATIO",1,NA
"MORPHINE TOXICITY",1,NA
"MORPHINE WITHDRAWAL",3,NA
"MORPHINE, DETERMINATION IN HUMAN HAIR",1,NA
"MORPHINE, EXAMINATION IN BLOOD SAMPLES",1,NA
"MORPHINE/CODEINE RATIO",1,NA
"MORPHINES",2,1
"MORPHOLOGIC CHANGES",1,NA
"MORPHOLOGICAL AND BIOCHEMICAL ASPECTS",1,NA
"MORPHOLOGICAL CHANGES",1,NA
"MORPHOLOGICAL DEMONSTRATION IN CHRONIC DRUG ABUSE",1,NA
"MORPHOLOGICAL INVESTIGATIONS, REQUIRED STANDARD",1,NA
"MORPHOLOGICALLY DIRECTED RAMAN SPECTROSCOPY",1,NA
"MORPHOLOGY",7,3
"MORPHOMETRY",2,NA
"MORS IN TABULA",1,NA
"MORTALITY",57,3
"MORTALITY INFORMATION SYSTEM",1,NA
"MORTALITY RATE",3,NA
"MORTALITY RATES",1,NA
"MORTALITY RISK",1,NA
"MORTALITY STATISTICS",4,NA
"MORTUARY",4,NA
"MOS",1,NA
"MOSCOW ROUTE",1,1
"MOTHER",1,NA
"MOTHERS",2,NA
"MOTIF",1,NA
"MOTIFS",1,NA
"MOTIVATION",7,1
"MOTIVATIONAL DISTORTION IN 16PF, NARCOTIC ADDICTS IN TREATMENT",1,NA
"MOTIVATIONAL INTERVIEWING",1,NA
"MOTIVATIONAL INTERVIEWING - AND COGNITIVE BEHAVIORAL INTERVENTIONS, TESTED AND FOUND EFFECTIVE",1,NA
"MOTIVATIONAL INTERVIEWING TREATMENT INTEGRITY CODING SYSTEM",1,NA
"MOTIVATIONS",1,NA
"MOTIVE",3,NA
"MOTIVES",3,NA
"MOTIVES FOR DRUG CONSUMPTION",1,NA
"MOTOR IMPULSIVITY",1,NA
"MOTOR VEHICLE",1,NA
"MOTOR VEHICLE ACCIDENT",2,NA
"MOTOR VEHICLE COLLISION",1,NA
"MOTOR VEHICLES",3,NA
"MOTORCYCLE",3,NA
"MOTORCYCLIST",1,NA
"MOTORCYLCE FATALITIES",1,NA
"MOTORIST",1,NA
"MOTORISTS",1,NA
"MOUNTING MEDIUM",1,NA
"MOUSE",3,1
"MOVEMENT DISORDER ASSESSMENT",1,NA
"MOVING OBJECT DETECTION",1,NA
"MOVING REACTION BOUNDARY",1,NA
"MOYAMOYA",1,NA
"MOZZARELLA CHEESE",1,NA
"MPA",1,1
"MPEG-7",1,NA
"MPF-47700",1,NA
"MPHP",1,1
"MPS",1,NA
"MRI",1,NA
"MRM",1,4
"MRM-EPI-MRM3",1,NA
"MRM MODE",1,NA
"MRM OPTIMIZATION",1,NA
"MRNA MARKER",1,NA
"MRNA PROFILE",1,NA
"MRNA PROFILING",14,NA
"MRNA QUANTIFICATION",1,NA
"MRNA TRANSCRIPTS",1,NA
"MRO",1,NA
"MS-MS",3,1
"MS ANALYSIS",1,1
"MSCT",1,NA
"MSFORID",1,1
"MSI",1,NA
"MSP",1,1
"MSPAK GF",1,NA
"MSTFA",2,3
"MT-45",5,4
"MT-45 [1-CYCLOHEXYL-4-(1,2-DIPHENYLETHYL)PIPERAZINE, SYNONYM: I-C6]",1,1
"MT DNA",1,NA
"MTBSTFA",1,NA
"MTDNA COI",1,NA
"MTSNP MARKERS",1,NA
"MU-OPIOID RECEPTOR",1,2
"MUCOUS PLUGS",1,NA
"MULE",1,NA
"MULES",1,NA
"MULTI-ANALYTE",4,1
"MULTI-ANALYTE LC-MS/MS METHOD",1,NA
"MULTI-ANALYTE SCREENING",2,NA
"MULTI-ANALYTICAL APPROACH",1,1
"MULTI-AXIAL FORENSIC ASSESSMENT",1,NA
"MULTI-CHEMICAL POISONING",1,NA
"MULTI-COLLECTOR",1,NA
"MULTI-COLLECTOR ICP-MS",1,NA
"MULTI-COLLECTOR INDUCTIVELY-COUPLED PLASMA MASS SPECTROMETRY",1,NA
"MULTI-COLLECTOR MASS SPECTROMETRY",2,NA
"MULTI-DISCIPLINARY COLLABORATION",1,NA
"MULTI-DRUG ABUSE",1,NA
"MULTI-DRUG DEATHS",1,NA
"MULTI-DRUG METHOD",1,NA
"MULTI-DRUG POISONING",1,NA
"MULTI-DRUG USE",1,NA
"MULTI-LOCUS SEQUENCE TYPING",1,NA
"MULTI-LOCUS VARIABLE NUMBER TANDEM REPEAT ANALYSIS",1,NA
"MULTI-MEDIA TRAINING",1,NA
"MULTI-METAL DEPOSITION",1,NA
"MULTI-METHOD",1,NA
"MULTI-PARAMETRIC TESTS",1,NA
"MULTI-PRECURSOR ION SCANNING",1,NA
"MULTI-PROFESSIONAL PRACTICE",1,NA
"MULTI-RESIDUE",2,1
"MULTI-SITE TREATMENT TRIAL",1,NA
"MULTI-SPHERES ADSORPTIVE MICRO-EXTRACTION (MSAΜE)",1,NA
"MULTI-TARGET ANALYSES",1,NA
"MULTI-TARGET SCREENING",2,NA
"MULTI-WALL CARBON NANOTUBES",1,1
"MULTI-WALLED CARBON NANOTUBES",2,4
"MULTI-WAVELENGTH EXCITATION",1,1
"MULTI ORGAN DAMAGE",1,NA
"MULTI PHASE POST MORTEM CT ANGIOGRAPHY (MPMCTA)",1,NA
"MULTI PROXY COMPARIONS",1,NA
"MULTIAGENCY COLLABORATION",1,NA
"MULTIANALYTE",1,NA
"MULTICENTER STUDY",3,NA
"MULTICENTRE STUDY",1,NA
"MULTICLASS ANALYSIS",1,NA
"MULTICOLLECTOR ICP-MS",1,NA
"MULTIDETECTOR COMPUTED TOMOGRAPHY",1,NA
"MULTIDIMENSIONAL FAMILY THERAPY",1,NA
"MULTIDIMENSIONAL GAS CHROMATOGRAPHY",1,1
"MULTIDIMENSIONAL HIGH PERFORMANCE LIQUID CHROMATOGRAPHY",1,2
"MULTIDISCIPLINARITY",1,NA
"MULTIDISCIPLINARY",1,NA
"MULTIDISCIPLINARY APPROACH",2,NA
"MULTIDISCIPLINARY CHILD PROTECTION TEAM",1,NA
"MULTIDISCIPLINARY INTERVENTION",1,NA
"MULTIDRUG INTOXICATION",3,NA
"MULTIDRUG RESISTANCE",1,1
"MULTIDRUGS",1,NA
"MULTILOCUS",1,NA
"MULTIMEDIA-BASED LEARNING",2,NA
"MULTIMERIC ENZYME",1,NA
"MULTIMORBIDITY",1,NA
"MULTINOMIAL DATA",1,NA
"MULTIORGANIC FAILURE",1,NA
"MULTIPARAMETER EVALUATION",1,NA
"MULTIPARTICULATE(S)",1,NA
"MULTIPATH EXCITATION",1,NA
"MULTIPHASE SAMPLES",1,NA
"MULTIPLE",1,NA
"MULTIPLE-ANTIGENIC PEPTIDE",1,NA
"MULTIPLE BRAIN INFARCTIONS",1,NA
"MULTIPLE CAUSES OF DEATH",1,NA
"MULTIPLE CHIRAL ANALYTES",1,1
"MULTIPLE DISPLACEMENT AMPLIFICATION",1,NA
"MULTIPLE DRUG",1,NA
"MULTIPLE DRUG ABUSE",1,1
"MULTIPLE DRUG ANALYSIS",1,NA
"MULTIPLE DRUG INTOXICATION",1,NA
"MULTIPLE DRUG POISONING",2,NA
"MULTIPLE DRUG USE",1,NA
"MULTIPLE HEADSPACE SOLID-PHASE MICROEXTRACTION",1,NA
"MULTIPLE HOMICIDE",1,NA
"MULTIPLE INJURIES",1,NA
"MULTIPLE ION COUNTER",1,NA
"MULTIPLE ISOTOPICALLY LABELED INTERNAL STANDARDS",1,NA
"MULTIPLE LINEAR REGRESSION",2,3
"MULTIPLE LINEAR REGRESSION (MLR)",1,1
"MULTIPLE MURDERS",1,NA
"MULTIPLE ORGAN FAILURE",1,NA
"MULTIPLE ORGAN/TISSUE PERFORATION",1,NA
"MULTIPLE PCR",1,NA
"MULTIPLE PERSONALITY DISORDER",1,NA
"MULTIPLE PSYCHOTROPIC DRUGS",1,NA
"MULTIPLE PULSE AMPEROMETRY (MPA)",1,1
"MULTIPLE REACTION MONITORING",1,NA
"MULTIPLE SCLEROSIS",1,NA
"MULTIPLE SEQUENCE ALIGNMENT",1,NA
"MULTIPLE SEX PARTNERS",1,NA
"MULTIPLE TATTOOS",1,NA
"MULTIPLE TRANSDERMAL PATCHES",1,NA
"MULTIPLE TRAUMA/CLASSIFICATION/DIAGNOSIS/MORTALITY",1,NA
"MULTIPLEX",2,NA
"MULTIPLEX AMPLIFICATION",1,NA
"MULTIPLEX POLYMERASE CHAIN REACTION (PCR)",3,NA
"MULTIPLEX POLYMERASE CHAIN REACTION SYSTEM",1,NA
"MULTIPLEX REAL-TIME PCR",1,NA
"MULTIPLEX RT-PCR",3,NA
"MULTIPLY CHARGED DYE",1,NA
"MULTIPOINT IMMOBILIZATION",1,NA
"MULTIPUMPING",1,1
"MULTIRESIDUE PESTICIDE ANALYSIS",1,NA
"MULTIRESIDUE SCREENING",2,NA
"MULTISPECIALTY PRACTICE",1,NA
"MULTISTAGE (MSN) MS",1,NA
"MULTISTAGE SAMPLING",2,NA
"MULTIVARIATE ANALYSIS (MVA)",18,19
"MULTIVARIATE CLASSIFICATION MODEL",1,1
"MULTIVARIATE CURVE RESOLUTION",1,6
"MULTIVARIATE DISTRIBUTIONS",1,1
"MULTIVARIATE KERNEL DENSITY",1,NA
"MULTIWAVELENGTH DETECTION",1,NA
"MULTIWAVELENGTH DETECTOR",1,NA
"MUMMIES",1,NA
"MUMMIFICATION",1,NA
"MUMMIFIED BODY",1,NA
"MUMMY",1,NA
"MUNCHA USEN'S",1,NA
"MUNCHAUSEN SYNDROME",3,NA
"MUNCHAUSEN SYNDROME BY PROXY",7,NA
"MURDER",14,NA
"MURDER-SUICIDE",1,NA
"MURDER BY POISON",1,NA
"MURDER CLEARANCE",1,NA
"MURDER FOLLOWED BY SUICIDE",1,NA
"MURDER WEAPON",1,NA
"MUREXIDE COLOR REACTION",1,NA
"MUSCIMOL",3,1
"MUSCINA STABULANS",1,NA
"MUSCLE",12,1
"MUSCLE DAMAGE",1,NA
"MUSCLE METABOLITES",1,NA
"MUSCLE NECROSIS",2,NA
"MUSCLE POPPING",1,NA
"MUSCLE RELAXANT",4,NA
"MUSCLE RELAXANT REVERSAL AGENT",1,NA
"MUSCLE RELAXANTS",3,NA
"MUSCLE TISSUE",1,NA
"MUSCONE",1,NA
"MUSCULAR HEMORRHAGE",1,NA
"MUSCULAR HYPOTONIA",1,NA
"MUSEUM COLLECTIONS",1,NA
"MUSHROOM",2,NA
"MUSHROOM POISONING",1,NA
"MUSHROOM TOXINS",1,1
"MUSHROOMS",1,3
"MUSIC FESTIVAL",2,2
"MUSIC FESTIVALS",1,1
"MUSK DEER",1,NA
"MUTATION",5,NA
"MUTATION DETECTION",1,NA
"MUTATION P.GLY798_PRO815DEL",1,NA
"MUTATION SCANNING",1,NA
"MUTATION SCREENING",1,NA
"MUTATIONAL ANALYSIS",1,NA
"MUTILATION",2,NA
"MVA",1,1
"MWCNTS",1,2
"MWCNTS-COOH",1,NA
"MXE",2,NA
"MYCOBACTERIA",1,NA
"MYCOBACTERIUM TUBERCULOSIS",1,NA
"MYCOLOGY",1,NA
"MYCOTIC VASCULITIS",1,NA
"MYCOTOXIN",1,8
"MYDRIATICS",1,NA
"MYELIN BASIC PROTEIN",1,NA
"MYELOFIBROSIS",1,NA
"MYELOPEROXIDASE",1,NA
"MYIASIS",3,NA
"MYOCARD FIBROSIS",1,NA
"MYOCARDIAL BINDING OF DIGOXIN",1,NA
"MYOCARDIAL BRIDGING",4,NA
"MYOCARDIAL DAMAGE",2,NA
"MYOCARDIAL FIBROSIS",1,NA
"MYOCARDIAL HYPERTROPHY",3,NA
"MYOCARDIAL INFARCT SIZE",1,NA
"MYOCARDIAL INFARCTION",13,NA
"MYOCARDIAL INFLAMMATION",1,NA
"MYOCARDIAL INJURY",2,NA
"MYOCARDIAL ISCHEMIA",3,NA
"MYOCARDIAL NECROSIS",1,NA
"MYOCARDIAL REMODELING",2,NA
"MYOCARDIAL SCAR",1,NA
"MYOCARDITIS",5,NA
"MYOCARDITIS/IMMUNOLOGY",1,NA
"MYOCARDITIS/PATHOLOGY",1,NA
"MYOCARDIUM",3,NA
"MYOCARDIUM ISCHEMIA -REPERFUSION",1,NA
"MYOCYTE NECROSIS",1,NA
"MYOCYTES",1,NA
"MYOCYTES DISARRAY",1,NA
"MYOFIBRILLAR DEGENERATION OF THE CARDIOCYTES",1,NA
"MYOGLOBIN",10,NA
"MYOGLOBIN-RELATED RENAL INJURY",1,NA
"MYOGLOBINEMIA",1,NA
"MYOGLOBINURIA",1,NA
"MYOSIN HEAVY CHAINS",1,NA
"MYRTENOL",1,NA
"MYSTICAL EXPERIENCE",1,NA
"MYSTICETI",1,NA
"MYTHIC INFALLIBILITY",1,NA
"N-(1-ADAMANTYL)-1-(TETRAHYDROPYRAN-4-YLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE",1,NA
"N-(1-ADAMANTYL)-1-PENTYL- 1H-INDAZOLE-3-CARBOXAMIDE",1,1
"N-(1-ADAMANTYL)-1-PENTYL-1 H-INDOLE-3-CARBOXAMIDE",1,1
"N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 3-CARBOXAMIDE (AB-FUBINACA)",1,1
"N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDOLE-3-CARBOXAMIDE (AB-FUBICA)",1,1
"N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-BENZYL-1H-INDOLE-3-CARBOXAMIDE (AB-BICA)",1,1
"N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (AB-PINACA",1,1
"N-(1-AMINO-3,3-DIMETHYL-1- OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB-FUBINACA)",1,1
"N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDOLE-3-CARBOXAMIDE (ADB-FUBICA)",1,1
"N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-BENZYL-1H-INDAZOLE-3-CARBOXAMIDE (ADB-BINACA)",1,1
"N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDOLE-3-CARBOXAMIDE (ADBICA)",1,1
"N-(1-PHENYLCYCLOHEXYL)-3-METHOXYPROPANAMINE",1,NA
"N-2",1,NA
"N-ACETYLCYSTEINE",1,NA
"N-ACETYLMETHAMPHETAMINE",1,1
"N-ACETYLTAURINE",1,NA
"N-ACYLETHANOLAMIDE",1,NA
"N-ALKANES",1,1
"N-ALKYL-3-(1-NAPHTHOYL)INDOLE",1,1
"N-ALKYL DERIVATIZATION",1,NA
"N-ALKYLDIMETHYLAMINE GAS CHROMATOGRAPHY",1,NA
"N-ALKYLDIMETHYLBENZYLAMMONIUM CHLORIDE",1,NA
"N-BENZYL-SUBSTITUTED PHENETHYLAMINES",1,NA
"N-BENZYLPIPERAZINE",3,1
"N-BENZYLPIPERAZINE (BZP)",1,NA
"N-BOMB",2,4
"N-BUTANE",1,NA
"N-BUTANE METABOLITE",1,NA
"N-BUTANOL",1,NA
"N-BUTYL ACETATE",1,NA
"N-BUTYL NITRITE",1,NA
"N-BUTYLCHLOROFORMATE",1,NA
"N-CARBOXYMETHYLMETHAMPHETAMINE",1,NA
"N-CYANOMETHYL-N-METHYL-1-(3′,4′- METHYLENEDIOXYPHENYL)-2-PROPYLAMINE",1,NA
"N-DEMETHYL- LSD",1,NA
"N-DEMETHYLATION",1,1
"N-DESALKYL METABOLITES",1,NA
"N-DESALKYLFLURAZEPAM",1,NA
"N-DESALKYLQUETIAPINE",1,NA
"N-DESMETHYL-OLANZAPINE",1,NA
"N-DESMETHYLCLOZAPINE",1,NA
"N-DESMETHYLFLUNITRAZEPAM",1,NA
"N-DESMETHYLSIBUTRAMINE",1,NA
"N-DESMETHYLSILDENAFIL",1,NA
"N-DESMETHYLTRAMADOL",2,1
"N-DESMETHYLZOPICLONE",1,NA
"N-DIALLYLTRYPTAMINE",1,NA
"N-ETHYL-3,4-METHYLENDIOXYAMPHETAMINE (MDE)",2,2
"N-ETHYL-3,4-METHYLENEDIOXYAMPHETAMINE",1,NA
"N-ETHYL-Α-ETHYLPHENETHYLAMINE",1,NA
"N-ETHYL HEXEDRONE",1,NA
"N-ETHYL PENTYLONE",1,NA
"N-ETHYLCATHINONE",1,2
"N-ETHYLHEXEDRONE",4,2
"N-ETHYLPENTYLONE",1,NA
"N-ETHYLPENTYLONE, N-BUTYLPENTYLONE, N-ETHYLHEPTEDRONE",1,1
"N-FORMYLMETHYLAMPHETAMINE",1,1
"N-HEXANE",1,1
"N-HYDROXYPENTYL METABOLITE",1,NA
"N-ISOAMYL ACETATE",1,NA
"N-METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-BUTANAMINE",1,1
"N-METHYL-3,4- METHYLENEDIOXY AMPHETAMINE (MDMA)",1,1
"N-METHYL-3,4-METHYLENDIOXYAMPHETAMINE (MDMA)",2,2
"N-METHYL-3,4-METHYLENEDIOXY-AMPHETAMINE HYDROCHLORIDE",1,1
"N-METHYL-3,4-METHYLENEDIOXYCATHINONE",1,NA
"N-METHYL-D-ASPARTATE",1,NA
"N-METHYL NORFENTANYL",1,NA
"N-METHYLAMPHETAMINE",1,1
"N-NITROSOFENFLURAMINE",1,NA
"N-NONANE",1,NA
"N-OH MDMA",1,1
"N-PENTANOIC ACID METABOLITE",1,NA
"N-TRIFLUROACETYLPROLYL CHLORIDE",1,NA
"N -CHLOROMETHYLPHTHALIMIDE",1,NA
"N EUROLEPTIC",1,NA
"N,N'-DIPHENYL-N,N'- DIETHYLUREA (ETHYL CENTRALITE)",1,NA
"N,N-DIALKYLATED TRYPTAMINE",1,1
"N,N-DIALLYL-5-METHOXYTRYPTAMINE",1,NA
"N,N-DIMETHYLAMPHETAMINE",1,3
"N,N-DIMETHYLTRYPTAMINE",2,5
"N,O-DIDESMETHYLTRAMADOL",1,NA
"N,Α-DIETHYLPHENETHYLAMINE (NADEP)",1,NA
"N/S RATIO",1,NA
"N2/P3A",1,NA
"NABIXIMOLS",1,NA
"NADA PROTOCOL",1,NA
"NADH",1,NA
"NADOLOL",1,NA
"NAFLD",1,NA
"NAFTIDROFURYL",1,NA
"NAGAI METHOD",1,2
"NAGINATA",4,1
"NAGINATA DATABASE",1,NA
"NAGLY",1,NA
"NAIL",8,NA
"NAIL ANALYSIS",7,NA
"NAIL CLIPPING",2,NA
"NAIL COSMETICS",1,NA
"NAIL DISEASE PREDICTION",1,NA
"NAIL PATHOLOGY",1,NA
"NAIL PSORIASIS",1,NA
"NAILCLIPPINGS",1,NA
"NAILFOLD CAPILLAROSCOPY NFC",1,NA
"NAILS",12,NA
"NAILS IN BIO-METRIC RECOGNITION SYSTEMS",1,NA
"NAILS IN FORENSIC SCIENCES",1,NA
"NAILS, LC/ESI/MS",1,NA
"NALBUPHINE",2,5
"NALDI",1,1
"NALOXONE",7,4
"NALTREXONE",4,2
"NALTREXONE MEDICATION",1,NA
"NANDROLONE",3,2
"NANO-BASED SENSOR",1,NA
"NANO-ELECTROSPRAY",1,NA
"NANO-ENABLED TOOLS",1,NA
"NANO-FORENSICS",1,NA
"NANO-HYBRIDS",1,1
"NANO-INIFERTER",1,NA
"NANO-LC",1,NA
"NANO-LIQUID CHROMATOGRAPHY",1,1
"NANO-PHOSPHORS",1,NA
"NANO-PHOTONIC TECHNOLOGIES",1,NA
"NANO-SAMPLE",1,NA
"NANO-STRUCTURED FIBER SENSORS",1,NA
"NANO TRACKER",1,NA
"NANOBIO-BASED METHOD",1,NA
"NANOBIOMEDICINE",2,NA
"NANOBIOSENSOR",1,1
"NANOCALORIMETER",1,NA
"NANOCARRIERS",1,NA
"NANOCHIPS",1,NA
"NANOCOMPOSITE",1,7
"NANOCOMPOSITES",1,NA
"NANOCRYSTAL",1,NA
"NANOFABRICATION",2,NA
"NANOFILM",1,1
"NANOFLOW LIQUID CHROMATOGRAPHY",1,NA
"NANOGAP BIOSENSOR",1,NA
"NANOHYBRIDS",1,NA
"NANOLITER HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY",1,NA
"NANOMANIPULATION",1,NA
"NANOMATERIAL",4,NA
"NANOMATERIALS",9,3
"NANOPARTICLE SHEETS",1,NA
"NANOPARTICLES",13,5
"NANOPARTICLES/ NANOTECHNOLOGY",1,NA
"NANOPARTICLES/NANOTECHNOLOGY",1,1
"NANOPATHOLOGY",2,NA
"NANOPORE",2,1
"NANOPROBES",1,NA
"NANOSCALE",2,NA
"NANOSCIENCE",1,NA
"NANOSENSOR",2,5
"NANOSPRAY",1,1
"NANOSPRAY IONIZATION",1,NA
"NANOSTRUCTURED SURFACES",1,1
"NANOSTRUCTURES",3,1
"NANOTECHNOLOGY",12,3
"NANOTHERAPEUTICS",1,NA
"NANOTOXICOLOGY",1,NA
"NAPHAZOLINE",1,NA
"NAPHTHALEN-1-YL-(1-PENTYLINDOL-3-YL) METHANONE",1,1
"NAPHTHALENE",3,1
"NAPHTHENIC ACIDS",2,NA
"NAPHYRONE",2,3
"NAPPY",1,NA
"NARANJO",1,NA
"NARANJO ALGORITHM",1,NA
"NARCISSISTIC PERSONALITY INVENTORY-13",1,NA
"NARCO-ANALYSIS",1,NA
"NARCOLEPTIC BREASTFEEDING MOTHERS",1,NA
"NARCOTIC ABUSE",1,NA
"NARCOTIC ADDICTS",1,NA
"NARCOTIC ANALGESIA",1,NA
"NARCOTIC CONTROL",1,1
"NARCOTIC DRUG",1,NA
"NARCOTIC DRUGS",8,3
"NARCOTIC DRUGS, ANALYTICAL DATA",1,NA
"NARCOTIC LUNG",1,NA
"NARCOTIC POISONING",1,NA
"NARCOTIC SCREENING",1,NA
"NARCOTIC STIMULANT",1,NA
"NARCOTIC SUBSTANCES",1,NA
"NARCOTIC/ILLICIT DRUGS",1,NA
"NARCOTICS",31,23
"NARCOTICS-RELATED SUICIDES",1,NA
"NARCOTICS (HEROIN, MORPHINE, CODEINE, COCAINE, AND AMPHETAMINES)",1,1
"NARCOTICS ANALYSIS",1,1
"NARCOTICS LAW",1,NA
"NARCOTICS TRACE DETECTION",1,1
"NARCOTINE",2,6
"NARKOSEZWISCHENFALL",1,NA
"NARMADA",1,NA
"NARRATIVE EXPOSURE",1,NA
"NARRATIVE EXPOSURE THERAPY",1,NA
"NARRATIVE EXPOSURE THERAPY (NET)",1,NA
"NARROW-BORE CAPILLARY",1,1
"NARROW-BORE CAPILLARY COLUMN",1,NA
"NARTEST",1,1
"NASAL BLOOD",1,NA
"NASAL MUCOSA",2,NA
"NASAL SECRETION",2,NA
"NATIONAL CENTER ON ADDICTION AND SUBSTANCE ABUSE AT COLUMBIA UNIVERSITY",1,NA
"NATIONAL COHORT",1,NA
"NATIONAL FIGURES",1,NA
"NATIONAL FORENSIC LABORATORY INFORMATION SYSTEM",1,NA
"NATIONAL FORENSIC RAPID LABORATORY (AUSTRALIA)",1,1
"NATIONAL FORENSIC SERVICE",1,1
"NATIONAL MONITORING CENTRE FOR DRUGS",1,NA
"NATIONAL PROGRAMME OF MENTAL HEALTH PROTECTION",2,NA
"NATIONAL SECURITY",2,1
"NATIONAL SURVEY",1,NA
"NATIONAL SURVEY ON DRUG USE AND HEALTH",1,1
"NATIONAL TRANSPORTATION SAFETY BOARD",1,NA
"NATRIURETIC PEPTIDE",1,NA
"NATURAL",2,NA
"NATURAL AGING",1,NA
"NATURAL CANNABINOIDS",1,NA
"NATURAL DATA SETS",1,NA
"NATURAL DEATH",5,NA
"NATURAL DEATHS",2,NA
"NATURAL DRUGS",1,1
"NATURAL DYES",1,NA
"NATURAL GAS",1,NA
"NATURAL HAZARD",1,NA
"NATURAL ISOTOPIC VARIATIONS",1,1
"NATURAL MEDICINES",1,NA
"NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY (NOTES)",1,NA
"NATURAL OUTDOOR POND",1,NA
"NATURAL POISONS",1,NA
"NATURAL PRODUCT",1,NA
"NATURAL PRODUCTS",3,15
"NATURAL SUBSTANCES",1,NA
"NATURAL TOXIC SUBSTANCES",1,NA
"NATURAL TOXINS",1,1
"NAUSEA",1,NA
"NAUSEA/VOMITING",1,NA
"NAZI",1,NA
"NAZI METHOD",1,1
"NBD CHLORIDE",1,NA
"NBF",1,NA
"NBOH",5,6
"NBOHS",1,1
"NBOME",13,21
"NBOME DERIVATIVES",1,NA
"NBOMES",1,2
"NCI-GAS CHROMATOGRAPHY-MASS SPECTROMETRY",2,1
"NCI-GC-MS",1,NA
"NCI-GC/MS",1,NA
"NCI - GAS CHROMATOGRAPHY MASS SPECTROMETRY",1,NA
"NCNOS",1,NA
"NCRMD DEFENCE",1,NA
"ND AND SM ISOTOPIC RATIOS",1,NA
"ND4 GENE",1,NA
"NDPS",1,NA
"NDPS ACT",1,1
"NEAR-BODY DRUG SCREENING",1,NA
"NEAR-INFRARED",7,10
"NEAR-INFRARED DETECTION",1,NA
"NEAR-INFRARED REFLECTANCE SPECTROSCOPY",1,NA
"NEAR-INFRARED SPECTROMETRY",1,4
"NEAR-INFRARED SPECTROSCOPY",3,17
"NEAR-PATIENT TESTING",1,NA
"NEAR FATAL ASTHMA",2,NA
"NEAR FATALITY",1,NA
"NEAREST NEIGHBOR",1,NA
"NEBRASKA",1,NA
"NECK",2,NA
"NECK INJURY",1,NA
"NECK PAIN",1,NA
"NECK TRAUMA",1,NA
"NECROBIA RUFIPES",1,NA
"NECROBIOME",1,NA
"NECROKINETIC",2,NA
"NECROPHAGES",2,NA
"NECROPHAGIA",1,NA
"NECROPHAGOUS",1,NA
"NECROPHAGOUS DIPTERA",1,NA
"NECROPHAGOUS INSECTS",1,NA
"NECROPHILIA",2,NA
"NECROPSY",4,NA
"NECROPSY EXAMINATION",1,NA
"NECROSCOPIC",1,NA
"NECROSIS",3,NA
"NECROSIS AND GANGRENE OF EXTREMITIES",1,NA
"NECROTIC PURPURA",1,NA
"NECROTIZING ANGIITIS",1,NA
"NECROTIZING FASCIITIS",3,NA
"NED KELLY",1,NA
"NEED",1,NA
"NEEDLE",1,NA
"NEEDLE EMBOLIZATION",1,NA
"NEEDS ASSESSMENT",1,NA
"NEFAZODONE",1,NA
"NEGATIVE",1,1
"NEGATIVE-ION CHEMICAL IONIZATION",1,1
"NEGATIVE AND POSITIVE CHEMICAL IONIZATION",1,NA
"NEGATIVE AUTOPSY",1,NA
"NEGATIVE CHEMICAL IONIZATION",1,1
"NEGATIVE FORENSIC EVIDENCE",1,NA
"NEGATIVE ION",2,NA
"NEGATIVE ION CHEMICAL IONIZATION",3,NA
"NEGATIVE RESULTS",1,NA
"NEGATIVE SOCIETAL ATTITUDE",1,NA
"NEGATIVE SYMPTOMS",1,NA
"NEGATIVE TEST RESULTS",1,NA
"NEGLECT",2,NA
"NEGLIGENCE",2,NA
"NEGLIGENCE (INCLUDING PROFESSIONAL NEGLIGENCE OR """"MALPRACTICE"""")",1,NA
"NEIGHBORHOOD EFFECTS",1,NA
"NEOCUPROINE",1,1
"NEODYMIUM ISOTOPE RATIO",1,NA
"NEODYMIUM ISOTOPES",1,NA
"NEOFORMATION",1,NA
"NEONATAL",1,NA
"NEONATAL DEATH",1,NA
"NEONATAL TESTING",1,NA
"NEONATE",2,NA
"NEONATE HAIR",1,NA
"NEONATICIDE",1,NA
"NEONATICIDE DURING BIRTH",1,NA
"NEONICOTINOID",1,NA
"NEONICOTINOIDS",1,NA
"NEOTROPICAL REGION",1,NA
"NEPAL",1,NA
"NEPHELOMETRIC IMMUNOASSAY",1,NA
"NEPHROLOGY",1,NA
"NEPHROPATHY",1,NA
"NEPHROTIC SYNDROME",1,NA
"NEPHROTOXICITY",1,NA
"NEPS",1,NA
"NEPTUNIUM",1,NA
"NEREISTOXIN",2,NA
"NERIUM OLEANDERS L.",1,NA
"NERVE AGENT",2,NA
"NERVE AGENT METABOLITES",1,NA
"NERVE AGENTS",5,NA
"NET",1,NA
"NET WEIGHTS",1,NA
"NETWORK ANALYSIS",1,NA
"NETWORK FORENSIC",1,NA
"NETZWERK PROBEWEIS",1,NA
"NEURAL BLOCKADE",1,NA
"NEURAL MECHANISMS",1,NA
"NEURAL NETWORK",7,7
"NEURAL NETWORK MODELS",1,1
"NEUREXIN",1,NA
"NEURO-INTERVENTION",1,NA
"NEUROACTIVE SUBSTANCES",1,NA
"NEUROBEHAVIOR",1,NA
"NEUROBEHAVIORAL",1,NA
"NEUROBEHAVIORAL ASSESSMENT",1,NA
"NEUROBEHAVIORAL MANIFESTATIONS",2,NA
"NEUROBIOLOGICAL PROCEDURES",1,1
"NEUROBIOLOGY",1,NA
"NEUROCHEMICALS",1,NA
"NEURODEGENERATION",2,1
"NEURODEGENERATIVE DISEASES",1,NA
"NEURODEVELOPMENTAL DISORDERS",1,NA
"NEURODISABILITY",1,NA
"NEUROENDOCRINE",1,NA
"NEUROENHANCEMENT",1,NA
"NEUROETHICS",3,NA
"NEUROFEEDBACK",5,NA
"NEUROFEEDBACK-LEARNING",1,NA
"NEUROFILAMENT PROTEIN",1,NA
"NEUROFILAMENTS",1,NA
"NEUROGENETICS",2,NA
"NEUROGLOBIN",1,NA
"NEUROGLYCOPENIA",1,NA
"NEUROIMMUNOLOGY",1,NA
"NEUROINFLAMMATION",1,NA
"NEUROLEPTIC",1,NA
"NEUROLEPTIC AGENT",1,NA
"NEUROLEPTIC MALIGNANT SYNDROME",6,NA
"NEUROLEPTICS",8,NA
"NEUROLOGIC DISORDERS",1,NA
"NEUROLOGIC DRUGS",1,NA
"NEUROLOGIC MISADVENTURES",1,NA
"NEUROLOGICAL",1,NA
"NEUROLOGICAL LIABILITY",1,NA
"NEUROLOGY OF SEXUAL ACTIVITY",1,NA
"NEUROMUSCULAR BLOCKING AGENT",1,NA
"NEURON SYNAPTIC PLASTICITY",1,NA
"NEURONAL ADAPTATION AND CHRONIC EXPOSURE IN THE HUMAN BRAIN",1,NA
"NEURONAL APOPTOSIS",2,NA
"NEURONAL DAMAGE",1,NA
"NEURONS",1,NA
"NEUROPATHIC",1,NA
"NEUROPATHOLOGY",2,NA
"NEUROPATHY",1,NA
"NEUROPROTECTION",1,NA
"NEUROPSYCHIATRIC DISORDER",1,NA
"NEUROPSYCHIATRIC DISORDERS",1,NA
"NEUROPSYCHOLOGICAL",1,NA
"NEUROPSYCHOLOGICAL ASSESSMENT",1,NA
"NEUROPSYCHOLOGICAL PSYCHIATRY",1,NA
"NEUROPSYCHOLOGICAL TESTING",1,NA
"NEUROPSYCHOLOGY",3,NA
"NEUROPSYCHOLOGY IN SELF-HARM",1,NA
"NEUROPSYCHOPHARMACOLOGY",1,NA
"NEUROPSYCHOTIC DRUGS",1,NA
"NEURORADIOLOGY",1,NA
"NEUROROXICITY",1,NA
"NEUROSCIENCE",2,1
"NEUROSURGERY",1,NA
"NEUROTHERAPY",1,NA
"NEUROTOXIC",1,NA
"NEUROTOXICITY",6,2
"NEUROTOXICOLOGY",1,NA
"NEUROTOXIN",1,NA
"NEUROTOXINS",1,NA
"NEUROTRANSMITTERS",5,NA
"NEUTRAL",1,NA
"NEUTRAL AMINO ACID TRANSPORTERS",1,NA
"NEUTRAL AND ACIDIC CANNABINOIDS",1,2
"NEUTRAL DRUGS",1,NA
"NEUTRAL FAT",1,NA
"NEUTRAL SURFACTANT",1,1
"NEUTRON ACTIVATION",2,NA
"NEUTRON ACTIVATION ANALYSIS",5,NA
"NEUTROPENIA/BLOOD/CHEMICALLY INDUCED/ETHNOLOGY/",1,NA
"NEUTROPHIL",1,NA
"NEUTROPHILS",2,NA
"NEUTROPHILS.",1,NA
"NEVADA MENTAL HEALTH COURTS",1,NA
"NEW-GENERATION ANTIDEPRESSANTS (NGAS)",1,NA
"NEW-TYPE DRUG",1,NA
"NEW-TYPE SYNTHETIC CANNABINOIDS",1,NA
"NEW """"SPIKE99"""" SPICE",1,NA
"NEW 25-NBOME-TYPE DESIGNER DRUGS",1,1
"NEW AGE",1,NA
"NEW ANALYTICAL TECHNOLOGY",1,NA
"NEW CHROMOGENIC REAGENT",1,NA
"NEW DESIGNER DRUG",1,NA
"NEW DESIGNER DRUGS",2,6
"NEW DRUGS",3,2
"NEW EMERGING PSYCHOACTIVE SUBSTANCES",1,NA
"NEW FENTANYLS",1,NA
"NEW INJURY SEVERITY SCORE",3,NA
"NEW INSTRUMENTAL ANALYSIS",1,NA
"NEW METABOLITE",1,NA
"NEW MEXICO",1,NA
"NEW MOLECULAR BIOMARKERS",1,NA
"NEW MPA GUIDELINES",1,NA
"NEW OPIOIDS",1,NA
"NEW OXIDIZED METABOLITES",1,NA
"NEW POLYMER COLUMN",2,NA
"NEW POLYMER COLUMN (MSPAK GF-310)",1,NA
"NEW PSYCHOACTIVE AGENTS",1,NA
"NEW PSYCHOACTIVE STIMULANTS",1,1
"NEW PSYCHOACTIVE SUB-STANCES",1,NA
"NEW PSYCHOACTIVE SUBSTANCE (NPS)",5,2
"NEW PSYCHOACTIVE SUBSTANCES (NPSS)",1,NA
"NEW PSYCHOACTIVE SUBSTANCES (NSP)",1,NA
"NEW PSYCHOACTIVE SUBSTANCES NPS",3,NA
"NEW PSYCHOACTIVE SUBSTRANCE",1,NA
"NEW PSYCHOACTIVES",2,NA
"NEW PSYCHOMETRIC TESTS",1,NA
"NEW PSYCHOTROPIC SUBSTANCES",2,1
"NEW QUESTIONNAIRES",1,NA
"NEW REGULATIONS",1,NA
"NEW RELIGIOUS AND SPIRITUAL MOVEMENTS",1,NA
"NEW SORBENT MEDIA",1,NA
"NEW SORBENTS",1,NA
"NEW SYNTHETIC CATHINONES",1,1
"NEW SYNTHETIC METHOD",1,NA
"NEW SYNTHETIC OPIOIDS",5,1
"NEW TECHNOLOGIES",1,NA
"NEW YEAR",1,NA
"NEW YORK CITY",5,NA
"NEW YORK POLICE DEPARTMENT (NYPD)",1,NA
"NEW ZEALAND",2,4
"NEWBERYITE",1,NA
"NEWBORN",5,NA
"NEWBORN INFANTS, ETHANOL METABOLISM, ALCOHOL TOLERANCE",1,NA
"NEWBORNS",1,NA
"NEWS REPORTS",1,NA
"NEWTON, ISAAC",1,NA
"NEXT GENERATION SEQUENCER (NGS)",1,NA
"NEXT GENERATION SEQUENCING (NGS)",14,1
"NEXUS",1,1
"NF200",1,NA
"NG",1,NA
"NGM SELECT",1,NA
"NGRI",3,NA
"NI-NTA CHROMATOGRAPHY",1,NA
"NI-TI ALLOY ELECTRODE",1,NA
"NI(II) DITHIOCARBAMATE",1,NA
"NICARDIPINE",1,NA
"NICE GUIDELINES",1,NA
"NICI-MS/MS",1,NA
"NICKEL CYTOCHEMISTRY",2,NA
"NICKEL TITANATE",1,NA
"NICOTIANA GLAUCA",1,NA
"NICOTINA TABACUM",1,NA
"NICOTINAMIDE",1,1
"NICOTINE",18,5
"NICOTINE ADDICTION",1,NA
"NICOTINE CONSUME",1,NA
"NICOTINE INTOXICATION",1,NA
"NICOTINE SULFATE",1,NA
"NICOTINE, ANTIBIOTICS, KANER, CRESOL, ANILINE AND KEROSENE OIL, NITROBENZENE",1,NA
"NICOTINTEST",1,NA
"NICOTINVERGIFTUNG",1,NA
"NIDATION",1,NA
"NIFEDIPINE",2,NA
"NIFOXIPAM",1,1
"NIGERIA",1,NA
"NIGHTCLUB PATRONS",1,NA
"NIGHTLIFE",1,NA
"NILE RED",1,NA
"NIMETAZEPAM",3,2
"NIMORAZOLE",1,NA
"NINHYDRIN",17,1
"NINHYDRIN-L-ALANINE",1,NA
"NINHYDRIN-PHENOL ADDUCT",1,NA
"NINHYDRIN-REACTIVE NITROGEN",1,NA
"NINHYDRIN ANALOGUES",2,NA
"NIR",3,7
"NIR SPECTROSCOPY",2,3
"NIST",1,NA
"NIST 11",1,1
"NITRACAINE",1,2
"NITRAMINE",2,NA
"NITRAMINES",2,1
"NITRATE",2,NA
"NITRATE ESTERS",3,1
"NITRAZEPAM",2,6
"NITRAZOLAM",1,NA
"NITRIC ACID",2,NA
"NITRIC ACID REDUCTION",1,NA
"NITRIC ACID TEST",1,1
"NITRIC OXIDE",1,1
"NITRITE",1,NA
"NITRITES",2,1
"NITRITES IN URINE",1,NA
"NITROAROMATIC COMPOUND",4,1
"NITROAROMATIC EXPLOSIVE",1,NA
"NITROBENZENE",1,NA
"NITROBENZODIAZEPINES",1,NA
"NITROCELLULOSE",2,NA
"NITROCELLULOSE FINGERPRINTS",1,NA
"NITROETHANE",1,1
"NITROGEN",4,2
"NITROGEN-16",1,NA
"NITROGEN-PHOSPHORUS DETECTION",1,NA
"NITROGEN-PHOSPHORUS DETECTION (NPD)",1,NA
"NITROGEN-PHOSPHORUS DETECTOR",1,NA
"NITROGEN-PHOSPHORUS SPECIFIC DETECTOR",1,1
"NITROGEN ASPHYXIATION",1,NA
"NITROGEN CHEMILUMINESCENCE DETECTION",3,1
"NITROGEN INHALATION",1,NA
"NITROGEN ISOTOPE RATIO",1,1
"NITROGEN ISOTOPES",1,NA
"NITROGEN PHOSPHORUS DETECTOR",1,NA
"NITROGEN TRIFLUORIDE",1,NA
"NITROGENOUS COMPOUNDS",1,NA
"NITROGENOUS FUMES",1,NA
"NITROGLYCERIN",4,NA
"NITROGLYCERIN AND DIPHENYLAMINE",1,NA
"NITROGLYCERINE",2,NA
"NITROMETHANE",1,1
"NITROPROPANE",1,NA
"NITROSAMINES",1,NA
"NITROSTARCH",1,NA
"NITROUS OXIDE",2,2
"NITROUSE OXIDE",1,NA
"NIVOLUMAB",1,NA
"NLSY97",1,NA
"NMDA RECEPTOR",6,4
"NMI01",1,2
"NMR APPLICATION",1,1
"NMR IDENTIFICATION",2,2
"NMR TITRATION",1,NA
"NMR/ESR",1,2
"NNEI, MN-18",1,NA
"NO OBSERVED ADVERSE EFFECT LEVEL",1,NA
"NO SYNTHASE",1,NA
"NOAEL",1,NA
"NOBLE METAL NANOPARTICLES",1,NA
"NOBLE METAL SILICA-BASED MONOLITH",1,NA
"NOCICEPTION",1,NA
"NOCTURNAL DISSOCIATIVE DISORDERS",1,NA
"NOCTURNAL EATING DISORDERS",1,NA
"NOCTURNAL PENILE TUMESCENCE (NPT)",1,NA
"NOCTURNAL SCRATCHING DISORDERS",1,NA
"NOCTURNAL SEIZURE DISORDERS",1,NA
"NOCTURNAL SEIZURES",1,NA
"NODE-LINK MAPPING",1,NA
"NOMENCLATURE",1,2
"NOMOGRAM",1,NA
"NOMOGRAM METHOD",1,NA
"NON-ACCIDENTAL HEAD INJURY",1,NA
"NON-ACCIDENTAL POISONING - CHILDREN",1,NA
"NON-ALCOHOLIC BEER",1,NA
"NON-ALCOHOLIC DRINK",1,1
"NON-ALCOHOLIC PSYCHOTROPIC SUBSTANCE",1,NA
"NON-AQUEOUS BACKGROUND ELECTROLYTE",1,NA
"NON-AQUEOUS CAPILLARY ELECTROPHORESIS",2,3
"NON-AQUEOUS ELECTROPHORESIS",1,NA
"NON-CANNABINOID IMMUNOGEN",1,NA
"NON-COMPLETION",1,NA
"NON-CONTACT",1,1
"NON-CONVENTIONAL BIOLOGICAL MATRICES",1,NA
"NON-DESTRUCTIVE ANALYSIS",1,NA
"NON-DESTRUCTIVE TESTING",1,NA
"NON-DRUG POISONS",1,NA
"NON-FATAL DROWNING",1,NA
"NON-FATAL INTOXICATION",2,2
"NON-FATAL OVERDOSE",1,NA
"NON-FATAL POISONINGS",1,NA
"NON-FENTANYL AND FENTANYL ANALOGS",1,1
"NON-HUMAN DNA",1,NA
"NON-HUMAN EVIDENCE",1,NA
"NON-HUMAN REMAINS",1,NA
"NON-INTENDED DEATH",1,1
"NON-INVASIVE",4,3
"NON-INVASIVE ANALYSIS",1,NA
"NON-INVASIVE DETECTION OF ILLICIT DRUGS USING SORS",1,1
"NON-INVASIVE PRENATAL DIAGNOSIS",1,NA
"NON-INVASIVE PRENATAL TESTING",1,NA
"NON-INVASIVE PROBING, BOTTLES OF RUM WITHOUT, AND WITH DISSOLVED COCAINE",1,1
"NON-INVASIVE SAMPLING",1,NA
"NON-LABELLED SENSING OF RECREATIONAL DRUGS",1,NA
"NON-LETHAL SUBSTANCE ABUSE IN ROMANIA",1,NA
"NON-LINEAR KINETICS",1,NA
"NON-METALS",1,NA
"NON-NATURAL DEATH",2,NA
"NON-NATURAL MANNER OF DEATH",1,NA
"NON-OXIDATIVE",1,NA
"NON-OXIDATIVE ETHANOL METABOLITES",1,NA
"NON-OXIDATIVE METABOLISM",1,NA
"NON-OXIDATIVE METABOLITES",1,NA
"NON-PENETRATING BALLISTIC IMPACT",1,NA
"NON-POROUS",1,NA
"NON-POROUS MATERIALS",1,NA
"NON-POROUS OBJECTS",1,NA
"NON-POROUS SURFACES",1,NA
"NON-PRESCRIBED USE",1,NA
"NON-PROLIFERATION",1,NA
"NON-PROXIMATE MASS SPECTROMETRY",1,NA
"NON-RADIOACTIVE IMMUNOASSAY",1,NA
"NON-REM PARASOMNIA",1,NA
"NON-REM PARASOMNIAS",1,NA
"NON-STERIODAL ANTI-INFLAMMATORY DRUGS (NSAIDS)",1,NA
"NON-STEROIDAL ANTI-INFLAMMATORY DRUGS",5,2
"NON-STIMULANTS",2,NA
"NON-SUBSTITUTIVE USE",1,NA
"NON-SUICIDAL SELF-INJURY",2,NA
"NON-SYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISMS",1,NA
"NON-TARGET SCREENING",1,NA
"NON-TARGETED ANALYSIS",2,NA
"NON-TARGETED METABOLOMICS",1,NA
"NON-TARGETED PROFILING",1,NA
"NON-TARGETED SCREENING",4,NA
"NON-VOLATILE BUFFER",1,1
"NON AQUEOUS CAPILLARY ELECTROPHORESIS",1,NA
"NON BIOLOGICAL EVIDENCES",1,NA
"NON CRIMINALLY RESPONSIBLE",1,NA
"NON FATAL-CASE",1,NA
"NON NATURAL DEATH",1,NA
"NONABSORBABLE SUTURES",1,NA
"NONADHERENCE",2,NA
"NONAQUEOUS CAPILLARY ELECTROPHORESIS/FLUORESCENCE SPECTROSCOPY (NACE/FS)",1,1
"NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY",1,NA
"NONBENZODIAZEPINE HYPNOTIC",1,NA
"NONCODING RNA",1,NA
"NONCOMPLIANCE",1,NA
"NONCONSENSUAL",1,NA
"NONCOVALENT COMPLEX",1,1
"NONCOVALENT COMPLEXES",1,NA
"NONDRUG DEPENDENT",1,NA
"NONINVASIVE",2,NA
"NONINVASIVE DETECTION",1,1
"NONINVASIVE PRENATAL DIAGNOSIS",1,NA
"NONINVASIVE PRENATAL PATERNITY TESTING",1,NA
"NONINVASIVE PRENATAL PATERNITY TESTING (NIPPT)",1,NA
"NONINVASIVE SAMPLING",1,NA
"NONINVASIVE TECHNIQUES",1,NA
"NONLINEAR OPTICS",1,NA
"NONMAJOR COURSES",2,1
"NONMEDICAL USE OF OPIOIDS",1,NA
"NONMEDICAL USE OF PSYCHOTHERAPEUTIC DRUGS",1,NA
"NONNATURAL DEATH",1,NA
"NONNATURAL MANNER OF DEATH",1,NA
"NONOXIDATIVE ETHANOL METABOLISM",1,NA
"NONOXYNOL-9",1,NA
"NONPRESCRIPTION",1,NA
"NONPRESCRIPTION DRUGS",2,NA
"NONSTEROIDAL ANTI-INFLAMMATORY DRUG",1,NA
"NONSTEROIDAL ANTI-INFLAMMATORY DRUGS",1,NA
"NONSUICIDAL SELF-INJURIOUS BEHAVIOR",1,NA
"NONTARGETED ANALYSIS",1,1
"NONTARGETED CHEMOMETRIC ANALYSIS",1,1
"NONTARGETED DIAGNOSTIC ION NETWORK ANALYSIS (NINA)",1,NA
"NONTARGETED DIAGNOSTIC IONS (NIS)",1,NA
"NONVIOLENT CRIMES",1,NA
"NONYLPHENOLETHOXYLATES",1,NA
"NOOPEPT [ETHYL 2-(1-(2-PHENYLACETYL)PYRROLIDINE-2-CARBOXAMIDO)ACETATE, SYNONYM: GVS-111]",1,1
"NOOTROPIC",1,1
"NOOTROPICS",1,NA
"NOR-KETAMINE",1,NA
"NORBORNYL METHYL SIDE CHAIN",1,1
"NORBUPRENORPHINE",6,NA
"NORCARFENTANIL",1,NA
"NORCLOZAPINE",3,NA
"NORCOCAINE",4,3
"NORDAZEPAM",1,NA
"NORDIAZEPAM",4,1
"NORDIC COUNTRIES",1,2
"NORDOXEPIN",1,NA
"NOREPHEDRINE",5,11
"NOREPHEDRINE (PHENYLPROPANOLAMINE)",1,NA
"NORFENTANYL",6,1
"NORFLUOXETINE",1,1
"NORIBOGAINE",1,NA
"NORKETAMINE",14,4
"NORM",1,NA
"NORMAL",2,NA
"NORMAL AUTOPSY",1,NA
"NORMAL ORGAN WEIGHTS",1,NA
"NORMAL PHASE CHIRAL CHROMATOGRAPHY",1,1
"NORMALIZATION",4,2
"NORMALIZATION ALGORITHM",1,1
"NORMALIZATION IN QUANTITATIVE PCR",1,NA
"NORMETABOLITES",1,NA
"NORMORPHINE",1,1
"NORMS",1,NA
"NORPAR",1,NA
"NORPROPOXYPHENE",1,NA
"NORPSEUDOEPHEDRINE",1,1
"NORSERTRALINE",1,NA
"NORTH-WEST INDIA",1,NA
"NORTH AFRICA",1,NA
"NORTH AFRICAN HASHISH",1,NA
"NORTH BRISBANE BURIAL GROUND",1,NA
"NORTH KOREA",1,NA
"NORTHEAST ASIA",1,NA
"NORTHEAST CHINA",1,NA
"NORTHERN IRELAND",1,NA
"NORTHERN ITALY",2,NA
"NORTHERN THAILAND",1,1
"NORTHERN WETLANDS",1,NA
"NORTRIPTYLINE",16,NA
"NORVERAPAMIL",1,NA
"NORWAY",3,NA
"NOSCAPINE",1,9
"NOSCAPINE METABOLITES",1,NA
"NOSOCOMIAL INFECTION",1,NA
"NOSOCOMIAL TUBERCULOSIS",1,NA
"NOSOLOGY",1,NA
"NOT CRIMINALLY RESPONSIBLE",1,NA
"NOVEL ANALYTICAL APPROACHES",1,NA
"NOVEL APPLICATIONS",1,NA
"NOVEL BENZODIAZEPINE",1,NA
"NOVEL BENZODIAZEPINES",1,NA
"NOVEL CATHINONE DERIVATIVE",1,1
"NOVEL DESIGNER DRUGS",1,NA
"NOVEL ILLICIT OPIOIDS",1,NA
"NOVEL OPIOIDS",1,NA
"NOVEL PSYCHOACTIVE DRUGS (NPDS)",3,3
"NOVEL PSYCHOACTIVE SUBSTANCES (NPS)",310,278
"NOVEL PSYCHOACTIVE SUBSTANCES (NPSS)",2,NA
"NOVEL SYNTHETIC OPIOIDS",13,4
"NOVEL SYNTHETIC OPIOIDS (NSO)",2,NA
"NOXIOUS SUBSTANCES",1,NA
"NP-TLC",1,NA
"NPEP",1,NA
"NPPD",1,NA
"NPS-RELATED DEATHS",1,NA
"NPS ANALYSIS",1,NA
"NPS INTOXICATION CASES",1,NA
"NPS ISOMERS",1,NA
"NPS METABOLISM",1,NA
"NPTX2",1,NA
"NREM SLEEP PARASOMNIAS",1,NA
"NRG-1",3,4
"NRG-2",1,2
"NS5B REGION",1,NA
"NSAID",1,NA
"NSAIDS",4,2
"NSE",1,NA
"NSMOL",1,NA
"NSO",1,NA
"NSP",1,NA
"NT-PROBNP",2,NA
"NTO",1,NA
"NTRK2",1,NA
"NUCLEAR ANALYTICAL TECHNIQUES",1,NA
"NUCLEAR DATA",1,NA
"NUCLEAR DECAY DATA",1,NA
"NUCLEAR DNA",1,NA
"NUCLEAR ELEMENTS OF MTDNA",1,NA
"NUCLEAR FALLOUT",1,NA
"NUCLEAR FIREBALL",1,NA
"NUCLEAR FORENSIC SCIENCE",1,NA
"NUCLEAR FORENSIC SIGNATURES",3,NA
"NUCLEAR FORENSICS",93,NA
"NUCLEAR FORENSICS AND SAFEGUARDS",1,NA
"NUCLEAR FORENSICS INTERNATIONAL TECHNICAL WORKING GROUP (ITWG)",1,NA
"NUCLEAR FUEL PELLET",1,NA
"NUCLEAR INDUSTRY PERSONNEL",1,NA
"NUCLEAR MAGNETIC RESONANCE (NMR)",67,143
"NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY",1,1
"NUCLEAR NONPROLIFERATION",1,NA
"NUCLEAR SAFEGUARDS",6,NA
"NUCLEAR SECURITY",1,NA
"NUCLEAR SMUGGLING",1,NA
"NUCLEAR STRUCTURE",1,NA
"NUCLEAR TECHNIQUES",1,NA
"NUCLEAR TERRORISM",1,NA
"NUCLEAR WASTE",1,NA
"NUCLEAR WEAPONS",2,NA
"NUCLEIC ACID DETECTION",3,NA
"NUCLEIC ACID EXTRACTION",1,NA
"NUCLEIC ACID TESTING",1,NA
"NUCLEIC ACIDS",1,1
"NUCLEIC ACIDS (DNA | RNA)",1,NA
"NUCLEOTIDE SEQUENCE",2,3
"NUCLEUS ACCUMBENS",1,NA
"NULL ALLELE",1,NA
"NUMBER OF CONTRIBUTORS",2,NA
"NUMERICAL MODELING",1,NA
"NUMTS",1,NA
"NUOVE SOSTANZE PSICOATTIVE",1,NA
"NURSE",2,NA
"NURSE-LED MODEL OF CARE",1,NA
"NURSE-PATIENT RELATIONSHIP",1,NA
"NURSING CARE",1,NA
"NURSING HOME",1,NA
"NURSING HOMES",3,NA
"NURSING MANAGER",1,NA
"NURSING STAFF",1,NA
"NUTRITION",1,NA
"NUTRITIONAL STATUS",2,NA
"NYLON",1,1
"NYLON TRANSFER MEMBRANES",1,NA
"NYQUIL",1,NA
"NYSTAGMUS",2,NA
"O-6-MONOACETYLMORPHINE",1,NA
"O-DEBUTYL METABOLITE",1,NA
"O-DESMETHYLTRAMADOL",3,2
"O-DIANISIDINE",1,NA
"O-DICHLORBENZENE",1,NA
"O-METHYLATION",1,NA
"O-PHENYLENEDIAMINE",1,1
"O6- MONOACETYLMORPHINE",1,NA
"OASIS HLB",2,NA
"OASIS HLB CARTRIDGE COLUMN",1,NA
"OB-GYN",1,NA
"OBESITY",10,2
"OBESITY RELATED PULMONARY EMBOLISM",1,NA
"OBFUSCATION",1,NA
"OBJECT-ORIENTED PROGRAMMING",1,1
"OBJECTIVE",1,NA
"OBJECTIVITY",1,NA
"OBLIGATION TO MEDICAL TREATMENT",1,NA
"OBLIGATORY PSYCHIATRIC TREATMENT",1,NA
"OBLIGATORY TREATMENT",1,NA
"OBSERVATION TIME",1,NA
"OBSESSIVE-COMPULSIVE",1,NA
"OBSTETRIC",1,NA
"OBSTETRICS",1,NA
"OBSTRUCTION",1,NA
"OBSTRUCTIVE SLEEP APNEA",1,NA
"OBVIOUS MENTAL NORMALITY",1,NA
"OCA2",1,NA
"OCA2 GENE",1,NA
"OCCASIONAL USE",1,NA
"OCCLUDED SOLVENTS",2,2
"OCCUPATION",1,NA
"OCCUPATION-RELATED SUICIDE",1,NA
"OCCUPATIONAL",3,1
"OCCUPATIONAL ADAPTATION",1,NA
"OCCUPATIONAL CASUALTY",1,NA
"OCCUPATIONAL DEATHS",1,NA
"OCCUPATIONAL EXPOSURE",2,NA
"OCCUPATIONAL FATALITY",1,NA
"OCCUPATIONAL HAZARDS",1,1
"OCCUPATIONAL HEALTH",2,NA
"OCCUPATIONAL HEALTH AND SAFETY",2,2
"OCCUPATIONAL IDEOLOGIES",1,NA
"OCCUPATIONAL INJURY",1,NA
"OCCUPATIONAL MEDICINE",2,NA
"OCCUPATIONAL RISK",1,NA
"OCCUPATIONAL THERAPY",1,NA
"OCFENTANIL",3,3
"OCULAR CONTUSIVE TRAUMA",1,NA
"OCULAR MICRODIALYSIS",1,NA
"OCULAR TISSUES",4,NA
"ODDBALL",1,NA
"ODOLLAM TREE",1,NA
"ODONTOLOGY",2,NA
"ODOR",2,1
"ODOR DETECTION",1,1
"ODOR IMAGING SENSOR",1,NA
"ODOR VISUALIZATION",1,NA
"ODOROLOGY",1,NA
"ODOUR ANALYSIS",2,NA
"ODUTS",1,NA
"ODUVAN (CLEISTANTHUS COLLINUS)",1,NA
"OECD",1,NA
"OECD TEST",1,NA
"OEDEMA",1,NA
"OENOLOGY",1,1
"OESTRIDAE",1,NA
"OESTROGEN RECEPTORS",1,NA
"OFF-LABEL",4,NA
"OFF-LABEL PRESCRIBING",1,NA
"OFF-LABEL USE",3,NA
"OFF-LINE AND ON-LINE PRE-CONCENTRATION METHODS",1,NA
"OFF-LINE PRE-CONCENTRATION",1,NA
"OFF-LINE TLC-MS",1,NA
"OFFENCE",2,NA
"OFFENDER",5,NA
"OFFENDER CHARACTERISTICS",2,NA
"OFFENDER CLASSIFICATION",1,NA
"OFFENDER HEALTH",1,NA
"OFFENDER MENTAL HEALTH",1,NA
"OFFENDER POPULATION",2,NA
"OFFENDER PSYCHOPATHOLOGY",1,NA
"OFFENDER REHABILITATION",1,NA
"OFFENDER RISK ASSESSMENT",1,NA
"OFFENDER SUFFERING FROM SUBSTANCE DISORDER",1,NA
"OFFENDER THERAPY",1,NA
"OFFENDER TREATMENT",12,NA
"OFFENDER TYPOLOGY",1,NA
"OFFENDERS",15,NA
"OFFENDERS THERAPEUTIC COMMUNITY",1,NA
"OFFENDERS WITH MENTAL ILLNESS",1,NA
"OFFENDING",12,NA
"OFFENDING BEHAVIOUR",2,NA
"OFFENSE",3,NA
"OFFENSE SPECIALIZATION",1,NA
"OFFENSE TYPES",1,NA
"OFFENSIVE SEARCH",1,NA
"OFFICE OF CHIEF MEDICAL EXAMINER (OCME)",1,NA
"OFFICE PAPER",1,NA
"OFFICER-INVOLVED SHOOTINGS",1,NA
"OFFICIAL STATISTICS",1,NA
"OFFLABEL-MEDICATION",1,NA
"OFFLINE CHROMATOGRAPHY",1,1
"OFLOXACIN",1,NA
"OGSR",1,NA
"OHIO",4,1
"OHMEFENTANYL",1,1
"OIL-BASED INJECTABLES",1,1
"OIL AND GAS EXTRACTION",1,NA
"OIL DIFFUSION METHOD",1,NA
"OIL DROPLET",1,NA
"OIL EMBOLISM",1,NA
"OIL FINGERPRINTING",1,NA
"OIL INJECTIONS",1,NA
"OIL SANDS",1,NA
"OIL SANDS PROCESS-AFFECTED WATERS",1,NA
"OIL SPILL",1,NA
"OIL WEATHERING",1,NA
"OILS",1,NA
"OLANZAPINE",12,2
"OLANZAPINE PAMOATE",1,NA
"OLD AGE PSYCHIATRY",1,NA
"OLD AND BURNED BONES",1,NA
"OLD DOCUMENTS",1,NA
"OLD STAINS",1,NA
"OLDER ADULTS",1,NA
"OLDER AGE GROUP",1,NA
"OLDER OFFENDERS",1,NA
"OLDER PATIENTS",1,NA
"OLEANDER",1,NA
"OLEANDRIN",2,NA
"OLEANDRINE",1,NA
"OLEORESIN CAPSICUM",1,NA
"OLEORESIN CAPSICUM (OC)",1,NA
"OLFACTOMETER",1,NA
"OLFACTORY PROTEINS",1,NA
"OLIGODENDROGLIOMA",1,NA
"OLIGONUCLEOTIDE IMMOBILIZATION",1,NA
"OLIGONUCLEOTIDES",1,NA
"OLIGOPHRENIA",1,NA
"OLOPATADINE",1,1
"OMBUDSMAN",1,NA
"OMEGA BIO-TEK E.Z.N.A.® PLANT DS MINI KIT",1,1
"OMICS",1,1
"OMICS ANALYSIS",1,NA
"OMT",1,NA
"ON-COLUMN METHYLATION",2,NA
"ON-FIBER DERIVATIZATION",2,2
"ON-LINE ANALYSIS",2,NA
"ON-LINE COLUMN SWITCHING",1,NA
"ON-LINE COUPLING",1,NA
"ON-LINE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY",1,1
"ON-LINE MEASUREMENT",1,1
"ON-LINE PRECONCENTRATION",2,1
"ON-LINE SAMPLING",1,NA
"ON-LINE SOLID-PHASE EXTRACTION",1,3
"ON-SCENE DETECTION",1,1
"ON-SITE",1,2
"ON-SITE ANALYSIS",5,6
"ON-SITE DETECTION",1,2
"ON-SITE DRUG-TESTING",1,NA
"ON-SITE DRUG TESTING",4,NA
"ON-SITE DRUG TESTS",1,NA
"ON-SITE IMMUNOASSAY DRUG SCREENING",1,NA
"ON-SITE REAL-TIME DETECTION",1,NA
"ON-SITE SCREENING",3,1
"ON-SITE TEST",8,2
"ON-SITE TESTING",7,4
"ON-SPOT DERIVATIZATION",1,NA
"ONCOLOGY",1,NA
"ONE-CLASS CLASSIFICATION",1,NA
"ONE-POINT INTERNAL CALIBRATION",1,NA
"ONLINE",1,NA
"ONLINE COUPLING",1,NA
"ONLINE DRUGS",1,NA
"ONLINE EXTRACTION",1,NA
"ONLINE GPC",1,NA
"ONLINE PHARMACIES",1,2
"ONLINE SOLID PHASE EXTRACTION",1,1
"ONSET",1,NA
"ONTARIO",3,1
"ONYCHOMATRICOMA",1,NA
"ONYCHOMYCOSIS",1,NA
"OPEN ACCESS",1,NA
"OPEN FRACTURE",1,NA
"OPEN LIBRARY CONCEPT",1,NA
"OPEN SOURCE",1,NA
"OPEN SOURCE INTELLIGENCE",1,1
"OPEN SOURCE SOFTWARE",1,1
"OPEN STUDY",1,NA
"OPENING METHOD",1,NA
"OPERATING SYSTEM EXTENSIONS",1,NA
"OPERATING SYSTEMS",1,NA
"OPERATING WHILE INTOXICATED",1,NA
"OPERATIONAL DECISION-MAKING",1,1
"OPERATOR BIAS",1,NA
"OPHTHALMIC MATERIALS",1,NA
"OPIATE-MAINTENANCE PROGRAM",1,NA
"OPIATE ABUSE",3,NA
"OPIATE ADDICTION",2,1
"OPIATE AND DERIVATIVES",111,31
"OPIATE DEPENDENCE",2,1
"OPIATE DEPENDENCY PROGRAMS",1,NA
"OPIATE DRUG SCREEN",1,NA
"OPIATE IMPURITIES",1,NA
"OPIATE MAINTENANCE PROGRAMME (OMT)",1,NA
"OPIATE SUBSTITUTION",1,NA
"OPIATE SUBSTITUTION TREATMENT",1,NA
"OPIATE TOLERANCE",1,NA
"OPIATES OVERDOSE",3,NA
"OPIATES RELATED DEATH",1,NA
"OPIOD AND DERIVATIVES",143,129
"OPIOD MAINTENANCE THERAPY",1,NA
"OPIODS",1,NA
"OPIOID-RELATED DEATH",1,NA
"OPIOID-RELATED DEATHS",2,NA
"OPIOID-RELATED MORTALITY",1,NA
"OPIOID-RELATED OVERDOSE",1,NA
"OPIOID ABUSE",6,5
"OPIOID ABUSERS",1,NA
"OPIOID ADDICTION",1,1
"OPIOID AGONIST",1,1
"OPIOID AGONIST TREATMENT",2,NA
"OPIOID AGONIST TREATMENT (OAT)",1,NA
"OPIOID ANALGESIC",3,10
"OPIOID CRISIS",1,2
"OPIOID DEATH",1,NA
"OPIOID DEATHS",1,NA
"OPIOID DEPENDENCE",7,5
"OPIOID DETECTION",1,1
"OPIOID DETOXIFICATION",1,NA
"OPIOID EPIDEMIC",1,NA
"OPIOID INTOXICATION",3,1
"OPIOID MAINTENANCE TREATMENT",1,1
"OPIOID MISUSE",1,NA
"OPIOID OVERDOSE",3,1
"OPIOID OVERDOSE DEATHS",1,NA
"OPIOID PAIN RELIEVER",1,NA
"OPIOID PAINKILLERS",1,NA
"OPIOID PEPTIDE",1,NA
"OPIOID PHARMACOLOGY",1,1
"OPIOID PRESCRIPTION",1,NA
"OPIOID RECEPTOR",1,NA
"OPIOID RECEPTORS",2,1
"OPIOID REPLACEMENT THERAPY",2,NA
"OPIOID SUBSTITUTION THERAPY",3,1
"OPIOID SUBSTITUTION TREATMENT",1,NA
"OPIOID SURVEILLANCE PROGRAM",1,NA
"OPIOID THERAPY",1,NA
"OPIOID TOXIDROME",1,1
"OPIOID USE DISORDER",1,NA
"OPIOIDS-FENTANYL",1,NA
"OPIPRAMOL",1,1
"OPIUM-ALKALOIDS, DETECTION IN STAINS OF BLOOD AND URINE",1,NA
"OPIUM ALKALOIDS",4,16
"OPIUM POISONING",1,NA
"OPPORTUNISTIC INFECTIONS",1,NA
"OPPORTUNISTIC INFECTIONS, CYTOMEGALO VIRUS",1,NA
"OPRD1",1,NA
"OPRM1",2,NA
"OPRM1 GENE",1,NA
"OPTICAL",1,1
"OPTICAL ABSORPTION",1,NA
"OPTICAL BIOSENSORS",2,NA
"OPTICAL COHERENCE TOMOGRAPHY",1,NA
"OPTICAL DETECTION",1,NA
"OPTICAL ENHANCEMENT",1,NA
"OPTICAL EXAMINATION",1,NA
"OPTICAL ISOMERISM",1,NA
"OPTICAL LENSES",1,NA
"OPTICAL METHODS",1,NA
"OPTICAL PRESCRIPTION STRENGTH",1,NA
"OPTICAL PROPERTIES",2,NA
"OPTICAL RESOLUTION",2,4
"OPTICAL SENSOR",3,4
"OPTICS",2,NA
"OPTIMIZATION",8,9
"OPTIMIZATION OF PRETREATMENT METHOD",1,NA
"OPTOGRAMS",1,NA
"ORAL",2,NA
"ORAL-EZE®",1,NA
"ORAL ADMINISTRATION",1,NA
"ORAL ANTICOAGULANTS",2,NA
"ORAL ANTIDIABETICS",2,NA
"ORAL BIOLOGY",1,NA
"ORAL CANNABIS CONSUMPTION",1,NA
"ORAL CONTRACEPTIVE",1,NA
"ORAL DISEASES",2,NA
"ORAL FLUID",119,21
"ORAL FLUID ANALYSIS",2,NA
"ORAL FLUID AND URINE ANALYSIS",1,NA
"ORAL FLUID COLLECTION",1,NA
"ORAL FLUID COLLECTION DEVICES",2,NA
"ORAL FLUID DRUG TESTING",1,NA
"ORAL FLUID SCREENING",1,NA
"ORAL FLUID SCREENING TEST DEVICE",1,NA
"ORAL FLUID TESTING",3,NA
"ORAL FLUID TO BLOOD RATIO",1,NA
"ORAL INGESTION",1,1
"ORAL INTOXICATION",1,NA
"ORAL MANIFESTATIONS",1,NA
"ORAL MEDICATION",1,NA
"ORAL MEDICINE",1,NA
"ORAL ONCOLOGY",1,NA
"ORALEASE",1,NA
"ORATECT",1,NA
"ORATECT® III",1,NA
"ORBITOFRONTAL CORTEX",1,NA
"ORBITRAP",18,13
"ORBITRAP-MS",2,2
"ORBITRAP ANALYZERS",1,NA
"ORBITRAP HIGH-RESOLUTION MASS SPECTROMETRY",1,NA
"ORBITRAP MASS SPECTROMETRY",1,NA
"ORDEAL",1,NA
"ORDER",1,NA
"ORDINARY DRUGS",1,NA
"ORDNANCE GELATIN",1,NA
"ORELLANINE",1,NA
"ORGAN",4,NA
"ORGAN CHANGES",2,NA
"ORGAN DISTRIBUTION",3,NA
"ORGAN ENLARGEMENT",1,NA
"ORGAN TISSUE IDENTIFICATION",1,NA
"ORGAN TRANSPLANTATION",1,NA
"ORGAN WEIGHTS",2,NA
"ORGANELLE",1,1
"ORGANIC",1,1
"ORGANIC ACID ION",1,NA
"ORGANIC ACIDS",1,1
"ORGANIC BRAIN DISORDERS",1,NA
"ORGANIC BRAIN DYSFUNCTION",1,NA
"ORGANIC CHEMISTRY",1,2
"ORGANIC DELUSIONAL DISORDER",1,NA
"ORGANIC DYES",1,NA
"ORGANIC EXPLOSIVE",1,NA
"ORGANIC EXPLOSIVES",5,NA
"ORGANIC GUN SHOT RESIDUE (OGSR)",1,NA
"ORGANIC GUNSHOT RESIDUE",3,NA
"ORGANIC IMPAIRMENT",1,NA
"ORGANIC IMPURITY",1,8
"ORGANIC IMPURITY PROFILING",1,1
"ORGANIC MATTER",1,NA
"ORGANIC RESIDUES",2,NA
"ORGANIC SOLVENT",1,3
"ORGANICITY",1,NA
"ORGANISATION AND DECISIONS",1,1
"ORGANISATION FOR THE PROHIBITION OF CHEMICAL WEAPONS",1,NA
"ORGANISED CRIME",1,NA
"ORGANISED CRIMES",1,NA
"ORGANIZATION",1,NA
"ORGANIZED CRIME",1,2
"ORGANIZED DOPING",2,NA
"ORGANIZED DRUGS",1,NA
"ORGANO- PHOSPHOROUS INSECTICIDES",1,NA
"ORGANO CHLORO INSECTICIDE",1,NA
"ORGANOCHLORINE INSECTICIDES",1,NA
"ORGANOCHLORINE PESTICIDES",2,1
"ORGANOPHOSPHATE",4,NA
"ORGANOPHOSPHATE (OP)",1,NA
"ORGANOPHOSPHATE COMPOUND",1,NA
"ORGANOPHOSPHATE INSECTICIDE",1,NA
"ORGANOPHOSPHATE POISONING",1,NA
"ORGANOPHOSPHATES",4,NA
"ORGANOPHOSPHOROUS",3,NA
"ORGANOPHOSPHORUS",5,NA
"ORGANOPHOSPHORUS COMPOUND",4,NA
"ORGANOPHOSPHORUS COMPOUNDS",1,NA
"ORGANOPHOSPHORUS FUNGICIDES (OPF)",1,NA
"ORGANOPHOSPHORUS HERBICIDE GLYPHOSATE",1,NA
"ORGANOPHOSPHORUS HYDROLASE",1,NA
"ORGANOPHOSPHORUS INSECTICIDE",1,NA
"ORGANOPHOSPHORUS INSECTICIDES",2,NA
"ORGANOPHOSPHORUS PESTICIDE",2,NA
"ORGANOPHOSPHORUS PESTICIDES",2,NA
"ORGANOPHOSPOROUS",1,NA
"ORGANOSPHOSPHATE PESTICIDES",1,NA
"ORGANOTHIOPHOSPHORUS INSECTICIDES",1,NA
"ORGANSCHÄDEN BEI DROGENKONSUMENTEN",1,NA
"ORIGIN",3,3
"ORIGIN AND MIGRATION PATTERNS",1,NA
"ORIGIN ASSIGNMENT",1,1
"ORIGIN CLASSIFICATION",2,3
"ORIGIN TRACKING",1,1
"ORIPAVINE",2,1
"ORNIDAZOLE",1,NA
"ORO-DISPERSIBLE",1,NA
"OROFACIAL INJURIES",1,NA
"ORP-150",1,NA
"ORPHENADINE POISONING",1,NA
"ORPHENADRINE",2,NA
"ORPHENADRINE, LETHAL INTOXICATION",1,NA
"ORTHO-PHENYLENEDIAMINE",1,NA
"ORTHO-TOLIDINE",1,NA
"ORTHO SELECTIVE",1,NA
"ORTHODONTICS",1,NA
"ORTHOPEDIC DEVICE MANUFACTURERS",1,NA
"ORTHOPEDIC DEVICES",1,NA
"ORTHOSTATIC HYPOTENSION",1,NA
"ORYZA SATIVA L (BLACK RICE)",1,NA
"OS PUBIS",1,NA
"OSAS",1,NA
"OSLER-WEBER-RENDU DISEASE",1,NA
"OSMOPROTECTIVE GENES",1,NA
"OSTEOMETRY",2,NA
"OSTEOPETROSIS",1,NA
"OSTEOSYNTHESIS",1,NA
"OTC",1,NA
"OTHELLO SYNDROME",1,NA
"OTHER-ETHNICITY EFFECT",1,NA
"OTHER SUBSTANCES",1,NA
"ÖTZI",1,NA
"OUT-LINE",1,NA
"OUT-OF-HOSPITAL DEATH",1,NA
"OUT-PATIENT TREATMENT",1,NA
"OUTBREAK",1,NA
"OUTCOME",5,NA
"OUTCOME ASSESSMENT (HEALTH CARE)",1,NA
"OUTCOME STUDIES",1,NA
"OUTCOMES",2,NA
"OUTCOMES ASSESSMENT",1,NA
"OUTCRY WITNESS",1,NA
"OUTLAW",1,NA
"OUTPATIENT",3,NA
"OUTPATIENT CARE",1,NA
"OUTPATIENT COMMITMENT",1,NA
"OUTPATIENT TREATMENT",1,NA
"OVER-DOSE",1,NA
"OVER-THE-COUNTER COLD MEDICATIONS",1,NA
"OVER-THE-COUNTER DRUGS",3,NA
"OVER-THE-COUNTER MEDICATIONS",1,NA
"OVERDOSAGE",1,NA
"OVERDOSE",131,20
"OVERDOSE CRISIS",1,NA
"OVERDOSE DEATHS",2,NA
"OVERDOSE DEATHS FROM NARCOTIC DRUGS",1,NA
"OVERDOSE DEATHS FROM PSYCHOTROPIC SUBSTANCES",1,NA
"OVERDOSE DRUG",1,NA
"OVERDOSE MORTALITY",1,NA
"OVERDOSE/MORTALITY",2,NA
"OVERDOSES",2,NA
"OVERKILL",1,NA
"OVERKILLING",1,NA
"OVERLAP OF CELLS",1,NA
"OVERLAPPING",1,NA
"OVERLAPPING JURISDICTIONS",1,NA
"OVERLAYING",1,NA
"OVERLOADING",1,1
"OVERSULFATED CHONDROITIN SULFATE",1,NA
"OVERVIEW",1,NA
"OVERWEIGHT",2,NA
"OVIPOSITION AND DEVELOPMENT",1,NA
"OWI",1,NA
"OXALIC ACID",1,NA
"OXAZEPAM",4,3
"OXAZEPAM-GLUCURONIDE",1,NA
"OXAZOLAM",1,NA
"OXAZOLIDINE",1,NA
"OXAZOLIDINES",1,1
"OXAZOLOBENZODIAZEPINES",1,NA
"OXCARBAZEPINE",2,NA
"OXI",1,1
"OXICAM DERIVATIVES",1,NA
"OXIDADO",1,1
"OXIDATION",2,9
"OXIDATION/REDUCTION",1,1
"OXIDATIVE",1,1
"OXIDATIVE DAMAGE",1,NA
"OXIDATIVE DECOMPOSITION",1,1
"OXIDATIVE DEGRADATION",1,1
"OXIDATIVE HAIR TREATMENT",1,NA
"OXIDATIVE INJURY",1,NA
"OXIDATIVE STRESS",4,1
"OXIGEN",1,NA
"OXIME DERIVATIZATION",1,1
"OXPRENOLOL",2,1
"OXYANIONS",1,NA
"OXYCODONE",15,17
"OXYCODONE RELATED DEATHS",1,NA
"OXYDEMETON-METHYL",1,NA
"OXYGEN CONCENTRATION",1,NA
"OXYGEN DEFICIENCY",1,NA
"OXYGEN ELECTRODE",1,NA
"OXYGEN ISOTOPE",1,1
"OXYGEN LEVELS",1,NA
"OXYGEN REGULATED PROTEIN 150-KDA",1,NA
"OXYGEN REGULATOR FIRE",1,NA
"OXYGEN SATURATION",1,NA
"OXYHEMOGLOBIN",1,NA
"OXYMORPHONE",1,1
"OXYTOCIN",2,NA
"OZONE",1,NA
"P- DIMETHYLAMINOBENZALDEHYDE",1,NA
"P- HYDROXYMETHAMPHETAMINE",1,1
"P-450 ENZYME SYSTEM",1,NA
"P-BUTYLAMINOBENZOIC ACID",3,NA
"P-DIMETHYLAMINOBENZALDEHYDE",3,1
"P-DIMETHYLAMINOBENZALDEHYDE (P-DMAB)",1,NA
"P-DIMETHYLAMINOCINNAMALDEHYDE",3,NA
"P-DIMETHYLAMINOCINNAMALDEHYDE (P-DMAC)",1,NA
"P-FLUOROFENTANYL",1,1
"P-GLYCOPROTEIN",1,NA
"P-HYDROXY-N-ETHYLAMPHETAMINE",1,NA
"P-HYDROXYAMPHETAMINE",1,NA
"P-HYDROXYMETHAMPHETAMINE",2,NA
"P-IODOAMPHETAMINE",1,NA
"P-METHOXYAMPHETAMINE",3,2
"P-METHOXYMETHAMPHETAMINE",1,1
"P-METHOXYMETHYLAMPHETAMINE",1,NA
"P-PHENYLENEDIAMINE",3,NA
"P-VALUE",1,NA
"P2P",1,2
"P3B",1,NA
"P450",1,NA
"P450 (CYP)",1,NA
"P450 POLYMORPHISM",1,NA
"P53 MUTATION DETECTION",1,NA
"P70S6K",1,NA
"PA-231",1,NA
"PA-231 STANDARDISATION",1,NA
"PA-IR",1,1
"PAC",1,1
"PACIFIC CIGUATOXIN",1,NA
"PACKAGING",1,4
"PACKAGING MATERIAL",1,1
"PACKAGING METHOD",1,NA
"PACKAGING TAPES",1,1
"PACKED SORBENT",1,NA
"PACKED SORBENTS",1,NA
"PADUA POPULATION",1,NA
"PAGODA RED",1,NA
"PAH DIAGNOSTIC RATIOS",1,NA
"PAH DISSOLUTION",1,NA
"PAHS",3,NA
"PAI-A",1,NA
"PAIN",3,8
"PAIN KILLERS",1,NA
"PAIN MANAGEMENT",5,3
"PAIN MANAGEMENT DRUGS",1,NA
"PAIN MEDICATION",1,NA
"PAIN THERAPY",1,NA
"PAINKILLER TOXICITY",1,NA
"PAINT",4,4
"PAINT ANALYSIS",2,NA
"PAINT COMPOSITIONS",1,NA
"PAINT SMEAR",1,NA
"PAINT TYPES",1,NA
"PALEOECOLOGY",1,1
"PALIPERIDONE",2,NA
"PALIPERIDONE PALMITATE",1,NA
"PALIPERIDONE PALMITATE 3-MONTHLY INJECTION",1,NA
"PALLADIUM SHELL",1,1
"PALLIATIVE CARE",3,1
"PALLIATIVE MEDICINE",1,1
"PALLIATIVE PAIN THERAPY",1,NA
"PALLIDAL LESIONS",1,NA
"PALMAR FLEXION CREASES",1,NA
"PALMAR SWEAT",3,NA
"PALUDISME",1,NA
"PALUDISME DES AÉROPORTS",1,NA
"PALYNOLOGY",4,1
"PAMPA",1,NA
"PANAEOLUS",1,3
"PANCARDITIS",1,NA
"PANCHNAMA",1,NA
"PANCREATIC CANCER",1,NA
"PANCREATITIS",1,NA
"PANCURONIUM",3,NA
"PANCURONIUM BROMIDE",1,NA
"PANCURONIUM BROMIDE (PAVULON)",1,NA
"PANDEMIC",1,NA
"PANGOLINS",1,NA
"PANHYPOPITUITARISM",1,NA
"PANIC",1,NA
"PANIC ATTACK",1,NA
"PAPAVER",2,5
"PAPAVER SETIGERUM",1,2
"PAPAVER SOMNIFERUM",4,35
"PAPAVER SOMNIFERUM L.",3,11
"PAPAVERINE",1,10
"PAPAVERINE HCL",1,NA
"PAPAVERIS PERICARPIUM",1,NA
"PAPER",6,NA
"PAPER-BASED ANALYTICAL DEVICE",1,1
"PAPER-BASED DEVICES",1,NA
"PAPER-BASED ELECTRODES",1,1
"PAPER-BASED SENSORS",1,1
"PAPER ANALYSIS",1,NA
"PAPER BASED MICROFLUIDICS",1,NA
"PAPER BLOTTERS",1,NA
"PAPER CONE SPRAY IONIZATION",2,1
"PAPER CONE SPRAY IONIZATION (PCSI)",1,NA
"PAPER CURRENCY",1,3
"PAPER MICROFLUIDIC DEVICE",1,NA
"PAPER SPRAY",2,1
"PAPER SPRAY-MS",1,NA
"PAPER SPRAY IONIZATION",3,3
"PAPER SPRAY IONIZATION (PSI)",1,1
"PAPER SPRAY IONIZATION MASS SPECTROMETRY",1,1
"PAPER SPRAY IONIZATION QTOF-MS",1,1
"PAPER SPRAY MASS SPECTROMETRY",1,1
"PAPER SPRAY MASS SPECTROMETRY (PS-MS)",1,1
"PAPER SUBSTRATE",2,1
"PAPER SURFACE ENHANCED RAMAN SPECTROSCOPY",2,2
"PAPERSPRAY IONIZATION",1,NA
"PARA-AMINOHIPPURIC ACID",1,NA
"PARA-DIMETHYLAMINOCINNAMALDEHYDE",1,NA
"PARA-FLUOROFENTANYL",1,1
"PARA-METHOXYETHYLAMPHETAMINE",1,1
"PARA-METHOXYMETHAMFETAMINE",1,NA
"PARA PHENYLENE DIAMINE",1,NA
"PARACETAMOL",13,22
"PARACETAMOL AND COMBIFLAM",1,NA
"PARACHUTING",1,1
"PARADNA",1,NA
"PARADOXICAL EMBOLIZATION",1,NA
"PARADOXICAL REACTION",2,NA
"PARAESOPHAGEAL HIATUS HERNIA",1,NA
"PARAFAC",1,1
"PARAFFIN-EMBEDDED TISSUE",1,NA
"PARAFFIN EMBEDDED TISSUE",1,NA
"PARAFFINS",1,NA
"PARAHYDROGEN",1,NA
"PARALLEL",1,NA
"PARALLEL ARTIFICIAL LIQUID MEMBRANE EXTRACTION",1,1
"PARALLEL ARTIFICIAL LIQUID MEMBRANE EXTRACTION (PALME)",1,NA
"PARALLEL REACTION MONITORING",2,NA
"PARALLEL SERVICE MODEL",1,NA
"PARALYTIC SHELLFISH POISONING",1,NA
"PARALYTIC SHELLFISH TOXINS",1,NA
"PARAMEDIC",1,NA
"PARAMETHHOXYMETHAMPHETAMINE",1,NA
"PARAMETHOXYAMPHETAMINE",2,NA
"PARAMETHOXYAMPHETAMINE (PMA)",1,NA
"PARAMETHOXYMETHAMPHETAMINE",4,NA
"PARANOIA",1,NA
"PARANOID DELUSION",1,NA
"PARANOID DELUSIONS",1,NA
"PARAOXONE",1,NA
"PARAPHENYLENE DIAMINE",1,NA
"PARAPHILIA",11,NA
"PARAPHILIAS",3,NA
"PARAPHILIC DISORDER",2,NA
"PARAPHILIC DISORDERS",1,NA
"PARAQUAT",16,1
"PARAQUAT DISTRIBUTION",1,NA
"PARAQUAT HERBICIDE",1,NA
"PARASAILING",1,NA
"PARASITES",1,NA
"PARASITOSIS",1,NA
"PARASOMNIA",3,NA
"PARASOMNIA OVERLAP DISORDER",1,NA
"PARASOMNIAS",4,NA
"PARASUBICULUM",1,NA
"PARATHION",2,NA
"PARATHION POISONING",1,NA
"PARAVERTEBRAL BLOCK",1,NA
"PARCEL SCREENING",1,NA
"PARECOXIB",1,NA
"PARENT ION",1,1
"PARENTAGE",1,1
"PARENTAL EXPOSURE",1,NA
"PARENTAL ISSUE",1,NA
"PARENTAL LIABILITY",1,NA
"PARENTAL MONITORING",1,NA
"PARENTAL SUBSTANCE ABUSE",1,NA
"PARENTAL SUBSTANCE USE",1,NA
"PARENTERAL DRUG ABUSE",1,NA
"PARENTING",1,NA
"PARENTS",1,NA
"PARKINSON",1,NA
"PARKINSON'S DISEASE",4,NA
"PARKINSONISM",1,NA
"PAROLE",1,NA
"PAROLEE",1,NA
"PAROLEES",2,NA
"PAROXETINE",9,1
"PARRICIDE",6,NA
"PARTIAL DENIAL",1,NA
"PARTIAL LEAST SQUARE",1,NA
"PARTIAL LEAST SQUARE ANALYSIS (PLS)",1,NA
"PARTIAL LEAST SQUARE DISCRIMINANT ANALYSIS",1,NA
"PARTIAL LEAST SQUARES-DISCRIMINANT ANALYSIS (PLS-DA)",3,4
"PARTIAL LEAST SQUARES (PLS)",8,16
"PARTIAL LEAST SQUARES REGRESSION",2,4
"PARTICLE-PICKING",1,NA
"PARTICLE IDENTIFICATION",1,NA
"PARTICLE SIZE",4,3
"PARTICLE TRACKING",1,NA
"PARTITION COEFFICIENT",4,4
"PARTITIONING",2,NA
"PARTITIONS",1,NA
"PARVALBUMIN",1,NA
"PASSENGER",1,NA
"PASSENGER CELLS",1,NA
"PASSENGERS FATALITIES",1,NA
"PASSERINE",1,NA
"PASSIVE",1,NA
"PASSIVE ADSORPTION",2,1
"PASSIVE EXPOSURE",5,NA
"PASSIVE INHALATION",1,NA
"PASSIVE SAMPLER",1,1
"PASSIVE SMOKING",1,NA
"PATAGONIA FJORDS",1,NA
"PATCH",1,NA
"PATCH-TEST",1,NA
"PATCH CLAMP",1,NA
"PATCHES",2,NA
"PATENT",2,NA
"PATENT ANALYSIS",1,NA
"PATENT FORAMEN OVALE",1,NA
"PATENT STATISTICS",1,NA
"PATERNITY",3,1
"PATH LENGTH",1,NA
"PATHOGEN",2,NA
"PATHOGEN DETECTION",2,NA
"PATHOGENESIS",3,NA
"PATHOGENIC BACTERIA",1,NA
"PATHOGENIC MUTATION",1,NA
"PATHOGENS",1,1
"PATHOHISTOLOGY OF HEART",1,NA
"PATHOLOGIC",1,NA
"PATHOLOGIC FINDINGS",1,NA
"PATHOLOGIC/AETIOLOGY",1,NA
"PATHOLOGICAL BIOMARKERS",1,NA
"PATHOLOGICAL CARDIAC HYPERTROPHY",1,NA
"PATHOLOGICAL FINDINGS",1,NA
"PATHOLOGICAL GAMBLING",3,NA
"PATHOLOGICAL JEALOUSY",1,NA
"PATHOLOGICAL LYING",1,NA
"PATHOLOGICAL MORPHOLOGY",1,NA
"PATHOLOGICAL ORGANIZATION",1,NA
"PATHOLOGICAL SCORE",1,NA
"PATHOLOGIST RESPONSIBILITY",1,NA
"PATHOLOGISTS",1,NA
"PATHOLOGISTS’ ASSISTANTS",1,NA
"PATHOLOGY",29,NA
"PATHOLOGY AND BIOLOGY",12,NA
"PATHOLOGY OF HIV/AIDS",1,NA
"PATHOLOGY, ANALYTICAL TOXICOLOGY",1,NA
"PATHOMIMESIS",1,NA
"PATHOMORPHOLOGICAL FINDINGS",1,NA
"PATHOMORPHOLOGICAL MANIFESTATIONS OF PYRROLIDINOVALEROPHENONE POISONING.",1,NA
"PATHOPHYSIOLOGY",6,NA
"PATHWAYS TO CARE",1,NA
"PATIENT-CENTERED CARE",1,NA
"PATIENT-CONTROLLED ANALGESIA (PCA)",1,NA
"PATIENT ADVISORY COUNCIL",1,NA
"PATIENT AND STAFF PERSPECTIVES",1,NA
"PATIENT AUTONOMY",1,NA
"PATIENT CHARACTERISTICS",1,NA
"PATIENT COMPLIANCE",1,NA
"PATIENT DROPOUTS",1,NA
"PATIENT PERPETRATED VIOLENCE",1,NA
"PATIENT READMISSION",1,NA
"PATIENT RIGHTS",1,NA
"PATIENT SAFETY",4,NA
"PATIENT SAFETY CULTURE",2,NA
"PATIENT SAFETY INTERVENTION",1,NA
"PATIENT’S SAFETY",1,NA
"PATIENTS",2,NA
"PATRIARCHY",1,NA
"PATRICIDE",3,NA
"PATTERN",2,NA
"PATTERN ANALYSIS",1,1
"PATTERN EVIDENCE",1,NA
"PATTERN OF INJURIES",1,NA
"PATTERN OF INJURY",1,NA
"PATTERN OF POISONING",1,NA
"PATTERN RECOGNITION",8,13
"PATTERN RECOGNITION ALGORITHMS",1,1
"PATTERN RECOGNITION ANALYSIS",2,NA
"PATTERNED SKIN WOUNDS",1,NA
"PATTERNING",1,NA
"PATTERNS OF DRUG CONSUMPTION",1,NA
"PB-22",1,NA
"PBDE",1,NA
"PBDES",1,NA
"PBGD",1,NA
"PBPK",1,NA
"PBS",1,NA
"PC12 CELLS",1,NA
"PCA-LDA",1,NA
"PCBS",1,NA
"PCI-GC-MS",2,NA
"PCL-R",5,NA
"PCMPA",1,NA
"PCP",4,5
"PCPY",1,1
"PCR-RFLP",3,NA
"PCR AMPLIFICATION ABILITY",1,1
"PCR ARRAY",1,NA
"PCR FIDELITY",1,NA
"PCR INHIBITION",4,1
"PCR INHIBITOR",1,NA
"PCR INHIBITORS",5,NA
"PCR METHOD",1,NA
"PCR MULTIPLEX",1,NA
"PCR TYPING",1,NA
"PCSOT",1,NA
"PD (PHYSICAL DEVELOPER)",1,NA
"PD@PT CORE-SHELL NANOPARTICLES",1,NA
"PDA",1,1
"PDE-5 INHIBITORS",2,6
"PDMS",1,1
"PDQEX PHYTOGEM",1,1
"PEA15",1,NA
"PEAK HEIGHT RATIO",1,NA
"PEANUT ALLERGY",1,NA
"PEARSON",1,1
"PEARSON'S DISTANCE",1,1
"PEARSON CORRELATION",1,NA
"PECA MULTIBAND",1,NA
"PECHINI METHOD",1,NA
"PEDESTRIAN",2,NA
"PEDESTRIAN FATALITIES",1,NA
"PEDIATRIC",8,NA
"PEDIATRIC ACUTE-LIVER FAILURE",1,NA
"PEDIATRIC CONDITION FALSIFICATION",1,NA
"PEDIATRIC EMERGENCY CARE",1,NA
"PEDIATRIC EMERGENCY DEPARTMENT",1,NA
"PEDIATRIC INTENSIVE CARE UNIT",1,NA
"PEDIATRIC POISONING",1,NA
"PEDIATRIC TOXICOLOGY",2,NA
"PEDIATRICS",2,1
"PEDIATRICS EMERGENCY",1,NA
"PEDIGREE",1,1
"PEDOPHILIA",5,NA
"PEDOT",1,NA
"PEER-REVIEW NETWORKS",1,NA
"PEER COACHING",1,NA
"PEER REVIEW",1,2
"PEER SUPPORT",1,NA
"PEER SUPPORT WORKERS",1,NA
"PEERS",1,NA
"PEG",1,NA
"PEG OLIGOMERS",1,NA
"PEGANINE",1,NA
"PEGANUM HARMALA",1,4
"PEL",1,NA
"PELIOSIS",2,NA
"PELIOSIS HEPATIS",1,NA
"PELLET",1,NA
"PELLETS",1,NA
"PELVIC FRACTURE",1,NA
"PELVIC FRACTURES",1,NA
"PEMOLINE",2,1
"PEN",1,NA
"PENAL",1,NA
"PENAL DETENTION",1,NA
"PENAL RESPONSIBILITY",1,NA
"PENALLY ORDERED CARE",1,NA
"PENALTIES",1,NA
"PENBUTOLOL",1,NA
"PENCIL ELECTRODE",1,NA
"PENCIL LEAD ELECTRODE",1,NA
"PENETRATING IMPACT",1,NA
"PENETRATION",2,1
"PENFLURIDOL",1,NA
"PENICILLIN G",1,NA
"PENICILLINASE",2,NA
"PENICILLINASE-PRODUCING NEISSERIA GONORRHOAEA",1,NA
"PENILE PLETHYSMOGRAPHY",1,NA
"PENILE SWABS",1,NA
"PENINSULAR MALAYSIA",1,NA
"PENIS PEARLS",1,NA
"PENITENTIARY'S PHYSICIAN",1,NA
"PENNING IONIZATION",1,NA
"PENTACHLOROPHENOL",1,NA
"PENTACOZINE, DETECTION IN HUMAN URINE",1,NA
"PENTAE",1,NA
"PENTAERYTHRITOL",1,NA
"PENTAERYTHRITOL TETRANITRATE (PETN)",9,1
"PENTAFLUOROBENZYL",1,NA
"PENTAFLUOROBENZYL BROMIDE",1,NA
"PENTAFLUOROBENZYL DERIVATIVES",1,1
"PENTAFLUOROPHENYLPROPYL STATIONARY PHASE",1,3
"PENTAFLUOROPROPIONYL DERIVATIVE",1,NA
"PENTAMIDINE",1,NA
"PENTANUCLEOTIDE REPEAT MOTIF",1,NA
"PENTAZOCINE",4,1
"PENTEDRONE",4,6
"PENTOBARBITAL",5,4
"PENTOBARBITAL INTOXICATION",2,NA
"PENTOBARBITONE",2,1
"PENTOSIDINE",1,NA
"PENTOTHAL",1,NA
"PENTOXYVERINE",1,NA
"PENTOXYVERINE METABOLITES",1,NA
"PENTYLENETETRAZOL",1,NA
"PEPPER PRODUCTS",1,NA
"PEPPER SPRAY",6,NA
"PEPPER SPRAYS",1,NA
"PEPTIDE",8,7
"PEPTIDE ALKALOIDS",1,1
"PEPTIDE CLEAVAGE",1,NA
"PEPTIDE IDENTIFICATION",1,NA
"PEPTIDE MAPS",1,NA
"PEPTIDE METABOLISM",1,NA
"PEPTIDE SCREENING",1,NA
"PEQUI",2,2
"PER-SE LIMITS",1,NA
"PER SE LIMITS",1,NA
"PERACID OXIDATION",1,2
"PERCEIVED COERCION",2,NA
"PERCENTAGE PURITY",1,NA
"PERCENTILES",1,NA
"PERCEPTION",1,NA
"PERCHLORATE",2,NA
"PERCHLOROETHYLENE",1,NA
"PERCUTANEOUS ABSORPTION",2,NA
"PERCUTANEOUS CORONARY INTERVENTION",1,NA
"PERFLUORINATED COMPOUNDS",2,NA
"PERFLUOROACYLATION",2,7
"PERFLUOROHYDROCARBON",1,NA
"PERFLUOROOCTANOIC ACID COMPLEXATION REAGENT",1,NA
"PERFLUOROOCTANOYL",1,NA
"PERFLUOROOCTANOYL DERIVATIVE",1,NA
"PERFORATION",2,NA
"PERFORMANCE",2,1
"PERFORMANCE-ENHANCING DRUG",1,NA
"PERFORMANCE CRITERIA",1,NA
"PERFORMANCE ENHANCING DRUGS",3,3
"PERFORMANCE IMPROVEMENT",1,NA
"PERFORMANCE MANAGEMENT SYSTEMS",1,NA
"PERFORMANCE STANDARDS",2,NA
"PERFORMANCE VALIDITY TESTING",1,NA
"PERFORMANCE VALIDITY TESTS",1,NA
"PERFUSION RATES",1,NA
"PERGOLIDE",1,NA
"PERHYDROGENATED DIQUAT",1,NA
"PERHYDROGENATED PARAQUAT",1,NA
"PERI-PARTUM DEATH",1,NA
"PERICARDIAL FLUID",15,NA
"PERICARDIUM-TAMPONADE, OVERTREATMENT",1,NA
"PERIGASTRITIS",1,NA
"PERINATAL DEATH",1,NA
"PERINATAL RISK",1,NA
"PERINATAL SYNDROMES",1,NA
"PERINEAL LACERATIONS",1,NA
"PERIODONTAL DISEASE",1,NA
"PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR",1,NA
"PERIPHERAL BLOOD",11,NA
"PERIPHERAL VENOUS CATHETER",1,NA
"PERITONITIS",1,NA
"PERITONSILLAR ABSCESS",1,NA
"PERIUNGAL ERYTHEMA",1,NA
"PERLAPINE",1,NA
"PERMETHRIN",1,NA
"PERMITTIVITY",1,NA
"PEROXIDE",1,NA
"PEROXIDE EXPLOSIVES",2,NA
"PEROXYOXALATE",1,2
"PERPETRATORS",1,NA
"PERSERVATIVES",1,NA
"PERSISTENCE",1,NA
"PERSISTENCE DATA",1,NA
"PERSISTENT OFFENDERS",1,NA
"PERSISTENT ORGANIC POLLUTANTS",3,NA
"PERSON MEMORY",1,NA
"PERSONAL CARE PRODUCTS",2,1
"PERSONAL IDENTIFICATION",12,NA
"PERSONAL RIGHTS",1,NA
"PERSONAL SOCIAL NETWORK",1,NA
"PERSONALISED MEDICINE",1,NA
"PERSONALITY",9,NA
"PERSONALITY ASSESSMENT INVENTORY",2,NA
"PERSONALITY ASSESSMENT INVENTORY-ADOLESCENT",1,NA
"PERSONALITY CHANGES",1,NA
"PERSONALITY CORRELATES, MARIHUANA USAGE, 18-28 YR OLD OFFENDERS",1,NA
"PERSONALITY DETERMINANTS OF CRIMINALS' RE-ADAPTATION",1,NA
"PERSONALITY DISORDER",18,NA
"PERSONALITY DISORDERS",7,NA
"PERSONALITY FACTORS",3,NA
"PERSONALITY TRAITS",3,NA
"PERSONALIZED",1,NA
"PERSONALIZED MEDICINE",3,NA
"PERSONNEL",1,NA
"PERSONS AGED 15-50 YEARS",1,NA
"PERSONS IN CUSTODY",1,NA
"PERSPIRATION",2,NA
"PERTUSSIS",1,NA
"PERU",2,NA
"PERVASIVE DEVELOPMENTAL DISORDERS",1,NA
"PERVERSITY",1,NA
"PESTICIDE",8,NA
"PESTICIDE INTOXICATION",1,NA
"PESTICIDE POISONING",1,NA
"PESTICIDES",40,7
"PESTICIDES/ENDOCRINE DISRUPTORS",1,NA
"PET",2,NA
"PETECHIAL HEMORRHAGE",1,NA
"PETG",1,NA
"PETH",2,NA
"PETHIDINE",9,5
"PETHIDINE AND NORPETHIDINE",1,NA
"PETHIDINE, GAS CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"PETROGENIC",1,NA
"PETROLEUM",1,1
"PETROLEUM DERIVATIVE",1,NA
"PETROLEUM DISTILLATE",1,NA
"PETROLEUM HYDROCARBONS",1,NA
"PETROLEUM HYDROCARBONS (PHC)",1,NA
"PEYOTE",2,4
"PFAS",1,NA
"PGM",1,NA
"PGM3",1,NA
"PGMI",1,NA
"PGNAA",1,NA
"PH",6,1
"PH-MEDIATED STACKING",1,1
"PH-MTOR",1,NA
"PH/ORGANIC SOLVENT GRADIENT HPLC",1,1
"PHARMACEUTIC",1,NA
"PHARMACEUTICAL ABUSE/DRUG MISUSE",2,NA
"PHARMACEUTICAL ACTIVITY",1,NA
"PHARMACEUTICAL ANALYSIS",12,33
"PHARMACEUTICAL BOTTLE",1,NA
"PHARMACEUTICAL COMPANIES",1,NA
"PHARMACEUTICAL COUNTERFEITING",1,NA
"PHARMACEUTICAL CRIMES",1,NA
"PHARMACEUTICAL DOSAGE FORMS",1,1
"PHARMACEUTICAL DRUGS",3,2
"PHARMACEUTICAL FORMULATION",4,18
"PHARMACEUTICAL INTEGRATION INITIATIVES",1,NA
"PHARMACEUTICAL LAW",2,NA
"PHARMACEUTICAL OPIOIDS",1,2
"PHARMACEUTICAL POISONS",1,NA
"PHARMACEUTICAL PREPARATION",2,8
"PHARMACEUTICAL TOXICOLOGICAL ANALYSIS",1,1
"PHARMACEUTICALS",52,79
"PHARMACEUTICALS ABUSE",1,NA
"PHARMACEUTICALS AND PERSONAL CARE PRODUCTS (PPCPS)",1,3
"PHARMACEUTICALS INDUSTRY",1,NA
"PHARMACEUTICALS USAGE",1,1
"PHARMACIES, HOSPITAL",1,NA
"PHARMACISTS",1,NA
"PHARMACOBEZOAR",1,NA
"PHARMACOBEZOARS",1,NA
"PHARMACODYNAMIC",1,NA
"PHARMACODYNAMIC INTERACTION",1,NA
"PHARMACODYNAMICS",18,8
"PHARMACOEPIDEMIOLOGY",7,9
"PHARMACOGENETICS",22,NA
"PHARMACOGENOMICS",6,NA
"PHARMACOGNOSY",3,2
"PHARMACOKINETIC DRUG INTERACTION",1,NA
"PHARMACOKINETIC INTERACTIONS",1,NA
"PHARMACOKINETIC MODEL",1,NA
"PHARMACOKINETIC MODELING",2,NA
"PHARMACOKINETIC PROFILE",1,1
"PHARMACOKINETIC STUDY",2,1
"PHARMACOKINETICS",109,21
"PHARMACOLOGIC",1,NA
"PHARMACOLOGICAL",1,NA
"PHARMACOLOGICAL AND GEOGRAPHICAL PERSPECTIVE",1,NA
"PHARMACOLOGICAL EFFECTS",1,NA
"PHARMACOLOGICAL PECULIARITIES",1,NA
"PHARMACOLOGICAL PROPERTIES",1,NA
"PHARMACOLOGICAL TREATMENT",1,NA
"PHARMACOLOGY",20,15
"PHARMACOLOGY AND THERAPEUTICS",1,NA
"PHARMACOLOGY AND TOXICOLOGY",1,3
"PHARMACOLOGY/PATHOPHYSIOLOGY",1,NA
"PHARMACOPROPHYLAXIS",1,NA
"PHARMACOTHERAPY",7,NA
"PHARMACOTOXICOLOGY",1,NA
"PHARMACOVIGILANCE",5,2
"PHARMACY",2,NA
"PHARMACY SHOPPING",1,NA
"PHARMAKOKINETICS",2,1
"PHASE-CONTRAST X-RAY IMAGING",1,1
"PHASE-II-METABOLISM",1,NA
"PHASE ANALYSIS",2,1
"PHASE I AND II METABOLITES",1,NA
"PHASE I AND PHASE II METABOLISM",1,NA
"PHASE I ENZYMES",1,NA
"PHASE I METABOLISM",1,1
"PHASE I METABOLITES",1,NA
"PHASE II METABOLITES",1,1
"PHASEOLAMIN",1,NA
"PHENACETIN",4,2
"PHENAGLYCODOL",1,NA
"PHENANTHROLINE",1,1
"PHENAZEPAM",5,2
"PHENAZONE",1,NA
"PHENAZOPYRIDINE",1,NA
"PHENCYCLIDINE",17,15
"PHENCYCLIDINE (PCP)",1,1
"PHENCYCLIDINES",1,NA
"PHENDIMETRAZINE",1,NA
"PHENETHYLAMINE",24,41
"PHENETHYLAMINE-TYPE DRUGS",1,NA
"PHENETHYLAMINE COMPOUNDS",1,NA
"PHENETHYLAMINE DERIVATIVE",1,NA
"PHENETHYLAMINE DERIVATIVES",4,2
"PHENETHYLAMINE REGIOISOMERS",1,1
"PHENETHYLAMINE DERIVATIVES",1,NA
"PHENFLURAMINE",2,NA
"PHENFORMIN",1,NA
"PHENIDATE ANALOGUES",1,NA
"PHENIDATES",1,NA
"PHENMETRAZI NE",1,NA
"PHENMETRAZIN",1,NA
"PHENMETRAZINE",4,3
"PHENMETRAZINES",1,NA
"PHENOBARBITAL",9,12
"PHENOBARBITAL—IN VITRO ADSORPTION ONTO ACTIVATED CHARCOAL, DESORPTION, BINDING",1,NA
"PHENOBARBITAL (PHENOBARBITONE)",1,NA
"PHENOBARBITONE",1,2
"PHENOCONVERSION",1,NA
"PHENOLPHTHALEIN",1,1
"PHENOLS",4,10
"PHENOMENOLOGY",1,NA
"PHENOTHIAZINE",14,12
"PHENOTHIAZINE ANTIPSYCHOTIC",1,NA
"PHENOTHIAZINE DERIVATIVES",1,NA
"PHENOTYPE",4,3
"PHENOTYPING",2,NA
"PHENOXYALKANOIC ACID HERBICIDES",1,NA
"PHENPROCOUMON",1,NA
"PHENTERMINE",4,1
"PHENYL",1,NA
"PHENYL-2-PROPANONE",2,4
"PHENYL COLUMN",1,2
"PHENYLACETIC ACID",1,2
"PHENYLALKYLAMINE",1,NA
"PHENYLALKYLAMINE DERIVATIVES",1,NA
"PHENYLALKYLAMINES",1,NA
"PHENYLBUTAZONE",1,NA
"PHENYLETHYLAMINE",3,14
"PHENYLETHYLAMINE AND DERIVATIVES",1,NA
"PHENYLETHYLAMINE DERIVATIVES",1,1
"PHENYLFENTANYL",1,NA
"PHENYLHYDRAZINE",1,NA
"PHENYLPIPERAZINES",1,2
"PHENYLPIRACETAM",1,NA
"PHENYLPROPANOLAMINE",4,7
"PHENYTOIN",4,4
"PHI29 DNA POLYMERASE",1,NA
"PHILIPPINES",1,NA
"PHLM",1,NA
"PHOLCODINE",2,NA
"PHORATE",2,NA
"PHORMIA REGINA",1,NA
"PHOSGEN INTOXICATION",1,NA
"PHOSPHATE",2,3
"PHOSPHATE ROCKS",1,NA
"PHOSPHATIDYL ETHANOL",2,NA
"PHOSPHATIDYLCHOLINE",1,NA
"PHOSPHATIDYLETHANOL",8,NA
"PHOSPHATIDYLINOSITOL 3-KINASE",1,NA
"PHOSPHINE",1,1
"PHOSPHINE GAS",2,1
"PHOSPHINE POISONING",1,NA
"PHOSPHITE",1,1
"PHOSPHO-AKT",1,NA
"PHOSPHO-PI3K",1,NA
"PHOSPHODIESTERASE",1,NA
"PHOSPHODIESTERASE-5 (PDE-5) INHIBITOR",1,6
"PHOSPHODIESTERASE 5 INHIBITORS",1,NA
"PHOSPHODIESTERASE INHIBITOR",1,NA
"PHOSPHODIESTERASE ISOENZYMES",1,NA
"PHOSPHODIESTERASE TYPE-5 (PDE-5) INHIBITORS",1,3
"PHOSPHODIESTERASE TYPE 5 INHIBITOR",2,NA
"PHOSPHOGLUCOMUTASE",1,NA
"PHOSPHOGLUCOMUTASE, SELTENE VARIANTEN",1,NA
"PHOSPHOLIPID REMOVAL",1,NA
"PHOSPHOLIPIDS",1,1
"PHOSPHONIC ACIDS",1,NA
"PHOSPHOR",1,NA
"PHOSPHORIC ACID",1,NA
"PHOSPHOROUS ACID",1,1
"PHOSPHOROUS CONTAINING AMINO ACID HERBICIDES",1,NA
"PHOSPHORS",1,NA
"PHOSPHORSÄUREESTER-VERGIFTUNG, KOMBINIERT MIT ALKOHOL",1,NA
"PHOSPHORUS",2,3
"PHOSPHORUS-CONTAINING AMINO ACID",1,NA
"PHOSPHORUS POISONING",1,NA
"PHOTO-OXIDATION",1,NA
"PHOTO DIODE ARRAY DETECTION",1,1
"PHOTOACOUSTIC",1,NA
"PHOTOACOUSTIC RESPONSE",2,NA
"PHOTOACTIVITY",1,1
"PHOTOBLEACHING",2,1
"PHOTOCHEMICAL DERIVATIZATION",1,1
"PHOTOCHEMICAL REACTION",1,NA
"PHOTOCOAGULATION",1,NA
"PHOTODEGRADATION",4,1
"PHOTODIODE-ARRAY",1,1
"PHOTODIODE ARRAY DETECTION",4,2
"PHOTODIODE ARRAY DETECTOR",1,NA
"PHOTODIODE ARRAY ULTRAVIOLET DETECTION",1,NA
"PHOTOGRAMMETRY",1,NA
"PHOTOGRAPH COMPARISON",1,NA
"PHOTOGRAPHIC PAPER",1,NA
"PHOTOGRAPHY",1,NA
"PHOTOLYSIS",1,1
"PHOTOLYTIC DERIVATIZATION",1,NA
"PHOTONIC CRYSTAL",1,NA
"PHOTONIC CRYSTAL FIBERS",1,NA
"PHOTONIC CRYSTALS",1,1
"PHOTONICS",1,NA
"PHOTOPEAK EFFICIENCY",1,NA
"PHOTORESISTIVITY",1,NA
"PHOTOSENSITIVITY",1,2
"PHTHALAMIC ACID",1,NA
"PHTHALIMIDE",1,NA
"PHYLLOMEDUSA BICOLOUR",1,NA
"PHYLOGENETIC ANALYSIS",2,4
"PHYLOGENETIC TREE",1,NA
"PHYLOGENY",5,4
"PHYSICAL ABUSE",1,NA
"PHYSICAL ACTIVITY",2,NA
"PHYSICAL AGENTS",1,NA
"PHYSICAL AND MECHANICAL PROPERTIES",1,NA
"PHYSICAL AND PSYCHOLOGICAL NEEDS",1,NA
"PHYSICAL CHARACTERISTIC",1,3
"PHYSICAL CHARACTERIZATION",1,2
"PHYSICAL CONTAINMENT",1,NA
"PHYSICAL DEVELOPER",1,NA
"PHYSICAL DEVELOPER (PD)",1,NA
"PHYSICAL DISABILITIES",1,NA
"PHYSICAL EXAMINATION",3,NA
"PHYSICAL FEATURES",1,NA
"PHYSICAL FINDINGS",1,NA
"PHYSICAL FIT",2,NA
"PHYSICAL HEALTH",4,NA
"PHYSICAL HEALTH STATUS",1,NA
"PHYSICAL ILLNESSES",1,NA
"PHYSICAL INJURIES",1,NA
"PHYSICAL MATCH",1,NA
"PHYSICAL PROFILING",1,NA
"PHYSICAL RESTRAINT",3,NA
"PHYSICAL STRESS",2,NA
"PHYSICAL TRAITS",1,NA
"PHYSICIAN",2,NA
"PHYSICIAN'S PRACTICE PATTERNS",1,NA
"PHYSICIAN HEALTH PROGRAMS",1,NA
"PHYSICIAN SUPPORT",1,NA
"PHYSICIANS",2,NA
"PHYSICOCHEMICAL AND PHARMACOKINETIC PARAMETERS",1,NA
"PHYSICOCHEMICAL PROPERTIES",3,NA
"PHYSIOLOGICAL EFFECTS",1,NA
"PHYSIOLOGICAL FUNCTIONS",1,NA
"PHYSIOLOGICAL SIGNS",1,NA
"PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING",1,NA
"PHYSIOLOGY OF SALIVA",1,NA
"PHYSOSTIGMINE",1,NA
"PHYTOCANNABINOID",1,1
"PHYTOCANNABINOID SYNTHESIS",1,NA
"PHYTOCANNABINOIDS",1,4
"PHYTOCHEMISTRY",2,8
"PHYTOLACCATOXIN",1,NA
"PHYTOLACCOSIDE",1,NA
"PHYTOPATHOLOGY",1,NA
"PHYTOREMEDIATION",1,1
"PHYTOTHERAPY",1,NA
"PHYTOTOXIN",1,NA
"PICA",1,NA
"PICRATE-RESORCINOL",1,NA
"PIEDS",1,NA
"PIG",3,1
"PIGE",1,NA
"PIGLET CARCASSES",1,NA
"PIGMENT",4,3
"PIGMENT IDENTIFICATION",2,NA
"PIGMENTATION",6,NA
"PIGS",9,NA
"PILL-TESTING KITS",1,1
"PILLOW",1,NA
"PILLS",2,1
"PILOCARPINE",1,NA
"PILOT FATALITIES",5,NA
"PILOT FATALITY SPECIMENS",1,NA
"PILSICAINIDE",1,NA
"PIMOZIDE",1,NA
"PIN MIGRATION",1,NA
"PINACA",1,2
"PINDOLOL",1,NA
"PINK TEETH",1,NA
"PINK TOOTH",1,NA
"PINK1",1,NA
"PIOPHILA CASEI",1,NA
"PIPAMPERONE",1,NA
"PIPAZETHATE, LETHAL INTOXICATION",1,NA
"PIPE BOMB",1,NA
"PIPE BOMBS",2,NA
"PIPECURONIUM BROMIDE INTOXICATION",1,NA
"PIPERAZINE",13,16
"PIPERAZINE DERIVATIVES",4,4
"PIPERIDINES",1,NA
"PIPERONAL",1,1
"PIPERONYL METHYL KETONE ACETAL DERIVATIVE (PMKA)",1,NA
"PIPETTE-TIP EXTRACTION",1,NA
"PIPETTE TIP",2,NA
"PIPETTE TIP SOLID-PHASE EXTRACTION",1,NA
"PIPETTING",1,NA
"PIRACETAM",2,2
"PIRITRAMIDE",1,NA
"PIROXICAM",1,NA
"PITFALL",1,NA
"PITFALLS",4,NA
"PITUITARY GLAND",1,NA
"PITUITARY TUMOUR",1,NA
"PIWI-INTERACTING RNA (PIRNA)",1,NA
"PK STUDY",1,NA
"PK/PD",1,NA
"PLA",1,NA
"PLACEBO-CONTROLLED",2,NA
"PLACEMENT",1,NA
"PLACENTA",3,NA
"PLACENTA FORMATION",1,NA
"PLACENTAL TRANSFER",2,NA
"PLAN OF CRIMINAL ACT",1,NA
"PLANAR ARRAY INFRARED",1,1
"PLANCTOMYCETES",1,NA
"PLANKTON",2,NA
"PLANNED COMPLEX SUICIDE",1,NA
"PLANT-BASED DRUGS",1,1
"PLANT-BASED DRUGS OF ABUSE",2,2
"PLANT-MICROBE INTERACTION",1,NA
"PLANT-WATER RELATIONS",1,1
"PLANT ALKALOIDS",1,NA
"PLANT ANALYSIS",1,1
"PLANT AND ANIMAL MATERIAL",1,1
"PLANT CHEMISTRY",1,NA
"PLANT DNA EXTRACTION",1,1
"PLANT EXTRACT",2,6
"PLANT LEAF ANALYSIS",1,NA
"PLANT ORIGIN",1,NA
"PLANT POISONING",4,NA
"PLANT PRODUCT",1,2
"PLANT PRODUCT IDENTIFICATION",1,1
"PLANT SECONDARY METABOLITES",1,1
"PLANT SEED",1,NA
"PLANT STRUCTURES",1,NA
"PLANTS",6,4
"PLANTS ANALYSIS",1,NA
"PLAQUE",1,NA
"PLASMA",64,17
"PLASMA AND URINE",1,NA
"PLASMA AND WHOLE BLOOD",1,NA
"PLASMA ASSAYS",1,NA
"PLASMA CONCENTRATION",4,NA
"PLASMA CONCENTRATIONS",4,1
"PLASMA CORRELATION",1,NA
"PLASMA DEPROTEINIZATION",1,NA
"PLASMA DETERMINATION",1,NA
"PLASMA HALF-LIFE",1,NA
"PLASMA LEVEL",1,NA
"PLASMA LEVELS",2,NA
"PLASMA PRECIPITATION",1,NA
"PLASMA PRINTING",1,1
"PLASMA PROTEIN BINDING",2,NA
"PLASMA SAMPLES",1,4
"PLASMA:WHOLE BLOOD DISTRIBUTION: CLOZAPINE",1,NA
"PLASMODIUM",1,NA
"PLASMODIUM FALCIPARUM",4,NA
"PLASMONIC NANOPARTICLES",1,1
"PLASMONIC NANOSENSOR",1,1
"PLASMONIC NANOSTRUCTURES",1,NA
"PLASMONICS",3,NA
"PLASTERCAST",1,NA
"PLASTIC",9,5
"PLASTIC BAG",8,NA
"PLASTIC BAG ASPHYXIA",1,NA
"PLASTIC BAG EXAMINATION",1,NA
"PLASTIC BAG SUFFOCATION",2,NA
"PLASTIC BAGS",2,NA
"PLASTIC CHEMISTRY",1,NA
"PLASTIC DEFORMATION IN METALS",1,NA
"PLASTIC EVIDENCE BAGS",1,NA
"PLASTIC SURGERY",1,NA
"PLASTIC TECHNOLOGY",1,NA
"PLASTICIZER",1,1
"PLATE",1,NA
"PLATELET AGGREGATION",1,NA
"PLATELET MONOAMINE OXIDASE",1,NA
"PLATELETS",1,NA
"PLATINUM",2,NA
"PLATINUM NANOPARTICLE",1,NA
"PLE",2,NA
"PLEUROCYBELLA PORRIGENS",1,NA
"PLS",3,5
"PLS-DA",6,4
"PLUMMERS ISLAND",1,NA
"PLUTONIUM",9,NA
"PLUTONIUM ISOTOPE RATIO",1,NA
"PLUTONIUM METAL",1,NA
"PLUTONIUM REPROCESSING",1,NA
"PMA",5,1
"PMA IN BLOOD",1,NA
"PMCT",4,1
"PMCTA",1,NA
"PMI",6,NA
"PMI ESTIMATION",2,NA
"PMMA",5,1
"PMR",1,NA
"PNEUMATOSIS INTESTINALIS",1,NA
"PNEUMOCOCCAL",1,NA
"PNEUMOCYSTIS CARINII PNEUMONIA",1,NA
"PNEUMONIA",3,NA
"PNEUMONITIS",1,NA
"PNEUMOTHORAX",2,NA
"POACHING",2,NA
"POC",1,NA
"POCT",2,1
"POINT-OF-CARE",2,2
"POINT-OF-CARE-TESTING",2,NA
"POINT-OF-CARE (POC)",1,NA
"POINT-OF-CARE DEVICES",1,NA
"POINT-OF-CARE DIAGNOSTICS",1,1
"POINT-OF-CARE TEST",2,NA
"POINT-OF-CARE TESTING",6,3
"POINT-OF-COLLECTION TEST",1,NA
"POINT-OF-COLLECTION TESTING DEVICES",1,NA
"POINT OF CARE TESTING",1,NA
"POISON",17,NA
"POISON (DRUG)",1,NA
"POISON CENTER",1,1
"POISON CENTERS",2,NA
"POISON CONTROL CENTER",3,NA
"POISON CONTROL CENTERS",1,NA
"POISON INFORMATION CENTRES",1,NA
"POISONING",206,10
"POISONING BROMUREIDES IN CADAVER",1,NA
"POISONING BY MERCURIC CHLORIDE",1,NA
"POISONING CASES",1,NA
"POISONING DEATH",2,NA
"POISONING DEATHS",3,NA
"POISONING IN CHILDREN",1,NA
"POISONING INDEX",1,NA
"POISONING MORTALITY",1,NA
"POISONING OF INSECTIDES",1,NA
"POISONING WITH",1,NA
"POISONING, ACID",1,NA
"POISONING, ANILERIDINE, PETHIDINE",1,NA
"POISONING, BY BRAKE FLUID",1,NA
"POISONING, CLOMETHIAZOL",1,NA
"POISONING, COCAINE",1,NA
"POISONING, COLCHICINE",1,NA
"POISONING, DEXTROPROPOXYPHENE",1,NA
"POISONING, DIGOXIN",2,NA
"POISONING, DIGOXIN AND DIGITOXIN",1,NA
"POISONING, DIPHENHYDRAMINE",1,NA
"POISONING, DISTRIBUTION IN HUNGARY",1,NA
"POISONING, HEART MUSCLE",1,NA
"POISONING, HYDROCYANIC ACID",1,NA
"POISONING, ORPHENADINE",1,NA
"POISONING, PIPAZETHATE",1,NA
"POISONING, VESPARAX",1,NA
"POISONOUS AGENTS",1,NA
"POISONOUS COMPOUNDS CLASSIFICATION",1,NA
"POISONOUS COMPOUNDS SYSTEMATIC ANALYSIS",1,NA
"POISONOUS MUSHROOMS",1,1
"POISONS",18,2
"POISONS AND DRUGS RESULTS",1,NA
"POISONS CENTER",1,NA
"POISONS INFORMATION",1,NA
"POKEWEED",1,NA
"POLAND",3,1
"POLAR ANALYTES",1,NA
"POLAR COMPOUNDS",1,NA
"POLAR ORGANIC COMPOUNDS",1,NA
"POLAR ORGANICS",1,NA
"POLARIMETER",1,NA
"POLARITY",1,NA
"POLARITY SWITCHING ELECTROSPRAY IONIZATION",1,NA
"POLARIZATION",1,NA
"POLARIZED LIGHT MICROSCOPY",2,1
"POLARIZING PLATE",1,1
"POLAROGRAPHIE, DIFFERENTIAL-PULS",1,NA
"POLAROGRAPHY",2,1
"POLICE",18,4
"POLICE- ASSISTED SUICIDE",1,NA
"POLICE-ASSISTED SUICIDE",1,NA
"POLICE COMPLAINTS",1,NA
"POLICE CONFRONTATIONS",1,NA
"POLICE CONTACT",1,NA
"POLICE CUSTODY",15,NA
"POLICE DATA INTEGRATION",1,NA
"POLICE DEADLY FORCE ENCOUNTERS",1,NA
"POLICE DETAINEES",1,NA
"POLICE DETENTION",1,NA
"POLICE HAZARDS",1,NA
"POLICE INTERVIEWS",1,NA
"POLICE LESS LETHAL FORCE ENCOUNTERS",1,NA
"POLICE NEAR MISS INCIDENTS",1,NA
"POLICE OPERATION",1,1
"POLICE PRESENTATIONS",1,NA
"POLICE REFORM ACT",1,NA
"POLICE SEIZURE",1,1
"POLICE SURGEON",2,NA
"POLICE USE OF FORCE",1,NA
"POLICED MEASURES",1,NA
"POLICING",1,1
"POLICY",5,7
"POLICY MAKER",1,NA
"POLIO",1,NA
"POLITICS AND PSYCHIATRY",1,NA
"POLLEN",4,1
"POLLEN CONTENT",1,NA
"POLLUTION",1,1
"POLLUTION SOURCES",1,NA
"POLY-ASSUMPTION",1,NA
"POLY-DRUG ABUSERS",1,NA
"POLY-DRUG MISUSE",1,NA
"POLY-DRUG POISONING",1,NA
"POLY-DRUG USE",5,NA
"POLY (DIMETHYLSILOXANE)",1,NA
"POLY BAGS",1,NA
"POLY ETHYLENE GLYCOL",1,NA
"POLY(DIALLYL-DIMETHYLAMMONIUM CHLORIDE",1,NA
"POLY(STYRENE-DIVINYLBENZENE) STATIONARY PHASES",1,NA
"POLY(TRIMETHELYNE TEREPHTHALATE) - PTT",1,NA
"POLY(VINYL ALCOHOL)",1,1
"POLY(VINYL ALCOHOL) AEROGEL",1,NA
"POLYABUSE",1,NA
"POLYACRYLAMIDE",1,NA
"POLYAMIDE",1,NA
"POLYANILINE",1,NA
"POLYAROMATIC HYDROCARBONS",1,NA
"POLYCHLORINATED BIPHENYLS",2,NA
"POLYCLONAL",1,NA
"POLYCLONAL ANTIBODY",1,2
"POLYCRYSTAL",1,NA
"POLYCYANO UV",1,NA
"POLYCYCLIC AROMATIC HYDROCARBONS",8,NA
"POLYCYCLIC AROMATIC SULFUR HETEROCYCLES",1,NA
"POLYDIMETHYLSILOXANE",2,2
"POLYDIPSIA",2,NA
"POLYDRUG",5,NA
"POLYDRUG-ABUSE",1,NA
"POLYDRUG ABUSE",2,1
"POLYDRUG TOXICITY",1,NA
"POLYDRUG USE",4,5
"POLYESTER",2,1
"POLYETHYLENE",4,2
"POLYETHYLENE BAGS",2,NA
"POLYETHYLENE GLYCOL",2,2
"POLYETHYLENE GLYCOL (PEG)",1,NA
"POLYETHYLENE GLYCOL ETHER SURFACTANTS",1,1
"POLYETHYLENE TEREPHTHALATE GLYCOL",1,NA
"POLYGRAPH",2,NA
"POLYGRAPH TESTING",1,NA
"POLYGRAPHY",1,NA
"POLYHYDRIC ALCOHOL",1,1
"POLYINTOXICATION",1,NA
"POLYISOBUTYLENE",1,NA
"POLYLACTIC ACID",2,NA
"POLYMARKER",1,NA
"POLYMER",13,13
"POLYMER-COATING",1,NA
"POLYMER BANKNOTE",1,NA
"POLYMER BANKNOTES",1,NA
"POLYMER BONDING",1,NA
"POLYMER SENSOR ARRAY",1,NA
"POLYMER SURFACE FUNCTIONALIZATION",1,NA
"POLYMERASE CHAIN REACTION (PCR)",24,11
"POLYMERASE FUNCTION",1,NA
"POLYMERIC MONOLITH-BASED CAPILLARY LIQUID CHROMATOGRAPHY",1,NA
"POLYMERIC NANOPARTICLES",1,NA
"POLYMERISATION",1,1
"POLYMERS/SURFACTANTS",1,NA
"POLYMETHYL METHACRYLATE",1,NA
"POLYMETHYLSILOXANE",1,NA
"POLYMORPHIC FORMS",1,NA
"POLYMORPHISM",22,6
"POLYMORPHISM IN CYTOSOLIC ALDH 1",1,NA
"POLYMORPHISMS",4,1
"POLYMORPHISMUS",1,NA
"POLYMORPHS",1,NA
"POLYNUCLEAR AROMATIC HYDROCARBONS",1,1
"POLYPHARMACY",11,NA
"POLYPHARMACY-RELATED DEATH",1,NA
"POLYPROPYLENE",1,1
"POLYPYRIDYL COMPLEX",1,NA
"POLYPYRROLE",2,3
"POLYPYRROLES",1,NA
"POLYSACCHARIDE CHIRAL COLUMN",1,NA
"POLYSOMNOGRAPHY",5,NA
"POLYSOMNOGRAPHY/SLEEP EEG",1,NA
"POLYSTYRENE RESIN",1,NA
"POLYSTYRENE SPHERES",1,NA
"POLYSUBSTANCE ABUSE",1,NA
"POLYSUBSTANCE USE",3,1
"POLYSULPHIDES",1,NA
"POLYTETRAFLUOROETHYLENE",1,NA
"POLYTHIOPHENES",1,NA
"POLYTOXICOMANIA",1,NA
"POLYUNSATURATED FATTY ACID",1,NA
"POLYURETHANE COMBUSTION",1,NA
"POLYURIA",1,NA
"POLYVALENT DRUG ABUSE",1,NA
"POMPEII",1,NA
"POMPIDOU QUESTIONNAIRE",1,NA
"POOLED HUMAN LIVER S9 FRACTION",1,NA
"POOR MEDICO-LEGAL WORK",1,NA
"POOR METABOLIZER",2,NA
"POOR METABOLIZERS",1,NA
"POP7™",1,NA
"POPLITEAL BLOOD",2,NA
"POPPY FIELDS",1,NA
"POPPY HEADS",1,NA
"POPPY SEED",10,6
"POPPY SEED DEFENSE",2,NA
"POPPY SEED FOOD",1,NA
"POPPY SEED PRODUCTS",1,NA
"POPPY SEED TEA",3,3
"POPS",1,NA
"POPULARITY",1,NA
"POPULATION",4,NA
"POPULATION-SPECIFIC",1,NA
"POPULATION APPROACH",1,NA
"POPULATION CHARACTERISTICS",1,NA
"POPULATION GENETIC STRUCTURE",1,1
"POPULATION GENETICS",10,1
"POPULATION MARKER",1,NA
"POPULATION PHARMACOKINETIC MODELING",1,NA
"POPULATION STRUCTURE",2,1
"POPULATION STUDY",2,NA
"POPULATION TOXICOKINETIC MODELING",1,NA
"PORCINE",1,NA
"PORCINE GROWTH HORMONE",1,NA
"PORK AUTHENTICATION",1,NA
"POROSITY",1,NA
"POROUS MEMBRANE-PROTECTED MICRO-SOLID PHASE EXTRACTION",1,NA
"POROUS MICROSTRUCTURE",1,NA
"POROUS POLYMER BEADS",1,NA
"POROUS SURFACES",3,NA
"PORPHYRIA CUTANEA TARDA",1,NA
"PORPHYRIA CUTANEA TARDA, CHLOROQUINE INTOXICATION",1,NA
"PORPHYROXINE",1,2
"PORT SAID",1,NA
"PORTA-POTTY",1,NA
"PORTABLE",4,4
"PORTABLE 1064 NM RAMAN",1,NA
"PORTABLE ANALYTICAL DEVICES",1,NA
"PORTABLE ANALYTICAL INSTRUMENTS",1,NA
"PORTABLE ANALYTICAL PLATFORMS",1,1
"PORTABLE ANALYTICS",1,NA
"PORTABLE AND HANDHELD SPECTROMETERS, BEING THE CURRENT GOAL",1,NA
"PORTABLE CHEMICAL SENSORS",1,NA
"PORTABLE COCAINE-SELECTIVE ELECTRODE",1,NA
"PORTABLE CONFIRMATORY TECHNIQUE FOR FORENSIC ANALYSIS",1,NA
"PORTABLE DETECTOR",1,NA
"PORTABLE DEVICE",1,2
"PORTABLE DEVICES",1,1
"PORTABLE FORENSIC ANALYSIS",1,1
"PORTABLE GAS CHROMATOGRAPHY/MASS SPECTROMETRY",1,NA
"PORTABLE GC",1,NA
"PORTABLE GC-MS",1,NA
"PORTABLE INSTRUMENTATION",2,2
"PORTABLE INSTRUMENTATION, OBTAINING CRIME SCENE INFORMATION IN TIMELY MANNER",1,NA
"PORTABLE INSTRUMENTS",1,2
"PORTABLE LIQUID CHROMATOGRAPHY",1,1
"PORTABLE MASS SPECTROMETRY",2,NA
"PORTABLE METHOD",1,1
"PORTABLE NANO-LIQUID CHROMATOGRAPHY ELECTRON IONIZATION MS",1,NA
"PORTABLE PRESSURE METER",1,NA
"PORTABLE RAMAN ANALYSIS",1,NA
"PORTABLE RAMAN SPECTROMETER",2,1
"PORTABLE RAMAN SPECTROSCOPY",2,2
"PORTABLE SENSOR",1,NA
"PORTABLE SPECTROMETERS",1,1
"PORTABLE SYSTEM",1,2
"PORTAL LYMPHADENOPATHY",1,NA
"POSE REPRODUCTION",1,NA
"POSIONING",1,NA
"POSITION ISOMERS",1,1
"POSITIONAL ASPHYXIA",6,NA
"POSITIONAL ASPHYXIATION",2,NA
"POSITIONAL ISOMER",8,12
"POSITIONAL ISOMER DIFFERENTIATION",3,1
"POSITIONAL ISOMERIC DIFFERENTIATION",1,NA
"POSITIONAL ISOMERS OF FLUOROMETHCATHINONES",1,1
"POSITIVE CONTROL",1,NA
"POSITIVE IDENTIFICATION",1,NA
"POSITIVE IMPRESSION MANAGEMENT",2,NA
"POSITIVE ION ELECTROSPRAY IONIZATION",1,1
"POSITIVE PREDICTIVE VALUE",1,NA
"POSITIVE SYMPTOMS",2,NA
"POST- MORTEM",1,NA
"POST-ANALYSIS CUSTODY",1,NA
"POST-BLAST",3,NA
"POST-BLAST DEBRIS",1,NA
"POST-BLAST RESIDUES",1,NA
"POST-CHEMOTHERAPY COGNITIVE IMPAIRMENT",1,NA
"POST-CONVICTION SEX OFFENDER TESTING",1,NA
"POST-DETONATION",1,NA
"POST-DETONATION MATERIAL",1,NA
"POST-EXPLOSION ANALYSIS",1,NA
"POST-EXPLOSION RESIDUES",2,NA
"POST-EXPOSURE PROPHYLAXIS",1,NA
"POST-GENOMIC",1,NA
"POST-MORTEM ALCOHOL ANALYSIS",1,NA
"POST-MORTEM ALTERATION",1,NA
"POST-MORTEM ALTERNATIVE MATERIALS",1,NA
"POST-MORTEM ANALYSIS",3,1
"POST-MORTEM ANGIOGRAPHY",2,NA
"POST-MORTEM BIOCHEMISTRY",1,NA
"POST-MORTEM BIOMARKERS",1,NA
"POST-MORTEM BLOOD",9,NA
"POST-MORTEM BLOOD AND TISSUE-LEVELS, CHLOROQUINE",1,NA
"POST-MORTEM BLOOD SAMPLES",2,NA
"POST-MORTEM BROWSER FORENSICS",1,NA
"POST-MORTEM COMPUTED TOMOGRAPHY",2,NA
"POST-MORTEM COMPUTED TOMOGRAPHY ANGIOGRAPHY",1,NA
"POST-MORTEM CONCENTRATION",2,NA
"POST-MORTEM CONCENTRATIONS",1,NA
"POST-MORTEM CT",3,NA
"POST-MORTEM CT-ANGIOGRAPHY",1,NA
"POST-MORTEM DATABASE",2,NA
"POST-MORTEM DIAGNOSIS",1,NA
"POST-MORTEM DISTRIBUTION",5,NA
"POST-MORTEM DRUG DISPOSITION",1,NA
"POST-MORTEM DRUG REDISTRIBUTION",2,NA
"POST-MORTEM DRUGS",1,NA
"POST-MORTEM EXAMINATION",6,NA
"POST-MORTEM EXAMINATIONS",1,NA
"POST-MORTEM FORENSIC TOXICOLOGY",2,NA
"POST-MORTEM IMAGINING",1,NA
"POST-MORTEM INJURIES",1,NA
"POST-MORTEM INTERVAL",19,NA
"POST-MORTEM INTERVAL (PMI)",2,NA
"POST-MORTEM INTERVAL (PMI) - TAPHONOMY - MOLECULAR GENETICS - DNA - RNA - NAIL - TOOTH.",1,NA
"POST-MORTEM INTERVAL ESTIMATION",2,NA
"POST-MORTEM INVESTIGATION",3,NA
"POST-MORTEM LESIONS",1,NA
"POST-MORTEM MATERIAL",3,NA
"POST-MORTEM MICROBIOLOGY",2,NA
"POST-MORTEM MR",1,NA
"POST-MORTEM REDISTRIBUTION",12,NA
"POST-MORTEM REDISTRIBUTION: CLOZAPINE",1,NA
"POST-MORTEM SAMPLES",5,NA
"POST-MORTEM STABILITY",1,NA
"POST-MORTEM TIME INTERVAL (PMI) ESTIMATION",1,NA
"POST-MORTEM TISSUE",1,NA
"POST-MORTEM TOXICOLOGY",23,2
"POST-MORTEM TRACHEAL AND GASTRIC INFUSION",1,NA
"POST-MORTEM URINE",1,NA
"POST-MORTEM WHOLE BLOOD",1,NA
"POST-MORTEM WOUNDED SKIN",1,NA
"POST-OFFENCE DRINKING",1,NA
"POST-TRANSLATIONAL MODIFICATION",1,NA
"POST-TRAUMATIC HEADACHE",1,NA
"POST-TRAUMATIC STRESS",1,NA
"POST-TRAUMATIC STRESS DISORDER",6,NA
"POST-TRAUMATIC STRESS DISORDER (PTSD)",1,NA
"POST BLAST RESIDUE DETECTION",1,1
"POST EXPOSURE PROPHYLAXIS",1,NA
"POST GRADUATE TRAINING",1,NA
"POST MARKETING DRUG SURVEILLANCE",1,NA
"POST MORTEM",10,NA
"POST MORTEM ANALYSIS",1,NA
"POST MORTEM BIOCHEMISTRY",1,NA
"POST MORTEM BLOOD SAMPLES",1,NA
"POST MORTEM CHANGES",1,NA
"POST MORTEM CONCENTRATIONS",1,NA
"POST MORTEM DELAY",1,NA
"POST MORTEM INTERVAL",2,NA
"POST MORTEM INTERVALS",1,NA
"POST MORTEM MSCT ANGIOGRAPHY",1,NA
"POST MORTEM REDISTRIBUTION",2,NA
"POST MORTEM SAMPLES",2,NA
"POST MORTEM SPECIMENS",1,NA
"POST MORTEM TOXICOLOGY",5,NA
"POST MORTEM TRYPTASE",1,NA
"POST MORTEM WHOLE BLOOD",1,NA
"POST TRAUMATIC STRESS DISORDER",1,NA
"POSTAL PACKAGING MATERIAL",1,NA
"POSTBLAST RESIDUE",1,NA
"POSTBLAST RESIDUES",1,NA
"POSTCOLUMN-INFUSED INTERNAL STANDARD (PCI-IS)",1,NA
"POSTCOLUMN INFUSED-INTERNAL STANDARD (PCI-IS)",1,NA
"POSTERIOR ASSOCIATE REGION",1,NA
"POSTEXPLOSION",1,NA
"POSTGRADUATE TRAINING IN PSYCHIATRY",2,NA
"POSTMORTAL INJURIES",1,NA
"POSTMORTEM ALTERATION",1,NA
"POSTMORTEM ANALYSIS",1,NA
"POSTMORTEM ANGIOGRAPHY",4,NA
"POSTMORTEM ARTEFACT",1,NA
"POSTMORTEM BIOCHEMICAL ANALYSES",1,NA
"POSTMORTEM BIOCHEMICAL MARKERS",1,NA
"POSTMORTEM BIOCHEMISTRY",23,NA
"POSTMORTEM BIOLOGICAL MATRICES",1,NA
"POSTMORTEM BLOOD",16,NA
"POSTMORTEM BLOOD AND URINE",2,NA
"POSTMORTEM BLOOD DRUG CONCENTRATION",1,NA
"POSTMORTEM BLOOD FLOW",1,NA
"POSTMORTEM BLOOD FLUX",1,NA
"POSTMORTEM BLOOD LEVELS",1,NA
"POSTMORTEM BONE",1,NA
"POSTMORTEM BRAIN TISSUE",1,NA
"POSTMORTEM CASES",3,NA
"POSTMORTEM CEREBROSPINAL FLUID",1,NA
"POSTMORTEM CHANGE",19,NA
"POSTMORTEM COMPUTED TOMOGRAPHY",13,NA
"POSTMORTEM COMPUTED TOMOGRAPHY (PMCT)",1,NA
"POSTMORTEM COMPUTED TOMOGRAPHY ANGIOGRAPHY",1,NA
"POSTMORTEM COMPUTED TOMOGRAPHY ANGIOGRAPHY (PMCTA)",2,NA
"POSTMORTEM CONCENTRATION",5,NA
"POSTMORTEM CONCENTRATIONS",2,NA
"POSTMORTEM CONTAMINATION",1,NA
"POSTMORTEM COOLING CURVE",1,NA
"POSTMORTEM CT",7,NA
"POSTMORTEM CT OF ANGIOEDEMA",1,NA
"POSTMORTEM DIAGNOSIS",6,NA
"POSTMORTEM DIAGNOSIS FOR SCHIZOPHRENIA",1,NA
"POSTMORTEM DIAGNOSTICS",1,NA
"POSTMORTEM DIFFUSION",3,NA
"POSTMORTEM DIFFUSION OF LIDOCAINE",2,NA
"POSTMORTEM DIFFUSION OF URINARY DRUGS",1,NA
"POSTMORTEM DIGOXIN CONCENTRATIONS",1,NA
"POSTMORTEM DISCOVERY",1,NA
"POSTMORTEM DISTRIBUTION",20,NA
"POSTMORTEM DISTRIBUTION/REDISTRIBUTION",1,NA
"POSTMORTEM DRUG SCREEN",1,NA
"POSTMORTEM DRUG TESTING",2,NA
"POSTMORTEM DRUGS",1,NA
"POSTMORTEM EXAMINATION",9,NA
"POSTMORTEM EYE CHANGES",1,NA
"POSTMORTEM EYE TEMPERATURE",1,NA
"POSTMORTEM FETAL EXTRUSION",1,NA
"POSTMORTEM FORENSIC TOXICOLOGY",3,NA
"POSTMORTEM FORENSIC TOXICOLOGY, A MEDICOLEGAL INVESTIGATION INTO CAUSE",1,NA
"POSTMORTEM FORMATION",1,NA
"POSTMORTEM HISTOPATHOLOGY",2,NA
"POSTMORTEM HYPERTHERMIA",1,NA
"POSTMORTEM IMAGING",3,NA
"POSTMORTEM IMMUNOHISTOCHEMISTRY",1,NA
"POSTMORTEM INJURY",1,NA
"POSTMORTEM INTERVAL",45,NA
"POSTMORTEM INTERVAL (PMI)",4,NA
"POSTMORTEM INTERVAL ESTIMATION",2,NA
"POSTMORTEM INVESTIGATION",4,NA
"POSTMORTEM LEVELS",1,NA
"POSTMORTEM LIVER",1,NA
"POSTMORTEM MAGNETIC RESONANCE IMAGING",2,NA
"POSTMORTEM MAGNETIC RESONANCE SPECTROSCOPY",1,NA
"POSTMORTEM MATERIAL",2,NA
"POSTMORTEM METABOLISM",1,NA
"POSTMORTEM METABOLOMICS",2,NA
"POSTMORTEM MICROBIOME",1,NA
"POSTMORTEM MICROSCOPIC SKIN CHANGES",1,NA
"POSTMORTEM MOLECULAR SCREENING",1,NA
"POSTMORTEM MRI",1,NA
"POSTMORTEM MRNA EXPRESSION",1,NA
"POSTMORTEM NARCOTIC TESTING",1,NA
"POSTMORTEM PATHOLOGY",1,NA
"POSTMORTEM PREANALYTIC PHASE",1,NA
"POSTMORTEM PRODUCTION",2,NA
"POSTMORTEM RADIOGRAPHY",1,NA
"POSTMORTEM REDISTRIBUTION",62,NA
"POSTMORTEM REDISTRIBUTION (PMR)",2,NA
"POSTMORTEM REDISTRIBUTION FACTOR",1,NA
"POSTMORTEM REDISTRIBUTION OF BASIC DRUGS",1,NA
"POSTMORTEM REFERENCE CONCENTRATIONS",1,NA
"POSTMORTEM SAMPLES",4,NA
"POSTMORTEM SAMPLING",1,NA
"POSTMORTEM SEROLOGY",1,NA
"POSTMORTEM SERUM",1,NA
"POSTMORTEM SPECIMENS",1,NA
"POSTMORTEM STABILITY",4,NA
"POSTMORTEM STABILITY OF COCAINE",2,NA
"POSTMORTEM STABILITY OF PESTICIDES",1,NA
"POSTMORTEM STUDY",1,NA
"POSTMORTEM SUBMERGED INTERVAL",1,NA
"POSTMORTEM TESTING",2,NA
"POSTMORTEM TIME",1,NA
"POSTMORTEM TISSUE",1,NA
"POSTMORTEM TISSUE DISTRIBUTION",1,NA
"POSTMORTEM TOXICOLOGICAL ANALYSIS",1,NA
"POSTMORTEM TOXICOLOGY",29,NA
"POSTMORTEM TREATMENT",1,NA
"POSTMORTEM URINE",1,NA
"POSTMORTEM URINE VERSUS BLOOD NARCOTIC TESTING",1,NA
"POSTMORTEM WOUNDS",1,NA
"POSTMORTEMS",1,NA
"POSTOPERATIVE PYODERMA GANGRENOSUM",1,NA
"POSTPARTUM INFANTICIDE",1,NA
"POSTSYNAPTIC DENSITY-95",1,NA
"POSTTRAUMATIC INTERVAL (PTI)",1,NA
"POSTTRAUMATIC STRESS DISORDER",1,NA
"POSTTRAUMATIC STRESS DISORDER (PTSD)",1,NA
"POSTURAL CONTROL",1,NA
"POSTUROGRAPHY",1,NA
"POTASSISUM DEHYDROGENATE ORTHOPHOSPHATE",1,NA
"POTASSIUM",4,NA
"POTASSIUM BLOOD CONCENTRATION",1,NA
"POTASSIUM CHLORIDE",3,NA
"POTASSIUM CYANIDE",1,NA
"POTASSIUM DICHROMATE",1,NA
"POTASSIUM HEXACYANOFERRATE (III)",1,NA
"POTASSIUM HYDROXIDE",1,NA
"POTASSIUM NITRITE",1,NA
"POTASSIUM THIOCYANATE",1,NA
"POTENCY",8,20
"POTENCY TESTING",2,1
"POTENT PHARMACEUTICAL PREPARATIONS",1,1
"POTENTIAL POSTMORTEM REDISTRIBUTION",1,NA
"POTENTIOMETRIC ANALYSIS USING ION-SELECTIVE ELECTRODE",1,NA
"POTENTIOMETRIC RECOGNITION",1,NA
"POTENTIOMETRY",3,9
"POTT'S PUFFY TUMOR",1,NA
"POTTERY",1,NA
"POWDER",1,2
"POWDER DATA",1,NA
"POWDER DIFFRACTION",2,NA
"POWDER DRAINS",1,NA
"POWDER DRUGS",1,1
"POWDER SUSPENSION",1,NA
"POWDER X-RAY DIFFRACTION",1,NA
"POWDERED MATERIAL",1,1
"POWDERY SUBSTANCES",1,NA
"POWER",3,1
"POWER GRADIENT",1,NA
"POWER OF A TEST",1,NA
"POWER OF IDENTIFICATION",1,NA
"POWER PRIORS",1,NA
"POWER STEERING FLUID",1,NA
"POWERPLEX®Y",1,NA
"POZNAN CITY",1,NA
"PPAR- Δ AGONIST",1,NA
"PPES",1,NA
"PPI",1,NA
"PRACTICABILITY AND OUTLOOK APPLICATIONS",1,NA
"PRACTICAL FLOWCHART IN SD",1,NA
"PRACTICE",1,NA
"PRACTICE GUIDELINE",2,NA
"PRAJMALIUM BITARTRATE",1,NA
"PRALIDOXIME",1,NA
"PRANOPROFEN",1,NA
"PRAVADOLINE",1,NA
"PRAZEPAM",1,1
"PRE-ANAESTHETIC CHECKUP",1,NA
"PRE-ANALYTICAL AND ANALYTICAL TECHNIQUES",1,NA
"PRE-ANALYTICAL STABILITY",1,NA
"PRE-ANALYTICAL VARIATION",3,NA
"PRE-COLUMN DERIVATIZATION",1,2
"PRE-CONCENTRATION",4,1
"PRE-DISPOSITION",1,NA
"PRE-PCR PROCESSING",1,NA
"PRE-PRECURSOR APAA",1,NA
"PRE-SENTENCE DIVERSION",1,NA
"PRE-SUPPLEMENTARY AREA",1,NA
"PRE-TREATMENTS",1,1
"PRE-TRIAL ASSESSMENT",1,NA
"PRE-TRIAL DETENTION",1,NA
"PRE-TRIAL REPORTS",1,NA
"PREANALYTICAL PHASE",1,NA
"PREANALYTICAL STABILITY",1,NA
"PREAPPEARANCE INTERVAL",1,NA
"PRECARIOUSNESS",1,NA
"PRECAUTIONS",1,NA
"PRECIPITATION",1,2
"PRECISE AND HIGHLY REPRODUCIBLE RF AND K‐DATA FOR STRUCTURE DETERMINATION",1,NA
"PRECISION",6,1
"PRECISION MEDICINE",1,NA
"PRECLINICAL TESTING",1,NA
"PRECONCENTRATION",6,4
"PRECURSOR",5,5
"PRECURSOR CHEMICALS",1,2
"PRECURSOR DRUG",1,NA
"PRECURSOR MONITORING",1,1
"PRECURSORS",5,4
"PREDATORY DRUGS",1,2
"PREDICTION",8,1
"PREDICTION MODEL",1,NA
"PREDICTION OF HUMAN PHARMACOKINETICS",1,NA
"PREDICTION OF HUMAN TOXICOKINETICS",1,NA
"PREDICTION STRATEGIES",1,NA
"PREDICTION TOOL",1,NA
"PREDICTIVE APPROACH",1,1
"PREDICTIVE DISTRIBUTIONS",1,NA
"PREDICTIVE FACTORS",1,NA
"PREDICTIVE MODELS",1,NA
"PREDICTIVE VALIDITY",1,NA
"PREDICTIVE VALUE",2,NA
"PREDICTORS",1,NA
"PREDICTORS OF DEATH",1,NA
"PREDISPOSITION EVALUATIONS",1,NA
"PREDNISOLONE",1,NA
"PREFERENTIAL AMPLIFICATION",1,NA
"PREFERENTIAL LYSIS",1,NA
"PREFRONTAL",1,NA
"PREFRONTAL CORTEX",1,NA
"PREGABALIN",9,14
"PREGNANCY",12,NA
"PREGNANT WOMEN",2,NA
"PREHOSPITAL",1,NA
"PREJUDICE",1,NA
"PRELIMINARY CRIMINAL PROCEEDINGS",1,NA
"PRELIMINARY TECHNIQUES",1,NA
"PREMATURE DEATH",1,NA
"PREMATURE DEATH IN EPILEPSY",1,NA
"PREMATURE EJACULATION",1,1
"PREMATURE MORTALITY",2,NA
"PREMIER ÉPISODE DE PSYCHOSE",1,NA
"PREMORBID ADJUSTMENT",1,NA
"PREMORBID BACKGROUND1",1,NA
"PREMORBID DIFFICULTIES",1,NA
"PRENATAL EXPOSURE",4,NA
"PRENATAL EXPOSURE TO ALCOHOL AND DRUGS",1,NA
"PRENATAL PATERNITY TEST",1,NA
"PRENATAL PATERNITY TESTING",1,NA
"PRENYLAMINE",1,NA
"PRENYLAMINE METABOLISM",1,NA
"PREOPERATIVE SELECTION AND INFORMING OF RISK GROUPS",1,NA
"PREPARATION",2,NA
"PREPARATIVE HPLC",1,3
"PREPROCESSING",2,1
"PRESCRIBED DRUGS",3,NA
"PRESCRIBING",3,NA
"PRESCRIBING PRACTICES",1,NA
"PRESCRIPTION",7,NA
"PRESCRIPTION DATA",1,NA
"PRESCRIPTION DRUG",14,5
"PRESCRIPTION DRUG-RELATED DEATHS",1,NA
"PRESCRIPTION DRUG ABUSE",3,6
"PRESCRIPTION DRUG DIVERSION",1,NA
"PRESCRIPTION DRUG MISUSE",1,1
"PRESCRIPTION DRUG USE",1,NA
"PRESCRIPTION DRUGS/POISONING",1,NA
"PRESCRIPTION MEDICATION",1,NA
"PRESCRIPTION MEDICINES",1,NA
"PRESCRIPTION MONITORING PROGRAM",1,NA
"PRESCRIPTION MONITORING PROGRAMS",1,NA
"PRESCRIPTION OPIOID USE",1,NA
"PRESCRIPTION PRACTICES",1,NA
"PRESCRIPTION RATE",1,NA
"PRESCRIPTION REGISTRY",1,NA
"PRESCRIPTION RULES",1,NA
"PRESCRIPTIONS OPIATES",1,NA
"PRESERVATION",2,1
"PRESERVATION OF EVIDENCE",1,1
"PRESERVATIVE",4,2
"PRESERVATIVE ETC.",1,NA
"PRESS",1,NA
"PRESSURE",1,NA
"PRESSURE CYCLING TECHNOLOGY",1,NA
"PRESSURE INDEX",1,NA
"PRESSURE SENSITIVE ADHESIVE (PSA)",1,NA
"PRESSURISED BRONCHODILATING AEROSOL",1,NA
"PRESSURIZED LIQUID EXTRACTION",2,2
"PRESUBICULUM",1,NA
"PRESUMPTIVE CHEMICAL TEST",2,2
"PRESUMPTIVE DRUG TEST",2,1
"PRESUMPTIVE DRUG TESTING",1,NA
"PRESUMPTIVE FORENSIC TEST",1,NA
"PRESUMPTIVE IDENTIFICATION",2,2
"PRESUMPTIVE TEST",5,4
"PRESUMPTIVE TESTING",2,NA
"PRETREATED SCREEN-PRINTED ELECTRODES",1,NA
"PRETREATMENT",3,1
"PRETREATMENT METHODS",1,NA
"PRETRIAL DIVERSION",1,NA
"PRETRIAL RELEASE",1,NA
"PREVALENCE",26,8
"PREVALENCE CHANGES",1,NA
"PREVALENCE OF DRUGS",1,NA
"PREVALENCE STATISTICS",1,2
"PREVENT",1,NA
"PREVENTION",26,1
"PREVENTIVE DETENTION",1,NA
"PREVENTIVE MEASURES",2,NA
"PREWORKOUT SUPPLEMENT",1,NA
"PRICE SETTING",1,NA
"PRILOCAINE",1,NA
"PRIMARY AMINE",1,1
"PRIMARY CARDIAC TUMOR",1,NA
"PRIMARY CARE",2,NA
"PRIMARY CELL CULTURE",1,NA
"PRIMARY HEALTH CARE",2,NA
"PRIMARY HUMAN HEPATOCYTES",1,NA
"PRIMARY SURVEY",1,NA
"PRIMARY, SECONDARY, AND TERTIARY LEVELS OF PREVENTION",1,NA
"PRIMATE",1,NA
"PRIMER",1,NA
"PRIMER EXTENSION CAPTURE",1,NA
"PRIMER INGREDIENTS",1,NA
"PRIMERS",1,NA
"PRINCIPAL-COMPONENTS ANALYSIS (PCA)",1,NA
"PRINCIPAL ALKALOIDS",1,2
"PRINCIPAL COMPONENT ANALYSIS (PCA)",44,75
"PRINTER",1,NA
"PRINTING AND WRITING SUBSTRATE ANALYSIS",1,NA
"PRISCUS SUBSTANCES",1,NA
"PRISON",33,2
"PRISON-INDUSTRIAL COMPLEX",1,NA
"PRISON DEATHS",1,NA
"PRISON HEALTH SERVICES",1,NA
"PRISON HOSPITAL",1,NA
"PRISON INMATES",1,NA
"PRISON MEDICINE",1,NA
"PRISON REGIME",2,NA
"PRISON SUICIDE",3,NA
"PRISON TRANSFERS",2,NA
"PRISON VIOLENCE",1,NA
"PRISONER",2,NA
"PRISONER ADJUSTMENT",2,NA
"PRISONER HEALTH",1,NA
"PRISONERS",16,NA
"PRISONIZATION",1,NA
"PRISONS",9,3
"PRISTANE",1,NA
"PRIVACY",2,NA
"PRIVACY AND DIGNITY",1,NA
"PRM1",1,NA
"PRM2",1,NA
"PRN MEDICATIONS",1,NA
"PRO-ARRHYTHMIC AGENTS",1,NA
"PROACTIVE",1,1
"PROACTIVE AGGRESSION",2,NA
"PROACTIVE FORENSIC SCIENCE",1,1
"PROBABILITY",4,4
"PROBABILITY DISTRIBUTION",1,NA
"PROBABLE CAUSE",1,NA
"PROBATION",3,NA
"PROBATION SERVICE USERS",1,NA
"PROBATION SUPERVISION",1,NA
"PROBATIONERS",4,NA
"PROBATIVE VALUE",1,NA
"PROBE ELECTROSPRAY IONIZATION",1,NA
"PROBE SENSING",1,NA
"PROBENECID",1,1
"PROBLEM-ORIENTED APPROACH",1,1
"PROBLEM-SOLVING COURTS",1,NA
"PROBLEM BEHAVIOR",1,NA
"PROBLEM DRINKING",1,NA
"PROBLEM SOLVING COURTS",1,NA
"PROBLEM SOLVING/DECISION MAKING",1,3
"PROBLEMATIC GAMBLING",1,NA
"PROBLEMATISATIONS",1,NA
"PROBLEMS",1,NA
"PROCAINE",4,2
"PROCALCITONIN",2,NA
"PROCEDURAL ACTIONS",1,NA
"PROCEDURAL JUSTICE",2,1
"PROCEDURES",2,NA
"PROCEDURES INVOLVED",1,NA
"PROCESS",1,1
"PROCESS ANALYTICAL CHEMISTRY",2,2
"PROCESS CONTROL",1,1
"PROCESS INFORMATION",1,NA
"PROCESS MONITORING",3,2
"PROCESS OIL",1,NA
"PROCESS PATENT PROTECTION",1,1
"PROCESSING",1,2
"PROCESSING CONDITIONS",1,NA
"PROCESSING METHOD",1,NA
"PROCESSING SEQUENCE",1,NA
"PROCYCLIDINE",1,NA
"PRODRUGS",1,NA
"PRODUCT ION MASS SPECTROMETRY",2,6
"PRODUCT ION SPECTRA",2,NA
"PRODUCT LIABILITY",1,NA
"PRODUCT PROTECTION",1,1
"PRODUCT TAMPERING",4,1
"PRODUCT TAMPERINGS",1,NA
"PRODUCTION",1,1
"PRODUCTION DATE",1,NA
"PROFENOPHOS",1,NA
"PROFESSIONAL",1,NA
"PROFESSIONAL CLOSURE",1,NA
"PROFESSIONAL ETHICS",1,NA
"PROFESSIONAL RE-INTEGRATION",1,NA
"PROFESSIONAL RESPONSIBILITY",1,NA
"PROFESSIONS",1,NA
"PROFICIENCY",1,1
"PROFICIENCY TEST",4,NA
"PROFICIENCY TESTING",7,4
"PROFICIENCY TESTS",1,NA
"PROFILE OF MURDERER",1,NA
"PROFILE SCREENING",1,1
"PROFILER PLUS",1,NA
"PROFILES",1,1
"PROFILING",37,47
"PROFILING OF CANNABIS PRODUCTS",1,NA
"PROFILING OF DRUG IMPURITIES",1,1
"PROFILING OF IMPURITIES",1,2
"PROFILING OF TRACE IMPURITIES",1,NA
"PROFITS",1,NA
"PROGENESIS QI",1,NA
"PROGESTAGENS",1,1
"PROGESTOGEN DRUGS",1,NA
"PROGNOSIS",6,NA
"PROGNOSIS OF DANGEROUSNESS",1,NA
"PROGNOSTIC LANDMARKS",1,NA
"PROGRAM ELIGIBILITY",1,NA
"PROGRAM EVALUATION",5,NA
"PROGRAMME OF PSYCHIATRIC HEALTH PROTECTION",2,NA
"PROGRAMMED CELL DEATH 1 RECEPTOR",1,NA
"PROGRANULIN",1,NA
"PROGRESS",2,NA
"PROGRESSIVE SUPRANUCLEAR PALSY",1,NA
"PROHORMONES",1,2
"PROINSULIN",1,NA
"PROJECTILE",1,NA
"PROLACTIN",2,NA
"PROLINE-RICH PROTEINS",1,NA
"PROLINTANE METABOLITES",1,NA
"PROLONGED CHOLINERGIC CRISIS",1,NA
"PROLONGED EXCRETION",1,NA
"PROMAZINE",3,NA
"PROMEGA DNA IQ™",1,NA
"PROMETHAZINE",3,NA
"PROMETHAZINE AND ITS METABOLITE",1,NA
"PROMETRYNE",1,NA
"PROMISES CHALLENGES",1,NA
"PROMPT GAMMA ANALYSIS",1,NA
"PRONE",1,NA
"PRONE POSITIONING",1,NA
"PRONE RESTRAINT",1,NA
"PROOF IN COURT THAT A PROPER EXAMINATION CARRIED OUT",1,NA
"PROOF OF CANNABIS IMPORTATION",1,NA
"PROOF OF MEDICATION",1,NA
"PROPADIENE",1,NA
"PROPANE",3,NA
"PROPANE-BUTANE MIXTURE",1,NA
"PROPANOL",1,NA
"PROPANOLAMINE",1,NA
"PROPANOLOL",1,NA
"PROPAPHENONE",1,NA
"PROPELLANT",2,1
"PROPELLANT CHARGE",1,NA
"PROPELLANT POWDER",1,NA
"PROPELLANT POWDER STABILIZERS",1,NA
"PROPELLANT STABILIZES RESIDUES",1,NA
"PROPENSITY SCORE",1,1
"PROPENSITY SCORE MATCHING",1,NA
"PROPER PACKAGING",1,NA
"PROPERTIES OF NEW PSYCHOACTIVE SUBSTANCES",1,NA
"PROPERTY CRIME",2,NA
"PROPHYLAXIS",4,NA
"PROPHYLAXIS IN OUTPATIENTS",1,NA
"PROPIONIC ACID DERIVATIVES",2,NA
"PROPIONIC ANHYDRIDE",1,NA
"PROPOFOL",22,2
"PROPOFOL GLUCURONIDE",5,NA
"PROPOFOL INTOXICATION",1,NA
"PROPORTIONALITY",1,NA
"PROPOXYPHENE",4,1
"PROPOXYPHENE POISONING",2,NA
"PROPRANOLOL",3,NA
"PROPYL CHLOROFORMATE",2,1
"PROPYL GLUCURONIDE",3,NA
"PROPYLENE GLYCOL",3,NA
"PROSECUTION",3,NA
"PROSECUTOR",1,NA
"PROSECUTOR'S FALLACY",1,NA
"PROSPECTUSES",1,NA
"PROSTAGLANDIN",1,NA
"PROSTATE",2,NA
"PROSTATE-SPECIFIC ANTIGEN",4,NA
"PROSTATE SPECIFIC ANTIGEN",2,NA
"PROSTATE SPECIFIC ANTIGEN (PSA OR P30)",1,NA
"PROSTATE SPECIFIC ANTIGEN TEST",1,NA
"PROSTATIC NEOPLASMS",1,NA
"PROSTITUTES",1,NA
"PROSTITUTION",1,NA
"PROTACTINIUM",6,NA
"PROTACTINIUM-231",1,NA
"PROTAMINE",1,NA
"PROTEASE",1,NA
"PROTECTING GROUPS",1,2
"PROTECTION",1,NA
"PROTECTIVE FACTORS",3,NA
"PROTEIN-BASED HUMAN IDENTIFICATION",2,NA
"PROTEIN-DERIVED APAP-CYS",1,NA
"PROTEIN-LIPID REMOVAL FILTER CARTRIDGE",1,NA
"PROTEIN ADDUCTS",2,NA
"PROTEIN AGGREGATION",2,NA
"PROTEIN BINDING",1,2
"PROTEIN CARBONYL",1,NA
"PROTEIN CHIP",1,NA
"PROTEIN CONTENT",1,NA
"PROTEIN DEGRADATION",1,NA
"PROTEIN ENGINEERING",1,NA
"PROTEIN EXTRACTION",1,NA
"PROTEIN FOLDING/UNFOLDING",1,NA
"PROTEIN FORMULATION(S)",1,NA
"PROTEIN G",1,NA
"PROTEIN GASTRIC DIGESTION",1,NA
"PROTEIN HYDROLYSATE",1,1
"PROTEIN HYDROLYSIS",1,NA
"PROTEIN KINASE B",1,NA
"PROTEIN MICROARRAY",1,1
"PROTEIN PHOSPHATASE 2A",1,NA
"PROTEIN PRECIPITATION",3,1
"PROTEIN PROFILE",2,NA
"PROTEIN PROFILING",2,NA
"PROTEIN QUANTIFICATION",1,NA
"PROTEIN SEQUENCE",1,NA
"PROTEINASE K",2,NA
"PROTEINS",13,4
"PROTEOLYSIS",1,NA
"PROTEOLYTIC",1,NA
"PROTEOLYTIC ENZYME",1,NA
"PROTEOME",1,NA
"PROTEOMIC",2,1
"PROTEOMIC ANALYSIS",1,NA
"PROTEOMIC GENOTYPING",2,NA
"PROTEOMIC REPRODUCIBILITY",1,NA
"PROTEOMICS",16,6
"PROTHIADIN",1,NA
"PROTHIPENDYL",2,NA
"PROTHIPENDYL SULFOXIDE",1,NA
"PROTOCOL",3,NA
"PROTON IRRADIATION",1,NA
"PROTON TRANSFER REACTION MASS SPECTROMETRY",1,NA
"PROTONATED MOLECULAR ION",1,1
"PROTONATED MOLECULE",1,NA
"PROTOPLASM",1,NA
"PROTOTYPES",1,NA
"PROVENANCE",3,NA
"PROVENANCE ASSESSMENT",1,NA
"PROVENANCING",4,1
"PROVIDER CHANGE",1,NA
"PROVIDES LEGIBILITY",1,NA
"PROVIDES UNIFORMITY",1,NA
"PROXIMAL CLINICAL RISK FACTORS",1,NA
"PROXIMAL SENSING",1,1
"PROXIMAL TUBULES",1,NA
"PROXIMATE CAUSE",1,NA
"PROXIMITY LIGATION",1,NA
"PROXIMITY LIGATION REAL-TIME PCR",1,NA
"PROXIMITY PROBES",1,NA
"PROXY",1,NA
"PROZAC",1,NA
"PRP HAEIII SUBFAMILY 1/2",1,NA
"PRUSSIAN BLUE",1,NA
"PS-MS",1,1
"PSA",4,NA
"PSA-NCAM",1,NA
"PSCP1 GENOTYPING",1,NA
"PSEDUOMONAS SYRINGAE PATHOVAR TOMATO",1,NA
"PSEUDO-OPERATIONAL TRIAL",1,NA
"PSEUDO-OPERATIONAL TRIALS",1,NA
"PSEUDO-SUBARACHNOID HEMORRHAGE",1,NA
"PSEUDOANEURYSM",2,NA
"PSEUDOEPHEDRINE",19,52
"PSEUDOMETHAMPHETAMINE",1,1
"PSEUDOMONAS AERUGINOSA",1,NA
"PSEUDOSCLERADERMATOUS TRIAD AND """"CRACK HANDS""""",1,NA
"PSEUDOVARDENAFIL",1,NA
"PSILACETIN",1,NA
"PSILOCIN",10,19
"PSILOCIN GLUCURONIDE",2,NA
"PSILOCYBE",4,9
"PSILOCYBE CUBENSIS",1,3
"PSILOCYBE SUBCUBENSIS",1,1
"PSILOCYBIN",12,25
"PSILOCYBIN/PSILOCIN",1,1
"PSILOCYN",2,1
"PSORIASIS",1,NA
"PSY-CHOMOTOR FUNCTION",1,NA
"PSYCHACTIVE SUBSTANCES",1,NA
"PSYCHEDELIC",4,12
"PSYCHEDELIC DRUG ABUSE",1,NA
"PSYCHEDELIC FUNGI",2,2
"PSYCHIATRIC",3,NA
"PSYCHIATRIC-NEUROLOGICAL DIAGNOSTIC SPECTRUM",1,NA
"PSYCHIATRIC ANAMNESIS",1,NA
"PSYCHIATRIC ASSESSMENT",1,NA
"PSYCHIATRIC CARE",1,NA
"PSYCHIATRIC CHARACTERISTICS",1,NA
"PSYCHIATRIC COERCION",1,NA
"PSYCHIATRIC COMORBIDITY",3,NA
"PSYCHIATRIC DIAGNOSIS",3,NA
"PSYCHIATRIC DISORDER",6,NA
"PSYCHIATRIC DISORDERS",6,NA
"PSYCHIATRIC DRUG",1,NA
"PSYCHIATRIC DRUGS",5,1
"PSYCHIATRIC EMERGENCY",1,NA
"PSYCHIATRIC EVALUATION",1,NA
"PSYCHIATRIC EXPERTISE",3,NA
"PSYCHIATRIC FORENSIC COMMITTMENT",1,NA
"PSYCHIATRIC FORENSIC EXPERTISE",1,NA
"PSYCHIATRIC HEALTH CARE IN POLAND",4,NA
"PSYCHIATRIC HOSPITAL",1,NA
"PSYCHIATRIC HOSPITAL ADMISSION",1,NA
"PSYCHIATRIC HOSPITALS",1,NA
"PSYCHIATRIC ILLNESS",3,NA
"PSYCHIATRIC ILLNESSES",1,NA
"PSYCHIATRIC INPATIENT UNITS",1,NA
"PSYCHIATRIC INSTITUTIONS",1,NA
"PSYCHIATRIC INTENSIVE CARE UNIT",2,NA
"PSYCHIATRIC INTENSIVE CARE UNITS (PICU)",1,NA
"PSYCHIATRIC INTERNMENT",1,NA
"PSYCHIATRIC MORBIDITY",2,NA
"PSYCHIATRIC NOSOGRAPHIC DIAGNOSIS",1,NA
"PSYCHIATRIC NURSING",1,NA
"PSYCHIATRIC PATIENT RIGHTS",2,NA
"PSYCHIATRIC PATIENTS",4,NA
"PSYCHIATRIC REHABILITATION",1,NA
"PSYCHIATRIC SECURE UNIT",1,NA
"PSYCHIATRIC SERVICES",4,NA
"PSYCHIATRIC SUPPORT OF A SUICIDE WITNESS",1,NA
"PSYCHIATRIC TREATMENT",2,NA
"PSYCHIATRIC TREATMENT TRANSFORMATION",2,NA
"PSYCHIATRIE",1,NA
"PSYCHIATRIZATION OF VIOLENT BEHAVIOR",1,NA
"PSYCHIATRY",42,NA
"PSYCHIATRY AND SEX OFFENDING",1,NA
"PSYCHIATRY IN EUROPE",1,NA
"PSYCHIATRY IN THE GDR",1,NA
"PSYCHIC TRAUMA",1,NA
"PSYCHICAL DEVIATIONS",1,NA
"PSYCHO-MOTOR AGITATION",1,NA
"PSYCHOACTIVE",4,5
"PSYCHOACTIVE AGENTS",2,NA
"PSYCHOACTIVE DRUG",15,8
"PSYCHOACTIVE DRUG POISONING",1,NA
"PSYCHOACTIVE DRUGS IN DRIVERS",1,NA
"PSYCHOACTIVE EFFECT",1,NA
"PSYCHOACTIVE PLANTS",1,1
"PSYCHOACTIVE SUBSTANCE ABUSE",1,NA
"PSYCHOACTIVE SUBSTANCE USE DISORDER",1,NA
"PSYCHOACTIVE SUBSTANCES",32,15
"PSYCHOACTIVITY",1,3
"PSYCHOANALYSIS",1,NA
"PSYCHODERMATOLOGY",1,NA
"PSYCHODYNAMIC",1,NA
"PSYCHODYNAMIC FACTORS",1,NA
"PSYCHODYNAMICS",1,NA
"PSYCHOEDUCATION",1,NA
"PSYCHOLOGICAL",1,1
"PSYCHOLOGICAL AUTOPSY",6,NA
"PSYCHOLOGICAL COUNSELING",1,NA
"PSYCHOLOGICAL DISORDERS",2,NA
"PSYCHOLOGICAL DISTRESS",1,NA
"PSYCHOLOGICAL INTERVENTION",1,NA
"PSYCHOLOGICAL INVENTORY OF CRIMINAL-THINKING STYLES",1,NA
"PSYCHOLOGICAL PROFILES",1,NA
"PSYCHOLOGICAL STATE",1,NA
"PSYCHOLOGICAL STRESS",1,NA
"PSYCHOLOGICAL SYMPTOMS",1,NA
"PSYCHOLOGICAL TECHNIQUES",1,NA
"PSYCHOLOGICAL VULNERABILITIES",1,NA
"PSYCHOLOGIST EXPERT",1,NA
"PSYCHOLOGIST WITNESS",1,NA
"PSYCHOLOGY",7,NA
"PSYCHOMETRICS",5,NA
"PSYCHOMETRY AND ASSESSMENTS IN PSYCHIATRY",1,NA
"PSYCHOMOTOR",1,NA
"PSYCHOMOTOR ABILITIES",1,NA
"PSYCHOMOTOR AGITATION",2,NA
"PSYCHOMOTOR FUNCTION",1,NA
"PSYCHOMOTOR PERFORMANCE",3,NA
"PSYCHOMOTOR PERFORMANCE/DRUG EFFECTS",1,NA
"PSYCHOMOTOR SEIZURE",1,NA
"PSYCHOPATH",1,NA
"PSYCHOPATHIC PERSONALITY",2,NA
"PSYCHOPATHIC PERSONALITY INVENTORY-REVISED",2,NA
"PSYCHOPATHIC TRAITS",1,NA
"PSYCHOPATHOLOGY",13,NA
"PSYCHOPATHY",32,NA
"PSYCHOPATHY-CHECKLIST",1,NA
"PSYCHOPATHY CHECKLIST",1,NA
"PSYCHOPATHY MEASURES",1,NA
"PSYCHOPHARMACOLOGIC",1,NA
"PSYCHOPHARMACOLOGIC TREATMENT",1,NA
"PSYCHOPHARMACOLOGICAL THERAPY",1,NA
"PSYCHOPHARMACOLOGICAL TREATMENT",1,NA
"PSYCHOPHARMACOLOGY",9,3
"PSYCHOPHARMACOTHERAPY",3,NA
"PSYCHOPHYSIOLOGICAL EXAMINATION",1,NA
"PSYCHOSES",2,NA
"PSYCHOSES, SUBSTANCE-INDUCED",1,NA
"PSYCHOSIS",16,1
"PSYCHOSIS CANNABIS",1,NA
"PSYCHOSIS DEVELOPMENT",1,NA
"PSYCHOSOCIAL",3,NA
"PSYCHOSOCIAL FUNCTIONING",1,NA
"PSYCHOSOCIAL FUNCTIONINGT",1,NA
"PSYCHOSOCIAL REHABILITATION",1,NA
"PSYCHOSOCIAL SUPPORT",1,NA
"PSYCHOSTIMULANTS",9,8
"PSYCHOTHERAPEUTIC DRUGS",1,NA
"PSYCHOTHERAPY",4,NA
"PSYCHOTIC AGENT",1,NA
"PSYCHOTIC BEHAVIOR",1,NA
"PSYCHOTIC DISORDER",1,NA
"PSYCHOTIC DISORDERS",8,1
"PSYCHOTIC DISORDERS (INCL SCHIZOPHRENIA)",1,NA
"PSYCHOTIC FIRESETTERS",1,NA
"PSYCHOTIC SYMPTOMS",1,NA
"PSYCHOTOMIMETIC PROPERTY",1,1
"PSYCHOTROPIC",2,1
"PSYCHOTROPIC AND NARCOTIC DRUGS",1,NA
"PSYCHOTROPIC DRUGS",39,8
"PSYCHOTROPIC DRUGS, ENZYMIC DIGESTION",1,NA
"PSYCHOTROPIC MEDICATION",2,NA
"PSYCHOTROPIC MEDICATIONS",1,NA
"PSYCHOTROPIC MUSHROOMS",2,1
"PSYCHOTROPIC SUBSTANCES (PSS)",1,5
"PSYCHOTROPICS",1,NA
"PSYCOTROPIC MATERIALS",1,NA
"PSZH-13",1,NA
"PTCA",1,NA
"PTECA",1,NA
"PTOMAINES",2,NA
"PTR-MS",1,3
"PTR‐MS",1,NA
"PTSD",5,NA
"PTV-LVI",1,NA
"PUBIC HAIR",4,NA
"PUBLIC ACCESS",1,NA
"PUBLIC HEALTH",22,10
"PUBLIC HEALTH ADMINISTRATION",1,NA
"PUBLIC HEALTH ENGLAND (PHE)",1,NA
"PUBLIC HEALTH INTERVENTION",1,NA
"PUBLIC INTEREST",1,NA
"PUBLIC OPINION",1,NA
"PUBLIC PROBLEM",1,NA
"PUBLIC PROSECUTION, MORPHOLOGICAL INVESTIGATIONS",1,NA
"PUBLIC SAFETY",1,NA
"PUBLIC UNDERSTANDING/OUTREACH",2,4
"PUBLICATION TRENDS",1,NA
"PUBLICATIONS",1,NA
"PUBLISHING",1,NA
"PUERTO RICO",1,1
"PUFFER FISH",1,NA
"PULICAT LAKE",1,NA
"PULMONARY ADMINISTRATION",3,NA
"PULMONARY ASPIRATION",1,NA
"PULMONARY EDEMA",4,1
"PULMONARY EMBOLISM",3,NA
"PULMONARY FAT EMBOLISM",2,NA
"PULMONARY GRANULOMAS",1,NA
"PULMONARY GRANULOMATA",1,NA
"PULMONARY GRANULOMATOSIS",2,NA
"PULMONARY HISTOPATHOLOGY",1,NA
"PULMONARY HYPERTENSION",2,NA
"PULMONARY SURFACTANT-ASSOCIATED PROTEIN A",2,NA
"PULMONARY THROMBOEMBOLISM",4,NA
"PULMONARY THROMBOSIS",1,NA
"PULMONARY TUBERCULOSIS",1,NA
"PULMONARY VASCULAR LESIONS",1,NA
"PULMONARY VASCULITIS",1,1
"PULP",1,NA
"PULSE",1,NA
"PULSE-HEATING METHOD",1,NA
"PULSE GRADIENT CHROMATOGRAPHY",1,NA
"PULSE HEATING",2,NA
"PULSE OXIMETRY",1,NA
"PULSE PILE-UP",1,NA
"PULSE VOLTAMMETRY",1,1
"PULSED-DISCHARGE ELECTRON CAPTURE DETECTOR",1,1
"PULSED ELECTROCHEMICAL DETECTION",1,NA
"PULVERIZATION",1,NA
"PUMPING",1,NA
"PUNCTURE",1,NA
"PUNISHMENT",4,NA
"PUNISHMENTS",1,NA
"PUPAE",2,NA
"PUPAE STAGES",1,NA
"PUPAL PERIOD",1,NA
"PUPARIAL CASES",1,NA
"PUPATION",1,NA
"PUPIL PHARMACOLOGICAL REACTIVITY",1,NA
"PUPILLARY LIGHT REFLEX",2,NA
"PUPILLOGRAPHY",1,NA
"PURE CAFFEINE",1,NA
"PURE SUBSTANCE REFERENCE MATERIALS",1,NA
"PURIFICATION",2,2
"PURIFICATION OF BIOLOGICAL EXTRACTS",1,NA
"PURITY",5,11
"PURITY OF STREET HEROIN",1,1
"PURKINJE CELLS",2,NA
"PURKINJE FIBERS",1,NA
"PURKINJE IMAGES",1,NA
"PURKINJE SHIFT",1,NA
"PURKINJE TREE",1,NA
"PURKINJE, JAN",1,NA
"PURPLE COLON",1,NA
"PUTAMEN",1,NA
"PUTATIVE METABOLITE IDENTIFICATION",1,NA
"PUTREFACTION",17,NA
"PUTREFACTION GAS",1,NA
"PUTREFACTIVE DEGRADATION",1,NA
"PUTREFACTIVE PROCESS",1,NA
"PUTREFIED BLOOD",1,NA
"PUTREFIED CORPSES EXPOSED TO THE AIR, CHEMICOTOXICOLOGICAL ANALYSIS OF ORGANIC MEDICAMENTS",1,NA
"PUTREFIED TISSUE",1,NA
"PV7",1,NA
"PV8",1,NA
"PV9",3,NA
"PVAL",1,NA
"PYOMYOSITIS",2,NA
"PYRAZOLAM",2,2
"PYRETHROID",1,NA
"PYRETHROIDES",1,NA
"PYRETHROIDS",2,NA
"PYRIDINE",1,1
"PYRIDINE METABOLITE",1,NA
"PYRIDYLDIPHENYL TRIAZINE (PDT)",2,NA
"PYRIMETHAMINE",1,NA
"PYRITHYLDIONE—GLC ANALYSIS, PUTRIFIED BRAIN AND INTESTINE",1,NA
"PYROGENIC PAHS",1,NA
"PYROLIDINOPHENONE",1,1
"PYROLIQUID GUN",1,NA
"PYROLYSIS",8,6
"PYROLYSIS-GAS CHROMATOGRAPHY-MASS",1,NA
"PYROLYSIS-GAS CHROMATOGRAPHY/MASS-SPECTROMETRY",1,NA
"PYROLYSIS CHROMATOGRAPHY",1,NA
"PYROLYSIS PRODUCTS",2,1
"PYROLYTIC PRODUCTS",1,1
"PYROMANIA",1,NA
"PYROMARK® INSTRUMENTS",1,NA
"PYROSEQUENCING",4,NA
"PYROSEQUENCING®",2,NA
"PYROTECHNICS",3,NA
"PYROVALERON",1,NA
"PYROVALERONE DERIVATIVES",1,NA
"PYROVALERONES",1,NA
"PYRROLE-2,3,5-TRICARBOXYLIC ACID (PTCA)",1,NA
"PYRROLES",1,1
"PYRROLIDINE-TYPE CATHINONES",1,1
"PYRROLIDINEDITHIOCARBAMATE",1,NA
"PYRROLIDINO CATHINONES",1,NA
"PYRROLIDINOPHENONE",9,6
"PYRROLIDINOVALEROPHENONE",1,NA
"PYRROLIZIDINE ALKALOIDS",1,4
"Q-EXACTIVE",1,1
"Q EXACTIVE-ORBITRAP",1,NA
"Q EXACTIVE FOCUS",1,NA
"Q.E.D.®, ALCO-SCREEN(TM)",1,NA
"QCM SENSOR",1,NA
"QED",1,NA
"QIAQUICK™ PCR PURIFICATION",1,NA
"QNMR",2,7
"QQTOF-MS/MS",1,NA
"QSAR",3,4
"QSAR SOFTWARE COPYRIGHT",1,NA
"QSPR MODELS",1,NA
"QT-PROLONGATION",1,NA
"QT INTERVAL PROLONGATION",1,NA
"QT PROLONGATION",1,NA
"QT PROLONGING DRUGS",1,NA
"QTC INTERVAL PROLONGATION",1,NA
"QTC PROLONGATION",2,NA
"QTOF",2,1
"QTRAP",1,NA
"QUADRATIC ASSIGNMENT PROBLEM (QAP)",1,NA
"QUADRATIC CALIBRATION",1,NA
"QUADROCOPTER",1,NA
"QUADRUPOLE-TIME-OF-FLIGHT MASS SPECTROMETRY (Q-TOF/MS)",1,NA
"QUADRUPOLE ION TRAP",1,2
"QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRY",5,2
"QUADRUPOLE TIME OF FLIGHT",1,NA
"QUALIFICATION LEVEL",1,NA
"QUALIFICATIONS",1,NA
"QUALITATIVE",1,1
"QUALITATIVE ANALYSIS",10,8
"QUALITATIVE AND QUANTITATIVE ANALYSIS",2,2
"QUALITATIVE AND QUANTITATIVE TOXICOLOGIC ANALYSIS",1,NA
"QUALITATIVE DECISION POINT METHODS",1,NA
"QUALITATIVE IDENTIFICATION ANALYSIS",1,1
"QUALITATIVE METHODOLOGY",1,NA
"QUALITATIVE RESEARCH",15,2
"QUALITATIVE SPATIAL REPRESENTATION",1,NA
"QUALITY ASSURANCE",20,5
"QUALITY ASSURANCE AND CONTROL",1,NA
"QUALITY CONTROL",18,11
"QUALITY IMPROVEMENT",1,NA
"QUALITY MANAGEMENT",3,NA
"QUALITY MANAGEMENT CRITERIA",1,NA
"QUALITY OF LIFE",1,NA
"QUALITY SCORES",1,NA
"QUALITY SYSTEMS",1,NA
"QUANTIFICATION",30,24
"QUANTISAL",2,NA
"QUANTITATION",14,24
"QUANTITATIVE",4,5
"QUANTITATIVE ANALYSIS",17,22
"QUANTITATIVE BIOANALYSIS",1,2
"QUANTITATIVE DETECTION",1,NA
"QUANTITATIVE DETERMINATION",5,9
"QUANTITATIVE DNA",1,NA
"QUANTITATIVE EEG",1,NA
"QUANTITATIVE MORPHOMETRY",1,NA
"QUANTITATIVE PCR METHODS",1,NA
"QUANTITATIVE REAL-TIME PCR",2,NA
"QUANTITATIVE RT-PCR",2,NA
"QUANTITATIVE RT-PCR (QRT-PCR)",1,NA
"QUANTITATIVE SAMPLING",2,3
"QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS (QSAR)",1,NA
"QUANTITATIVE VALIDATION",1,NA
"QUANTITY ESTIMATION",3,1
"QUANTUM",1,NA
"QUANTUM CHEMICAL CALCULATIONS",1,NA
"QUANTUM CHEMICAL INVESTIGATIONS",1,NA
"QUANTUM CHEMISTRY",2,NA
"QUANTUM DOT",2,NA
"QUANTUM DOTS",1,1
"QUANTUM DOTS (MIP-QDS)",1,NA
"QUARANTINE",1,NA
"QUARTZ GRAIN SURFACE TEXTURE ANALYSIS (QGSTA)",1,NA
"QUASI-EXPERIMENTAL",1,NA
"QUASI-PROSPECTIVE",1,NA
"QUATERNARY AMMONIUM COMPOUNDS",1,NA
"QUATERNARY AMMONIUM DRUGS",1,NA
"QUATERNARY NITROGEN MUSCLE RELAXANTS",1,NA
"QUAZEPAM",3,NA
"QUCHIC",1,NA
"QUECHERS",23,14
"QUECHERS-GC",1,1
"QUECHERS EXTRACTION",2,NA
"QUECHERS METHOD",1,NA
"QUECHERS METHODOLOGY",1,NA
"QUEENSLAND",1,1
"QUENCHING",1,NA
"QUERETARO",1,NA
"QUESTIONARE",1,NA
"QUESTIONED DOCUMENT",15,NA
"QUESTIONED DOCUMENT EXAMINATION",5,NA
"QUESTIONNAIRE",3,NA
"QUESTIONNAIRE SURVEY",1,NA
"QUETIAPINE",16,2
"QUETIAPINE FUMARATE",2,NA
"QUICK-DB FORENSIC",1,NA
"QUICK ANALYSIS OF ILLICIT DRUGS",1,NA
"QUICK, EASY, CHEAP, EFFECTIVE, RUGGED, AND SAFE",1,1
"QUINACRIDONE MAGENTA",1,NA
"QUINACRIDONE MAGENTA B",1,NA
"QUINACRIDONE RED Y",1,NA
"QUINACRIDONE VIOLET",1,NA
"QUINACRIDONES",1,NA
"QUININE",2,NA
"QUININE SULFATE",1,NA
"QUINOLIN-8-YL 1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3-CARBOXYLATE (QUCHIC)",1,1
"QUINOLIN-8-YL 1-PENTYL-(1H-INDOLE)-3-CARBOXYLATE (QUPIC)",2,1
"QUINOLINYL- AND ISOQUINOLINYL-SUBSTITUTED REGIOISOMERS OF 5F-PB-22",1,NA
"QUINOLOZIDINE ALKALOIDS",1,NA
"QUPIC N-(5-FLUOROPENTYL) ANALOG (SYNONYM: 5-FLUORO-PB-22)",1,1
"QUPPE",1,NA
"R-/S-AMPHETAMINE",1,1
"R-AMPHETAMINE",1,NA
"R-METHAMPHETAMINE",1,NA
"R SOFTWARE",1,NA
"R(F)(C)VALUE",1,NA
"R,S-METHADONE",1,NA
"R/S-AMPHETAMINE",2,NA
"R/S-ENANTIOMERS",1,NA
"R/S-METHADONE",2,NA
"R/S-METHAMPHETAMINE",2,NA
"RA NITIDINE",1,NA
"RABBIT LIVER SLICES",1,NA
"RABBITS",21,NA
"RABIES",1,NA
"RACE BIAS",1,NA
"RACE/COLOR",1,NA
"RACE/ETHNICITY",1,NA
"RACHACHA",1,NA
"RACIAL ADMIXTURE",1,NA
"RACIAL DIFFERENCES",1,NA
"RACIAL DISPARITIES",2,NA
"RACIAL GROUPS",1,NA
"RACIAL IDENTIFICATION",1,NA
"RACING",3,NA
"RACISM",1,NA
"RADIAL DIFFUSION",1,NA
"RADIATION-INDUCED CANCER",1,NA
"RADIATION AC-CIDENTS",1,NA
"RADIATION DENSITY MEASUREMENTS",1,NA
"RADIATION DISPERSAL DEVICES",1,NA
"RADIATION DOSAGE",1,NA
"RADIATION DOSE REDUCTION",1,NA
"RADIATION SAFETY",1,NA
"RADIATIVE DATA",1,NA
"RADIO-CHRONOMETRY",1,NA
"RADIO-IMMUNOASSAY OF",1,NA
"RADIOACTIVE WASTE",1,NA
"RADIOACTIVITY",1,NA
"RADIOCAESIUM ISOTOPES",1,NA
"RADIOCARBON",1,1
"RADIOCHEMICAL ANALYSIS",1,NA
"RADIOCHEMICAL SEPARATION",1,1
"RADIOCHEMISTRY",3,NA
"RADIOCHRONOMETER",1,NA
"RADIOCHRONOMETRY",15,NA
"RADIOEPIDEMIOLOGY",1,NA
"RADIOGENIC",1,NA
"RADIOGRAPHY",3,NA
"RADIOIMMUNOASS AY",1,NA
"RADIOIMMUNOASSAY",15,1
"RADIOIMMUNOASSAY (RIA)",2,1
"RADIOIMMUNOASSAY (RIA), OPIUM-ALKALOIDS",1,NA
"RADIOIMMUNOASSAY, DIGOXIN",1,NA
"RADIOIMUNOASSAY",1,NA
"RADIOLIGAND BINDING ASSAY",1,NA
"RADIOLOGICAL FORENSICS",1,NA
"RADIOLOGY",2,NA
"RADIOLOGY AT LARGE",1,NA
"RADIOMETRIC EVALUATION, ISOLATION OF SALICYLIC ACID IN BIOLOGIC MATERIAL",1,NA
"RADIONUCLIDE",1,NA
"RADIONUCLIDE IMAGING",1,NA
"RADIONUCLIDE METROLOGY",1,NA
"RADIONUCLIDES",3,NA
"RADIOPACITY PRODUCED BY THE STOMACH CONTENTS",1,NA
"RADIOPAQUE AGENTS",1,NA
"RADIOPHARMACEUTICAL",1,NA
"RADIOXENON",1,NA
"RADIUM",1,NA
"RADIX ASTRAGALI",1,NA
"RAFT POLYMERIZATION",1,NA
"RAFTING",1,NA
"RAILWAY",1,NA
"RAIPUR (C.G)",1,NA
"RAMAN",41,54
"RAMAN-ACTIVE SURFACE",1,NA
"RAMAN ANALYSIS OF LIQUIDS, AND DETERMINATION OF PRODUCTION METHOD",1,NA
"RAMAN AREA SCAN",1,1
"RAMAN IN FORENSIC DRUGS CASEWORK, DETECTING DRUGS IN SEIZED SAMPLES",1,NA
"RAMAN MICRO-SPECTROSCOPY",1,1
"RAMAN OPTICAL ACTIVITY (ROA)",1,NA
"RAMAN SCATTERING",1,1
"RAMAN SCATTERING METHODS, ANALYSIS OF DRUGS OF ABUSE",1,NA
"RAMAN SPECTRA, OF THREE MEMBERS OF THE """"ECSTASY"""" FAMILY",1,NA
"RAMAN SPECTROMETRY",1,4
"RAMAN SPECTROSCOPY",59,63
"RAMAN SPECTROSCOPY, ALTERNATIVE TO NON-INVASIVE OPTICAL SPECTROSCOPY",1,NA
"RAMAN SPECTROSCOPY, IN POSITIVE IDENTIFICATION OF METHAMPHETAMINE",1,NA
"RAMELTEON",1,NA
"RANDOM ACCESS CHEMISTRY SYSTEMS",1,NA
"RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE",1,1
"RANDOM DRUG TESTING",1,NA
"RANDOM MAN NOT EXCLUDED (RMNE)",1,NA
"RANDOM SAMPLING",2,1
"RANDOMISED TRIAL",1,NA
"RANDOMIZED CLINICAL TRIALS",1,NA
"RANDOMIZED CONTROLLED TRIAL",2,NA
"RANITIDINE",1,NA
"RAPD",1,2
"RAPE",41,1
"RAPE CASE",1,NA
"RAPE DRUGS",3,1
"RAPE LEGISLATION",1,NA
"RAPE TRAUMA SYNDROME (RTS)",1,NA
"RAPE TREATMENT",1,NA
"RAPID-SCANNING MULTICHANNEL DETECTION",1,NA
"RAPID ANALYSIS",3,1
"RAPID DETERMINATION",1,NA
"RAPID DIAGNOSTICS",1,NA
"RAPID DRUG-SCREENING",3,3
"RAPID DRUG SCREEN",1,NA
"RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER",1,NA
"RAPID GC-MS",1,NA
"RAPID METHOD DEVELOPMENT",1,NA
"RAPID MRNA ANALYSIS",1,NA
"RAPID PROTOTYPING",1,NA
"RAPID PROTOTYPING (RP)",1,NA
"RAPID QUANTITATION",1,NA
"RAPID RADIOCHEMISTRY",1,NA
"RAPID RESOLUTION LIQUID CHROMATOGRAPHY",1,NA
"RAPID SCREENING",6,4
"RAPID SEPARATION",2,2
"RAPID SEPARATIONS",1,NA
"RAPID SOLVENT EXTRACTION",1,NA
"RAPID TEST",1,NA
"RAPID TRANQUILLISATION",1,NA
"RAPIDTRACE",1,NA
"RARE ALLELE",1,NA
"RARE ALLELES",1,NA
"RARE EARTH ELEMENTS",2,NA
"RARE EARTH SEPARATIONS",1,NA
"RAT",41,3
"RAT BRAIN",1,NA
"RAT CARCASSES",1,NA
"RAT LIVER MICROSOME",1,1
"RAT PLASMA",1,1
"RAT TISSUE",1,NA
"RATE",1,NA
"RATE OF RETURN ON COSTS",1,NA
"RATHKE-CLEFT CYST",1,NA
"RATIO",3,NA
"RATIONAL USE OF DRUG",1,NA
"RATOL RODENTICIDE PASTE",1,NA
"RAUSCHDROGEN",1,NA
"RAUVOLFIA",2,NA
"RAVE",1,2
"RAW MATERIAL RESIDUES",1,NA
"RBCL",1,NA
"RBCL GENE",1,1
"RCA120",1,NA
"RCBF- SPECT",1,NA
"RCS-2-C4",1,1
"RCS-4-C4",1,1
"RCS-4 ANALOGUES",1,1
"RCS-4 ISOMER",1,1
"RCT",1,NA
"RDD",1,NA
"RE-ADAPTATION OF PRISONERS",1,NA
"RE-ADDICTION",1,NA
"RE-ARREST RATE",1,NA
"RE-ENROLLMENT",1,NA
"RE-GRANTING OF DRIVERS' LICENCES",1,NA
"RE-HOSPITALISATION",1,NA
"RE-LICENSING",1,NA
"RE-OFFENCE",1,NA
"RE-OFFENDERS",1,NA
"RE-OFFENDING",3,NA
"REACH NEW LAWS OF REGISTRATION",1,NA
"REACTION GAS",1,NA
"REACTION MECHANISM",1,1
"REACTION MONITORING",1,1
"REACTIONS WITH ALCOHOLS",1,1
"REACTIVATION",1,NA
"REACTIVE",1,NA
"REACTIVE AGGRESSION",2,NA
"REACTIVE DYES",1,NA
"REACTIVE OXYGEN SPECIES",1,NA
"REACTIVE PSYCHOSES",1,NA
"REACTOR MODELING",1,NA
"READDICTION",1,NA
"READMISSION",1,NA
"REAGENT",1,NA
"REAL-TIME",1,2
"REAL-TIME DETECTION",1,NA
"REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION (RT-QPCR)",1,NA
"REAL-TIME QUANTITATIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION",1,NA
"REAL-TIME RT-PCR",1,1
"REAL OR COUNTERFEIT",1,NA
"REAL SAMPLE",1,NA
"REAL TIME RT-PCR",2,NA
"REANALYSIS",1,NA
"REASONABLE SUSPICION",1,NA
"REASONING & REHABILITATION PROGRAM",1,NA
"REASSEMBLING",1,NA
"REBOUND DILATION",1,NA
"REBOUND TOXICITY",1,NA
"RECALL",1,NA
"RECEIVER OPERATING CHARACTERISTIC",1,1
"RECENT DEVELOPMENT",1,NA
"RECENT DEVELOPMENTS",1,NA
"RECENTLY RELEASED PRISONERS",1,NA
"RECEPTOR",1,1
"RECEPTOR ANTAGONIST",1,NA
"RECEPTOR BINDING",1,NA
"RECEPTOR PROBES",1,1
"RECEPTOR, CANNABINOID, CB1",1,NA
"RECEPTOR, CANNABINOID, CB2",1,NA
"RECEPTORS",2,NA
"RECIDIVISM",27,NA
"RECIDIVISM RATES",1,NA
"RECLAMATION",1,NA
"RECOMBINANT ANTIBODY",1,NA
"RECOMBINANT DNA",1,NA
"RECOMBINANT ERYTHROPOIETIN",2,NA
"RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR",1,NA
"RECOMBINAT CYPS",1,NA
"RECOMMENDATION",1,NA
"RECOMMENDATION SYSTEM",1,NA
"RECOMMENDATIONS",1,NA
"RECONSTRUCTION",1,NA
"RECONVICTION",1,NA
"RECORD AUDIT",1,NA
"RECORD LINKAGE",1,NA
"RECORDS EXAMINATION",1,NA
"RECOVERY",9,3
"RECOVERY FROM MENTAL ILLNESS",1,NA
"RECOVERY ORIENTATION",1,NA
"RECOVERY RATE",1,NA
"RECOVERY SYSTEMS",1,NA
"RECREATION",1,NA
"RECREATIONAL CANNABIS LAWS",1,1
"RECREATIONAL DRUG",9,6
"RECREATIONAL DRUG USE",1,NA
"RECREATIONAL DRUG USE AND DEALING",1,NA
"RECREATIONAL USE",2,3
"RECTAL",1,NA
"RECTAL MUCOSA",1,NA
"RECTAL TEMPERATURE",1,NA
"RECTUM",1,NA
"RECURRENT NETWORK",1,NA
"RED BALLPOINT PEN INKS",1,NA
"RED CELL ENZYMES",1,NA
"RED INKS",1,NA
"RED LIPSTICKS",2,NA
"RED PHOSPHORUS",2,2
"RED SANDALWOOD",1,NA
"RED STINKWOOD",1,NA
"REDDIT",1,1
"REDISTRIBU TION",1,NA
"REDISTRIBUTION",17,NA
"REDOX MECHANISM",1,1
"REDOX PATHWAYS",1,1
"REDUCED-SIZE STR (RSTR) PCR SYSTEM",1,NA
"REDUCED GRAPHENE OXIDE",2,4
"REDUCED ISO-Α-ACIDS",1,NA
"REDUCED MOBILITY",1,NA
"REDUCING RESTRICTIVE PRACTICES",1,NA
"REDUCTION",3,7
"REDUCTION OF ACETONE TO 2-PROPANOL",1,NA
"REDUCTION OF HARM",1,NA
"REDUCTION PRODUCTS OF N-ALKYLDIMETHYLBENZYLAMMONIUM CHLORIDE",1,NA
"REDUCTION SYSTEM OF NABH4 AND NICL2",1,NA
"REDUCTIONISM",1,NA
"REDUCTIVE AMINATION",1,6
"REE PATTERNS",1,NA
"REENTRY",3,NA
"REENTRY PLANNING",1,NA
"REFERENCE BIOMARKER",1,NA
"REFERENCE COMPOUND",1,3
"REFERENCE CONCENTRATIONS",1,NA
"REFERENCE DOSE",1,NA
"REFERENCE GENES",2,NA
"REFERENCE INTERVALS",1,NA
"REFERENCE MATERIAL",7,2
"REFERENCE MATERIALS PRODUCTION",1,NA
"REFERENCE RANGE",2,NA
"REFERENCE RANGES",1,NA
"REFERENCE STANDARD",2,4
"REFERENCE STANDARD AUTHENTICATION",1,1
"REFERENCE STANDARD COLLECTION IN ZEBRAFISH WATER TANK",1,NA
"REFERENCE STANDARDS",3,2
"REFERENCE VALUES",1,NA
"REFERENCE VARIABLES FOR RISK INDICATORS",1,NA
"REFERRAL",2,NA
"REFERRAL AND CONSULTATION",1,NA
"REFINED PETROLEUM PRODUCTS",1,NA
"REFLECTION ABSORPTION",1,NA
"REFLEX SYMPATHETIC DYSTROPHY",1,NA
"REFLUX",2,NA
"REFORM",1,NA
"REFRACTION FACTOR",1,NA
"REFRACTORY MENTAL ILLNESS",1,NA
"REFUGEES",1,NA
"REFUSAL",1,NA
"REGENERATIVE POINT GRAPHICAL TECHNIQUE",1,NA
"REGIOISOMER DIFFERENTIATION",3,2
"REGIOISOMER SEPARATION",1,NA
"REGIOISOMERIC DIFFERENTIATION",3,4
"REGIOISOMERS",15,28
"REGION OF ORIGIN",1,NA
"REGIONAL SECURE UNIT",1,NA
"REGISTER",1,NA
"REGISTERED TOXICOLOGISTS",1,NA
"REGISTRATION",1,NA
"REGRESSION MODEL",1,NA
"REGRESSION MODELS",1,1
"REGULATED BIOANALYSIS",1,NA
"REGULATED PATHOGENS",1,NA
"REGULATION",3,10
"REGULATORY",1,NA
"REGULATORY DOCUMENTS",1,NA
"REGULATORY ROLE",1,NA
"REGULATORY THRESHOLD",1,NA
"REHABILITATION",5,NA
"REHABILITATION CENTER",2,NA
"REHABILITATION MODEL",1,NA
"REHABILITATION PROGRAM",2,NA
"REHABILITATION PROGRAMMES",1,NA
"REIFICATION",1,NA
"REIMBURSEMENT",1,NA
"REIMS",1,NA
"REINCARCERATION",2,NA
"REINFORCEMENT",1,NA
"REJECTION",1,NA
"REL",1,NA
"RELAPS PREVENTION",1,NA
"RELAPSE",6,1
"RELAPSE PREVENTION",2,NA
"RELAPSING IN TREATMENT",1,NA
"RELATED COMPOUNDS",1,NA
"RELATED DEATH",1,NA
"RELATED DISCIPLINES",1,NA
"RELATED DISORDERS",1,NA
"RELATED POTENTIAL",1,NA
"RELATIONSHIP",1,NA
"RELATIONSHIP-BASED CARE",1,NA
"RELATIONSHIP BETWEEN DRUG INTAKE AND HAIR DRUG LEVEL",1,NA
"RELATIVE AGEING",1,NA
"RELATIVE DEATH RISK",1,NA
"RELATIVE EXPRESSION RATIO",2,NA
"RELATIVE QPCR",1,NA
"RELATIVE RISK",2,NA
"RELATIVES",1,NA
"RELAXATION",1,NA
"RELEASE",1,NA
"RELEASE ON SCENE",1,NA
"RELEVANT IMPROVEMENTS",1,NA
"RELIABILITY",7,NA
"RELIABILITY OF RAMAN IDENTIFICATION",1,NA
"RELIGION",3,1
"RELIGIOSITY",2,NA
"RELIGIOUS",1,NA
"RELIGIOUS BEHAVIOR",1,NA
"RELIGIOUS COMMUNITIES",1,NA
"RELIGIOUS SALIENCE",1,NA
"RELIGIOUSNESS",1,NA
"RELOCATION",1,NA
"REM BEHAVIOR DISORDER",1,NA
"REM SLEEP",1,NA
"REM SLEEP BEHAVIOR DISORDER",1,NA
"REMAND",1,NA
"REMEDI",1,NA
"REMEDI-HS®",2,NA
"REMEDI HS",3,NA
"REMEDI HS®",1,NA
"REMEDIATION",1,NA
"REMIFENTANIL",3,NA
"REMISSION",2,NA
"REMOTE ACCESS",1,1
"REMOTE SENSING",1,2
"REMOVAL OF PCR INHIBITORS",1,NA
"REMS",2,NA
"REMYELINATION",1,NA
"RENAL DIALYSIS",1,NA
"RENAL EXCRETION",1,NA
"RENAL FAILURE",3,NA
"RENAL IMPAIRMENT",1,NA
"RENAL TRANSPLANTATION",1,NA
"RENAL VEINS",1,NA
"REOFFENDING",2,NA
"REOFFENDING RATE",1,NA
"REPEAT ALLELE STRUCTURE",1,NA
"REPEAT OFFENCE",1,NA
"REPEAT OFFENCES",1,NA
"REPEAT OFFENDERS",2,NA
"REPEAT OFFENDING",1,NA
"REPEATABILITY",1,NA
"REPEATED EXPOSURE",1,NA
"REPEATS OFFENCE",1,NA
"REPELLENT AIR FRESHENER",1,NA
"REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS)",1,NA
"REPORT ON OFFENDERS' PROGNOSIS",1,NA
"REPORTED HEALTH",1,NA
"REPORTING",3,NA
"REPORTING/DISCLOSURE",1,NA
"REPRESENTATIVE DRUG SAMPLING",1,NA
"REPRESENTATIVENESS",2,1
"REPRESENTATIVITY",1,NA
"REPRODUCIBILITY",5,1
"REPRODUCTIVE MEDICINE",1,NA
"REPUBLIC OF IRELAND",1,1
"REPUBLIC OF KOREA",1,NA
"REQUEST FORM",1,NA
"RESEARCH",6,3
"RESEARCH CHEMICAL",7,4
"RESEARCH DIRECTIVE",1,NA
"RESEARCH ETHICS",1,1
"RESEARCH FOR THE BENEFIT OF OTHERS",1,NA
"RESEARCH HONEYPOTS",1,NA
"RESEARCH METHODS",2,NA
"RESEARCH PROGRESS",2,1
"RESEQUENCING",1,NA
"RESERPINE",1,NA
"RESIBUFOGENIN",2,1
"RESIDENT-INTRUDER",1,NA
"RESIDENTIAL CARE",1,NA
"RESIDENTIAL DRUG AND ALCOHOL TREATMENT",1,NA
"RESIDENTIAL MOBILITY",1,NA
"RESIDENTIAL REHAB CAMPUS",1,NA
"RESIDENTIAL REHABILITATION",1,NA
"RESIDENTIAL SERVICES FOR THE EXECUTION OF SECURITY MEASURES",1,NA
"RESIDENTS' AUTONOMY",1,NA
"RESIDUAL",1,1
"RESIDUAL ACID",1,NA
"RESIDUAL SOLVENTS",5,12
"RESIDUE",6,11
"RESIDUE ANALYSIS",1,4
"RESILIENCE",1,NA
"RESIN",2,3
"RESISTANT HYPERTENSION",1,NA
"RESISTIVE THERMAL DEVICE",1,NA
"RESOLUTION",2,2
"RESONANCE EXCITATION",1,1
"RESONANCE IONIZATION MASS SPECTROMETRY",1,NA
"RESONANCE RAMAN",2,NA
"RESORPTIONSDEFIZIT, ROLLE DER LEBER",1,NA
"RESOURCES",1,NA
"RESPIRATION",2,NA
"RESPIRATORS",1,NA
"RESPIRATORY ARREST",1,1
"RESPIRATORY DEPRESSION",6,NA
"RESPIRATORY DISTRESS",2,NA
"RESPIRATORY FUNCTION",1,NA
"RESPIRATORY INHIBITION",2,NA
"RESPIRATORY INSUFFICIENCY",1,NA
"RESPONSE CURVE",1,NA
"RESPONSE INHIBITION",1,NA
"RESPONSE STYLE",1,NA
"RESPONSE SURFACE METHODOLOGY",1,7
"RESPONSE TIME",1,NA
"RESPONSE TO TRAUMA",1,NA
"RESPONSIBILITY",5,NA
"RESPONSIBILITY, UNDER DRUG INFLUENCE",1,NA
"RESPONSIVITY",1,NA
"RESTLESS LEGS SYNDROME",1,NA
"RESTORATION",1,NA
"RESTORATIONS",1,NA
"RESTORATIVE JUSTICE",1,NA
"RESTRAINT",9,NA
"RESTRAINT ASPHYXIA",4,NA
"RESTRAINT COERCION",1,NA
"RESTRAINTS",1,NA
"RESTRICTED ACCESS EXTRACTION COLUMN",1,NA
"RESTRICTED ACCESS MATERIAL",1,NA
"RESTRICTED ACCESS MATERIALS",1,NA
"RESTRICTED MOVEMENT AND ABILITY TO WORK",1,NA
"RESTRICTED PATIENTS",1,NA
"RESTRICTION ANALYSIS",1,1
"RESTRICTION MAPPING",1,1
"RESTRICTIVE PRACTICES",1,NA
"RESULT INTERPRETATION",1,NA
"RESUSCITATION",3,NA
"RESUSCITATION MEDICATION",1,NA
"RETAINED DRUGS",1,NA
"RETENTION",1,NA
"RETENTION DATA",1,NA
"RETENTION INDEX",4,6
"RETENTION INDEX BENZODIAZEPINES",1,NA
"RETENTION INDEX VALUES, HPLC",1,NA
"RETENTION TIME",2,2
"RETENTION TIME LOCKING",1,NA
"RETICULAR PURPURA",1,NA
"RETICULINE",1,3
"RETINA",3,NA
"RETINAL DETACHMENT",1,NA
"RETIREMENT",1,NA
"RETRIBUTION",1,NA
"RETRIBUTIVISM",1,NA
"RETROGRADE EXTRAPOLATION",1,NA
"RETRORSINE-N-OXIDE",1,NA
"RETROSPECTIVE",2,NA
"RETROSPECTIVE ANALYSIS",8,4
"RETROSPECTIVE AND PROSPECTIVE PATIENT-MONITORING",1,NA
"RETROSPECTIVE COMPARISON",1,1
"RETROSPECTIVE DATA-ANALYSIS",1,NA
"RETROSPECTIVE DETECTION",1,NA
"RETROSPECTIVE MONITORING",2,NA
"RETROSPECTIVE SCREENING",1,NA
"RETROSPECTIVE STUDY",15,NA
"RETURN ON INVESTMENT",1,NA
"REUNIFICATION",1,1
"REUPTAKE INHIBITORS",1,NA
"REVENUE",1,NA
"REVERSE-PHASE HPLC",1,NA
"REVERSE DEVELOPMENT",1,NA
"REVERSED-PHASE",2,4
"REVERSED-PHASE CHROMATOGRAPHY",1,1
"REVERSED-POLARITY CAPILLARY ELECTROPHORESIS",1,1
"REVERSED COLUMN SET",1,NA
"REVERSED PHASE EXTRACTION",1,NA
"REVERSED POLARITY",2,1
"REVIEW",112,51
"REVIEWFPUBLICATION TYPE]",1,NA
"REVIEWS[PUBLICATION TYPE]",1,NA
"RFCVALUES, BENZODIAZEPINES",1,NA
"RGB COLOUR SYSTEM",1,3
"RH D ANTIGEN",1,NA
"RHABDOMYOLYSIS",19,2
"RHEOLOGY",1,NA
"RHEUMATIC CARDITIS",1,NA
"RHEUMATOID ARTHRITIS",1,NA
"RHINOPHYMA",1,NA
"RHODAMINE",2,NA
"RHODAMINE 6G",1,NA
"RHODAMINE B",1,1
"RHYOLITHIC PUMICE",1,NA
"RHYTHMIC GENE EXPRESSION",1,NA
"RIA",1,NA
"RIB",1,NA
"RIBOFLAVIN",1,NA
"RIBONUCLEASE",1,NA
"RIBOSOMAL DNA",1,2
"RIBULOSE BISPHOSPHATE CARBOXYLASE/OXYGENASE",1,1
"RICE HOPPER",1,NA
"RICIN",8,1
"RICIN-LIKE PROTEINS",1,NA
"RICININE",3,NA
"RICINUS COMMUNIS",1,NA
"RICINUS COMMUNIS L.",1,NA
"RICOTTA CHEESE",1,NA
"RIDGE DENSITY",1,NA
"RIFLE BULLET",1,NA
"RIGHT-TO-DIE-ORGANISATION",1,NA
"RIGHT-TO-DIE-ORGANISATIONS",1,NA
"RIGHT HEART BLOOD",1,NA
"RIGHT TO FAIR TRIAL",1,NA
"RIGHT TO REFUSE",1,NA
"RIGHT TO REFUSE TREATMENT",1,NA
"RIGHT TO SILENCE",1,NA
"RIGHTS",1,NA
"RIGHTS OF NATURE",1,NA
"RIGOR MORTIS",3,NA
"RIN",1,NA
"RIO DE JANEIRO",1,2
"RIOT CONTROL",2,NA
"RIOTS",1,NA
"RISK",6,NA
"RISK-FACTOR",1,NA
"RISK-NEED-RESPONSIVITY",1,NA
"RISK-NEEDS-RESPONSIVITY (RNR)",1,NA
"RISK-STRATIFIED ANALYSIS",1,NA
"RISK ASSESSMENT",31,9
"RISK ASSESSMENT AND MANAGEMENT",2,NA
"RISK BEHAVIOUR VALIDITY",1,NA
"RISK DIFFERENCES",1,NA
"RISK FACTOR",44,1
"RISK FACTORS FOR VIOLENCE",1,NA
"RISK FOR VIOLENCE",1,NA
"RISK MANAGEMENT",6,1
"RISK OF DRUG INTERACTIONS",1,NA
"RISK OF TREATMENT",1,NA
"RISK PREDICTION",2,NA
"RISK PROFILES",1,NA
"RISK PROGNOSIS",1,NA
"RISK RELEVANCE",1,NA
"RISK SITUATIONS",1,NA
"RISK TAKING",2,1
"RISK/BENEFIT ANALYSIS",1,NA
"RISPERIDONE",3,NA
"RITALIN",1,1
"RITALIN®",1,NA
"RITALINIC ACID",3,1
"RIVER",1,1
"RIVER POLLUTION PREVENTION",1,NA
"RIVER WATER",1,5
"RLE",1,NA
"RM2000",1,NA
"RMNE",1,NA
"RNA",8,1
"RNA ASSAY",1,NA
"RNA DEGRADATION",2,NA
"RNA INTEGRITY",2,NA
"RNA MARKERS",1,NA
"RNA PROFILE INTERPRETATION",1,NA
"RNA SEQUENCING",1,1
"RNA, RIBOSOMAL, 16S",1,NA
"RNA, SMALL INTERFERING",1,NA
"RNASEQ",1,NA
"ROAD ACCIDENT RECONSTRUCTION",1,NA
"ROAD ACCIDENT VICTIMS",1,NA
"ROAD ACCIDENTS",4,NA
"ROAD FATALITIES",1,NA
"ROAD SAFETY",2,NA
"ROAD SAFETY POLICY",1,NA
"ROAD SIDE TESTING",1,NA
"ROAD SITE",1,NA
"ROAD TRAFFIC",3,NA
"ROAD TRAFFIC ACT",2,NA
"ROAD TRAFFIC ACT (RTA)",1,NA
"ROAD TRAFFIC ACT, SECTION 24 A STVG",1,NA
"ROAD TRAFFIC OFFENDERS ACT",1,NA
"ROAD TRAFFIC SAFETY",1,NA
"ROAD TRAUMA",1,NA
"ROADSIDE ACCIDENTS",1,NA
"ROADSIDE DRUG TEST",2,1
"ROADSIDE DRUG TESTING",1,1
"ROADSIDE SURVEY",3,NA
"ROADSIDE TEST",1,NA
"ROADSIDE TESTING",3,NA
"ROADSIDE TESTS",1,NA
"ROADWORTHINESS",2,NA
"ROBBERY",2,NA
"ROBBERY AND WEAPONS OFFENCES",1,NA
"ROBERT HOUSE",1,NA
"ROBOTICS",1,NA
"ROBOTS",1,NA
"ROBUST ESTIMATION",1,NA
"ROBUSTNESS",1,2
"ROC",1,NA
"ROC-CURVES",1,NA
"ROC CURVE",1,1
"ROC CURVES",1,NA
"ROCURONIUM",2,NA
"RODENTICIDE",4,1
"RODENTICIDES",5,1
"RODRIGO DUTERTE",1,NA
"ROHYPNOL",2,5
"ROHYPNOL®",1,NA
"ROHYPNOL® (FLUNITRAZEPAM)",1,1
"ROLE AND DUTY",1,NA
"ROLES OF INTESTINAL GLYCAN LIGANDS",1,NA
"ROOM- TEMPERATURE FLUORESCENCE",1,NA
"ROPE",1,NA
"ROPINIROLE",1,NA
"ROPIVACAINE",1,NA
"RORSCHACH",1,NA
"ROS",1,NA
"ROSE BENGAL",1,NA
"ROSUVASTATIN",1,NA
"ROTAMERS",1,1
"ROTENONE",1,NA
"ROTOR-STATOR",1,NA
"ROUTE-SPECIFIC BY-PRODUCTS",1,NA
"ROUTE-SPECIFIC MARKERS",1,2
"ROUTE ANALYSES",1,NA
"ROUTE ESTIMATION",1,1
"ROUTE OF ADMINISTRATION",1,3
"ROUTE OF EXPOSURE",1,NA
"ROUTE SPECIFIC AND 4,6-DIMETHYL-3,5-DIPHENYLPYRIDIN-2-ONE",1,1
"ROUTINE ACTIVITY THEORY",1,NA
"ROUTINE ANALYSIS",1,1
"ROUTINE DIAGNOSIS",1,NA
"ROUTINE OUTCOME MONITORING",2,NA
"RP-HPTLC",1,NA
"RPGT",1,NA
"RPS16 INTRON",1,NA
"RPTLC",1,NA
"RRNA GENE CLUSTER",1,NA
"RS10868235",1,NA
"RS1800407",1,NA
"RS397729601",1,NA
"RS4307059",1,NA
"RS4680",1,NA
"RS6265",1,NA
"RS930752",1,NA
"RSID-BLOOD",1,NA
"RSID™-BLOOD",1,NA
"RT-PCR",1,1
"RT-PCR MULTIPLEX",1,NA
"RT-QPCR",4,NA
"RT QPCR",1,NA
"RTA",2,NA
"RUBBER STOPPER",1,NA
"RUGGEDNESS",1,NA
"RUHEMANN'S PURPLE",1,NA
"RULE-BASED RECOMMENDATION",1,NA
"RULE-BREAKING",1,NA
"RUN LENGTH ENCODING",1,NA
"RUN OVER",3,NA
"RUNNING ONTO A KNIFE",1,NA
"RUPICAPRA PYRENAICA",1,NA
"RUPTURE",1,NA
"RUPTURE OF VESSEL WALLS",1,NA
"RUPTURED AORTIC ANEURYSM",1,NA
"RURAL AREA",1,NA
"RURAL AUSTRALIA",1,NA
"RUSSIA",1,NA
"RUSSIAN ROULETTE",1,NA
"RUTHENIUM",1,1
"RUTHENIUM TETROXIDE",1,1
"RYANODINE",1,NA
"RYANODINE RECEPTOR",1,NA
"RYANODINE RECEPTOR 1",2,NA
"RYANODINE RECEPTOR1",1,NA
"RYR2 VARIATIONS",1,NA
"S-ADENOSYL- L -HOMOCYSTEINE",1,NA
"S-LOST",1,NA
"S-PHASE ARREST",1,NA
"S: ANTIDEPRESSANTS",1,NA
"S100A9",1,NA
"S100B",1,NA
"S1PR3",1,NA
"SABRE",1,NA
"SABRE 4000",1,NA
"SACCADIC EYE MOVEMENT",1,NA
"SACCHARIN",1,2
"SACCHAROMYCES CEREVISIAE",2,3
"SACCULAR ANEURYSM",1,NA
"SACRAMENT OF TRANSITION",1,NA
"SADISM",2,NA
"SADOMASOCHISM",1,NA
"SAFE DRUGS",1,NA
"SAFEGUARDING",1,NA
"SAFER CUSTODY",1,NA
"SAFETY",9,6
"SAFETY MARGINS",1,NA
"SAFETY MEASURE OF OBLIGATORY PSYCHIATRIC TREATMENT",1,NA
"SAFETY MEASURES",1,NA
"SAFETY OF VACCINES",1,NA
"SAFETY PHARMACOGENETICS",1,NA
"SAFETY RULES",1,NA
"SAFETY/SECURITY POST",1,NA
"SAFROLE",2,4
"SALBUTAMOL",2,3
"SALDI",1,NA
"SALDI-MS",4,NA
"SALIANT",1,NA
"SALICYLATES",1,NA
"SALICYLIC ACID",5,4
"SALIVA",64,8
"SALIVA AGE ESTIMATION",1,NA
"SALIVA BIOMARKERS",1,NA
"SALIVA DETECTION",1,NA
"SALIVA IDENTIFICATION",4,NA
"SALIVA SAMPLES",1,NA
"SALIVA TESTING",2,NA
"SALIVA TESTS",1,NA
"SALIVA/ORAL FLUID",1,NA
"SALIVARY ALPHA AMYLASE",1,NA
"SALIVARY BIOMARKERS",2,NA
"SALIVARY COMPOSITION",1,NA
"SALIVARY DNA",1,NA
"SALIVARY EXCRETION",1,NA
"SALIVARY GLAND",1,NA
"SALIVARY GLANDS",1,NA
"SALIVARY PROTEIN POLYMORPHISMS",1,NA
"SALIVARY PRP 2",1,NA
"SALIVARY RNA",1,NA
"SALIVARY Α-AMYLASE",1,NA
"SALMONELLA TYPHIMURIUM",1,NA
"SALT FORM",1,NA
"SALTING-OUT",1,NA
"SALTING-OUT ASSISTED LIQUID-LIQUID EXTRACTION",2,1
"SALVIA DIVINORUM",3,23
"SALVIA DIVINORUM EPLING & JÁTIVA-M.",1,NA
"SALVIA SPP",1,NA
"SALVINORIN A",5,27
"SALVINORIN B",1,1
"SAMHSA",1,1
"SAMPLE",1,1
"SAMPLE-TO-SAMPLE COMPARISON",1,NA
"SAMPLE COLLECTION",4,NA
"SAMPLE COMPARISON",3,2
"SAMPLE CONCENTRATION/DESORPTION",1,NA
"SAMPLE ENRICHMENT TECHNIQUES",1,NA
"SAMPLE EXTRACTION",1,NA
"SAMPLE MANIPULATION",1,NA
"SAMPLE MINING",1,NA
"SAMPLE PREPA-RATION",1,NA
"SAMPLE PREPARATION",49,20
"SAMPLE PREPARATION FOR DRUG ANALYSIS",1,NA
"SAMPLE PREPARATION FOR HAIR ANALYSIS",1,NA
"SAMPLE PREPARATION METHODS",1,NA
"SAMPLE PREPARATION TECHNIQUES",2,NA
"SAMPLE PRETREATMENT",8,1
"SAMPLE SIZE",3,NA
"SAMPLE SIZE CALCULATION",1,1
"SAMPLE TAMPERING",1,NA
"SAMPLE TEMPERING",1,NA
"SAMPLE TREATMENT",2,1
"SAMPLE VOLUME",1,NA
"SAMPLE WORKUP",1,NA
"SAMPLES",3,1
"SAMPLING",21,11
"SAMPLING CHAMBER",1,NA
"SAMPLING METHODS",1,NA
"SAMPLING PROTOCOL",1,NA
"SAMPLING SITE",4,NA
"SAMPLING TECHNIQUES",1,NA
"SAMPLING THEORY",2,3
"SAMPLING TIME POINT",1,NA
"SAMPLING UNCERTAINTY",1,1
"SAN FRANCISCO",1,NA
"SAN FRANCISCO/USA",1,NA
"SAND ANALYSIS",1,NA
"SANDISON”S REHYDRATING SOLUTION",1,NA
"SANDWICH ENZYME IMMUNOASSAY",1,NA
"SANE",1,NA
"SANGUINARINE",2,NA
"SANITARY",1,NA
"SANITY",2,NA
"SANTA",1,NA
"SARC",2,NA
"SARCONESIOPSIS MAGELLANICA",2,NA
"SARCOPHAGA ARGYROSTOMA",1,NA
"SARCOPHAGA TIBIALIS",1,NA
"SARCOPHAGID FLIES",1,NA
"SARCOPHAGIDAE",6,NA
"SARCOPTES SCABIEI",1,NA
"SARCOSAPHAGOUS FLIES",1,NA
"SARCOSAPHAGOUS INSECTS",1,NA
"SARCS",1,NA
"SARI",1,NA
"SARIN",3,NA
"SARIN AND SOMAN ASSAY",1,NA
"SARIN INCIDENTS",1,NA
"SARM S1",1,NA
"SARS-COV-2",1,NA
"SARS-COV-2 ANTIBODIES",1,NA
"SART",1,NA
"SASSAFRAS OIL",1,1
"SASSI-4",1,NA
"SATIVEX®",1,NA
"SATRATOXINS",1,NA
"SAUDI ARABIA",1,NA
"SAUDI ARABIAN",1,NA
"SAUNA",1,1
"SAWN",1,NA
"SB-FREE PRIMERS",1,NA
"SBSE",1,NA
"SC",1,NA
"SCALE DEVELOPMENT",1,NA
"SCANNING DENSITOMETRY",1,NA
"SCANNING ELECTRON MICROSCOPY-ENERGY-DISPERSIVE X-RAY DETECTOR (SEM-EDX)",1,NA
"SCANNING ELECTRON MICROSCOPY - ENERGY DISPERSIVE X-RAY SPECTROSCOPY (SEM-EDX)",1,NA
"SCANNING ELECTRON MICROSCOPY (SEM)",18,2
"SCANNING ELECTRON MICROSCOPY/ENERGY DISPERSIVE SPECTROSCOPY",1,NA
"SCAPULA",3,NA
"SCAR",2,NA
"SCAR-REENTRY",1,NA
"SCATCHARD PLOTS",2,NA
"SCATOLOGY",1,NA
"SCATTERING EFFECTS",1,1
"SCAVENGING",1,NA
"SCENE",1,NA
"SCENE ANALYSIS",1,NA
"SCENE INVESTIGATION",5,NA
"SCENE RECONSTRUCTION",1,NA
"SCENT",1,NA
"SCENT MARKERS",1,NA
"SCENT TRANSFER",1,NA
"SCGN",1,NA
"SCHEDULE IV CONTROLLED SUBSTANCE",1,NA
"SCHEDULED DRUGS",1,NA
"SCHEDULED MRM",1,NA
"SCHEDULING",1,2
"SCHIFF BASE",3,2
"SCHIFF BASES",1,1
"SCHISTOSOMIASIS",1,NA
"SCHIZOAFFECTIVE DISORDER",1,NA
"SCHIZONTICIDES",1,NA
"SCHIZOPHRENIA",89,1
"SCHIZOPHRENIA SPECTRUM DISORDERS",1,NA
"SCHIZOPHRENIA/DRUG THERAPY",1,NA
"SCHIZOPHRENIC ILLNESSES",1,NA
"SCHIZOPHRENIC OFFENDERS",1,NA
"SCHIZOPHRENIC PATIENTS",1,NA
"SCHIZOPHRÉNIE",1,NA
"SCHIZOTYPAL PERSONALITY DISORDER",1,NA
"SCHLIEREN PHOTOGRAPHY",1,NA
"SCHOOL SHOOTINGS",1,NA
"SCHOOLS",1,NA
"SCHREGER ANGLE",1,NA
"SCIATIC NERVE INJURY",3,NA
"SCIENCE AND TECHNOLOGY STUDIES",1,NA
"SCIENCE COMMUNICATION",1,NA
"SCIENCE VISUALIZATION",1,NA
"SCIENTIFIC CRIME INVESTIGATION",1,NA
"SCIENTIFIC DATA",1,NA
"SCIENTIFIC EVIDENCE",4,1
"SCIENTIFIC JOURNALS",1,NA
"SCIENTIFIC OUTPUT",1,NA
"SCIENTIFIC RESEARCH",1,NA
"SCIENTIFIC STUDY",1,NA
"SCIENTIST-PRACTITIONER",1,NA
"SCIFINDER",1,1
"SCIMS",1,NA
"SCLERODERMA",1,NA
"SCLEROTHERAPY",1,NA
"SCN5A",2,NA
"SCOLINE",1,NA
"SCOOTER",1,NA
"SCOPOLAMINE N-BUTYLBROMIDE",1,NA
"SCORE-BASED-MODEL",1,NA
"SCOTLAND",2,NA
"SCOTT'S TEST",1,NA
"SCOTT TEST",1,1
"SCREEN",3,NA
"SCREEN-PRINTED ELECTRODE",9,16
"SCREENING",71,41
"SCREENING ANALYSIS",2,NA
"SCREENING AND IDENTIFICATION",1,NA
"SCREENING AND IMMUNOENZYMATIC METHODS",1,NA
"SCREENING AND QUANTITATION",1,NA
"SCREENING AUTOMATICALLY",1,NA
"SCREENING FOR ILLEGAL DRUGS",2,NA
"SCREENING INSTRUMENTS",1,NA
"SCREENING INSTRUMENTS, FOR SUBSTANCE USE PROBLEMS - MICHIGAN ALCOHOLISM SCREENING TEST (MAST) OR ALCOHOL USE DISORDER IDENTIFICATION TEST (AUDIT)",1,NA
"SCREENING METHOD",5,1
"SCREENING METHODS",2,1
"SCREENING OF DRUGS",3,NA
"SCREENING OF DRUGS AND POISONS",1,NA
"SCREENING RADIOIMMUNOASSAY",1,NA
"SCREENING TECHNIQUE",1,NA
"SCREENING TEST",3,4
"SCREENING TESTS",5,2
"SCREENING, BENZODIAZEPINES",1,NA
"SCREENING, SYNTHETIC CANNABINOIDSURINE",1,NA
"SCUBA DIVING",1,NA
"SDS",1,2
"SEAHORSE",1,NA
"SEARCH",1,NA
"SEARCH ASSETS",1,NA
"SEARCH PHASES",1,NA
"SEARCH STRATEGY",1,NA
"SEARCHABLE",2,NA
"SEASON",1,NA
"SEASONAL VARIATION",1,NA
"SEAT BELT SAFETY",1,NA
"SEBACEOUS COMPOUNDS",1,NA
"SEBACEOUS SWEAT",1,NA
"SEBUM",1,NA
"SECLUSION",3,NA
"SECNIDAZOLE",1,NA
"SECOBARBITAL",1,NA
"SECOND-GENERATION",1,NA
"SECOND DERIVATIVE SPECTRA",1,1
"SECOND GENERATION",1,NA
"SECOND GENERATION ANTI-PSYCHOTIC DRUG",1,NA
"SECONDARY COMPONENTS",1,1
"SECONDARY DNA TRANSFER",1,NA
"SECONDARY IMMUNODEFICIENCY",3,NA
"SECONDARY ION MASS SPECTROMETRY",2,NA
"SECONDARY ION MASS SPECTROMETRY (SIMS)",1,NA
"SECONDARY IONISATION MASS SPECTROMETRY (SIMS)",1,NA
"SECONDARY SURVEY",1,NA
"SECRETS",1,NA
"SECTION 37/41",1,NA
"SECTION 64 OF THE GERMAN CRIMINAL CODE",1,NA
"SECURE",1,NA
"SECURE CARE",2,NA
"SECURE FORENSIC REHABILITATION",1,NA
"SECURE HOSPITAL",3,NA
"SECURE PSYCHIATRIC FACILITIES",1,NA
"SECURE RESIDENTIAL CARE",1,NA
"SECURE SERVICES",1,NA
"SECURE SETTINGS",1,NA
"SECURITY",8,NA
"SECURITY-RELEVANT SUBSTANCES",2,NA
"SECURITY CONTROL",1,NA
"SECURITY LEVEL",1,NA
"SEDATED BEHAVIOUR",1,NA
"SEDATING DRUGS",1,NA
"SEDATION",2,1
"SEDATION/ANESTHESIA",1,NA
"SEDATIVE",1,NA
"SEDATIVE-HYPNOTIC",5,4
"SEDATIVE-HYPNOTIC DRUGS",1,NA
"SEDATIVE DRUGS",1,NA
"SEDATIVE HYPNOTIC DRUGS",1,NA
"SEDATIVES",8,NA
"SEDATIVES—CHLORDIAZEPOXIDE AND DESMETHYL METABOLITE, DERIVATIZATION AND GLC ANALYSES, BULK DRUG",1,NA
"SEDATIVES—GLUTETHIMIDE, METABOLITES IDENTIFIED IN HUMAN URINE, SYNTHESIZED",1,NA
"SEDATIVES—PYRITHYLDIONE, GLC ANALYSIS IN PUTRIFIED BRAIN AND INTESTINE",1,NA
"SEDIMENT",3,4
"SEDIMENT CONTAMINATION",1,NA
"SEDIMENT QUALITY TRIAD",1,NA
"SEED SPECIES IDENTIFICTION",1,NA
"SEGMENT",1,NA
"SEGMENTAL ANALYSIS",15,NA
"SEGMENTAL HAIR",1,NA
"SEGMENTAL HAIR ANALYSIS",15,NA
"SEGMENTAL HAIR TESTING",1,1
"SEGMENTATION",3,NA
"SEGMENTED HAIR ANALYSIS",1,NA
"SEGMENTS",1,NA
"SEIZED-DRUG ANALYSIS",2,2
"SEIZED COCAINE",1,3
"SEIZED DRUG",3,2
"SEIZED DRUG ANALYSIS",2,4
"SEIZED DRUG IDENTIFICATION",1,1
"SEIZED DRUGS",14,20
"SEIZED MARIJUANA",1,1
"SEIZED MATERIAL",6,6
"SEIZED SAMPLES",2,2
"SEIZED STREET SAMPLES",1,1
"SEIZED TABLETS",1,3
"SEIZURE",15,11
"SEIZURE DISORDER",1,NA
"SEIZURE HOMOGENEITY",1,1
"SEIZURE INFORMATION",1,1
"SEIZURE TOXICOLOGICAL ANALYSIS",1,NA
"SEIZURE, PSYCHOMOTOR",1,NA
"SELECTED-ION MASS SPECTROMETRY",1,NA
"SELECTION",1,2
"SELECTION BIAS",2,NA
"SELECTION OF SAMPLES",1,NA
"SELECTIVE CYP ENZYME INHIBITOR",1,NA
"SELECTIVE LASER SINTERING",1,NA
"SELECTIVE SEPARATION",1,NA
"SELECTIVE SEROTONIN-REUPTAKE INHIBITOR",1,NA
"SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS",1,NA
"SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS (SSRI)",1,NA
"SELECTIVE SEROTONIN REUPTAKE INHIBITOR",2,NA
"SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI)",1,NA
"SELECTIVE SEROTONIN REUPTAKE INHIBITORS",6,1
"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)",1,NA
"SELECTIVITY",5,7
"SELEGILINE",5,1
"SELEGILINE METABOLITES",1,NA
"SELENIUM",2,NA
"SELF",1,NA
"SELF-APPRAISAL QUESTIONNAIRE",2,NA
"SELF-ASSEMBLY",2,3
"SELF-ATTENUATION COMPENSATION",1,NA
"SELF-CARE SYSTEM",1,NA
"SELF-CENTERED IMPULSIVITY",2,NA
"SELF-CONTROL",2,NA
"SELF-DESTRUCTIVE BEHAVIOUR",1,NA
"SELF-DETERMINATION",1,NA
"SELF-DETERMINATION THEORY",1,NA
"SELF-HARM",9,NA
"SELF-HARM IN PRISON",1,NA
"SELF-IMMOLATION",5,NA
"SELF-INFLICTED",1,NA
"SELF-INFLICTED BURNS",1,NA
"SELF-INFLICTED INJURIES",1,NA
"SELF-INFLICTED INJURY",1,NA
"SELF-INJECTION",1,NA
"SELF-INJURIOUS BEHAVIOR",1,NA
"SELF-INJURIOUS BEHAVIOUR",1,NA
"SELF-INTOXICATION",1,NA
"SELF-MUTILATION",2,NA
"SELF-MUTILATION BEHAVIOURS",1,NA
"SELF-POISONING",3,NA
"SELF-POWERED",1,NA
"SELF-REPORT",5,NA
"SELF-REPORTING",1,NA
"SELF-STRANGULATION",1,NA
"SELF-SUSTAINABLE",1,NA
"SELF-TESTING",1,NA
"SELF ASSEMBLY",1,NA
"SELF HARM",1,NA
"SELF MUTILATION",1,NA
"SEM-EDX",2,2
"SEM ANALYSIS",2,NA
"SEMANTIC",1,NA
"SEMANTIC ANALYSIS",2,NA
"SEMEN",17,NA
"SEMEN-SPECIFIC SNP TYPING",1,NA
"SEMEN DETECTION",1,NA
"SEMEN IDENTIFICATION",7,NA
"SEMEN INFERTILITY",3,NA
"SEMENOGELIN",5,NA
"SEMENOGELIN (SG)",1,NA
"SEMENOGELIN I",1,NA
"SEMENOGELIN TEST",1,NA
"SEMENOGELINS",1,NA
"SEMG1",1,NA
"SEMI-INFINITE SOURCES",1,NA
"SEMI-MICRO ATMOSPHERIC PRESSURE CHEMICAL IONIZATION (S-APCI)",1,NA
"SEMI-OPEN SYSTEM",1,NA
"SEMI-POROUS",1,NA
"SEMI QUANTITATIVE ANALYSIS",1,NA
"SEMICARBAZONE, PHENAGLYCODOL—ANALYSIS",1,NA
"SEMICONDUCTOR DETECTOR",1,NA
"SEMINAL EVIDENCE",1,NA
"SEMINAL FLUID",2,NA
"SEMINAL PLASMA MOTILITY INHIBITOR",1,NA
"SEMINAL VESICLE SPECIFIC ANTIGEN",1,NA
"SEMINAL VESICLE SPECIFIC ANTIGEN (SVSA)",1,NA
"SEMINAL VESICLES",1,NA
"SEMINAL VESICLES SPECIFIC ANTIGEN",1,NA
"SEMNAN",1,NA
"SENECIO CORONATUS",1,NA
"SENESCENCE",1,NA
"SENOLYTIC DRUGS",1,NA
"SENSATION-SEEKING",1,NA
"SENSATION SEEKING",1,NA
"SENSE OF COHERENCE",1,NA
"SENSING PERFORMANCE",1,NA
"SENSITIVE TANDEM MASS SPECTROMETRY",1,NA
"SENSITIVITY",14,3
"SENSITIVITY AND SPECIFICITY",2,NA
"SENSITIVITY ENHANCEMENT",1,NA
"SENSOR",14,39
"SENSOR TECHNOLOGY",1,NA
"SENSORY DEPRIVATION",1,NA
"SENTENCING",1,NA
"SENTENCING JUDGE",1,NA
"SEP-PAK C18 CARTRIDGE",1,NA
"SEP-PAK C18 CARTRIDGES",2,NA
"SEP-PAK CARTRIDGE",1,NA
"SEP-PAK18 CARTRIDGES",1,NA
"SEPARATION",6,8
"SEPARATION DATA",1,NA
"SEPARATION SCIENCE",1,1
"SEPARATIONS",1,NA
"SEPSIS",8,NA
"SEPSIS-RELATED DEATH",1,NA
"SEPSIS DIAGNOSED OR CONFIRMED AT THE AUTOPSY",1,NA
"SEPSIS DIAGNOSIS",1,NA
"SEPTA",1,NA
"SEPTIC EMBOLIZATION",1,NA
"SEPTIC INFARCT",1,NA
"SEPTIC PULMONARY EMBOLISM",1,NA
"SEPTIC SHOCK",1,NA
"SEPTICAEMIA",1,NA
"SEPTICEMIC SHOCK",1,NA
"SEPTO-HIPPOCAMPAL",1,NA
"SEPTO-OPTIC DYSPLASIA",1,NA
"SEQUENCE",1,NA
"SEQUENCING",5,NA
"SEQUENTIAL HAIR ANALYSIS",1,NA
"SEQUENTIAL INJECTION ANALYSIS",2,4
"SEQUENTIAL ORGAN FAILURE ASSESSMENT",1,NA
"SEQUENTIAL WINDOWED ACQUISITION OF ALL THEORETICAL FRAGMENT ION MASS SPECTRA (SWATH)",1,NA
"SERIAL ANALYSIS OF GENE EXPRESSION",1,NA
"SERIAL FIRE",1,NA
"SERIAL KILLER",1,NA
"SERIAL KILLING",2,NA
"SERIAL MEASUREMENTS",1,NA
"SERIAL NUMBER RESTORATION",1,NA
"SERIOUS ADVERSE EVENTS",1,NA
"SERIOUS MENTAL ILLNESS",3,NA
"SERIOUS MENTAL ILLNESS AND VIOLENCE",1,NA
"SEROLOGICAL TESTING",1,NA
"SEROLOGY",2,NA
"SEROPREVALENCE",2,NA
"SEROTONERGIC ANTIDEPRESSANT",1,NA
"SEROTONERGIC DRUGS",1,NA
"SEROTONIN",15,6
"SEROTONIN-MODULATED PROTEIN SMP-69",1,NA
"SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS",1,NA
"SEROTONIN ANTAGONISTS",1,NA
"SEROTONIN NORADRENALINE REUPTAKE INHIBITOR",1,NA
"SEROTONIN REUPTAKE INHIBITOR",2,NA
"SEROTONIN SYNDROME",8,1
"SEROTONIN SYNDROME-OVERDOSE",1,NA
"SEROTONIN TOXICITY",5,NA
"SEROTONIN TRANSPORTER",1,1
"SEROTONIN UPTAKE INHIBITORS",1,NA
"SEROTYPING",1,NA
"SERRATIA MARCESCENS",1,NA
"SERS",16,34
"SERS DETECTION",1,NA
"SERTINDOLE",1,NA
"SERTRALINE",7,NA
"SERUM",41,10
"SERUM ALBUMIN",2,NA
"SERUM ANALYSIS",2,NA
"SERUM AND HAIR ANALYSIS",1,NA
"SERUM CONCENTRATION",1,NA
"SERUM LEVEL",2,NA
"SERUM LEVELS",1,NA
"SERUM PROTEINS",1,NA
"SERUM SAMPLE",1,NA
"SERUM TRYPTASE",1,NA
"SERUM, BLOOD, POST-MORTEM BLOOD",1,NA
"SERUM, SALIVA AND URINE CONCENTRATIONS",1,NA
"SERVICE-LEARNING",2,NA
"SERVICE DELIVERY MODEL",1,NA
"SERVICE DESIGN",1,NA
"SERVICE PROVISION",1,NA
"SERVICE USE",2,NA
"SERVICE USER COLLABORATION",1,NA
"SESI‐MS",1,NA
"SESQUITERPANES",1,NA
"SESQUITERPENES",1,1
"SETIPTILINE",3,NA
"SETTINGS",1,NA
"SETTLED INSANITY",1,NA
"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2",2,NA
"SEVERE ASTHMA",1,NA
"SEVERE ASTHMA EXACERBATIONS",1,NA
"SEVERE CONTAMINATION CONDITIONS",1,NA
"SEVERE MENTAL DISORDERS",2,NA
"SEVERE MENTAL ILLNESS",3,NA
"SEVERITY OF DEPENDENCY",1,NA
"SEVOFLURANE",1,NA
"SEWAGE",2,5
"SEWAGE EPIDEMIOLOGY",6,19
"SEWAGE FORENSICS",2,1
"SEWER",1,1
"SEX",4,1
"SEX-OFFENDER",1,NA
"SEX ADDICTION",1,NA
"SEX AND PLEASURE",1,NA
"SEX DETERMINATION",1,NA
"SEX DIFFERENCE",1,NA
"SEX DRIVE REDUCTION",1,NA
"SEX LINKAGE",1,1
"SEX OFFENCE",1,NA
"SEX OFFENDER",3,NA
"SEX OFFENDER TREATMENT",3,NA
"SEX OFFENDERS",10,NA
"SEX OFFENDING",1,NA
"SEX OFFENSES",3,NA
"SEX RATIO",1,NA
"SEXOFFENDER COMORBIDITIES",1,NA
"SEXSOMNIA",3,NA
"SEXUAL ABUSE",12,1
"SEXUAL ACTIVITY",4,NA
"SEXUAL ASSAULT",97,1
"SEXUAL ASSAULT CASEWORK",1,NA
"SEXUAL ASSAULT CENTER",1,NA
"SEXUAL ASSAULT EVIDENCE",2,NA
"SEXUAL ASSAULT FORENSIC EXAMINERS",1,NA
"SEXUAL ASSAULT KITS",1,NA
"SEXUAL ASSAULT MEDICAL FORENSIC EXAMS",1,NA
"SEXUAL ASSAULT SAMPLES",1,NA
"SEXUAL ASSAULTS",1,NA
"SEXUAL ASSAULTS CENTRE",1,NA
"SEXUAL BEHAVIOR",3,NA
"SEXUAL BEHAVIOR/EXPERIENCE",1,NA
"SEXUAL BEHAVIOUR",1,NA
"SEXUAL CRIME",1,NA
"SEXUAL DELINQUENCY",4,NA
"SEXUAL DELINQUENT",1,NA
"SEXUAL DEVIANT BEHAVIOR",1,NA
"SEXUAL DEVIATION",1,NA
"SEXUAL DIMORPHISM",1,NA
"SEXUAL DYSFUNCTION",1,NA
"SEXUAL ENHANCERS",1,1
"SEXUAL EXPLOITATION",1,NA
"SEXUAL FANTASIES",1,NA
"SEXUAL FANTASIES AND PRACTICE",1,NA
"SEXUAL FANTASY",2,NA
"SEXUAL HARASSMENT",1,NA
"SEXUAL HOMICIDE",4,NA
"SEXUAL HORMONE-BINDING GLOBULIN",1,NA
"SEXUAL OFFENCES",4,NA
"SEXUAL OFFENDER",2,NA
"SEXUAL OFFENDER THERAPY",1,NA
"SEXUAL OFFENDERS",5,NA
"SEXUAL OFFENDING",2,NA
"SEXUAL OFFENSES",1,NA
"SEXUAL PRACTICE",1,NA
"SEXUAL VIOLENCE",10,NA
"SEXUALITY",1,NA
"SEXUALLY RELATED OFFENCES",1,NA
"SEXUALLY TRANSMITTED DISEASES",1,NA
"SEXUALLY TRANSMITTED INFECTION",1,NA
"SEXUALLY TRANSMITTED INFECTION SCREENING AND PROPHYLAXIS, CHILDREN, ADOLESCENT",1,NA
"SEXUALLY TRANSMITTED INFECTIONS",6,NA
"SEXUALLY VIOLENT PREDATOR",1,NA
"SFC",1,NA
"SFC-ESI-MS/MS",1,1
"SFE",1,NA
"SFST",1,NA
"SFSTS",1,NA
"SG",1,NA
"SH-SY5Y",1,NA
"SH-SY5Y CELL LINE",1,1
"SHADOWGRAPH PHOTOGRAPHY",1,NA
"SHADOWING PURSUIT",1,NA
"SHAKEN INFANT SYNDROME",1,NA
"SHAME",1,NA
"SHAMPOO",1,NA
"SHANGHAI",2,NA
"SHAPE CLASSIFICATION",1,NA
"SHARED PSYCHOTIC DISORDER.",1,NA
"SHARP",1,NA
"SHARP FORCE",3,NA
"SHARP FORCE INJURIES",1,NA
"SHARP FORCE INJURY",1,NA
"SHEATH LIQUID INTERFACE",1,NA
"SHERLOCK",1,NA
"SHERLOCK HOLMES",1,NA
"SHIPMAN",1,NA
"SHOCK ORGAN",1,NA
"SHOCK WAVE-INDUCED NERVOUS INJURY",1,NA
"SHOEPRINT",1,NA
"SHOOTING DISTANCE",1,1
"SHOOTINGS",2,NA
"SHORT-AMPLICON-LENGTH PCR ASSAY",1,NA
"SHORT-END INJECTION",3,2
"SHORT-LIVED",1,NA
"SHORT-TERM STABILITY",1,NA
"SHORT MESSAGE SERVICE (SMS) MESSAGES",1,NA
"SHORT TANDEM REPEAT (STR)",42,14
"SHORT TANDEM REPEAT ANALYSIS",3,NA
"SHORT TANDEM REPEATS SEQUENCES",1,NA
"SHOTGUN CARTRIDGES",1,NA
"SHOTGUN SEQUENCING",1,NA
"SHOTGUN SUICIDE",1,NA
"SHOTGUN USING",1,NA
"SHOWER",1,NA
"SIALIC ACID",1,NA
"SIALOCHEMISTRY",3,NA
"SIALOMETRY",1,NA
"SIBUTRAMINE",9,10
"SID",1,NA
"SIDAWAY'S CASE",1,NA
"SIDE-EFFECTS",2,NA
"SIDE EFFECT",15,4
"SIDE EFFECTS OF KETAMINE",1,1
"SIDE SCAN SONAR",1,NA
"SIDEROPHAGES",1,NA
"SIDS",8,NA
"SIFT‐MS",1,NA
"SIGMOID OBSTRUCTION",1,NA
"SIGMOIDECTOMY",1,NA
"SIGN TEST",1,NA
"SIGNAL-TO-NOISE RATIO",1,NA
"SIGNAL AMPLIFICATION",1,3
"SIGNAL SEPARATION",1,1
"SIGNATURE",4,3
"SIGNATURE PROFILE",1,NA
"SIGNATURES ANALYSIS",1,1
"SIGNIFICANCE",1,NA
"SIGNIFICANCE LEVEL",1,NA
"SIGNIFICANCE OF VITAL REACTIONS, BRAIN DEATH",1,NA
"SIGNIFICANT OTHERS",1,NA
"SIGNS",1,NA
"SIGNS AND SYMPTOMS",1,1
"SIGNS OF DRUG USE",1,NA
"SILANISATION",1,1
"SILDENAFIL",23,18
"SILDENAFIL ANALOGUES",1,NA
"SILDENAFIL ANALOGUES METABOLITES",1,NA
"SILDENAFIL CITRATE (VIAGRA)",1,6
"SILICA",1,3
"SILICA GEL",1,NA
"SILICA GEL-G",1,NA
"SILICA GEL-G LAYERS",1,NA
"SILICA GEL ENCAPSULATION",1,NA
"SILICA GEL G",1,NA
"SILICA GEL TLC",1,NA
"SILICA HYDRIDE",1,NA
"SILICA HYDRIDE STATIONARY PHASES",1,NA
"SILICA MONOLITH",1,1
"SILICON",2,NA
"SILICON CARBIDE PAPER",1,NA
"SILICON NANOWIRE",1,NA
"SILICONE",1,NA
"SILICONE BREAST IMPLANTS",2,NA
"SILICONE ELASTOMERS",1,NA
"SILK ROAD",2,NA
"SILPHIDAE",3,NA
"SILVER",4,NA
"SILVER CHIP",1,1
"SILVER CHLORIDE",1,NA
"SILVER NANOPARTICLE",4,7
"SILVER NITRATE",1,1
"SILVER SUBSTRATES",1,NA
"SIM",1,1
"SIMCA",7,6
"SIMCYP",1,NA
"SIMON'S REAGENT",1,NA
"SIMS",3,NA
"SIMULANT",1,NA
"SIMULATED FINGERMARK",1,NA
"SIMULATED GASTRIC JUICE",1,NA
"SIMULATION",2,2
"SIMULTANEOUS ANALYSIS",2,3
"SIMULTANEOUS DETECTION",1,NA
"SIMULTANEOUS DETERMINATION",6,7
"SIMULTANEOUS DETERMINATION OF 75 ABUSE DRUGS",1,NA
"SIMULTANEOUS DRUG ABUSE",1,NA
"SINGAPORE CONTEXT",1,NA
"SINGLE-BASE EXTENSION",1,NA
"SINGLE-CALIBRANT QUANTIFICATION",1,NA
"SINGLE-CHAIN VARIABLE FRAGMENT",1,NA
"SINGLE-COLLECTOR MASS SPECTROMETRY",1,NA
"SINGLE-CRYSTAL X-RAY DIFFRACTION ANALYSIS",1,1
"SINGLE-NUCLEOTIDE POLYMORPHISM",1,NA
"SINGLE-PARTICLE SPECTROSCOPY",1,NA
"SINGLE-STRAND CONFORMATION",1,NA
"SINGLE-STRANDED DNA",2,NA
"SINGLE-SUBJECT DESIGNS",1,NA
"SINGLE-VEHICLE CRASH",1,NA
"SINGLE-VEHICLE CRASHES",1,NA
"SINGLE AMINO ACID POLYMORPHISM",1,NA
"SINGLE BULLET-TWO ENTRANCES",1,NA
"SINGLE CELL",1,NA
"SINGLE DOSE",2,NA
"SINGLE DROP MICROEXTRACTION (SDME)",1,1
"SINGLE DRUG EXPOSURE",1,NA
"SINGLE EXPOSURE",1,NA
"SINGLE HAIR",1,NA
"SINGLE HAIR ANALYSIS",1,NA
"SINGLE HAIR FIBER",1,NA
"SINGLE INJECTION GC-MS ANALYSIS",1,NA
"SINGLE LAYER GRAPHENE",1,NA
"SINGLE LOCUS",1,NA
"SINGLE MOLECULE",1,NA
"SINGLE MOLECULE DETECTION",1,NA
"SINGLE MOTHERS",1,NA
"SINGLE NUCLEOTIDE POLYMORPHISM (SNP)",27,6
"SINGLE PHOTON IONIZATION",1,NA
"SINGLE POINT CALIBRATION",1,NA
"SINGLE PORT LAPAROSCOPY",1,NA
"SINGLE QUADRUPOLE MASS SPECTROMETRY",1,NA
"SINGLE RADIAL ENZYME DIFFUSION",1,NA
"SINGLE STAB",1,NA
"SINGLE STRAND CONFORMATIONAL POLYMORPHISM",1,NA
"SINGLE VEHICLE COLLISION",1,NA
"SINICUICHI",1,NA
"SINSEMILLA",1,3
"SINUS NODE",1,NA
"SINUSOIDAL MACROPHAGES",1,NA
"SIR ARTHUR CONAN DOYLE",1,NA
"SISTEMA NAZIONALE DI ALLERTA PRECOCE",1,NA
"SIT42",1,NA
"SITE DEPENDENCE",1,NA
"SITE ENHANCEMENT OIL",1,NA
"SITE OF ADMINISTRATION",1,NA
"SITUATIONAL APPROACH",1,NA
"SIZE",1,NA
"SIZE FRACTIONATION",1,NA
"SJTREC",1,NA
"SKELETAL AGING",1,NA
"SKELETAL FRAGMENTS",1,NA
"SKELETAL MUSCLE",4,NA
"SKELETAL MUSCLE CONTUSION",1,NA
"SKELETAL PATHOLOGY",1,NA
"SKELETAL PREPARATION",1,NA
"SKELETAL REMAINS",1,NA
"SKELETAL TISSUE",4,NA
"SKELETAL TISSUES",1,NA
"SKELETAL TRAUMA",1,NA
"SKELETAL TROPONIN I",1,NA
"SKELETFUNDE, VERGIFTUNGSNACHWEIS",1,NA
"SKELETONISED HUMAN REMAINS",1,NA
"SKENAN",1,NA
"SKILLS",1,NA
"SKILLS TRAINING",1,NA
"SKIN",7,2
"SKIN BACTERIA",1,NA
"SKIN CONTUSION",1,NA
"SKIN LESIONS",1,NA
"SKIN LESIONS IN DIABETES",1,NA
"SKIN MICROBIOME",1,NA
"SKIN NECROSIS",1,NA
"SKIN REGENERATION",1,NA
"SKIN SURFACE LIPIDS",2,NA
"SKIN TISSUE MICROSOMES",1,NA
"SKIN WOUNDS",1,NA
"SKIN WRINKLING, FACTORS OF INFLUENCE",1,NA
"SKULL FRACTURE",1,NA
"SKULL OPENING",1,NA
"SKULL SIMULANT",1,NA
"SKUNK",1,1
"SKUNK DEFENSIVE SPRAY",1,NA
"SLAMSEX",1,1
"SLC45A2 GENE",1,NA
"SLE",2,NA
"SLEEP",7,NA
"SLEEP-RELATED DISSOCIATIVE DISORDERS",1,NA
"SLEEP-RELATED VIOLENCE",1,NA
"SLEEP APNEA",1,NA
"SLEEP BEHAVIOR DISORDER",1,NA
"SLEEP DEPRIVATION",2,NA
"SLEEP DISORDER",2,NA
"SLEEP DISORDERS",2,NA
"SLEEP DISTURBANCES",1,NA
"SLEEP FORENSICS",1,NA
"SLEEP HYGIENE",1,NA
"SLEEP IN MOVEMENT DISORDERS",1,NA
"SLEEP INERTIA",1,NA
"SLEEP RELATED INJURY/SLEEP VIOLENCE",1,NA
"SLEEP RELATED/NOCTURNAL SEIZURES",1,NA
"SLEEP SEX",1,NA
"SLEEP TERROR",1,NA
"SLEEP VIOLENCE",1,NA
"SLEEPING AID",1,NA
"SLEEPWALKING",6,NA
"SLEEPWALKING/SLEEP TERRORS/DISORDERS OF AROUSAL",1,NA
"SLIMMING",1,NA
"SLIMMING AGENTS",1,1
"SLOPE RATIO",1,NA
"SLOVENIA",1,1
"SLOW-RELEASE MORPHINE",1,NA
"SLOW-RELEASE ORAL MORPHINE",1,NA
"SLOW INWARD CURRENT",1,NA
"SLOW METABOLIZER",1,NA
"SLOW VERTEX RESPONSES",1,NA
"SLOW WAVE ACTIVITY",1,NA
"SLUG-FLOW MICROEXTRACTION",1,1
"SLUG-TYPE BULLET",1,NA
"SMALL-MOLECULAR REFERENCE RNA",1,NA
"SMALL-VOLUME LIQUID EXTRACTION",1,NA
"SMALL BLOOD SAMPLES",1,NA
"SMALL ENDOGENOUS MOLECULES OF CLINICAL SIGNIFICANCE",1,1
"SMALL MOLECULAR RNA",1,NA
"SMALL MOLECULE",4,4
"SMALL ORGANIC MOLECULES",1,NA
"SMALL PARTICLE REAGENT",1,NA
"SMALL RNA SEQUENCING",1,NA
"SMALL VESSELS",1,NA
"SMALL VOLUME LIQUID EXTRACTION",1,NA
"SMART DRUG",1,NA
"SMART DRUGS",4,NA
"SMART PHONES",2,NA
"SMART SENSOR",1,NA
"SMARTPHONE",3,NA
"SMARTPHONE COLORIMETRY",1,NA
"SMD",1,NA
"SMOKE",1,1
"SMOKE-FREE",1,NA
"SMOKELESS GUNPOWDERS",1,NA
"SMOKELESS POWDER",4,NA
"SMOKELESS POWDER ADDITIVES",1,NA
"SMOKELESS POWDERS",3,NA
"SMOKER CELLS",1,NA
"SMOKING",6,3
"SMOKING CESSATION",2,NA
"SMOOTH BORE",1,NA
"SMOOTH MUSCLE",1,NA
"SMOOTHNESS",1,NA
"SMOTHERING",2,NA
"SMRM-IDA-EPI",1,NA
"SMUGGLER",2,NA
"SMUGGLING",2,3
"SMUGGLING PATHS CHANGED",1,NA
"SNAKEBITE",1,NA
"SNAKEBITE TRAINING",1,NA
"SNAPDRAGON",1,1
"SNAPSHOT",2,NA
"SNAPSHOT™ MULTIPLEX KIT",1,NA
"SNFPR",1,NA
"SNIFF EVIDENCE",1,NA
"SNIFFING DEATH, FORENSIC CHEMISTRY",1,NA
"SNORTING",1,NA
"SNOW GROOMER VEHICLE",1,NA
"SNOWBALL SAMPLING",1,NA
"SNOWBOARDER",1,NA
"SNP-STR",1,NA
"SNP ANALYSIS",1,NA
"SNP GENOTYPING",1,NA
"SNP TYPING",2,NA
"SNPFORID",2,NA
"SNRI",1,NA
"SNV",1,1
"SOAKING",1,NA
"SOBRIETY TESTING",2,NA
"SOCIAL-DEVIANT DIMENSION",1,NA
"SOCIAL AND FORENSIC IMPLICATIONS",1,NA
"SOCIAL AND POLITICAL ISSUES",1,NA
"SOCIAL BACKGROUND FACTORS",1,NA
"SOCIAL CARE",1,NA
"SOCIAL CLASS",1,NA
"SOCIAL CLIMATE",1,NA
"SOCIAL CONTROL",2,NA
"SOCIAL DEFICITS",1,NA
"SOCIAL DEPRIVATION",1,NA
"SOCIAL DESIRABILITY",1,NA
"SOCIAL DESIRABILITY RESPONSE BIAS",1,NA
"SOCIAL DETERMINANTS OF HEALTH",1,NA
"SOCIAL ENVIRONMENT",1,NA
"SOCIAL INNOVATION",1,NA
"SOCIAL INTEGRATION",1,NA
"SOCIAL INTERVENTIONS",1,NA
"SOCIAL ISOLATION",1,NA
"SOCIAL JUSTICE",1,NA
"SOCIAL LEARNING",1,NA
"SOCIAL LEARNING THEORY",1,NA
"SOCIAL NETWORK ANALYSIS",2,1
"SOCIAL NETWORKS",1,1
"SOCIAL PRACTICES",1,NA
"SOCIAL REINTEGRATION",1,NA
"SOCIAL RISK FACTORS",1,NA
"SOCIAL SERVICES",1,NA
"SOCIAL STATUS",1,NA
"SOCIAL SUPERVISION",1,NA
"SOCIAL SUPPLY",1,NA
"SOCIAL SUPPORT",4,NA
"SOCIAL WORK",3,NA
"SOCIAL WORK EDUCATION",1,NA
"SOCIALIZATION",1,NA
"SOCIALLY DANGEROUS ACTIONS",1,NA
"SOCIALRISKSFACTORS",1,NA
"SOCIETY NARCOTIZATION",1,NA
"SOCIO-DEMOGRAPHIC FACTORS",1,NA
"SOCIO-DEMOGRAPHIC PROFILE",1,NA
"SOCIO-ECONOMIC CONDITIONS",1,NA
"SOCIO-ECONOMIC STATUS",1,NA
"SOCIODEMOGRAPHIC RISK FACTORS",1,NA
"SOCIOECONOMIC FACTORS",1,NA
"SOCIOECONOMIC INEQUALITIES",1,NA
"SOCIOPATHIC PERSONALITY",1,NA
"SODIUM",1,NA
"SODIUM-22",1,NA
"SODIUM-ACETATE-FORMALIN FIXATIVE",1,NA
"SODIUM ADDUCT",1,NA
"SODIUM AMYTAL",1,NA
"SODIUM AZIDE",2,NA
"SODIUM BOROHYDRIDE",1,NA
"SODIUM BOROHYDRIDE-NICKEL CHLORIDE",1,NA
"SODIUM CHANNELS",1,NA
"SODIUM CYANIDE",1,NA
"SODIUM HYDROXIDE",2,1
"SODIUM HYPOCHLORITE",1,NA
"SODIUM NITRITE",3,NA
"SODIUM NITROPRUSSIDE",2,NA
"SODIUM OXYBATE",2,4
"SODIUM OXYBATE (GAMMA-HYDROXYBUTYRATE)",1,1
"SODIUM PENTOTHAL",1,NA
"SODIUM PERCARBONATE",2,NA
"SODIUM PHOSPHATE",1,NA
"SODIUM POLYSTYRENE SULFONATE",1,NA
"SODIUM RHODIZONATE",3,NA
"SODIUM THIOSULFATE",1,NA
"SODIUM TRIPOLYPHOSPHATE",1,NA
"SODIUMBOROHYDRIDE-NICKEL CHLORIDE",1,NA
"SODIUMBOROHYDRIDE-TRANSITION MATAL SALT",1,NA
"SOFT BLOOD CLOT",1,NA
"SOFT CHEMICAL IONISATION-MASS SPECTROMETRY",1,NA
"SOFT DRINKS",1,2
"SOFT INDEPENDENT MODELING OF CLASS ANALOGY",2,6
"SOFT IONIZATION",3,2
"SOFT TISSUE INJURIES",1,NA
"SOFT TISSUE THICKNESS",1,NA
"SOFTWARE",2,1
"SOFTWARE-ASSISTED DATA MINING",1,NA
"SOFTWARE-BASED IMAGE COMBINING",1,1
"SOFTWARE DEVELOPMENT",1,NA
"SOFTWARE TOOL",1,1
"SOFTWARE VALIDATION",1,NA
"SOIL",12,7
"SOIL BIOTA",1,NA
"SOIL MICROBIAL PROFILING",1,NA
"SOIL MORPHOLOGY",1,NA
"SOIL PH",1,NA
"SOIL TAPHONOMY",1,NA
"SOILS AND SEDIMENT",1,NA
"SOILS EXTRACTION",1,NA
"SOL-GEL",2,8
"SOL-GEL CHEMISTRY",1,NA
"SOL-GEL GLASS",1,NA
"SOL-GEL PROCESS",1,NA
"SOL-GELS",1,NA
"SOLAR LIGHT",1,NA
"SOLE INCISIONS",1,NA
"SOLID-LIQUID EXTRACTION WITH LOW TEMPERATURE PARTITIONING (SLE-LTP)",1,NA
"SOLID-PHASE",1,NA
"SOLID-PHASE DISPERSIVE EXTRACTION",1,NA
"SOLID-PHASE DYNAMIC EXTRACTION",1,NA
"SOLID-PHASE MICRO-EXTRACTION (SPME)",1,NA
"SOLID-PHASE MICROEXTRACTION (SPME)",64,54
"SOLID-PHASE MICROEXTRACTION/MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY",1,1
"SOLID-STATE FLUORESCENCE SPECTROSCOPY",1,1
"SOLID-SUPPORTED LIQUID-LIQUID EXTRACTION",1,NA
"SOLID DEPOSITION GC-FTIR INTERFACE",1,1
"SOLID DEPOSITION GC-IRD",1,NA
"SOLID DEPOSITION INTERFACE",1,1
"SOLID DOSAGE FORMS",1,NA
"SOLID FREE-FORM TECHNOLOGY (SFF)",1,NA
"SOLID MATERIAL ANALYSIS",1,NA
"SOLID PHASE DERIVATIZATION",1,1
"SOLID PHASE EXTRACTION (SPE)",148,59
"SOLID PHASE MICRO-EXTRACTION MEMBRANE (SPMEM)",2,NA
"SOLID PHASE MICROEXTRACTION-ION MOBILITY SPECTROMETRY",1,NA
"SOLID STATE NUCLEAR MAGNETIC RESONANCE",1,1
"SOLID SUPPORT",1,NA
"SOLID SUPPORTED LIQUID/LIQUID EXTRACTION (SLE)",1,NA
"SOLID TISSUE",1,NA
"SOLID TISSUE ANALYSIS",1,NA
"SOLIDIFICATION",1,NA
"SOLITARY CONFINEMENT",1,NA
"SOLSTICE® PF",1,NA
"SOLUBILITY",5,6
"SOLUBILITY IN BEVERAGES",1,NA
"SOLUBILITY TESTS",1,NA
"SOLUENE-350",1,NA
"SOLUTION FOCUSED BRIEF THERAPY",1,NA
"SOLUTION STABILITY",1,NA
"SOLVABILITY FACTORS",1,NA
"SOLVATES",1,NA
"SOLVENT",8,3
"SOLVENT-FREE",1,NA
"SOLVENT-FREE SAMPLE PREPARATION",1,NA
"SOLVENT ABUSE",2,1
"SOLVENT BLACK 3",2,NA
"SOLVENT DISPERSIVE LIQUID-LIQUID MICROEXTRACTION",1,NA
"SOLVENT EXTRACTION",2,1
"SOLVENT MICROEXTRACTION (SME)",1,2
"SOLVENT RESIDUES",1,2
"SOLVENT SNIFFING",1,NA
"SOLVENT SYSTEM",1,NA
"SOLVENT SYSTEM ETC.",1,NA
"SOMAN",2,NA
"SOMATIC COMORBIDITY",1,NA
"SOMATIC COMPLAINTS",1,NA
"SOMATIC MOSAICISM",1,NA
"SOMATIZATION",1,NA
"SOMNAMBULISM",3,NA
"SOMNOPHILIA",2,NA
"SONATA",1,NA
"SONIC SPRAY IONIZATION",1,NA
"SONIC SPRAY IONIZATION (SSI)",2,NA
"SOOT INHALATION",1,NA
"SOP",1,NA
"SORBENT",1,NA
"SORBENT-COATED WIRE MESH",1,NA
"SORPTION",2,1
"SORPTIVE EXTRACTION",3,1
"SORS",3,2
"SORS USE IN SECURITY SCREENING OF MAIL, AND IN CLOTHINGS OF PEOPLE",1,1
"SORS, ILLICIT DRUGS THROUGH OPAQUE CONTAINERS, PAPER ENVELOPES",1,1
"SORS, ILLICIT SUBSTANCES IN PLASTIC, DIFFUSELY SCATTERING BOTTLES",1,1
"SOTALOL",1,NA
"SOUND SPECTROGRAM",1,NA
"SOURCE",1,2
"SOURCE ALLOCATION",1,NA
"SOURCE APPORTIONMENT",2,1
"SOURCE CODES",1,1
"SOURCE DETERMINATION",1,1
"SOURCE DISCRIMINATION",1,2
"SOURCE IDENTIFICATION",4,2
"SOURCE INFERENCE",4,3
"SOURCE OF CONTAMINATION",1,NA
"SOURCE OF HEROIN",1,1
"SOURCES OF INCOME",1,NA
"SOURCING",1,1
"SOUTH KOREA",1,2
"SOUTH SCOTLAND",1,NA
"SOUTHERN AREA OF SOUTH KOREA",1,NA
"SOUTHWEST CHINA",1,NA
"SOVEREIGNTY",1,NA
"SOY SAUCE",1,NA
"SPAIN",4,3
"SPAIN FINANCIAL LAW NETWORK",1,NA
"SPAM1",1,NA
"SPANISH POPULATION",2,NA
"SPATIAL CONTAGION",1,NA
"SPATIAL PATTERNS",1,NA
"SPATIALLY OFFSET RAMAN SPECTROSCOPY",4,6
"SPATIALLY OFFSET RAMAN SPECTROSCOPY (SORS)",1,NA
"SPATIO-TEMPORAL PATTERNS",1,NA
"SPDE",1,NA
"SPE-LC-MS/MS",1,NA
"SPE PRESSURISED LIQUID EXTRACTION",1,NA
"SPE PROCEDURE",1,1
"SPE SEP-PAK C18 CARTRIDGES",1,NA
"SPE TIP",1,NA
"SPECIAL HOSPITALS",2,NA
"SPECIAL NUCLEAR MATERIALS",1,NA
"SPECIAL PROGRAM",1,NA
"SPECIAL TREATMENT METHODS",1,NA
"SPECIALIST SEARCH DOG",1,NA
"SPECIALIST SUBSTANCE MISUSE TRAINING",2,NA
"SPECIALIZATION",1,NA
"SPECIES",1,1
"SPECIES-SPECIFIC",1,1
"SPECIES-SPECIFY",1,NA
"SPECIES IDENTIFICATION",15,6
"SPECIES IDENTIFICATION OF ANIMALS AND PLANTS",1,NA
"SPECIES SPECIFIC-PROBES",2,NA
"SPECIES SPECIFICITY",2,NA
"SPECIFIC ABSORBANCE",1,NA
"SPECIFIC CAUSATION",1,NA
"SPECIFIC FINDINGS",1,NA
"SPECIFIC IMMUNOGLOBULINE E",1,NA
"SPECIFIC IMMUNOTHERAPY",1,NA
"SPECIFIC INTENT",1,NA
"SPECIFIC OPTICAL ROTATION",1,NA
"SPECIFIC POSTMORTEM SIGNS",1,NA
"SPECIFICITY",9,3
"SPECIMEN",3,NA
"SPECIMEN COLLECTION",2,NA
"SPECIMEN SELECTION/COLLECTION",2,NA
"SPECIMEN VALIDITY TEST",1,NA
"SPECIMEN VALIDITY TESTING",1,NA
"SPECIMENS",1,NA
"SPECIMENS CORRELATION",1,NA
"SPECIOCILIATINE",1,NA
"SPECTACLE PRESCRIPTIONS",2,NA
"SPECTRAL ANALYSIS",2,NA
"SPECTRAL CHARACTERIZATION",1,1
"SPECTRAL CLUSTERING",1,1
"SPECTRAL COLOUR",1,NA
"SPECTRAL COMBINATION ANALYSIS",1,1
"SPECTRAL CT",1,NA
"SPECTRAL DECONVOLUTION",1,1
"SPECTRAL DIFFERENCES",1,1
"SPECTRAL ENHANCEMENT",1,NA
"SPECTRAL IMAGING",1,NA
"SPECTRAL LIBRARIES",1,NA
"SPECTRAL LIBRARY",3,1
"SPECTRAL POWER ANALYSIS",1,NA
"SPECTROFLUORIMETRY",2,3
"SPECTROMETRY",15,22
"SPECTROMETRY, FLUORESCENCE",1,NA
"SPECTROMICROGRAPHY",1,NA
"SPECTROPHOTOMETRIC DETERMINATION",1,NA
"SPECTROPOLARIMETRY.",1,NA
"SPECTROSCOPIC COMPARISONS",1,1
"SPECTROSCOPIC DETECTION",1,NA
"SPECTROSCOPIC IMAGING",2,NA
"SPECTROSCOPY",24,25
"SPECTRUM",1,NA
"SPECTRUM-STRUCTURE RELATIONSHIPS",1,NA
"SPECTRUM LIBRARY",1,NA
"SPECTRUM USER LIBRARY",1,NA
"SPEED",1,1
"SPEEDBALL",1,1
"SPEKTROMETRIE, ATOMABSORPTION",1,NA
"SPENT FUEL ANALYSIS",1,NA
"SPENT FUEL ISOTOPIC COMPOSITION (SFCOMPO) DATABASE",1,NA
"SPENT NUCLEAR FUEL",3,NA
"SPERM CELL",1,NA
"SPERM HY-LITER PI",1,NA
"SPERM STAINS",1,NA
"SPERM TEST",1,NA
"SPERMATOGENESIS",2,NA
"SPERMATOGENESIS.",1,NA
"SPERMATOZOA",8,NA
"SPERMATOZOA DETECTION",1,NA
"SPHERICAL DEPOSIT",1,NA
"SPHEROIDS",1,NA
"SPICE",33,35
"SPICE DRUGS",2,1
"SPICE PRODUCTS",1,NA
"SPICE TOXICITY",1,NA
"SPICES",1,NA
"SPIDER TELANGIECTASIAS",1,NA
"SPIKE",1,NA
"SPIKE REFERENCE MATERIAL",1,NA
"SPIKED BIOFLUID",1,NA
"SPIKED DRINKS",1,NA
"SPIKING",2,2
"SPIN COLUMN",1,NA
"SPIN SYSTEM MODELING",1,1
"SPINAL ANESTHESIA",4,NA
"SPINAL CORD",1,NA
"SPIRAL GANGLION NEURONS",1,NA
"SPIRITUALITY",1,NA
"SPIRONOLACTONE",1,NA
"SPIROPERIDOL",1,NA
"SPLEEN",6,NA
"SPLEEN AND PORTAL LYMPHNODE SECTION",1,NA
"SPLENIC ANGIOSARCOMA",1,NA
"SPLENIC ARTERY",1,NA
"SPLENIC EOSINOPHILS",1,NA
"SPLENIC MAST CELLS",1,NA
"SPLIT TREATMENT",1,NA
"SPME-DART-MS",1,NA
"SPME-GC-MS",1,NA
"SPME-MS",1,1
"SPME LC TIPS C18",1,NA
"SPME/GC/MS",1,NA
"SPMI",1,NA
"SPONSORING ORGANIZATIONS OF SWGTOX, CODES OF CONDUCT/ETHICAL",1,NA
"SPONTANEOUS COMBUSTION",1,NA
"SPONTANEOUS CORONARY DISSECTION",1,NA
"SPONTANEOUS NOCTURNAL ERECTIONS",1,NA
"SPONTANEOUS SPLENIC RUPTURE",1,NA
"SPORES",2,1
"SPORT",7,3
"SPORT DOPING",3,NA
"SPORT DRUG TESTING",3,NA
"SPORTS DRUG TESTING",5,1
"SPORTS MEDICINE",2,NA
"SPORTS SUPPLEMENT",1,NA
"SPOT-TEST REAGENTS",1,1
"SPOT TESC ETC",1,NA
"SPOT TEST",10,5
"SPOT TEST ETC",1,NA
"SPOTLIGHT",1,NA
"SPOUSE ABUSE",1,NA
"SPRAY CLEANER",1,NA
"SPRAY GUN",1,NA
"SPRAY REAGENT",1,NA
"SPRAYING",1,NA
"SPREADING OF DRUGS",1,NA
"SPTB",1,NA
"SPY DUST",1,NA
"SQL",1,1
"SQUALENE",2,1
"SQUALENE IN HAIR",1,NA
"SQUARE-WAVE ADSORPTIVE STRIPPING VOLTAMMETRY",1,1
"SQUARE-WAVE VOLTAMMETRY",2,8
"SQUARE WAVE VOLTAMMETRY",3,4
"SR",1,NA
"SR 812.121.11",1,NA
"SR, BA, MG",1,NA
"SRB",1,NA
"SRM-995",1,NA
"SSCP",2,NA
"SSD, SUDDEN SNIFFING DEATH",1,NA
"SSIDS",1,NA
"SSO7D FUSION PROTEINS",1,NA
"SSRI",4,NA
"SSRI LITERATUR:",1,NA
"SSRIS",3,1
"STA",1,NA
"STAB",1,NA
"STAB AND CUT WOUNDS",1,NA
"STAB CHANNELS",1,NA
"STAB WOUND",3,NA
"STABILISATION",1,NA
"STABILITY",63,29
"STABILITY-INDICATING",1,4
"STABILITY CONSTANTS",1,NA
"STABILITY DURING STORAGE",1,NA
"STABILITY OF AZIDE IN BLOOD",1,NA
"STABILITY OF NITRAZEPAM",1,NA
"STABILITY OF THE MEASURABLE QUANTITIES WITHIN THE SAMPLE MATRIX",1,NA
"STABILITY OF TOLUENE",1,NA
"STABILITY STUDY",3,1
"STABILIZER",1,NA
"STABLE ELECTROLYTES",1,NA
"STABLE ISOTOPE",18,22
"STABLE ISOTOPE ANALYSIS",3,3
"STABLE ISOTOPE DILUTION",1,NA
"STABLE ISOTOPE RATIO",5,10
"STABLE ISOTOPE RATIO MASS SPECTROMETRY",2,3
"STABLE ISOTOPES MASS SPECTROMETRY",1,1
"STACKING",6,5
"STAFF -PATIENT RATIO",1,NA
"STAFF SAFETY",1,NA
"STAGES OF DECOMPOSITION",1,NA
"STAIN ANALYSIS",2,NA
"STAINING",1,NA
"STAINING METHOD",1,NA
"STAINLESS STEEL",1,NA
"STAINS OF BLOOD AND URINE",1,NA
"STAINS OF BLOOD AND URINE, DETECTION OF MORPHINE (RIA)",1,NA
"STAKEHOLDER PARTICIPATION",1,NA
"STALE BLOODSTAINS",1,NA
"STALKER CHARACTERISTICS",1,NA
"STALKING",5,NA
"STALKING TRAUMA SYNDROME (STS)",1,NA
"STAMP",1,NA
"STAMP INK",1,NA
"STAND-OFF EXPLOSIVES DETECTION",1,1
"STANDARD",9,14
"STANDARD ADDITION",3,1
"STANDARD ADDITION METHOD",3,1
"STANDARD HEROIN",1,1
"STANDARD NORMAL VARIATE",1,1
"STANDARD OPERATING PROCEDURES",1,NA
"STANDARD OPERATIONAL PROCEDURE (SOP)",1,NA
"STANDARD PRECAUTION",1,NA
"STANDARD REFERENCE DATA",1,1
"STANDARD REFERENCE MATERIAL 4340",1,NA
"STANDARD SOLUTIONS",1,1
"STANDARDISATION",2,2
"STANDARDIZATION",1,NA
"STANDARDIZED FIELD SOBRIETY TEST",1,NA
"STANDARDIZED FIELD SOBRIETY TESTS",1,NA
"STANDARDIZED MORTALITY RATIO",1,NA
"STANDARDS OF CARE",2,NA
"STANDARDS OF MEDICAL CARE",3,NA
"STANDARDS OF PROOF",2,NA
"STANDOFF DETECTION",1,2
"STAPHYLOCOCCUS AUREUS",3,1
"START",1,NA
"STARVATION",1,NA
"STAT ASSAY",1,NA
"STATE",2,NA
"STATE HOSPITAL",2,NA
"STATE OF FLORIDA V. JARDINES",1,1
"STATHERIN",2,NA
"STATIC HEADSPACE",3,3
"STATIC HEADSPACE-GAS CHROMATOGRAPHY",1,2
"STATINS",2,NA
"STATIONARY AND MOBILE PHASE",1,NA
"STATIONARY PHASE",3,5
"STATIONARY PHASES, LC",2,2
"STATISTICAL & NUMERICAL DATA",1,NA
"STATISTICAL ANALYSIS",3,7
"STATISTICAL CLASSIFICATION",2,NA
"STATISTICAL CONFIDENCE",1,NA
"STATISTICAL DATA",2,NA
"STATISTICAL DATA-MINING",1,NA
"STATISTICAL DESIGN OF EXPERIMENTS (DOE)",1,NA
"STATISTICAL EXPERIMENTAL DESIGN",1,NA
"STATISTICAL MODEL",2,NA
"STATISTICAL RELIABILITY",1,NA
"STATISTICAL ROBUSTNESS",1,NA
"STATISTICAL SIGNIFICANCE",1,NA
"STATISTICAL TECHNIQUES",1,1
"STATISTICS",25,14
"STATISTICS AND THE LAW",1,NA
"STATISTIK, AUSWERTUNG FORENSISCH-TOXIKOLOGISCHER BEFUNDE",1,NA
"STATSURE SALIVA SAMPLER™",1,NA
"STATUS EPILEPTICUS",1,NA
"STATUTORY AND PRIVATE HEALTH INSURANCE",1,NA
"STATUTORY COMMUNITY AFTERCARE",1,NA
"STATUTORY DEFENSES UNDER THE RTA 1988",1,NA
"STATUTORY RAPE",1,NA
"STEADY STATE",1,NA
"STEATOHEPATITIS",2,NA
"STEATOSIS",2,NA
"STEEL MOLD",1,NA
"STEL",1,NA
"STEM EDUCATION",1,NA
"STENT",1,NA
"STENT IMPLANTATION",1,NA
"STENT THROMBOSIS",1,NA
"STERANES",2,NA
"STEREOCHEMICAL ANALYSES",1,NA
"STEREOCHEMICAL ANALYSIS",1,1
"STEREOISOMER",3,1
"STEREOLOGY",1,NA
"STEREOMICROSCOPE",1,NA
"STEREOMICROSCOPY",1,NA
"STEREOSCOPIC LIGHT MICROSCOPY",3,NA
"STEREOSELECTIVE",1,NA
"STEREOSELECTIVE METABOLISM",2,1
"STEREOSELECTIVITY",2,NA
"STERILITY",1,NA
"STERILIZATION",1,NA
"STERNOCLAVICULAR JOINT",1,NA
"STEROID-INDUCED PSYCHIATRIC DISORDERS",1,NA
"STEROID DOPING",1,NA
"STEROID INJECTION",1,NA
"STEROID METABOLITES",1,NA
"STEROID PSYCHOSIS",1,NA
"STEROIDS",9,25
"STEROLS",1,2
"STEVEN-JOHNSON SYNDROME",1,NA
"STICKY-SIDE POWDER",1,NA
"STILLBIRTH",1,NA
"STILLBORNS",1,NA
"STILLE COUPLING",1,1
"STIM1",1,NA
"STIMULANT",18,21
"STIMULANT DRUG",2,2
"STIMULANT DRUG DETERMINATION",1,NA
"STIMULATED BEHAVIOUR",1,NA
"STIMULUS-RESPONSE FAMILIARITY",1,NA
"STIR-BAR SORPTIVE EXTRACTION (SBSE)",1,NA
"STN EXPRESS",1,1
"STOCKHOLM",1,NA
"STOMACH",1,NA
"STOMACH CONTENT",1,NA
"STOMACH CONTENTS",7,NA
"STOMACH MUCOSA",1,NA
"STOMACH PERFORATION",1,NA
"STOMACH WASH",4,NA
"STORAGE",7,1
"STORAGE AMPHETAMINE",1,NA
"STORAGE CONDITION",2,NA
"STORAGE CONDITIONS",5,2
"STORAGE DURATION",1,NA
"STORED SAMPLES",1,NA
"STORED VAGINAL SWABS",1,NA
"STORMWATER",1,NA
"STR ANALYSIS",2,NA
"STR DNA",1,NA
"STR DNA PROFILING",1,NA
"STR GENOTYPING",2,NA
"STR PROFILING",3,NA
"STR TYPING",2,NA
"STRAIN TYPING",1,NA
"STRAND-DISPLACEMENT POLYMERIZATION",1,2
"STRANGULATION",5,NA
"STRAP MUSCLE",1,NA
"STRATEGIC INTELLIGENCE",1,1
"STRATEGY",1,NA
"STRATHCLYDE",3,NA
"STRAW DISCRIMINATION",1,NA
"STREAMLINED DETECTION",1,NA
"STREET CHILDREN",1,NA
"STREET COCAINE",1,NA
"STREET COCAINE SAMPLE",1,NA
"STREET DOSES",2,2
"STREET DRUG ANALYSIS",1,2
"STREET DRUG DETECTION INSTRUMENTS",1,1
"STREET DRUG TESTING",1,NA
"STREET DRUGS",15,8
"STREET HEROIN",5,1
"STREET SAMPLES",1,1
"STREPTOCOCCAL TOXIC SHOCK SYNDROME",2,NA
"STREPTOCOCCUS MITIS",1,NA
"STREPTOCOCCUS PYOGENES",1,NA
"STRESS",6,NA
"STRESS-REST 99MTC-MIBI SPECT",1,NA
"STRESS CARDIOMYOPATHY",2,NA
"STRESS DISORDERS",1,NA
"STRESS INCONTINENCE",1,NA
"STRESS PROTEIN",2,NA
"STRESS SYMPTOMS",1,NA
"STRESSORS",1,NA
"STRIATED MUSCLE",1,NA
"STRIATION MARKS",1,1
"STRIATUM",2,NA
"STRICT OR ABSOLUTE LIABILITY",1,NA
"STRIDE LENTH, BAC",1,NA
"STRIP OF GOLD-LABELED ANTI-HUMAN-HEMOGLOBIN",1,NA
"STRIPPING VOLTAMMETRY",1,1
"STRMIX",1,NA
"STROKE",7,NA
"STROKES",1,NA
"STRONG ACIDS",1,NA
"STRONTIUM",2,NA
"STRONTIUM ISOTOPES",3,NA
"STRUCTURAL ANALOGUES",1,1
"STRUCTURAL ANALYSIS",2,1
"STRUCTURAL DYNAMICS",1,NA
"STRUCTURAL ELUCIDATION",4,5
"STRUCTURAL EXPLANATIONS",1,NA
"STRUCTURAL ISOMER",3,2
"STRUCTURAL ISOMER SEPARATION",1,1
"STRUCTURAL LOW OF HEALTH",1,NA
"STRUCTURAL PROBE OF CELL-MEMBRANES",1,NA
"STRUCTURALLY COMPLICATED MATERIALS",1,NA
"STRUCTURE",2,NA
"STRUCTURE-ACTIVITY-RELATIONSHIP (SAR)",2,4
"STRUCTURE-ACTIVITY RELATIONSHIPS (SAR)",1,NA
"STRUCTURE ELUCIDATION",5,16
"STRUCTURE IDENTIFICATION",3,3
"STRUCTURE OF THE DRUG SCENE",1,NA
"STRUCTURED LIGHT SCANNING",1,NA
"STRYCHNINE",9,NA
"STRYCHNINE POISONING",1,NA
"STRYCHNOS NUX-VOMICA",1,NA
"STRYCHNOS NUX VOMICA",1,NA
"STS-135",3,1
"STUD GUN",1,NA
"STUN GUN",1,NA
"STYLOMETRIC ANALYSIS",1,NA
"STYRYL 11",1,NA
"SU-8",1,NA
"SUB SCALE",1,NA
"SUBACUTE COMBINED DEGENERATION",1,NA
"SUBARACHNOID",1,NA
"SUBARACHNOID ADMINISTRATION",1,NA
"SUBARACHNOID HAEMORRHAGE",2,NA
"SUBARACHNOID HEMORRHAGE",5,NA
"SUBARACHNOID HEMORRHAGE (SAH)",1,NA
"SUBARACHNOID HEMORRHAGIC",1,NA
"SUBCELLULAR LOCATION",1,NA
"SUBCLAVIAN BLOOD",1,NA
"SUBCUTANEOUS FATTY TISSUE",1,NA
"SUBCUTANEOUS ORGANOPHOSPHATE INJECTION",1,NA
"SUBDURAL",1,NA
"SUBDURAL HEMATOMA",2,NA
"SUBDURAL HEMATOMAS",1,NA
"SUBDURAL HEMORRHAGE",1,NA
"SUBENDOCARDIAL HAEMORRHAGE",1,NA
"SUBGROUPS",1,NA
"SUBHAPLOGROUP",1,NA
"SUBICULUM",1,NA
"SUBJECTIVE EFFECTS",1,1
"SUBJECTIVE PERCEPTION",1,NA
"SUBJECTIVE VISUAL PHENOMENA",1,NA
"SUBJECTIVE WELLBEING",1,NA
"SUBLIMATION",1,1
"SUBLIMINAL",1,NA
"SUBMERGED OBJECT SEARCHES",1,NA
"SUBMERGED SEARCH METHODS",1,NA
"SUBOXONE",1,NA
"SUBPIAL BLEEDING",1,NA
"SUBSCRIBER INFORMATION",1,NA
"SUBSTANCE-EXPOSED CHILDREN",1,NA
"SUBSTANCE-RELATED DISORDERS",51,10
"SUBSTANCE ABUSE",268,69
"SUBSTANCE ABUSE AND CRIME",1,NA
"SUBSTANCE ABUSE AND CRIME PREVENTION ACT",1,NA
"SUBSTANCE ABUSE DETECTION",28,16
"SUBSTANCE ABUSE DISORDER",2,1
"SUBSTANCE ABUSE IN PANDEMIC",1,NA
"SUBSTANCE ABUSE MORTALITY",1,NA
"SUBSTANCE ABUSE TESTING",3,NA
"SUBSTANCE ABUSE TREATMENT",4,1
"SUBSTANCE ABUSE TREATMENT CENTERS",1,NA
"SUBSTANCE ABUSING OFFENDERS",1,NA
"SUBSTANCE ABUSING PATIENTS - COMING INTO CONTACT WITH CRIMINAL JUSTICE SYSTEM",1,NA
"SUBSTANCE ABUSING PATIENTS - DIAGNOSED WITH ANTISOCIAL PERSONALITY DISORDER",1,NA
"SUBSTANCE DEPENDENCY",1,NA
"SUBSTANCE GROUPS",1,NA
"SUBSTANCE IDENTIFICATION",2,NA
"SUBSTANCE INDUCED PSYCHOSIS",1,NA
"SUBSTANCE MISUSE DETAINEE",1,NA
"SUBSTANCE MISUSE TREATMENT",1,NA
"SUBSTANCE MISUSER",1,NA
"SUBSTANCE OF ABUSE",2,NA
"SUBSTANCE USE AND DEPENDENCE",1,NA
"SUBSTANCE USE DISORDER (SUD)",2,NA
"SUBSTANCE USE DISORDER TREATMENT PROGRAM",1,NA
"SUBSTANCE USE DISORDER/DETECTION",1,NA
"SUBSTANCE USE DISORDERS AND CRIMINAL BEHAVIOR - VULNERABILITIES AND PERSONALITY PATHOLOGY",1,NA
"SUBSTANCE USE/MISUSE",1,NA
"SUBSTANCES",1,NA
"SUBSTANCES ASSOCIATED WITH FORENSIC TOXICOLOGY",1,NA
"SUBSTANTIAL ASSISTANCE DEPARTURES",1,NA
"SUBSTITUTE DRUG",1,NA
"SUBSTITUTED PHENYLETHYLAMINES",1,1
"SUBSTITUTES",1,NA
"SUBSTITUTION",8,2
"SUBSTITUTION PROGRAM",2,NA
"SUBSTRATE INTERFERENCES",1,NA
"SUBSTRATES",2,NA
"SUBTRACTIVE MANUFACTURING",1,NA
"SUBTYPES",1,NA
"SUBUNGUAL HEMATOMA",1,NA
"SUBUTEX",1,NA
"SUBVERSIVE ACTIVITY",1,NA
"SUCCESSIVE PROJECTIONS ALGORITHM",1,1
"SUCCINATE DEHYDROGENASE (SDH)",1,NA
"SUCCINIC SEMIALDEHYDE REDUCTASE",1,NA
"SUCCINYLCHOLINE",6,NA
"SUCCINYLDICHOLINE",2,NA
"SUCCINYLMONOCHOLINE",6,NA
"SUCHT",1,NA
"SUCROSE",1,NA
"SUD",2,1
"SUD TREATMENT",1,NA
"SUDAN BLACK",1,NA
"SUDDEN",5,1
"SUDDEN AMNESIA",1,NA
"SUDDEN ARRHYTHMIC DEATH SYNDROME",1,NA
"SUDDEN CARDIAC DEATH",28,NA
"SUDDEN CARDIAC DEATH (SCD)",3,NA
"SUDDEN CHILDHOOD DEATH",1,NA
"SUDDEN CORONARY DEATH",1,NA
"SUDDEN DEATH",86,NA
"SUDDEN DEATH (SD)",1,NA
"SUDDEN DEATH IN CUSTODY",1,NA
"SUDDEN DEATH INTOXICATION",1,NA
"SUDDEN DEATH SYNDROME",1,NA
"SUDDEN IN-CUSTODYRESTRAINT DEATHS (SIRD)",1,NA
"SUDDEN IN CUSTODY DEATH",1,NA
"SUDDEN INFANT DEATH",3,NA
"SUDDEN INFANT DEATH SYNDROME",10,NA
"SUDDEN INFANT DEATH SYNDROME (SIDS)",1,NA
"SUDDEN INFANT UNEXPECTED DEATH (SID)",1,NA
"SUDDEN MYOCARDIAL INJURY",1,NA
"SUDDEN NATURAL DEATH",2,NA
"SUDDEN SNIFFING DEATH",1,NA
"SUDDEN SNIFFING DEATH SYNDROME",1,NA
"SUDDEN SNIFFING DEATHS",1,NA
"SUDDEN UNDEXPLAINED DEATH",1,NA
"SUDDEN UNEXPECTED DEATH",6,NA
"SUDDEN UNEXPECTED DEATH IN EPILEPSY",6,NA
"SUDDEN UNEXPECTED DEATH IN INFANCY",2,NA
"SUDDEN UNEXPECTED NOCTURNAL DEATH SYNDROME",1,NA
"SUDDEN UNEXPLAINED DEATH",2,NA
"SUDEN DEATH",1,NA
"SUDEP",5,NA
"SUDEP INCIDENCE",1,NA
"SUDEP SUDDEN UNEXPECTED DEATH",1,NA
"SUDI",2,NA
"SUFENTANIL",1,1
"SUFFOCATING GAS",1,NA
"SUFFOCATION",7,NA
"SUGAMMADEX",1,NA
"SUGAR",1,3
"SUGGESTIBILITY",1,NA
"SUGGESTIVE QUESTIONS",1,NA
"SUICID, INJEKTION VON SPEISEÖL",1,NA
"SUICIDAL",3,NA
"SUICIDAL BEHAVIOR AND SUBSTANCE ABUSE - CLOSELY LINKED",1,NA
"SUICIDAL COMMUNICATION",1,NA
"SUICIDAL GUNSHOT TO THE HEAD",1,NA
"SUICIDAL IDEATION",3,NA
"SUICIDAL INGESTION",1,NA
"SUICIDAL INJECTION",1,NA
"SUICIDAL INTOXICATION",1,NA
"SUICIDAL LIGATURE STRANGULATION",1,NA
"SUICIDAL POISONING",1,NA
"SUICIDAL POISONINGS",1,NA
"SUICIDALITY",1,1
"SUICIDE",292,2
"SUICIDE-BY-COP",1,NA
"SUICIDE AMONG PHYSICIANS",1,NA
"SUICIDE AND HOMICIDE UNDER THE INFLUENCE OF NPS.",1,NA
"SUICIDE ATTEMPT",8,NA
"SUICIDE ATTEMPTS",1,NA
"SUICIDE BEHAVIOR",1,NA
"SUICIDE BY COP",2,NA
"SUICIDE BY DRUG OVERDOSE",1,NA
"SUICIDE BY INHALATION",1,NA
"SUICIDE BY JUMPING",1,NA
"SUICIDE DEATHS",1,NA
"SUICIDE IDEATION",1,NA
"SUICIDE METHOD",2,NA
"SUICIDE METHODS",8,NA
"SUICIDE NOTE",3,NA
"SUICIDE PACT",1,NA
"SUICIDE PREDICTORS",1,NA
"SUICIDE PREVENTION",5,NA
"SUICIDE RATES",1,NA
"SUICIDE RISK",1,NA
"SUICIDE RISK ASSESSMENT",1,NA
"SUICIDE RISK FACTORS",1,NA
"SUICIDE RISK MANAGEMENT",1,NA
"SUICIDE TRENDS",1,NA
"SUICIDE, FIRE DEATHS",1,NA
"SUICIDE, INTOXICATION",1,NA
"SUICIDE, NEUROMUSCULAR BLOCKER",1,NA
"SUICIDE/SELF-HARM",1,NA
"SUICIDES, IN EAST BERLIN",1,NA
"SULBACTAM",1,NA
"SULFADIAZINE",1,NA
"SULFATE",1,1
"SULFATE CONJUGATE",1,NA
"SULFATE ION",1,NA
"SULFATED CYCLODEXTRIN",2,5
"SULFHYDRYL",1,NA
"SULFOXIDE",1,NA
"SULFUR CHEMICAL STATES",1,NA
"SULFUR MUSTARD",3,NA
"SULFUR MUSTARD ANTIBODY",1,NA
"SULFURIC ACID",1,NA
"SULFURIC ACID INJURY",1,1
"SULOPHONAMIDES",1,NA
"SULPHIDE",1,NA
"SULPIRIDE",1,NA
"SUM FREQUENCY",1,NA
"SUMMER",1,NA
"SUPER ACCELERATED VACCINATION REGIMEN",1,NA
"SUPER OXIDE DISMUTASE, COX-2",1,NA
"SUPERABSORBENT POLYMER",1,NA
"SUPERABSORBENT POLYMERS",1,1
"SUPERCHIRAL",1,NA
"SUPERCRITICAL FLUID AND SOLID-PHASE EXTRACTION",1,1
"SUPERCRITICAL FLUID CHROMATOGRAPHY",14,20
"SUPERCRITICAL FLUID EXTRACTION",3,8
"SUPERFICIAL TEMPORAL ARTERY",1,NA
"SUPERFICIALLY POROUS PARTICLES (SPP)",1,NA
"SUPERGLUE FUMING",1,NA
"SUPERHYDROPHOBIC TEXTURES",1,NA
"SUPERSONIC MOLECULAR BEAM",1,NA
"SUPERVISED LEARNING",1,1
"SUPERVISED MACHINE LEARNING",1,NA
"SUPERVISED TECHNIQUES",1,NA
"SUPERVISION",1,2
"SUPERWARFARIN",1,NA
"SUPERWARFARIN INTOXICATION",1,NA
"SUPERWARFARINS",1,NA
"SUPPLEMENTS, RANDOMIZED CONTROL TRIAL",1,NA
"SUPPLY AND DEMAND",1,1
"SUPPLY CHAIN",1,NA
"SUPPLY OF DRUGS",1,NA
"SUPPLY REDUCTION",1,NA
"SUPPORT",1,NA
"SUPPORT VECTOR MACHINE (SVM)",6,9
"SUPPORTED-LIQUID-EXTRACTION (SLE)",1,NA
"SUPPORTED EMPLOYMENT",1,NA
"SUPPORTED LIQUID EXTRACTION",4,1
"SUPPORTED LIQUID MEMBRANES (SLMS)",1,NA
"SUPPORTED VECTOR MACHINE (SVM)",1,NA
"SUPPRESSED CONDUCTIVITY",1,NA
"SUPRAMOLECULAR SOLVENT",2,NA
"SUPRAMOLECULAR SOLVENTS",1,1
"SUPRAVENTRICULAR AND VENTRICULAR ARRHYTHMIAS",1,NA
"SUPRAVITAL PHASE",1,NA
"SUPRAVITAL REACTION",1,NA
"SURFACE-ASSISTED LASER DESORPTION IONIZATION-MASS SPECTROMETRY",1,NA
"SURFACE-ENHANCED RAMAN",1,1
"SURFACE-ENHANCED RAMAN SPECTROSCOPY (SERS)",2,2
"SURFACE-ENHANCED SPECTROSCOPY (SERS)",1,NA
"SURFACE-IONIZATION MASS SPECTROMETRY",1,NA
"SURFACE-WEB MONITORING",2,NA
"SURFACE ACOUSTIC WAVE NEBULIZATION",1,NA
"SURFACE AREA",1,NA
"SURFACE CHEMISTRY",1,NA
"SURFACE DESORPTION",1,NA
"SURFACE DESORPTION ATOMOSPHERIC PRESSURE CHEMICAL IONIZATION (DAPCI)",1,NA
"SURFACE DESORPTION/IONIZATION",1,1
"SURFACE ENHANCEMENT RAMAN SPECTROSCOPY",1,1
"SURFACE FITTING",1,NA
"SURFACE IMPRINTING",1,NA
"SURFACE IONIZATION",3,3
"SURFACE IONIZATION DETECTION",2,NA
"SURFACE IONIZATION DETECTION (SID)",1,NA
"SURFACE PLASMON RESONANCE (SPR)",3,5
"SURFACE ROUGHNESS",1,1
"SURFACE SAMPLING",2,1
"SURFACE SEDIMENT",1,NA
"SURFACE WATER",3,20
"SURFACES",1,NA
"SURFACTANT",7,6
"SURGERY",5,NA
"SURGICAL ABORTION",1,NA
"SURGICAL SUTURES",1,NA
"SURGICAL TREATMENT",1,NA
"SURREPTITIOUS DRUG ADMINISTRATION",1,1
"SURROGATE GLASSES",1,NA
"SURROGATE NUCLEAR EXPLOSION DEBRIS",2,NA
"SURROGATE SPIKE",1,1
"SURVEILLANCE",15,5
"SURVEY",7,7
"SURVIVAL",2,NA
"SURVIVAL ANALYSIS",2,NA
"SURVIVAL PERIOD",1,NA
"SURVIVAL RATE",1,NA
"SURVIVAL TIME",3,NA
"SURVIVAL TIME ESTIMATION",1,NA
"SURVIVE",1,NA
"SURVIVOR",1,NA
"SUS SCROFA",2,NA
"SUSCEPTIBILITY",1,NA
"SUSPECT",1,NA
"SUSPECT SCREENING",1,1
"SUSPECTED POISONING",1,NA
"SUSPENDED PARTICULATE MATTER",1,NA
"SUSPENDED SOLIDS",1,NA
"SUSPENSION",1,NA
"SUSPICION",1,NA
"SUSPICION OF POISONING",1,NA
"SUSTENTACULAR CELLS",1,NA
"SUTURE EMBOLISM",1,NA
"SUVOREXANT",6,NA
"SUXAMETHONIUM",3,NA
"SUXAMETHONIUM CHLORIDE",1,NA
"SUZUKI CROSS-COUPLING",1,1
"SVD",1,NA
"SVSA",1,NA
"SWAB",1,1
"SWAB-SAMPLING",1,NA
"SWAB TECHNIQUES",1,NA
"SWAB TOUCH SPRAY IONIZATION (STSI)",1,NA
"SWABBING",1,NA
"SWABS",3,NA
"SWALLOWING OF POINTED OBJECTS",1,NA
"SWASTIKA",1,NA
"SWATH",2,NA
"SWEAT",17,1
"SWEAT-PATCH TESTING",1,NA
"SWEAT-SPECIFIC PEPTIDE",1,NA
"SWEAT ANALYSIS",6,2
"SWEAT GLAND DEGENERATION",1,NA
"SWEAT IDENTIFICATION",1,NA
"SWEAT PATCH",3,NA
"SWEAT PATCHES",1,NA
"SWEAT TESTING",1,NA
"SWEATING RATES",1,NA
"SWEDEN",6,NA
"SWEDEN DRUG MARKET",1,1
"SWEDISH",1,NA
"SWEDISH INTRAVENOUS HEROIN ADDICTS",1,NA
"SWEEPING",2,5
"SWEEPING-MEKC",1,1
"SWGDRUG",1,3
"SWGDRUG DRUG IDENTIFICATION, INTERNATIONAL IN SCOPE, BUT LESS USED",1,NA
"SWGTOX",3,NA
"SWIMMING",1,NA
"SWIMMING POOL",1,NA
"SWINE",2,NA
"SWIPE SAMPLE",1,NA
"SWISS CANTONS",1,1
"SWISS CHEESE PATTERN",1,NA
"SWISS LABORATORIES",1,NA
"SWISS LEGISLATION",1,NA
"SWISS NATIONAL SCIENCE FOUNDATION",1,NA
"SWITCHABLE HYDROPHILICITY SOLVENT",1,2
"SWITZERLAND",3,1
"SYBR-GREEN",1,NA
"SYBR GREEN",1,NA
"SYBR GREEN I",1,1
"SYBR GREEN REAL-TIME QPCR",1,NA
"SYMCLOSENE",1,NA
"SYMMETRIC PERIPHERAL GANGRENE",1,NA
"SYMPATHETIC NERVOUS SYSTEM",1,NA
"SYMPATHOMIMETIC AMINE",1,1
"SYMPOSIUM",1,NA
"SYMPTOM SEVERITY",1,NA
"SYMPTOM VALIDITY TEST",1,NA
"SYMPTOMATOLOGY",1,NA
"SYMPTOMS",2,1
"SYNANTHROPIC",1,NA
"SYNAPSE",1,NA
"SYNAPTIC PLASTICITY",1,NA
"SYNAPTOPHYSIN",1,NA
"SYNCHRONOUS SPECTROFLUORIMETRY",1,NA
"SYNCHROTRON",1,NA
"SYNCHROTRON RADIATION",2,2
"SYNCRETIC",1,NA
"SYNDEMICS",1,NA
"SYNDROMES",1,NA
"SYNERGISM",1,NA
"SYNOVIA OF THE KNEE JOINT",1,NA
"SYNOVIAL FLUID",1,NA
"SYNPERONIC N",1,NA
"SYNTETHIC OPIOID",1,NA
"SYNTHESIS",21,36
"SYNTHESIS BY-PRODUCTS",3,2
"SYNTHESIS METHOD",1,NA
"SYNTHESIS METHODS",1,NA
"SYNTHESIS WASTE ANALYSIS",1,1
"SYNTHESIZED NARCOTIC",1,NA
"SYNTHETIC AMPHETAMINES",1,NA
"SYNTHETIC CANNABIMIMETICS",1,3
"SYNTHETIC CANNABINOID RECEPTOR AGONIST",2,1
"SYNTHETIC CANNABINOID RECEPTOR AGONISTS",6,2
"SYNTHETIC CANNABINOID(S)",1,NA
"SYNTHETIC CANNABINOIDS (SC)",50,37
"SYNTHETIC CANNABINOIDS (SCS), PSYCHOACTIVE SUBSTANCES",1,1
"SYNTHETIC CANNABINOIDS AND METABOLITES",1,NA
"SYNTHETIC CANNABINOIDS DESIGNER DRUGS",1,1
"SYNTHETIC CANNABINOIDS RECEPTOR AGONISTS",1,NA
"SYNTHETIC CANNABIS",2,1
"SYNTHETIC CATHINONE",71,64
"SYNTHETIC DESIGNER DRUG",1,NA
"SYNTHETIC DRUG SCHEDULING",1,NA
"SYNTHETIC DRUGS",14,10
"SYNTHETIC GLUES",1,NA
"SYNTHETIC HALLUCINOGEN",1,NA
"SYNTHETIC INSULINS",1,NA
"SYNTHETIC MARIJUANA",2,5
"SYNTHETIC MARKER",1,1
"SYNTHETIC METHOD",2,6
"SYNTHETIC OPIOIDS",20,11
"SYNTHETIC ROUTE",1,NA
"SYNTHETIC ROUTE AND ROUTE SPECIFIC IMPURITIES",1,1
"SYNTHETIC TRYPTAMINE",1,NA
"SYNTHETICCANNABINOIDS",1,NA
"SYNTHETICDRUGSCHEDULING",1,NA
"SYNTHETICS",1,1
"SYNTHETICS DRUGS",1,1
"SYRHPHIDAE",1,NA
"SYRINGE",1,1
"SYRINGE-LIKE DART",1,NA
"SYRINGE SHARING",1,NA
"SYRINGES",1,1
"SYRINGYL/GUAIACYL RATIO",1,NA
"SYSTEM",1,NA
"SYSTEMATIC REVIEW",8,3
"SYSTEMATIC TOXICOLOGICAL ANALYSES",1,NA
"SYSTEMATIC TOXICOLOGICAL ANALYSIS",22,3
"SYSTEMIC DISEASE",1,NA
"SYSTEMIC DISEASES",4,NA
"SYSTEMIC DISSEMINATION",1,NA
"SYSTEMIC GRANULOMATOSIS",1,NA
"SYSTEMIC INFLAMMATORY RESPONSE SYNDROME",1,NA
"SYSTEMIC RELATION",1,NA
"SYSTEMIC SCLEROSIS",1,NA
"SYSTEMS AND CENTERS OF DRUG REGULATION",1,NA
"SYSTEMS BIOLOGY",2,NA
"SYSTEMS DEFICIT",1,NA
"SYSTEMS OF CARE",1,NA
"SYSTEMS1-3",1,NA
"T.NERIFOLIA",1,NA
"T/E",1,NA
"T/E MARKER",1,NA
"TABA",1,NA
"TABLET",5,13
"TABLET ANALYSIS",1,1
"TABLET FILLER EMBOLI",1,NA
"TABLET REMAINS",1,NA
"TABLET RESIDUES IN THE STOMACH CONTENTS, SCREENING METHOD",1,NA
"TABLET SEIZED",1,NA
"TABLETS/PHYSICAL CHARACTERISTICS",1,NA
"TACHYCARDIA",1,NA
"TACT",1,NA
"TACTILE SYMBOLS",1,NA
"TADALAFIL (TAD)",7,12
"TAIWAN",2,1
"TAIWAN MED-X",1,NA
"TAKAYAMA",1,NA
"TAKE CARE",1,NA
"TALC",1,NA
"TALC EMBOLISM",1,NA
"TAMILNADU",1,NA
"TAMOXIFEN",1,1
"TAMPER-EVIDENT",1,NA
"TAMPERING",1,5
"TANATODIAGNOSTICS",1,1
"TANAX®(T-61)",1,NA
"TANDEM LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"TANDEM MASS SPECTROMETRY (MS/MS)",60,36
"TANDEM MS SPECTROSCOPY",2,NA
"TANDEM REPEAT",2,1
"TANGENT METHOD",1,NA
"TANNERY EFFLUENTTOXICITY OF CHROMIUM",1,NA
"TANNIC ACID",1,NA
"TANZANIA",2,NA
"TAP WATER",2,4
"TAPE",2,NA
"TAPE STRIPPING",1,NA
"TAPENDATOL",1,NA
"TAPENTADOL",1,5
"TAPHONOMY",3,NA
"TAQ POLYMERASE",1,NA
"TAQ1A",1,NA
"TAQMAN",1,NA
"TAQMAN PROBE",1,NA
"TAQMAN QPCR",1,NA
"TAQMAN REAL TIME PCR",1,NA
"TARAXASTEROL",1,NA
"TARDIVE DYSKINESIA",2,NA
"TARGET ANALYSIS",1,NA
"TARGET ANALYTE",1,NA
"TARGET COMPOUNDS STABILITY",1,NA
"TARGET SCREENING",1,1
"TARGET STANDARD DEVIATION",1,NA
"TARGETED",1,NA
"TARGETED ANALYSIS",1,1
"TARGETED ASSAY",1,NA
"TARGETED CONTRAST AGENT INJECTION OF VISCERAL ORGANS",1,NA
"TARGETED MASS SPECTROMETRY",1,NA
"TARGETED MASSIVELY PARALLEL SEQUENCING",1,NA
"TARGETED QUANTIFICATION",1,NA
"TARGETED RNA SEQUENCING",1,NA
"TARGETED VIOLENCE",1,NA
"TASC",1,NA
"TASER",7,NA
"TASER GUN",1,NA
"TASMANIAN POPPIES",1,1
"TATP (TRIACETONE TRIPEROXIDE), RDX (HEXAHYDRO-1,3,5-TRINITRO-S-TRIAZINE)",1,NA
"TATTOO",4,NA
"TATTOO INKS",1,NA
"TATTOOING",2,NA
"TATTOOS",7,NA
"TAURINE",1,1
"TAXINE",1,NA
"TAXINE B",1,NA
"TAXINE B, 3,5-DIMETHOXYPHENOL",1,NA
"TAXINE B/ISOTAXINE B ANALYSIS",1,NA
"TAXINE POISONING",1,NA
"TAXOIDS",1,NA
"TAXOL",2,NA
"TAXONOMIES",3,2
"TAXUS",2,NA
"TAXUS BACCATA",2,NA
"TAXUS SPP.",1,NA
"TBI",1,NA
"TBI MARKERS",1,NA
"TCA",1,NA
"TCAS",2,NA
"TCI",1,NA
"TCNQ",1,NA
"TCSCI ETC",1,NA
"TCU CRIMINAL THINKING SCALES",1,NA
"TD",1,NA
"TD-DART-MS",2,NA
"TD-GC/MS",1,NA
"TDM",1,NA
"TDX DRUGS OF ABUSE ASSAYS",1,NA
"TEA",2,3
"TEAR TESTS",1,NA
"TEARING",1,NA
"TEARS",1,NA
"TEARS ANALYSIS",1,NA
"TECAN ROBOT",1,NA
"TECHNICAL",1,NA
"TECHNICAL ADVANCEMENTS",1,NA
"TECHNICAL METHODS",1,NA
"TECHNIQUE SEQUENCING",1,NA
"TECHNOLOGY",5,3
"TEENAGE",1,NA
"TEENAGE BOYS",1,NA
"TEENAGE SUICIDE",1,NA
"TEETH",5,NA
"TEFLON",1,NA
"TEFLONOMA",1,NA
"TEGRETOL",1,NA
"TEHRAN",1,1
"TEKTITE",1,NA
"TELEMETRY DATA",1,NA
"TELEPATHOLOGY",1,NA
"TELEPHONE CORD",1,NA
"TELEPSYCHIATRY",1,NA
"TELOMERASE ACTIVITY",1,NA
"TEM",1,NA
"TEMAZEPAM",6,NA
"TEMAZEPAM-GLUCURONIDE",1,NA
"TEMPERATURE",4,6
"TEMPERATURE-DEPENDENT",1,NA
"TEMPERATURE-RESPONSIVE",1,NA
"TEMPERATURE AT MOMENT OF DEATH",1,NA
"TEMPERATURE DEPENDENCE",2,1
"TEMPERATURE MEASUREMENT",1,NA
"TEMPERATURE PLATEAU EFFECT (TPE)",1,NA
"TEMPERATURE RATIO",1,NA
"TEMPLATE MATCHING",1,NA
"TEMPO",1,NA
"TEMPORAL",1,NA
"TEMPORAL LOBE",1,NA
"TEMPORAL LOBE EPILEPSY",1,NA
"TEMPORAL LOBE SEIZURE",1,NA
"TEMPORARY CAVITY",2,NA
"TEN KEY COMPONENTS",1,NA
"TENAX-GC",1,NA
"TENSILE TESTS",1,NA
"TENSION",2,NA
"TENSION FREE VAGINAL SLING PROCEDURES",1,NA
"TERAHERTZ",2,5
"TERAHERTZ SPECTROSCOPY",1,2
"TERATOGENECITY",1,NA
"TERATOLOGY",1,NA
"TERBUTALINE",2,2
"TERLIPRESSIN",1,NA
"TERMINAL BALLISTICS",1,NA
"TERMINAL PATIENT MANAGEMENT",1,NA
"TERMINOLOGY",2,1
"TERNARY DIAGRAM",1,NA
"TERNARY DIAGRAMS",1,NA
"TERPANES",1,NA
"TERRITORIAL",1,NA
"TERRITORY",1,NA
"TERRITORY OF RUSSIA",1,NA
"TERROR",1,NA
"TERROR PREVENTION",1,NA
"TERRORISM",4,2
"TERRORIST",1,NA
"TERTIARY-AMINE-CONTAINING FUNCTIONAL POLYMERS",1,NA
"TERTIARY AMINE",1,1
"TERTIARY AMINE DEHYDROGENATION",1,NA
"TERTIARY AMINES",1,1
"TERTIARY CARE",1,NA
"TERTIARY CARE HOSPITAL",1,NA
"TEST-RETEST RELIABILITY &",1,NA
"TEST-STRIPS",1,NA
"TEST CHAMBERS",1,NA
"TEST EXTRACTOR MARKS",1,NA
"TEST KIT",2,NA
"TEST MATERIAL",1,1
"TEST OF MEMORY MALINGERING",1,NA
"TEST STRIP",1,NA
"TEST STRIPS",1,1
"TEST VALIDATION",1,NA
"TESTABILITY",1,NA
"TESTAMENT",1,NA
"TESTAMENTARY CAPACITY",1,NA
"TESTICLES",1,NA
"TESTIMONY.",1,NA
"TESTING",1,1
"TESTING ARTIFACTS",1,1
"TESTING SYSTEM",1,NA
"TESTING TECHNOLOGY",1,NA
"TESTOSTERONE",13,10
"TESTOSTERONE-LOWERING MEDICATION",1,NA
"TESTOSTERONE ESTERS",1,1
"TESTOSTERONE GEL",1,NA
"TETANUS",1,NA
"TETHERING",1,NA
"TETRABROMOPHENOLPHTHALEIN ETHYL ESTER",1,1
"TETRACAINE",5,NA
"TETRACHLOROETHYLENE",1,NA
"TETRACYCLIC ANTIDEPRESSANTS",2,NA
"TETRADIHYDROCANNABINOL",1,NA
"TETRAHEDRON",1,1
"TETRAHYDRO-Β-CARBOLINES",1,NA
"TETRAHYDROBENZYLISOQUINOLINE",1,1
"TETRAHYDROCANNABINOL",49,44
"TETRAHYDROCANNABINOL (THC) / HEMP FOOD",1,NA
"TETRAHYDROCANNABINOL METABOLITE, DETECTION IN URINE",1,NA
"TETRAHYDROCANNABINOLIC ACID A",1,1
"TETRAHYDROCANNABINOLIC ACID SYNTHASE GENE",1,1
"TETRAHYDROCANNABIVARIN (THCV)",1,1
"TETRAHYDROFURAN, IN HISTOLOGIC MATERIALS",1,NA
"TETRAHYDROHARMINE",1,1
"TETRAHYDROZOLINE",2,NA
"TETRAMETHYLAMMONIUM HYDROXIDE",1,NA
"TETRAMETHYLBENZIDINE",2,NA
"TETRAMETHYLENEDISULFOTETRAMINE",1,NA
"TETRAMINE",5,NA
"TETRAMISOLE",1,1
"TETRANITRO TETRAAZA CYCLOCOCTATETRAENE",1,NA
"TETRANUCLEOTIDE STR LOCUS",1,NA
"TETRAZEPAM",3,NA
"TETRODOTOXIN",5,NA
"TETS",1,NA
"TEXT MINING",1,2
"TEXTBOOKS",1,NA
"TEXTILE",1,1
"TEXTILE DYE",2,1
"TEXTILE FIBRES",1,1
"TEXTILE IMPREGNATION",1,1
"TEXTURE",1,NA
"TFMPP",3,3
"TGA",1,NA
"TGF-Β3",1,NA
"TGLA122",1,NA
"TGLA53",1,NA
"TH01 POLYMORPHISM",1,NA
"THAILAND",2,2
"THALLIUM",1,NA
"THALLIUM DETERMINATION",1,NA
"THALLIUM POISONING",2,NA
"THALLIUMNACHWEIS, IM LEICHENMATERIAL",1,NA
"THALLIUMVERGIFTUNG",1,NA
"THANATO-CHEMISTRY",1,NA
"THANATOCHEMISTRY",2,NA
"THANATOMICROBIOME",2,NA
"THANATOPRAXY",1,NA
"THANATOPSY",1,NA
"THANATOTRANSCRIPTOME",1,NA
"THC-COOH",4,2
"THC-COOH, SPME",1,NA
"THC CONCENTRATION",1,NA
"THC OXIDATION",1,NA
"THC RECOVERY",1,NA
"THC THRESHOLD",1,NA
"THC/CBD RATIO",1,NA
"THC/CBN",1,NA
"THCA",2,4
"THCA SYNTHASE",3,2
"THCA SYNTHASE GENE",5,2
"THCAS",2,2
"THCCOOH",4,NA
"THCCOOH-GLUC",1,NA
"THCCOOH-GLUCURONIDE",1,NA
"THCCOOH HAIR ANALYSIS",2,NA
"THCCOOH ISOMER",1,NA
"THE 70 KDA HEAT SHOCK PROTEIN",1,NA
"THE AGE OF GEL INK ENTRIES",1,NA
"THE CAUSE OF DEATH",1,NA
"THE CAUSES OF DEATH",1,NA
"THE DAUBERT RULING OF THE US FEDERAL COURT, AND USE OF PHYSICAL EVIDENCE",1,NA
"THE FOUR DS",1,NA
"THE FRONTAL CORTEX",1,NA
"THE HYPOTHALAMUS",1,NA
"THE INTERNATIONAL COOPERATION",1,NA
"THE LENS OF RISK",1,NA
"THE NETHERLANDS",3,NA
"THE NUMBER OF NOT REPORTED CASES",1,NA
"THE ONION ROUTER",1,NA
"THE PSYCHOPATHY CHECKLIST - REVISED",1,NA
"THE RESULT",1,NA
"THE SYSTEM OF EXPERTISE",1,NA
"THE UROS",1,NA
"THE USE OF A TEMPLATE PREVENTS MOST ERRORS OF OMISSION",1,NA
"THEBAINE",3,16
"THEBAINE METABOLISM",1,NA
"THEFT",1,NA
"THEMATIC ANALYSIS",1,NA
"THEOBROMINE",2,2
"THEOPHYLLINE",6,9
"THEORETICAL CALCULATIONS",1,1
"THEORETICAL POSTMORTEM REDISTRIBUTION FACTOR (FT)",1,NA
"THEORETICAL STUDY",1,1
"THEORY",1,NA
"THERAGNOSTIC",1,NA
"THERAPEUTIC",2,2
"THERAPEUTIC BIOMARKERS",1,NA
"THERAPEUTIC COMMUNITIES",1,NA
"THERAPEUTIC COMMUNITY",6,NA
"THERAPEUTIC COMPETENCE",1,NA
"THERAPEUTIC COMPLICATION",4,NA
"THERAPEUTIC CONCEPTS",1,NA
"THERAPEUTIC DRUG LEVELS",1,NA
"THERAPEUTIC DRUG MANAGEMENT",1,NA
"THERAPEUTIC DRUG MONITORING",33,NA
"THERAPEUTIC DRUG MONITORING (TDM)",4,NA
"THERAPEUTIC DRUG MONITORING METHADONE-ASSOCIATED DEATH",1,NA
"THERAPEUTIC DRUGS",3,1
"THERAPEUTIC INJUNCTION",1,NA
"THERAPEUTIC JURISPRUDENCE",2,NA
"THERAPEUTIC JUSTICE",1,NA
"THERAPEUTIC LEVELS",1,NA
"THERAPEUTIC MANAGEMENT",1,NA
"THERAPEUTIC PROCESS",1,NA
"THERAPEUTIC PROCESS RESEARCH",1,NA
"THERAPEUTIC RANGES",1,NA
"THERAPEUTIC RISK ASSESSMENT",1,NA
"THERAPEUTIC USE",2,NA
"THERAPEUTIC USE OF ALCOHOL",1,NA
"THERAPEUTIC USE.",1,NA
"THERAPEUTIC WINDOW",4,NA
"THERAPEUTICAL CONCENTRATIONS",1,NA
"THERAPEUTICS",1,NA
"THERAPY",4,2
"THERAPY COMPLIANCE",1,NA
"THERAPY EFFECTIVENESS",1,NA
"THERAPY EFFICACY",1,NA
"THERAPY FAILURE",1,NA
"THERAPY LIMITATION",1,NA
"THERAPY OF DRUG ADDICTS",1,NA
"THERAPY OUTCOME",1,NA
"THERAPY PROCESS",1,NA
"THERAPY.",1,NA
"THERMAL",1,NA
"THERMAL ANALYSIS",4,6
"THERMAL DECOMPOSITION",1,3
"THERMAL DEGRADATION",6,4
"THERMAL DESORPTION",2,6
"THERMAL DESORPTION-GAS CHROMATOGRAPHY-MASS SPECTROMETRY (TD-GC-MS)",1,NA
"THERMAL DESTRUCTION OF CORPSES",1,NA
"THERMAL ENERGY ANALYZER (TEA)",1,NA
"THERMAL ENVIRONMENT IN FIRE",1,NA
"THERMAL HAIR STRAIGHTENING",1,NA
"THERMAL IMAGING",1,NA
"THERMAL IONIZATION MASS SPECTROMETER (TIMS)",1,NA
"THERMAL IONIZATION MASS SPECTROMETRY",3,1
"THERMAL PAPER",4,NA
"THERMAL STABILITY",1,1
"THERMALLY ASSISTED HYDROLYSIS AND METHYLATION PYROLYSIS GAS CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"THERMANIN",1,NA
"THERMOCHROMATOGRAPHY",1,NA
"THERMOGRAVIMETRIC ANALYSIS (TGA)",4,NA
"THERMOGRAVIMETRY",1,NA
"THERMOLUMINESCENCE",1,NA
"THERMOPLASTIC EXTRUSION",1,NA
"THERMOPLASTIC POLYURETHANE ELASTOMERS",1,NA
"THERMOREGUALTION AND DRUGS",1,NA
"THERMOREGULATION",1,NA
"THERMORESPONSIVE POLYMER COLUMN",1,NA
"THERMOSPECTROMETRY",1,NA
"THERMOSPRAY LIQUID CHROMOTOGRAPHY/MASS SPECTROMETRY",1,1
"THERMOSTABLE DNA POLYMERASE",1,NA
"THERMOSTABLE PROTEINASE",1,NA
"THEVETIN",1,NA
"THEVETIN B",1,NA
"THIENODIAZEPINES",1,NA
"THIENYL ANALOGUE OF CATHINONE",1,1
"THIGHBONE",1,NA
"THIN-LAYER CHROMATOGRAPHY-DENSITOMETRY",1,NA
"THIN-LAYER CHROMATOGRAPHY (TLC)",2,NA
"THIN‐LAYER CHROMATOGRAPHY",1,NA
"THIN‐LAYER CHROMATOGRAPHY, HPTLC",1,NA
"THIN FILM MATERIALS",1,NA
"THIN LAYER CHROMATOGRAPHY (TLC)",54,48
"THINNER",1,NA
"THINNER ABUSER",1,NA
"THIOACETAL",1,NA
"THIOAILDENAFIL",1,NA
"THIOCHROME REACTION",1,NA
"THIOCYANATE",2,1
"THIOCYANATE EXCRETION",2,NA
"THIODICARB",1,NA
"THIOHOMOSILDENAFIL",1,NA
"THIOKETALS",1,1
"THIOL-ENE POLYMERS",1,NA
"THIOLS",1,NA
"THIOMORPHOLINE 3-CARBOXYLATE",1,NA
"THIOPENTAL",3,NA
"THIOPROPYL SEPHAROSE 6B",1,NA
"THIORIDAZINE",2,1
"THIOSILDENAFIL",1,NA
"THIOTHINONE",1,1
"THIRD-PARTY REPORTING",1,NA
"THIRD MOLAR",1,NA
"THIRD PARTY INSURANCE",1,NA
"THJ-018",1,1
"THJ-2201",2,NA
"THO",1,NA
"THORACIC",1,NA
"THORACOLUMBAR SPINE",1,NA
"THORIUM",8,NA
"THORIUM ISOTOPES",1,NA
"THREAD SPRAY",1,NA
"THREAT",1,NA
"THREAT ASSESSMENT",1,NA
"THREAT LIST",1,NA
"THREAT MAIL",1,NA
"THREAT ODORS",1,NA
"THREATS OF HARM",1,NA
"THREE-DIMENSIONAL COORDINATES",1,NA
"THREE-DIMENSIONAL CULTURE",1,NA
"THREE ZONES IN HAIR FOLLICLES, ROOT BULB AS INDICATOR OF CHEMICALS",1,NA
"THRESHOLD CHARACTERS",1,NA
"THRESHOLD VALUES",1,NA
"THROMBOEMBOLISM",2,NA
"THROMBOSIS",1,NA
"THROMBOTIC EVENTS",1,NA
"THROMBOTIC MICROANGIOPATHY",1,NA
"THROMBOXANE",1,NA
"THROMBUS AGE",1,NA
"THROUGH BARRIER DETECTION",1,NA
"THROUGHCARE",1,NA
"THUJONE",1,1
"THUNDERSTORM ASTHMA",1,NA
"THYMOGLOBULIN",1,NA
"THYMUS",1,NA
"THYMUS ALTERATIONS",1,NA
"THYROGLOBULIN",1,NA
"THYROID CANCER",1,NA
"THYROID GLAND",1,NA
"THYROID HORMONES",1,NA
"THYROID PEROXIDASE",1,NA
"THYROID STIMULATING HORMONE",1,NA
"THYROXINE",1,NA
"TIAFT AND SOFT, AND FUNDING THROUGH NIJ",1,NA
"TIANEPTINE",2,2
"TIBETAN",1,NA
"TIBETAN PILLS",1,NA
"TIBIA INFUSION",1,NA
"TICLOPIDINE",1,NA
"TIERED",1,NA
"TILETAMINE",2,NA
"TILIDINE",2,NA
"TILINE",1,NA
"TIME-DEPENDENT DENSITY FUNCTIONAL THEORY",1,1
"TIME-DEPENDENT POSTMORTEM REDISTRIBUTION",5,NA
"TIME-LINE FOLLOW-BACK INTERVIEW (TLFB) - A SEMISTRUCTURED INTERVIEW, METHOD FOR ASSESSING ALCOHOL AND DRUG USE PATTERNS",1,NA
"TIME-OF-FLIGHT",11,8
"TIME-OF-FLIGHT (TOF)",1,NA
"TIME-OF-FLIGHT MASS SPECTROMETRY (TOF-MS)",20,20
"TIME-OF-FLIGHT MS",1,NA
"TIME-OF FLIGHT MASS SPECTROMETRY",1,NA
"TIME AND FINANCIAL BUDGETING",1,NA
"TIME BETWEEN DRINKING AND DEATH",1,NA
"TIME CRITICAL",1,NA
"TIME DEPENDENCY",1,NA
"TIME DOMAIN",2,1
"TIME FACTORS",1,NA
"TIME OF ACCIDENT",1,NA
"TIME OF DEATH",7,NA
"TIME OF DEATH (TOD)",1,NA
"TIME OF FLIGHT DETECTION",1,1
"TIME OF FLIGHT MS",1,NA
"TIME RESOLUTION",1,NA
"TIME RESOLVED IMMUMOASSAY",1,NA
"TIME SINCE DEATH",12,1
"TIME SINCE DEPOSITION (TSD)",1,NA
"TIME SINCE DISCHARGE",3,NA
"TIME TENDENCY",1,NA
"TIME TRENDS",1,NA
"TIMING CONSTRAINT",1,NA
"TIMIPERONE",1,NA
"TIMOLOL",1,NA
"TIMS",3,NA
"TINIDAZOLE",1,NA
"TIP-ENHANCED RAMAN",1,1
"TIRE RUBBER",1,NA
"TISSUE",10,4
"TISSUE-DRUG CONCENTRATION",1,NA
"TISSUE-DRUG CONCENTRATIONS",1,NA
"TISSUE-SPECIFIC DIFFERENTIALLY METHYLATED REGIONS",1,NA
"TISSUE (LIVER) SAMPLES",1,NA
"TISSUE ANALYSIS",2,NA
"TISSUE CONCENTRATIONS",3,NA
"TISSUE DIGOXIN CONCENTRATIONS",1,NA
"TISSUE DISTRIBUTION",30,NA
"TISSUE DISTRIBUTION - POISONING",1,NA
"TISSUE DISTRIBUTION OF DIGOXIN",1,NA
"TISSUE DISTRIBUTION OF ETHANOL",1,NA
"TISSUE DISTRIBUTION OF LIDOCAINE",1,NA
"TISSUE DISTRIBUTIONS OF PESTICIDES",1,NA
"TISSUE DONATION",1,NA
"TISSUE ENGINEERING",2,NA
"TISSUE FACTOR",1,NA
"TISSUE IDENTIFICATION",3,NA
"TISSUE LEVELS",1,NA
"TISSUE LOSS",1,NA
"TISSUE PLASMINOGEN ACTIVATOR",1,NA
"TISSUE PRESERVATION",1,NA
"TISSUE PROPERTY",1,NA
"TISSUE REGENERATION",1,NA
"TISSUE SAMPLES",1,NA
"TISSUE SAMPLES-GC",1,NA
"TISSUE SOLUBILIZATION",1,NA
"TISSUE SPECIMEN",1,NA
"TISSUE STORAGE",1,NA
"TITANIUM",2,1
"TITANIUM DIOXIDE",2,NA
"TITANIUM DIOXIDE PIGMENTS (RUTILE)",1,NA
"TIVOLI GARDENS",1,NA
"TL-INTOXICATION",1,NA
"TLA",1,NA
"TLC DRUG SCREEN",1,NA
"TLC SCANNING CHROMATOGRAPHY",1,NA
"TLV",1,NA
"TNF-Α",1,NA
"TNT DETECTION",1,NA
"TOAD",1,NA
"TOBACCO",2,3
"TOBACCO SMOKE",1,NA
"TOCSY",1,1
"TOENAIL",1,NA
"TOENAILS",1,NA
"TOF-SIMS",3,NA
"TOF/MS",1,NA
"TOFISOPAM",1,NA
"TOKEN ECONOMIES",1,NA
"TOLERABILITY",2,1
"TOLERANCE",8,1
"TOLERANCE INTERVAL",1,NA
"TOLFENPYRAD",1,NA
"TOLPERISONE",1,NA
"TOLUENE",8,2
"TOLUENE EXPOSURE",1,NA
"TOLUENE INHALATION",1,NA
"TOLUENE RELATED DEATHS",1,NA
"TOLUIDINE BLUE",1,NA
"TOMATO SEED",1,NA
"TOMM",1,NA
"TOMOGRAPHY",1,1
"TONERS",2,1
"TONGUE PIERCING",1,NA
"TOOLMARKS",1,NA
"TOOTH ENAMEL",1,NA
"TOOTH EROSION",1,NA
"TOOTHPASTE",1,NA
"TOOTHPICK",1,NA
"TOP-DOWN APPROACH",1,NA
"TOPIC",1,NA
"TOPIC MODELING",2,NA
"TOPICAL APPLICATION",1,NA
"TOPIRAMATE",2,NA
"TOPOLOGICAL DESCRIPTORS",1,1
"TOPOLOGICAL INDICES",1,1
"TOR BROWSER",1,NA
"TORASEMIDE",1,NA
"TORSADES DE POINTES",3,NA
"TORTURE",4,NA
"TOTAL AREA",1,NA
"TOTAL BODY WATER",1,NA
"TOTAL DRUG WEIGHT",2,NA
"TOTAL ERROR",1,NA
"TOTAL EVAPORATION",1,NA
"TOTAL HEMOGLOBIN",1,NA
"TOTAL ION CHROMATOGRAM",1,NA
"TOTAL ION MASS SPECTRUM",1,NA
"TOTAL MORPHINE",2,NA
"TOTAL MORTALITY",1,NA
"TOTAL REFLECTION",1,2
"TOTAL REFLECTION X-RAY FLUORESCENCE ANALYSIS",3,1
"TOTAL TESTOSTERONE",1,NA
"TOTAL VAPORIZATION",1,1
"TOTAL VOLATILE BASIC NITROGEN",1,NA
"TOUCH-SCREEN TECHNOLOGY",1,NA
"TOUCH DEPOSIT",1,NA
"TOUCH DEPOSITS",1,NA
"TOUCH DNA",13,NA
"TOUCH DNA (TDNA)",1,NA
"TOUCH SPRAY IONIZATION",1,NA
"TOURIST",1,NA
"TOURIST REGION",1,1
"TOURNIQUET SHOCK",1,NA
"TOXFINDER",1,NA
"TOXIC",5,NA
"TOXIC ACTIONS",1,NA
"TOXIC ALCOHOLS",1,NA
"TOXIC ALKALOIDS",3,NA
"TOXIC AMMUNITION",1,NA
"TOXIC ANION ETC",1,NA
"TOXIC ATMOSPHERE",1,NA
"TOXIC BLOOD-LEVELS",1,NA
"TOXIC CHEMICALS",2,NA
"TOXIC COMPOUNDS",2,NA
"TOXIC CONCENTRATION",1,NA
"TOXIC CONCENTRATIONS",1,NA
"TOXIC DIGOXIN CONCENTRATION",1,NA
"TOXIC ELEMENTS",1,1
"TOXIC EPIDERMAL NECROLYSIS",2,NA
"TOXIC FUMES",1,NA
"TOXIC HEPATITIS",1,NA
"TOXIC LEUKOENCEPHALOPATHY",1,NA
"TOXIC METALS",1,NA
"TOXIC MYOCARDITIS",1,NA
"TOXIC PLANTS",2,NA
"TOXIC PLASMA CONCENTRATIONS",1,NA
"TOXIC PROJECTILE",1,NA
"TOXIC PSYCHOSIS",3,NA
"TOXIC SUBSTANCE",2,NA
"TOXIC SUBSTANCES",1,NA
"TOXIC TORTS",1,NA
"TOXICANTS",2,NA
"TOXICATION",1,NA
"TOXICITY",81,21
"TOXICITY MECHANISM",1,NA
"TOXICITY OF COMBUSTION PRODUCTS",1,NA
"TOXICITY TESTS",1,NA
"TOXICODY-NAMIC",1,NA
"TOXICOGENETICS",4,NA
"TOXICOKINETIC",1,NA
"TOXICOKINETIC MODELING",1,NA
"TOXICOKINETIC STUDY",1,NA
"TOXICOKINETICS",15,4
"TOXICOL DRUGS",1,NA
"TOXICOLOGIAL SCREENING",1,NA
"TOXICOLOGIC FINDINGS",1,NA
"TOXICOLOGICAL",3,NA
"TOXICOLOGICAL ANALYSES",1,NA
"TOXICOLOGICAL ANALYSIS",42,4
"TOXICOLOGICAL ANALYSIS OF ANAESTHETIC DRUGS",1,NA
"TOXICOLOGICAL ANALYSIS OF LSD",1,NA
"TOXICOLOGICAL DETECTION",1,NA
"TOXICOLOGICAL EVALUATION",1,NA
"TOXICOLOGICAL EXAMINATION",1,NA
"TOXICOLOGICAL EXPERTISE",1,NA
"TOXICOLOGICAL EXPOSURE",1,NA
"TOXICOLOGICAL FINDINGS",4,NA
"TOXICOLOGICAL FORENSIC REPORT",1,NA
"TOXICOLOGICAL INTERPRETATION",1,NA
"TOXICOLOGICAL INVESTIGATION",2,NA
"TOXICOLOGICAL INVESTIGATIONS",1,NA
"TOXICOLOGICAL SAMPLES",1,NA
"TOXICOLOGICAL SCREENING",19,2
"TOXICOLOGICAL SIGNIFICANCE SCORE",1,NA
"TOXICOLOGIE",1,NA
"TOXICOLOGY",457,54
"TOXICOLOGY ANALYSIS",2,NA
"TOXICOLOGY AND NAS REPORT, LEADERSHIP ROLE BY ABFT",1,NA
"TOXICOLOGY CLINICAL",1,NA
"TOXICOLOGY DATA BASE",1,NA
"TOXICOLOGY EXPERT",1,NA
"TOXICOLOGY LABORATORIES",1,NA
"TOXICOLOGY LABORATORY",1,NA
"TOXICOLOGY REPORTS",1,NA
"TOXICOLOGY SURVEY",1,NA
"TOXICOLOGY TESTING",2,NA
"TOXICOLOGY TESTS",2,NA
"TOXICOLOGY TRAINING",1,NA
"TOXICOLOGY TSCA",1,NA
"TOXICOLOGY, CLINICAL",1,NA
"TOXICOLOGY, COMPUTER-AIDED",1,NA
"TOXICOLOGY, COMPUTER-SUPPORTED",1,NA
"TOXICOLOGY, DEXTROPROPOXYPHENE IN BLOOD",1,NA
"TOXICOLOGY, METHAMPHETAMINE, AMPHETAMINE",1,NA
"TOXICOLOGY, PARAFFIN-EMBEDDED ORGAN PARTS",1,NA
"TOXICOLOGY, PENTACOZINE",1,NA
"TOXICOLOGY/METHODS",1,NA
"TOXICOSIS",1,NA
"TOXICS",1,NA
"TOXIDROME",1,1
"TOXIDROMES",1,NA
"TOXIKOLOGIE, GASCHROMATOGRAPHIE",1,NA
"TOXIN",2,NA
"TOXIN-INDUCED HISTOPATHOLOGY",1,NA
"TOXIN SUBTYPE",1,NA
"TOXINS",6,1
"TOXIROLOGIC EXAMINATION",1,NA
"TOXOPLASMA GONDII",2,NA
"TOXTYPER®",1,NA
"TPH1",1,NA
"TPOX",1,NA
"TPU",1,NA
"TRACE",3,2
"TRACE-EXPLOSIVE DETECTION",1,NA
"TRACE ACIDS",1,NA
"TRACE ANALYSIS",10,8
"TRACE ANALYSIS AND HUMAN BLOOD",1,NA
"TRACE BIOLOGICAL EVIDENCE",1,NA
"TRACE CHEMICAL MARKER POWDER",1,NA
"TRACE CHEMICALS",1,1
"TRACE DETECTION",5,5
"TRACE DNA",3,1
"TRACE ELEMENT",10,6
"TRACE ELEMENT ANALYSIS OF URANIUM ORE CONCENTRATES",1,NA
"TRACE ELEMENT COMPOSITION",1,NA
"TRACE ELEMENTS DETERMINATION",1,NA
"TRACE ENRICHMENT",1,NA
"TRACE ENVIRONMENTAL ACTINIDE ANALYSIS",1,NA
"TRACE EVIDENCE",13,3
"TRACE EVIDENCE COLLECTION",1,NA
"TRACE EVIDENCE PROTOCOLS",1,NA
"TRACE IMPURITIES",1,NA
"TRACE INORGANIC ELEMENTS",1,NA
"TRACE ISOTOPE",1,NA
"TRACE MATERIAL EVIDENCE",1,NA
"TRACE METAL DETECTION",1,NA
"TRACE METAL DETECTION (TMDT)",1,NA
"TRACE METAL DETECTION TEST (TMDT)",1,NA
"TRACE METAL IMPURITY PROFILING",1,1
"TRACE SAMPLE",1,NA
"TRACE TIMING",1,NA
"TRACEABILITY",1,2
"TRACER",1,NA
"TRACES",3,NA
"TRACES OF GUNFIRE",1,NA
"TRACING AND MOBILITY STUDIES",1,NA
"TRACKING",1,NA
"TRACKING TECHNOLOGY",1,NA
"TRADITIONAL AND ALTERNATIVE BIOLOGICAL MATERIALS",1,NA
"TRADITIONAL CHINESE MEDICINE",2,7
"TRADITIONAL CHINESE MEDICINES (TCMS)",1,NA
"TRADITIONAL HERBAL MEDICINES (THMS)",2,2
"TRADITIONAL MEDICINE",1,2
"TRAFFIC",4,1
"TRAFFIC-MEDICINE",1,NA
"TRAFFIC ACCIDENT",40,NA
"TRAFFIC CASES",1,NA
"TRAFFIC FATALITIES",2,1
"TRAFFIC MEDICINE",4,NA
"TRAFFIC SAFETY",7,NA
"TRAFFIC USERS",1,NA
"TRAFFIC VIOLATION",1,NA
"TRAFFICKER",1,NA
"TRAFFICKERS",1,1
"TRAFFICKING",1,NA
"TRAIN",1,NA
"TRAINING",1,5
"TRAINING PERIOD OF CITIZENSHIP",1,NA
"TRAINING REQUIREMENTS",1,NA
"TRAINING SCHOOL",1,NA
"TRAJECTORY",2,NA
"TRAJECTORY ANALYSIS",1,NA
"TRAJECTORY MODELING",1,NA
"TRAMADOL",44,52
"TRAMADOL ANALYSIS",1,NA
"TRAMODOL HYDROCHLORIDE",1,NA
"TRANQUILISERS",1,NA
"TRANQUILIZER",1,NA
"TRANQUILIZERS",1,NA
"TRANQUILLIZERS",2,NA
"TRANS-INSTITUTIONAL COLLABORATION",1,NA
"TRANS-PLACENTAL DRUG DELIVERY",1,NA
"TRANS-PLACENTAL TRANSFER",1,NA
"TRANSBRONCHIAL LUNG",1,NA
"TRANSCRANIAL DIRECT CURRENT STIMULATION (TDCS)",1,NA
"TRANSCRIPTION",1,NA
"TRANSCRIPTION FACTOR BINDING SITES (TFBS)",1,NA
"TRANSCRIPTOME ANALYSIS",1,1
"TRANSCRIPTOME SEQUENCING",1,NA
"TRANSCRIPTOMICS",1,NA
"TRANSCULTURAL FORENSIC TREATMENT",1,NA
"TRANSCULTURAL PSYCHIATRY",1,NA
"TRANSCUTANEOUS COLLECTION DEVICE",1,NA
"TRANSCUTANEOUS DRUG DELIVERY",1,NA
"TRANSDERMAL",7,NA
"TRANSDERMAL ADMINISTRATION",1,NA
"TRANSDERMAL COLLECTION DEVICE",1,NA
"TRANSDERMAL FENTANYL PATCH",2,2
"TRANSDERMAL PATCH",3,2
"TRANSDERMAL ROUTE",1,NA
"TRANSDERMAL THERAPEUTIC SYSTEM",1,NA
"TRANSESTERIFICATION",2,1
"TRANSFER",2,1
"TRANSFERRIN",1,NA
"TRANSFERRIN MICRO-HETEROGENEITY",1,NA
"TRANSFLECTION",1,1
"TRANSFORMATION PRODUCT",2,3
"TRANSFUSION ERROR",1,NA
"TRANSGENDER",1,NA
"TRANSGENDER PERSONS",1,NA
"TRANSGENERATIONAL INHERITANCE",1,NA
"TRANSIENT GLOBAL ISCHAEMIA",1,NA
"TRANSIENT ISOTACHOPHORESIS",1,NA
"TRANSITION INTO COMMUNITY LIFE",1,NA
"TRANSITION METALS",1,NA
"TRANSLATED QUESTIONNAIRES",1,NA
"TRANSLATION",1,NA
"TRANSLESION SYNTHESIS",1,NA
"TRANSMISSION SPECTROSCOPY",1,1
"TRANSMITTED LIGHT",1,NA
"TRANSMUCOSAL",1,NA
"TRANSNATIONAL ORGANIZED CRIME",1,NA
"TRANSPARENCY",2,NA
"TRANSPLANTATION",2,NA
"TRANSPORTER",1,1
"TRANSRECTAL",1,NA
"TRANSVESTISM",1,NA
"TRANSVESTITISM",1,NA
"TRANYLCYPROMINE",2,NA
"TRAUMA",31,NA
"TRAUMA-INFORMED CARE",1,NA
"TRAUMA ANALYSIS",1,NA
"TRAUMA CNS /PNS",1,NA
"TRAUMA SEVERITY INDICES",1,NA
"TRAUMATIC AXONAL INJURY",2,NA
"TRAUMATIC BRAIN INJURY",9,NA
"TRAUMATIC BRAIN INJURY (TBI)",1,NA
"TRAUMATIC SPINAL CORD INJURY",1,NA
"TRAUMATIC SUBARACHNOID HEMORRHAGE (TSAH)",1,NA
"TRAUMATISM",1,NA
"TRAUMATOLOGY",1,NA
"TRAUMATOLOGY, FRACTURES CAUSED BY MUSCLE TRACTION",1,NA
"TRAVEL MEDICINE",1,NA
"TRAZODONE",5,NA
"TREATMENT",48,1
"TREATMENT-RELATED INFECTION",1,NA
"TREATMENT-RESISTANCE",1,NA
"TREATMENT-RESISTANT SCHIZOPHRENIA",3,NA
"TREATMENT ACCESS",1,1
"TREATMENT ADHERENCE",1,NA
"TREATMENT ADMISSION",1,NA
"TREATMENT AND REHABILITATION OF ADDICTS",1,NA
"TREATMENT CENTRE FOR DRUG ADDICTS",1,NA
"TREATMENT COMPLETION",1,NA
"TREATMENT COMPLIANCE",1,NA
"TREATMENT CONTINUUM",1,NA
"TREATMENT DYNAMICS",1,NA
"TREATMENT EFFECTIVENESS",3,NA
"TREATMENT ENGAGEMENT",2,NA
"TREATMENT EVALUATION",2,NA
"TREATMENT EXPERTISE",1,NA
"TREATMENT FAILURE",1,NA
"TREATMENT GUIDELINES",2,NA
"TREATMENT IMPLICATIONS",1,NA
"TREATMENT NEEDS",1,NA
"TREATMENT OF ADDICTED DELINQUENTS",1,NA
"TREATMENT OF ADDICTION AND ADDITIONAL PSYCHIATRIC DISORDERS",1,NA
"TREATMENT OF DOMESTIC VIOLENCE",1,NA
"TREATMENT OF DRUG ADDICTS",1,NA
"TREATMENT OF INTIMATE PARTNER VIOLENCE",1,NA
"TREATMENT OF INTOXICATION",2,NA
"TREATMENT OF POISONING",1,NA
"TREATMENT OUTCOME",4,NA
"TREATMENT OUTCOMES",3,NA
"TREATMENT PATHWAYS",1,NA
"TREATMENT PERFORMANCE",1,NA
"TREATMENT PLANNING",2,NA
"TREATMENT POLICY",1,NA
"TREATMENT PROCESS",1,NA
"TREATMENT PROGNOSIS",3,NA
"TREATMENT PROGRAMS",1,NA
"TREATMENT PROTOCOL",1,NA
"TREATMENT RECOMMENDATIONS",1,NA
"TREATMENT REFUSAL",1,NA
"TREATMENT RESISTANCE",2,NA
"TREATMENT RESPONSE",1,NA
"TREATMENT RETENTION",1,NA
"TREATMENT STATUS",1,NA
"TREATMENT SUCCESS",1,NA
"TREATMENT TERMINATION",1,NA
"TREE-CNN",1,NA
"TREE SCANNING",1,NA
"TREND",2,NA
"TREND ANALYSIS",1,3
"TRENDS",6,5
"TRENDS IN BIOANALYSIS",1,NA
"TRENDS OF POISONING",1,NA
"TRIACETONE TRIPEROXIDE (TATP)",15,NA
"TRIAGE",4,2
"TRIAGE DOA",1,NA
"TRIAGE KIT",1,NA
"TRIAGE(TM)",2,NA
"TRIAGE® DOA",1,NA
"TRIAGE® DRUG OF ABUSE PANEL",1,NA
"TRIARCHIC MODEL",1,NA
"TRIAZOLAM",20,1
"TRIAZOLAM AND METABOLITE Α-HYDROXYTRIAZOLAM",1,NA
"TRIAZOLAM POISONING",1,NA
"TRIAZOPHOS",2,NA
"TRIBAL",1,NA
"TRIBAL MARKING",1,NA
"TRIBULUS TERRESTRIS",1,NA
"TRIBUTYL PHOSPHATE",2,NA
"TRICHLORETHYLENE POISONING",1,NA
"TRICHLOROACETIC ACID DETERMINATION",1,NA
"TRICHLOROCYANURIC ACID",1,NA
"TRICHLOROETHANOL",2,NA
"TRICHLOROETHANOL DETERMINATION",1,NA
"TRICHLOROETHYLENE INTOXICATION",1,NA
"TRICHLOROISOCYANURIC ACID",1,NA
"TRICHOLOMA USTALE",1,NA
"TRICLOPYR",1,NA
"TRICYCLIC",2,NA
"TRICYCLIC ANTIDEPRESSANT",5,NA
"TRICYCLIC ANTIDEPRESSANT DRUGS",3,NA
"TRICYCLIC ANTIDEPRESSANT SCREEN",1,NA
"TRICYCLIC ANTIDEPRESSANTS",12,2
"TRICYCLIC ANTIDEPRESSANTS (TCAS)",1,NA
"TRICYCLIC ANTIDEPRESSANTS (TRICYCLICS)",1,NA
"TRICYCLIC ANTIDEPRESSANTS, UNEXPECTED DEATH",1,NA
"TRICYCLIC NEUROLEPTICS, SULPHONAMIDES",1,NA
"TRIETHYLENE GLYCOL",1,NA
"TRIFLUORO-ACETYL DERIVATIVE",1,NA
"TRIFLUOROACETYL-L-PROLYL CHLORIDE",1,NA
"TRIFLUOROACETYL DERIVATIVE",2,NA
"TRIFLUOROACETYL DERIVATIZATION",1,1
"TRIFLUOROACETYLATION",2,2
"TRIFLUOROACETYLPROLYL DERIVATIZATION",1,NA
"TRIGENE™",1,NA
"TRIGGER",1,NA
"TRIGGERS",1,NA
"TRIGLYCERIDE ACCUMULATION",1,NA
"TRIGLYCERIDE FATTY ACIDS",1,NA
"TRIGLYCERIDES",3,NA
"TRIHEXYPHENIDYL",2,1
"TRILEPTAL",1,NA
"TRIMECAINE",1,NA
"TRIMEPRAZ INE (ALIMEMAZINE)",1,NA
"TRIMETHOXYAMPHETAMINE",1,2
"TRIMETHOXYAMPHETAMINES (TMAS)",1,NA
"TRIMETHYLAMINE",1,NA
"TRIMETHYLORNITHINE",1,NA
"TRIMETHYLSILYL (TMS) DERIVATIVES",1,NA
"TRIMETHYLSILYLATION",1,2
"TRIMIPRAMINE",3,NA
"TRINIDAD",1,NA
"TRINITITE",8,NA
"TRIOLEIN",1,NA
"TRIPDIOLIDE",1,NA
"TRIPLE-EXPONENTIAL EQUATION",1,NA
"TRIPLE-EXPONENTIAL METHOD",1,NA
"TRIPLE-TOF",1,1
"TRIPLE QUADRUPOLE",2,5
"TRIPLE QUADRUPOLE MASS SPECTROMETRY",1,2
"TRIPLE WATERSHED",1,NA
"TRIPLETOF",1,NA
"TRIPLEX ASSAY",1,NA
"TRIPTERINE",1,NA
"TRIPTERYGIUM",1,NA
"TRIPTERYGIUM WILFORDII HOOK. F.",1,NA
"TRIPTOLIDE",2,NA
"TRIS(1,10-PHENANTHROLINE)IRON(II)",1,NA
"TRISKEM LN RESIN",1,NA
"TRITERPANES",1,NA
"TRITHION",1,NA
"TRITON B",1,1
"TRITON X-114",1,1
"TRL LEVEL 2",1,NA
"TRNH-PSBA",1,NA
"TRNL-TRNF IGS",1,NA
"TROFODERMIN",1,NA
"TROIKA",1,NA
"TROPANE ALKALOIDS",7,33
"TROPICAL FRUIT JUICE",1,NA
"TROPICAL TIMBER",1,NA
"TROPONIN",2,NA
"TROPONIN I",2,NA
"TROUBLESHOOTING",1,NA
"TRUENESS",1,NA
"TRUNARC",1,1
"TRUNCATED WASH KINETIC METHODS",1,NA
"TRUSCAN",1,NA
"TRUTH SERUM",2,NA
"TRUXILLINES",1,1
"TRYPSIN DIGESTION",1,1
"TRYPTAMINE",23,38
"TRYPTAMINE-DERIVED DRUGS OF ABUSE",1,NA
"TRYPTAMINE ANALOGUES",1,1
"TRYPTAMINE DERIVATIVE",1,3
"TRYPTASE",12,NA
"TRYPTASES",1,NA
"TRYPTOPHAN",1,1
"TSC22D3",1,NA
"TSP-1",1,NA
"TTR",1,NA
"TUBERCULOSIS",5,NA
"TUBING",1,NA
"TUBOCURARINE POISONINGS",1,NA
"TUMESCENT LOCAL ANAESTHESIA",1,NA
"TUMOR",1,NA
"TUMOR METASTASES",1,NA
"TUMOR NECROSIS FACTOR-ALPHA (TNFΑ)",1,NA
"TUMOUR MARKER",1,NA
"TUNABLE LIGHT SOURCE",1,NA
"TUNE CHECK",1,NA
"TUNED EMISSION",1,NA
"TUNING FREQUENCY",1,NA
"TUNISIA",3,NA
"TURBID",1,NA
"TURBID MEDIA",1,1
"TURBULENT FLOW CHROMATOGRAPHY",2,NA
"TURKEY",12,3
"TURKISH",1,NA
"TURKISH CRIMINAL LAW",1,NA
"TURKISH TRAFFIC REGULATIONS",1,NA
"TURNERA DIFFUSA",1,2
"TURPENTINE",1,NA
"TURQUOISE",1,NA
"TUSSIONEX PENNKINETIC",1,1
"TVT",1,NA
"TWEEN 20",1,NA
"TWELVE STEP FACILITATION",1,NA
"TWIG",1,NA
"TWINE AND ROPE",1,1
"TWINS",2,NA
"TWISTER- STIR BAR",1,NA
"TWO-DIMENSIONAL CHROMATOGRAPHY",1,1
"TWO-DIMENSIONAL GAS CHROMATOGRAPHY",1,1
"TWO-STEP DERIVATIZATION",1,NA
"TWO-STEP IONIZATION",1,1
"TWO DIMENSIONAL GAS CHROMATOGRAPHY",1,NA
"TXRF",1,NA
"TYPE II ALCOHOLISM",1,NA
"TYPE OF CRIME",1,NA
"TYPES",1,2
"TYPOLOGIES",1,NA
"TYPOLOGY",3,NA
"TYROL",1,NA
"TYROPHAGOUS LONGIOR",1,NA
"U-47,700",1,NA
"U-47700",14,6
"U-49900",1,NA
"U-50488",1,1
"U-COMPOUNDS",1,1
"U-DRUGS",1,2
"U-DRUGS NOVEL SYNTHETIC OPIOIDS",1,NA
"U-SERIES",1,NA
"U-SERIES RADIOCHRONOMETRY",2,NA
"U.S. DRUG ENFORCEMENT ADMINISTRATION",1,NA
"U3O8",1,NA
"U47700",1,NA
"UABE",1,NA
"UBIQUITIN",2,1
"UDAR",1,NA
"UDP-GLUCURONOSYLTRANSFERASE",1,NA
"UDP-GLUCURONOSYLTRANSFERASE 1A9",1,NA
"UDP-GLUCURONOSYLTRANSFERASES",1,NA
"UDP GLUCURONOSYLTRANSFERASE",1,NA
"UDP GLUCURONOSYLTRANSFERASE PHARMACOGENOMICS",1,NA
"UFLC",1,NA
"UFLC-MS-MS",1,NA
"UFLC OR UPLC",2,NA
"UGT",1,NA
"UHPLC-HRMS",6,2
"UHPLC-HRMS/MS",1,NA
"UHPLC-MS",1,1
"UHPLC-MS-MS",1,NA
"UHPLC-MS/MS",30,11
"UHPLC-MS/MS ANALYSIS",1,NA
"UHPLC-QTOF-MS",1,1
"UHPLC-TOF-MS WITH FRAGMENTATION",1,NA
"UHPSFC-MS/MS",1,NA
"UHSA",1,NA
"UK",1,NA
"ULCERATION",1,NA
"ULTANE",2,NA
"ULTRA-HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",2,NA
"ULTRA-HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (UHPLC)",1,NA
"ULTRA-HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY",1,NA
"ULTRA-HIGH LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY-MASS SPECTROMETRY",1,NA
"ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-HIGH RESOLUTION TANDEM MASS SPECTROMETRY (UHPLC-HRMS/MS)",1,NA
"ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-LINEAR ION TRAP QUADRUPOLE-ORBITRAP MASS SPECTROMETRY (UPLC-LTQ-ORBITRAP MS)",1,NA
"ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-PHOTODIODE ARRAY-MASS SPECTROMETRY (UHPLC-PDA-MS)",1,NA
"ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-PHOTODIODE ARRAY/MASS SPECTROMETRY",1,1
"ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (UHPLC-MS/MS)",2,NA
"ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY",1,NA
"ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY",1,NA
"ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",1,NA
"ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (UPLC-MS/MS)",2,NA
"ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY−TANDEM MASS SPECTROMETRY",1,NA
"ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY",1,NA
"ULTRA HIGH PERFORMANCE LIQUID CHROMATOGRAPHY",1,4
"ULTRA HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",2,NA
"ULTRA HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (UHPLC-MS/MS)",1,NA
"ULTRA HIGH PERFORMANCE LIQUID CHROMATOGRAPHY COMBINED WITH TIME-OF-FLIGHT MASS SPECTROMETRY",1,2
"ULTRA HIGH PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (UPLC-MS/MS)",1,NA
"ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-QUADRUPOLE TIME-OF-FLIGHT-MASS SPECTROMETRY (UPLC-Q-TOF MS)",2,NA
"ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-QUADRUPOLE TIME-OF-FLIGHT-MASS SPECTROMETRY (UPLC-QTOF MS)",2,NA
"ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (UPLC-MS/MS)",3,NA
"ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY MASS SPECTROMETRY (UPLC-MS)",1,2
"ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY",1,NA
"ULTRA SONICATION",1,NA
"ULTRAFAST ANALYSIS",1,1
"ULTRAFAST CAPILLARY ELECTROPHORESIS MASS SPECTROMETRY",1,NA
"ULTRAFILTRATION",1,2
"ULTRASONIC EXTRACTION",2,1
"ULTRASONIC WAVE",1,NA
"ULTRASONICATION",1,NA
"ULTRASOUND",4,1
"ULTRASOUND-ASSISTED DISPERSIVE LIQUID-LIQUID MICROEXTRACTION",1,NA
"ULTRASOUND-ASSISTED DISPERSIVE LIQUID-LIQUID MICROEXTRACTION (UA-DLLME)",1,NA
"ULTRASOUND-ASSISTED LIQUID-LIQUID MICROEXTRACTION",1,NA
"ULTRASTRUCTURAL PATHOLOGY",1,NA
"ULTRASTRUCTURE",1,NA
"ULTRATHIN POLYACRYLAMIDE",1,NA
"ULTRAVIOLET",3,2
"ULTRAVIOLET-VISIBLE SPECTROPHOTOMETRY",1,NA
"ULTRAVIOLET-VISIBLE SPECTROSCOPY",3,2
"ULTRAVIOLET DETECTION",2,3
"ULTRAVIOLET RAYS",1,NA
"ULTRAVIOLET SPECTROPHOTOMETRY",1,NA
"ULTRAVIOLET SPECTROSCOPY",2,NA
"UMBELLIFERONE MATRIX",1,NA
"UMBILICAL CORD",3,NA
"UMBRELLA",1,NA
"UMBRELLA REVIEW",1,NA
"UN-1",1,NA
"UNA",1,NA
"UNASCERTAINED DEATH",1,NA
"UNBOUND DRUGS",1,NA
"UNBOUND FRACTION",1,NA
"UNCERTAIN CASES OF DEATH",1,NA
"UNCERTAINTY",4,9
"UNCERTAINTY EVALUATION",1,NA
"UNCERTAINTY OF MEASUREMENT",3,2
"UNCERTAINTY OF RESULTS",1,NA
"UNCLAIMED BODIES",1,NA
"UNCONJUGATED THC-COOH",1,NA
"UNCONSCIOUSNESS",3,NA
"UNCONVENTIONAL MATRICES",1,NA
"UNCONVENTIONAL MATRIX",2,NA
"UNCONVENTIONAL SAMPLES",1,NA
"UNDECENANOIC ACID STATIONARY PHASE",1,NA
"UNDECLARED ACTIVE PHARMACEUTICAL INGREDIENTS",1,1
"UNDECLARED SOURCES",1,NA
"UNDER THE INFLUENCE",1,NA
"UNDERGRADUATE EDUCATION",1,NA
"UNDERGRADUATE RESEARCH",1,NA
"UNDERIVATISED DRUGS",1,1
"UNDERWATER CRIMES",1,NA
"UNDETECTED CASES",1,NA
"UNDIAGNOSED",1,NA
"UNEXPECTED DEATH",6,NA
"UNEXPECTED FINDING",1,NA
"UNEXPLAINED CARDIAC FAILURE",1,NA
"UNEXPLAINED DEATH",2,NA
"UNIDENTIFIED CADAVER",1,NA
"UNIDENTIFIED CADAVERS",1,NA
"UNINTENTIONAL DEATH",1,NA
"UNINTENTIONAL DROWNING",1,NA
"UNINTENTIONAL INJURY",1,NA
"UNITED KINGDOM",2,NA
"UNITED KINGDOM (UK)",2,NA
"UNITED NATIONS",1,NA
"UNITED NATIONS DRUG CONTROL PROGRAM",1,NA
"UNITED STATES",4,5
"UNITED STATES CUSTOMS SERVICE",1,NA
"UNITHIOL",1,NA
"UNIVERSAL DETECTION",1,NA
"UNIVERSALITY",1,NA
"UNIVERSITY",1,2
"UNJUST ENRICHMENT",1,NA
"UNKNOWING INGESTION",1,NA
"UNKNOWN HUMAN REMAINS",1,NA
"UNKNOWN IDENTIFICATION",2,1
"UNKNOWN POISON",1,NA
"UNKNOWN SIGNIFICANCE VARIANTS",1,NA
"UNKNOWN XENOBIOTICS",1,NA
"UNLICENSED DRUGS",1,NA
"UNMANNED AERIAL VEHICLES",1,NA
"UNMARRIED",1,NA
"UNNATURAL",2,NA
"UNNATURAL DEATH",6,NA
"UNNATURAL DEATHS",1,NA
"UNNATURAL MANNER OF DEATH",1,NA
"UNODC",1,NA
"UNPROFESSIONAL CONDUCT",1,NA
"UNREGISTERED DRUGS",1,1
"UNRELIABILITY",1,NA
"UNRESOLVED COMPLEX MIXTURE",1,NA
"UNSAFE DRIVING BEHAVIOR",1,NA
"UNSEQUENCED ORGANISMS",1,NA
"UNSUPERVISED MACHINE LEARNING",1,1
"UNSUPERVISED TECHNIQUES",1,NA
"UNTARGETED DATA-MINING",1,NA
"UNTARGETED HIGH-RESOLUTION MASS SPECTROMETRY SCREENING",1,NA
"UNTARGETED MASS SCREENING",1,NA
"UNTARGETED METABOLOMICS",1,NA
"UNTARGETED METABOLOMICS PROFILING",1,NA
"UNTARGETED SCREENING",1,NA
"UNTARGETED TOXICOLOGICAL SCREENING",1,NA
"UNWANTED EFFECTS/ADVERSE REACTIONS",1,NA
"UNWANTED TOUCHING",1,NA
"UP-CONVERTERS",1,NA
"UPCONVERSION",1,NA
"UPLC",9,20
"UPLC-ESI-QTOF-MS",1,NA
"UPLC-HR-TOFMS",1,NA
"UPLC-MS/MS",45,5
"UPLC-MS/MS™",1,NA
"UPLC-PDA",1,1
"UPLC-Q-TOF-MS",1,NA
"UPLC-Q-TRAP/MS",1,NA
"UPLC-TOF",1,1
"UPLC-TOF-MS",2,NA
"UPLC-TOFMS",2,1
"UPLC/MS/MS",1,NA
"UPLC/Q-TOF MS",1,NA
"UPPER-DIVISION UNDERGRADUATE",6,2
"UPPER AIRWAY DISEASES",1,NA
"UR-144",5,3
"URANIUM",17,NA
"URANIUM-232",1,NA
"URANIUM AGE",1,NA
"URANIUM ALLOY",1,NA
"URANIUM ASSAY",1,NA
"URANIUM CHEMICALS",1,NA
"URANIUM HEXAFLUORIDE",1,NA
"URANIUM MASS FRACTION",1,NA
"URANIUM METAL",2,NA
"URANIUM ORE CONCENTRATE",7,NA
"URANIUM ORE CONCENTRATE (UOC)",1,NA
"URANIUM ORE CONCENTRATES",1,NA
"URANIUM ORES",1,NA
"URANIUM ORES AND CONCENTRATES",1,NA
"URANIUM OXIDE",5,NA
"URANIUM OXIDE HYDROLYSIS",1,NA
"URANIUM OXIDES",1,NA
"URANIUM PEROXIDE",1,NA
"URANIUM SEPARATIONS",1,NA
"URANIUM THORIUM",1,NA
"URANIUM TRIOXIDE",1,NA
"URANYL OXALATE",1,NA
"URB597",1,2
"URBAN COMMUNITIES",1,NA
"URBAN ENVIRONMENT",1,NA
"URBAN WASTEWATER",1,4
"URBANIZATION",1,1
"URCHIN LIKE AG@ PD SHELL NANO-HYBRIDS",1,1
"UREA",2,1
"UREA NITRATE",7,NA
"UREA NITROGEN",3,NA
"UREASE",1,NA
"UREASE-TRIMETHYLSILYLATION METHOD",1,NA
"URETEROPELVIC JUNCTION OBSTRUCTION",1,NA
"URETHRA",1,NA
"UREY SIGNATURES",1,1
"URIC ACID",3,1
"URICASE",1,NA
"URINALYSIS",48,14
"URINALYSIS AND HAIR ANALYSIS OF KETAMINE",1,1
"URINALYSIS OF KETAMINE",1,NA
"URINARY METABOLITES",1,1
"URINARY SCREENING",1,NA
"URINARY STAINS",1,NA
"URINARY STEROID PROFILE",1,NA
"URINARY STEROIDAL PROFILE",1,NA
"URINARY THCCOOH",1,NA
"URINE",270,47
"URINE ADULTERANTS",1,NA
"URINE ADULTERATION",3,1
"URINE AND BRAIN TISSUE SAMPLES",1,NA
"URINE AND HAIR ANALYSIS",1,NA
"URINE COLLECTION",1,NA
"URINE CONCENTRATIONS",1,NA
"URINE DETERMINATION",1,NA
"URINE DIPSTICK",1,NA
"URINE DIPSTIX FOR DRUGS",1,NA
"URINE DRUG ANALYSIS",1,NA
"URINE DRUG SCREEN",1,1
"URINE DRUG SCREENING",2,NA
"URINE DRUG TEST",2,NA
"URINE DRUG TESTING",12,NA
"URINE ETHANOL/BLOOD ETHANOL RATIO",1,NA
"URINE EXCRETION",1,NA
"URINE FINGERPRINTING",1,NA
"URINE LUCK",2,NA
"URINE MANIPULATION",1,NA
"URINE MATRIX",1,NA
"URINE METABOLITE",1,NA
"URINE METABOLOME",1,NA
"URINE NARCOTIC ANALYSIS",1,NA
"URINE PROFILES",1,NA
"URINE QUANTIFICATION",1,NA
"URINE SAMPLE",9,8
"URINE SCREENING",4,NA
"URINE SCREENS",1,NA
"URINE SEDIMENT",1,NA
"URINE SPECIMEN",1,NA
"URINE TEST",2,NA
"URINE TOXICOLOGY",1,1
"URONIUM NITRATE",1,NA
"URSUS",1,NA
"USABILITY",1,NA
"USE",1,4
"USE OF FORCE",1,NA
"USED ENGINE OILS",1,NA
"USED SYRINGES",1,NA
"USEFULNESS",1,NA
"USER INVOLVEMENT",1,NA
"USERS' VIEWS",1,NA
"USFDA",1,NA
"USS IOWA",1,NA
"USTALIC ACID",1,NA
"UTERINE GANGRENA",1,NA
"UTEROPLACENTAL APOPLEXY",1,NA
"UTEVA",1,NA
"UTI",1,NA
"UTILIZATION",1,NA
"UV-DETECTOR",1,NA
"UV-SPECTROPHOTOMETRY",1,NA
"UV-SPECTROSCOPY",1,1
"UV-VIS SPECTROPHOTOMETRY",1,NA
"UV-VISIBLE",1,1
"UV-VISIBLE SPECTROPHOTOMETRY",2,1
"UV-VISIBLE SPECTROSCOPY",1,1
"UV DERIVATIVE SPECTROPHOTOMETRY",1,NA
"UV LIGHT ETC",1,NA
"UV SPECTRA",1,1
"UV SPECTROPHOTOMETRY",2,3
"UV SPECTROPHOTOMETRY—ANALYSIS",1,NA
"UV VISIBLE SPECTROPHOTOMETER",1,NA
"UVB",1,NA
"V-HYDROXYBUTYRIC ACID",1,NA
"VACA",1,NA
"VACCINATION",2,NA
"VACCINE",1,NA
"VACCINE STRATEGIES",1,NA
"VACCINES",1,NA
"VACUUM-OUTLET GC-MS",1,NA
"VACUUM-ULTRAVIOLET",2,1
"VACUUM CAPTURE",1,NA
"VACUUM METAL DEPOSITION",2,NA
"VACUUM ULTRAVIOLET",1,NA
"VACUUM ULTRAVIOLET DETECTION",2,1
"VAGINAL",1,NA
"VAGINAL DRUG ADMINISTRATION",1,NA
"VAGINAL EPITHELIUM",1,NA
"VAGINAL FLUID",2,NA
"VAGINAL MATERIAL",1,NA
"VAGINAL SECRETION",1,NA
"VAGINAL SECRETIONS",1,NA
"VAGINAL SECRETIONS IDENTIFICATION",1,NA
"VALENTIN, GABRIEL",1,NA
"VALERYL FENTANYL",1,NA
"VALERYLFENTANYL",1,NA
"VALIDATED DETERMINATION",1,NA
"VALIDATED METHOD",1,1
"VALIDATION",68,69
"VALIDITY",5,NA
"VALIDITY OF ASSESSMENT",1,NA
"VALIDITY OF DEATH CERTIFICATION",1,NA
"VALONE",1,NA
"VALPROATE",2,NA
"VALPROIC-ACID.",1,NA
"VALPROIC ACID",6,NA
"VALUE CRISIS",1,NA
"VALUES",2,NA
"VANCOMYCIN-RESISTANT ENTEROCOCCI",1,NA
"VANISH MODE",1,NA
"VAPING",1,4
"VAPOR",1,NA
"VAPOR PHASE INFRARED DETECTION",1,1
"VARDENAFIL",6,5
"VARDENAFIL ANALOGUES",1,NA
"VARENICLINE",1,NA
"VARIABILITY",5,1
"VARIABLE NUMBER TANDEM REPEAT",2,NA
"VARIAN ORALAB®6",1,NA
"VARIANTS",1,NA
"VARIATION",4,NA
"VARIATION, SOURCE OF",1,NA
"VARIATIONAL AUTOENCODER",1,NA
"VARICOSE VEIN SURGERY",1,NA
"VARICOSE VEINS",2,NA
"VARIED PATTERN",1,NA
"VASCULAR ENDOTHELIAL GROWTH FACTOR",1,NA
"VASCULAR MALFORMATION",1,NA
"VASCULAR PERMEABILITY",1,NA
"VASCULAR TYPE",1,NA
"VASCULITIS",2,NA
"VASELINE",1,NA
"VASODILATION",1,NA
"VASOPLEGIA",1,NA
"VECURONIUM",3,NA
"VEGETABLE JUICE",1,NA
"VEGETABLE OIL",1,4
"VEGETAMIN",1,NA
"VEGF INHIBITORS",1,NA
"VEHICLE",2,NA
"VEHICLE ASSISTED STRANGULATION",1,NA
"VEHICLE CRASH INVESTIGATION",1,NA
"VEHICLE ROLLOVER",1,NA
"VEHICLES",1,NA
"VEHICULAR HOMICIDE",1,NA
"VENEFICA",2,NA
"VENEFICIUM",2,NA
"VENENUM",2,NA
"VENLAFAXINE",16,1
"VENLAFAXINE METABOLITE",1,NA
"VENOM AND INSECT ALLERGY DEATHS",1,NA
"VENOMOUS SPINE",1,NA
"VENOUS THROMBOSIS",1,NA
"VENOUS TROMBOSIS",1,NA
"VENTILATION",1,NA
"VENTROMEDIAL PREFRONTAL CORTEX (VMPFC)",1,NA
"VERACRUZ, MEXICO",1,NA
"VERAPAMIL",5,NA
"VERBAL HANDOVERS",1,NA
"VERGIFTUNG",1,NA
"VERGIFTUNGEN, E 605",1,NA
"VERGIFTUNGEN, THALLIUM",1,NA
"VERIFICATION",1,1
"VERIFICATION-ANALYSIS",1,NA
"VERIFICATION ANALYSIS",2,NA
"VERRUCAE VULGARIS",1,NA
"VERSATILITY",1,NA
"VERTEBRAL ARTERY",1,NA
"VERTEBRAL ARTERY INJURY",1,NA
"VERTIGO",1,NA
"VERY-LONG-CHAIN ACYL-COA DEHYDROGENASE",1,NA
"VERY LONG-CHAIN ACYL-COA DEHYDROGENASE",1,NA
"VERY SMALL PARTICLES",3,NA
"VESPARAX-INTOXICATIONS, QUANTITATIVE DETERMINATION IN ORGANS",1,NA
"VETERANS",2,NA
"VETERINARY",2,NA
"VETERINARY CONTROL",1,1
"VETERINARY DRUG",3,5
"VETERINARY FORENSIC MEDICINE",1,NA
"VETERINARY FORENSIC PATHOLOGY",1,NA
"VETERINARY MEDICAL ERRORS",1,NA
"VETERINARY MEDICINE",2,NA
"VHC PREVALENCE",1,NA
"VIAGRA®",4,NA
"VIBRATIONAL",1,NA
"VIBRATIONAL SPECTROSCOPY",1,5
"VICARIOUS LIABILITY",1,NA
"VICTIM",7,NA
"VICTIM-PRECIPITATED HOMICIDE",1,NA
"VICTIM AGE",1,NA
"VICTIM CHARACTERISTICS",1,NA
"VICTIM DNA",1,NA
"VICTIM IDENTIFICATION",2,NA
"VICTIM NEEDS",1,NA
"VICTIM TOXICOLOGY",1,NA
"VICTIMISATION",1,NA
"VICTIMIZATION",5,NA
"VICTIMIZATION BY OPPORTUNISTIC DFSA",1,NA
"VICTIMOLOGY",2,NA
"VICTIMS PROFILES",1,NA
"VIDEO-POLYSOMNOGRAPHY",1,NA
"VIDEO-SURVEILLANCE",1,NA
"VIDEO SPECTRAL COMPARATOR",1,NA
"VIDEO SPECTRAL COMPARATOR-2000 HR",1,NA
"VIDEO SURVEILLANCE",1,NA
"VIENNA",2,NA
"VIETNAM WAR",1,NA
"VIETNAMESE",1,NA
"VIGABATRIN",2,NA
"VIGILANCE",4,NA
"VIMENTIN",1,NA
"VINBLASTINE",1,1
"VINCRISTINE",2,NA
"VINYL FLOORING",1,NA
"VINYL TAPE",1,NA
"VINYLPOLISILOXANE",1,NA
"VIOLATION",1,NA
"VIOLENCE",100,NA
"VIOLENCE AGAINST PERSON",1,NA
"VIOLENCE AGAINST WOMEN",5,NA
"VIOLENCE AND AGGRESSION",1,NA
"VIOLENCE AND DRUGS",1,NA
"VIOLENCE IN PRISON",1,NA
"VIOLENCE PRONENESS",1,NA
"VIOLENCE RISK",2,NA
"VIOLENCE RISK ASSESSMENT",3,NA
"VIOLENCE RISK MANAGEMENT",1,NA
"VIOLENCE/AGGRESSION",1,NA
"VIOLENT",2,NA
"VIOLENT BEHAVIOR",5,NA
"VIOLENT BEHAVIORS",1,NA
"VIOLENT BEHAVIOUR",2,NA
"VIOLENT CRIME",3,NA
"VIOLENT CRIMES",2,NA
"VIOLENT DEATH",3,NA
"VIOLENT DEATHS",2,NA
"VIOLENT OFFENCES",1,NA
"VIOLENT OFFENDERS",2,NA
"VIOLENT OFFENSE",1,NA
"VIOLENT RECIDIVISM",1,NA
"VIOLENT REOFFENDING RISK",1,NA
"VIOLOGENS",1,NA
"VIRAL",1,NA
"VIRAL DISEASE",1,NA
"VIRAL HEPATITIS",2,NA
"VIRAL HEPATITIS EPIDEMIOLOGY",1,NA
"VIRAL MYOCARDITIS",1,NA
"VIROLOGY",1,NA
"VIRTOPSY",10,NA
"VIRTUAL AUTOPSY",1,NA
"VIRTUAL REALITY",2,NA
"VIRTUAL SCREENING",1,2
"VIRULENCE DETERMINANTS",1,NA
"VIRUS",1,NA
"VIS-NIR SPECTROPHOTOMETRY",1,NA
"VIS SPECTROSCOPY",1,NA
"VISCERA",4,NA
"VISCERA CONCENTRATIONS",1,NA
"VISCOELASTICITY",1,NA
"VISIBLE AND ULTRAVIOLET SPECTROMETERS",1,NA
"VISIBLE PARTICLES",1,NA
"VISION",1,NA
"VISION LOSS",1,NA
"VISUAL ACUITY",1,NA
"VISUAL ANALYSIS",1,NA
"VISUAL ANALYTICS",1,NA
"VISUAL DEMONSTRATION",1,NA
"VISUAL EVIDENCE",1,NA
"VISUALIZATION",8,NA
"VITAL REACTION",1,NA
"VITAL SIGN",1,NA
"VITALITY",3,NA
"VITALITY DIAGNOSIS",1,NA
"VITAMIN A-SPIEGEL",1,NA
"VITAMIN B12",1,NA
"VITAMIN C",1,NA
"VITAMIN D",1,NA
"VITAMIN D STATUS",1,NA
"VITAMIN K",1,NA
"VITAMIN K ANTAGONIST",1,NA
"VITAMINS",1,2
"VITELLOGENINS",1,NA
"VITREOUS",5,NA
"VITREOUS BODY",1,NA
"VITREOUS HUMOR",40,NA
"VITREOUS HUMOUR",12,NA
"VITREUS",1,NA
"VIVIANITE",1,NA
"VLA-4",1,NA
"VNTR",1,NA
"VOCAL CORDS",1,NA
"VOCATIONAL REHABILITATION",1,NA
"VOCS",3,1
"VOICE FINGERPRINTING",1,NA
"VOLATILE ABUSE",2,NA
"VOLATILE COMPOUND DETECTION",1,1
"VOLATILE COMPOUNDS",1,1
"VOLATILE CONGENERS",2,NA
"VOLATILE CONGENERS OF ALCOHOLIC BEVERAGES",1,NA
"VOLATILE DEGRADANTS",1,NA
"VOLATILE INHALATION",1,NA
"VOLATILE INK COMPOUND DATING",1,NA
"VOLATILE ODOR SIGNATURES",2,NA
"VOLATILE ORGANIC COMPOUNDS",8,4
"VOLATILE ORGANIC COMPOUNDS (VOC)",1,NA
"VOLATILE POISON",1,NA
"VOLATILE POISONS",1,NA
"VOLATILE SOLVENT ABUSE",1,NA
"VOLATILE SOLVENTS",2,NA
"VOLATILE SUBSTANCE",1,NA
"VOLATILE SUBSTANCE ABUSE",5,NA
"VOLATILE SUBSTANCE INHALATION",1,NA
"VOLATILE SUBSTANCE MISUSE",1,NA
"VOLATILE SUBSTANCES",2,NA
"VOLATILE: HALOTHANE",1,NA
"VOLATILES",2,2
"VOLATILES PROFILE",1,NA
"VOLTAGE-GATED CALCIUM CHANNELS",1,NA
"VOLTAGE SENSOR",1,NA
"VOLTAMMETRIC FINGERPRINTS",1,1
"VOLTAMMETRIC SENSOR",1,3
"VOLTAMMETRIC SENSORS",1,3
"VOLTAMMETRIC TECHNIQUES",1,2
"VOLTAMMETRY",18,38
"VOLUME",1,NA
"VOLUME OF DISTRIBUTION",1,NA
"VOLUME VERIFICATION",1,NA
"VOLUMETRIC ABSORPTIVE MICROSAMPLING",3,NA
"VOLUMETRIC ABSORPTIVE MICROSAMPLING (VAMS)",1,NA
"VOLUNTARILY AND INVOLUNTARILY COMMITTED PATIENTS",1,NA
"VOLUNTARY ACTS",1,NA
"VOLUNTARY SUICIDE",1,NA
"VOLUNTARY THERAPY INSTEAD OF PENAL SANCTION",1,NA
"VOLUNTARY/INVOLUNTARY PATIENTS",1,NA
"VOMIT",2,NA
"VOMITING",3,NA
"VORARLBERG",1,NA
"VOUCHER-BASED REINFORCEMENT THERAPY",1,NA
"VOYEURISM",1,NA
"VTA",1,NA
"VULNERABILITY",2,NA
"VULNERABLE POPULATIONS",1,NA
"VULTURE",1,NA
"VULTURES",1,NA
"VUV",1,NA
"VUV-SPECTROSCOPY",1,NA
"VUV ABSORPTION SPECTROSCOPY",1,1
"VWA",1,NA
"VX",1,NA
"W-15",1,NA
"W-18",4,1
"W-SERIES",1,NA
"W/O/W EMULSION",2,NA
"WALD-WOLFOWITZ RUNS TEST",1,NA
"WALL DYNAMIC COATING",1,NA
"WALL JET CONFIGURATION",1,NA
"WALLER INDEX",1,1
"WAR ON DRUGS",3,1
"WARD ATMOSPHERE SCALE",1,NA
"WARD CLIMATE SCALE",1,NA
"WARD ENVIRONMENT",1,NA
"WARFARE",1,NA
"WARFARE AGENTS",1,NA
"WARFARIN",1,1
"WARFARIN POTASSIUM",1,NA
"WARNING",1,NA
"WARPED GAUSSIAN MIXTURE",1,NA
"WARTS",1,NA
"WASH CRITERION",1,NA
"WASH/HAIR RATIO",1,NA
"WASHERWOMENS'S HANDS",1,NA
"WASHING",2,NA
"WASHING AND DECOMPOSITION",1,NA
"WASON SELECTION TASK",1,NA
"WASTEWATER",15,61
"WASTEWATER-BASED EPIDEMIOLOGY",1,33
"WASTEWATER-BASED EPIDEMIOLOGY (WBE)",1,NA
"WASTEWATER ANALYSIS",4,23
"WASTEWATER MARKERS",1,1
"WASTEWATERS",1,NA
"WATCH COUNTERFEITS",1,NA
"WATER-PHASE RECOGNITION",1,NA
"WATER ANALYSIS",2,2
"WATER CONTENT",1,NA
"WATER IMMERSION",1,NA
"WATER INTOXICATION",3,NA
"WATER QUALITY",2,2
"WATER QUALITY ANALYSIS",1,NA
"WATER SAMPLES",1,2
"WATER SOLUBLE",1,NA
"WATERPROOF",1,NA
"WAVELENGTH IDENTIFICATION",1,NA
"WAVENUMBER IDENTIFICATION",1,NA
"WAVENUMBER SELECTION",1,2
"WAVESET LOTION",1,NA
"WAX ESTERS",1,NA
"WAX PRINTING",1,NA
"WAXES",1,NA
"WAY POINTS",1,NA
"WDXRF",1,NA
"WEAKNESSES",1,NA
"WEAPON",1,NA
"WEAPON USE",1,NA
"WEAPONS AND MUNITIONS",1,NA
"WEARABLE",1,NA
"WEARABLE CHEMICAL SENSOR",1,NA
"WEARABLE CHEMICAL SENSORS",1,NA
"WEARABLE DEVICES",1,NA
"WEARABLE SENSORS",3,1
"WEARER",1,NA
"WEATHER",1,NA
"WEATHERING",1,NA
"WEB",1,1
"WEB BROWSER FORENSICS",1,NA
"WEB CRAWLING",2,NA
"WEB RESOURCES",1,NA
"WEBPAGE",1,NA
"WEBSITES",1,NA
"WEDGING",2,NA
"WEIGHT",2,NA
"WEIGHT-LOSS DRUGS",2,2
"WEIGHT GAIN",3,1
"WEIGHT LOSS",3,2
"WEIGHT MANAGEMENT",1,NA
"WEIGHTED PRINCIPAL COMPONENT ANALYSIS",1,NA
"WEIGHTED RETRACE",1,NA
"WEINBERGER ADJUSTMENT INVENTORY",1,NA
"WELCH-SATTERTHWAITE EQUATION",1,NA
"WELL-BEING",1,NA
"WENDER UTAH RATING SCALE",1,NA
"WERNICKE'S ENCEPHALOPATHY",1,NA
"WESTERN AUSTRIA",1,NA
"WESTERN BLOT",1,NA
"WESTERN BLOTTING",2,NA
"WET",1,NA
"WETLANDS",1,NA
"WGA",1,NA
"WHEY PROTEINS",1,NA
"WHIPLASH INJURY",2,NA
"WHISKEY",1,NA
"WHITE HAIR",1,NA
"WHITE HISPANIC",1,NA
"WHITE KIDNEY BEAN DIET",1,NA
"WHITE MATTER ENCEPHALOPATHY",1,NA
"WHITE NON-HISPANIC",1,NA
"WHITE SPIRIT",1,NA
"WHITE SUPREMACIST",1,NA
"WHITENING",1,NA
"WHITEWATER",1,NA
"WHO",1,NA
"WHOLE-BLOOD SCREENING ANALYSIS",1,NA
"WHOLE-BODY DISTRIBUTION",1,NA
"WHOLE-SLIDE IMAGING",1,NA
"WHOLE BLOOD",74,4
"WHOLE BLOOD ANALYSIS",3,1
"WHOLE BLOOD MICROSAMPLING",1,NA
"WHOLE BLOOD SAMPLE",1,NA
"WHOLE BLOOD SAMPLES",2,1
"WHOLE EXOME SEQUENCING",1,NA
"WHOLE GENOME AMPLIFICATION",2,NA
"WHOLE GENOME SEQUENCING",2,NA
"WIDE-BORE CAPILLARY GAS CHROMATOGRAPHY",1,NA
"WIDE-BORE CAPILLARY GAS CHROMATOGRAPHY, BUTYROPHENONES",1,NA
"WIDE-BORE CAPILLARY GC",1,NA
"WIDESPREAD SEPTIC EMBOLIZATION",1,NA
"WIDMARK FACTOR",1,NA
"WIDMARK FACTORS",1,NA
"WILD LIFE FORENSICS",1,NA
"WILD SILK",1,NA
"WILDLIFE",1,NA
"WILDLIFE CRIME",2,NA
"WILDLIFE FORENSIC",2,NA
"WILDLIFE FORENSIC SCIENCE",1,NA
"WILDLIFE FORENSICS",5,NA
"WILDLIFE PROTECTION",1,NA
"WILEY REGISTRY MSMS",1,1
"WILLPOWER",1,NA
"WIN-55,212-2",1,NA
"WIN48098",1,NA
"WINDOW OF DETECTION",2,NA
"WINDOWING",1,NA
"WINDOWS OF DETECTION",1,NA
"WINDOWS PHONE PLATFORM",1,NA
"WINE",1,8
"WINE ENEMA",1,NA
"WINTER",1,NA
"WIPE-TEST",1,NA
"WITHDRAWAL",7,1
"WITHDRAWAL CLINIC",1,NA
"WITHDRAWAL EFFECT",1,NA
"WITHDRAWAL STATE",1,NA
"WITHDRAWAL SYNDROME",3,NA
"WITHDRAWAL TIME",1,NA
"WITHDRAWAL TREATMENT",1,NA
"WITHHOLDING TREATMENT",1,NA
"WITHOUT EVAPORATION AND DERIVATIZATION",1,NA
"WITNESS",2,NA
"WITNESSED SUICIDE",1,NA
"WOLBACHIA",1,NA
"WOMEN'S HAIR CARE PRODUCT",1,NA
"WOMEN'S HEALTH",2,NA
"WOMEN OFFENDERS",1,NA
"WOMEN PRISONERS",1,NA
"WOOD",1,NA
"WOOD ANATOMY",1,NA
"WOOD DECKING",1,NA
"WOODEN TOOTHPICK",1,NA
"WORD MEMORY TEST",1,NA
"WORDNET",1,NA
"WORK PLACE DRUG TESTING",1,NA
"WORKFLOW",1,NA
"WORKFORCE",1,NA
"WORKING MEMORY",1,NA
"WORKPLACE",6,1
"WORKPLACE DRUG TESTING",13,1
"WORKPLACE TESTING",1,NA
"WORKPLACE URINE DRUG TESTING",1,NA
"WORKPLACE VIOLENCE",2,NA
"WORKSHOP",3,NA
"WORLD ANTI-DOPING CODE",1,NA
"WORMWOOD",1,NA
"WOUND",2,NA
"WOUND AGE",2,NA
"WOUND AGE DETERMINATION",1,NA
"WOUND AGE ESTIMATION",4,NA
"WOUND BALLISTICS",1,NA
"WOUND HEALING",2,NA
"WOUND IRRIGATION",1,NA
"WOUNDING INTERVAL ESTIMATION",1,NA
"WOUNDS",1,NA
"WOUNDS AND INJURIES",3,NA
"WRAADDS",1,NA
"WRIST-CUTTING",1,NA
"WRITING INK",1,NA
"WRITING MATERIALS",1,NA
"WRITING PROCESS",1,NA
"WRITTEN APPRAISAL",1,NA
"X-LINKED LYMPHOPROLIFERATIVE DISEASE",1,NA
"X-LINKED MYOTUBULAR MYOPATHY",1,NA
"X-RAY",2,NA
"X-RAY CRYSTALLOGRAPHY",2,11
"X-RAY DIFFRACTION (XRD)",6,5
"X-RAY DIFFRACTION: POWDER PATTERN",1,NA
"X-RAY FLUORESCENCE (XRF)",8,7
"X-RAY FLUORESCENCE SPECTROMETRY",1,NA
"X-RAY FLUORESCENCE SPECTROMETRY (EDX)",1,NA
"X-RAY FLUORESCENCE SPECTROSCOPY (EDX)",1,NA
"X-RAY PHOTOELECTRON SPECTROSCOPY",1,1
"X-RAY POWDER DIFFRACTION",3,7
"X-RAY REFRACTION CONTRAST",1,NA
"X-RAY SPECTRA",1,NA
"X-RAY SPECTROSCOPY",1,NA
"X-RAY SPECTROSCOPY (XPS | XRF | EDX)",1,1
"X CHROMOSOME",1,NA
"X CHROMOSOME STR",1,NA
"XAD-2 EXTRACTION",1,NA
"XAM NEUTRAL MEDIUM-IMPROVED WHITE",1,NA
"XANES",1,NA
"XANTHINES",1,NA
"XANTHOPSIA",1,NA
"XANTHYDROL",1,NA
"XAS",1,NA
"XENOBIOTIC",2,NA
"XENOBIOTICS",13,1
"XENOBIOTICS/BLOOD",1,NA
"XENOBIOTICS/TOXICITY",1,NA
"XENON",1,NA
"XENON ARC",1,NA
"XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP F (XPF)",1,NA
"XEROSTOMIA",1,NA
"XLR-11",4,1
"XPS",1,NA
"XRD",2,NA
"XRF-EDS",1,NA
"XRPD",1,1
"XTC",2,1
"XYLAZINE",8,7
"XYLENE",1,1
"XYLITOLPENTANITRATE",1,NA
"XYREM",1,1
"Y-CHROMOSOMAL DNA",1,NA
"Y-CHROMOSOMAL SHORT TANDEM REPEAT",1,NA
"Y-STR",2,NA
"Y-STR VALIDATION",1,NA
"Y CHROMOSOME",5,1
"Y FAMILY",1,NA
"YAKUZA",2,NA
"YAZ",1,NA
"YEARS LIVED WITH DISABILITY",1,NA
"YEAST",1,3
"YELLOW PHOSPHOROUS",1,NA
"YELLOW PHOSPHORUS",1,NA
"YELLOWCAKE",1,NA
"YEW",2,NA
"YEW INTOXICATION",1,NA
"YEW LEAVES, USED FOR SUICIDE",1,NA
"YFM1",1,NA
"YOGA",1,NA
"YOHIMBINE",2,1
"YOLO",1,NA
"YOUNG",2,NA
"YOUNG ALCOHOLICS",1,NA
"YOUNG DRINKING OFFENDERS",1,NA
"YOUNG GERMAN IMMIGRANTS FROM THE FORMER SOVIET UNION",1,NA
"YOUNG OFFENDER",1,NA
"YOUNG OFFENDERS",2,NA
"YOUNG PERSON",1,NA
"YOUNG PERSONS",1,NA
"YOUNG WOMEN",2,NA
"YOUTH DETENTION",1,NA
"YOUTH MENTAL HEALTH",1,NA
"YOUTH OFFENDERS",1,NA
"YOUTH PSYCHOPATHIC TRAITS INVENTORY - SHORT",1,NA
"YOUTH VIOLENCE",2,NA
"YPI",1,NA
"YSR (YOUTH SELF-REPORT)",1,NA
"YTTRIUM",1,NA
"YUNEEC TYPHOON H",1,NA
"Z-DRUG",1,NA
"Z-DRUGS",4,1
"Z-HYPNOTICA",1,NA
"Z-HYPNOTICS",2,NA
"ZALEPLON",4,6
"ZAR-PRO",1,NA
"ZEBRA FINCHES",1,NA
"ZEBRAFISH",5,1
"ZEBRAFISH LARVAE",1,NA
"ZEOLITE",1,NA
"ZERO-LIMITS",2,NA
"ZERO-ORDER KINETICS",1,NA
"ZERO-TOLERANCE APPROACH",1,NA
"ZERO-TOLERANCE CUT-OFFS",2,NA
"ZERO TOLERANCE",2,NA
"ZINC",3,NA
"ZINC CHLORIDE",1,NA
"ZINC CONTAMINATION",1,NA
"ZINC OXIDE NANOFLOWERS",1,NA
"ZINC OXIDE SHAKE LOTION",1,NA
"ZINC PHOSPHIDE",3,NA
"ZINC SALTS",1,NA
"ZINC SMELTER",1,NA
"ZINC SULPHIDE",1,NA
"ZIP-LOCK POLYETHYLENE BAGS",1,NA
"ZIRCONIA-BASED HYBRIDSPE",1,NA
"ZIRCONIA-COATED CARTRIDGE",1,NA
"ZOLAZEPAM",2,NA
"ZOLPIDEM",39,14
"ZOLPIDEM 6-CARBOXYLIC ACID",1,NA
"ZOLPIDEM METABOLISM",1,NA
"ZOLPIDEM PHENYL-4-CARBOXYLIC ACID",2,NA
"ZOLPIDEM TARTRATE",1,3
"ZOO",1,NA
"ZOPICLONE",22,9
"ZUCLOPENTHIXOL",1,NA
"ZYGOSITY",1,NA
"ZYPREXA",1,NA
"Α- HYDROXYTRIAZOLAMM",1,NA
"Α-2-HS-GLYCOPROTEIN",1,NA
"Α-AMYLASE",1,NA
"Α-CHACONINE",1,NA
"Α-CLEAVAGE",1,NA
"Α-CYANO-4-HYDROXY CINNAMIC ACID (CHCA)",2,NA
"Α-CYANO-4-HYDROXYCINNAMIC ACID",1,NA
"Α-CYANO-4-HYDROXYCINNAMIC ACID (CHCA)",1,NA
"Α-CYCLODEXTRIN",1,NA
"Α-HYDROXY METOPROLOL",1,NA
"Α-HYDROXYFLUALPRAZOLAM",1,NA
"Α-HYDROXYLATION",1,NA
"Α-HYDROXYTRIAZOLAM",2,NA
"Α-LACTALBUMIN",1,NA
"Α-METHYL-3,4-METHYLENEDIOXYPHENYL-PROPIONAMIDE",1,NA
"Α-METHYLENE-Γ-BUTYROLACTONE",1,NA
"Α-METHYLFENTANYL",3,NA
"Α-OXIDATION",1,1
"Α-PBP",2,NA
"Α-PHP",1,NA
"Α-PHTHALIMIDOPROPIOPHENONE",1,NA
"Α-PIHP",1,1
"Α-POP",3,NA
"Α-PVP",7,NA
"Α-PVP METABOLISM",1,NA
"Α-PVT",1,NA
"Α-PYRROLIDINOBUTIOPHENONE (Α-PBP)",1,NA
"Α-PYRROLIDINOHEPTANOPHENONE",1,NA
"Α-PYRROLIDINOHEXIOPHENONE (Α-PHP)",1,NA
"Α-PYRROLIDINOPENTIOPHENONE",1,1
"Α-PYRROLIDINOVALEOROPHENONE",1,NA
"Α-PYRROLIDINOVALEROPHENONE",3,NA
"Α-PYRROLIDINOVALEROPHENONE (Α-PVP)",4,NA
"Α-PYRROLIDINOVALEROTHIOPHENONE (Α-PVT)",1,NA
"Α-SOLANINE",1,NA
"Β-ADRENERGIC DRUG",1,NA
"Β-AGONISTS",1,NA
"Β-AMYLOID PRECURSOR PROTEIN",1,NA
"Β-APP",1,NA
"Β-BLOCKERS",5,NA
"Β-CARBOLINE ALKALOIDS",1,NA
"Β-CYCLODEXTRIN PHENYLCARBAMATE-BONDED SILICA COLUMN",1,NA
"Β-D-GLUCURONIDASE",1,NA
"Β-ENOLASE",1,NA
"Β-GLUCURONIDASE",4,NA
"Β-KETO-3,4-METHYLENEDIOXYPHENYLALKYLAMINES",1,NA
"Β-KETONE ANALOGUE",1,NA
"Β-LACTAMASE INHIBITION",1,NA
"Β-LACTOGLOBULIN",1,NA
"Β-OXIDATION",1,1
"Β-SARCOGLYCAN",1,NA
"Β-TRYPTASE",1,NA
"Β2-AGONISTS",1,NA
"Γ- HYDROXYBUTYRIC ACID",1,NA
"Γ-AMINOBUTYRIC ACID",1,NA
"Γ-BUTYROLACTONE",3,1
"Γ-BUTYROLACTONE (GBL)",3,NA
"Γ-CARBOLINONE DERIVED SYNTHETIC CANNABINOIDS",1,NA
"Γ-HYDROXYBUTYRATE",3,NA
"Γ-HYDROXYBUTYRATE (GBH)",1,NA
"Γ-HYDROXYBUTYRATE (GHB)",1,NA
"Γ-HYDROXYBUTYRIC ACID",5,NA
"Γ-HYDROXYBUTYRIC ACID (GHB)",5,1
"Γ-HYDROXYBUTYROLACTONE",1,NA
"Γ-HYDROXYVALERIC ACID",1,NA
"Γ-SPECTROMETRY",1,NA
"Δ 13C",1,NA
"Δ 9-THC",1,NA
"Δ​9-THC",1,NA
"Δ13C VALUES",1,NA
"Δ8- TETRAHYDROCANNABINOL",1,NA
"Δ9- TETRAHYDROCANNABINOL",1,NA
"Δ9-TETRAHYDROCANNABINOL",17,2
"Δ9-TETRAHYDROCANNABINOL (THC)",3,1
"Δ9-TETRAHYDROCANNABINOL (Δ9-THC)",1,NA
"Δ9-TETRAHYDROCANNABINOL ACETATE",1,NA
"Δ9-TETRAHYDROCANNABINOLIC ACID A",1,NA
"Δ9-THC",4,1
"Δ9-THC-COOH",2,NA
"Δ9-THC METABOLISM",1,NA
"Δ9 THC POTENCY",1,NA
"Μ-ELECTRON CAPTURE DETECTOR",1,NA
"Μ-OPIOID RECEPTOR",2,1
"Μ-OPIOID RECEPTOR (OPRM1)",1,NA
"ΜATR-FTIR",1,1
"ΜPADS",1,NA
"吗啡",1,NA
"腐败血",1,NA
"超高效液相色谱-串联质谱",1,NA
"'ICE'",NA,2
"'RESEARCH CHEMICALS'",NA,1
"'STREET' SAMPLES",NA,1
"-PHENOBARBITAL",NA,1
"-SNO2/Α-FE2O3 HIERARCHICAL NANORODS",NA,1
"""GENERAL UNKNOWN SCREENING""",NA,1
"""LEGAL HIGHS""",NA,2
"""PINK""",NA,1
"""PRISMA"" METHOD",NA,1
"""SIMPLEX"" METHOD",NA,1
"(-)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE",NA,1
"(-)-CATHINONE",NA,1
"(-)-COCAINE HCL",NA,1
"(-)-EPHEDRINE",NA,1
"(-)-EPHEDRINE (EP)",NA,1
"(-)-NOREPHEDRINE",NA,1
"(-)-PSEUDOCOCAINE",NA,1
"(+)- PSEUDOCOCAINE",NA,1
"(+)-CATHINE",NA,1
"(+)-COCAINE BASE",NA,1
"(+)-PSEUDOCOCAINE",NA,1
"(+)-PSEUDOEPHEDRINE (PEP)",NA,1
"(1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE (DP-UR-144)",NA,1
"(1R, 2S)-NOREPHEDRINE",NA,1
"(1R, 2S) EPHEDRINE AND (1S, 2S) PSEUDOEPHEDRINE",NA,1
"(1RS,3SR)-3-[4-(1,1- DIMETHYLOCTYL)-2-HYDROXYPHENYL]CYCLOHEXAN-1-OL",NA,1
"(1S,2S)-1-METHYLAMINO-1-PHENYL-2-CHLOROPROPANE",NA,1
"(2-HYDROXY)PROPYL-Œ≤-CYCLODEXTRIN",NA,1
"(2RS)[(DIMETHYLAMINO)METHYL]CYCLOHEXANONE",NA,1
"(3R, 5R, 7Z)-3-HYDROXY-5-DEC-7-ENOLIDE",NA,1
"(4-ETHYLNAPHTYL)-AM-2201 (EAM-2201)",NA,1
"(Ã‚Â±)-2,5-DIMETHOXY-4- BROMOAMPHETAMINE",NA,1
"(Ã‚Â±)-2,5-DIMETHOXYAMPHETAMINE",NA,1
"(Ã‚Â±)-4-METHOXYAMPHETAMINE",NA,1
"(Ã‚Â±)-PAEOVEITOL",NA,1
"(ÃƑÂ€ŠÃ‚Â±)-OCTOPAMINE",NA,1
"(ÃƑÂ€ŠÃ‚Â±)-SYNEPHRINE",NA,1
"(CONTINUOUS) PREPARATIVE CHROMATOGRAPHY",NA,1
"(DIS)SIMILARITY APPROACHES",NA,1
"(N,5-DIMETHYL-N-(1-OXO-1-(P-TOLYL) BUTAN-2-YL)-2-(N'-(P-TOLYL)UREIDO)BENZAMIDE)",NA,1
"(NEURO)TOXIC",NA,1
"(NON-)CHLORINATED POLYSACCHARIDE-BASED SELECTORS",NA,1
"(R)-(-)-DBD-PY-NCS",NA,1
"(R)-METHADONE",NA,1
"(R)-PHENYLACETYLCARBINOL",NA,2
"(R, S)-3‚Ä≤-HYDROXY-N-METHYLCOCLAURINE 4‚Ä≤-O-METHYLTRANSFERASE",NA,1
"(RS)-KETAMINE",NA,1
"(S)-AMPHETAMINE",NA,1
"(S)-LEVOFLOXACIN",NA,1
"(S)-METHADONE",NA,1
"(S)-METHAMPHETAMINE",NA,1
"?9 -TETRAHYDROCANNABINOL",NA,1
"[ 35S]GTP_S BINDING ASSAY",NA,1
"[35S]-GTPΓS ASSAY",NA,1
"[35S]GTPÃŽÂ³S BINDING ASSAY",NA,1
"[35S]GTPÃŽÂ³S BINDING ASSAYS",NA,1
"[4.4.3]PROPELLANE",NA,1
"_-9-TETRAHYDROCANNABINOL",NA,2
"_-BUTYROLACTONE",NA,1
"_-CLEAVAGE",NA,1
"_-HYDROXYBUTYRIC ACID",NA,1
"_-KETO-3,4-METHYLENEDIOXYPHENYLALKYLAMINES",NA,1
"_-METHYL-3,4-METHYLENEDIOXYPHENYL-PROPIONAMIDE",NA,1
"_-PHTHALIMIDOPROPIOPHENONE",NA,1
"_ 13C",NA,1
"_9-TETRAHYDROCANNABINOL",NA,2
"_9-TETRAHYDROCANNABINOL (_9-THC)",NA,1
"_9-TETRAHYDROCANNABINOLIC ACID A",NA,1
"_K-MBDB",NA,1
"“PSEUDO-TARGET” SCREENING",NA,1
"1-(1",NA,1
"1-(1',4'-CYCLOHEXADIENYL)-2-METHYLAMINOPROPANE",NA,1
"1-(2,3-METHYLENEDIOXYPHENYL)-2-BUTANAMINE",NA,1
"1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE",NA,1
"1-(3,4-DIFLUOROMETHYLENEDIOXYBENZYL)PIPERAZINE (DF-MDBP)",NA,1
"1-(4-CHLOROPHENYL)-2-(DIMETHYLAMINO)PROPAN-1-ONE",NA,1
"1-(4-FLUOROBENZYL)-N-(1-METHOXYCARBONYL-2,2-DIMETHYLPROPYL)-1H-INDAZOLE-3-CARBOXAMIDE [MDMB(N)-BZ-F]",NA,1
"1-(4-FLUOROPHENYL)-2-(PYRROLIDIN-1-YL)HEXAN-1-ONE",NA,1
"1-(M-(TRIFLUOROMETHYL)PHENYL)PIPERAZINE",NA,1
"1-AMINOANTHRACENE LIGAND CHEMISTRY",NA,1
"1-ANDROSTENEDIOL",NA,1
"1-BENZYLPIPERAZINE",NA,1
"1-BUTANOL",NA,1
"1-BUTYL-3-(1-(4-METHYL)NAPHTHOYL)INDOLE",NA,1
"1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE",NA,1
"1-CYCLOHEXYLETHYLAMINE",NA,1
"1-ETHYL-3-METHYLIMIDAZOLIUM METHANESULFONATE",NA,1
"1-FLUORO-2",NA,1
"1-FLUOROCODEINE ANALOGS",NA,1
"1-FLUORODIHYDROMORPHINE",NA,1
"1-FLUOROMORPHINE",NA,1
"1-HYDROXYTROPACOCAINE.",NA,1
"1-HYDROXYTRYPTAMINE",NA,1
"1-IODOCODEINE ANALOGUES",NA,1
"1-IODODIHYDROMORPHINE",NA,1
"1-IODOMORPHINE",NA,1
"1-METHYL-3-OCTYLIMIDAZOLIUM TETRAFLUOROBORATE",NA,1
"1-PENTYL-3-(1-ADAMANTOYL)INDOLE",NA,1
"1-PHENYL-2-(1-PYRROLIDINYL)-1-PENTANONE (Α-PVP)",NA,1
"1-PHENYL-2-PROPANONE (P2P)",NA,1
"1-TESTOSTERONE",NA,1
"1-YEAR STUDY",NA,1
"1 8-NAPHTHALIMIDE",NA,1
"1 H-NMR",NA,1
"1,2-DIARYLETHYLPIPERAZINES",NA,1
"1,2-DIMETHYLIMIDAZOLE-4-SULFONYL CHLORIDE (DMISC)",NA,1
"1,2-DIPHENYLETHYLAMINES",NA,1
"1,3-DIAMINES",NA,1
"1,3-DIMETHYLAMYLAMINE",NA,1
"1,3-DIPROPYLIMIDAZOLIUM BROMIDE",NA,1
"1,3-METHOXYL SHIFT",NA,1
"1,4-BENZODIAZEPINE",NA,1
"10-HYDROXYMORPHINE",NA,1
"10-OXOMORPHINE",NA,1
"10-S-HYDROXYMORPHINE",NA,1
"13C",NA,2
"13C-LABELLING",NA,1
"13C AND 15N ISOTOPE RATIOS",NA,1
"13C ISOTOPE LABELING",NA,1
"13C ISOTOPE RATIO MASS SPECTROMETRY",NA,1
"13C NMR",NA,3
"15N NMR",NA,1
"15N/ 14N RATIO",NA,1
"17ÃŽÂ±-HYDROXYPROGESTERONE CARPROATE",NA,1
"18-CROWN-6-ETHER",NA,1
"18C6H4",NA,1
"19-NORANDROSTENEDIONE",NA,1
"19-NORANDROSTERONE",NA,1
"19-NORETIOCHOLANOLONE",NA,1
"1981-1992",NA,1
"19F NMR",NA,2
"1D-NMR AND 2D-NMR EXPERIMENTS",NA,1
"1H-NMR SPECTROSCOPY",NA,1
"1H HR-MAS NMR",NA,1
"1H NMR SPECTRA",NA,1
"1HNMR",NA,2
"1P-LSD",NA,1
"2-(2-METHOXYPHENYL)- 1-{1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDOL-3-YL}ETHANONE",NA,1
"2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-[(3,4-METHYLENEDIOXYPHENYL)METHYL]ETHANAMINE (25I-NB34MD)",NA,1
"2-(ETHYLAMINO)-1-(3-METHYLPHENYL)PROPAN-1-ONE",NA,1
"2-(N,N-DIMETHYLAMINOMETHYL)MORPHINE",NA,1
"2-, 3- AND 4-METHYLAMPHETAMINE",NA,1
"2-, 3- AND 4-METHYLMETHAMPHETAMINE",NA,1
"2-ADAMANTYL ISOMER",NA,1
"2-ADRENORECEPTOR ANTAGONIST",NA,1
"2-AMINO-3–(2-CHLOROBENZOYL)-5-ETHYLTHIOPHENE",NA,1
"2-AMINONAPH-THOXAZOL",NA,1
"2-AMINOPROPYLBENZOFURAN",NA,1
"2-BENZYLBENZIMIDAZOLE ‘NITAZENE’ OPIOIDS",NA,1
"2-BENZYLBENZIMIDAZOLES",NA,2
"2-CARBOXYETHYL-3-CYANO-5-METHYLHEXANOIC ACID ETHYL ESTER",NA,1
"2-CHLOROPHENOTHIAZINE",NA,1
"2-DIMETHYLAMINO-1-(METHOXYPHENYL)ETHANONE",NA,1
"2-FLUORODESCHLORO",NA,1
"2-HYDROXYPROPYL-ÃƑÅ½Ã‚Â²-CYCLODEXTRIN",NA,2
"2-HYDROXYPROPYL-Β-CYCLODEXTRIN",NA,2
"2-METHOXYDIBENZO[B,D]FURAN ALDEHYDE REGIOISOMERS",NA,1
"2-METHYLAMINO-5-CHLOROBENZOPHENONE",NA,1
"2-OXOGLUTARATE/FE(II)-DEPENDENT DIOXYGENASES",NA,1
"2-PHENOXYPROPIONIC ACID",NA,1
"2-PICOLYLAMINE LIGAND CHEMISTRY",NA,1
"2-THIOBARBITURIC ACID",NA,1
"2, 4-DIMETHYL-N/-[1-(2, 3-DIHYDROXY PHENYL) METHYLIDENE] ANILINE",NA,1
"2,2Ã¢Â‚¬Â²-DIFLUOROFENTANYL",NA,1
"2,2Ã¢Â‚¬Â²-DIPYRIDYL",NA,1
"2,3-DEHYDRODESACETYLDILTIAZEM",NA,1
"2,3-DIHYDROXYPROPYL-ÃƑÅ½Ã‚Â²-CYCLODEXTRIN",NA,1
"2,3-METHYLENEDIOXYAMPHETAMINE",NA,1
"2,3,4-TRICHLORO-5,6-DIMETHOXYPHENETHYLAMINE",NA,1
"2,3,4,6-TETRA-O-ACETYL-ÃƑÅ½Ã‚Â²-D-GLUCOPYRANOSYL ISOTHIOCYANATE",NA,1
"2,3,5-TRIPHENYL-2H-TETRAZOLIUM CHLORIDE (TTC)",NA,1
"2,3,6-TRICHLORO-3,6-DIMETHOXYPHENETHYLAMINE",NA,1
"2,4-DIPHENYLHYDRAZINE",NA,1
"2,4,5-TRICHLORO-3,6-DIMETHOXYPHENETHYLAMINE",NA,1
"2,5-DIMETHOXY-4-ETHYLTHIO-Œ≤-PHENETHYLAMINE",NA,1
"2,5-DIMETHOXY-4-METHYL-Œ≤-PHENETHYLAMINE",NA,1
"2,5-DIMETHOXY-4-PROPYLTHIO-Œ≤-PHENETHYLAMINE",NA,1
"2,5-DIMETHOXYANILINE",NA,1
"2,6-DICHLORO-P-AMINOPHENOL",NA,1
"2,6-DIMETHYLANILINE",NA,1
"2,6-XYLIDINE",NA,1
"2_-(1,2,4-OXADIAZOL-5-METHYL)-3_-PHENYLTROPANE",NA,1
"2001 AUSTRALIAN HEROIN SHORTAGE",NA,1
"2021 IUPAC-SOLVAY AWARD",NA,1
"22 FACTORIAL DESIGN",NA,1
"25-B-NBOME",NA,1
"25-NBOH DRUGS",NA,1
"25-NBOME DRUGS",NA,1
"25H-NBOME",NA,1
"25R-NBOH",NA,1
"2C-B, 2C-T-2, 2C-T-7",NA,1
"2C-COMPOUNDS",NA,1
"2C-D",NA,1
"2C-E",NA,1
"2C-X",NA,1
"2C DRUGS",NA,1
"2D-GEL ELECTROPHORESIS",NA,1
"2D-OPLC",NA,1
"2D CORRELATION SPECTROSCOPY",NA,1
"2D DOSY 1H NMR",NA,1
"2D DOSY NMR",NA,1
"2D MOLECULAR SIMILARITY",NA,1
"2D THZ SIGNATURE",NA,1
"2F-QMPSB",NA,1
"2H-INDAZOLE ISOMER",NA,1
"2H-INDAZOLE REGIOISOMER",NA,1
"2H/1H RATIO",NA,1
"3-([1,3]-THIAZOL-2-YL)INDOLE",NA,1
"3-(1,8-NAPHTHALIMIDO)PROPYL-MODIFIED SILYL SILICA GEL",NA,1
"3-(4-SULFO-1,8-NAPHTHALIMIDO)PROPYL-MODIFIED SILYL SILICA GEL",NA,1
"3-[(3-DEHYDROABIETAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESUL- FONATE",NA,1
"3-ARYL PYRROLIDINES",NA,1
"3-BENZODIOXOL-5-YL)-2-(TERT-BUTYLAMINO)PROPAN-1-ONE",NA,1
"3-FLUOROETHAMPHETAMINE",NA,1
"3-HYDROXY PHENCYCLIDINE",NA,1
"3-HYDROXYDESMETHYLFLUNITRAZEPAM",NA,1
"3-HYDROXYPROPYL-ÃƑÅ½Ã‚Â²-CYCLODEXTRIN",NA,1
"3-METHYLMETHCATHINONE (3-MMC)",NA,1
"3-MONOACETYLMORPHINE",NA,1
"3-NITROBENZONITRILE",NA,1
"3-PHENIBUT",NA,1
"3-TFMPP",NA,1
"3,4-DIMETHYL-5-PHENYL-2-OXAZOLIDONE",NA,1
"3,4-DMA-NBOME",NA,1
"3,4-METHYLENE-DIOXY-PYROVALERONE (MDPV)",NA,1
"3,4-METHYLENEDIOXYAMPHETAMINE DERIVATIVES",NA,1
"3,4-METHYLENEDIOXYETHYLAMPHETAMINE (MDEA)",NA,1
"3,4-METHYLENEDIOXYMETAMFETAMINE",NA,1
"3,4-METHYLENEDIOXYMETHAMPHETAMINE INTERMEDIATES",NA,1
"3,5-DICHLOROMETHCATHINONE",NA,1
"3,5-DIFLUORO-ISOMETHCATHINONE",NA,1
"3,5-DIFLUOROMETHCATHINONE",NA,1
"3,6-DI-O-ACETYL-1-IODOMORPHINE",NA,1
"3ÃƑÂ¢Ã‚Â‚¬Ã‚Â²-HYDROXYSTANOZOLOL",NA,1
"3D-AUNPS",NA,1
"3D-PRINTING",NA,1
"3D-QSAR",NA,1
"3D DOSY-COSY NMR",NA,1
"3D GRAPHENE",NA,1
"3D HIERARCHICAL MOWS2",NA,1
"3D MOLECULAR STRUCTURE",NA,1
"3D STRUCTURE",NA,1
"4'-METHYLETHCATHINONE (4-MEC)",NA,1
"4- CHLORODIAZEPAM",NA,1
"4-(N,N-DIMETHYLAMINOSULFONYL)-7-FLUORO-2,1,3-BENZOXADIAZOLE",NA,2
"4-BEC",NA,1
"4-BR-PVP",NA,1
"4-BROMO-2,5-DIMETHOXY-Œ≤-PHENETHYLAMINE",NA,1
"4-BROMO-2,5-DIMETHOXYBENZYLPIPERAZINE",NA,2
"4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE",NA,1
"4-CHLORDIAZEPAM",NA,1
"4-CHLOROBUTYLCATHINONE",NA,1
"4-CHLORODEHYDROMETHYL TESTOSTERONE",NA,1
"4-CHLOROMETHAMPHETAMINE (4-CMA)",NA,1
"4-CL-ÃŽÂ±-PPP",NA,1
"4-CL-ÃŽÂ±-PVP",NA,1
"4-CL-PPP",NA,1
"4-DIMETHYLAMINOPYRIDINE",NA,1
"4-DINITROBENZENE",NA,1
"4-DMAP",NA,1
"4-EA-NBOME",NA,1
"4-ETHYL-2,5-DIMETHOXY-Œ≤-PHENETHYLAMINE",NA,1
"4-FBF",NA,1
"4-FLUORAMPHETAMINE",NA,1
"4-FLUORO-7-NITRO-2,1,3-BENZOXADIAZOLE",NA,1
"4-FLUORO-PV9",NA,1
"4-FLUOROBUTYRFENTANYL",NA,1
"4-FPD",NA,1
"4-HYDROXY-2-(TRIPHENYLPHOSPHONIO)PHENOLATE",NA,1
"4-HYDROXYBUTYRATE",NA,1
"4-IODO-2,5-DIMETHOXY-Œ≤-PHENETHYLAMINE",NA,1
"4-MBC",NA,1
"4-MDMC",NA,1
"4-MEAP",NA,1
"4-METHOXY-ÃŽÂ±-PVP",NA,1
"4-METHOXYPHENOL",NA,1
"4-METHYLBUPHEDRONE",NA,1
"4-METHYLENEDIOXYPHENYL-2-PROPANONE",NA,1
"4-MMA-NBOME",NA,1
"4-MMC",NA,1
"4-MPD",NA,2
"4-MPHP",NA,1
"4-PENTENYL-AKB48",NA,1
"4 4-DIMETHYLAMINOREX",NA,1
"4,14-DIMETHYCHOLESTANE",NA,1
"4,4Ã¢Â‚¬Â²-DMAR",NA,1
"4FÃ¢Â‚¬Â€ŒPHP",NA,1
"4OMT",NA,1
"4T1 TUMOR CELLS",NA,1
"5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO) FLUORESCEIN (DTAF)",NA,1
"5-(HYDROXYMETHYL)-2-FURFURAL",NA,1
"5-AEDB",NA,1
"5-AMINOSALICYLIC ACID",NA,1
"5-APB-NBOME",NA,2
"5-F-DALT",NA,1
"5-FLUORO-ADB-PINACA",NA,1
"5-FLUORO MDMB-PINACA",NA,1
"5-FLUOROPENTYL-3-PYRIDINOYLINDOLE",NA,1
"5-HT RECEPTOR AGONIST",NA,1
"5-HT2ARECEPTOR",NA,1
"5-MAPDB",NA,1
"5-MEO-DMT",NA,1
"5-METHOXY-BUFOTENINE",NA,1
"5-METHOXY-N,N-DI-ISO-PROPYL-TRYPTAMINE",NA,1
"5-METHOXY-N,N-DI-N-PROPYL-TRYPTAMINE",NA,1
"5-METHOXY-N,N-DIMETHYLTRYPTAMINE",NA,1
"5-METHOXYTRYPTAMINE",NA,1
"5-PENTYL-2-(2-PHENYLPROPAN-2-YL)-2,5-DIHYDRO-1H-PYRIDO[4,3-B]INDOL-1-ONE",NA,1
"5 F-AKB48",NA,1
"5 F-APINACA",NA,1
"5 F-PB-22",NA,1
"5 F-QUPIC",NA,1
"5,6-MD-DALT",NA,1
"5617",NA,1
"5CL-AKB48",NA,1
"5F-AB-PINACA",NA,1
"5F-AMPPPCA",NA,1
"5F-CUMYL-PINACA",NA,2
"5FÃ¢Â‚¬Â€ŒADBICA",NA,1
"5FÃ¢Â‚¬Â€ŒPB-22",NA,1
"5S-RRNA SPACER REGION",NA,1
"5S RRNA-NON-TRANSCRIBED SPACER (NTS)",NA,1
"5SÃ¢Â‚¬Â€ŒRRNA",NA,1
"6-APB",NA,1
"6-BR-MDMA",NA,1
"6-CHLORODESOXYCODEINE, OXIDATION",NA,1
"6-MAPB",NA,1
"6-METHOXY-ÃƑÅ½Ã‚Â±-METHYL-2-NAPHTHALENEACETIC ACID",NA,1
"6-METHOXYTRYPTAMINE",NA,1
"6OMT",NA,1
"7-AMINO-FLUNITRAZEPAM",NA,1
"7-ME-DALT",NA,1
"7, 7, 8, 8-TETRACYANO-QUINODIMETHANE",NA,1
"8-FLUOROAPOCODEINE",NA,1
"8-HYDROXYQUINOLINE",NA,1
"8-HYDROXYQUINOLINE-Β-CYCLODEXTRIN-GRAPHENE OXIDE",NA,1
"8-IODOAPOCODEINE",NA,1
"8-QUINOLINYL 4-METHYL-3-(1-PIPERIDINYLSULFONYL)BENZOATE (QMPSB)",NA,1
"87SR/86SR RATIO",NA,1
"9,10-UNSATURATED ERGOLINE",NA,1
"A-836339",NA,1
"A HISTORY OF OPIUM",NA,1
"A PRIORI SELECTION OF THE SCALE STEP",NA,1
"A. NATURAL FIBRE",NA,1
"Ã¢Â‚¬Å“BATH SALTSÃ¢Â‚¬Â",NA,1
"Ã¢Â‚¬Å“KROKODILÃ¢Â‚¬Â",NA,1
"Ã¢Â‚¬Å“LEGAL HIGHSÃ¢Â‚¬Â",NA,2
"Ã¢Â‚¬Å“MASKEDÃ¢Â‚¬Â METHAMPHETAMINE",NA,1
"Ã¢Â‚¬Å“PSEUDO-TARGETÃ¢Â‚¬Â SCREENING",NA,1
"Ã¢Â‚¬Å“WET AMPHETAMINEÃ¢Â‚¬Â",NA,1
"Ã¢Â‚¬ËŒRESEARCH CHEMICALSÃ¢Â‚¬Â„¢",NA,1
"Ã¢Ë†Â€ 9-THC",NA,1
"ÃÂ€°-TRANSAMINASE",NA,1
"A549 CANCER CELL LINE",NA,1
"AB-CHFUPYCA [N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(CYCLOHEXYLMETHYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-5-CARBOXAMIDE]",NA,1
"AB-CHMFUPPYCA ISOMERS",NA,2
"AB INITIO",NA,2
"AB SLIM",NA,1
"ABDOMINAL PLAIN FILM",NA,1
"ABDOMINAL RADIOGRAPHY",NA,1
"ABIOTIC STRESS",NA,1
"ABLATION",NA,1
"ABSCISIC ACID",NA,1
"ABSINTHISM",NA,1
"ABSOLUTE CONFIGURATION",NA,2
"ABSOLUTE PURITY",NA,1
"ABSOLUTE QUANTIFICATION",NA,2
"ABSORPTION SPECTROSCOPY",NA,1
"ABUSE-DETERRENT",NA,10
"ABUSE-DETERRENT FORMULATION",NA,9
"ABUSE DETERRENCE",NA,2
"ABUSE POTENTIAL",NA,2
"ABUSE POTENTIAL STIMULANTS",NA,1
"ABUSE RISK",NA,1
"ABUSED DRUG ANALYSIS",NA,1
"ABUSED DRUG DETECTION",NA,2
"ACACIA CONFUSA",NA,1
"ACACIA RIGIDULA",NA,1
"ACADEMIC ACHIEVEMENT",NA,1
"ACADEMIC DRUG DISCOVERY",NA,1
"ACCELERANT",NA,1
"ACCEPTANCE AREA",NA,1
"ACCUPRIL¬Æ",NA,1
"ACCURATE MASS DART-TOF-MS MASS SPECTRA FROM TABLETS AND CAPSULES IN REPRESENTATIVE YAA-CHUD BAG",NA,1
"ACCURATE MASS MEASUREMENT",NA,2
"ACCURATE RELATIVE MOLECULAR MASS",NA,1
"ACCURATE RESULTS",NA,1
"ACD/LABS",NA,1
"ACD/MS MANAGER SUITE",NA,1
"ACETIC ANHYDRIDE",NA,1
"ACETIC ANHYDRIDE (AA)",NA,1
"ACETOHYDROXYACID SYNTHASE",NA,1
"ACETOHYDROXYACID SYNTHASE I",NA,1
"ACETYL-Β-CYCLODEXTRIN",NA,2
"ACETYL CHLORIDE",NA,1
"ACETYL CODEINE",NA,1
"ACETYL MORPHINE",NA,1
"ACETYLATION OF MORPHINE",NA,1
"ACETYLCHOLINESETERASE",NA,1
"ACETYLFENTANYL DFT",NA,1
"ACETYLTHEBAOL",NA,1
"ACF",NA,1
"ACHE INHIBITORY ACTIVITY",NA,1
"ACHIRAL SCREENING",NA,1
"ACHIRAL SFC",NA,1
"ACHNATHERUM ROBUSTUM",NA,1
"ACID-BASE DISSOCIATION",NA,1
"ACID-BASE INDICATORS",NA,1
"ACID DISSOCIATION",NA,1
"ACIDIC ADULTERANTS",NA,1
"ACIDIC AND NEUTRAL MANUFACTURING IMPURITIES",NA,1
"ACIDIC COMPOUNDS",NA,1
"ACIDIC SALT",NA,1
"ACIDITY",NA,3
"ACQUISITION CONDITIONS",NA,1
"ACQUITY",NA,1
"ACRIVASTINE",NA,2
"ACTAEA RACEMOSA",NA,1
"ACTIFED",NA,1
"ACTIVATED CARBON",NA,3
"ACTIVATED SLUDGE",NA,1
"ACTIVATED SLUDGE BATCH EXPERIMENTS",NA,1
"ACTIVATION EFFECT",NA,1
"ACTIVATION ENERGY",NA,2
"ACTIVATORS AND INHIBITORS OF ALKALOIDS FORMATION",NA,1
"ACTIVE INGREDIENT",NA,1
"ACTIVE PHARMACEUTICAL INGREDIENT FINGERPRINTING",NA,1
"ACTIVE PHARMACEUTICAL INGREDIENT STARTING",NA,1
"ACTIVITY-BASED BIOASSAY",NA,1
"ACTIVITY-BASED DETECTION",NA,1
"ACTUAL CONDITIONS",NA,1
"ACYLATION/ESTERIFICATION",NA,1
"ADAMANT PLATES",NA,1
"ADAMANTAN-1-YL 1-PENTYL-1H-INDAZOLE-3-CARBOXYLATE (APINAC)",NA,1
"ADAMANTANE",NA,1
"ADAPTATION",NA,1
"ADB-4EN-PINACA",NA,1
"ADB-BICA",NA,1
"ADB-BUTINACA",NA,1
"ADDED INGREDIENTS",NA,1
"ADDICTION DRUG",NA,1
"ADME-TOX",NA,1
"ADRENALINE",NA,1
"ADRENERGIC STIMULANTS",NA,1
"ADSORPTION COEFFICIENT",NA,1
"ADSORPTION ISOTHERM",NA,2
"ADSORPTIVE CATHODIC STRIPPING VOLTAMMETRY",NA,1
"ADULTACHECK 6",NA,1
"ADULTERATE",NA,1
"ADULTERATED PRODUCTS",NA,1
"ADULTERATED SAMPLES",NA,1
"ADULTERATED SUPPLEMENTS",NA,1
"ADULTERATION BEHAVIORS",NA,1
"ADULTERATION WEIGHT LOSS SUPPLEMENTS",NA,1
"ADVANCED OXIDATION PROCESS",NA,1
"ADVANCED OXIDATION PROCESSES",NA,1
"ADVANCES IN RAMAN SPECTROSCOPY",NA,1
"ADVERSE HEALTH EFFECTS",NA,1
"AEROSOL",NA,1
"AERUGINASCIN",NA,1
"AERVA JAVANICA",NA,3
"AETYLSALICYLIC ACID",NA,1
"AF",NA,1
"ÃƑÅ½Ã‚Â€9-TETRAHYDROCANNABINOL",NA,4
"ÃƑÅ½Ã‚Â€9-TETRAHYDROCANNABINOL ACETATE",NA,1
"ÃƑÅ½Ã‚Â€9-TETRAHYDROCANNABINOLIC ACID",NA,1
"ÃƑÅ½Ã‚Â€9-THC",NA,1
"ÃƑÅ½Ã‚Â±-METHYLFENTANYL",NA,2
"ÃƑÅ½Ã‚Â±-PHENYLETHYLAMINE",NA,1
"ÃƑÅ½Ã‚Â±-PHTHALIMIDOPROPIOPHENONE",NA,1
"ÃƑÅ½Ã‚Â±-PYRROLIDINOPHENONE SUBSTRUCTURE",NA,1
"ÃƑÅ½Ã‚Â¼GC",NA,1
"ÃƑÅ½Ã‚Â²- CYCLODEXTRINS",NA,1
"ÃƑÅ½Ã‚Â²-CARBOLINES",NA,1
"ÃƑÅ½Ã‚Â²-CYCLODEXTRIN",NA,4
"ÃƑÅ½Ã‚Â²-CYCLODEXTRIN POLYMER",NA,1
"ÃƑÅ½Ã‚Â²-KETONE ANALOGUE",NA,1
"ÃƑÅ½Ã‚Â³-HYDROXYBUTYRATE",NA,1
"ÃƑÅ½Ã‚Âº",NA,1
"ÃƑÅ½Ã¢Â‚¬Â9-TETRAHYDROCANNABINOL",NA,1
"ÃƑÅ½Ã¢Â‚¬Â9-THC",NA,1
"AFFINITY ELECTROKINETIC CHROMATOGRAPHY",NA,1
"AFFORDABILITY",NA,1
"AFLP MARKERS",NA,1
"AGAT",NA,1
"AGE VERIFICATION",NA,1
"AGGLOMERATIVE CLUSTERING",NA,1
"AGGREGATES",NA,1
"AGGREGATION AGENT",NA,2
"AGGREGATION INDUCED EMISSION",NA,1
"AGONIST",NA,3
"AGONIST 5-HT2A SEROTONIN RECEPTOR",NA,1
"AGP",NA,1
"AGP-CHIRAL STATIONARY PHASE",NA,1
"AGRO-ECOLOGICAL ZONES OF PAKISTAN",NA,1
"AGROBACTERIUM",NA,1
"AGROBACTERIUM TUMEFACIENS",NA,1
"AICAR",NA,1
"AIR-ASSISTED LIQUID–LIQUID MICROEXTRACTION",NA,1
"AIR ANALYSIS",NA,1
"AIR MONITORING",NA,1
"AIR SAMPLES",NA,1
"AIRBORNE PARTICULATE MATTER",NA,1
"AIRBORNE PARTICULATES",NA,3
"AKABORI-MOMOTANI REACTION",NA,1
"AL-LAD",NA,1
"ALASKA",NA,1
"ALBUMIN",NA,1
"ALBUTEROL",NA,1
"ALCOHOLIC DRINKS",NA,1
"ALDOL REACTION",NA,1
"ALEXANDER TSCHIRCH",NA,1
"ALGAE",NA,1
"ALIASING",NA,1
"ALIE",NA,1
"ALIGNER MEDIATED CLEAVAGE",NA,1
"ALIGNMENT OPTIMIZATION",NA,1
"ALIMENTARY OBESITY",NA,1
"ALKALOID BIOSYNTHESIS",NA,5
"ALKALOID CONTENT",NA,3
"ALKALOID ENRICHMENT",NA,1
"ALKALOIDS PRECURSORS",NA,1
"ALKALOIDS PROFILE",NA,1
"ALKALOIDY",NA,1
"ALKENES",NA,2
"ALKOXYCARBONYLATION",NA,1
"ALKYL HOMOLOGUES",NA,1
"ALKYLAMINOINDOLE",NA,1
"ALKYLATED PAH",NA,1
"ALKYLXANTHINES",NA,1
"ALKYNES",NA,1
"ALL-SOLID-STATE ION SELECTIVE ELECTRODE (ISE)",NA,1
"ALL SOLID STATE",NA,1
"ALLOBARBITONE",NA,1
"ALLYLATION",NA,2
"ALLYLBENZENE",NA,1
"ALOYSIA",NA,1
"ALTERNATIVE TO NON-INVASIVE OPTICAL SPECTROSCOPY",NA,1
"ALUMINUM SEC-BUTOXIDE",NA,1
"AM 694",NA,1
"AM1/SM5.4",NA,1
"AMARANTHACEAE",NA,1
"AMAZONAS",NA,1
"AMAZONIAN PRACTICES",NA,1
"AMB",NA,1
"AMB-FUBUNACA",NA,1
"AMBIENT DESORPTION/IONIZATION MASS SPECTROMETRY",NA,1
"AMBIENT IONIZATION MASS",NA,1
"AMBIENT IONIZATION METHODS",NA,1
"AMBROXOL",NA,1
"AMD",NA,1
"AMI-DO BLACK 10B",NA,1
"AMIDE",NA,2
"AMINATIONS",NA,1
"AMINE DRUGS",NA,1
"AMINE N-OXIDES",NA,1
"AMINO",NA,1
"AMINO-MODIFIED SILICA",NA,1
"AMINO ALCOHOLS",NA,2
"AMINOREX DERIVATIVES",NA,1
"AMINOTADALAFIL",NA,1
"AMINOTRANSFERASE",NA,1
"AMITRIPTYLINE HCL",NA,2
"AMITRIPTYLINE HYDROCHLORIDE.",NA,1
"AMITRIPTYLINE METABOLITES",NA,1
"AMNESTY BIN",NA,1
"AMORPHOUS",NA,1
"AMOVA",NA,1
"AMPEROMETRIC I-T CURVE METHOD",NA,1
"AMPHENICOL",NA,1
"AMPHETAMINE-LIKE COMPOUNDS",NA,1
"AMPHETAMINE-LIKE STIMULANT",NA,1
"AMPHETAMINE-TYPE (ATS) DRUGS",NA,1
"AMPHETAMINE-TYPE DERIVATIVE",NA,1
"AMPHETAMINE-TYPE SIMULANTS",NA,1
"AMPHETAMINE-TYPE STIMULANT DRUGS",NA,1
"AMPHETAMINE DERIVATIVES, ECSTASY, GCD ANALYSIS, DRAG ABUSE, FORENSIC SAMPLES, NOVI SAD",NA,1
"AMPHETAMINE ENANTIOMERS",NA,1
"AMPHETAMINE HYDROCHLORIDE",NA,2
"AMPHETAMINE IMMUNOASSAY",NA,1
"AMPHETAMINE ISOMER",NA,1
"AMPHETAMINE PROFILING",NA,1
"AMPHETAMINE TYPE STIMULANTS (ATS)",NA,1
"AMPHETAMINE TYPE STIMULANTS (ATS) USE",NA,1
"AMPLIFICATION REFRACTORY MUTATION SYSTEM (ARMS)",NA,1
"AMPPPCA",NA,1
"AMYLOSE",NA,1
"AMYLOSE TRIS(3-CHLORO-5-METHYLPHENYLCARBAMATE).",NA,1
"ANABOLIC",NA,1
"ANABOLIC AGENTS",NA,4
"ANABOLIC STEROID-INDUCED HYPOGONADISM",NA,1
"ANABOLIC STEROID, SYNTHESIS",NA,1
"ANALGESIA, PATIENT-CONTROLLED",NA,1
"ANALGESIC AND ANTI-ADDICTIVE DRUG",NA,1
"ANALGESIC EFFICACY",NA,1
"ANALOGIES/TRANSFER",NA,1
"ANALOGUES OF 3-CARBONYLINDOLES",NA,1
"ANALYSIS OF BOTANICAL SAMPLES",NA,1
"ANALYSIS OF DRUGS OF ABUSE",NA,1
"ANALYSIS OF HALLUCINOGENS",NA,1
"ANALYTE CONFIRMATION",NA,1
"ANALYTE PULSE PERTURBATION",NA,1
"ANALYTE PULSE PERTURBATION TECHNIQUE (APP)",NA,1
"ANALYTE STRUCTURE",NA,1
"ANALYTICAL",NA,2
"ANALYTICAL AND CONTROL WORKFLOW",NA,1
"ANALYTICAL CHARACTERIZATION",NA,1
"ANALYTICAL DATA",NA,1
"ANALYTICAL DETECTION METHODS",NA,1
"ANALYTICAL MARKERS",NA,1
"ANALYTICAL METHODS HARMONISATION",NA,1
"ANALYTICAL PERFORMANCE CHARACTERISTICS",NA,1
"ANALYTICAL PROCEDURE OPTIMIZATION",NA,1
"ANALYTICAL PROFILING",NA,1
"ANALYTICAL RESULTS HARMONISATION",NA,1
"ANALYTICAL TECHNIQUES IN DETECTING COUNTERFEIT PRODUCTS",NA,1
"ANALYTICAL WORKFLOW COMPARISON",NA,1
"ANAPLASTIC LYMPHOMA KINASE",NA,1
"ANATOMICAL STRUCTURE",NA,1
"ANCIENT PLANT SEEDS",NA,1
"ANDEAN TEPUI",NA,1
"ANDROGEN BIOASSAY",NA,1
"ANDROGENIC ANABOLIC STEROIDS",NA,1
"ANDROGENIC AND ANABOLIC STEROID",NA,1
"ANDROGENS",NA,3
"ANDROLOGY",NA,1
"ANDROSTANE ISOMERS",NA,1
"ANESTHETIC AGENTS",NA,2
"ANESTHETIC DRUG",NA,1
"ANGEL DUST",NA,1
"ANGELICA PUBESCENS AND ANGELICA SINENSIS",NA,1
"ANHYDROECGONINE",NA,1
"ANHYDROUS",NA,1
"ANI",NA,1
"ANIMAL-DERIVED FOOD",NA,1
"ANIMAL FEED",NA,2
"ANIONIC ADDITIVE",NA,1
"ANIONIC CYCLODEXTRINS",NA,2
"ANISODAMINE",NA,2
"ANISODUS TANGUTICUS ROOT",NA,1
"ANNOTATIONS",NA,1
"ANOMALY DETECTION",NA,1
"ANOREXICS",NA,1
"ANT COLONY OPTIMIZATION",NA,1
"ANTAGONIST",NA,2
"ANTAGONIST EFFECT AT CRF 1 RECEPTORS",NA,1
"ANTHOCYANINS",NA,1
"ANTI-ANGINAL DRUG",NA,1
"ANTI-BACTERIAL",NA,1
"ANTI-COUNTERFEITING TECHNOLOGY",NA,1
"ANTI-DOPING TEST",NA,1
"ANTI-DRUG SITUATIONAL AWARENESS",NA,1
"ANTI-INFLAMMATORY",NA,2
"ANTI-INFLAMMATORY ACTIVITY",NA,1
"ANTI-INFLUENZA",NA,1
"ANTI-LEISHMANIAL",NA,1
"ANTI-MALARIAL",NA,1
"ANTI-MG MAB",NA,1
"ANTI-MITRAGYNINE MONOCLONAL ANTIBODY",NA,1
"ANTI-MORPHINE ANTIBODY",NA,1
"ANTI-MUTAGENIC ACTIVITY",NA,1
"ANTI-NOCICEPTIVE MECHANISMS",NA,1
"ANTI-OBESITY",NA,1
"ANTI-OBESITY DRUG",NA,1
"ANTIASTHMATIC DRUGS",NA,1
"ANTIASTHMATIC TABLETS",NA,1
"ANTIBACTERIAL",NA,1
"ANTIBIOTICA: LIPID REGULATING AGENTS",NA,1
"ANTICANCER",NA,1
"ANTICHOLINERGIC",NA,1
"ANTICHOLINERGIC SYNDROME",NA,1
"ANTICOUNTERFEITING METHOD",NA,1
"ANTIEPILEPTIC ACTIVITY",NA,1
"ANTIEPILEPTIC DRUG",NA,1
"ANTIFOULING",NA,1
"ANTIFUNGAL",NA,1
"ANTIFUNGALS",NA,1
"ANTIGOUT",NA,1
"ANTILEISHMANIAL",NA,2
"ANTILEISHMANIAL ACTIVITY",NA,1
"ANTILEISHMANIAL BISINDOLES",NA,1
"ANTIMICROBIAL",NA,4
"ANTIMICROBIAL ACTIVITY",NA,1
"ANTIMICROBIAL AGENTS",NA,1
"ANTIMICROBIAL PROPERTIES",NA,1
"ANTIMONY FILM ELECTRODE",NA,1
"ANTIMONY OXIDE",NA,1
"ANTIMUTAGENIC",NA,1
"ANTINOCICEPTIVE",NA,1
"ANTINUTRITIONAL COMPOUNDS",NA,1
"ANTIOSTEOPOROSIS",NA,1
"ANTIOXIDANT AND ANTIGLYCATION ACTIVITIES",NA,1
"ANTIOXIDANT CAPACITY",NA,3
"ANTIPSYCOTIC",NA,1
"ANTITUSSIVES",NA,1
"ANTIVIRALS",NA,1
"ANUCS308",NA,1
"ANXIETY BEHAVIOR",NA,1
"ANXIOLYTIC",NA,4
"APCT",NA,1
"APHRODISIAC CHEMICAL INGREDIENTS",NA,1
"API-MS",NA,1
"APICAL BUD",NA,1
"APINACA 2H-INDAZOLE ANALOGUE",NA,1
"APINACA ANALOGUES",NA,1
"APO ENZYME",NA,1
"APOMORPHINE",NA,1
"APPETITE DEPRESSANTS",NA,1
"APPLICATION OF FORENSIC SEDIMENT ANALYSIS",NA,1
"APPLICATIONS OF RAMAN SPECTROSCOPY",NA,1
"APPS",NA,1
"APTASENSOR",NA,4
"AQUATIC PLANTS",NA,1
"AQUATIC PRODUCT",NA,1
"AQUATIC TOXICITY",NA,1
"AQUATIC TOXICOLOGY",NA,1
"AQUEOUS AND NONAQUEOUS BUFFERS",NA,1
"ARBUTIN",NA,1
"ARENEDIAZONIUM TETRAFLUOROBORATES",NA,1
"ARF EXCIMER LASER",NA,1
"ARID REGIONS",NA,1
"ARIMA",NA,1
"ARIMA-INTERVENTION ANALYSIS",NA,1
"ARIMA MODELS",NA,1
"ARINTO",NA,1
"AROMA",NA,1
"AROMATIC AMINES",NA,1
"AROMATIC AMINO ACIDS",NA,3
"AROMATIZATION",NA,1
"ARRHENIUS EQUATION",NA,1
"ARTANE¬Æ",NA,1
"ARTEMISIA ABSINTHIUM L.",NA,1
"ARTIFICIAL INTELLIGENCE TECHNIQUES",NA,1
"ARTIFICIAL NOSE",NA,1
"ARTWORKS",NA,1
"ARYL IODIDES",NA,1
"ARYL VINYL KETONES",NA,1
"ARYL Α-AMINO KETONES",NA,1
"ARYLSULFONAMIDES",NA,1
"ARYLZINC REAGENTS",NA,1
"ARYMO ER",NA,1
"ARYNES",NA,1
"AS SEQUENTIAL FORWARD FLOATING SELECTION (SFFS)",NA,1
"AS SPECIATION",NA,1
"ASI-MV",NA,1
"ASPIRIN (ACETYLSALICYLIC ACID)",NA,1
"ASSAY",NA,2
"ASSESSMENT TOOL",NA,1
"ASSIGNMENT OF VIBRATION",NA,1
"ASSOCIATED PARTICLE TECHNIQUE",NA,1
"ASSOCIATIVE LEARNING",NA,1
"ASYMMETRIC",NA,1
"ASYMMETRIC PICTET-SPENGLER REACTION",NA,1
"ASYMMETRIC SYNTHESIS",NA,3
"ASYMMETRIC SYNTHESIS OF MORPHINANE DERIVATIVES",NA,1
"ATC CODE",NA,1
"ATHLETIC NUTRITION",NA,1
"ATMOSPHERE",NA,1
"ATMOSPHERE PRESSURE THERMODESORPTION SURFACE IONIZATION SPECTROSCOPY",NA,1
"ATMOSPHERIC CONTAMINANTS",NA,2
"ATMOSPHERIC PRESSURE MATRIX-ASSISTED LASER DESORPTION/IONIZATION",NA,1
"ATMOSPHERIC PRESSURE PHOTOIONIZATION",NA,3
"ATOMIC CHARGE",NA,1
"ATOMIC SPECTROMETRY",NA,1
"ATOMIC SPIN DENSITY",NA,1
"ATP SENSITIVE K+ CHANNEL",NA,1
"ATR-(N) IR",NA,3
"ATR-FT-IR IMAGING",NA,1
"ATRÃ¢Â‚¬Â€ŒFTIR",NA,1
"ATROPA BELLADONNA",NA,3
"ATROPISOMERS",NA,3
"ATRP",NA,1
"ATSS",NA,1
"ATTENUATE TOTAL REFLECTANCE MID-INFRARED",NA,1
"ATTENUATED TOTAL REFLECTION FOURIER TRANSFORM INFRARED SPECTROMETER",NA,1
"AU-MESOPOROUS SILICA NANOPARTICLES",NA,1
"AU-POLYPYRROLE NANOCOMPOSITE",NA,1
"AU NANOCLUSTERS",NA,1
"AU NANOPARTICLES",NA,1
"AU NPS",NA,1
"AU@AG",NA,1
"AUNPS",NA,3
"AUSTRALIAN HEROIN MARKET",NA,1
"AUTOMATED METHOD SCOUTING",NA,1
"AUTOMATED SEQUENTIAL 2D GC-GC/MS",NA,1
"AUTOMATIC COMPARISON",NA,1
"AUTOREGRESSIVE MODEL",NA,1
"AUTOSAMPLER",NA,2
"AVAILABILITY",NA,1
"AVERAGELY LINEAR-QUANTIFIED FINGERPRINT",NA,1
"AVIDIN",NA,2
"AXSYM",NA,1
"AYAHUASCA BEVERAGE",NA,1
"ÃŽÂ´ 13C",NA,1
"ÃŽÂ´9-TETRAHYDROCANNABINOL (ÃŽÂ´9-THC)",NA,1
"ÃŽÂ€ 9-TETRAHYDROCANNABINOL",NA,1
"ÃŽÂ€Ã¢Â‚¬Â€¹9-THC",NA,1
"ÃŽÂ€Œ-AMINOBUTYRIC ACID RECEPTOR",NA,1
"ÃŽÂ±-CYANO-4-HYDROXYCINNAMIC ACID",NA,1
"ÃŽÂ±-GALACTOSIDASES",NA,1
"ÃŽÂ±-HEMOLYSIN",NA,1
"ÃŽÂ±-HUMULENE",NA,1
"ÃŽÂ±-PBT",NA,1
"ÃŽÂ±-PHP",NA,1
"ÃŽÂ±-PNP",NA,1
"ÃŽÂ±-PVP",NA,7
"ÃŽÂ±-PVT",NA,1
"ÃŽÂ±-PYRROLIDINOHEPTANOPHENONE",NA,1
"ÃŽÂ±-PYRROLIDINOPENTIOPHENONE",NA,1
"ÃŽÂ±-PYRROLIDINOPHENONES",NA,1
"ÃŽÂ±-PYRROLIDINOVALEROPHENONE",NA,2
"ÃŽÂ±-PYRROLIDINOVALEROPHENONE (PVP)",NA,1
"ÃŽÂ±-PYRROLIDINOVALEROTHIOPHENONE (ÃŽÂ±-PVT)",NA,1
"ÃŽÂ±-TOCOPHEROL",NA,1
"ÃŽÂ±L-ACID GLYCOPROTEIN",NA,1
"ÃŽÂ¼-OPIOID RECEPTOR",NA,1
"ÃŽÂ¼-OPIOID RECEPTOR AGONIST",NA,2
"ÃŽÂ¼XRF",NA,1
"ÃŽÂ²-CARBOLINE, HARMALA ALKALOIDS",NA,1
"ÃŽÂ²-CARBOLINES",NA,1
"ÃŽÂ²-CYCLODEXTRIN",NA,6
"ÃŽÂ²-ENAMINONE",NA,1
"ÃŽÂ²-KETONE PHENETHYLAMINE STIMULANT",NA,1
"ÃŽÂ²-METHYLPHENYLETHYLAMINE",NA,1
"ÃŽÂ²-PHENYLETHYLAMINES AND NBOME DERIVATIVES",NA,1
"ÃŽÂ²-TH-NAPHYRONE",NA,1
"ÃŽÂ²-THNPH",NA,1
"ÃŽÂ²K-MDMA",NA,1
"ÃŽÂ³- HYDROXYBUTYRIC ACID",NA,1
"ÃŽÂ³-BUTYROLACTONE",NA,1
"ÃŽÂ³-CARBOLINE, HERBAL BLENDS",NA,1
"ÃŽÂ³-HYDROXYBUTYRATE",NA,1
"ÃŽÂ³-HYDROXYBUTYRIC ACID",NA,1
"ÃŽÂ³-HYDROXYBUTYRIC ACID (GHB)",NA,1
"ÃŽÂ³-HYDROXYBUTYROLACTONE",NA,1
"AZAALLYL ANIONS",NA,1
"AZAINDAZOLE",NA,1
"AZAPHENOTHIAZINE",NA,1
"AZAPHENOXAZINE",NA,1
"B. MICROSTRUCTURE",NA,1
"B12N12",NA,1
"B16F10",NA,1
"B3LYP",NA,2
"B3LYP AND HSEH1PBE",NA,1
"BABY FOOD",NA,1
"BABY FOODS",NA,1
"BACKGROUND ELECTROLYTE",NA,1
"BACKGROUND ELECTROLYTE COMPOSITION",NA,2
"BACKGROUND ELECTROLYTE SELECTION",NA,2
"BACTERIAL ADHESION",NA,1
"BAEOCYSTIN",NA,1
"BAEYER-VILLIGER REACTION",NA,1
"BAFE12O19 NANOPARTICLES",NA,1
"BAKERY PRODUCT",NA,1
"BALANSIA EPICHLOE",NA,1
"BALANSIEAE",NA,1
"BAMBUTEROL",NA,1
"BAND GAP",NA,1
"BANISTERIOPSIS CAAPI",NA,1
"BAR/CHIP CODING",NA,1
"BARBADOS",NA,1
"BARBITONE",NA,1
"BARBITURATE ANION",NA,1
"BARBITURATE DERIVATIVES",NA,3
"BARBITURATES AND PHENYTOIN",NA,1
"BARBITURIC ACID",NA,5
"BARK",NA,1
"BARK-CORE RATIO",NA,1
"BASIC COMPOUNDS",NA,1
"BASIC DRUG OF ABUSE",NA,1
"BASIC PRINCIPLES",NA,1
"BASIC SOLUTES",NA,1
"BASICITY",NA,1
"BASIDIOMYCOTINA",NA,1
"BASIFIED MODIFIER",NA,1
"BAST FIBER",NA,1
"BAST FIBRE",NA,1
"BATCH-TO-BATCH COMPARISON",NA,1
"BATCH INJECTION ANALYSIS",NA,1
"BATCH MEMBERSHIP",NA,1
"BATCH ORIGIN",NA,1
"BATCH RELATIONS",NA,2
"BAYES' THEOREM",NA,2
"BAYESIAN ANALYSIS",NA,2
"BAYESIAN CLASSIFICATION",NA,1
"BAYESIAN MODELLING",NA,1
"BAYESIAN THEORY",NA,1
"BD, 1,4-BD",NA,1
"BDDE",NA,1
"BDE",NA,1
"BEIJING",NA,2
"BENCHMARKING CHEMICALS",NA,1
"BENCHTOP INSTRUMENTS",NA,1
"BENCHTOP NMR SPECTROSCOPY",NA,1
"BENCHTOP RAMAN ANALYSIS",NA,1
"BENEFITS",NA,1
"BENZENE RING SUBSTITUENTS",NA,1
"BENZIMIDAZOLES",NA,1
"BENZO[H]QUINOLONE",NA,1
"BENZODIAZEPINE DERIVATIVES",NA,1
"BENZODIAZEPINE PHOTOSTABILITY",NA,1
"BENZODIAZEPINES (BDZ)",NA,1
"BENZODIAZEPINES (BZDS)",NA,1
"BENZODIAZEPINONE PHARMACEUTICALS",NA,1
"BENZOFURY",NA,1
"BENZOFURYLETHYLAMINE",NA,1
"BENZOIC ACID RECYCLING",NA,1
"BENZOIC ACIDS",NA,1
"BENZOPHENOTHIAZINE",NA,1
"BENZOPHENOXAZINE",NA,1
"BENZOQUINONE REAGENT, HALLUCINOGEN, NBOME, NEW PSYCHOACTIVE SUBSTANCES, PRESUMPTIVE DRUG TEST",NA,1
"BENZOXAZOCINE",NA,1
"BENZOYL DERIVATIVES OF BARBITURIC ACID",NA,1
"BENZOYLECGONINE ILLICIT DRUGS",NA,1
"BENZYL AMINO PURINE",NA,1
"BENZYL METHYL KETONE",NA,1
"BENZYLATION",NA,1
"BENZYLISOQUINOLINE ALKALOID",NA,13
"BENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS",NA,1
"BENZYLPIPERAZINE DERIVATIVES",NA,1
"BENZYLTETRAHYDOISOQUINOLINES",NA,1
"BENZYLZINC REAGENTS",NA,1
"BERBERINE BRIDGE ENZYME",NA,2
"BETA-BLOCKER DRUGS",NA,1
"BETA-KETONE ANALOGUES",NA,1
"BETA-KETONE METHYLENEDIOXYMETHAMPHETAMINE",NA,1
"BETEL VINE LANDRACES",NA,1
"BETELVINE (PIPER BETLE L.)",NA,1
"BETULAPLATOSIDE",NA,1
"BIA",NA,2
"BIACORE",NA,1
"BIASED SAMPLING",NA,1
"BIBLIOMETRIC",NA,1
"BIBLIOMETRIC ANALYSIS",NA,2
"BILAYER TABLET",NA,1
"BILLS",NA,1
"BINAPHTHOL",NA,1
"BINARY COSOLVENT MIXTURES",NA,1
"BINARY MIXTURES",NA,3
"BINDING ACTIVITY",NA,1
"BINDING CONSTANTS",NA,2
"BINGE EATING",NA,1
"BIO-ACTIVE MOLECULES",NA,1
"BIO-COMPATIBLE DEEP EUTECTIC SOLVENT",NA,1
"BIO-OIL",NA,1
"BIOACTIVE AMINE",NA,1
"BIOACTIVITY",NA,3
"BIOANALYSES",NA,1
"BIOANALYTICAL ANALYSIS",NA,1
"BIOAVAIL",NA,1
"BIOCATALYSIS",NA,3
"BIOCHEMICAL AND PHARMACOLOGICAL ACTIONS",NA,1
"BIOCHEMICAL METHODS",NA,1
"BIOCONCENTRATION",NA,1
"BIOCONJUGATES",NA,1
"BIOCONVERSION",NA,1
"BIODEGRADABLE POLYMER",NA,1
"BIODEGRADATION ASSAYS",NA,1
"BIOENGINEERING",NA,1
"BIOLAYER INTERFEROMETRY",NA,1
"BIOLOGIC PHARMACEUTICALS",NA,1
"BIOLOGICAL ACCUMULATION COEFFICIENT",NA,1
"BIOLOGICAL AND ELECTRICAL CONDUCTIVITY",NA,1
"BIOLOGICAL CHARACTERISTICS",NA,1
"BIOLOGICAL MONITORING",NA,1
"BIOLOGICAL SOURCES",NA,1
"BIOLOGICAL SPECIMEN EXTRACTION AND LIQUID-LIQUID, OR SOLID-PHASE MICROEXTRACTION",NA,1
"BIOLOGICAL TISSUES",NA,1
"BIOLOGICAL VIRTUES",NA,1
"BIOLOGICALLY- ACTIVE COMPOUNDS",NA,1
"BIOMARKER ANALYSIS",NA,1
"BIOMARKERS OF CONSUMPTION",NA,1
"BIOMASS",NA,1
"BIOMEDICAL RESEARCH",NA,1
"BIOMEDICAL SCIENCE",NA,2
"BIONIC LIQUID",NA,1
"BIOSECURITY",NA,1
"BIOSENSORS AND BODY FLUIDS",NA,1
"BIOSYNTHESIS",NA,9
"BIOSYNTHESIS PATHWAY EVOLUTION",NA,1
"BIOSYNTHETIC ENZYME",NA,1
"BIOSYNTHETIC GENE DISCOVERY",NA,1
"BIOSYNTHETIC PATHWAY",NA,2
"BIOTECHNOLOGICAL PRODUCT",NA,1
"BIOTECHNOLOGICAL PRODUCTION",NA,1
"BIOTECHNOLOGY",NA,2
"BIOTIC STRESS",NA,1
"BIOTIN",NA,2
"BIPHASIC DELIVERY SYSTEM TECHNOLOGY",NA,1
"BIPLOT",NA,1
"BIRCH REDUCTION",NA,1
"BIS-N,O-TRIMETHYLSILYL TRIFLUOROACETAMIDE (BSTFA) DERIVATIZATION",NA,1
"BISIGNATE-SHAPED CD SPECTRUM",NA,1
"BITHIOPHENE",NA,1
"BITTER ORANGE",NA,1
"BITTERNESS-MASKING EFFECT",NA,1
"BIVARIATE CORRELATION ANALYSIS",NA,1
"BK-EPDP",NA,1
"BLACK MARKET PRODUCTS",NA,1
"BLENDING",NA,1
"BLIND STUDIES",NA,1
"BLISTER PACKAGING",NA,1
"BLOODSTREAM INFECTIONS",NA,1
"BLOTTING PAPER",NA,1
"BLUE LOTUS FLOWER",NA,1
"BLUNT",NA,1
"BMK DETECTION",NA,1
"BMPEA",NA,1
"BODYPACK",NA,1
"BOHAI SEA",NA,1
"BOLIVIA",NA,1
"BOMB-PULSE CARBON-14 DATING",NA,1
"BOOTSTRAP",NA,1
"BORON-DOPED DIAMOND",NA,2
"BORON NITRIDE",NA,1
"BORROWING HYDROGEN",NA,1
"BOTANICAL",NA,1
"BOTANICAL DIETARY SUPPLEMENTS (BDS)",NA,3
"BOTANICAL MEDICINE",NA,1
"BOTRYDIAL",NA,1
"BOX-BEHNKEN DESIGN",NA,4
"BOX-BEHNKEN STATISTICAL DESIGN",NA,1
"BRACHYBOTRYNE",NA,1
"BRACHYBOTRYNEÂ€“N-OXIDE",NA,1
"BRAGG DIFFRACTION",NA,1
"BRAIN HOMOGENATE",NA,1
"BRANCHING RATIOS",NA,1
"BRASSINOSTEROIDS",NA,1
"BRAY",NA,1
"BRAY-LIEBHAFSKY REACTION",NA,1
"BRAZILIAN PAPER CURRENCY",NA,1
"BREAD",NA,2
"BREATHALYZER",NA,1
"BREEDING",NA,2
"BREEDING PROGRAMS",NA,1
"BRIGHTNESS",NA,1
"BROAD-SPECIFIC ANTIBODIES",NA,2
"BROLAMPHETAMINE",NA,1
"BROMIDE- OR CHLORIDE-CONTAINING PHARMACEUTICAL PREPARATIONS",NA,1
"BROMODIMETHOXY BENZYL PIPERAZINES",NA,1
"BROMOPHENYLPIPERAZINE",NA,1
"BROMOTHIENYL ANALOGS",NA,1
"BROMOXY-LENOL BLUE",NA,1
"BRONCHODILATORS",NA,1
"BROOK REARRANGEMENT",NA,1
"BROWN TROUT",NA,1
"BRUGMANSIA ARBOREA",NA,1
"BTEX",NA,1
"BU TYLCANNABINOL",NA,1
"BUBBLE COLUMN EXTRACTION",NA,1
"BUCKWHEAT",NA,2
"BUCKWHEAT AND RELATED FOOD",NA,1
"BUFFER ADDITIVE",NA,1
"BUFFER COMPOSITION",NA,8
"BULBS",NA,1
"BULK HYDROGEN ANALYSIS",NA,1
"BUPRENORPHINE TREATMENT",NA,1
"BURNED DOCUMENTS",NA,1
"BURUNDANGA",NA,1
"BUSCOPANÃ‚Â®",NA,1
"BUTANOL",NA,1
"BUTORPHANOL",NA,1
"BUTRANS",NA,1
"BUTYLCANNABIDIOL",NA,1
"BUTYLONE",NA,2
"BUTYLSCOPOLAMINE",NA,1
"BUTYLTETRAHYDROCANNABINOL",NA,1
"BZE-DADOO",NA,1
"C-19 STEROID",NA,1
"C-MET",NA,1
"C 60",NA,1
"C. NUMERICAL ANALYSIS",NA,1
"C1 STATIONARY PHASE",NA,1
"C18",NA,1
"C18/SCX",NA,1
"C3-KETOSTEROIDS",NA,1
"CA-CHANNEL BLOCKERS",NA,1
"CA. MEDICINES",NA,1
"CÃ¢Ë†Â€™C COUPLING",NA,1
"CACO-2 CELL LINE",NA,1
"CACTUS",NA,1
"CADMIUM SULFIDE QUANTUM DOTS",NA,1
"CAFFEINE DIETARY INTAKE",NA,1
"CAFFEINE, EPHEDRINE AND PSEUDO-EPHEDRINE",NA,1
"CALCICOLE",NA,1
"CALCIFUGE",NA,1
"CALCULATED WEIGHT",NA,1
"CALIBRANTS",NA,1
"CALIBRATION AND VALIDATION",NA,1
"CALIFORNIA POPPY",NA,4
"CALLUS",NA,2
"CALLUS INDUCTION",NA,1
"CALORIFIC VALUE",NA,1
"CALYSTEGINE",NA,3
"CAMP ASSAY",NA,1
"CANABIDIOL",NA,1
"CANADIAN PHARMACIES",NA,1
"CANANBIS",NA,1
"CANCER CELLS",NA,1
"CANCER PAIN",NA,2
"CANDIDA TROPICALIS",NA,1
"CANINE OLFACTION DETECTION",NA,1
"CANINES",NA,1
"CANNABACEAE",NA,12
"CANNABICHROMANONE",NA,1
"CANNABIDIOLIC ACID",NA,1
"CANNABIFLAVONOIDS",NA,1
"CANNABIGEROLIC ACID",NA,1
"CANNABIMIMETIC ALKYLINDOLES",NA,1
"CANNABINACEAE",NA,1
"CANNABINOID ANALOG",NA,1
"CANNABINOID ANALYSIS",NA,4
"CANNABINOID BIOSYNTHESIS",NA,1
"CANNABINOID COMPOUNDS",NA,2
"CANNABINOID DETECTION",NA,1
"CANNABINOID DISTRIBUTION",NA,1
"CANNABINOID EXTRACTION",NA,1
"CANNABINOID MIMETIC",NA,1
"CANNABINOID PROFILE",NA,1
"CANNABINOID RECEPTORS",NA,1
"CANNABINOIDS AND CHIRAL CANNABINOIDS",NA,1
"CANNABINOIDS CONTENT",NA,1
"CANNABINOIDS MASS SPECTRA",NA,1
"CANNABINOIDS STABILITY",NA,1
"CANNABINOMIMETICS",NA,1
"CANNABIS ACCESSIONS AND ENVIRONMENTAL CONDITIONS",NA,1
"CANNABIS BLUNT",NA,1
"CANNABIS CANNABINOIDS",NA,2
"CANNABIS CONSTITUENTS",NA,1
"CANNABIS CULTIVATION",NA,1
"CANNABIS EDIBLES",NA,1
"CANNABIS FLOS MONOGRAPH",NA,1
"CANNABIS FLOWER ANALYSIS",NA,1
"CANNABIS INDICA",NA,1
"CANNABIS LEGALIZATION",NA,1
"CANNABIS LEGISLATION",NA,1
"CANNABIS MARKETS",NA,1
"CANNABIS MEDICINAL EXTRACTS",NA,1
"CANNABIS PLANTATION",NA,1
"CANNABIS POLICY",NA,2
"CANNABIS REGULATION",NA,1
"CANNABIS SATIVA F. SATIVA",NA,1
"CANNABIS SATIVA L. METABOLOME",NA,1
"CANNABIS SATIVA L. VARIETIES",NA,1
"CANNABIS SATIVA L.SSP. SANTHICA",NA,1
"CANNABIS SATIVA LINNAEU",NA,1
"CANNABIS SMOKE",NA,1
"CANNABIS SOLVENT EXTRACTS",NA,1
"CANNABIS SUPPLY",NA,1
"CANNABIS THINNING AGENTS",NA,1
"CANNABIS USE",NA,1
"CANNABIS VAPORIZATION",NA,1
"CANNABISIN",NA,1
"CANNABISPIRONE",NA,1
"CANNAHIS SATIVA",NA,1
"CANNFLAVIN A",NA,1
"CANONICAL VARIATE ANALYSIS",NA,1
"CANTILEVERS",NA,1
"CAPACITIVE BIOSENSOR",NA,1
"CAPACITIVE DETECTION",NA,1
"CAPACITIVE SENSOR",NA,1
"CAPACITIVELY COUPLED CONTACTLESS CONDUCTIVITY DETECTION (C4D)",NA,4
"CAPILLARY",NA,1
"CAPILLARY ELECTROCHROMATOGRAPHY (CEC)",NA,1
"CAPILLARY ELECTROKINETIC CHROMATOGRAPHY",NA,1
"CAPILLARY ELECTROPHORESIS-INDUCTIVELY COUPLED PLASMA-MASS SPECTROMETRY",NA,1
"CAPILLARY ELECTROPHORESIS-TANDEM MASS SPECTOMETRY",NA,1
"CAPILLARY ELECTROPHORESIS - REVIEW",NA,1
"CAPILLARY ELECTROPHORESISÃ¢Â‚¬Â€ŒMASS SPECTROMETRY",NA,1
"CAPILLARY GAS CHROMATOGRAPHY/MASS SPECTROMETRY",NA,1
"CAPILLARY LC",NA,1
"CAPILLARY MICROEXTRACTION OF VOLATILES (CMV)",NA,1
"CAPILLARY PP TUBING",NA,1
"CAPTAGON",NA,3
"CARBOCATION-MEDIATED EPIMERIZATION",NA,1
"CARBOLIGATION",NA,2
"CARBOMETALLATION REACTION",NA,1
"CARBON-14 WIGGLE-MATCHING",NA,1
"CARBON ADSORBENTS",NA,1
"CARBON FIBRE VEIL",NA,1
"CARBON FILTER",NA,1
"CARBON IONIC LIQUID ELECTRODE (CILE)",NA,1
"CARBON ISOTOPIC ANALYSES",NA,1
"CARBON MAGNETIC HEXAGONAL NANOTUBES",NA,1
"CARBON NANOONION",NA,1
"CARBON NUTRIENT BALANCE",NA,1
"CARBON PASTE ELECTRODE",NA,3
"CARBONYL PRODUCTION",NA,1
"CARBONYLATION",NA,2
"CARBORANE",NA,1
"CARBOXAMIDE-TYPE SYNTHETIC CANNABINOIDS",NA,1
"CARBOXAMIDES",NA,1
"CARBOXYLIC ACID RESIN",NA,1
"CARBOXYMETHYL-Β-CYCLODEXTRIN",NA,2
"CARCINOGEN",NA,1
"CARMAGEROL",NA,1
"CARRAGEEN AN",NA,1
"CARS",NA,1
"CARSPLS",NA,1
"CART",NA,1
"CARTRIDGE",NA,1
"CAS 1622-62-4",NA,1
"CAS 956-90-1",NA,1
"CASCADE REACTIONS",NA,2
"CASE WORK",NA,1
"CASOMORPHINS",NA,1
"CASTOR OIL",NA,1
"CATALYSIS",NA,4
"CATHA EDULIS FORSK",NA,1
"CATHA EDULIS(VAHL) ENDL",NA,1
"CATHARANTHUS ROSEUS",NA,3
"CATHEDULINS",NA,1
"CATHINE IDENTIFICATION",NA,1
"CATHINONE AND AMPHETAMINE DERIVATIVES",NA,1
"CATHINONE TYPE SYNTHETIC DRUGS",NA,1
"CATHINONES ENANTIOMERS",NA,1
"CATHODIC PRETREATMENT",NA,1
"CATION-SELECTIVE EXHAUSTIVE INJECTION",NA,2
"CATION EXCHANGE RESTRICTED ACCESS MATERIAL",NA,1
"CATIONIC COMPOUNDS",NA,1
"CATIONIC HYDROGENATION",NA,1
"CATIONS AND ANIONS",NA,1
"CAVITANDS",NA,1
"CB2R",NA,1
"CBCA SYNTHASE",NA,1
"CBD OIL",NA,1
"CBDA-SYNTHASE",NA,1
"CBL-2201",NA,1
"CCC",NA,1
"CD",NA,1
"CD-MEDIATED CE",NA,1
"CD-MODIFIED MICELLAR ELECTROKINETIC CHROMATOGRAPHY",NA,1
"CD/TE QUANTUM DOTS",NA,1
"CDO NANOPARTICLES",NA,1
"CDS QUANTUM DOTS",NA,1
"CDSE/ZNS CORE-SHELL QUANTUM DOTS",NA,1
"CE-LIF",NA,1
"CE-TOF-MS",NA,1
"CE-UV",NA,2
"CE/MS/MS",NA,1
"CE3+",NA,1
"CEDRUS",NA,1
"CELASTERACEAE",NA,1
"CELASTRACEAE",NA,1
"CELECOXIB",NA,1
"CELL AND TISSUE CULTURE",NA,1
"CELLS LINES",NA,1
"CELLULAR-SIGNALING PROCESSES",NA,1
"CELLULAR AND SUBCELLULAR LOCALIZATION",NA,1
"CELLULAR COMPARTMENTALIZATION",NA,1
"CELLULOSE ACETATE",NA,1
"CELLULOSE DERIVATIVE",NA,1
"CELLULOSE TRIS(3,5-DIMETHYLPHENYLCARBAMATE)",NA,1
"CENSORED DATA",NA,1
"CENTRAL COMPOSITE DESIGN",NA,8
"CENTRIFUGAL MICROFLUIDICS",NA,1
"CENTRIFUGAL PARTITION CHROMATOGRAPHY",NA,2
"CERAMIC ELECTRODE",NA,1
"CEREAL",NA,8
"CEREAL-BASED PRODUCT SAFETY",NA,1
"CEREAL PRODUCTS",NA,2
"CEREAL SAMPLE",NA,1
"CEREALS AND GRAIN",NA,1
"CERIUM(IV)",NA,1
"CERRIC AMMONIUM SULFATE",NA,1
"CETIRIZINE",NA,2
"CETIRIZINE DIHYDROCHLORIDE",NA,1
"CETOSTEARYL ALCOHOL",NA,1
"CETP INHIBITORY ACTIVITY",NA,1
"CETYL ALCOHOL",NA,1
"CGC-MSD",NA,1
"CGE",NA,1
"CHAETOMIUM COCHLIODES",NA,1
"CHAFING DISH CONDIMENTS",NA,1
"CHANGING EXCITATION WAVELENGTH",NA,1
"CHARACTERISTIC FRAGMENTATION MECHANISM",NA,1
"CHARACTERISTIC PEAKS METHOD",NA,1
"CHARACTERIZATION OF IMPURITIES",NA,1
"CHARACTERIZATION TECHNIQUES",NA,1
"CHARGE-TRANSFER COMPLEX",NA,2
"CHARGE-TRANSFER REACTION",NA,1
"CHARGE DESCRIPTORS",NA,1
"CHARGE TRANSFER",NA,1
"CHARGE TRANSFER ANALYSIS.",NA,1
"CHARGED AEROSOL DETECTION",NA,1
"CHARGED CYCLODEXTRINS",NA,1
"CHART OF NUCLIDES",NA,1
"CHECKLIST",NA,1
"CHELATE COMPLEX",NA,1
"CHELATING RESIN",NA,1
"CHEMICAL ANALYSIS AND IDENTIFICATION",NA,1
"CHEMICAL BIOLOGY",NA,1
"CHEMICAL CONSTITUENT",NA,2
"CHEMICAL DIVERSION",NA,2
"CHEMICAL DIVERSITY",NA,1
"CHEMICAL DRUG",NA,2
"CHEMICAL EXPOSURE",NA,1
"CHEMICAL IONIZATION: CI",NA,1
"CHEMICAL MASKING",NA,1
"CHEMICAL MODIFIERS",NA,1
"CHEMICAL PROBE",NA,1
"CHEMICAL PROFILES SIMILARITY",NA,1
"CHEMICAL REACTION",NA,1
"CHEMICAL SENSING",NA,1
"CHEMICAL SENSOR TECHNOLOGY",NA,1
"CHEMICAL SIGNATURE",NA,1
"CHEMICAL STRUCTURE REPRESENTATION",NA,1
"CHEMICAL SUBSTANCES",NA,1
"CHEMICAL SUBTRACTION",NA,1
"CHEMICAL VARIATION",NA,1
"CHEMICALS OF EMERGING CONCERN",NA,1
"CHEMILUMINESCENCE ARRAY",NA,1
"CHEMILUMINESCENCE ARRAY SENSOR",NA,1
"CHEMILUMINESCENT ENZYME IMMMUNOASSY",NA,1
"CHEMINFORMATIC",NA,1
"CHEMINFORMATICS",NA,2
"CHEMIRESISTOR",NA,1
"CHEMISTRY DATA",NA,1
"CHEMISTRY DATA ANALYSIS",NA,1
"CHEMISTRY EDUCATION",NA,1
"CHEMO-TYPE",NA,1
"CHEMOMETRIC CLASSIFICATION",NA,1
"CHEMOMETRIC METHODS",NA,2
"CHEMOMETRIC OPTIMIZATION",NA,1
"CHEMOMETRIC TECHNIQUES",NA,2
"CHEMOMETRICS AND STATISTICS",NA,1
"CHEMOMETRICS MODELING",NA,1
"CHEW",NA,1
"CHICKEN LIVER",NA,1
"CHICKEN MUSCLE",NA,1
"CHICKEN TISSUES",NA,1
"CHINESE CRUDE DRUGS",NA,1
"CHINESE EPHEDRA",NA,1
"CHINESE HERBAL FORMULAE",NA,1
"CHINESE PATENT DRUG",NA,1
"CHINESE TEA",NA,1
"CHINESE TRADITIONAL DRUGS",NA,1
"CHIP-BASED ANALYSIS",NA,1
"CHIRAL ADDITIVE",NA,1
"CHIRAL AMINE",NA,2
"CHIRAL ANALYSIS OF PHARMACEUTICAL COMPOUNDS",NA,1
"CHIRAL AND ACHIRAL SEPARATIONS",NA,1
"CHIRAL AUXILIARY",NA,1
"CHIRAL BASIC DRUGS",NA,1
"CHIRAL DERIVATIZATION METHOD",NA,1
"CHIRAL DERIVATIZING REAGENT",NA,1
"CHIRAL DETERMINATION",NA,2
"CHIRAL DIFFERENTIATION",NA,1
"CHIRAL GC",NA,1
"CHIRAL GC-MS",NA,1
"CHIRAL HPLC",NA,4
"CHIRAL ILLICIT DRUGS",NA,1
"CHIRAL IMPURITY",NA,1
"CHIRAL ION EXCHANGER",NA,1
"CHIRAL IONIC LIQUIDS",NA,1
"CHIRAL MICELLE",NA,2
"CHIRAL NONAQUEOUS CAPILLARY ELECTROPHORESIS",NA,1
"CHIRAL OPEN-TUBULAR COLUMN",NA,1
"CHIRAL POLYMERIC SURFACTANT",NA,1
"CHIRAL POLYMETRIC SURFACTANT",NA,1
"CHIRAL PROFILING",NA,1
"CHIRAL QUANTUM DOT",NA,1
"CHIRAL RECOGNITION",NA,2
"CHIRAL RECOGNITION MECHANISM",NA,2
"CHIRAL RESOLUTION BY COLUMN CHROMATOGRAPHY",NA,1
"CHIRAL SEPARATION PRINCIPLES",NA,1
"CHIRAL SOLVATING AGENT",NA,2
"CHIRAL SOLVATING REAGENT",NA,1
"CHIRAL STATIONARY PHASES, LC",NA,3
"CHIRAL SURFACTANT",NA,1
"CHIRAL SWITCH",NA,1
"CHIRALCEL OD",NA,1
"CHIRALPAK AD-H",NA,1
"CHLORANILIC ACID",NA,1
"CHLORDIAZEPOXIDE DRUG",NA,1
"CHLORIDE INTERFERENCES",NA,1
"CHLORINATED PHENOLS",NA,1
"CHLORINATION",NA,1
"CHLOROCOCAINE",NA,1
"CHLOROEPHEDRINE",NA,2
"CHLOROFLUOROPHENYLPIPERAZINE",NA,1
"CHLOROPHENYLPIPERAZINE ISOMERS",NA,1
"CHLOROPHYLLS",NA,1
"CHLOROPLAST GENOMES",NA,1
"CHLOROPLAST HOTSPOT",NA,1
"CHLOROPLASTIC DNA",NA,1
"CHLOROSIPENTRAMINE",NA,1
"CHLORPHENAMINE-IMPRINTED POLYMER",NA,1
"CHLORPHENIRAMINE MALEATE (CPM)",NA,2
"CHLORPROMAZINE HYDROCHLORIDE",NA,1
"CHLORSULFURON",NA,1
"CHLORZOXAZONE",NA,1
"CHMINACA",NA,1
"CHROMATICITY",NA,1
"CHROMATO-MASS SPECTROMETRY",NA,1
"CHROMATOGRAPHIC BASELINES",NA,1
"CHROMATOGRAPHIC DATA",NA,1
"CHROMATOGRAPHIC FINGERPRINT",NA,1
"CHROMATOGRAPHIC FINGERPRINTS",NA,3
"CHROMATOGRAPHIC HERBAL FINGERPRINTS",NA,1
"CHROMATOGRAPHIC OPTIMIZATION",NA,1
"CHROMATOGRAPHIC PARAMETERS",NA,1
"CHROMATOGRAPHIC PEAKS",NA,1
"CHROMATOGRAPHIC SIMULATION",NA,1
"CHROMATOGRAPHY-MASS SPECTROMETRY",NA,3
"CHROMATOGRAPHY - GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC/MS)",NA,1
"CHROMATOPROBE",NA,1
"CHROMOPHORE",NA,2
"CHROMOPHORE CHARACTERIZATION",NA,1
"CHRONIC LOW BACK PAIN",NA,1
"CHRONIC OSTEOARTHRITIS PAIN",NA,1
"CHRONOAMPEROMETRY",NA,2
"CHRONOLOGY",NA,1
"CI-GC-MS/MS",NA,1
"CIALIS TABLET",NA,1
"CIALIS¨",NA,2
"CIALIS1¨",NA,1
"CIALIS1Ã‚Â®",NA,1
"CIALISÃ‚Â®",NA,1
"CID, COLLISION-INDUCED DISSOCIATION",NA,1
"CIDER APPLE",NA,1
"CIDERS",NA,1
"CIEF",NA,1
"CIMATEROL",NA,1
"CINNAMAMIDE",NA,1
"CIRCULAR DICHROISM DETECTION",NA,1
"CIRCULATING COOLING SPME",NA,1
"CIS-CINNAMOYLCOCAINE",NA,2
"CIS-PERMETRINIC ACID",NA,1
"CIS-TRAMADOL",NA,1
"CITALOPRAM CHROMATOGRAPHY",NA,1
"CITIZEN SAFETY AND SECURITY",NA,1
"CITP",NA,1
"CITRUS AURANTIUM",NA,3
"CLANDESTINE DRUG MANUFACTURE",NA,1
"CLANDESTINE SYNTHESIS",NA,5
"CLASS-WIDE SCHEDULING",NA,1
"CLASS IDENTITY RECOGNITION",NA,1
"CLASS SEPARATION",NA,1
"CLASSIC PSYCHEDELIC",NA,1
"CLASSICAL AYURVEDIC FORMULATION",NA,1
"CLASSICAL LEAST SQUARES",NA,1
"CLASSICAL REVERSED STATIONARY PHASES",NA,1
"CLASSIFICATION MODEL",NA,1
"CLASSIFICATION OF HYPERSPECTRAL DATA",NA,1
"CLASSIFICATION, PHENOLS",NA,1
"CLATHRATE HYDRATE",NA,1
"CLAVICEPS",NA,3
"CLAVICEPS AFRICANA",NA,1
"CLAVICEPS PURPUREA",NA,3
"CLEANING VALIDATION",NA,1
"CLEAVAGE FROM RING SYSTEMS",NA,1
"CLENBUTEROL ENANTIOMERS",NA,1
"CLENBUTEROL IN PLASMA",NA,1
"CLICK CHEMISTRY",NA,1
"CLIDINIUM BROMIDE",NA,1
"CLINICAL AND PHARMACEUTICAL ANALYSIS",NA,1
"CLINICAL USE OF GHB IN HUMANS",NA,1
"CLIOQUINOL",NA,1
"CLOSTRIDIUM NOVYI TYPE A",NA,1
"CLOUD-ENABLED SMARTPHONE",NA,1
"CLUB AND RECREATIONAL DRUGS",NA,1
"CLUB DRUG USE",NA,1
"CLUMPED ISOTOPE",NA,1
"CLUSIACEAE",NA,1
"CMUT",NA,1
"CNC MILLING",NA,1
"CNS/PSYCHOLOGICAL",NA,1
"CNT",NA,1
"CO-CONSUMPTION",NA,2
"CO-PROCESSED DRY BINDERS",NA,1
"CO-PROCESSING",NA,2
"CO-SOLVENT",NA,1
"CO-SUBSTANCE USE",NA,1
"CO ION",NA,1
"CO2 EXTRACTION",NA,1
"COACERVATE",NA,2
"COATED-WIRE ELECTRODE",NA,1
"COATED AND COVALENTLY IMMOBILIZED POLYSACCHARIDE-BASED CHIRAL STATIONARY PHASES",NA,1
"COATED PHOTODETECTORS",NA,1
"COATING THICKNESS",NA,1
"COBALT",NA,1
"COBALT (II) THIOCYANATE",NA,1
"COBALT OXIDE",NA,1
"COBALT OXIDE PARTICLE",NA,1
"COCA BUSH",NA,1
"COCA CROP",NA,1
"COCA EXTRACTS",NA,1
"COCA TEA BAGS",NA,1
"COCAINE-PLASTIC",NA,1
"COCAINE-POLYMETHYL METHACRYLATE (PMMA)",NA,1
"COCAINE ANALOGUE",NA,1
"COCAINE ANALOGUES",NA,1
"COCAINE APTAMER",NA,2
"COCAINE ASSAY",NA,1
"COCAINE BASE SMOKING",NA,1
"COCAINE DEGRADATION",NA,1
"COCAINE FREE BASE",NA,2
"COCAINE POWDER",NA,1
"COCAINE PROBE",NA,1
"COCAINE PROFILING",NA,1
"COCAINE QUANTIFICATION",NA,1
"COCAINE SENSOR",NA,2
"COCAINE STEREOISOMERS",NA,1
"COCAINE TRAFFICKING",NA,1
"COCAINE USE DISORDER",NA,1
"COCONUT CHARCOAL",NA,1
"CODEINE-N-OXIDE",NA,1
"CODEINE PHOSPHATE",NA,5
"CODEINE PHOSPHATE COMPLEXES",NA,1
"CODEINE PHOSPHATE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY",NA,1
"CODEINE PHOSPHATE IMPURITIES",NA,1
"CODEINE STRUCTURE, MASS SPECTROMETRY",NA,1
"CODEINONE REDUCTASE",NA,1
"CODERGOCRINE MESILATE",NA,1
"COEFFICIENT OF DETERMINATION",NA,1
"COLD DRUG",NA,1
"COLD EI",NA,1
"COLD FORMULATION",NA,2
"COLD MEDICINE",NA,1
"COLD PRESS",NA,1
"COLD PRESSING",NA,1
"COLD REMEDY INGREDIENTS",NA,1
"COLD SYNTHESIS",NA,1
"COLIMYCIN",NA,1
"COLLEGE BASKETBALL",NA,1
"COLLEGE CAMPUS",NA,2
"COLLEGE STUDENTS",NA,1
"COLLISION ENERGY",NA,1
"COLLISON NEBULIZER",NA,1
"COLLOIDAL CRYSTAL",NA,1
"COLLOIDS, SUBSTRATE FOR SERS, REDUCING INTERFERENCE FROM CONTAMINANTS",NA,1
"COLOPHONY",NA,1
"COLOR-BLINDNESS",NA,1
"COLOR CHANGES",NA,1
"COLOR TEMPERATURE",NA,1
"COLORADO",NA,3
"COLORIMETRIC APP",NA,1
"COLORIMETRIC ASSAYS",NA,1
"COLORIMETRIC SENSING",NA,2
"COLORIMETRIC SENSORS",NA,1
"COLOUR TEST",NA,1
"COLUMN CHARACTERISATION SYSTEM",NA,1
"COLUMN CHARACTERIZATION",NA,2
"COLUMN CHEMISTRY",NA,1
"COLUMN COUPLING",NA,1
"COLUMN SELECTION",NA,1
"COLUMN SELECTIVITY",NA,1
"COLUMN TEMPERATURE",NA,1
"COMAMONAS TESTOSTERONI",NA,1
"COMBINATION STATIONARY PHASE",NA,1
"COMBINATORIAL SCREENING",NA,1
"COMBINED TABLETS",NA,1
"COMBUSTION",NA,1
"COMETABOLISM",NA,1
"COMFA",NA,1
"COMMERCIAL CANNABIS PRODUCTS",NA,2
"COMMERCIAL CULTIVATION",NA,1
"COMMERCIAL HERBAL DRUGS AND EXTRACTS",NA,1
"COMMERCIALLY AVAILABLE CANNABIS OIL",NA,1
"COMMERCIALLY AVAILABLE KIT",NA,1
"COMMON COLD",NA,1
"COMMON COLD DRUGS",NA,1
"COMMON ORIGIN",NA,1
"COMMUNICATION/WRITING",NA,1
"COMMUNITY CONSUMPTION",NA,2
"COMMUNITY PHARMACIES",NA,1
"COMPACT NMR",NA,1
"COMPACTION",NA,1
"COMPACTS",NA,1
"COMPARABILITY",NA,1
"COMPARATIVE",NA,1
"COMPARATIVE GENOME ANALYSIS",NA,1
"COMPARISON ANALYSIS",NA,3
"COMPARISON INTRA-AND INTER-LOCATION SAMPLES",NA,1
"COMPARISON OF DRUG USE",NA,1
"COMPATIBILITY STUDY",NA,1
"COMPENDIAL METHODS",NA,1
"COMPETITION",NA,2
"COMPETITIVE AFFINITY",NA,1
"COMPETITIVE COMPLEXATION",NA,1
"COMPETITIVE ELISA",NA,1
"COMPETITIVE IONIZATION",NA,1
"COMPLEMENTARY STRAND",NA,1
"COMPLEX BIOLOGICAL ACTIVITY",NA,1
"COMPLEX BIOLOGICAL FLUID",NA,1
"COMPLEX BIOLOGICAL MATRICES",NA,1
"COMPLEX REAL SAMPLES",NA,1
"COMPLEX WITH COLLOIDAL GOLD",NA,1
"COMPLICATIONS OF POISONING",NA,1
"COMPONENT PATTERN ANALYSIS",NA,2
"COMPOSITE ANALYSIS",NA,1
"COMPOSITE NANOFIBERS",NA,2
"COMPOSITE NANOSORBENT",NA,1
"COMPOSITION",NA,1
"COMPOSITIONAL DATA ANALYSIS",NA,1
"COMPOSTING",NA,1
"COMPOUND",NA,1
"COMPOUND-SPECIFIC",NA,1
"COMPOUND ELUCIDATION",NA,1
"COMPOUNDED CAPSULES",NA,1
"COMPREHENSIVE TWO-DIMENSIONAL LIQUID CHROMATOGRAPHY",NA,1
"COMPREHENSIVE WEIGHTS",NA,1
"COMPUTATIONAL CHEMISTRY",NA,2
"COMPUTATIONAL DESIGN",NA,1
"COMPUTATIONAL SIMULATION",NA,1
"COMPUTATIONAL VIBRATIONAL SPECTROSCOPY",NA,1
"COMPUTER-BASED LEARNING",NA,1
"COMPUTER DATA PROCESSING",NA,1
"COMPUTER SIMULATION",NA,1
"COMPUTERIZED PROFILING",NA,2
"CONCENTRATION AND ENANTIOMERIC PROFILING",NA,1
"CONCEPTUAL SITE MODEL",NA,1
"CONCOMITANT OPIOID MISUSE",NA,1
"CONCRETE",NA,1
"CONDENSATION",NA,1
"CONDENSED TANNIN",NA,1
"CONDUCTIVE INK",NA,1
"CONDUCTIVITY DETECTION",NA,1
"CONFIDENTIALITY AND PRIVACY",NA,1
"CONFIRMATORY METHOD",NA,1
"CONFOCAL RAMAN MICROSCOPE",NA,1
"CONFOCAL RAMAN SPECTROMETERS, CONFOCAL OPTICS WITH BETTER RESOLUTION",NA,1
"CONFOCAL X-RAY FLUORESCENCE",NA,1
"CONFORMATIONAL ANALYSIS",NA,2
"CONFORMATIONAL SEARCH",NA,1
"CONJUGATE ADDITION",NA,1
"CONJUGATE CUPRATE ADDITION",NA,1
"CONJUGATED STEROID ESTROGENS",NA,1
"CONJUGATES",NA,1
"CONOCYBE CYANOPUS",NA,1
"CONSCIOUSNESS",NA,1
"CONSECUTIVELY MANUFACTURED TOOLS",NA,1
"CONSTIPATION",NA,1
"CONSTITUENT CONTENT CHARACTERIZATION AND QUANTIFICATION",NA,1
"CONSUMER ACCEPTANCE",NA,1
"CONSUMER SAFETY",NA,1
"CONSUMPTION RATE",NA,1
"CONTACT DERMATITIS",NA,1
"CONTAMINANTS OF EMERGING CONCERN",NA,3
"CONTAMINATED WATER",NA,1
"CONTAMINATION TRENDS",NA,1
"CONTENT ANALYSIS",NA,1
"CONTENT DETERMINATION",NA,1
"CONTENT UNIFORMITY",NA,3
"CONTINUOUS-FLOW STIRRED TANK REACTOR (CSTR)",NA,1
"CONTINUOUS BEDS",NA,1
"CONTINUOUS CAPILLARY ELECTROPHORESIS",NA,1
"CONTINUOUS FLOW",NA,3
"CONTINUOUS FREE FLOW ELECTROPHORESIS",NA,1
"CONTOUR PLOTS",NA,1
"CONTRABAND MATERIALS",NA,1
"CONTROL OF IMPURITIES",NA,1
"CONTROL STRATEGIES",NA,1
"CONTROL, QUALITY",NA,1
"CONTROLLED-POTENTIAL COULOMETRY",NA,1
"CONTROLLED DETECTION",NA,1
"CONTROLLED RELEASE",NA,6
"CONTROLLED RELEASE DOSAGE FORMS",NA,1
"CONTROLLED RELEASE MATRIX TABLET",NA,1
"CONTROLLED RELEASE SYSTEM",NA,1
"CONTROLLED STUDY",NA,1
"CONTROLLED SUBSTANCE IDENTIFICATION",NA,3
"CONTROLLED SUBSTANCES ACT",NA,2
"CONTROLLED SUBSTANCES ACT (CSA)",NA,1
"CONTROLLED SUBSTANCES, REVIEW",NA,1
"CONVERSION YIELD",NA,1
"CONVOLUTION",NA,1
"COOL-SEASON CEREAL GRAIN",NA,1
"COOPERATION WITH POLICE",NA,1
"COPELANDIA",NA,1
"COPHENETIC CORRELATION",NA,1
"COPOLYMERIZATION REACTION",NA,1
"COPPER NANOPARTICLES",NA,1
"COPPER SULPHATE",NA,1
"COPPER(II) OXIDE",NA,1
"COPY NUMBER VARIATION",NA,1
"COR",NA,1
"CORD BLOOD",NA,1
"CORE",NA,1
"CORE-SATELLITE STRUCTURE",NA,1
"CORE-SHELL MAGNETIC CARBON NANOPARTICLES",NA,1
"CORE-SHELL PARTICLE",NA,2
"CORNSTARCH",NA,1
"CORONA DISCHARGE IONIZATION-ION MOBILITY SPECTROMETRY (CD-IMS)",NA,1
"CORONALON",NA,1
"CORRECT SAMPLING",NA,1
"CORRECTION FACTORS",NA,1
"CORRELATION OF PRODUCT IONS WITH STRUCTURE",NA,1
"CORRELATION RESEARCH",NA,1
"CORRELATION VALUES",NA,1
"CORRELATIVE SEM-RAMAN MICROSCOPY",NA,1
"CORTICOSTEROIDS (CORT)",NA,1
"CORYNANTHE ALKALOIDS",NA,1
"COSANE",NA,1
"COSINE FUNCTION",NA,1
"COSINE FUNCTION MODELLING",NA,2
"COSOLVENT",NA,1
"COUGH-COLD SYRUP",NA,1
"COUGH MEDICINE",NA,1
"COUGH SYRUP",NA,1
"COUMARIN",NA,1
"COUMATETRALYL",NA,1
"COUNTER-FLOW INTRODUCTION",NA,1
"COUNTER-ION",NA,1
"COUNTER-ION ANALYSIS",NA,1
"COUNTERCURRENT CHROMATOGRAPHY (CCC)",NA,1
"COUNTERFEIT ANALYSIS PROMISING WITH SORS",NA,1
"COUNTERFEIT CHECK",NA,1
"COUNTERFEIT CIALIS TABLETS",NA,1
"COUNTERFEIT DETECTION",NA,1
"COUNTERFEIT DRUG DETECTION",NA,1
"COUNTERFEIT DRUG LABELLING WITHOUT AUTHORISATION, OF DRUG MANUFACTURERS",NA,1
"COUNTERFEIT LIPITORÂ® LABELS, USING SMITHS DETECTION ILLUMINATIRÂ„¢ FT-IR, WITH ATR",NA,1
"COUNTERFEIT MEDICINE DETECTION",NA,1
"COUNTERFEIT PHARMACEUTICAL PRODUCTS - REAL THREAT TO PATIENTS' HEALTH, REPUTATION AND COMMERCIAL SUCCESS OF LEGITIMATE PRODUCERS OF GENUINE TABLETS",NA,1
"COUNTERFEIT TABLETS",NA,1
"COUNTERFEITERS' TARGET",NA,1
"COUNTERFEITING API",NA,1
"COVALENT BINDING",NA,1
"COVALENT COATING",NA,1
"COVALENTLY ATTACHMENT OF APTAMER",NA,1
"COVARIATE SHIFT",NA,1
"COX2",NA,1
"CP-DNA",NA,1
"CP 47,497-C8",NA,1
"CPC",NA,1
"CR",NA,1
"CREATINE",NA,5
"CREATINE FORMULATION",NA,1
"CREATINE MONOHYDRATE",NA,1
"CREATINE TO CREATININE CONVERSION",NA,1
"CREDIBLE INTERVAL",NA,1
"CRESOL RED",NA,1
"CRIME STATISTICS",NA,1
"CRIMINAL EVOLUTION",NA,1
"CRIMINAL JUSTICE POLICY",NA,1
"CRIMINAL TRIALS",NA,1
"CRIMINALISTICS MEASUREMENTS",NA,1
"CRISPR-CAS12A",NA,1
"CROCODILE",NA,1
"CROP",NA,2
"CROSCARMALLOSE SODIUM",NA,1
"CROSS-NATIONAL",NA,1
"CROSS-SECTIONAL SURVEY",NA,1
"CROSS EXAMINATION",NA,1
"CROTON",NA,1
"CROWN ETHERS",NA,2
"CRUDE EXTRACT",NA,1
"CRUSH-RESISTANT",NA,1
"CRYOFOCUSING",NA,1
"CRYOGENIC OVEN TRAPPING",NA,1
"CRYPTOCOCCUS NEOFORMANS",NA,1
"CRYSTAL ENGINEERING",NA,1
"CRYSTAL POLYMORPHISM",NA,1
"CRYSTAL TESTS",NA,1
"CRYSTALLIZATION",NA,1
"CRYTPOMARKETS",NA,1
"CU(II)-CATALYZED OSCILLATING REACTION",NA,1
"CU(III)/AG(III) COMPLEX",NA,1
"CUBE-ROOT LAW",NA,1
"CUCURBIT[8]URIL",NA,1
"CUCURBITURILS",NA,2
"CULTIVAR",NA,4
"CULTIVATED COCA",NA,1
"CULTIVATION ZONE",NA,1
"CULTURAL VALUE",NA,1
"CUMYL-4CN-B7AICA",NA,1
"CUMYL-PINACA",NA,2
"CUO NANOPARTICLE",NA,1
"CURTIS SIMILARITY",NA,1
"CURVE RESOLUTION",NA,1
"CUTS",NA,1
"CUTTAGE",NA,1
"CUTTING PRODUCTS",NA,1
"CYANO",NA,1
"CYANOACRYLATE-FUMED FINGERPRINTS",NA,1
"CYANOSTILBENES",NA,1
"CYCLIC FLOW INJECTION METHOD",NA,1
"CYCLIZATION",NA,2
"CYCLOADDITION",NA,2
"CYCLOAMINE",NA,1
"CYCLOBARBITONE",NA,1
"CYCLODEXTRIN-MODIFIED MICROEMULSION ELECTROKINETIC CHROMATOGRAPHY",NA,1
"CYCLODEXTRINS AND DERIVATIVES",NA,1
"CYCLOHEXENONES",NA,1
"CYCLOOXIGENASE",NA,1
"CYCLOPENTYLTADALAFIL",NA,1
"CYCLOPIAZONIC ACID",NA,1
"CYP450 INHIBITION",NA,1
"CYTOCHROME-P450",NA,2
"CYTOCHROME C",NA,1
"CYTOCHROME P450 2B4",NA,1
"CYTOTOXIC",NA,1
"CYTOTOXIC ACTIVITY",NA,1
"CYTOTOXICITY ACCORDING TO ENANTIOMERS",NA,1
"D-AMPHETAMINE AND DIPHENHYDRAMINE",NA,1
"D-PSEUDOEPHEDRINE",NA,1
"D. SURFACE ANALYSIS",NA,1
"D9-TETRAHYDROCANNABINOL",NA,1
"DA",NA,2
"DAEMONOROPS",NA,1
"DAEMONOROPS DRACO",NA,1
"DAIDZEIN",NA,1
"DAIME",NA,1
"DAIRY FEED",NA,1
"DANCE DRUGS",NA,1
"DANDELION-LIKE CO3O4 NANOFLOWERS",NA,1
"DANSYL CHLORIDE",NA,2
"DAPOXETINE",NA,1
"DARK NET DRUG MARKETS",NA,1
"DARK NET MARKETPLACES",NA,1
"DART-MASS SPECTROMETRY",NA,4
"DATA EXPLORATION",NA,1
"DATA INTEGRATION",NA,1
"DATA MANAGEMENT",NA,1
"DATA MODELING",NA,1
"DATA PRE-PROCESSING",NA,1
"DATA PREPROCESSING",NA,1
"DATA PROCESSING",NA,1
"DATA PROCESSING METHODS",NA,1
"DATA PROVIDING A SPECTROSCOPIC FINGERPRINT",NA,1
"DATA QUALITY OBJECTIVES",NA,1
"DATA TREATMENT",NA,2
"DATA VISUALIZATION",NA,1
"DATE-RAPE DRUG",NA,1
"DATE-RAPE DRUG DETECTION, AND GENE EXPRESSION PROFILING, ENZYME-BASED TEST FOR GHB",NA,1
"DATE-RAPE DRUGS AND GHB, PRODRUG CONVERSION TO GHB, AND RELATED METABOLITES",NA,1
"DATE-RAPE PILLS",NA,1
"DATING",NA,1
"DATURA INNOXIA",NA,2
"DATURA METEL",NA,1
"DATURA STRAMONIUM L",NA,1
"DATURA STRAMONIUM L.",NA,1
"DATURADIOL",NA,1
"DATURAE FLOS",NA,1
"DAUBERT CHALLENGES",NA,1
"DAY LENGTH",NA,1
"DBDI-MS",NA,1
"DC-POLAROGRAPHY",NA,1
"DDQ",NA,1
"DEALKYL-SDB-006",NA,1
"DEBARYOMYCES",NA,1
"DECARBOXYLATION KINETICS",NA,1
"DECISION 2002/657/EC",NA,1
"DECOCTION",NA,1
"DECONTAMINATION LINE",NA,1
"DECORATED NANOGRAPHENE",NA,1
"DEEP SEQUENCING",NA,1
"DEFECTIVE MESOPOROUS CARBON",NA,1
"DEFLECTION ANGLE",NA,1
"DEGRADANT",NA,2
"DEGRADATION CONDITIONS",NA,1
"DEGRADATION MECHANISM",NA,3
"DEGRADATION STUDY",NA,1
"DEGRANDANT IDENTIFICATION",NA,1
"DEGREE OF SUBSTITUTION",NA,1
"DEHYDRATION",NA,1
"DEHYDROEPIANDROSTERONE",NA,1
"DELPHI",NA,1
"DELTA-9-THC TO DELTA-8-THC ISOMERIZATION",NA,1
"DELTA-9 TETRAHYDROCANNABINOL",NA,1
"DELTA VALUES",NA,1
"DEMAND",NA,1
"DENITRIFIER METHOD",NA,1
"DENOMINATORS",NA,1
"DENSITOMETRIC ANALYSIS",NA,1
"DENSITOMETRIC MEASUREMENT",NA,1
"DEOXYACONITINE",NA,1
"DEOXYEPHEDRINE",NA,1
"DEOXYPEGANINE",NA,1
"DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)",NA,1
"DEPOSITION OF AUNPS",NA,1
"DEPTH OF PENETRATION",NA,2
"DEPTH PROFILING",NA,1
"DEREPLICATION",NA,1
"DERIVATIVE RATIO SPECTRODENSITOMETRY",NA,1
"DERIVATIVE SPECTROPHOTOMETRY",NA,2
"DERIVATIVE UV-VIS",NA,1
"DERIVATIVES OF INDAZOL-3-CARBOXYLATES",NA,1
"DERIVATIVES OF INDOL-3-CARBOXYLATES",NA,1
"DERIVATIZED CELLULOSE",NA,1
"DERIVATIZED FLUOXETINE",NA,1
"DERRINGER'S DESIRABILITY FUNCTION",NA,2
"DERRINGER DESIRABILITY FUNCTIONS",NA,2
"DESACETYLDILTIAZEM",NA,1
"DESCRIPTION",NA,1
"DESCRIPTOR PROPERTIES",NA,1
"DESCRIPTOR SELECTION",NA,1
"DESI-MS",NA,1
"DESI IMAGING",NA,1
"DESIGN DRUG",NA,1
"DESIGNATED HALLUCINOGENIC PHENETHYLAMINES",NA,1
"DESIGNATED SUBSTANCES (SHITEI-YAKUBUTSU)",NA,1
"DESIGNER AMINES",NA,1
"DESIGNER AMPHETAMINES",NA,1
"DESIGNER CANNABINOIDS",NA,2
"DESIGNER DRUGS-OF-ABUSE",NA,1
"DESIGNER DRUGS, NBOMES, HALLUCINOGENS, CLINICAL AND LABORATORIAL",NA,1
"DESIGNER STEROID",NA,2
"DESIRABILITY",NA,1
"DESLORATADINE",NA,1
"DESMETHYLFLUNITRAZEPAM",NA,1
"DESOXY-D2PM",NA,1
"DET",NA,1
"DETECT ILLICIT DRUGS AND EXPLOSIVES",NA,1
"DETECTING DRUGS IN SEIZED SAMPLES",NA,1
"DETECTION AND DETERMINATION TECHNIQUES",NA,1
"DETECTION AND IDENTIFICATION",NA,1
"DETECTION OF COCAINE",NA,1
"DETECTION, ELECTROPHORESIS",NA,1
"DETECTION/ACQUISITION STUDIES",NA,1
"DETECTOR",NA,2
"DETECTORS, LC",NA,1
"DETERMINATION OF BARBITURATES",NA,1
"DETERMINATION OF MORPHINE",NA,1
"DETERMINATION OF ORIGIN",NA,1
"DETERX",NA,1
"DETHYLBARBITURIC ACID",NA,1
"DEUTERIUM LABELLED",NA,4
"DEUTERIUM LABELLING",NA,4
"DEUTERIUM NUCLEAR MAGNETIC RESONANCE",NA,1
"DEVELOPMENTAL STAGES",NA,2
"DEVELOPMENTS IN RAMAN SPECTROSCOPY",NA,1
"DEVIANT CONTENT",NA,1
"DEVICES",NA,1
"DEXAMPHETAMINE",NA,1
"DEXTRAN SULFATE",NA,1
"DEXTROMETHORPHEN HYDROBROMIDE",NA,1
"DEXTROMETHORPHEN HYDROBROMIDE AND DIPHENHYDRAMINE HYDROCHLORIDE",NA,1
"DEXTROPHAN",NA,1
"DFT METHOD",NA,1
"DI-ACETYL MORPHINE",NA,1
"DI(ÃƑÅ½Ã‚Â²-PHENYLISOPROPYL)AMINE",NA,1
"DIACETYL MORPHINE",NA,2
"DIAGNOSTIC IONS",NA,1
"DIALLEL HYBRIDIZATION",NA,1
"DIAMETER",NA,1
"DIAMINOMALENONITRILE",NA,1
"DIAMORPHINE",NA,3
"DIARYLMETHYLPIPERAZINES",NA,1
"DIASTEREOISOMERIC CLUSTERS",NA,1
"DIASTEREOISOMERIC SALT",NA,2
"DIASTEREOMERIC HYDRAZONES",NA,1
"DIASTEREOMERS WITHR-BINOL",NA,1
"DIASTEREOSELECTIVE ALKYLATION",NA,1
"DIASTEREOSELECTIVE REDUCTION",NA,1
"DIAZEPAM DETERMINATION",NA,1
"DIAZEPAM IN HUMAN PLASMA",NA,1
"DIAZEPAM INJECTION",NA,1
"DIAZONIUM SALTS",NA,1
"DICLOFENAC AND TRAMADOL",NA,1
"DICLOFENAC SODIUM",NA,2
"DICLZEPAM",NA,1
"DICYCLOMINE",NA,1
"DIELECTROPHORESIS",NA,1
"DIESEL",NA,1
"DIETARY PRODUCTS",NA,1
"DIETARY SUPPLEMENTS ANALYSIS",NA,2
"DIETHYLAMINE LIGAND CHEMISTRY",NA,1
"DIFFERENT CALCULATION METHOD OF REGRESSION ANALYSIS",NA,1
"DIFFERENT CEREALS",NA,1
"DIFFERENTIAL-DERIVATIVE SPECTROPHOTOMETRY",NA,1
"DIFFERENTIAL EXPRESSION GENE",NA,1
"DIFFERENTIAL LC-LC GRADIENT",NA,1
"DIFFERENTIAL NMR",NA,1
"DIFFERENTIAL PULSE ADSORPTIVE STRIPPING VOLTAMMETRY",NA,1
"DIFFERENTIAL PULSE VOLTAMMETRY",NA,11
"DIFFERENTIATION OF ISOMERS",NA,1
"DIFFUSION-BASED CALIBRATION",NA,1
"DIFFUSION-ORDERED 1H NMR SPECTROSCOPY",NA,1
"DIFFUSIVE GRADIENTS IN THIN FILMS (DGT)",NA,1
"DIGITAL CAPTURE",NA,1
"DIGITAL DATA",NA,1
"DIGITAL HEALTH",NA,1
"DIGITAL IMAGES COLORIMETRY",NA,1
"DIGITAL SIGNAL PROCESSING",NA,1
"DIGITAL SURVEILLANCE",NA,1
"DIGITAL TRACE METHODOLOGY",NA,1
"DIHYDROERGOSINE",NA,1
"DIHYDROERGOTAMINE",NA,1
"DIHYDROLYSERGOL",NA,1
"DIHYDROXYISOECHINULIN",NA,1
"DIKETOPIPERAZINE INDOLE ALKALOIDS",NA,1
"DILTIAZEM DETERMINATION",NA,1
"DILTIAZEM HCL",NA,1
"DILTIAZEM HYDROCHLORIDE",NA,2
"DILTIAZEM HYDROCHLORIDE/COMPOUNDED CAPSULES",NA,1
"DILTIAZEM HYDROCHLORIDE/TABLETS",NA,1
"DILUTE-AND-INJECT",NA,1
"DIMEDONE",NA,1
"DIMENSION REDUCTION",NA,1
"DIMERIC TRYPTAMINE-RELATED ALKALOID",NA,1
"DIMETCARB",NA,1
"DIMETHAZINE",NA,1
"DIMETHOXY-ÃŽÂ±-PHP",NA,1
"DIMETHOXYAMPHETAMINES (DMA)",NA,2
"DIMETHOXYBENZOYLPIPERAZINES",NA,1
"DIMETHPRAMIDE",NA,1
"DIMETHYL-ETHER EXTRACTION",NA,1
"DIMETHYL-Œ≤-CD",NA,1
"DIMETHYLAMPHETAMINE",NA,1
"DIMETHYLAMYLAMINE",NA,2
"DIMETHYLSULFOXIDE",NA,1
"DIMS",NA,2
"DIODE ARRAY UV DETECTION",NA,1
"DIOECIOUS HEMP",NA,1
"DIOL SILICA GEL",NA,1
"DIONINE",NA,1
"DIOS",NA,1
"DIOXYAMPHETAMINE",NA,1
"DIPEPTIDES",NA,1
"DIPHENYL(PYRROLIDIN-2-YL)METHANOL (D2PM)",NA,1
"DIPOLE MOMENT",NA,2
"DIPROPYLAMINE",NA,2
"DIRECT-HEATING",NA,1
"DIRECT ANALYSIS IN REAL TIME-HIGH-RESOLUTION MASS SPECTROMETRY",NA,2
"DIRECT COMPRESSION",NA,1
"DIRECT DETECTION OF STIMULANTS IN SPORTING EVENTS, AS AMPHETAMINE",NA,1
"DIRECT ENANTIOMER SEPARATION BY HPLC",NA,1
"DIRECT IONIZATION-MASS SPECTROMETRY",NA,1
"DIRECT LASER DESORPTION IONIZATION (DLDI)",NA,1
"DIRECT SAMPLE PREPARATION",NA,1
"DIRECT SAMPLING",NA,1
"DIRECT SOLID ANALYSIS",NA,1
"DIRT",NA,1
"DISCONTINUOUS ATMOSPHERIC PRESSURE INTERFACE",NA,1
"DISCRIMINANT ANALYSIS AND SOURCE IDENTIFICATION",NA,1
"DISCRIMINANT PARTIAL LEAST-SQUARES",NA,1
"DISCRIMINATION OF BATCHES",NA,1
"DISCUSSION FORUM",NA,1
"DISCUSSION FORUMS",NA,1
"DISEASE RESISTANCE",NA,2
"DISINFECTION BY-PRODUCTS",NA,2
"DISPENSARIES",NA,2
"DISPENSINGS",NA,1
"DISPERSION CORRECTION",NA,1
"DISPERSIVE LIQUID-LIQUID",NA,1
"DISPERSIVE LIQUIDÃ¢Â‚¬Â€ŒLIQUID MICROEXTRACTION",NA,1
"DISPERSIVE LIQUIDÃ¢Â‚¬Â€ŒLIQUID MICROEXTRACTIONÃ¢Â‚¬Â€ŒSOLDIFIED FLOATING ORGANIC DROP",NA,1
"DISPERSIVE NANOMATERIAL-ULTRASOUND ASSISTED MICROEXTRACTION",NA,1
"DISPERSIVE RAMAN",NA,1
"DISPERSIVE SOLID-PHASE MICROEXTRACTION",NA,1
"DISRUPTION OF ILLICIT NETWORKS",NA,1
"DISSOCIATION CONSTANT",NA,1
"DISSOCIATION PATHWAYS",NA,1
"DISSOCIATIVE",NA,1
"DISSOLUTION KINETICS",NA,1
"DISSOLUTION PROFILE",NA,1
"DISSOLUTION TEST",NA,2
"DISTINCTION",NA,1
"DISTRIBUTION COEFFICIENTS",NA,1
"DISTRIBUTION FUNCTIONS",NA,1
"DISTRIBUTION NETWORKS",NA,1
"DITERPENE",NA,2
"DITERPENOID",NA,2
"DIVERSITY ANALYSIS",NA,1
"DIVERTED USE OF DRUGS",NA,1
"DIVISION",NA,1
"DKW",NA,1
"DMA",NA,1
"DMAA",NA,2
"DMBA-CHMINACA",NA,1
"DMBZPS",NA,1
"DMG",NA,1
"DMT",NA,11
"DNA DETECTION KIT",NA,1
"DNA MICROARRAY",NA,1
"DNA PROFILES",NA,1
"DNA SEQUENCE ANALYSIS",NA,1
"DNA STRUCTURES",NA,1
"DNA TESTING",NA,1
"DNA/PROTEIN INTERACTION",NA,1
"DND",NA,1
"DNS-AMINO ACIDS",NA,1
"DOAU",NA,1
"DODDER TRANSMISSION",NA,1
"DOEHLERT MATRIX OPTIMIZATION",NA,1
"DOELHERT DESIGN",NA,1
"DOFFING",NA,1
"DOG FOOD",NA,1
"DOM",NA,3
"DOMAIN ADAPTATION",NA,1
"DOMESTICATION",NA,2
"DOMINO REACTION",NA,1
"DONOR–ACCEPTOR STENHOUSE ADDUCT",NA,1
"DOPAMINE ACTIVITY",NA,1
"DOPAMINE REUPTAKE BLOCKING",NA,1
"DOPED GRAPHENE",NA,1
"DOPING COMPOUNDS",NA,1
"DOPING PRODUCTS",NA,1
"DOSAGE",NA,3
"DOSAGE FORM",NA,1
"DOSE DUMPING",NA,2
"DOSE PROPORTIONALITY",NA,1
"DOSY",NA,1
"DOUBLE-BLIND STUDY",NA,1
"DOUBLE-DIVISOR RATIO SPECTRA DERIVATIVE",NA,1
"DOUBLE-TERNARY GRADIENT HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY",NA,1
"DOWNY MILDEW",NA,2
"DOX",NA,1
"DOXYLAM",NA,1
"DP-MS",NA,1
"DPMP",NA,1
"DPT",NA,1
"DPV",NA,1
"DRACAENA",NA,1
"DRACORHODIN",NA,1
"DRAEGER DRUGTEST 5000",NA,1
"DRAGON'S BLOOD",NA,1
"DRC-ICP-MS",NA,1
"DRIFT TUBE ION MOBILITY SPECTROMETRY",NA,1
"DRINKING WATER",NA,8
"DRINKING WATER, SURFACE WATER, AND WASTEWATER",NA,1
"DROUGHT",NA,1
"DROWNING-OUT CRYSTALLIZATION",NA,1
"DRŠGER DCD 5000",NA,1
"DRUG-ACCEPTOR INTERACTION",NA,1
"DRUG-FACILITATED RAPE",NA,1
"DRUG-RELATED CRIMES",NA,1
"DRUG-RELATED IMPURITIES",NA,1
"DRUG-WITHDRAWAL THERAPY",NA,1
"DRUG ABUSE PATTERN IN TAIWAN",NA,1
"DRUG ABUSE/USE",NA,1
"DRUG ADULTERATION",NA,1
"DRUG ANALYSIS BY LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONISATION MASS SPECTROMETRY (LC-ESI-MS)",NA,1
"DRUG BEHAVIOR",NA,1
"DRUG CATEGORIES",NA,1
"DRUG CHECKING SERVICE",NA,1
"DRUG CLASSIFICATION",NA,2
"DRUG CONFIRMATION TESTS",NA,1
"DRUG CONSUMPTION FACILITIES",NA,1
"DRUG CONSUMPTION ROOM",NA,1
"DRUG CONSUMPTION, CORRELATION, EUROPE-WIDE STUDY, SEIZURES, SALES STATISTICS",NA,1
"DRUG CONTROL POLICY",NA,1
"DRUG CUTS",NA,1
"DRUG DEALING",NA,2
"DRUG DELIVER",NA,1
"DRUG DESIGN",NA,1
"DRUG DEVELOPMENT",NA,2
"DRUG DIFFUSION",NA,1
"DRUG DISPOSAL",NA,1
"DRUG DISPOSAL PROGRAM",NA,1
"DRUG EDUCATION",NA,1
"DRUG ENCAPSULATION",NA,1
"DRUG ENFORCEMENT",NA,1
"DRUG ENFORCEMENT ADMINISTRATION",NA,3
"DRUG ENFORCEMENT ADMINISTRATION (DEA)",NA,1
"DRUG EPIDEMIOLOGY",NA,4
"DRUG FORMULATION",NA,2
"DRUG HABIT",NA,1
"DRUG IMAGE RECOGNITION",NA,1
"DRUG IMPURITIES",NA,1
"DRUG IMPURITY PROFILING",NA,3
"DRUG INFORMATION REPORTING SYSTEM",NA,1
"DRUG KNOWLEDGE",NA,1
"DRUG LAW ENFORCEMENT",NA,2
"DRUG LIKING",NA,2
"DRUG MARKET SIZE ESTIMATES",NA,1
"DRUG MECHANISM",NA,1
"DRUG MEDICINES",NA,1
"DRUG OF CONCERN",NA,1
"DRUG PANIC",NA,1
"DRUG PEDIGREE",NA,1
"DRUG POISONING DEATHS",NA,1
"DRUG PRECURSOR CHEMICALS",NA,1
"DRUG PRESUMPTIVE TEST",NA,2
"DRUG PRICE",NA,2
"DRUG PRODUCT",NA,7
"DRUG PRODUCT DEGRADANTS",NA,1
"DRUG PRODUCTION",NA,1
"DRUG QUALITY",NA,2
"DRUG REFORMULATION",NA,1
"DRUG RELEASE KINETICS",NA,1
"DRUG REMOVAL EFFICACY",NA,1
"DRUG RESEARCH",NA,2
"DRUG SAFETY",NA,2
"DRUG SAFETY TESTING",NA,1
"DRUG SCHEDULING",NA,2
"DRUG SCREENING TESTS",NA,1
"DRUG SIGNATURE",NA,1
"DRUG SOLUTION",NA,1
"DRUG STORAGE",NA,2
"DRUG STRATEGY",NA,1
"DRUG STREET SAMPLES",NA,2
"DRUG SUBSTANCE",NA,7
"DRUG SUPPLY",NA,2
"DRUG SUPPRESSION",NA,2
"DRUG TABLET",NA,1
"DRUG TRADE",NA,2
"DRUG TREATMENT NEEDS",NA,1
"DRUG TREND MONITORING",NA,1
"DRUG TYPE",NA,1
"DRUGS ABUSE",NA,1
"DRUGS AND DRUGS OF ABUSE IN BULK MATERIALS",NA,1
"DRUGS DATABASE",NA,1
"DRUGS IN FINGERPRINTS",NA,1
"DRUGS INTELLIGENCE",NA,1
"DRUGS OF ABUSE DETECTION, USING SERS",NA,1
"DRUGS OF ABUSE, HANDHELD FT-IR AND RAMAN SPECTROMETERS",NA,1
"DRUGS ON BILLS",NA,1
"DRUGS PREVALENCE",NA,1
"DRUGS PROPERTIES",NA,1
"DRUGS, BASIC",NA,2
"DRY GRASSLAND",NA,1
"DRYLABÃ‚Â®",NA,1
"DSHEA",NA,1
"DUAL-ENERGY CT",NA,1
"DUAL AFFINITY",NA,1
"DUAL CATALYSIS",NA,1
"DUAL RETENTION MECHANISM",NA,1
"DUAL SELECTOR SYSTEM",NA,1
"DUAL TEST",NA,1
"DUAL WAVELENGTH",NA,1
"DUBOISIA HYBRIDS",NA,1
"DUBOISIA LEICHHARDTII",NA,1
"DUBOISIA MYOPOROIDES",NA,1
"DUCT TAPE",NA,1
"DUMMY TEMPLATE",NA,1
"DUQUENOIS-LEVINE",NA,1
"DUQUENOIS-LEVINE TEST",NA,1
"DUQUENOIS LEVINE TEST",NA,1
"DUQUENOIS REACTION",NA,1
"DYES/PIGMENTS",NA,1
"DYNAMIC CHIRAL CHROMATOGRAPHY",NA,1
"DYNAMIC CHROMATOGRAPHY",NA,1
"DYNAMIC COLLISION INDUCED DISSOCIATION (DCID)",NA,1
"DYNAMIC KINETIC RESOLUTION",NA,1
"DYNAMIC MASS REDISTRIBUTION",NA,1
"DYNAMIC QUENCHING",NA,1
"DYNAMIC SPME",NA,1
"DYNAMIC SURFACE ENHANCED RAMAN SPECTROSCOPY",NA,1
"DYNAMICALLY COATED CAPILLARY",NA,1
"E-COMMERCE",NA,1
"E-PEDIGREE",NA,1
"E/Z-OLEFINS",NA,1
"EÃŽÂ¼PAD",NA,1
"ECCD",NA,1
"ECD",NA,1
"ECD SPECTROSCOPY",NA,1
"ECHINACEA SPECIES",NA,1
"ECHINOPSIS PERUVIANA",NA,1
"ECO-TOXICITY",NA,1
"ECONOMIC ANALYSIS",NA,1
"ECOSYSTEM SERVICES",NA,1
"ECOTOXICITY",NA,2
"ECSTASY ILLICIT PILLS",NA,1
"ECSTASY PROFILING",NA,1
"EDESTIN",NA,1
"EDGE PLANE PYROLYTIC GRAPHITE ELECTRODES",NA,1
"EDIBLE OIL",NA,1
"EDIBLES",NA,10
"EFAROXAN",NA,1
"EFFECT SIZE",NA,1
"EFFECTS",NA,3
"EFFICIENCY OF THE RESOLUTION",NA,1
"EFFLUENT WASTEWATER",NA,1
"EGG",NA,1
"EI-MS",NA,1
"EIGHT FACTOR ANALYSIS",NA,1
"EIS SENSOR",NA,1
"ELDERLY PATIENTS",NA,1
"ELECTRE",NA,1
"ELECTRICAL CONDUCTIVITY",NA,1
"ELECTRO-OXIDATION",NA,2
"ELECTRO-PHOTOCATALYSIS",NA,1
"ELECTRO SOLID-PHASE MICROEXTRACTION",NA,1
"ELECTROCATALYSIS",NA,1
"ELECTROCHEMICAL APTASENSOR",NA,3
"ELECTROCHEMICAL BEHAVIOR",NA,1
"ELECTROCHEMICAL DEPOSITION",NA,1
"ELECTROCHEMICAL DETECTOR",NA,2
"ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY (EIS)",NA,4
"ELECTROCHEMICAL IMPRINTED SENSOR",NA,2
"ELECTROCHEMICAL MEASUREMENTS",NA,1
"ELECTROCHEMICAL METHOD",NA,1
"ELECTROCHEMICAL NANOAPTASENSOR",NA,1
"ELECTROCHEMICAL NANOSENSOR",NA,2
"ELECTROCHEMICAL OXIDATION",NA,1
"ELECTROCHEMICAL PRETREATMENT",NA,2
"ELECTROCHEMICAL PROFILING",NA,1
"ELECTROCHEMICALLY ACTIVATED SCREEN-PRINTED CARBON ELECTRODE MODIFIED WITH SODIUM DODECYL SULFATE",NA,1
"ELECTROCHEMILUMINESCENCE AND ELECTROANALYTICAL SENSING",NA,1
"ELECTROCHEMILUMINESCENCE SENSORS",NA,1
"ELECTROCHROMATOGRAPHY",NA,5
"ELECTROCYCLIC REACTION",NA,1
"ELECTRODE ARRAYS",NA,1
"ELECTRODE FOULING",NA,1
"ELECTRODEPOSITION",NA,1
"ELECTRODES",NA,1
"ELECTROFUSION",NA,1
"ELECTROLYTE PH",NA,1
"ELECTROMAGNETIC PIEZOELECTRIC ACOUSTIC SENSOR",NA,1
"ELECTROMIGRATION ORDER",NA,1
"ELECTROMIGRATION TECHNIQUES",NA,1
"ELECTRON DENSITY",NA,1
"ELECTRON ENERGY LOSS SPECTROSCOPY",NA,1
"ELECTRONIC CIGARETTE",NA,3
"ELECTRONIC CIRCULAR DICHROISM",NA,1
"ELECTRONIC LIQUIDS",NA,1
"ELECTRONIC MAIL",NA,1
"ELECTRONIC NICOTINE DELIVERY DEVICES",NA,1
"ELECTRONIC NICOTINE DELIVERY SYSTEMS",NA,1
"ELECTRONIC PROPERTIES",NA,1
"ELECTRONIC TONGUE",NA,1
"ELECTRONIC VAPING PRODUCTS",NA,1
"ELECTROOSMOTIC FLOW",NA,1
"ELECTROOXIDATION",NA,1
"ELECTROPHILIC SUBSTITUTION",NA,1
"ELECTROPHORETIC ENANTIOMERIC SEPARATION",NA,1
"ELECTROPHORETIC MOBILITY",NA,2
"ELECTROPHORETIC TECHNIQUES",NA,1
"ELECTROSPIN",NA,1
"ELECTROSPINNING",NA,3
"ELECTROSPRAY IONIZATION-ION MOBILITY SPECTROMETRY-MASS SPECTROMETRY",NA,1
"ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY",NA,2
"ELECTROSPRAY IONIZATION ION TRAP MASS SPECTROMETRY",NA,1
"ELECTROSPRAY(+) MASS SPECTROMETRY",NA,1
"ELECTROSPUN CARBON NANOFIBERS",NA,1
"ELECTROSTATIC",NA,1
"ELECTROSTATIC INTERACTION",NA,1
"ELECTROSTATIC POTENTIAL",NA,1
"ELECTROSTATIC REPULSION",NA,1
"ELECTROTHERMAL ATOMIC ABSORPTION SPECTROMETRY",NA,1
"ELEMENT SPECIATION",NA,1
"ELEMENTARY/MIDDLE SCHOOL SCIENCE",NA,2
"ELEMENTS",NA,2
"ELICITATION",NA,2
"ELUCIDATION",NA,1
"ELUTION ORDER",NA,1
"EMBEDDED PEAKS",NA,1
"EMDE METHOD",NA,1
"EMDE REACTION",NA,1
"EMDE SYNTHESIS",NA,1
"EMERGING MICROPOLLUTANTS",NA,1
"EMERGING ORGANIC CONTAMINANTS",NA,1
"EMISSION",NA,1
"EMITTING SPECIES",NA,1
"EMPATHOGEN",NA,2
"EMPIRICAL MODELLING",NA,1
"EMULSIFICATION MICROEXTRACTION BASED ON LOW-DENSITY SOLVENT",NA,1
"EMULSIONS",NA,1
"ENANTIOANALYSIS",NA,1
"ENANTIOMER DETERMINATION",NA,1
"ENANTIOMER MIGRATION ORDER",NA,1
"ENANTIOMER RATIO",NA,1
"ENANTIOMERIC DETERMINATION",NA,1
"ENANTIOMERIC IMPURITY PROFILING",NA,1
"ENANTIOMERIC PROFILE",NA,1
"ENANTIOMERIC PURITY",NA,3
"ENANTIOMERIC RESOLUTION",NA,3
"ENANTIOMERIZATION BARRIERS",NA,1
"ENANTIOMERIZATION ENERGY BARRIERS",NA,1
"ENANTIOMERS/CITALOPRAM",NA,1
"ENANTIORESOLUTION",NA,1
"ENANTIOSE-LECTIVE",NA,1
"ENANTIOSELECTION",NA,1
"ENANTIOSELECTIVE ANALYSIS",NA,3
"ENANTIOSELECTIVE HPLC",NA,1
"ENANTIOSELECTIVE HPLC-DAD-CD METHOD",NA,1
"ENANTIOSELECTIVE N-DEMETHYLATION",NA,1
"ENANTIOSELECTIVE POTENTIAL",NA,1
"ENANTIOSELECTIVE SYNTHESIS",NA,1
"ENANTIOSELECTIVITY",NA,3
"ENANTIOSEPARATION",NA,1
"END-USERS, IDENTIFYING CHEMICALS, NARCOTICS, WITH HANDHELD/PORTABLE UNITS",NA,1
"ENDEMIC SPECIES",NA,1
"ENDOCANNABINOIDOME",NA,1
"ENDOCRINE DISRUPTING COMPOUNDS (EDCS)",NA,2
"ENDOCRINE DISRUPTION",NA,1
"ENDOGENOUS MOLECULES",NA,1
"ENDOPHYTE",NA,2
"ENERGY CONVERSION",NA,1
"ENERGY RECOVERY",NA,1
"ENGINEERED BIOSYNTHESIS",NA,1
"ENRICHMENT BAG",NA,1
"ENRICHMENT/REVIEW MATERIALS",NA,1
"ENSEMBLE LEARNING",NA,1
"ENTHALPY-ENTROPY RELATION",NA,1
"ENVIRONMENTAL DEGRADATION",NA,1
"ENVIRONMENTAL EFFECTS",NA,1
"ENVIRONMENTAL FACTORS",NA,1
"ENVIRONMENTAL HEALTH",NA,1
"ENVIRONMENTAL HEALTH PRACTICE",NA,1
"ENVIRONMENTAL IMPACT OF DRUG ABUSE",NA,1
"ENVIRONMENTAL INDICATOR",NA,1
"ENVIRONMENTAL MODELLING",NA,1
"ENVIRONMENTAL OCCURRENCE",NA,1
"ENVIRONMENTAL RISK",NA,2
"ENVIRONMENTAL RUGGEDNESS",NA,1
"ENVIRONMENTAL SAMPLE",NA,1
"ENVIRONMENTAL SAMPLES",NA,2
"ENVIRONMENTAL SUSTAINABILITY",NA,1
"ENVIRONMENTAL WATER",NA,2
"ENVIRONMENTAL WATER SAMPLES",NA,2
"ENZYMATIC BIOSENSOR",NA,1
"ENZYMATIC DETECTION",NA,1
"ENZYME ANALYSIS",NA,1
"ENZYME HYDROLYSIS",NA,1
"ENZYME INHIBITION",NA,1
"ENZYME ISOFORMS",NA,1
"ENZYME THERMISTOR (ET)",NA,1
"ENZYMES",NA,5
"EO-1 HYPERION",NA,1
"EOF",NA,1
"EP IMPURITIES",NA,1
"EPC",NA,1
"EPH",NA,1
"EPHEDRA ALATA",NA,1
"EPHEDRA ALATA ALENDA",NA,1
"EPHEDRA ALATA MONJAUZEANA",NA,1
"EPHEDRA ALATA SUBSP. ALENDA",NA,1
"EPHEDRA ALKALOID",NA,3
"EPHEDRA EQUISETINA",NA,1
"EPHEDRA EXTRACT",NA,1
"EPHEDRA FOLIATA",NA,1
"EPHEDRA FRAGILIS",NA,1
"EPHEDRA GENOMIC",NA,1
"EPHEDRA GERARDIANA",NA,1
"EPHEDRA HELVETICA",NA,1
"EPHEDRA HERB",NA,1
"EPHEDRA INTERMEDIA",NA,2
"EPHEDRA L",NA,1
"EPHEDRA LIKIANGENSIS",NA,1
"EPHEDRA MAJOR",NA,1
"EPHEDRA SINENSIS STAPF EPHEDRACEAE",NA,1
"EPHEDRA SINICA",NA,9
"EPHEDRA SINICA STAPF",NA,1
"EPHEDRA SPECIES",NA,2
"EPHEDRA TRIANDRA",NA,1
"EPHEDRA TWEEDIANA",NA,1
"EPHEDRACEAE",NA,5
"EPHEDRAE HERBA",NA,2
"EPHEDRINE ALKALOID",NA,13
"EPHEDRINE ALKALOIDS-FREE EPHEDRA HERB EXTRACT (EFE)",NA,1
"EPHEDRINE ANALOGUES",NA,1
"EPHEDRINE AS SYNTHESIS PRECURSOR",NA,1
"EPHEDRINE DERIVATIVES",NA,2
"EPHEDRINE DETECTION",NA,1
"EPHEDRINE DITHIOCARBAMATE",NA,1
"EPHEDRINE ENANTIOMERS",NA,1
"EPHEDRINE HCL",NA,2
"EPHEDRINE HYDROCHLORIDE",NA,5
"EPHEDRINE ROUTE",NA,1
"EPHEDRINE SENSOR",NA,1
"EPHEDRINE/PSEUDOEPHEDRINE",NA,1
"EPHERA HERB",NA,1
"EPHYLONE",NA,1
"EPI LIBRARY MATCH",NA,1
"EPICHLOË",NA,1
"EPICHLORHYDRIN CROSS-LINKING AGENT",NA,1
"EPIDEMIOLOGIC STUDY",NA,1
"EPIMER-SPECIFIC QUANTIFICATION",NA,1
"EPIMERS",NA,1
"EPINEPHRINE",NA,2
"EPIPOLYTHIODIOXOPIPERAZINE",NA,1
"EPOXY CANNABIGEROLIC ACID",NA,1
"EQUILIBRIUM EXTRACTION",NA,1
"ER OXYCODONE",NA,1
"ERADICATED SPECIMENS",NA,1
"ERAGROSTIS CAPILLARIS",NA,1
"ERAGROSTIS HIRSUTA",NA,1
"ERECTILE DYSFUNCTION DRUG",NA,1
"ERGOLINE",NA,1
"ERGOPEPTINE",NA,1
"ERGOT-LIKE ALKALOID",NA,1
"ERGOT ALKALOID DERIVATIVES",NA,1
"ERGOT ALKALOID MYCOTOXINS",NA,1
"ERGOT ANALYSIS",NA,1
"ERGOT SORGHUM",NA,1
"ERGOTAMINE",NA,2
"ERGOTAMINE TARTARATE",NA,1
"ERGOTISM",NA,1
"ERGOTOXINS",NA,1
"ERGOVALINE",NA,2
"ERIOCHROME BLACK T",NA,1
"ERIOCHROME CYANINE R",NA,1
"ERK1/2",NA,1
"ERROR PROPAGATION",NA,1
"ERROR RATES",NA,1
"ERY B",NA,1
"ERYTHROXYLACEAE",NA,5
"ERYTHROXYLUM COC VAR. COCA",NA,1
"ERYTHROXYLUM COCA",NA,4
"ERYTHROXYLUM COCA VAR. COCA",NA,1
"ERYTHROXYLUM COCA VAR. COCA LAM.",NA,1
"ERYTHROXYLUM COCA VAR. IPADU",NA,1
"ERYTHROXYLUM LAETEVIRENS",NA,1
"ERYTHROXYLUM LEAVES",NA,1
"ERYTHROXYLUM NOVOGRANATENSE",NA,1
"ERYTHROXYLUM NOVOGRANATENSE VAR. NOVOGRANATENSE",NA,1
"ERYTHROXYLUM NOVOGRANATENSE VAR. NOVOGRANATENSE (MORRIS) HIERON",NA,1
"ERYTHROXYLUM NOVOGRANATENSE VAR. TRUXILLENSE",NA,1
"ESCHSCHOLZIA CALIFORNICA",NA,3
"ESI-MS/MS",NA,1
"ESI, ELECTROSPRAY IONIZATION",NA,1
"ESI/MS",NA,1
"ESIÃ¢Â‚¬Â€ŒMS",NA,1
"ESKETAMINE",NA,1
"ESSENTIAL CHEMICALS",NA,1
"ESSENTIAL FATTY ACIDS",NA,1
"ESSENTIAL MEDICINES",NA,1
"EST-SSR",NA,1
"ESTER HYDROLYSIS",NA,1
"ESTERIFICATION",NA,1
"ESTIMABILITY",NA,1
"ESTIMATE",NA,1
"ESTIMATED POPULATION",NA,1
"ESTIMATION",NA,2
"ESTRADIOL",NA,1
"ESTRONE",NA,1
"ESTUARINE SEDIMENT",NA,1
"ESTUARINE WATER",NA,1
"ESTUARY",NA,2
"ETHANESULFONIC ACID",NA,1
"ETHANOL EXTRACTION",NA,1
"ETHANOLAMINES",NA,1
"ETHEPHON",NA,1
"ETHICAL",NA,1
"ETHIOPIA",NA,2
"ETHNOBOTANICS",NA,1
"ETHNOMYCOLOGY",NA,1
"ETHNOPHARMACOLOGY",NA,3
"ETHOCEL",NA,1
"ETHOXYPHENETHYLAMINES",NA,2
"ETHYL 3-OXO-2-PHENYLBUTYRATE",NA,1
"ETHYL 3-OXO-4-PHENYLBUTYRATE",NA,1
"ETHYL ACETATE",NA,1
"ETHYL MORPHINE HYDROCHLORIDE",NA,1
"ETHYLAMINES",NA,1
"ETHYLBENZENE",NA,1
"ETHYLBENZOYLECGONINE",NA,1
"ETHYLBENZOYLECOGNINE",NA,1
"ETHYLCELLULOSE",NA,1
"ETHYLCELLULOSE MATRIX",NA,1
"ETHYLENEDIOXYTHIOPHENE",NA,1
"ETODOLAC",NA,1
"ETONITAZENE",NA,2
"EUCLIDIAN DISTANCE",NA,2
"EUGENOL",NA,1
"EUPHORBIA HELIOSCOPIA",NA,1
"EUPHORBIACEAE",NA,1
"EURITRACK",NA,1
"EURITRACK SYSTEM",NA,1
"EURO BANKNOTES",NA,1
"EUROPEAN PHARMACOPOEIA",NA,1
"EVALI",NA,1
"EVALUATION MATRIX",NA,1
"EVANESCENT WAVE FIBRE BIOSENSOR",NA,1
"EVAPORATIVE LIGHT-SCATTERING DETECTOR",NA,1
"EVAPORATIVE LIGHT SCATTERING",NA,1
"EVAPORATIVE LIGHT SCATTERING DETECTION",NA,2
"EVIDENCE-BASED POLICY",NA,1
"EVIDENCE BY SKILLFUL",NA,1
"EVIDENCE TRIAGE",NA,1
"EVOLUTION",NA,1
"EXACT MASS",NA,1
"EXAMINATIONS OF ILLICIT DRUGS",NA,1
"EXCHANGE DYNAMICS",NA,1
"EXCITATION-EMISSION MATRICES",NA,1
"EXCITATION–EMISSION MATRIX FLUORESCENCE",NA,1
"EXCRETION FACTOR",NA,1
"EXFOLIATED GRAPHITE",NA,1
"EXHAUSTIVE EXTRACTION",NA,1
"EXONUCLEASE Ⅰ",NA,1
"EXONUCLEASE III",NA,1
"EXORPHIN",NA,1
"EXOTIC PLANT SPECIES",NA,1
"EXPECTANCY EFFECTS",NA,1
"EXPERIENTIAL LEARNING",NA,1
"EXPERIMENTAL SAMPLE OF ONBOARD HYPERSPECTRAL VIDEOSPECTROMETER SOKOL-SCP",NA,1
"EXPERT WITNESS CREDIBILITY",NA,1
"EXPLANT",NA,1
"EXPLORATORY ANALYSIS",NA,1
"EXPLORATORY SPATIAL DATA ANALYSIS",NA,1
"EXPLOSIVES SYNTHESIS",NA,1
"EXPONENTIAL-GAUSSIAN HYBRID",NA,1
"EXPOSED CHILDREN",NA,1
"EXPOSED SOLVENT",NA,1
"EXPOSURE ASSESSMENT",NA,1
"EXPOSURE ASSESSMENT FROM WIPE SAMPLES",NA,1
"EXPRESSED SEQUENCE TAG",NA,4
"EXPRESSED SEQUENCE TAGÃ¢Â‚¬Â€ŒSIMPLE SEQUENCE REPEAT (EST-SSR) MARKER",NA,1
"EXTEMPORANEOUS PREPARATIONS",NA,1
"EXTENDED-RELEASE",NA,5
"EXTENDED-RELEASE FORMULATION",NA,1
"EXTENDED-RELEASE HYDROMORPHONE",NA,1
"EXTENDED-RELEASE MATRIX TABLET",NA,1
"EXTENDED-RELEASE OXYCODONE",NA,2
"EXTERNAL ELECTRIC FIELD",NA,1
"EXTRA-COLUMN VARIANCE",NA,1
"EXTRACELLULAR AND INTRACELLULAR ALKALOIDS",NA,1
"EXTRACTED COMMON ION CHROMATOGRAM",NA,1
"EXTRACTION EFFICACY",NA,1
"EXTRACTION NEEDLE",NA,1
"EXTRACTION SELECTIVITY",NA,1
"EXTRACTION SPECTROPHOTOMETRY",NA,1
"EXTRACTION SPRAY",NA,1
"EXTRACTIONLESS GC/MS",NA,1
"EXTRACTIVE METHYLATION",NA,1
"EXTRACTS",NA,2
"EXTRAKCE",NA,1
"EXTRANEOUS VARIABILITY",NA,1
"F-MWCNTS @AUNPS NANOCOMPOSITE",NA,1
"F-MWCNTS@AUNPS NANOCOMPOSITE",NA,1
"F1 HYBRID",NA,1
"F2201",NA,1
"FACEBOOK",NA,4
"FACTORS",NA,1
"FAKE ANTIMICROBIAL AGENTS",NA,1
"FAKE TABLETS",NA,1
"FALSE-NEGATIVE",NA,1
"FALSE RESPONSE",NA,1
"FALSIFIED PRESCRIPTION",NA,1
"FAS KIT",NA,1
"FAST BLACK SALT",NA,1
"FAST BLUE",NA,1
"FAST DISSOLVING DRUG DELIVERY",NA,1
"FAST DRUG ANALYSIS",NA,2
"FAST GC-FID",NA,1
"FAST GCÃ¢Â‚¬Â€ŒMS",NA,1
"FAST HPLC",NA,1
"FAST IDENTIFICATION",NA,1
"FAST LIQUID CHROMATOGRAPHY",NA,1
"FAST NEUTRON INSPECTION",NA,1
"FAST SCREENING OF PHARMACEUTICALS FOR COUNTERFEITS",NA,1
"FATAL 4Ã‚Â ÃƑÂ€”Ã‚Â 100 FORMULA",NA,1
"FATE",NA,1
"FATTY ACID AMIDES",NA,1
"FDM",NA,1
"FDR",NA,1
"FDU-NNEI",NA,1
"FDW",NA,1
"FE3O4",NA,1
"FEATURE SELECTION",NA,1
"FEATURE SELECTION METHOD",NA,1
"FEED",NA,4
"FEED WATER",NA,1
"FEEDINGSTUFF",NA,1
"FEEDS",NA,1
"FENAMATES",NA,1
"FENETYLLINE",NA,1
"FENI3 NANOALLOY",NA,1
"FENTALOGUES",NA,1
"FENTANYL-LIKE COMPOUNDS",NA,1
"FENTANYL-RELATED SUBSTANCES",NA,2
"FENTANYL ANALOG SCREENING KIT",NA,1
"FENTANYL CITRATE",NA,1
"FENTANYL LACED HEROIN",NA,1
"FENTANYL OVERDOSE",NA,1
"FENTANYL TEST STRIP (FTS)",NA,1
"FENTANYL TRANSDERMAL PATCHES",NA,1
"FENTON-LIKE TREATMENT",NA,1
"FENTON REACTION",NA,1
"FERN√£O-PIRES",NA,1
"FERRATE(VI)",NA,1
"FERROCENE CARBOXYLIC ACID",NA,1
"FERROCENE CONJUGATED DNA APTAMER",NA,1
"FERTILISERS",NA,1
"FESTIVAL MEDICINE",NA,1
"FEXOFENADINE",NA,1
"FG2216",NA,1
"FIA",NA,2
"FIBER-SPRAY/MASS SPECTROMETRY",NA,1
"FIBER DYE IDENTIFICATION",NA,1
"FIBER HEMP PLANTS",NA,1
"FIBER SENSOR",NA,1
"FIBRE TYPE",NA,1
"FID",NA,1
"FIELD-DEPLOYABLE",NA,1
"FIELD ANALYSIS",NA,3
"FIELD CALIBRATION",NA,1
"FIELD DEPLOYABLE INSTRUMENTATION",NA,1
"FIELD MUSEUM RAPID INVENTORY",NA,1
"FIELD SCALE REACTIVE TRANSPORT MODELLING",NA,1
"FIELD SCREENING",NA,1
"FILTER DIAGONALIZATION METHOD",NA,1
"FINE-GRAINED SEDIMENT",NA,1
"FINGER MASHER",NA,1
"FINGERNAIL AND TOENAIL DIFFERENTIATION",NA,1
"FINGERPRINT SPECTRUM",NA,1
"FIREARMS AND TOOL MARK IDENTIFICATION",NA,1
"FIRST-ORDER PHASE TRANSFORMATION",NA,1
"FIRST DERIVATIVE",NA,1
"FIRST DERIVATIVE OF RATIO SPECTRA",NA,1
"FIRST DERIVATIVE SPECTRA",NA,1
"FIRST DERIVATIVE SPECTROPHOTOMETRY",NA,2
"FISHER'S LINEAR DISCRIMINANT MODELLING",NA,1
"FISHERY PRODUCTS",NA,1
"FITC",NA,2
"FIXED-DOSE COMBINATION",NA,1
"FLAME ATOMIC ABSORPTION SPECTROMETRY",NA,1
"FLAME IONISATION DETECTOR RESPONSE",NA,1
"FLAME IONIZATION DETECTOR",NA,1
"FLAMELESS ABSORPTION SPECTROMETRY",NA,1
"FLAT FIELD CONCAVE GRATING",NA,1
"FLAVOENZYME",NA,1
"FLAVONOID",NA,9
"FLAVONOID GLYCOSIDES",NA,1
"FLAVOR PROFILE ANALYSIS",NA,1
"FLAVYLIUM SALTS",NA,1
"FLEECE ADSORBER",NA,1
"FLEPHEDRONE",NA,1
"FLESH-EATING DRUG",NA,1
"FLIGHT TESTS",NA,1
"FLOATING",NA,1
"FLOATING TABLETS",NA,1
"FLORAL ODOR",NA,1
"FLORAL ORIGIN",NA,1
"FLORAL REVERSION",NA,1
"FLOS",NA,1
"FLOS DATURAE",NA,1
"FLOW-BATCH SYSTEM",NA,1
"FLOW-CELLS",NA,1
"FLOW-THROUGH",NA,1
"FLOW CELL",NA,1
"FLOW INJECTION ANALYSIS-HIGH-RESOLUTION MASS SPECTROMETRY",NA,1
"FLOW INJECTION ANALYSIS WITH ELECTROCHEMICAL DETECTION",NA,1
"FLOW SYSTEM",NA,1
"FLOW THROUGH CELL METHOD",NA,1
"FLOWER",NA,1
"FLOWING ATMOSPHERIC-PRESSURE AFTERGLOW",NA,1
"FLUBROMAZEPAM",NA,2
"FLUFENAMIC ACID",NA,1
"FLUORENE",NA,1
"FLUORESCEIN",NA,1
"FLUORESCENCE ANISOTROPY",NA,1
"FLUORESCENCE IMMUNOASSAY",NA,2
"FLUORESCENCE INTERFERENCE",NA,1
"FLUORESCENCE LABELING",NA,3
"FLUORESCENCE POLARIZATION",NA,1
"FLUORESCENCE QUENCHING",NA,2
"FLUORESCENCE SENSOR",NA,2
"FLUORESCENT APTASENSOR",NA,1
"FLUORESCENT ASSAY",NA,1
"FLUORESCENT FILM",NA,1
"FLUORESCENT PROBES",NA,1
"FLUORIDE ELECTRODE",NA,1
"FLUORIMETRY",NA,2
"FLUORINATED",NA,1
"FLUOXETINE DETERMINATION",NA,1
"FLUOXETINE HCL",NA,1
"FLUOXETINE HYDROCHLORIDE",NA,1
"FLUPENTIXOL DIHYDROCHLORIDE",NA,1
"FLURAZEP M",NA,1
"FLUROESCENCE",NA,1
"FOCAL PLANE ARRAY",NA,1
"FOCUS GROUP DISCUSSIONS",NA,1
"FOCUSÃƑÂ¢Ã¢Â‚¬Å¾Ã‚Â¢",NA,1
"FOCUSED MICROWAVE-ASSISTED EXTRACTION",NA,2
"FOCUSED ULTRASOUND EXTRACTION",NA,1
"FOCUSING",NA,1
"FOLK PHARMACOLOGY",NA,1
"FOOD AND DRUG ADMINISTRATION",NA,2
"FOOD AND DRUG ADMINISTRATION (FDA)",NA,1
"FOOD AND FEED",NA,1
"FOOD MYCOTOXINS",NA,1
"FOOD OF ANIMAL ORIGIN",NA,1
"FOOD SECURITY",NA,1
"FOOD SUPPLEMENT",NA,8
"FOODOMICS",NA,1
"FORAGE GRASS",NA,1
"FORCE FIELDS",NA,1
"FORCED DEGRADATION",NA,5
"FORENSIC-RELATED, EA-IRMS, DI-IRMS, GC-IRMS IN FORENSIC GEOCHEMISTRY",NA,1
"FORENSIC-TYPE, USING MID-IR AND RAMAN SPECTROSCOPY",NA,1
"FORENSIC APPLICATIONS AND SORS",NA,1
"FORENSIC DIAGNOSTIC",NA,1
"FORENSIC GEOLOGY AND EXAMINATION OF SOILS",NA,1
"FORENSIC GEOLOGY AND EXAMINATION OF SOILS, USE IN INTELLIGENCE WORK",NA,1
"FORENSIC MICROANALYSIS",NA,1
"FORENSIC POLYMERS",NA,1
"FORENSIC SCIENCE EPISTEMOLOGY",NA,1
"FORENSIC SCIENCE FUNDAMENTALS",NA,1
"FORENSIC SCIENCE SUMMIT",NA,1
"FORENSIC SCIENCES AND MEDICAL TESTING",NA,1
"FORENSIC TOXICOLOGY AND CRIMINALISTICS ANALYTICAL METHODS",NA,1
"FORENSICS, FORENSIC APPLICATIONS OF IRMS",NA,1
"FOREST",NA,1
"FORMALIN TEST",NA,2
"FOURIER SPOTTING",NA,1
"FOURIER TRANSFORM INFRARED SPECTRUM",NA,1
"FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETRY (FTICR-MS)",NA,1
"FOURIER TRANSFORM MASS SPECTROMETRY",NA,1
"FOURIER TRANSFORM NEAR INFRARED SPECTROSCOPY",NA,1
"FOURIER TRANSFORM RAMAN SPECTRUM",NA,1
"FOURIER TRANSFORMATION",NA,1
"FR",NA,1
"FRACTIONAL DISTILLATION",NA,1
"FRACTIONATED THERMAL DESORPTION",NA,1
"FRACTURE MATCHING",NA,1
"FRAGMENT ISOTOPE COMPOSITION",NA,1
"FRAGMENT PATHWAY",NA,1
"FRAGMENTATION ANALYSIS",NA,1
"FRAGMENTATION MECHANISM",NA,2
"FRAGMENTATION MECHANISMS",NA,1
"FREE BASE",NA,1
"FREE ENERGY OF SOLVATION",NA,1
"FREE LIQUID MEMBRANES",NA,1
"FREEZING-LIPID FILTRATION",NA,1
"FREQUENTIST STATISTICS",NA,1
"FRESHWATER",NA,2
"FRONTIER MOLECULAR ORBITALS",NA,2
"FT-ICR-MS, FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETRY",NA,1
"FT-ICR MASS SPECTROMETRY",NA,2
"FT-IR/ATR SPECTROSCOPY, IN BENCHTOP, PORTABLE AND HANDHELD FT-IR UNITS",NA,1
"FT-RAMAN SPECTRA",NA,1
"FTIR IMAGING",NA,1
"FTIR IMAGING IN MICRO- AND MACRO-ATR MODES - DISTINGUISHING, GENUINE FROM COUNTERFEIT TABLETS",NA,1
"FTIR SPECTROMETER",NA,1
"FTIR SPECTROSCOPIC IMAGING APPLICATIONS - IN PHARMACEUTICAL SCIENCE, SPECTROSCOPIC IMAGING USING VIBRATIONAL SPECTROSCOPY DURING STUDY OF PHARMACEUTICAL SAMPLES",NA,1
"FTIR SPECTROSCOPIC IMAGING IN MID-IR REGION - POWERFUL TOOL IN PHARMACEUTICAL SCIENCE AND TECHNOLOGY, AND FTIR SPECTROSCOPY FOR STUDY OF DRUG POLYMORPHISM",NA,1
"FTIR/ATR",NA,1
"FUB-144",NA,1
"FUEL CHARACTERIZATION",NA,1
"FULL-FACTORIAL DESIGN",NA,1
"FULL CHARACTERIZATION",NA,1
"FULL SCAN ANALYSIS",NA,1
"FULLERENE",NA,3
"FUNCTIONAL",NA,1
"FUNCTIONAL FOOD",NA,3
"FUNCTIONAL GROUP ANALYSIS",NA,1
"FUNCTIONAL GROUPS PRESENT (OR ABSENT), PATTERN-MATCHED TO LIBRARY DATABASE",NA,1
"FUNCTIONAL POLYMERS",NA,1
"FUNCTIONAL PRINCIPAL COMPONENT ANALYSIS",NA,1
"FUNCTIONALIZATION",NA,2
"FUNCTIONALIZED CARBON NANOTUBE",NA,2
"FUNCTIONALIZED MULTIWALL CARBON NANOTUBES",NA,1
"FUNGAL BIOTRANSFORMATIONS",NA,1
"FUNGAL ENDOPHYTES",NA,1
"FUNGAL IDENTIFICATION",NA,1
"FUNKY GREEN STUFF",NA,1
"FUR SEAL GINSENG PILLS",NA,1
"FURYLIDENE-MELDRUM'S ACID",NA,1
"FUSED-RING SYSTEMS",NA,1
"FUTURE PROTEIN SUPPLY",NA,1
"G-HYDROXYBUTYRIC ACID (GHB)",NA,1
"GABAA",NA,1
"GABAB AGONIST",NA,1
"GALANTAMINE",NA,1
"GAMMA-AMINOBUTYRIC ACID ABUSE",NA,1
"GAMMA-BUTYLOLACTONE",NA,1
"GAMMA-HYDROXYBUTYRATE DEHYDROGENASE",NA,1
"GAMMA-IRRADIATION",NA,1
"GAMMA HYDROXY BUTYRATE",NA,1
"GAMMA IRRADIATION",NA,1
"GAMT",NA,1
"GAN",NA,1
"GAS-TO-LIQUID EXTRACTION",NA,1
"GAS CHROMATOGRAPHIC",NA,1
"GAS CHROMATOGRAPHIC-MASS SPECTROMETRY",NA,2
"GAS CHROMATOGRAPHY-COMBUSTION- ISOTOPE-RATIO MASS SPECTROMETRY",NA,1
"GAS CHROMATOGRAPHY-FLAME IONIZATION DETECTOR",NA,1
"GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS)",NA,1
"GAS CHROMATOGRAPHY–ELECTRON IONIZATION MASS SPECTROMETRY (GC–EI–MS)",NA,1
"GAS CHROMATOGRAPHY–FLAME IONIZATION DETECTION",NA,1
"GAS CHROMATOGRAPHY–FLAME IONIZATION DETECTION (GC-FID)",NA,1
"GAS CHROMATOGRAPHY–INFRARΒED",NA,1
"GAS CHROMATOGRAPHY–MASS SPECTROMETRY",NA,5
"GAS CHROMATOGRAPHY–MASS SPECTROMETRY (GC-MS)",NA,1
"GAS CHROMATOGRAPHY ( GC)",NA,1
"GAS CHROMATOGRAPHY DETERMINATION",NA,1
"GAS CHROMATOGRAPHY WITH FLAME IONIZATION DETECTOR",NA,1
"GAS CHROMATOGRAPHYÃ¢Â‚¬Â€Œ",NA,1
"GAS CHROMATOGRAPHYÃ¢Â‚¬Â€ŒFOURIER TRANSFORM INFRARED",NA,1
"GAS CHROMATOGRAPHYÃ¢Â‚¬Â€ŒINFRARÃŽÂ²ED",NA,1
"GAS CHROMATOGRAPHYÃ¢Â‚¬Â€ŒMASS SPECTROMETRY",NA,7
"GAS CHROMATOGRAPHYÃ¢Â‚¬Â€ŒMASS SPECTROMETRY (GCÃ¢Â‚¬Â€ŒMS)",NA,2
"GAS/VAPOR DETECTION",NA,1
"GASCHROMATOGRAPHY",NA,1
"GASTRIC CONDITIONS",NA,1
"GASTRORETENTIVE DRUG DELIVERY SYSTEM",NA,1
"GAUIFENESIN",NA,1
"GAUSSIAN PEAK FUNCTION",NA,1
"GBL, ANALOGS",NA,1
"GC-ECD",NA,1
"GC-HS-FID",NA,1
"GC-IRMS, SEPARATION OF COMPLEX ORGANIC MIXTURES ON CAPILLARY GC",NA,1
"GC-MS DETECTION",NA,1
"GC-MS IT",NA,1
"GC-MSN",NA,1
"GC-PICI-ID-MS",NA,1
"GC-QQQMS",NA,1
"GC-TOF-MS",NA,1
"GC–CI-MS",NA,1
"GC–EI-MS",NA,1
"GC–IR",NA,1
"GC–MS",NA,15
"GC–MS/MS",NA,2
"GC × GC-TOFMS",NA,1
"GC √Ó GC",NA,1
"GC ÃƑÂ€” GC",NA,2
"GC ÃƑÂ€” GC-MS",NA,1
"GC ÃƑÆ’Ã‚Â€” GC",NA,1
"GC DEACTIVATED LINER",NA,1
"GC/FT-IR/MS",NA,1
"GC_GC",NA,1
"GCÃ¢Â‚¬Â€ŒCI-MS",NA,1
"GCÃ¢Â‚¬Â€ŒEI-MS",NA,1
"GCÃ¢Â‚¬Â€ŒEI/MS/MS",NA,1
"GCÃ¢Â‚¬Â€ŒIR",NA,1
"GCÃ¢Â‚¬Â€ŒMS",NA,16
"GCÃ¢Â‚¬Â€ŒMS-MS",NA,2
"GCÃ¢Â‚¬Â€ŒMS WITH COLD EI",NA,1
"GCÃ¢Â‚¬Â€ŒMSÃ¢Â‚¬Â€ŒMS",NA,1
"GCÃ¢Â‚¬Â€ŒTMS",NA,1
"GCÃƑÂ€”GC",NA,1
"GEL PERMEATION CHROMATOGRAPHY (GPC)",NA,1
"GENE BANK",NA,1
"GENE CHARACTERIZATION",NA,1
"GENE IDENTIFICATION",NA,1
"GENE ONTOLOGY",NA,1
"GENE REGULATION",NA,1
"GENE SEQUENCING",NA,1
"GENE TRANSCRIPT",NA,1
"GENE TRANSFORMATION",NA,1
"GENERAL METHOD",NA,1
"GENERAL POPULATION SURVEYS",NA,1
"GENERALIST",NA,1
"GENERIC ANALYTICAL PROCEDURE",NA,1
"GENERIC PRODUCT",NA,1
"GENERICS",NA,2
"GENETIC ARCHITECTURE",NA,1
"GENETIC ASSAY",NA,1
"GENETIC CONSERVATION",NA,1
"GENETIC IDENTIFICATION",NA,1
"GENETIC MAP",NA,1
"GENETIC RELATEDNESS",NA,1
"GENETIC RESOURCES",NA,1
"GENETIC TRANSFORMATION",NA,1
"GENETIC VARIABILITY",NA,2
"GENEVAC",NA,1
"GENOME-WIDE SPLICING",NA,1
"GENOME ASSEMBLIES",NA,1
"GENOME ASSEMBLY",NA,1
"GENOME EDITING",NA,1
"GENOME ORGANIZATION",NA,1
"GENOME SEQUENCING",NA,1
"GENOMIC RESOURCES",NA,1
"GENOMIC SSRS",NA,1
"GENOTOXIC IMPURITY",NA,3
"GENOTYPE DIVERSITY",NA,1
"GENOTYPES X ENVIRONMENT INTERACTION",NA,1
"GENUINE DRUG VARIABILITY",NA,1
"GENUINE US",NA,1
"GENUS ANADENANTHERA",NA,1
"GENUS PAPAVER",NA,1
"GEOCHEMICAL FINGERPRINTING",NA,1
"GEOGRAPHIC CLASSIFICATION",NA,1
"GEOGRAPHIC ORIGIN DISTINCTION",NA,1
"GEOGRAPHICAL DRUG MONITORING",NA,1
"GEOGRAPHICAL ORIGIN",NA,2
"GEOGRAPHY",NA,1
"GEOLOGY",NA,1
"GEOLOGY AND GEOMORPHOLOGY",NA,1
"GEOMETRIC ISOMERS",NA,1
"GEOMETRIC MORPHOMETRICS",NA,1
"GEOMETRICAL PARAMETERS",NA,1
"GEOSOURCING",NA,1
"GERMAN SITUATION",NA,2
"GERMINATION",NA,2
"GERMINATION TEST",NA,1
"GERMPLASM",NA,1
"GHB ACIDURIA DEFICIENCY IN SUCCINIC SEMIALDEHYDE DEHYDROGENASE",NA,1
"GHB DETECTION",NA,1
"GHB FREE ACID",NA,2
"GHB INTERPRETATION ISSUES AND POST-MORTEM PRODUCTION",NA,1
"GHOST PEAKS",NA,1
"GHRH",NA,1
"GHRP-2 ANALOG",NA,1
"GIAO",NA,1
"GIBBERELLIC ACID",NA,1
"GIBBS REACTION",NA,1
"GINSENOSIDE RG1",NA,1
"GLACIAL LANDFORM",NA,1
"GLASGOW",NA,1
"GLASS ANALYSIS",NA,1
"GLASS EVALUATION",NA,1
"GLASS TUBES",NA,1
"GLC",NA,1
"GLIADINS",NA,1
"GLOBAL DRUG TRENDS",NA,1
"GLOBAL POSITIONING",NA,1
"GLOBAL SOUTH COUNTRIES",NA,1
"GLOBAL TRENDS",NA,1
"GLOBALIZATION",NA,3
"GLOVE BASED-SENSOR",NA,1
"GLOW PARTIES",NA,1
"GLP",NA,1
"GLUTAMATE",NA,1
"GLUTATHIONE DETOXIFICATION",NA,1
"GLUTATHIONE REDUCTASE GENE",NA,1
"GLUTEN",NA,1
"GLYCEROL",NA,1
"GLYCOPEPTIDE",NA,1
"GLYCOSIDASES",NA,1
"GLYCOSIDE DERIVATIVES",NA,1
"GLYCOSIDE OF PEGANINE",NA,1
"GLYCYRRHETINIC ACID",NA,1
"GLYCYRRHIZIC ACID",NA,2
"GOLD AND SILVER NANOPARTICLES",NA,1
"GOLD BROMIDE",NA,1
"GOLD ELECTRODE",NA,2
"GOLD NANOCLUSTERS",NA,1
"GOOGLE",NA,1
"GPCR",NA,1
"GRADIENT CHROMATOGRAPHY",NA,1
"GRADIENT HPLC",NA,1
"GRADIENT RP HPLC",NA,1
"GRADIENT SCREENING",NA,1
"GRAPE VARIETY",NA,1
"GRAPH-SET DESCRIPTION",NA,1
"GRAPHENE NANORIBBON",NA,1
"GRAPHENE NANOSHEETS-CU COMPOSITE",NA,1
"GRAPHENE OXIDE NANOCOMPOSITE",NA,1
"GRAPHENE QUANTUM DOT",NA,1
"GRAPHENE QUANTUM DOTS",NA,3
"GRAPHENE/CO3O4 NANOCOMPOSITE",NA,1
"GRAPHICAL MODELS",NA,2
"GRAPHITE SCREEN PRINTED ELECTRODE",NA,4
"GRAPHITIZED CARBONS",NA,1
"GRAVEL",NA,1
"GRAY DEATHS",NA,1
"GREEN",NA,1
"GREEN-SYNTHESIS",NA,1
"GREEN LEAF VOLATILE",NA,1
"GREEN METHOD",NA,1
"GREEN SOLVENT",NA,1
"GREEN SOURCE CARBON DOT",NA,1
"GRID SEARCH",NA,1
"GRIESS ASSAY",NA,1
"GRIGNARD REACTION",NA,1
"GRIGNARD REAGENTS",NA,1
"GRIVILLOSIDE H",NA,1
"GROUND WATER",NA,1
"GROUP-BASED TRAJECTORY MODEL",NA,1
"GROW-KITS",NA,1
"GROWTH HORMONE RELEASING PEPTIDES",NA,1
"GROWTH PROMOTING AGENTS",NA,1
"GROWTH SETTING",NA,1
"GS-FLX PYROSEQUENCING TECHNOLOGY",NA,1
"GSSRS",NA,1
"GUAIACOL",NA,1
"GUAIPHENESIN",NA,1
"GUANIDINE-HCL",NA,1
"GUANIDINOACETATE",NA,1
"GUAR GUM",NA,1
"GUNSHOT ENTRY",NA,1
"GUSTATORY SENSATION TEST",NA,1
"GY",NA,1
"GYMNOSPERM",NA,1
"H-SHAPE STRUCTURE",NA,1
"HABITAT",NA,1
"HABITUATION",NA,1
"HACCP",NA,1
"HAIR-GROWTH",NA,1
"HAIRPIN STRUCTURE",NA,1
"HAIRY ROOT",NA,2
"HAIRY ROOT CULTURE",NA,2
"HALLUCENOGIC",NA,1
"HALLUCINOGENIC AND BLUEING SPECIES",NA,1
"HALLUCINOGENIC CACTACEAE",NA,1
"HALLUCINOGENIC COMPOUNDS",NA,1
"HALLUCINOGENIC DRUGS",NA,2
"HALLUCINOGENIC EFFECTS",NA,1
"HALLUCINOGENIC FUNGI",NA,3
"HALLUCINOGENIC HERB",NA,1
"HALLUCINOGENIC PHENETHYLAMINES",NA,1
"HALLUCINOGENIC SAGE",NA,1
"HALLUCINOGENIC/DISSOCIATIVE DRUGS",NA,1
"HALOPERIDOL/STABILITY/COMPATIBILITY",NA,1
"HALOPHYTE",NA,1
"HAND-HELD INSTRUMENTATION",NA,1
"HANDHELD SENSOR",NA,1
"HANDHELD SERS",NA,1
"HANDHELD SPECTROMETER",NA,1
"HAPLOID INDUCTION",NA,1
"HAPLOID PRODUCTION",NA,1
"HAPLOTYPE NETWORK",NA,1
"HAPPY CAPSÃ‚Â®",NA,1
"HARD-CAP ESPRESSO EXTRACTION",NA,1
"HARTREE-FOCK,METHYLPHENIDATE",NA,1
"HARTREE-FOCK/6-31G*",NA,1
"HARVESTER",NA,1
"HASHISH SOURCE IDENTIFICATION",NA,1
"HAZARD QUOTIENT",NA,2
"HAZARD QUOTIENTS",NA,1
"HAZARDOUS CHEMICAL DETECTION",NA,1
"HAZARDOUS HERBS",NA,1
"HAZARDOUS WASTE",NA,1
"HEADSPACE-GAS-CHROMATOGRAPHY-MASS-SPECTROMETRY",NA,1
"HEADSPACE COLLECTION",NA,1
"HEADSPACE SINGLE-DROP MICROEXTRACTION (HS-SDME)",NA,1
"HEALERS",NA,1
"HEALTH ATTRIBUTES",NA,1
"HEALTH AWARENESS",NA,1
"HEALTH CARE PRODUCTS",NA,1
"HEALTH CARE PROVIDER",NA,1
"HEALTH FOCUS: SOCIAL HEALTH",NA,1
"HEALTH FOOD",NA,5
"HEALTH FOOD PRODUCTS",NA,1
"HEALTH IMPACT",NA,1
"HEALTH IMPACTS",NA,1
"HEALTH PRODUCT",NA,1
"HEALTH PRODUCTS",NA,1
"HEALTH SUPPLEMENTS",NA,1
"HEALTHCARE PRODUCTS",NA,1
"HEAT AND ACID TOLERANCE",NA,1
"HEAT TREATMENT",NA,1
"HEATED INTERFACE",NA,1
"HEATED VAPOUR INHALATION",NA,1
"HEATS OF FORMATION",NA,1
"HEBBIAN LEARNING",NA,1
"HECK ARYLATION",NA,1
"HECK REACTION",NA,3
"HEDONIC MODELS",NA,1
"HELMAND",NA,1
"HEMIACETAL",NA,1
"HEMP (CANNABIS SATIVA L)",NA,1
"HEMP (CANNABIS SATIVA L.)",NA,3
"HEMP BIOMASS",NA,1
"HEMP CAKE OIL",NA,1
"HEMP DISEASES",NA,1
"HEMP GRINDING",NA,1
"HEMP PROCESSING",NA,1
"HEMP SEED",NA,3
"HEMPLC-MSLC-PDALIQUID CHROMATOGRAPHY (LC)MARIJUANA",NA,1
"HEN EGG",NA,1
"HEPTACYCLIC REARRANGEMENT",NA,1
"HEPTAFLUORO-1-BUTANOL (HFB)",NA,1
"HEPTAFLUOROBUTYRIC ANHYDRIDE",NA,1
"HER MAJESTY PRISON SERVICE",NA,1
"HERBA EPHEDRAE",NA,1
"HERBACETIN",NA,1
"HERBAL-BASED FORMULATIONS",NA,1
"HERBAL COSMETICS",NA,1
"HERBAL DIETARY SUPPLEMENT",NA,1
"HERBAL DISCRIMINATION",NA,1
"HERBAL EXTRACT",NA,1
"HERBAL FORMULATIONS",NA,1
"HERBAL INCENSES",NA,1
"HERBAL MARIJUANA ALTERNATIVE",NA,1
"HERBAL PHARMACEUTICAL",NA,1
"HERBAL SCENT",NA,1
"HERBAL SLIMMING FORMULATIONS",NA,1
"HERBAL SLIMMING PILLS",NA,1
"HERBAL SLIMMING SUPPLEMENTS",NA,1
"HERBAL SPICE",NA,1
"HERBAL SUBSTRATES",NA,1
"HERBAL SUPPLEMENTS",NA,1
"HERBAL TEAS",NA,1
"HERBAL WEIGHT LOSS DRUGS",NA,1
"HERION",NA,1
"HEROIN ANALYSIS",NA,1
"HEROIN DISTRIBUTION",NA,1
"HEROIN ECONOMICS",NA,1
"HEROIN SHORTAGE",NA,1
"HEROIN SIGNATURE ANALYSIS",NA,1
"HEROIN SUPPLY",NA,1
"HEROIN SYNTHESIS",NA,1
"HETERO-DIELS-ALDER CYCLOADDITION",NA,1
"HETEROCYCLE SYNTHESIS",NA,1
"HETEROGENEOUS CATALYSIS",NA,1
"HETEROGENEOUS FORMAT",NA,1
"HETEROGENEOUS MIXTURES",NA,1
"HETEROGENEOUS PHOTOCATALYSIS",NA,1
"HETEROLOGOUS ENZYME LINKED IMMUNOSORBENT ASSAY",NA,1
"HEURISTIC METHOD",NA,1
"HEXAMETHYLDISILAZANE",NA,1
"HEXEDRONE",NA,1
"HEXOBARBITONE",NA,1
"HF MEMBRANES",NA,1
"HIBISCUS CANNABINUS L.",NA,1
"HIDDEN MARKOV MODEL",NA,1
"HIDDEN WEB",NA,3
"HIERARCHICAL CLASSIFICATION ANALYSIS",NA,1
"HIERARCHICAL CLUSTER ANALYSIS (HCA)",NA,1
"HIERARCHICAL CLUSTER ANALYSIS OF GENUINE AND QUESTIONABLE CIALIS TABLETS",NA,1
"HIERARCHICAL CLUSTERING ANALYSIS (HCA)",NA,2
"HIERARCHICAL SCREENING",NA,1
"HIF",NA,1
"HIGH-PERFORMANCE LIQUID AND SUPERCRITICAL FLUID CHROMATOGRAPHY",NA,1
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-DIODE ARRAY DETECTION (HPLC-DAD)",NA,1
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY—ELECTROSPRAY IONIZATION—QUADRUPOLE-TIME-OF-FLIGHT-MASS SPECTROMETRY (HPLC–ESI–QTOF/MS)",NA,1
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AND SURFACE-ENHANCED RAMAN SCATTERING",NA,1
"HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH AN ULTRAVIOLET DETECTOR",NA,1
"HIGH-PRECISION QUANTIFICATION",NA,1
"HIGH-PROTEIN PLANTS",NA,1
"HIGH-PURITY METHAMPHETAMINE",NA,1
"HIGH-RESOLUTION SATELLITE IMAGE",NA,1
"HIGH-TEMPERATURE LIQUID CHROMATOGRAPHY",NA,1
"HIGH-THROUGHPUT NMR",NA,1
"HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS",NA,1
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS",NA,1
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-HYBRID ION TRAP/TIME-OF-FLIGHT MASS SPECTROMETRY",NA,1
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHY /METHOD VALIDATION",NA,1
"HIGH PERFORMANCE LIQUID CHROMATOGRAPHYION TRAP MASS SPECTROMETRY (HPLC-IT MS)",NA,1
"HIGH POTENCY",NA,2
"HIGH PRESSURE",NA,1
"HIGH RESOLUTION LIQUID CHROMATOGRAPHY",NA,1
"HIGH RESOLUTION MELT",NA,1
"HIGH RESOLUTION TANDEM MASS SPECTROMETRY",NA,1
"HIGH SCHOOL BASKETBALL",NA,1
"HIGH SCHOOL/INTRODUCTORY CHEMISTRY",NA,4
"HIGH SENSITIVITY",NA,1
"HIGH SPECIFIC ACTIVITY",NA,1
"HIGH SPEED LIQUID CHROMATOGRAPHY",NA,1
"HIGH TEMPERATURE HPLC",NA,1
"HIGH TEMPERATURE LIQUID CHROMATOGRAPHY",NA,1
"HIGH THROUGHPUT DRUG DISCOVERY APPLICATION",NA,1
"HIGHER-ENERGY COLLISIONAL DISSOCIATION",NA,1
"HIGHLY-CUT",NA,1
"HIGHLY SULFATED-Œ≥-CYCLODEXTRIN",NA,1
"HIGHLY SULFATED-Œ≥-CYCLODEXTRIN (HS-Œ≥-CD)",NA,1
"HIGHLY SULFATED ÃŽÂ³-CYCLODEXTRIN",NA,1
"HIGHLY SULFATED CYCLODEXTRINS",NA,1
"HILIC-MS/MS",NA,1
"HILIC COLUMN",NA,2
"HILIC/DAD",NA,1
"HISTORY OF ILLICIT USE OF GHB",NA,1
"HISTORY OF PHARMACY",NA,1
"HIV DIAGNOSES",NA,1
"HIV/AIDS",NA,1
"HN(COCA)NH",NA,1
"HNHA",NA,1
"HOLLOW-FIBER-PROTECTED 2-PHASE MICROEXTRACTION [HF(2)ME]",NA,1
"HOLLOW FIBER-PROTECTED 3-PHASE MICROEXTRACTION [HF(3)ME]",NA,1
"HOLLOW FIBER SOLID/ LIQUID PHASE MICROEXTRACTION",NA,1
"HOLLOW FIBERS",NA,2
"HOLOGRAPHIC SENSOR",NA,1
"HOME CULTIVATION",NA,1
"HOME PAGES",NA,1
"HOMEMADE DRUGS",NA,1
"HOMEOPATHIC PRODUCTS",NA,1
"HOMEOTIC GENES",NA,1
"HOMOGENEOUS",NA,1
"HOMOGENEOUS CATALYSIS",NA,1
"HOMOGENEOUS FORMAT",NA,1
"HOMOGENEOUS LIQUIDÃ¢Â‚¬Â€ŒLIQUID MICROEXTRACTION",NA,1
"HOMOGENEOUS LIQUIDÃ¢Â‚¬Â€ŒPHASE MICROEXTRACTION",NA,1
"HOMOLOG",NA,2
"HOMOLOGOUS SERIES",NA,1
"HOMOLOGUES",NA,1
"HOMOPIPERONYLAMINE",NA,1
"HONEY",NA,5
"HONOKIOL",NA,1
"HOOKAH",NA,1
"HOPS",NA,1
"HORDENINE",NA,1
"HORMONE RESIDUES",NA,1
"HORSE DISPOSAL",NA,1
"HOSPITAL EFFLUENT",NA,1
"HOSPITAL WASTEWATER",NA,1
"HOST-GUEST CHEMISTRY",NA,1
"HOST-GUEST COMPLEX",NA,1
"HOST-GUEST SYSTEMS",NA,1
"HOST−GUEST CHEMISTRY",NA,1
"HOSTÃ¢Â‚¬Â€ŒGUEST RECOGNITION",NA,1
"HOT-PLATE TEST",NA,1
"HOT-SPOTS",NA,1
"HOT MELT GRANULATION",NA,1
"HOT POT SOUP BASE",NA,1
"HOT WATER EXTRACTION",NA,1
"HOUSE",NA,1
"HOUSE DUST",NA,1
"HOUTTUYNIA CORDATA THUNB.",NA,1
"HPCE",NA,1
"HPLC-CHEMOMETRIC CALIBRATION",NA,1
"HPLC-DAD FINGERPRINT",NA,1
"HPLC-DAD METHOD",NA,1
"HPLC-ESI/MS/MS QUANTITATION",NA,1
"HPLC-FLD",NA,2
"HPLC-FLD-DAD",NA,1
"HPLC-FLUORESCENCE",NA,1
"HPLC-FLUORESCENCE DETECTION",NA,1
"HPLC-IR",NA,1
"HPLC-MS/MS ANALYSES",NA,1
"HPLC-Q-EXACTIVE-ORBITRAP-MS",NA,1
"HPLC-QQQ/MS/MS",NA,1
"HPLC-TOF/MS",NA,1
"HPLC-UV-SPE-NMR",NA,1
"HPLC–MS/MS",NA,2
"HPLC AND VALIDATION",NA,1
"HPLC FINGERPRINT",NA,1
"HPLC METHOD",NA,1
"HPLC ON CHIRAL STATIONARY PHASES",NA,1
"HPLC/UVÃ¢Â‚¬Â€ŒVIS SYSTEM",NA,1
"HPLCÃ¢Â‚¬Â€ŒDAD",NA,1
"HPTLC-ALIIVIBRIO FISCHERI ASSAY-ESIÃ¢Â‚¬Â€ŒMS",NA,1
"HPTLC-DENSITOMETRY",NA,1
"HRM",NA,1
"HRMS/MS",NA,2
"HS",NA,1
"HS-GC",NA,1
"HS-SPME-GC ÃƑÆ’Ã‚Â€” GC-QMS",NA,1
"HS-SPME/GC-MS",NA,1
"HS-SPME/GCÃ¢Â‚¬Â€ŒMS",NA,1
"HT-UPLC",NA,1
"HTLC",NA,2
"HUE",NA,1
"HUMAN ABUSE POTENTIAL",NA,4
"HUMAN CHORIONIC GONADOTROPIN",NA,1
"HUMAN ENHANCEMENT DRUGS",NA,1
"HUMAN HEALTH RISK CHARACTERIZATION",NA,1
"HUMAN PHARMACEUTICALS",NA,1
"HUMAN PLASMA AND SERUM SAMPLES",NA,1
"HUMAN RISK ASSESSMENT",NA,1
"HUMAN SERUM AND PHARMACEUTICAL FORMULATION SAMPLES",NA,1
"HUMAN SUBJECTS RESEARCH",NA,1
"HUMAN TEARS",NA,1
"HUMANITARIAN DE-MINING",NA,1
"HUMIC",NA,1
"HUMULUS LUPULUS",NA,1
"HYBRID",NA,2
"HYBRID MATERIALS",NA,1
"HYBRID NANOMATERIALS",NA,1
"HYBRIDIZATION-BASED TARGETED SEQUENCE CAPTURE",NA,1
"HYBRIDS",NA,1
"HYDRASTIS CANADENSIS",NA,1
"HYDRATE",NA,1
"HYDRAZINE",NA,1
"HYDRAZONE",NA,1
"HYDRIDE STATIONARY PHASES",NA,1
"HYDRIODIC ACID/RED PHOSPHORUS",NA,1
"HYDROAMINATION",NA,1
"HYDROCARBON ANALYSIS",NA,1
"HYDROGEN BOND",NA,1
"HYDROGEN BONDING",NA,2
"HYDROGEN CHLORIDE",NA,1
"HYDROGEN ISOTOPE RATIO",NA,1
"HYDROGENOLYSIS",NA,1
"HYDROLOGIC UNITS",NA,1
"HYDROLYSED",NA,1
"HYDROLYTIC KINETIC RESOLUTION",NA,1
"HYDROMORPHONE HYDROCHLORIDE",NA,2
"HYDROMORPHONE SYNTHESIS",NA,1
"HYDROMORPHONE,HYDROGEN BONDING",NA,1
"HYDROPHILIC INTERACTION CHROMATOGRAPHY",NA,2
"HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHY (HILIC)",NA,7
"HYDROPHOBIC DEEP EUTECTIC SOLVENT",NA,1
"HYDROPHOBIC GOLD NANOCLUSTERS",NA,1
"HYDROPHOBIC INTERACTION",NA,1
"HYDROPHOBICITY",NA,1
"HYDROPONIC CULTIVATION",NA,1
"HYDROTHERMAL",NA,1
"HYDROTHERMAL LIQUEFACTION",NA,1
"HYDROXY ACIDS",NA,1
"HYDROXYBENZOATES",NA,1
"HYDROXYCHLOROQUINE",NA,1
"HYDROXYHYDURILATE ANION",NA,1
"HYDROXYLAMINE",NA,1
"HYDROXYLAMINE (HA) DERIVATIZATION",NA,1
"HYDROXYPROPYL-ÃƑÅ½Ã‚Â²-CYCLODEXTRIN",NA,1
"HYDROXYPROPYL-ÃƑÆ’Ã‚Â¢-CYCLODEXTRIN",NA,1
"HYDROXYPROPYL-Œ≤-CYCLODEXTRIN",NA,1
"HYDROXYPROPYL METHYL CELLULOSE",NA,1
"HYDROXYPROPYLCELLULOSE",NA,1
"HYDROXYTROPANE",NA,1
"HYDROXYZINE HYDROCHLORIDE",NA,1
"HYOSCYAMINE",NA,3
"HYOSCYAMINE AND SCOPOLAMINE",NA,1
"HYOSCYAMINE SULFATE",NA,1
"HYOSCYAMUS ALBUS",NA,1
"HYOSCYAMUS NIGER",NA,1
"HYPACONITINE",NA,1
"HYPERACCUMULATOR",NA,1
"HYPERBRANCHED POLYMERS",NA,1
"HYPERICACEAE (GUTTIFERAE)",NA,1
"HYPERICUM PERFORATUM",NA,2
"HYPERPOLARISATION",NA,1
"HYPERSPECTRAL",NA,2
"HYPERSPECTRAL DATA",NA,1
"HYPERSPECTRAL IMAGE",NA,1
"HYPERSPECTRAL IMAGE ANALYSIS",NA,1
"HYPERSPECTRAL INFORMATION",NA,1
"HYPERSPECTRAL UNMIXING",NA,1
"HYPHENATED SEM-EDX/RAMAN SPECTROMETER SYSTEMS",NA,1
"HYPNOTIC",NA,2
"HYPNOTIC DRUG",NA,1
"HYPO METHOD",NA,1
"HYPROMELLOSE",NA,1
"HYPROMELLOSE ACETATE SUCCINATE",NA,1
"I/P (NAGAI, MOSCOW, OR HYPO) METHOD",NA,1
"IBOGAMINE",NA,1
"IBUPROFEN ESTER",NA,1
"IC, AN ANALYTICAL PROBLEM SOLVING TOOL",NA,1
"IC, IN FORENSIC INVESTIGATIONS",NA,1
"ICE METHAMPHETAMINE",NA,1
"ICELISA",NA,1
"ICH",NA,1
"ICH-GUIDELINE",NA,1
"ICH GUIDELINES",NA,1
"ICH Q3",NA,1
"ICP",NA,1
"ICS",NA,1
"ICTSS",NA,1
"IDENTIFICATION AND CHARACTERIZATION",NA,1
"IDENTIFICATION DATABASES",NA,1
"IDENTIFICATION FROM DIFFERENT ROUTE",NA,1
"IDENTIFICATION OF DRUGS",NA,1
"IDENTIFICATION OF EXPLOSIVES AND DRUGS",NA,1
"IDENTIFIER",NA,1
"IDENTIFYING TABLETS WITH CHARACTERISTICS DIFFERENT FROM THE GENUINE",NA,1
"IDIOSYNCRATIC",NA,1
"IGS (INTERGENIC SPACER)",NA,1
"IKBI",NA,1
"ILEX SPECIES",NA,1
"ILLEGAL ADDITION",NA,1
"ILLEGAL ADDITIVES",NA,2
"ILLEGAL ADULTERANT",NA,3
"ILLEGAL ADULTERATION",NA,3
"ILLEGAL COCAINE PRODUCTION",NA,1
"ILLEGAL COMPOUND",NA,1
"ILLEGAL DIETARY SUPPLEMENT",NA,1
"ILLEGAL DRUGS PRECURSORS",NA,1
"ILLEGAL E-COMMERCE",NA,1
"ILLEGAL FOOD SUPPLEMENTS",NA,1
"ILLEGAL HERBAL PRODUCTS",NA,1
"ILLEGAL LABORATORIES",NA,1
"ILLEGAL MARKET",NA,3
"ILLEGAL MEDICINES",NA,1
"ILLEGAL PRODUCTION",NA,1
"ILLEGALLY ADDED DRUGS",NA,1
"ILLEGALLY ADULTERATED",NA,1
"ILLEGALLY MANUFACTURED DRUGS",NA,1
"ILLICIT ADDITIVE",NA,1
"ILLICIT COCAINE HYDROCHLORIDE",NA,1
"ILLICIT DRUG ABUSE, GLOBAL PROBLEM WITH NO SOCIETY BEING IMMUNE-MEASURED CONCENTRATIONS (NG/L) OF DRUGS AND THEIR METABOLITES DURING REGULAR CLASS SESSIONS (2008)",NA,1
"ILLICIT DRUG CONSUMPTION IN SMALL POPULATIONS-NONINVASIVE DRUG TESTING OF STUDENT POPULATIONS",NA,1
"ILLICIT DRUG DERIVATIVES",NA,1
"ILLICIT DRUG HISTORY",NA,1
"ILLICIT DRUG LAWS",NA,1
"ILLICIT DRUG POLICY",NA,1
"ILLICIT DRUG PRECURSORS",NA,1
"ILLICIT DRUG PRODUCTION",NA,1
"ILLICIT DRUGS AND METABOLITES",NA,1
"ILLICIT DRUGS IDENTIFICATION",NA,1
"ILLICIT DRUGS OF ABUSE",NA,2
"ILLICIT DRUGS PRECURSOR",NA,1
"ILLICIT DRUGS SEIZURE",NA,1
"ILLICIT ERECTILE DYSFUNCTION PRODUCTS",NA,1
"ILLICIT ERECTILE MEDICATION",NA,1
"ILLICIT FENTANYL",NA,1
"ILLICIT FENTANYLS",NA,1
"ILLICIT GROWING",NA,1
"ILLICIT MARKET",NA,2
"ILLICIT MATERIALS",NA,1
"ILLICIT ONLINE PHARMACIES",NA,1
"ILLICIT PRODUCT",NA,1
"ILLICIT PRODUCTS",NA,1
"ILLICIT SUBSTANCE",NA,1
"ILLICIT SUBSTANCE DETECTION IN POSTAL ENVELOPES",NA,1
"ILLICIT SYNTHETIC OPIOIDS",NA,1
"ILLICIT TRADE",NA,1
"ILLICIT USE OF GBL AND 1,4BD",NA,1
"ILLUMINA SEQUENCING",NA,1
"IMAGING METHODS",NA,1
"IMAGING SPECTROSCOPY",NA,1
"IMARI PORCELAIN",NA,1
"IMIDAZOPYRIDINES",NA,1
"IMINE REDUCTION",NA,1
"IMINIUM ION",NA,1
"IMIPRAMINE HCL",NA,1
"IMITATIONS",NA,1
"IMMEDIATE-RELEASE",NA,1
"IMMEDIATE RELEASE DOSAGE FORMS",NA,1
"IMMOBILIZATION",NA,2
"IMMOBILIZED POLYSACCHARIDEBASED CHIRAL STATIONARY PHASES",NA,1
"IMMUNOAFFINITY COLUMN (IAC)",NA,2
"IMMUNOCHROMATOGRAPHIC ASSAY",NA,2
"IMMUNOCHROMATOGRAPHIC SENSOR",NA,1
"IMMUNOCHROMATOGRAPHIC STRIP",NA,1
"IMMUNOLOGICAL DIAGNOSTICS",NA,1
"IMMUNOSUPPRESSANT DRUGS",NA,1
"IMMUNOSUPPRESSIVE",NA,1
"IMPEDANCE SPECTROSCOPY",NA,1
"IMPROVED DETECTION",NA,1
"IMPURITIES OF RELATED STRUCTURE",NA,1
"IMPURITY CONTROL",NA,1
"IMPURITY DETECTION",NA,1
"IMPURITY DETERMINATION",NA,2
"IMPURITY PROFILE METHOD",NA,1
"IMPURITY QUALIFICATION",NA,1
"IMS ANALYSIS",NA,1
"IMS/MS",NA,1
"IN-CAPILLARY DERIVATIZATION",NA,1
"IN-FLASH HEATER DERIVATIZATION",NA,1
"IN-LINE FT-IR",NA,1
"IN-LINE OR ON-LINE PRECONCENTRATION",NA,1
"IN-PROCESS CONTROL",NA,1
"IN-PRODUCT IDENTIFICATION",NA,1
"IN-SEM RAMAN SYSTEMS",NA,1
"IN-SILICO PREDICTION MODEL",NA,1
"IN SEIZED PLANT MATERIAL",NA,1
"IN SILICO",NA,1
"IN SILICO MODELING",NA,1
"IN SILICO PREDICTIONS",NA,1
"IN SITU",NA,2
"IN SITU ION TRAP",NA,1
"IN VITRO ASSAYS",NA,1
"IN VITRO CULTURE",NA,1
"IN VITRO DISSOLUTION PROFILE",NA,1
"IN VITRO DRUG METABOLISM",NA,1
"IN VITRO IN VIVO CORRELATION",NA,1
"IN VIVO",NA,1
"IN VIVO AND INÃ‚Â VITRO METABOLISM",NA,1
"INCENSE",NA,1
"INCLUSION",NA,1
"INCLUSION CHROMATOGRAPHY",NA,1
"INCLUSION COMPLEX",NA,2
"INCLUSION LIST",NA,1
"INCLUSION STRUCTURE",NA,1
"INCREASING SELECTIVITY AND RESOLUTION",NA,1
"INDAZOLE-3-CARBOXAMIDES",NA,2
"INDAZOLE SYNTHETIC CANNABINOID",NA,1
"INDEPENDENT COMPONENT ANALYSIS",NA,1
"INDETERMINISM IN CAUSATIONS",NA,1
"INDIAN OPIUM",NA,1
"INDICATOR DISPLACEMENT ASSAY",NA,1
"INDIGENOUS",NA,1
"INDIGO CARMINE",NA,1
"INDIRECT COMPETITIVE ENZYME LINKED IMMUNOSORBENT ASSAY",NA,1
"INDIRECT DETECTION",NA,1
"INDIRECT DETECTION, ANTIBODY OR APTAMER IN INDIRECTLY DETECTING DRUGS",NA,1
"INDIRECT SAMPLING",NA,1
"INDIUM",NA,1
"INDIVIDUAL GENOTYPING",NA,1
"INDIVIDUALIZATION BY PHYSICAL MATCHING",NA,1
"INDIVIDUALIZATION OF SEIZED MARIJUANA",NA,1
"INDOCYBIN",NA,1
"INDOLE-3-CARBOXYLIC ACID",NA,1
"INDOLE ALKALOID",NA,6
"INDOLE POLYMERISATION",NA,1
"INDOLEALKYLAMINE",NA,2
"INDOOR AIR",NA,1
"INDOOR PLANTATION",NA,1
"INDOOR POLLUTION",NA,2
"INDOOR SWIMMING POOLS",NA,1
"INDUCED ABSORPTION",NA,1
"INDUCTIVELY COUPLED PLASMA-MASS SPECTROMETRY (ICP-MS)",NA,1
"INDUCTIVELY COUPLED PLASMA–MASS SPECTROSCOPY",NA,1
"INDUCTIVELY COUPLED PLASMA SECTOR FIELD MASS SPECTROMETRY",NA,1
"INDUCTIVELY COUPLED PLASMA TIME-OF-FLIGHT MASS SPECTROMETRY",NA,1
"INDUSTRIAL CHEMICALS",NA,1
"INDUSTRIAL HEMP",NA,3
"INDUSTRIAL USES",NA,1
"INDUSTRIALS",NA,1
"INDUSTRY SELF-REGULATION",NA,1
"INEPT",NA,1
"INFERENCE",NA,1
"INFLAMMABLE ORGANIC SOLVENT GAS",NA,1
"INFLUENCE OF DILUENTS",NA,1
"INFORMATION-RICH VIBRATIONAL SPECTRA",NA,1
"INFORMATION SEEKING BEHAVIOR",NA,1
"INFRA-RED DRYING METHOD",NA,1
"INFRARED (IR)",NA,1
"INFRARED ANALYSIS",NA,1
"INFRARED AND RAMAN SAMPLING TECHNIQUES, APPLICABLE AND ADAPTABLE",NA,1
"INFRARED AND RAMAN SPECTROSCOPIES",NA,1
"INFRARED CHEMICAL IMAGING",NA,1
"INFRARED MICROSPECTROPHOTOMETRY",NA,1
"INFRASTRUCTURES",NA,1
"INFUSION/DECOCTION/HYDROETHANOLIC EXTRACT",NA,1
"INHERITANCE",NA,1
"INITIAL IONIZATION SITE",NA,1
"INJECTABILITY",NA,1
"INJECTABLES",NA,1
"INJECTED SUBSTANCES",NA,1
"INJECTION DRUG USE",NA,1
"INJECTION DRUG USERS (IDUS)",NA,2
"INJECTION METHOD",NA,1
"INJECTION PORT ARTIFACTS",NA,1
"INJECTION PORT DERIVATIZATION",NA,1
"INK EVIDENCE",NA,1
"INKJET PRINTING",NA,2
"INKS EXAMINATION",NA,1
"INLET LINER",NA,1
"INORGANIC ANION",NA,3
"INORGANIC COMPOUNDS",NA,1
"INORGANIC ELEMENT",NA,4
"INORGANIC ION ANALYSIS",NA,1
"INSPECTION",NA,1
"INSTAGRAM",NA,1
"INSTITUTIONAL EFFORTS",NA,1
"INSTITUTIONAL REVIEW BOARD",NA,1
"INTECT 7",NA,1
"INTEGRAL CORRELATION CRITERIA",NA,1
"INTEGRATED ANALYTICAL SYSTEM",NA,1
"INTER-CONVERSION",NA,1
"INTER-LABORATORY STUDY",NA,1
"INTERACTOMIC MAPS",NA,1
"INTERDIGITATED ELECTRODE (IDE)",NA,1
"INTERFERANTS",NA,1
"INTERMEDIATES",NA,2
"INTERNAL REFERENCE STANDARD",NA,1
"INTERNAL TRANSCRIBED SPACER 1",NA,1
"INTERNAL TRANSCRIBED SPACER 2",NA,1
"INTERNAL TRANSCRIBED SPACER I",NA,1
"INTERNAL TRANSCRIBED SPACERS",NA,1
"INTERNAL TRANSCRIBING SEQUENCE (ITS)",NA,1
"INTERNATIONAL DRUG CONTRIOL TREATIES",NA,1
"INTERNATIONAL HEALTH",NA,1
"INTERNET-BASED DRUG FORUMS",NA,1
"INTERNET DRUG FORUMS",NA,1
"INTERNET DRUG MARKET",NA,1
"INTERNET DRUGS",NA,1
"INTERNET FORUM",NA,2
"INTERNET MONITORING",NA,1
"INTERNET MONITORING PROCESSES",NA,1
"INTERNET PHARMACIES",NA,1
"INTERNET PHARMACY",NA,1
"INTERNET SALES",NA,1
"INTERRUPTED TIME SERIES",NA,1
"INTERRUPTED TIME SERIES ANALYSIS",NA,1
"INTERVAL ESTIMATION",NA,1
"INTERVENTION EFFECT",NA,1
"INTOXICATED ITEMS",NA,1
"INTRAMOLECULAR CHARGE TRANSFE",NA,1
"INTRAMOLECULAR DIMER",NA,1
"INTRON OF TRNL AND INTERGENIC SPACER BETWEEN TRNL AND TRNF (TRNL/TRNF)",NA,1
"INVERSE KIRKWOOD-BUFF INTEGRALS",NA,1
"INVERSE KIRKWOODÃ¢Â‚¬Â€ŒBUFF INTEGRALS",NA,1
"IODIDE FUNCTIONALIZATION",NA,1
"IODIDE ION-SELECTIVE ELECTRODE",NA,1
"IODOCYCLIZATION",NA,1
"IODOEPHEDRINE",NA,1
"IODOPSEUDOEPHEDRINE",NA,1
"ION-INTERACTION HPLC",NA,1
"ION-PAIR COMPLEX",NA,1
"ION-PAIR LC",NA,1
"ION-PAIRING",NA,2
"ION-PAIRING CHROMATOGRAPHY",NA,1
"ION FUNNEL",NA,1
"ION IMPLANTATION",NA,1
"ION INTERACTION",NA,1
"ION MOBILITY INCREMENT SPECTROMETRY",NA,2
"ION MOBILITY SPECTROMETER/MASS SPECTROMETER",NA,1
"ION MOBILITY SPECTROMETRY IMS",NA,1
"ION PAIR",NA,2
"ION PAIR CHROMATOGRAPHY",NA,1
"ION PAIR FORMATION CONSTANT",NA,1
"ION PARTITION DIAGRAMS",NA,1
"ION SELECTIVE ELECTRODE",NA,1
"ION SIGNATURE DECONVOLUTION SOFTWARE",NA,1
"ION SOURCE",NA,1
"ION TRANSFER",NA,1
"ION TRANSFER VOLTAMMETRY",NA,1
"ION TRAP FRAGMENTATION",NA,1
"IONIC LIQUID-BASED HOMOGENEOUS LIQUIDÃ¢Â‚¬Â€ŒLIQUID MICROEXTRACTION",NA,1
"IONIC LIQUID CRYSTAL",NA,1
"IONIC LIQUID DISPERSIVE LIQUIDÃ¢Â‚¬Â€ŒLIQUID MICROEXTRACTION",NA,1
"IONIC LIQUID FOAM FLOATATION",NA,1
"IONIC MOBILITY",NA,1
"IONIZATION ENERGY",NA,1
"IONIZATION MECHANISM",NA,3
"IONMOBILITY SPECTROMETRY",NA,1
"IONSCAN",NA,1
"IPCA",NA,1
"IPHONE APP",NA,1
"IPTEI",NA,1
"IQVIA",NA,1
"IR AND MASS SPECTROMETRY",NA,1
"IR AND RAMAN SPECTROSCOPY",NA,1
"IR AND THZ RADIATION, ENERGY CONTINUUM OF ELECTROMAGNETIC SPECTRUM",NA,1
"IR ION SPECTROSCOPY",NA,1
"IR SPECTRA",NA,2
"IR, RAMAN AND THZ SPECTROSCOPY, TOOLS IN FORENSIC SCIENCE",NA,1
"IRIDIUM",NA,1
"IRMPD, INFRARED MULTIPHOTON DISSOCIATION",NA,1
"IRMS IN SCIENTIFIC FIELDS, FORENSIC SCIENCE, A RECENT ENTRY",NA,1
"IRMS, PRECISE MEASUREMENTS IN NATURAL ISOTOPIC ABUNDANCE",NA,1
"IRON-DIENE COMPLEXES",NA,2
"IRON COMPLEXES",NA,1
"IRON DECOMPLEXATION",NA,1
"IRON(II) PORPHYRINS",NA,1
"IRREVERSIBLE",NA,1
"ISATIN",NA,1
"ISFET",NA,1
"ISIL",NA,1
"ISO-4-BMC",NA,1
"ISOABSORPTIVE RATIO",NA,1
"ISOBARIC SUBSTANCES",NA,2
"ISOCATHINONES",NA,1
"ISOCRATIC ELUTION",NA,1
"ISOCRATIC TRANSFER",NA,1
"ISOFLAVONES",NA,1
"ISOFLURANE",NA,1
"ISOMER ABUNDANCE ANALYSIS",NA,1
"ISOMER SEPARATION",NA,2
"ISOPROPYL GROUP",NA,1
"ISOQUINOLINE ALKALOID",NA,2
"ISOQUINOLINES",NA,1
"ISOSAFROLE",NA,1
"ISOTHERMAL CALORIMETRY",NA,1
"ISOTOPE-DILUTION MASS SPECTROMETRY",NA,1
"ISOTOPE-LABELED INTERNAL STANDARDS",NA,1
"ISOTOPE PROFILE",NA,2
"ISOTOPE RATIO MEASUREMENTS",NA,1
"ISOTOPIC 13C NMR SPECTROMETRY",NA,1
"ISOTOPIC FINGERPRINT",NA,1
"ISOTOPIC NMR",NA,1
"ISOTOPIC SUBSTITUTION",NA,1
"ISOTOPICALLY LABELLED INTERNAL STANDARD",NA,1
"ISOTOPOMER",NA,1
"ISSR",NA,1
"ITIES",NA,2
"ITP",NA,1
"ITS-1",NA,1
"IUPAC-SOLVAY INTERNATIONAL AWARD FOR YOUNG CHEMISTS",NA,1
"IUPAC INORGANIC CHEMISTRY DIVISION",NA,1
"IV ABUSE",NA,1
"JIKETING GRANULE",NA,1
"JIULONG RIVER",NA,1
"JOB PLOTS",NA,1
"JOULE HEATING",NA,1
"JRC",NA,1
"JUICE",NA,1
"JWH-018 (N-4-HYDROXYPENTYL METABOLITE)",NA,1
"JWH-018 ADAMANTOYL DERIVATIVE",NA,1
"JWH-073-HOMOLOGUE",NA,1
"JWH-201",NA,1
"JWH-302",NA,1
"JWH-307",NA,1
"JWH COMPOUNDS",NA,1
"KAHALALIDE F",NA,1
"KAKKONTO",NA,1
"KALLAWAYA",NA,1
"KAMINI VIDRAWAN RAS",NA,1
"KAMPO MEDICINE",NA,2
"KAPPA",NA,1
"KAPPA OPIOID RECEPTOR",NA,1
"KARL FISCHER",NA,1
"KAVA-KAVA",NA,1
"KET QUANTITATIVE DETECTION",NA,1
"KETAMINE DERIVATIVES",NA,1
"KETAMINE DETECTION",NA,1
"KETO GROUPS' OXIMATION",NA,1
"KETONE OLEFINATION",NA,1
"KETOREDUCTASE",NA,1
"KETOROLAC TROMETHAMINE",NA,1
"KEY ADVANTAGE OF SERS, SENSITIVE AND MOLECULARLY SPECIFIC IN CRIME",NA,1
"KHAT (CATHA EDULIS)",NA,1
"KHAT ALKALOIDS",NA,1
"KHAT LEAVES",NA,1
"KHAT PLANT",NA,1
"KINASES",NA,1
"KINETIC ANALYSIS",NA,1
"KINETIC AND THERMODYNAMIC PARAMETERS",NA,1
"KINETIC FRACTIONATION",NA,1
"KINETIC METHOD",NA,2
"KINETIC PLOTS",NA,3
"KINETIC RESOLUTION",NA,2
"KINETIC SPECTROPHOTOMETRIC",NA,1
"KINETIC SPECTROPHOTOMETRIC DETERMINATION",NA,1
"KINETIC SPECTROPHOTOMETRY",NA,1
"KINETIN",NA,1
"KITAMINE HCL",NA,1
"KITCHEN CHEMISTRY",NA,1
"KNOCKOUTS",NA,1
"KOR LIGANDS",NA,1
"KORNBLUM OXIDATION",NA,1
"KP",NA,1
"KRATOM ALKALOIDS",NA,1
"KRATOM COCKTAIL",NA,2
"KRIGING",NA,1
"KROKODIL SYNTHESIS",NA,1
"KRONIC",NA,1
"L-(+)-TARTARIC ACID",NA,1
"L-ASCORBIC ACID",NA,1
"L-EPHEDRINE",NA,1
"L-HYOSCYAMINE",NA,1
"L-L EXTRACTION",NA,1
"L-LEUCINE CHIRAL SELECTOR",NA,1
"L-PAC",NA,3
"L-PHENYLACETYLCARBINOL",NA,2
"L-TYROSINE",NA,1
"LA-ICP-OES",NA,1
"LA 3+ DOPED FERN-LIKE CUO NANOLEAVES",NA,1
"LA3+/ZNO NANO-FLOWER",NA,1
"LAB-ON-A-CHIP",NA,3
"LAB-ON-CHIP",NA,1
"LAB ON PAPER",NA,1
"LABELED EXCIPIENTS",NA,1
"LABELLING AND PACKAGING",NA,1
"LABORATORIES (CLANDESTINE)",NA,1
"LABORATORY SUBSAMPLING",NA,1
"LABORATORY VESSELS",NA,1
"LACTOSE HYDRATE",NA,1
"LAESIÃ¢Â‚¬Â€ŒMASS SPECTROMETRY",NA,1
"LANCING",NA,1
"LANTHANIDE METAL OXIDE",NA,1
"LANTHANUM DOPED FERN-LIKE CUO NANOLEAVES",NA,1
"LAO PDR",NA,1
"LARGE VOLUME ON-LINE SOLID PHASE EXTRACTION",NA,1
"LAROCK HETEROANNULATION",NA,1
"LAS 35917",NA,1
"LASER-INDUCED BREAKDOWN SPECTROSCOPY (LIBS)",NA,4
"LASER-INDUCED FLUORESCENCE DETECTION",NA,1
"LASER CARBONIZATION",NA,1
"LASER SPECTROSCOPY",NA,2
"LASER SPRAY",NA,1
"LATERAL FLOW ASSAY (LFA)",NA,1
"LATERAL FLOW IMMUNOCHROMATOGRAPHIC ASSAY",NA,1
"LATERAL FLOW IMMUNOCHROMATOGRAPHY",NA,1
"LATERAL FLOW STRIP (LFS)",NA,1
"LATEX",NA,4
"LATICIFER",NA,2
"LATTICE ENERGY CALCULATIONS",NA,1
"LAUGHING GAS",NA,1
"LAW ENFORCEMENT PERCEPTIONS",NA,1
"LAXATIVES",NA,1
"LAY EPIDEMIOLOGY",NA,1
"LAYER-INDUCED SENSITIVITY ENHANCEMENT",NA,1
"LC-DAD-HESI-MSN",NA,1
"LC-ES-MS",NA,1
"LC-ESI-TOF/MS",NA,1
"LC-ESI/MS",NA,1
"LC-ESI/MSN",NA,1
"LC-FLD",NA,1
"LC-HR-MS/MS 4-EA-NBOME",NA,1
"LC-HRAM-MS",NA,1
"LC-MS/MS METHOD",NA,1
"LC-MS/MS, LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY/MASS SPECTROMETRY",NA,1
"LC-MSN",NA,1
"LC-ORBITRAP",NA,2
"LC-PDA",NA,1
"LC-TOF/MS",NA,2
"LC–DAD",NA,1
"LC–MS",NA,2
"LC–MS/MS",NA,5
"LC–MS/MS SCREENING",NA,1
"LC/PDA",NA,1
"LC/SPE/NMR",NA,1
"LCÃ¢Â‚¬Â€ŒDAD",NA,1
"LCÃ¢Â‚¬Â€ŒESI-IT-TOF-MS",NA,1
"LCÃ¢Â‚¬Â€ŒESIÃ¢Â‚¬Â€ŒQTOFÃ¢Â‚¬Â€ŒMS",NA,1
"LCÃ¢Â‚¬Â€ŒHRÃ¢Â‚¬Â€ŒMS/MS",NA,1
"LCÃ¢Â‚¬Â€ŒHRMS",NA,1
"LCÃ¢Â‚¬Â€ŒMS",NA,4
"LCÃ¢Â‚¬Â€ŒMS-MS",NA,1
"LCÃ¢Â‚¬Â€ŒMS/MS",NA,18
"LCÃ¢Â‚¬Â€ŒMSÃ¢Â‚¬Â€ŒMS",NA,1
"LCÃ¢Â‚¬Â€ŒMSN",NA,2
"LCÃ¢Â‚¬Â€ŒPDA",NA,1
"LCÃ¢Â‚¬Â€ŒQ-TOF/MS",NA,1
"LCÃ¢Â‚¬Â€ŒQTOF-MS/MS",NA,1
"LCGREEN PLUSÃ‚Â®",NA,2
"LDH/FE3O4@ GCE",NA,1
"LDI-MS",NA,1
"LDX",NA,1
"LEACHATE",NA,1
"LEARNING MOTIVATION",NA,1
"LEARNING THEORIES",NA,1
"LEBANESE TRADITIONAL MEDICINE",NA,1
"LED",NA,2
"LED-INDUCED FLUORESCENCE (LIF)",NA,1
"LEFETAMINE",NA,1
"LEGAL DRUGS",NA,2
"LEGAL PARTY PILLS",NA,1
"LEGALIZATION",NA,8
"LEGUMES",NA,1
"LESPEDAMINE",NA,1
"LEUCINE TRANSFER RNA",NA,1
"LEUCKART-WALLACH SYNTHESIS",NA,1
"LEUCKART IMPURITIES",NA,1
"LEUCKART METHOD",NA,3
"LEUCKART REACTION",NA,4
"LEWIS BASE",NA,1
"LGD2226",NA,1
"LIBERALIZATION",NA,1
"LIBRARY MATCHING",NA,1
"LIBRAX TABLETS",NA,1
"LICENCE",NA,1
"LIDOCAINE HCL",NA,1
"LIDOCAINE HYDROCHLORIDE",NA,1
"LIFESTYLE DRUGS",NA,1
"LIGAND-EXCHANGE",NA,1
"LIGAND DESIGN",NA,1
"LIGHT",NA,1
"LIGHT-SCATTERING",NA,1
"LIGHT MODULATION",NA,1
"LIGNANAMIDES",NA,2
"LIGNANS",NA,1
"LIGNIN STRUCTURE",NA,1
"LIKELIHOOD",NA,1
"LIMIT OF BLANK",NA,1
"LIMIT QUANTITY",NA,1
"LINEAR NEUTRAL POLYSACCHARIDES",NA,1
"LINEAR RESPONSE",NA,1
"LINEAR RETENTION INDEX",NA,1
"LINEAR SOLVENT STRENGTH THEORY",NA,1
"LINEAR SWEEP VOLTAMMETRY",NA,1
"LINEAR VARIABLE FILTER",NA,1
"LINEARITY",NA,1
"LINER TRAP QUADRUPOLE-ORBITRAP MASS SPECTROMETRY",NA,1
"LINK ESTABLISHMENT",NA,1
"LINKED-READ ASSEMBLY",NA,1
"LINKED MEDICATION SYSTEM",NA,1
"LINKING TABLETS",NA,1
"LIPASE",NA,1
"LIPID MEDIATORS",NA,1
"LIPOXYGENASE",NA,1
"LIPOXYGENASE PRODUCTS",NA,1
"LIPSTICKS",NA,1
"LIQUEFIED NATURAL GAS",NA,1
"LIQUID-LIQUID-LIQUID MICROEXTRACTION (LLLME)",NA,2
"LIQUID-LIQUID RE-EXTRACTION",NA,1
"LIQUID-PHASE MEMBRANE EXTRACTION",NA,1
"LIQUID–LIQUID EXTRACTION",NA,1
"LIQUID CHROMATOGRAPHY-ELECTROSPRAY TANDEM MASS SPECTROMETRY",NA,1
"LIQUID CHROMATOGRAPHY-NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY",NA,1
"LIQUID CHROMATOGRAPHY–ELECTROSPRAY IONIZATION LINEAR ION TRAP MASS SPECTROMETRY (LC–ESI–LIT–MS)",NA,1
"LIQUID CHROMATOGRAPHY–HIGH RESOLUTION TANDEM MASS SPECTROMETRY WITH QUADRUPOLE TIME-OF-FLIGHT ANALYZER (LC–QTOF-MS/MS)",NA,1
"LIQUID CHROMATOGRAPHY–MASS SPECTROMETRY",NA,2
"LIQUID CHROMATOGRAPHY–TANDEM MASS SPECTROMETRY (LC–MS/MS)",NA,1
"LIQUID CHROMATOGRAPHY ( LC)",NA,1
"LIQUID CHROMATOGRAPHY Ã¢Â‚¬Â€Œ TANDEM MASS SPECTROMETRY",NA,1
"LIQUID CHROMATOGRAPHY AND AMBIENT IONIZATION",NA,1
"LIQUID CHROMATOGRAPHY COUPLED TO TRIPLE QUADRUPOLE LINEAR-ION TRAP TANDEM MASS SPECTROMETRY",NA,1
"LIQUID CHROMATOGRAPHY COUPLED WITH TANDEM MASS SPECTROMETRY DETECTION (LC-MS/MS) ANALYSIS",NA,1
"LIQUID CHROMATOGRAPHY DUAL ELECTRODE DETECTION",NA,2
"LIQUID CHROMATOGRAPHY HIGH RESOLUTION TANDEM MASS SPECTROMETRY",NA,1
"LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC-MS/MS)",NA,1
"LIQUID CHROMATOGRAPHY WITH PHOTODIODE ARRAY",NA,1
"LIQUID CHROMATOGRAPHY/DIODE-ARRAY DETECTION/MASS SPECTROMETRY DETECTION",NA,1
"LIQUID CHROMATOGRAPHY/ION TRAP MASS SPECTROMETRY",NA,1
"LIQUID CHROMATOGRAPHYÃ¢Â‚¬Â€ŒMASS SPECTROMETRY",NA,2
"LIQUID CHROMATOGRAPHYÃ¢Â‚¬Â€ŒTANDEM MASS SPECTROMETRY",NA,2
"LIQUID DEPOSITION",NA,1
"LIQUID FORM",NA,1
"LIQUID ILLICIT DRUGS",NA,1
"LIQUID{DIVIDES}LIQUID INTERFACE",NA,1
"LIQUIDÃ¢Â‚¬Â€ŒLIQUID EXTRACTION",NA,1
"LIQUIDÃ¢Â‚¬Â€ŒLIQUID EXTRACTION WITH LOW TEMPERATURE PARTITIONING",NA,1
"LISDEXAMFETAMINE",NA,1
"LISDEXAMFETAMINE DIMESYLATE",NA,2
"LITHOSPERMUM ERYTHRORHIZON",NA,1
"LIVESTOCK PRODUCTS",NA,1
"LLE/TLC PROFILING",NA,1
"LOADING PLOTS",NA,1
"LOBIVINE",NA,1
"LOCAL STRAIGHT-LINE SCREENING",NA,1
"LOCOMOTOR BEHAVIOR",NA,1
"LOD/LOQ EVALUATION",NA,1
"LOI",NA,1
"LONG-TERM GROUNDWATER POLLUTION",NA,1
"LONG-TERM STORED CANNABIS OIL",NA,1
"LOOP-MEDIATED ISOTHERMAL AMPLIFICATION",NA,1
"LOOSE-SKIN MANDARINS",NA,1
"LOPHOPHINE",NA,1
"LOPHOPHORA",NA,1
"LORATADINE",NA,4
"LOSSEN REARRANGEMENT",NA,1
"LOTEPREDNOL ETABONATE",NA,1
"LOTUS LEAVES",NA,1
"LOW-CONTENT ACTIVE PHARMACEUTICAL INGREDIENT",NA,1
"LOW-FREQUENCY RAMAN",NA,1
"LOW-PASS ELECTRONIC NOISE FILTER",NA,1
"LOW-PRESSURE CHROMATOGRAPHY",NA,1
"LOW-QUALITY ANTIMICROBIALS",NA,1
"LOW-RESOLUTION TANDEM MASS SPECTROMETRY",NA,1
"LOW-TEMPERATURE BATH",NA,1
"LOW-TEMPERATURE FLUORESCENCE SPECTROSCOPY",NA,1
"LOW-WAVENUMBER RAMAN SPECTROSCOPY",NA,1
"LOW ANGLE SCATTER",NA,1
"LOW PRESSURE PHOTOIONIZATION",NA,1
"LOW TEMPERATURE",NA,1
"LOW TEMPERATURE HPLC",NA,1
"LOYALTY",NA,1
"LSD ANALOGUES",NA,1
"LSD, NOR-LSD, AND ISO-LSD IN URINE AND SERUM",NA,1
"LSER",NA,1
"LTP PROBE",NA,1
"LUMINESCENCE QUENCHING",NA,1
"LUX CELLULOSE-4 COLUMN",NA,1
"LUXPLATES",NA,1
"LYRICA",NA,1
"LYSERGIC ACID DIETHYLAMIDE DERIVATIVE",NA,1
"M-DINITROBENZENE",NA,1
"M. SPECIOSA",NA,1
"M2 MUSCARINIC RECEPTOR",NA,1
"MA",NA,1
"MA-HUANG",NA,4
"MAB-CHIMINACA",NA,1
"MACRO PROGRAMS",NA,1
"MACROARRAY",NA,1
"MACROCYCLE",NA,1
"MACROLIDES",NA,1
"MACROLINE",NA,1
"MADS-BOX GENES",NA,1
"MÃƑÂ¡K",NA,1
"MAGNESIUM CHLORIDE",NA,1
"MAGNESIUM NITRATE MODIFIER",NA,1
"MAGNETIC BEAD",NA,1
"MAGNETIC CARBON NANOTUBES",NA,1
"MAGNETIC CHITOSAN",NA,1
"MAGNETIC DISPERSIVE SOLID-PHASE EXTRACTION",NA,1
"MAGNETIC DISPERSIVE SOLID-PHASE MICROEXTRACTION (MDSPME)",NA,1
"MAGNETIC DISPERSIVE SOLID PHASE MICROEXTRACTION",NA,1
"MAGNETIC FIELD POLYMERISATION",NA,1
"MAGNETIC FLUORESCENT",NA,1
"MAGNETIC HYBRID MATERIAL",NA,1
"MAGNETIC LATERAL FLOW STRIP",NA,1
"MAGNETIC NANOADSORBENT",NA,1
"MAGNETIC RESONANCE",NA,1
"MAGNETIC RESONANCE SPECTROSCOPY",NA,1
"MAGNETIC SOLID PHASE MICRO-EXTRACTION",NA,1
"MAHUANG-FUZI-XIXIN DECOCTION",NA,1
"MAIL",NA,1
"MAIZE PROTEIN",NA,1
"MAJOR ALKALOID PROFILING",NA,1
"MAKOVINA",NA,1
"MAL (METHALLYLESCALINE)",NA,1
"MALAYSIAN WATER SAMPLE",NA,1
"MALDI-FT-ICR MS",NA,1
"MALDI-IMAGING",NA,1
"MALDI MASS SPECTROMETRY",NA,1
"MALDI MATRICES",NA,1
"MALDI/TOFMS",NA,2
"MALE SEXUAL POTENCY",NA,1
"MALPIGHIACEAE",NA,1
"MALTODEXTRIN",NA,1
"MANDRAGORA OFFICINARUM",NA,1
"MANDRAKE",NA,1
"MANDRAX",NA,1
"MANGANESE DIOXIDE",NA,1
"MANIPULATION",NA,2
"MANUFACTURING IMPURITY WITH CANNABINOID ACTIVITY",NA,1
"MAO",NA,1
"MAOI",NA,1
"MAOTO",NA,1
"MAPK",NA,1
"MARE REPRODUCTIVE LOSS SYNDROME",NA,1
"MARIJUANA-INFUSED PRODUCTS",NA,2
"MARIJUANA ANALYSIS",NA,1
"MARIJUANA BLUNT",NA,1
"MARIJUANA CIGARETTE SMOKING",NA,1
"MARIJUANA CONCENTRATES",NA,2
"MARIJUANA LAWS",NA,1
"MARIJUANA LEGALIZATION",NA,2
"MARIJUANA SMOKE",NA,1
"MARINE BIOTA",NA,1
"MARINE ENVIRONMENT",NA,1
"MARKER GENOTYPE",NA,1
"MARKET",NA,3
"MARKET MONITORING",NA,1
"MARKET STRUCTURE",NA,1
"MARKETING",NA,1
"MARQUIS",NA,1
"MARTINIQUE",NA,2
"MAS",NA,1
"MASKING",NA,1
"MASKING VEGETATION",NA,1
"MASS",NA,1
"MASS-MOBILITY RELATIONSHIPS",NA,1
"MASS-SPECTROMETRIC ANALYSIS",NA,1
"MASS BALANCE",NA,2
"MASS DETECTION",NA,2
"MASS FINGERPRINT",NA,1
"MASS FRAGMENTATION",NA,1
"MASS FRAGMENTATION IN SILICO",NA,1
"MASS FRAGMENTATION PATHWAY",NA,1
"MASS LOADING",NA,1
"MASS SPECTRAL COMPARISON",NA,1
"MASS SPECTRAL DATA",NA,3
"MASS SPECTROMETRY LIBRARY",NA,1
"MASS SPECTROMETRY METHODS",NA,1
"MASS TRANSFER",NA,1
"MATERIAL",NA,1
"MATERIAL FINGERPRINT",NA,1
"MATERIAL SCIENCE",NA,1
"MATERIALS",NA,1
"MATERIALS (API-SMS)",NA,1
"MATERIALS CHARACTERIZATION",NA,1
"MATERNAL INHERITANCE",NA,1
"MATHEMATICAL ADJUSTMENT",NA,1
"MATK",NA,1
"MATLABÃƑÂ€ŠÃ‚Â®",NA,1
"MATRIX-FREE LASER DESORPTION IONIZATION",NA,1
"MATRIX ASSISTED IONIZATION VACUUM",NA,1
"MATRIX SWELLING",NA,1
"MATRIX TABLETS",NA,2
"MATRIX TYPE",NA,2
"MATURITY",NA,1
"MAXIMUM ENTROPY",NA,1
"MC-ICP/MS",NA,1
"MCLAFFERTY REARRANGEMENT",NA,3
"MCMC",NA,1
"MDBP",NA,2
"MDBPS",NA,1
"MDMA (3,4 METHYLENE DIOXYMETHAMPHETAMINE)",NA,1
"MDMA CRYSTALS",NA,1
"MDMA METHYLENE HOMOLOG",NA,1
"MDMAI",NA,1
"MDMB",NA,1
"MDMC",NA,1
"MDMCATH",NA,1
"MDMMA",NA,1
"MDOB",NA,1
"MDP-2-P",NA,1
"MDP2P",NA,1
"MDPBP",NA,1
"MDPV ENANTIOMER",NA,1
"MEADOW FESCUE",NA,1
"MEANS OF AVOIDING FLUORESCENCE",NA,1
"MEASUREMENT OF SEVERAL ILLICIT DRUGS AND THEIR METABOLITES-IN WASTEWATER STREAMS, USING LIQUID CHROMATOGRAPHY AND TANDEM MASS SPECTROMETRY",NA,1
"MEAT",NA,4
"MEAT PRODUCTS",NA,1
"MECHANICAL DIGESTION",NA,1
"MECHANISM OF ELECTROCHEMICAL REACTION",NA,1
"MECHANISM OF FRAGMENTATION",NA,1
"MECLONAZEPAM",NA,1
"MEDAZEPAM",NA,1
"MEDICAL-IMAGE RECONSTRUCTION METHODS AND ALGORITHMS, COMPUTER-AIDED SO",NA,1
"MEDICAL CONSEQUENCES OF HEROIN USE",NA,1
"MEDICAL HERBS",NA,1
"MEDICAL MARIJUANA",NA,2
"MEDICAL MARIJUANA LAWS",NA,1
"MEDICAL USES",NA,2
"MEDICATION ASSISTED TREATMENT",NA,1
"MEDICATION SAFETY",NA,1
"MEDICATION TAKE BACK PROGRAMS",NA,1
"MEDICATION WASTE",NA,1
"MEDICATIONS FOR ADDICTION TREATMENT",NA,1
"MEDICINAL CANNABIS",NA,3
"MEDICINAL MARIJUANA",NA,1
"MEDICINAL MUSHROOMS",NA,2
"MEDICINAL PLANT RESEARCH",NA,1
"MEDICINAL USES",NA,2
"MEDICINES REGULATION",NA,1
"MEDITERRANEAN COUNTRIES",NA,1
"MEDIUM-FIELD NMR",NA,1
"MEDIUM-RESOLUTION ACCURATE MASS SPECTROMETRY",NA,1
"MEFENAMIC ACID",NA,2
"MEGALOBLASTOMA",NA,1
"MELT EXTRUSION",NA,1
"MEMBRANE-PROTECTED SOLVENT",NA,1
"MEMBRANE INTERFACE",NA,1
"MEMBRANE SEPARATION",NA,1
"MEMBRANES",NA,1
"MEMS",NA,1
"MENTABOLAN",NA,1
"MENTHA AQUATIC EXTRACT",NA,1
"MENTHOL",NA,1
"MENTHONE-THIOSEMICARBAZONE",NA,1
"MENTHYL CHLOROFORMATE",NA,1
"MEPHENTERMINE SULFATE",NA,1
"MEPHTETRAMINE",NA,1
"MERCURIMETRIC TITRATION",NA,1
"MESACONITINE",NA,1
"MESCALINE ACTIVITY",NA,1
"MESCALINE ANALOGUES",NA,1
"MESCALINE AND PEYOTE",NA,1
"MESEMBRYANTHEMUM",NA,1
"MESMA",NA,1
"MESOPOROUS SILICA NANOPARTICLES",NA,2
"METABOLIC ENGINEERING",NA,5
"METABOLIC FINGERPRINTING",NA,1
"METABOLISM AND EXCRETION",NA,1
"METABOLISM OF ENDOGENOUS GHB VERSUS INGESTED GHB, MULTIPLE PATHWAYS",NA,1
"METABOLITE CONCENTRATIONS",NA,1
"METABOLITE PROFILING",NA,3
"METABOLOMIC ANALYSIS",NA,1
"METABOLOMIC FINGERPRINT",NA,1
"METABOLYNX‚Ñ¢",NA,1
"METACHLOROPHENYLPIPERAZINE",NA,1
"METAL CATALYZED HYDROGENATION",NA,1
"METAL INTOXICATION",NA,1
"METAL OXIDE NANOPARTICLE",NA,1
"METAL OXIDES",NA,1
"METAL SENSORS",NA,1
"METALATION",NA,1
"METALIGN",NA,1
"METALLOCARBORANES",NA,1
"METAMERISM",NA,1
"METAMPHETAMINE HYDROCHLORIDE",NA,1
"METANDIENONE",NA,1
"METATHESIS",NA,1
"METEORIC PRECIPITATION",NA,1
"METH LAB",NA,1
"METHAMPHETAMINE AND RELATED COMPOUNDS",NA,1
"METHAMPHETAMINE CONTAMINATION OF HOMES",NA,1
"METHAMPHETAMINE DETECTION",NA,3
"METHAMPHETAMINE DIMER",NA,1
"METHAMPHETAMINE EXPOSURE",NA,1
"METHAMPHETAMINE ISOMERS",NA,1
"METHAMPHETAMINE PRODUCTION",NA,1
"METHAMPHETAMINE SURFACE MEASUREMENT",NA,1
"METHAMPHETAMINE WASTE",NA,1
"METHAMPHETAMINE,3,4-METHYLENEDIOXY-METHYLAMPHETAMINE",NA,1
"METHANDIENONE",NA,1
"METHANOL-WATER",NA,1
"METHAQUALONE",NA,4
"METHCATHINONE DERIVATIVES",NA,1
"METHEDRINE",NA,1
"METHEDRONE",NA,2
"METHELONE",NA,1
"METHOD COMPARISON",NA,3
"METHOD OF ANALYSIS, SYNTHESIS",NA,1
"METHOD OF SPECTRAL DYNAMICS ANALYSIS",NA,2
"METHOD OPTIMIZATION",NA,2
"METHOD VALIDATION AND QUALITY CONTROL",NA,1
"METHODS OF CHROMATOGRAPHY-MASS SPECTROMETRY (HPLC-MS/MS, GC-MS)",NA,1
"METHODS, MICROSCOPIC EXAMINATION WITH STEREO BINOCULAR MICROSCOPES",NA,1
"METHOHEXITONE",NA,1
"METHOXIME DERIVATIZATION",NA,1
"METHOXMETAMINE",NA,1
"METHOXYBENZOYLPIPERAZINES",NA,1
"METHOXYMETHCATHINONES",NA,1
"METHOXYMETHYLBENZYLPIPERAZINE",NA,1
"METHOXYPHENIDINE",NA,1
"METHOXYPIPERAMIDE",NA,1
"METHYL 2-[1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO]-3,3-DIMETHYLBUTANOATE",NA,1
"METHYL 3-OXO-4-PHENYLBUTYRATE",NA,1
"METHYL AM-1220",NA,1
"METHYL ECGONINE",NA,2
"METHYL IODIDE",NA,1
"METHYL JASMONATE",NA,3
"METHYL TESTOSTERONE",NA,1
"METHYLAMINE",NA,1
"METHYLAMPHETAMINE OPTICAL ISOMERS",NA,1
"METHYLENE BLUECATALYTIC",NA,1
"METHYLENEDIOXY-DERIVATES",NA,1
"METHYLENEDIOXY DIMETHYLAMPHETAMINE",NA,1
"METHYLENEDIOXYAMPHETAMINE ANALOGS",NA,1
"METHYLENEDIOXYBENZYLPIPERAZINE",NA,3
"METHYLENEDIOXYCATHINONE",NA,1
"METHYLENEDIOXYETHAMPHETAMINE",NA,1
"METHYLENEDIOXYMETHCATHINONE",NA,1
"METHYLHEXANEAMINE",NA,1
"METHYLPARABEN",NA,1
"METHYLPSEUDOEPHEDRINE",NA,1
"METHYLSTENBOLONE",NA,1
"METHYLTESTOSTERONE",NA,3
"METHYLXANTHINES",NA,1
"METOCLOPRAMIDE",NA,1
"METROLOGICAL APPROACHES",NA,1
"MEV-SIMS",NA,1
"MEXEDRONE",NA,3
"MGO NANOPARTICLE",NA,1
"MGO/SWCNTS",NA,1
"MGO/SWCNTS NANOCOMPOSITE",NA,1
"MIBG",NA,1
"MICELLAR ELECTROKINETIC CHROMATOGRAPHY-MASS SPECTROMETRY",NA,1
"MICELLE ENHANCED",NA,1
"MICELLE POLYMERS",NA,1
"MICELLEÃ¢Â‚¬Â€ŒCLAY COMPLEX",NA,1
"MICELLES",NA,1
"MICRO-ELECTROMEMBRANE EXTRACTION",NA,1
"MICRO-FTIR",NA,1
"MICRO-FTIR SPECTROSCOPY",NA,1
"MICRO-HPLC",NA,1
"MICRO-SOLID-PHASE EXTRACTION",NA,1
"MICRO-SYSTEMS",NA,1
"MICRO FLUIDIC PAPER-BASED ANALYTICAL DEVICE (EÃŽÂ¼PAD)",NA,1
"MICRO ION-SELECTIVE ELECTRODE (Ã‚ÂΜISE)",NA,1
"MICRO RAMAN",NA,2
"MICRO TOTAL ANALYSIS SYSTEMS (ÃŽÂ¼TAS)",NA,1
"MICRO/NANO-LIQUID CHROMATOGRAPHY",NA,1
"MICROBES",NA,1
"MICROBIAL SYNTHESIS",NA,1
"MICROBIOLOGICAL SCREENING",NA,1
"MICROCAPILLARY FILM PHOTOREACTOR",NA,1
"MICROCOLUMN LC",NA,1
"MICROCONCENTRIC NEBULIZER",NA,1
"MICROCONSTANT",NA,1
"MICRODIALYSIS-HPLC METHOD",NA,1
"MICROEMULSION ELECTROKINETIC CAPILLARY CHROMATOGRAPHY",NA,1
"MICROEMULSION ELECTROKINETIC CHROMATOGRAPHY",NA,6
"MICROEMULSION/IN VITRO RELEASE",NA,1
"MICROEMULSION/PHYSICOCHEMICAL CHARACTERIZATION",NA,1
"MICROFABRICATED CAPILLARY ARRAY ELECTROPHORESIS",NA,1
"MICROFLUIDIC PAPER-BASED ANALYTICAL DEVICES (ÃŽÂ¼PADS)",NA,1
"MICROFURNACE PYROLYZER",NA,1
"MICROMORPHOLOGY",NA,1
"MICROPLITIS CROCEIPES",NA,1
"MICROPROPAGATION",NA,1
"MICROREACTORS",NA,2
"MICROSATELLITE MARKERS",NA,1
"MICROSCOPIC PROTONATION CONSTANT",NA,1
"MICROSOFT VISUAL BASIC",NA,1
"MICROSPECTROMETRY",NA,1
"MICROSYSTEMATICS",NA,1
"MICROTHERMAL DESORPTION",NA,1
"MICROWAVE-ACCELERATED DERIVATIZATION",NA,1
"MICROWAVE DIGESTION",NA,1
"MID-INFRARED SPECTROSCOPY",NA,1
"MID-IR",NA,1
"MID-IR FT-IR AND RAMAN SPECTROSCOPY, IN BULK SAMPLE ANALYSIS",NA,1
"MID-IR, RAMAN SPECTRA, FINGERPRINTING TOOLS CHARACTERISING MOLECULAR STRUCTURES",NA,1
"MIDDLE MARKET",NA,1
"MILK",NA,1
"MIMOSA HOSTILIS",NA,1
"MIMOSA TENUIFLORA",NA,1
"MINERAL COMPOSITION",NA,1
"MINERALIZATION",NA,3
"MING PORCELAIN",NA,1
"MINIATURE ION TRAP MASS SPECTROMETER",NA,1
"MINIATURE MASS SPECTROMETRY SYSTEM",NA,1
"MINIATURE SPECTROMETER",NA,1
"MINIATURIZED CAPILLARY ELECTROPHORESIS WITH AMPEROMETRIC DETECTION",NA,1
"MINIATURIZED SENSOR",NA,1
"MINIMUM INFORMATION STANDARDS",NA,1
"MINIMUM STEP OF COLOR TEST SCALE",NA,1
"MIP-BASED MAGNETIC EXTRACTION",NA,1
"MIRAA",NA,1
"MISCLASSIFICATION",NA,1
"MISLABELED DRUGS",NA,2
"MISUSE TREND",NA,1
"MITRAGYNA",NA,3
"MITRAGYNA SPECIOSA ALKALOID EXTRACT",NA,1
"MITRAGYNA SPECIOSA KORTH",NA,1
"MITRAGYNA SPECIOSA KORTH.",NA,1
"MITRAGYNA SPECIOSA STRAINS",NA,1
"MITRAGYNALINE",NA,1
"MITRAGYNINE SPECIOSA",NA,1
"MIXED-MODE FIBER",NA,1
"MIXED-MODE SOLID-PHASE EXTRACTION",NA,1
"MIXED-MODE SPE",NA,1
"MIXED-MODE STATIONARY PHASE",NA,2
"MIXED-MODE WEAK CATION-EXCHANGE SORBENT",NA,1
"MIXED DRUG",NA,1
"MIXED EFFECTS MODELS",NA,1
"MIXTURE OF RELATED STRUCTURE RESOLVING AGENTS",NA,1
"MLSA",NA,1
"MMAI",NA,1
"MMBP",NA,1
"MMC",NA,1
"MMDA",NA,1
"MMFF94S",NA,1
"MN-DOPED ZNS QUANTUM DOT",NA,1
"MN@ CUS/ZNS-NCS-AC",NA,1
"MNFE2O4",NA,1
"MO-CALCULATION",NA,1
"MOBILE-PHASE PH",NA,1
"MOBILE-PHASE SELECTION",NA,1
"MOBILE DETECTION APPROACHES",NA,3
"MOBILE LABORATORY",NA,1
"MOBILE PHASE ADDITIVES",NA,2
"MOBILE SENSING",NA,1
"MODE OF ABUSE",NA,1
"MODE OF ACTION",NA,1
"MODEL OF ELECTROMIGRATION",NA,1
"MODEL SELECTION",NA,2
"MODERATE TO SEVERE PAIN",NA,1
"MODIFIED-NANOPARTICLES",NA,1
"MODIFIED CARBON PASTE ELECTRODE",NA,1
"MODIFIED ELECTROCHEMICAL SENSORS",NA,1
"MODIFIED GLASSY CARBON ELECTRODE",NA,1
"MODIFIED PAPER, DRUG",NA,1
"MODIFIED PENCIL-LEAD FIBER",NA,1
"MODIFIED QUECHERS",NA,1
"MODIFIED RELEASE",NA,1
"MODIFIED SCREEN PRINTED ELECTRODE",NA,1
"MODIFIED SENSOR",NA,1
"MODIFIED SENSORS",NA,1
"MOF",NA,1
"MOISTURE SORPTION/DESORPTION",NA,1
"MOLAR ABSORPTIVITY",NA,1
"MOLECULAR CONNECTIVITY",NA,1
"MOLECULAR DIAGNOSTIC TECNIQUES",NA,1
"MOLECULAR DIVERSITY",NA,1
"MOLECULAR DOCKING NLO",NA,1
"MOLECULAR DYNAMIC CALCULATION",NA,1
"MOLECULAR DYNAMICS",NA,1
"MOLECULAR DYNAMICS SIMULATION",NA,1
"MOLECULAR ELECTROSTATIC POTENTIAL",NA,1
"MOLECULAR IDENTIFICATION",NA,2
"MOLECULAR MECHANICS",NA,2
"MOLECULAR MODELS",NA,1
"MOLECULAR ORBITAL CALCULATION",NA,1
"MOLECULAR OXYGEN",NA,1
"MOLECULAR SPECTROSCOPY",NA,2
"MOLECULARLY IMPRINTED POLYMER (MIP)",NA,1
"MOLECULARLY IMPRINTED POLYMER NANOPARTICLES",NA,1
"MOLECULARLY IMPRINTED SENSOR",NA,1
"MOLECULARLY IMPRINTED SILICA",NA,1
"MOLECULARLY SPECIFIC SPECTRA, IN SITU IDENTIFICATION OF DRUGS AND NATURE OF SAMPLE",NA,1
"MOLLY",NA,2
"MOLLY USE",NA,1
"MOLYBDENUM DISULFIDE-GOLD NANOPARTICLE-BASED SENSORS",NA,1
"MONEY BOYS",NA,1
"MONGOLIA",NA,1
"MONITOR",NA,1
"MONITORING SYSTEM",NA,1
"MONITORING TECHNIQUES",NA,1
"MONOACETYL MORPHINE",NA,1
"MONOAMINE OXIDASE",NA,1
"MONOAMINERGIC SYSTEM",NA,1
"MONOAMINOXIDASE",NA,1
"MONOCLONAL ANTIBODIES",NA,2
"MONOCLONAL ANTIBODIES AND DETECTION",NA,1
"MONOCLONAL ANTIBODIES TO MORPHINE",NA,1
"MONOECIOUS HEMP",NA,1
"MONOESTER",NA,1
"MONOLITH",NA,2
"MONOLITH COLUMNS",NA,1
"MONOLITHIC SILICA COLUMNS",NA,1
"MONOTERPENOID INDOLE ALKALOID",NA,1
"MONOTERPENOID INDOLE ALKALOIDS",NA,1
"MONTEREY",NA,1
"MORFIN",NA,1
"MORGANELLA MORGANII",NA,1
"MORNING GLORY",NA,1
"MORPHINAN",NA,2
"MORPHINAN ALKALOIDS",NA,2
"MORPHINANDIENE",NA,1
"MORPHINANE ALKALOIDS",NA,1
"MORPHINANS",NA,1
"MORPHINE-6-O-SULFATE",NA,1
"MORPHINE (MOP)",NA,1
"MORPHINE ALKALOIDS",NA,4
"MORPHINE ANALOGUES",NA,1
"MORPHINE AND DICLOFENAC",NA,1
"MORPHINE APIS",NA,1
"MORPHINE BIOSYNTHESIS",NA,3
"MORPHINE CONTENT",NA,1
"MORPHINE DEGRADATION",NA,1
"MORPHINE GLYCOSIDES",NA,1
"MORPHINE HYDROCHLORIDE",NA,2
"MORPHINE N-OXIDE",NA,2
"MORPHINE SULFATE",NA,1
"MORPHINE SULPHATE PENTAHYDRATE",NA,1
"MORPHINE/STABILITY/COMPATIBILITY",NA,1
"MORPHOGENIC GENES",NA,1
"MOS2 NANOSHEETS",NA,1
"MOSCOW METHOD",NA,1
"MOSHER ESTER ANALYSIS",NA,1
"MOST RECENT EPISODE",NA,1
"MOTION SICKNESS PREVENTION",NA,1
"MOULDS",NA,1
"MPTP DETERMINATION",NA,1
"MR SENSOR",NA,1
"MRI (WHOLE BODY, CARDIOVASCULAR, BREAST, OTHERS), MR-ANGIOGRAPHY (MRA)",NA,1
"MS QUANTIFICATION AND SPECIFIC ION FRAGMENTS (SIM)",NA,1
"MT CHARACTERIZATION",NA,1
"MTF",NA,1
"MTPA",NA,2
"MU OPIOID RECEPTOR",NA,1
"MUCOADHESION",NA,1
"MUCOLYTIC DRUGS",NA,1
"MULTI-AGENT PERSPECTIVE",NA,1
"MULTI-ANGLE LIGHT SCATTERING",NA,1
"MULTI-BRANCHED GOLD NANOPARTICLES",NA,1
"MULTI-COMPONENT ANALYSIS",NA,1
"MULTI-COMPONENT DRUGS",NA,1
"MULTI-DIMENSIONAL CHROMATOGRAPHY",NA,1
"MULTI-DIMENSIONAL FINGERPRINTS",NA,1
"MULTI-ELEMENT COMPOSITION",NA,1
"MULTI-ELEMENTAL ANALYSIS",NA,1
"MULTI-INDICATOR APPROACH",NA,1
"MULTI-MILLIGRAM ENANTIORESOLUTION",NA,1
"MULTI-RESIDUE ANALYSIS",NA,1
"MULTI ORGAN FAILURE",NA,1
"MULTICHANNEL",NA,1
"MULTICHANNEL CAPILLARY ELECTROPHORESIS",NA,1
"MULTICHANNEL CARBON NANOTUBES",NA,1
"MULTICLASS EMERGING ORGANIC CONTAMINANTS (EOCS)",NA,1
"MULTICOLLECTOR",NA,1
"MULTICOMPONENT MIXTURES",NA,1
"MULTICOMPONENT REACTION",NA,1
"MULTICOMPONENT SPECTRAL CORRELATIVE CHROMATOGRAPHY",NA,1
"MULTIDIMENSIONAL NMR SPECTROSCOPY",NA,1
"MULTIELEMENTAL FRACTIONATION",NA,1
"MULTILINEAR REGRESSION",NA,1
"MULTIMILLIGRAM CHIRAL CHROMATOGRAPHY",NA,1
"MULTIMODAL ANALYSIS",NA,1
"MULTIPHASE EXTRACTION",NA,1
"MULTIPLE COLLECTOR INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY",NA,1
"MULTIPLE MASS SPECTROMETRY",NA,2
"MULTIPLE MYELOMA",NA,1
"MULTIPLE PULSE AMPEROMETRY",NA,1
"MULTIPLE REACTION MONITORING LC-MS/MS",NA,1
"MULTIPLEX TEST",NA,1
"MULTIPLEXED CAPILLARY ELECTROPHORESIS",NA,1
"MULTIPLY AND SINGLY CHARGED",NA,1
"MULTISTATE SYSTEMS",NA,1
"MULTIVARIATE",NA,2
"MULTIVARIATE CALIBRATION",NA,2
"MULTIVARIATE CHARACTERISTICS",NA,1
"MULTIVARIATE CLASSIFICATION",NA,2
"MULTIVARIATE CLASSIFICATION TECHNIQUES",NA,1
"MULTIVARIATE CURVE RESOLUTION-ALTERNATING LEAST SQUARES",NA,1
"MULTIVARIATE DATA",NA,1
"MULTIVARIATE IMAGING ANALYSIS",NA,1
"MULTIVARIATE PHYSICO-CHEMICAL DATA",NA,1
"MULTIVARIATE REGRESSION",NA,1
"MULTIVARIATE STATISTICAL ANALYSES",NA,2
"MULTIVARIATE STATISTICAL PROCEDURES",NA,1
"MULTIWALL CARBON NANOTUBE",NA,1
"MULTIWALL CARBON NANOTUBES",NA,1
"MULTIWALLED CARBON NANOTUBES",NA,1
"MUNICH",NA,1
"MUNICIPAL WASTEWATER",NA,2
"MUNSELL",NA,1
"MUSCARINE",NA,1
"MUSEUM GENOMICS",NA,1
"MWCNT",NA,1
"MYCOGEOGRAPHY",NA,1
"MYCOTOXINS - ERGOT",NA,1
"MYRCENE REARRANGEMENT",NA,1
"MYRISTIC ACID",NA,1
"MYRISTICA FRAGRANS",NA,1
"MYRISTICIN",NA,1
"N",NA,2
"N-(1-PHENYLCYCLOHEXYL)-3-ETHOXYPROPANAMINE",NA,1
"N-(INDOL-3-YL)METHYL-5-METHOXY-NMET-HYLTRYPTAMI NE",NA,1
"N-ACETYLATION",NA,1
"N-ALKYLATED BARBITURATES",NA,1
"N-ARYL PIPERAZINES",NA,1
"N-BENZYLMETHAMPHETAMINE",NA,1
"N-BENZYLPHENETHYLAMINES",NA,1
"N-BROMOSUCCINIMIDE",NA,1
"N-CHLOROMETHYL-N,N- DIMETHYLTRYPTAMINE",NA,1
"N-CONTAINING HETEROCYCLES",NA,1
"N-CYANOMETHYL-N-METHYL-1-(3ÃƑÂ¢Ã‚Â‚¬Ã‚Â²,4ÃƑÂ¢Ã‚Â‚¬Ã‚Â²- METHYLENEDIOXYPHENYL)-2-PROPYLAMINE",NA,1
"N-DESMETHYLDIAZEPAM",NA,1
"N-DIMETHYLTRYPTAMINE",NA,2
"N-ETHYL-_-ETHYLPHENETHYLAMINE",NA,1
"N-ETHYL-ÃŽÂ±-ETHYLPHENETHYLAMINE",NA,1
"N-ETHYLBENZYLAMINE",NA,1
"N-FORMYL AMPHETAMINE",NA,1
"N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE",NA,1
"N-HYDROXY-3,4-METHYLENEDIOXYMETHAMPHETAMINE",NA,1
"N-ISOPROPYLBENZYLAMINE",NA,1
"N-METHAMPHETAMINE",NA,1
"N-METHYL-1-(1,3-BENZDIOXOL-5-YL)-2-BUTANAMINE",NA,1
"N-METHYL-1-{4-[2-(METHYLAMINO) PROPYL]PHENYL}-1-PHENYLPROPAN-2-AMINE",NA,1
"N-METHYL-2-PHENYLACETAMIDE",NA,1
"N-METHYL-2-PYRROLIDONE",NA,1
"N-METHYL-3,4-METHYLDIOXYPHENYLISOPROPYLAMINE (ECSTASY)",NA,1
"N-METHYL-N-TIMETHYLSILYLTRIFLUOROACETAMIDE",NA,1
"N-METHYLBENZYLAMINE",NA,1
"N-METHYLTYRAMINE",NA,1
"N-MONO-DESMETHYLSIBUTRAMINE",NA,1
"N-NORLAUDANIDINE",NA,1
"N-OXIDATION",NA,1
"N-PIPERIDINYL ETONITAZENE ‘ETONITAZEPIPNE’",NA,1
"N-PLS",NA,1
"N-SUBSTITUTED AMPHETAMINES",NA,1
"N-WAY PARTIAL LEAST SQUARES (N-PLS)",NA,1
"N -BENZYL PHENETHYLAMINES",NA,1
"N -DESMETHYL ZOPICLONE",NA,1
"N N-DIMETHYLTRYPTAMINE",NA,1
"N,N-BIS(1-PENTYLINDOL-3-YL-CARBOXY)NAPHTYLAMINE (BIPICANA)",NA,1
"N,N-DIISOPROPYL-5-METHOXYINDOLE-3- GLYOXYLAMIDE",NA,1
"N,N-DIISOPROPYL-5-METHOXYTRYPTAMINE",NA,1
"N,N-DIMETHYL-2-(2,3- AND 3,4-METHYLENEDIOXYPHENYL)ETHANAMINE",NA,1
"N,N-DIMETHYL-2-(METHOXYMETHYLPHENYL)ETHANAMINE",NA,1
"N_-DIMETHYL-3,4-DIPHENYLHEXANE-2,5-DIAMINE",NA,1
"NÃ¢Â‚¬Â€ŒOH-EDMA",NA,1
"NAÃƑÆ’Ã‚Â¯VE BAYES CLASSIFIERS",NA,1
"NABILONE",NA,1
"NAC",NA,1
"NACL CRYSTAL",NA,1
"NÃƑÂ¢Ã‚Â‚¬Ã‚Â²-DIMETHYL-3,4-DIPHENYLHEXANE-2,5-DIAMINE",NA,1
"NAFION",NA,1
"NAGAI REACTION",NA,1
"NALBUPHINE HYDROCHLORIDE",NA,1
"NALORPINE",NA,1
"NANDROLONE AND PROHORMONES",NA,1
"NANDROLONE DECANOATE",NA,1
"NANDROLONE METABOLITE",NA,1
"NANO-STRUCTURED LEAD DIOXIDE",NA,1
"NANO GRAPHENE",NA,1
"NANO LIQUID CHROMATOGRAPHY",NA,1
"NANOARCHITECTONICS",NA,1
"NANOARCHITECTURE",NA,1
"NANOCLUSTERS",NA,1
"NANOCONFINEMENT",NA,1
"NANOCRYSTALLINE MATERIALS",NA,1
"NANODIAMOND",NA,2
"NANOELECTROSPRAY",NA,2
"NANOFIBER",NA,2
"NANOFIBRE MAT",NA,1
"NANOMIPS",NA,1
"NANOPAPER",NA,1
"NANOPARTICLE MODIFIERS",NA,1
"NANOPETAL-STRUCTURED MOWS2",NA,1
"NANOSCALE PROBES",NA,1
"NANOSTRUCTURE",NA,2
"NANOZYME",NA,1
"NAOH",NA,1
"NAPHTHALENE DERIVATIVE",NA,1
"NAPHTHOFURAN",NA,1
"NAPHTHOLS",NA,1
"NAPHTHYLPYROVALERONE",NA,1
"NAPROXEN",NA,2
"NAPROXEN SODIUM",NA,2
"NARCEINE",NA,1
"NARCOLEPSY",NA,2
"NARCOTIC ANALGESIC",NA,1
"NARCOTIC PLANT",NA,1
"NARCOTIC PLANTS",NA,1
"NARCOTIC SEIZURE",NA,1
"NARCOTIC SUBSTANCES CATIONS",NA,1
"NARCOTICS CONTROL",NA,1
"NARCOTICS DETECTION",NA,4
"NARCOTICS IDENTIFICATION WITH MID-IR, RAMAN AND NIR",NA,1
"NARINGENIN",NA,1
"NARROW-BORE COLUMNS",NA,1
"NASAL ABSORPTION",NA,1
"NASAL ABUSE",NA,1
"NATIONAL DRUG MONITORING",NA,1
"NATIONAL INSTITUTE OF FORENSIC SCIENCE",NA,1
"NATIONAL PARKS",NA,1
"NATIVE ÃƑÅ½Ã‚Â²-CYCLODEXTRIN",NA,1
"NATIVE AMERICAN CHURCH",NA,1
"NATIVE FLUORESCENCE",NA,2
"NATIVE NESI-MS",NA,1
"NATIVE VEGETATION",NA,1
"NATIVE Β-CYCLODEXTRIN",NA,2
"NATURAL ABUNDANCE",NA,1
"NATURAL ATTENUATION",NA,1
"NATURAL CONTAMINANT ATTENUATION",NA,1
"NATURAL ISOTOPIC ABUNDANCES MEASUREMENT",NA,1
"NATURAL LANGUAGE PROCESSING",NA,2
"NATURAL MEDICINE",NA,1
"NATURAL PRODUCT PHARMACEUTICALS",NA,1
"NATURAL PRODUCTS POTENTIAL",NA,1
"NATURAL WATER",NA,3
"NATURAL WEIGHT LOSS PILLS",NA,1
"NATURE OF CHEMISTRY",NA,1
"NAVIPPRO",NA,2
"NBD-F",NA,1
"NBOME COMPOUNDS",NA,1
"NBOME SERIES",NA,1
"NCBI AND USDA DATABASES",NA,1
"NDEI AND TAQI SITE PCR-RFLP",NA,1
"NEAPOLITAN AREA",NA,1
"NEAR INFRARED DIFFUSE REFLECTANCE SPECTROSCOPY",NA,1
"NEAR INFRARED SPECTROSCOPY DISCRIMINATING ABILITY",NA,1
"NEAT ORAL FLUID",NA,1
"NEEDLE-EXCHANGE PROGRAMMES",NA,2
"NEO-CLERODANE DITERPENE",NA,1
"NEOCLERODANE",NA,1
"NEOECHINULIN A",NA,1
"NEOMORPHINE",NA,1
"NEOPINE",NA,1
"NEOTROPICAL FLORA",NA,1
"NEPHRITE",NA,1
"NESTED CROSS-VALIDATION",NA,1
"NETHERLANDS",NA,1
"NETWORK SCALE UP",NA,1
"NETWORKS",NA,1
"NEURODEGENERATIVE DISORDERS",NA,1
"NEUROPHARMACOLOGY",NA,2
"NEUROTRANSMISSION",NA,1
"NEUROTRANSMITTER",NA,2
"NEUROTRANSMITTER TRANSPORTER",NA,1
"NEUTRAL AND ACIDIC IMPURITIES",NA,1
"NEUTRAL CANNABINOIDS",NA,1
"NEUTRAL LOSS",NA,2
"NEUTRAL LOSS SCAN",NA,1
"NEUTRAL RACEMATES",NA,1
"NEUTRAL SALT",NA,1
"NEUTRON ABSORPTION",NA,1
"NEUTRON DOSIMETRY",NA,1
"NEUTRON FLUX DETERMINATION",NA,1
"NEUTRON MODERATION",NA,1
"NEUTRON MODERATION AND DIFFUSION",NA,1
"NEUTRON SPECTROMETRY",NA,1
"NEW CATHINONE DERIVATIVES",NA,1
"NEW DIETARY INGREDIENT",NA,1
"NEW NEXUS",NA,1
"NEW RING OPENED ISOMER OF A-796,260",NA,1
"NEW SOUTH WALES",NA,1
"NEW SYNTHETIC DRUGS",NA,1
"NEW SYNTHETIC OPIOIDS (NSO)",NA,1
"NEW SYNTHETIC OPIOIDS (NSOS)",NA,1
"NEW TADALAFIL ANALOG",NA,1
"NHSDA",NA,1
"NI",NA,1
"NI-CATALYZED CARBOXYLATION",NA,1
"NICOCODEINE",NA,1
"NICOMORPHINE",NA,1
"NIDA",NA,2
"NIFS",NA,1
"NIGHTCLUB AND FESTIVAL ATTENDEES",NA,1
"NIKETHAMIDE",NA,1
"NIO-SWCNTS",NA,1
"NIO@CNTS NANOCOMPOSITE",NA,1
"NIR-CI",NA,1
"NIR HYPERSPECTRAL IMAGING",NA,1
"NIR IMAGING APPLICATIONS IN PHARMACEUTICAL INDUSTRY - CONTRACTED OUT FOR INTERMEDIATE-SIZED ONES",NA,1
"NIR SPECTROSCOPY (NIRS), ACROSS INDUSTRIES",NA,1
"NIRS",NA,3
"NIST SRM-2585 HOUSE DUST STANDARD REFERENCE MATERIAL",NA,1
"NIST SRM 1570A SPINACH",NA,1
"NITAZENES",NA,1
"NITROCELLULOSE MEMBRANE",NA,1
"NITROGEN-DOPING",NA,1
"NITROGEN-SUBSTITUTED MDA ANALOGUES",NA,1
"NITROGEN HETEROCYCLES",NA,2
"NITROGEN ISOTOPIC ABUNDANCE MEASUREMENT",NA,1
"NITROGEN ISOTOPIC RATIO",NA,1
"NITROGENOUS COMPOUND",NA,1
"NITROPROPENE ROUTE",NA,1
"NKTR-181",NA,1
"NLC-MS/MS",NA,1
"NLO AND NBO ANALYSIS",NA,1
"NLSU RRNA",NA,1
"NMDA",NA,1
"NMP",NA,1
"NMR ASSIGNMENT",NA,1
"NMR CHEMICAL SHIFTS",NA,1
"NMR DATA",NA,1
"NMR SCREENING",NA,1
"NMR SPECTRA",NA,1
"NNL-1",NA,1
"NNL-2",NA,1
"NO-D NMR",NA,1
"NO INHIBITION",NA,1
"NO3-",NA,1
"NOCICEPTIN ORPHANIN FQ PEPTIDE",NA,1
"NOCLERODANE DITERPENE",NA,1
"NODE",NA,1
"NOEPHEDRINE",NA,1
"NOESY",NA,1
"NOISY THZ PULSE",NA,1
"NON-AQUEOUS EMULSIONS",NA,1
"NON-AQUEOUS MEDIA",NA,1
"NON-CANNABINOID",NA,1
"NON-CANNABINOIDS",NA,1
"NON-CONGRUENT IMAGE CLASSIFICATION",NA,1
"NON-CONTROLLED SUBSTANCES",NA,1
"NON-EFFERVESCENT",NA,1
"NON-ENZYMATIC SENSING",NA,1
"NON-FOURIER METHODS",NA,1
"NON-LICENSED PHARMACEUTICALS",NA,1
"NON-LINEAR EFFECTS",NA,1
"NON-MEDICAL USE",NA,2
"NON-MEDICINAL",NA,1
"NON-METABOLIZABLE POLYMER",NA,1
"NON-MODEL SYSTEMS",NA,1
"NON-OPIOIDS",NA,1
"NON-PARAMETRIC MEASURE",NA,1
"NON-PARAMETRIC STATISTICS",NA,1
"NON-POROUS STATIONARY PHASE",NA,1
"NON-PRESCRIPTION DRUG",NA,1
"NON-PSEUDO ALTERNATIVES",NA,1
"NON-SELECTIVE RECEPTOR BINDING",NA,1
"NON-TARGET ANALYSIS",NA,1
"NON-TARGET IDENTIFICATION",NA,1
"NON-TARGETED CHEMICAL ANALYSIS",NA,1
"NON-TARGETING QUICK SCREENING",NA,1
"NONAQUEOUS CAPILLARY ELECTROCHROMATOGRAPHY",NA,1
"NONAQUEOUS CAPILLARY ELECTROPHORESIS",NA,7
"NONAQUEOUS CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRY",NA,1
"NONAQUEOUS MEDIA",NA,1
"NONBIOLOGICAL MATERIALS",NA,1
"NONFIBER COMPONENTS",NA,1
"NONINVASIVE QUALITATIVE AND QUANTITATIVE ANALYSIS",NA,1
"NONIONIC SURFACTANT",NA,2
"NONLINEAR BEHAVIOR",NA,1
"NONMEDICAL USE",NA,1
"NONMEDICAL USE OF PRESCRIPTION DRUGS",NA,1
"NONPARAMETRIC DENSITY ESTIMATION",NA,1
"NONPAREIL SUGAR SEEDS",NA,1
"NONTARGET SCREENING",NA,1
"NONVOLATILE COMPOUNDS",NA,1
"NORADRENALINE",NA,1
"NORBEOCYSTIN",NA,1
"NORCODEINE",NA,1
"NORDIHYDROGUAIARETIC ACID",NA,1
"NOREPINEPHRINE",NA,1
"NORETHISTERONE",NA,1
"NORFLUNITRAZEPAM",NA,1
"NORHEROIN",NA,1
"NORM INDEX",NA,1
"NORMAL- AND RESERVED-PHASE STATIONARY PHASES",NA,1
"NORMAL-PHASE LIQUID CHROMATOGRAPHY",NA,1
"NORMAL COORDINATE ANALYSIS",NA,1
"NORMAL PHASE MODE",NA,1
"NORORIPAVINE SYNTHESIS",NA,1
"NORTH AMERICA",NA,2
"NORTHEASTERN CHINA",NA,1
"NOSCAPINE ADDITION",NA,1
"NOTOGINSENG",NA,1
"NOVEL SYNTHETIC OPIOID",NA,1
"NOZZLE-SKIMMER DISSOCIATION",NA,1
"NP-HPLC",NA,1
"NPS OF NATURAL ORIGIN",NA,1
"NPS OPIOIDS",NA,1
"NPSS",NA,1
"NRG-3",NA,1
"NSD",NA,1
"NTRACLUSTER CORRELATIONS",NA,1
"NUCIFERINE",NA,1
"NUCLEAR QUADRUPOLE RESONANCE",NA,1
"NUCLEAR RIBOSOMAL DNA",NA,1
"NUCLEAR RIBOSOMAL DNA (NRDNA)",NA,1
"NUCLEOPHILIC SUBSTITUTION REACTION",NA,1
"NUCLEOSIDES",NA,1
"NUCLEOTIDE SIGNATURE",NA,1
"NUMERICAL TAXONOMY",NA,1
"NUMERICALLY UNITARY STRUCTURE INDICES",NA,1
"NUTMEG",NA,1
"NUTRACEUTICALS",NA,1
"NUTRIENT UPTAKE",NA,1
"NUTRITIONAL SUPPLEMENTS",NA,5
"NYAOPE",NA,2
"O- COUMARIC ACID",NA,1
"O-2482",NA,1
"O-6-ACETYLMORPHINE",NA,1
"O-ACETYLPSILOCIN",NA,1
"O-BENZENESULFONAMIDO-P-BENZOQUINONE",NA,1
"O-DEMETHYLATION",NA,1
"O-METHYLTRANSFERASE",NA,1
"O-PHENYLENEDIAMINES",NA,2
"O-TMS, N-TFA DERIVATIVES",NA,1
"O,OÃƑÂ¢Ã¢Â€ŠÂ¬Ã‚Â²-DI-P-TOLUOYLTARTARIC ACID",NA,1
"O,OÃƑÂ¢Ã¢Â€ŠÂ¬Ã‚Â²-DIBENZOYLTARTARIC ACID",NA,1
"OAT",NA,1
"OBJECT-BASED CLASSIFICATION",NA,1
"OBJECT DETECTION",NA,1
"OBJECTIVE PEOPLE",NA,1
"OCCLUDED SOLVENT ANALYSIS",NA,1
"OCCUPATIONAL HEALTH PSYCHOLOGY",NA,1
"OCCUPATIONAL HYGIENE",NA,1
"OCCUPATIONAL PHYSICIAN",NA,1
"OCCURRENCE",NA,9
"OCHRATOXIN A",NA,1
"ODOR CONCENTRATION",NA,1
"ODOUR SIGNATURES",NA,1
"Œ±-CYANO-4-HYDROXYCINNAMIC ACID (CHCA)",NA,1
"Œ±-CYCLODEXTRIN",NA,1
"Œ±-GLYCOPROTEIN",NA,1
"Œ±-LITHIATION",NA,1
"Œ±-PYRROLIDINOPHENONE SUBSTRUCTURE",NA,1
"Œ∫-OPIOID RECEPTOR",NA,1
"Œ∫ OPIOID-RECEPTOR",NA,1
"Œ∫ OPIOID RECEPTOR",NA,1
"Œ≤-AGONISTS",NA,1
"Œ≤-BLOCKERS",NA,2
"Œ≤-CD",NA,2
"Œ≤-CIT",NA,1
"Œ≤-CYCLODEXTRIN",NA,3
"Œ≤-CYCLODEXTRIN DERIVATIVE",NA,1
"Œ≥- HYDROXYBUTYRIC ACID",NA,1
"Œ≥-AMINO-Œ≤-HYDROXYBUTYRIC ACID",NA,1
"Œ≥-AMINO-Œ≤-HYDROXYPROPYLPHOSPHONIC ACID",NA,1
"Œ≥-BUTYROLACTONE (GBL)",NA,1
"Œ≥-HYDROXYBUTYRATE",NA,1
"Œ≥-HYDROXYBUTYRATE (GHB)",NA,1
"Œ≥-HYDROXYBUTYRIC ACID",NA,4
"Œ≥-HYDROXYVALERIC ACID",NA,1
"ŒÄ-ŒÄ INTERACTION",NA,1
"ŒÎ9-THC",NA,1
"ŒÎ9-THCA-A",NA,1
"OESTRADIOL",NA,1
"OIL",NA,2
"OIL CAKES",NA,1
"OIL SAMPLES",NA,1
"OILSEED",NA,1
"OLEAMIDE",NA,1
"OLEIC ACID",NA,1
"OLEUROPEIN",NA,1
"OLIVE BIOPHENOLS",NA,1
"OLIVE OIL",NA,3
"OLIVE TREE VARIETIES",NA,1
"OLIVETOL SYNTHASE",NA,1
"OMEBZPS",NA,1
"OMETHYLTRANSFERASE",NA,1
"ON-CHIP SEPARATION",NA,1
"ON-COLUMN CONCENTRATION",NA,1
"ON-COLUMN DERIVATIZATION",NA,2
"ON-LINE BACK-EXTRACTION",NA,1
"ON-LINE COLLECTION/CONCENTRATION",NA,1
"ON-LINE CONCENTRATION",NA,1
"ON-LINE DERIVATIZATION",NA,2
"ON-LINE FRACTIONATION",NA,1
"ON-LINE REGENERATION SYSTEM",NA,1
"ON-LINE SEARCH",NA,1
"ON-LINE TLC/MS",NA,1
"ON-SITE DRUG DETECTION",NA,1
"ON-SITE DRUG SCREENING",NA,1
"ON-SITE IDENTIFICATION",NA,1
"ON-SITE MASS SPECTROMETRY",NA,1
"ON RECEIPT INSPECTION",NA,2
"ONCE DAILY",NA,1
"ONE-DIMENSIONAL ROESY",NA,1
"ONLINE COMMUNITY",NA,2
"ONLINE CONCENTRATION",NA,1
"ONLINE DETECTION",NA,1
"ONLINE DRUG RESOURCES",NA,1
"ONLINE FORA",NA,1
"ONLINE ILLICIT DRUG SALES",NA,1
"ONLINE INFORMATION",NA,1
"ONLINE MARKETS",NA,1
"ONLINE MASS SPECTROMETRY",NA,1
"ONLINE MEDICINES",NA,1
"ONLINE PHARMACY",NA,1
"ONLINE PURCHASING",NA,1
"ONLINE QUANTIFICATION",NA,1
"ONLINE SHOPS",NA,1
"ONLINE SPE",NA,3
"ONLINE TRAFFIC ANALYSIS",NA,1
"ONTOGENY",NA,1
"OPEN-CHAIN FENTANYL ANALOGUES",NA,1
"OPEN-TUBULAR CAPILLARY ELECTROCHROMATOGRAPHY",NA,1
"OPEN PORT PROBE",NA,1
"OPENMSÃ‚Â®",NA,1
"OPIATE-DERIVED PHARMACEUTICALS",NA,1
"OPIATE ALKALOID BIOSYNTHESIS",NA,1
"OPIATE DETECTION",NA,1
"OPIATE DRUGS",NA,1
"OPIATE PAIN RELIEF DRUGS",NA,1
"OPIATE USE",NA,2
"OPINION MINING",NA,1
"OPIOID-RECEPTORS",NA,1
"OPIOID ACTIVITY",NA,1
"OPIOID ANALGESIC DRUGS",NA,1
"OPIOID ANTAGONIST",NA,2
"OPIOID CERTIFIED REFERENCE MATERIAL KIT",NA,1
"OPIOID CONSUMPTION",NA,1
"OPIOID CRM KIT",NA,1
"OPIOID DIVERSION",NA,1
"OPIOID INDUCED CONSTIPATION",NA,1
"OPIOID NPS",NA,1
"OPIOID OVERDOSE CRISIS",NA,1
"OPIOID POISONING",NA,1
"OPIOID PRICES",NA,1
"OPIUM CULTIVATION",NA,1
"OPIUM MARC",NA,2
"OPIUM POPPY (PAPAVER SOMNIFERUM)",NA,1
"OPIUM POPPY ALKALOIDS",NA,1
"OPIUM POPPY FIELD",NA,1
"OPIUM POPPY PROCESSING WASTE",NA,1
"OPIUM TINCTURE",NA,1
"OPIUM USE MARKER",NA,1
"OPIUM/HEROIN, COCA/COCAINE, CANNABIS AND AMPHETAMINE-TYPE",NA,1
"OPLC",NA,1
"OPLS-DA",NA,1
"OPTICAL CHEMICAL SENSOR",NA,1
"OPTICAL FIBER IMMUNOSENSOR",NA,1
"OPTICAL FIBRE",NA,1
"OPTICAL FIBRE LONG PERIOD GRATING",NA,1
"OPTICAL FIBRE SENSOR",NA,1
"OPTICAL ISOMER",NA,2
"OPTICAL PARAMETRIC GENERATION",NA,1
"OPTIMAL MIXTURE SIZE",NA,1
"OPTOELECTRONICS",NA,1
"OPTOPLASMONIC MATERIAL",NA,1
"ORAL DRUGS",NA,1
"ORAL MORPHINE EQUIVALENTS",NA,1
"ORAL ROUTE",NA,1
"ORAL SPRAY",NA,1
"ORALLY DISPERSIBLE TABLETS",NA,1
"ORANGE I",NA,1
"ORANGE JUICE",NA,1
"ORBITAL",NA,1
"ORCINOL",NA,1
"OREGANO",NA,1
"ORG OD14",NA,1
"ORGANIC AGRICULTURE",NA,1
"ORGANIC ANALYSIS",NA,1
"ORGANIC CATION EFFECT",NA,1
"ORGANIC FIELD-EFFECT TRANSISTORS",NA,1
"ORGANIC FOOD",NA,2
"ORGANIC MICROPOLLUTANTS",NA,1
"ORGANIC MODIFIER",NA,1
"ORGANIC POLLUTION INDICATOR",NA,1
"ORGANIC THIN-FILM TRANSISTORS",NA,1
"ORGANOCATALYSIS",NA,1
"ORGANOELECTRONICS",NA,1
"ORGANOGENESIS",NA,1
"ORGANOSILANE ADLAYER",NA,1
"ORGANOTIN DITHIOCARBAMATE",NA,1
"ORIENTAL CERAMICS",NA,1
"ORIGIN DETERMINATION",NA,1
"ORIGIN DIFFERENTIATION",NA,1
"ORIGIN IDENTIFICATION",NA,1
"ORIPAVINE SYNTHESIS",NA,1
"ORMOSILS",NA,1
"OROS",NA,1
"ORTHO EFFECT",NA,2
"ORTHOGONAL",NA,2
"ORTHOGONAL ARRAY DESIGN",NA,1
"ORTHOGONAL CHROMATOGRAPHIC SYSTEMS",NA,1
"ORTHOGONAL CHROMATOGRAPHY",NA,1
"ORTHOGONAL COLUMN SELECTION",NA,1
"ORTHOGONAL LIQUID CHROMATOGRAPHY",NA,1
"ORTHOGONAL PROJECTION",NA,1
"ORTHOGONAL SEPARATION",NA,1
"ORTHOGONALITY",NA,1
"ORVINOLS",NA,1
"OSIAP MONITORING PROGRAM",NA,1
"OSSS-IU-PARAFAC",NA,1
"OTA",NA,1
"OTHER",NA,1
"OUTCOME MEASURE: BEHAVIORAL",NA,1
"OUTLIER DETECTION",NA,1
"OVER-EXPRESSION",NA,1
"OVER-THE-COUNTER",NA,1
"OVER PRESSURED-LAYER CHROMATOGRAPHY",NA,1
"OVERDOSE DEATH",NA,1
"OVERPRESCRIBING",NA,1
"OVERPRESSURED-LAYER CHROMATOGRAPHY (OPLC)",NA,1
"OXAZOLIDINONES",NA,1
"OXIDATION DERIVATIZATION",NA,1
"OXIDATION OF PHENYLACETALDEHYDE",NA,1
"OXIDATION REACTION",NA,1
"OXIDATION STABILITY",NA,1
"OXIDATIVE PYROLYSIS",NA,1
"OXIDATIVE STABILITY",NA,2
"OXIME",NA,1
"OXINDOLE ALKALOID",NA,1
"OXINDOLE ALKALOIDS",NA,1
"OXYCODONE-NALOXONE",NA,1
"OXYCODONE CR",NA,1
"OXYCODONE DETERX",NA,1
"OXYCONTIN",NA,4
"OXYGEN-18",NA,3
"OXYGEN DETERMINATION",NA,1
"OXYGEN HETEROCYCLES",NA,1
"OXYGENATED CANNABINOIDS",NA,1
"OXYHALIDES",NA,1
"OXYTOCIC ACTIVITY",NA,1
"OXYTONA",NA,1
"OZONE OXIDATION",NA,1
"P-AMINOPHENOL",NA,1
"P-AMINOSTYRENE",NA,1
"P-COUMAROYLTYRAMINE",NA,1
"P-SULFONATED CALIX[6]ARENE",NA,1
"P. BRACTEATUM",NA,1
"P. ORIENTALE",NA,1
"P. PSEUDO-ORIENTALE",NA,1
"P.E.P. PILLS",NA,1
"P7AICA",NA,1
"PACE",NA,1
"PACIFIC",NA,2
"PAEDIATRICS",NA,1
"PAIN-KILLERS",NA,1
"PAIN MEDICINE",NA,1
"PAIN RELIEF",NA,2
"PAIN TREATMENT",NA,1
"PAIN, POSTOPERATIVE",NA,1
"PAIR DISTRIBUTION FUNCTION",NA,1
"PALAUDINE",NA,1
"PALLADACYCLES",NA,1
"PALLADIUM",NA,1
"PALLADIUM CATALYST",NA,1
"PALLADIUM NANOPARTICLES",NA,1
"PALMITIC ACID",NA,2
"PANICLE STEM LENGTH",NA,1
"PAPAVER ALKALOIDS",NA,1
"PAPAVER BRACTEATUM",NA,1
"PAPAVER NUDICAULE",NA,1
"PAPAVER ORIENTALE L",NA,1
"PAPAVER PLANTS",NA,1
"PAPAVER RHOEAS",NA,3
"PAPAVER SOMNIFERUM ALKALOIDS",NA,1
"PAPAVER SPECIES",NA,1
"PAPAVERACEAE",NA,3
"PAPAVERINE BIOSYNTHESIS",NA,1
"PAPAVERINE HYDROCHLORIDE",NA,1
"PAPER-BASED DEVICE",NA,2
"PAPER-STRIP ASSAY",NA,1
"PAPER CHROMATOGRAPHY",NA,1
"PAPER SENSOR",NA,1
"PAPER TEST",NA,1
"PARA-FLUOROPHENYLPIPERAZINE",NA,1
"PARA-METHOXYAMPHETAMINE",NA,1
"PARA-METHYL-4-METHYLAMINOREX",NA,1
"PARABENS",NA,3
"PARACETAMOL (ACETAMINOPHEN)",NA,1
"PARAFAC AND PARAFAC2",NA,1
"PARAFFIN-IMPREGNATED GRAPHITE ELECTRODE",NA,1
"PARALLEL FACTOR ANALYSIS",NA,1
"PARALLEL SEGMENTED FLOW CHEMILUMINESCENCE DETECTION",NA,1
"PARAMETER ESTIMATION",NA,2
"PARETO-OPTIMALITY",NA,1
"PARTIAL-FILLING",NA,1
"PARTIAL-FILLING-MICELLAR ELECTROKINETIC CHROMATOGRAPHY",NA,1
"PARTIAL-LEAST-SQUARES ANALYSIS",NA,1
"PARTIAL FILLING",NA,3
"PARTIAL FILLING MICELLAR ELECTROKINETIC CHROMATOGRAPHY",NA,3
"PARTIAL LEAST SQUARES- LEAST SQUARES- SUPPORT VECTOR MACHINES",NA,1
"PARTIAL LEAST SQUARES ALGORITHM",NA,1
"PARTIAL LEAST SQUARES ANALYSIS",NA,1
"PARTIAL LEAST SQUARES METHOD",NA,1
"PARTIAL ONSET SEIZURES",NA,1
"PARTICLE-LOADED MONOLITHS",NA,1
"PARTICULATE MATTER",NA,1
"PARTY DRUGS",NA,1
"PARTY PILL",NA,4
"PASSIVE SAMPLING",NA,2
"PAT",NA,5
"PATENT INFRINGEMENT",NA,1
"PATH ANALYSIS",NA,1
"PATHOGENESIS OF ADDICTION",NA,1
"PATTERN ARRAY",NA,1
"PATTERN COMPARISON",NA,1
"PATTERN RECOGNITION METHODS",NA,1
"PATTERN RECOGNITION TECHNIQUES",NA,2
"PATTERNS IN THE STATE OF NATURE",NA,1
"PATTERNS OF USE",NA,2
"PAUSONÃ¢Â‚¬Â€ŒKHAND REACTION",NA,1
"PAVEROLINES",NA,1
"PAW-PRESSURE TEST",NA,1
"PB",NA,1
"PCC",NA,1
"PCEPA",NA,1
"PCR-RESTRICTION FRAGMENT-LENGTH POLYMORPHISM (RFLP)",NA,1
"PCR-RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP) METHOD",NA,1
"PDC",NA,1
"PDE-5 ANALOGUES",NA,1
"PDE-5 INHIBITORS AND THEIR ANALOGUES",NA,1
"PDE-5I",NA,1
"PDE5IS",NA,1
"PDMA",NA,1
"PDO",NA,1
"PEAK ASYMMETRY",NA,1
"PEAK HEIGHT QUANTITATION",NA,1
"PEAK IDENTIFICATION",NA,1
"PEAK RECOGNITION ALGORITHM",NA,1
"PEAK TRACKING",NA,1
"PEARSON-CORRELATION COEFFICIENTS COLOR MAP",NA,1
"PED",NA,1
"PEG-RHGH",NA,1
"PEGANINE (VASICINE)",NA,1
"PEGANUM HARMALA L.",NA,1
"PEGYLATION SITE",NA,1
"PELLAEA TERNIFOLIA",NA,1
"PENCIL GRAPHITE ELECTRODE",NA,5
"PENICILLAMINE SULFONIC ACID",NA,1
"PENICILLIUM COMMUNE",NA,1
"PENTAFLUOROPHENYLPROPYL",NA,1
"PENTANOL",NA,1
"PENTANONE",NA,1
"PENTYLONE",NA,2
"PEOPLE WHO INJECT DRUGS",NA,1
"PEOPLE WHO INJECT DRUGS (PWID)",NA,1
"PEPPER",NA,1
"PEPTIDE FRAGMENTATION",NA,1
"PEPTIDE HORMONES",NA,2
"PERFLUOROACYL DERIVATIVES",NA,1
"PERFLUOROALKYLATION",NA,1
"PERFLUOROHEPTANOIC ACID",NA,1
"PERFLUOROOCTYL STATIONARY PHASE",NA,1
"PERFLUOROPROPIONYLATION",NA,1
"PERFORMANCE-ENHANCING SUBSTANCES",NA,1
"PERFORMANCE VERIFICATION TEST",NA,1
"PERFUME",NA,1
"PERICARPIUM PAPAVERIS",NA,1
"PERICARPIUM PAPEVERIS",NA,1
"PERIODIC TABLE",NA,1
"PERIPHERAL NEUROPATHY",NA,1
"PERIWINKLE",NA,1
"PERMANGANATE",NA,1
"PERMETHYL-Œ≤-CYCLODEXTRIN",NA,1
"PERONOSPORA ARBORESCENS",NA,1
"PERPHENAZINE",NA,1
"PERSIAN POPPY",NA,1
"PERSONAL DEVICE",NA,1
"PERSONALITY MEASURES",NA,1
"PERYLENE BISIMIDE",NA,1
"PESHAWAR",NA,1
"PESTICIDE RESIDUES",NA,1
"PETAL IDENTITY",NA,1
"PETITE MUTANTS",NA,1
"PEYOTE CACTUS",NA,1
"PFNA",NA,1
"PFPP",NA,1
"PGP KEY",NA,1
"PH GRADIENT",NA,1
"PH GRADIENT CHROMATOGRAPHY",NA,1
"PH/ORGANIC MODIFIER",NA,1
"PHALARIS AQUATICA",NA,1
"PHALLOTOXIN",NA,2
"PHARMACEUTICAL AMINES",NA,1
"PHARMACEUTICAL ANALYSIS VALIDATION",NA,1
"PHARMACEUTICAL APPLICATIONS",NA,2
"PHARMACEUTICAL CHARACTERIZATION",NA,1
"PHARMACEUTICAL CHEMISTRY",NA,1
"PHARMACEUTICAL COMPACTION",NA,1
"PHARMACEUTICAL COMPOUNDS",NA,1
"PHARMACEUTICAL CONTAMINATION",NA,1
"PHARMACEUTICAL COUNTERFEITING PROBLEM",NA,1
"PHARMACEUTICAL DEVELOPMENT",NA,1
"PHARMACEUTICAL DRUG SUBSTANCE",NA,1
"PHARMACEUTICAL IMPURITY",NA,3
"PHARMACEUTICAL INGREDIENTS",NA,2
"PHARMACEUTICAL MEDICATIONS",NA,1
"PHARMACEUTICAL PRODUCT SCREENING",NA,1
"PHARMACEUTICAL PRODUCTS",NA,1
"PHARMACEUTICAL PROFILING",NA,1
"PHARMACEUTICAL QUALITY CONTROL",NA,1
"PHARMACEUTICAL REGULATION",NA,1
"PHARMACEUTICAL SAMPLES",NA,3
"PHARMACEUTICAL SCIENCE",NA,1
"PHARMACEUTICAL SEPARATIONS",NA,1
"PHARMACEUTICAL TABLET",NA,2
"PHARMACEUTICAL TECHNOLOGY",NA,1
"PHARMACEUTICALS EXCIPIENTS",NA,1
"PHARMACEUTICS",NA,1
"PHARMACOECONOMICS",NA,1
"PHARMACOKINET",NA,1
"PHARMACOKINETIC ANALYSIS",NA,1
"PHARMACOLOGICAL ACTIVITY",NA,1
"PHARMACOLOGICAL EFFECT",NA,1
"PHARMACOLOGICAL FORMULATION",NA,1
"PHARMACOLOGICAL PROFILING",NA,1
"PHARMACOPOEIA",NA,1
"PHASE CORRECTION",NA,1
"PHASE SOLUBILITY METHOD",NA,1
"PHENCYCLIDINE DERIVATIVES, Œ±-TETRALONE, ANALGESIC EFFECT, PHASIC PAIN, SYNTHESIS",NA,1
"PHENETHYLAMINE ALKALOIDS",NA,1
"PHENETHYLAMINES, HEPTAKIS(2,3-DIACETYL)-ÃƑÅ½Ã‚Â²-CYCLODEXTRIN",NA,1
"PHENIBUT",NA,1
"PHENILPROPANOLAMINE HYDROCHLORIDE",NA,1
"PHENOBARBITAL/MICROEMULSION SYSTEM/EVALUATION",NA,1
"PHENOL DETECTION",NA,1
"PHENOLIC PROFILE/BIOACTIVITIES",NA,1
"PHENOLOGY",NA,1
"PHENOMENEX C-18",NA,1
"PHENOTYPIC VARIATION",NA,1
"PHENOXAZINE",NA,1
"PHENYL PROPANOLAMINE HYDROCHLORIDE",NA,1
"PHENYLACETALDEHYDE",NA,1
"PHENYLACETONE",NA,1
"PHENYLACETYLCARBINOL",NA,5
"PHENYLALANINE",NA,1
"PHENYLALKYLAMINE ALKALOID",NA,2
"PHENYLEPHRINE",NA,4
"PHENYLPIPERAZINE DERIVATIVES",NA,1
"PHENYLPROPANOIDS",NA,1
"PHENYLPROPANOLAMINE HYDROCHLORIDE",NA,1
"PHENYLPROPYLAMINO ALKALOIDS",NA,2
"PHENYLPYRUVIC ACID",NA,1
"PHENYLUREAS",NA,1
"PHEOPHYTINS",NA,1
"PHILOSOPHY",NA,2
"PHLOEM FIBRES",NA,1
"PHOSPHATE BUFFER",NA,1
"PHOSPHIDE",NA,1
"PHOSPHOCARNITINE",NA,1
"PHOSPHODIESTERASE-5",NA,2
"PHOSPHODIESTERASE TYPE 5 ENZYME INHIBITORS",NA,1
"PHOSPHODIESTERASE TYPE 5(PDE-5)",NA,1
"PHOSPHOLIPASE GENE",NA,1
"PHOSPHORESCENCE",NA,1
"PHOSPHORUS-DOPED GLASSY CARBON ELECTRODE",NA,1
"PHOSPHORYLATION",NA,2
"PHOSPHOTUNGSTIC ACID",NA,1
"PHOTO-CATALYSIS",NA,1
"PHOTO-ELECTROCHEMICAL",NA,1
"PHOTO-OXIDATION PROCESSES",NA,1
"PHOTOACOUSTIC SPECTROSCOPY",NA,1
"PHOTOCATALYSIS",NA,2
"PHOTOCHEMISTRY",NA,2
"PHOTODIODE ARRAY",NA,1
"PHOTOELECTROCHEMICAL SENSOR",NA,1
"PHOTOELECTROCHEMISTRY",NA,1
"PHOTOIONIZATION",NA,1
"PHOTOIONIZATION DETECTION PID",NA,1
"PHOTONIC FILMS",NA,1
"PHOTOPERIOD",NA,1
"PHOTOPLETHYSMOGRAPHY",NA,1
"PHOTOSTABILITY",NA,1
"PHP/MYSQL DATABASE",NA,1
"PHTHALIMIDES",NA,1
"PHYSICAL AND CHEMICAL COMPATIBILITY",NA,1
"PHYSICAL APPEARANCE",NA,1
"PHYSICAL DEPENDENCE WITHDRAWAL",NA,1
"PHYSICAL END MATCHING, STATISTICAL ANALYSIS",NA,1
"PHYSICAL MANIPULATION",NA,1
"PHYSICAL SAFETY",NA,1
"PHYSICAL VAPOR DEPOSITION",NA,1
"PHYSICO-CHEMICAL DATA",NA,1
"PHYSICO-CHEMICAL PREDICTION",NA,1
"PHYSICO-CHEMISTRY",NA,1
"PHYSICOCHEMICAL INTERACTIONS",NA,1
"PHYSICOCHEMICAL PARAMETERS",NA,1
"PHYSICOCHEMICAL PROFILING",NA,1
"PHYTOCHEMICAL CHARACTERIZATION",NA,1
"PHYTOL",NA,1
"PHYTOTHERAPEUTIC FORMULATIONS",NA,2
"PICKING TIME",NA,1
"PICTOGRAM",NA,1
"PIEZOELECTRIC COMPOSITION",NA,1
"PIG TISSUES",NA,1
"PIG URINE",NA,1
"PILL MILL LAW",NA,1
"PILL REPORTS",NA,1
"PILL TESTING",NA,2
"PINE NUTS",NA,1
"PINELLIA TERNATA",NA,2
"PINELLIA TUBER",NA,1
"PIPENZOLATE BROMIDE",NA,1
"PIPER",NA,1
"PIPER BETLE",NA,1
"PIPER METHYSTICUM",NA,1
"PIPER METHYSTICUM G. FORST.",NA,1
"PIPERACEAE",NA,1
"PIPERAZINE ISOMERS",NA,1
"PIPERIDENAFIL",NA,1
"PIPERIDINE",NA,2
"PIPETTE-TIP MICRO-SOLID PHASE EXTRACTION (PT-ΜSPE)",NA,1
"PIPETTE-TIP SOLID-PHASE EXTRACTION",NA,1
"PIRKLE-TYPE CHIRAL STATIONARY PHASE",NA,1
"PIXEL-BASED CLASSIFICATION",NA,1
"PIXEL RESOLUTION",NA,1
"PKA",NA,1
"PKA/PH",NA,1
"PLACKETT-BURMAN DESIGN",NA,1
"PLACKETTÃ¢Â‚¬Â€ŒBURMAN",NA,1
"PLANAR CHROMATOGRAPHY",NA,2
"PLANAR SOLID PHASE EXTRACTION (PSPE)",NA,1
"PLANAR SOLID PHASE MICROEXTRACTION",NA,1
"PLANT-FUNGUS ASSOCIATION",NA,1
"PLANT BREEDING",NA,1
"PLANT CANNABINOIDS",NA,1
"PLANT DNA",NA,2
"PLANT DNA PROFILING",NA,1
"PLANT FOOD SUPPLEMENTS",NA,2
"PLANT GROWTH REGULATORS",NA,1
"PLANT HORMONES",NA,1
"PLANT MATERIAL",NA,2
"PLANT METABOLISM",NA,1
"PLANT METABOLOMICS",NA,1
"PLANT STRESS",NA,1
"PLANT SUBSTRATE",NA,1
"PLANT TISSUE CULTURE",NA,1
"PLANT TOXINS",NA,1
"PLANT VOLATILES",NA,1
"PLASMONIC CRYSTAL",NA,1
"PLASTICITY",NA,1
"PLASTID DNA",NA,1
"PLATINUM-CATALYSED",NA,3
"PLATINUM ELECTRODE",NA,3
"PLATINUM NANOPARTICLES",NA,2
"PLS PREDICTION",NA,1
"PLS REGRESSION",NA,1
"PLSR",NA,1
"PM10",NA,2
"PNN",NA,1
"POCIS",NA,1
"POINT-OF-NEED VOLTAMMETRIC SENSORS",NA,1
"POINT OF CARE",NA,1
"POINT OF CARE DEVICES",NA,1
"POISON CONTROL",NA,1
"POISONOUS",NA,1
"POISONS CENTRES",NA,1
"POLAR BONDED STATIONARY PHASES",NA,1
"POLAR CHEMICALLY BONDED STATIONARY PHASES",NA,1
"POLAR IONIC MOBILE PHASE",NA,1
"POLAR ORGANIC CHEMICAL INTEGRATIVE SAMPLER",NA,1
"POLAR STATIONARY PHASES",NA,1
"POLAR STIMULANTS",NA,1
"POLAROGRAPHIC DETERMINATION",NA,1
"POLICE STRATEGIES",NA,1
"POLICE WORK",NA,1
"POLICY ANALYSIS",NA,2
"POLICY IMPACT",NA,1
"POLISH MYCOBIOTA",NA,1
"POLLEN GRAINS",NA,1
"POLONOVSKI REACTION",NA,2
"POLY(2,4,6-TRIAMINOPYRIMIDINE)",NA,1
"POLY(CTAB)",NA,1
"POLY(DIMETHYLSILOXANE)",NA,1
"POLY(ETHYLENE GLYCOL)",NA,1
"POLY(METHACRYLIC ACID-ETHYLENE GLYCOL DIMETHACRYLATE) MONOLITH MICROEXTRACTION",NA,1
"POLY(METHACRYLIC ACID-ETHYLENE GLYCOL DIMETHACRYLATE) MONOLITIC CAPILLARY COLUMN",NA,1
"POLY(METHYL-3,3,3-TRIFLUOROPROPYLSILOXANE)",NA,1
"POLY(MIMEOBS)-NI NANOCOMPOSITE",NA,1
"POLY(NILE BLUE A)",NA,1
"POLY(PYRROLE)S",NA,1
"POLY(STYRENE-DIVINYLBENZENE)",NA,1
"POLYACRYLAMIDE-COATED CAPILLARIES",NA,1
"POLYACRYLAMIDE-COATED COLUMNS",NA,2
"POLYACRYLONITRILE NANOFIBER",NA,1
"POLYCAPROLCATONE",NA,1
"POLYCONSUMPTION",NA,1
"POLYCYSTIC OVARIAN SYNDROME",NA,1
"POLYDIACETYLENE",NA,1
"POLYDIACETYLENE NANOSHEET",NA,1
"POLYDOPAMINE",NA,1
"POLYDURAMIDE",NA,1
"POLYETHYLENE OXIDE",NA,1
"POLYGALACTURONIC ACID",NA,1
"POLYHYDROXYBUTYRIC ACID",NA,1
"POLYMELAMINE FORMALDEHYDE",NA,1
"POLYMER-BOUNDED DRUG",NA,1
"POLYMERASE CHAIN REACTION-RESTRICTION FRAGMENT LENGTH POLYMORPHISM (PCR-RFLP)",NA,1
"POLYMERIC EXTRACTION CARTRIDGES",NA,1
"POLYMERIC IONIC LIQUIDS",NA,1
"POLYMERIC MATERIALS",NA,1
"POLYMERIC REAGENTS",NA,1
"POLYMERIC STRONG CATION EXCHANGE SORBENT",NA,1
"POLYMERIC SURFACTANT",NA,2
"POLYMETHACRYLATE ZWITTERIONIC MONOLITHIC COLUMNS",NA,1
"POLYMORPH",NA,2
"POLYMORPH IDENTIFICATION",NA,1
"POLYMORPHISM AND PSEUDOPOLYMORPHISM",NA,1
"POLYPHENOL",NA,5
"POLYPLOIDY",NA,1
"POLYSACCHARIDE-BASED CHIRAL STATIONARY PHASE",NA,1
"POLYSACCHARIDE-BASED STATIONARY PHASE",NA,1
"POLYSACCHARIDE STATIONARY PHASE",NA,3
"POLYSACCHARIDES",NA,1
"POLYSODIUM-N-UNDECENOYL-D-VALINATE",NA,1
"POLYTHIOPHENE",NA,1
"POLYTYRAMINE",NA,1
"POLYUNSATURATED FATTY ACIDS",NA,1
"POLYVINYL ALCOHOL",NA,2
"POOLED CALIBRATIONS",NA,1
"POOLED URINE ANALYSIS",NA,1
"POPPER",NA,1
"POPPY",NA,6
"POPPY ALKALOIDS",NA,1
"POPPY ANALYSIS",NA,1
"POPPY CAPSULES",NA,1
"POPPY SEED OIL",NA,2
"POPPY STRAW",NA,2
"POPPY, PAPAVER SOMNIFERUM L.",NA,1
"POPULATION ASSESSMENT",NA,1
"POPULATION HARM",NA,1
"POPULATION SAMPLE",NA,1
"POPULATION SURVEY",NA,1
"PORCINE MUSCLE",NA,1
"PORK",NA,1
"PORK MUSCLE",NA,1
"POROUS GRAPHENE",NA,1
"POROUS GRAPHITIZED CARBON",NA,1
"POROUS SILICON",NA,2
"PORTABLE ANALYSIS",NA,1
"PORTABLE CAPILLARY ELECTROPHORESIS",NA,1
"PORTABLE DIAGNOSTICS",NA,1
"PORTABLE GAS CHROMATOGRAPHY-MICROFLAME IONIZATION DETECTOR",NA,1
"PORTABLE GC–MS",NA,1
"PORTABLE INSTRUMENT",NA,1
"PORTABLE MASS SPECTROMETER",NA,1
"PORTABLE MASS SPECTROMETRY (MS)",NA,1
"PORTABLE METER",NA,1
"PORTABLE RAMAN, FT-IR UNITS IN PHARMACEUTICALS, FOR ID, COUNTERFEIT DETECTION",NA,1
"POSITION-SPECIFIC ISOTOPE",NA,1
"POSITIONAL SPECIFICITY",NA,1
"POSITIVE",NA,1
"POST-COLUMN DERIVATIZATION",NA,1
"POST-MARKETING SURVEILLANCE",NA,2
"POST-TARGETED ANALYSIS",NA,1
"POSTGRADUATE STUDENTS",NA,1
"POSTMARKETING SURVEILLANCE SYSTEM",NA,1
"POSTMORTEM BLOOD CONCENTRATIONS",NA,1
"POTABLE NIRS",NA,1
"POTASSIUM PERMANGANATE",NA,7
"POTENTIAL CHEMOTHERAPEUTIC",NA,1
"POTENTIAL ENERGY DISTRIBUTION",NA,1
"POTENTIAL MODULATION",NA,1
"POTENTIOMETRIC DETECTION",NA,1
"POTENTIOMETRIC MEMBRANE ELECTRODES",NA,1
"POTENTIOMETRIC SENSOR",NA,2
"POTENTIOMETRIC TITRATION",NA,1
"POWDER BLEND HOMOGENEITY",NA,1
"POWDER COLLECTION",NA,1
"POWDER FORM",NA,1
"POWDER IDENTIFICATION",NA,1
"POWDER TECHNOLOGY",NA,1
"POWDER XRD",NA,1
"POWERPLEXÃƑÂ€ŠÃ‚Â® 16",NA,1
"POWERPLEXÃƑÂ€ŠÃ‚Â® Y",NA,1
"PPA(N)-2201",NA,1
"PPCPS",NA,1
"PPE",NA,1
"PRACTICAL RELEVANCE OF PATTERN UNIQUENESS",NA,1
"PRE-PRECURSOR",NA,1
"PRECONCENTRATION OF MORPHINE AND CODEINE",NA,1
"PRECURSOR-ION SCAN",NA,1
"PRECURSOR CHEMICAL",NA,1
"PRECURSOR CHEMICAL LEGISLATION",NA,1
"PRECURSOR CHEMICAL REGULATION",NA,2
"PRECURSOR ION SCAN",NA,2
"PRECURSOR/PRODUCT RELATIONSHIP",NA,1
"PREFERENTIAL SOLVATION",NA,2
"PREMORTEM",NA,1
"PREPARATIVE",NA,1
"PREPARATIVE ENANTIOSEPARATION",NA,1
"PREPARATIVE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY",NA,1
"PREPARATIVE SCALE",NA,1
"PRESCREENING",NA,1
"PRESCRIBING DRUGSÃ¢Â‚¬Â„¢ ABUSE",NA,1
"PRESCRIPTION ABUSE",NA,1
"PRESCRIPTION DRUG MONITORING",NA,1
"PRESCRIPTION MEDICATION USE",NA,1
"PRESCRIPTION MISUSE",NA,1
"PRESCRIPTION OPIOID ABUSE",NA,3
"PRESCRIPTION OPIOID ANALGESIC",NA,2
"PRESCRIPTION OPIOID OVERDOSE",NA,1
"PRESCRIPTION OPIOIDS",NA,3
"PRESCRIPTION PAIN MEDICATION",NA,1
"PRESSURIZED CAPILLARY ELECTROCHROMATOGRAPHY",NA,1
"PRESSURIZED HOT WATER EXTRACTION",NA,1
"PRESUMPTIVE COLOUR TESTS",NA,1
"PRETERM BIRTH",NA,1
"PRETREATMENT-FREE",NA,1
"PREVALENT TREND",NA,1
"PRICE",NA,4
"PRIMARY SCREENING",NA,1
"PRINCIPAL COMPONENT REGRESSION",NA,1
"PRINCIPLE COORDINATE ANALYSIS",NA,2
"PRINCIPLE OF IDENTICAL TREATMENT",NA,1
"PRIOR AUTHORIZATION",NA,1
"PRIOR INFORMATION",NA,1
"PRIOR PROBABILITY SHIFT",NA,1
"PRIORITY CONTAMINANTS, EMERGING CONTAMINANTS, HIGH RESOLUTION, PESTICIDES, PHARMACEUTICALS, PERSONAL CARE PRODUCTS",NA,1
"PRO- AND ANTIOXIDANT ACTIVITY (LPO, NO2 Ã¢Ë†Â€™, TOTAL SOD, AND CAT)",NA,1
"PRO-DRUG",NA,1
"PRO-LONGED RELEASE",NA,1
"PROACTIVE POLICING",NA,1
"PROAPORPHINE HETERODIMERS",NA,1
"PROBABILITY DENSITY FUNCTION",NA,1
"PROBE ELECTROSPRAY",NA,1
"PROBLEM-ORIENTED POLICING",NA,1
"PROBLEM SOLVING",NA,1
"PROCAINE HCL",NA,2
"PROCESS-RELATED IMPURITIES",NA,1
"PROCESS ANALYTICAL TECHNOLOGIES (PAT)",NA,1
"PROCESS ANALYTICS TECHNOLOGY",NA,1
"PROCESS DEVELOPMENT",NA,1
"PROCESS EFFICIENCY",NA,1
"PROCESS IMPROVEMENT",NA,1
"PROCESS IMPURITIES",NA,1
"PROCESSED SAMPLES",NA,1
"PRODRUG",NA,1
"PRODUCT AND PROCESS UNDERSTANDING - IN PHARMACEUTICAL INDUSTRY, AND PAT INITIATIVE AND QBD, LAUNCHED BY U.S. FDA",NA,1
"PRODUCT ION",NA,1
"PRODUCT ION SPECTROMETRY",NA,1
"PRODUCT ION SPECTROMETRY OF CYCLOPROPOYLINDOLES",NA,1
"PROFILE",NA,1
"PROFILING ANALYSIS",NA,3
"PROGESTERONE",NA,2
"PROGESTOGENS",NA,2
"PROHIBITION",NA,2
"PROPANE EXTRACTION",NA,1
"PROPER ENRICHMENT",NA,1
"PROPERTY PREDICTION",NA,1
"PROPOFOL LONG-TERM MONITORING",NA,1
"PROPRIETARY CHINESE MEDICINES",NA,1
"PROPYL CANNABINOIDS",NA,1
"PROPYLPARABEN",NA,1
"PROSOLVÃ‚Â®",NA,1
"PROSPECTIVE MONITORING",NA,1
"PROTEIN ANALYSIS",NA,1
"PROTOALKALOIDS",NA,1
"PROTON-TRANSFER-REACTION",NA,1
"PROTON INDUCED _-RAY EMISSION",NA,1
"PROTON NMR",NA,1
"PROTON NUCLEAR MAGNETIC RESONANCE",NA,1
"PROTON TRANSFER REACTION MASS SPECTROMETRY (PTR-MS)",NA,1
"PROTONATION",NA,1
"PROVENANCE DETERMINATION",NA,1
"PS9",NA,1
"PSBA-TRNH",NA,1
"PSEUDO-EPHEDRINE",NA,1
"PSEUDO-STATIONARY PHASE",NA,1
"PSEUDO-STATIONARY PHASES",NA,2
"PSEUDOCOCAINE",NA,1
"PSEUDOEPHEDRINE HYDROCHBRIDE",NA,1
"PSEUDOEPHEDRINE HYDROCHLORIDE",NA,4
"PSEUDOEPHEDRINE SULFATE",NA,2
"PSEUDOMORPHINE",NA,2
"PSEUDOS",NA,1
"PSI",NA,1
"PSILOCYBE MERDARIA",NA,1
"PSILOCYBE SEMILANCEATA",NA,2
"PSYCHEDELIC DRUG USE",NA,1
"PSYCHIATRIC DISTURBANCES",NA,1
"PSYCHIATRIC PHARMACEUTICALS",NA,1
"PSYCHOACTIVE COMPOUNDS",NA,4
"PSYCHOACTIVE DESIGNER DRUG",NA,1
"PSYCHOACTIVE DRUG MARKETING",NA,1
"PSYCHOACTIVE EFFECTS",NA,1
"PSYCHOACTIVE HERBAL PRODUCTS",NA,1
"PSYCHOACTIVE PHARMACEUTICALS",NA,3
"PSYCHOACTIVE SUBSTANCES ACT, 2016",NA,1
"PSYCHOACTIVE SUBSTANCES ACT, NEW ZEALAND",NA,1
"PSYCHOACTIVE TRYPTAMINE",NA,1
"PSYCHONAUT PROJECT",NA,1
"PSYCHONAUTS",NA,1
"PSYCHOSTIMULANT CONSUMERS",NA,1
"PSYCHOSTIMULANT USE",NA,1
"PSYCHOTOMIMETIC ACTIVITY",NA,1
"PSYCHOTRIA BRACHYBOTRYA",NA,1
"PSYCHOTRIA VIRIDIS",NA,3
"PSYCHOTROPIC CONVENTION",NA,1
"PSYCHOTROPIC ILLICIT DRUGS",NA,1
"PSYCHOTROPIC PHARMACEUTICALS",NA,1
"PSYCHOTROPIC PLANTS",NA,2
"PSYCHOTROPIC TERPENOID",NA,1
"PT-PD-DOPED NIO NANOPARTICLE-DECORATED SINGLE-WALL CARBON NANOTUBES",NA,1
"PT DOPED NIO NANOPARTICLES",NA,1
"PT NANOPARTICLES",NA,1
"PTEROCARPUS",NA,1
"PTRI",NA,1
"PUBLIC POLICY",NA,2
"PUERARIN",NA,1
"PULMONARY ABSCESS",NA,1
"PULSE POTENTIOSTATIC METHOD",NA,1
"PULSE REGIME",NA,1
"PULSE SEQUENCES",NA,1
"PULSED LASER",NA,1
"PULSED RESONANT PHOTOACOUSTICS",NA,1
"PULSED SPLITLESS MODE",NA,1
"PUMP-PROBE TECHNIQUE",NA,1
"PURE NUCLEAR QUADRUPOLE RESONANCE",NA,1
"PURGE",NA,1
"PURITY ASSESSMENT",NA,1
"PURITY ASSIGNMENT",NA,1
"PURITY DETERMINATION",NA,2
"PUTRESCINE N-METHYLTRANSFERASE",NA,1
"PVP",NA,2
"PXRD",NA,1
"PY-GC/MS",NA,1
"PY-MS",NA,1
"PYRAZOLE",NA,2
"PYRAZOLE-CARBOXAMIDE DERIVATIVE",NA,3
"PYRAZOLO[1,5-A]PYRIMIDINES",NA,1
"PYRAZOLOPYRIDINE",NA,1
"PYREXIA",NA,1
"PYRIDAZINE",NA,1
"PYRIDOXAL 5Ã¢Â‚¬Â²-PHOSPHATE",NA,1
"PYRIMIDINE",NA,1
"PYROLYSIS-GAS CHROMATOGRAPHY",NA,2
"PYROVALERONE CATHINONES",NA,1
"PYRROLIDINE ANALOGUE",NA,1
"PYRROLIDINYL SUBSTITUTED CATHINONES",NA,1
"PYRUVATE DECARBOXYLASE",NA,2
"PZT",NA,1
"Q-ABSORPTION RATIO METHOD",NA,1
"Q-NMR",NA,1
"Q-ORBITRAP-MS",NA,1
"Q-TOF MS",NA,1
"Q-TRAP",NA,1
"QAT",NA,2
"QBD",NA,1
"QHNMR",NA,1
"QIANSHAN HUOXUE PLASTER",NA,1
"QQQ",NA,1
"QSRR",NA,1
"QSTR",NA,1
"QUADRUPOLE TIME-OF-FLIGHT TANDEM MASS SPECTROMETRY",NA,1
"QUALIFICATION",NA,3
"QUALIFY AND QUANTIFY",NA,1
"QUALITATION",NA,1
"QUALITATIVE COMPARISON",NA,1
"QUALITATIVE IDENTIFICATION",NA,1
"QUALITATIVE METHODS",NA,1
"QUALITATIVE MODEL",NA,1
"QUALITATIVE STUDY",NA,1
"QUALITATIVE VALIDATION",NA,1
"QUALITY",NA,6
"QUALITY-OF-LIFE",NA,1
"QUALITY CONTROL OF INTACT DOSAGE FORMS",NA,1
"QUALITY TESTING",NA,1
"QUALITY VERIFICATION",NA,1
"QUANTITATIVE CE",NA,1
"QUANTITATIVE COMPARISON",NA,1
"QUANTITATIVE DETERMINATION OF TESTOSTERONE",NA,1
"QUANTITATIVE IMPURITY PROFILING",NA,1
"QUANTITATIVE MODEL",NA,1
"QUANTITATIVE NMR",NA,5
"QUANTITATIVE NMR SPECTROSCOPY",NA,1
"QUANTITATIVE NUCLEAR MAGNETIC RESONANCE",NA,1
"QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP",NA,1
"QUANTITATIVE STRUCTURE-RETENTION RELATIONSHIPS (QSRRS)",NA,4
"QUANTUM CHEMICAL AND CHEMOMETRIC METHODS",NA,1
"QUARTZ CRYSTAL",NA,2
"QUARTZ CRYSTAL MICROBALANCE",NA,1
"QUARTZ CRYSTAL MICROBALANCE (QCM)",NA,1
"QUERCETIN",NA,1
"QUETIAPINE METABOLITES",NA,1
"QUICK-ACTION ANTI-MOTION CAPSULES",NA,1
"QUICKBIRD-2",NA,1
"QUINAPRIL HYDROCHLORIDE",NA,1
"QUINAZOLINONE",NA,1
"QUINOLIZIDINE",NA,1
"R AND S-AMPHETAMINE",NA,1
"R&D ADVANCEMENT",NA,1
"RACEMATE",NA,2
"RACEMIC REAGENT",NA,1
"RACIAL DISCRIMINATION",NA,1
"RADARS",NA,1
"RADARS SYSTEM",NA,1
"RADIANTÃ¢Â€ŽÂ¢ GREEN",NA,1
"RADIATION",NA,3
"RADICAL COUPLING",NA,1
"RADICAL CYCLIZATION",NA,1
"RADICAL SITE",NA,1
"RADICALS",NA,1
"RADIOACTIVE ISOTOPES",NA,1
"RADIOCARBON DATING",NA,1
"RADIOIODINATION",NA,1
"RADIUS BASIS FUNCTION NEURAL NETWORK",NA,1
"RAFFINOSE FAMILY OLIGOSACCHARIDES",NA,1
"RAMAN-SEM/EDX",NA,1
"RAMAN ANALYSIS",NA,1
"RAMAN AND NMR SPECTROSCOPIES",NA,1
"RAMAN CHEMICAL IMAGING, DETECTION OF TRACE QUANTITIES OF EXPLOSIVES",NA,1
"RAMAN HANDHELD DEVICES",NA,1
"RAMAN IN FORENSIC DRUGS CASEWORK",NA,1
"RAMAN SAMPLING SYSTEMS",NA,1
"RAMAN SCATTERING METHODS",NA,1
"RAMAN SCATTERING, DETECTION OF BULK SEIZURES OF SAMPLES AND ROAD SIDE TESTING",NA,1
"RAMAN SERS",NA,1
"RAMAN SPECTRA OF THREE MEMBERS OF THE ECSTASY FAMILY",NA,1
"RAMAN SPECTROSCOPY FOR ANALYSIS OF COUNTERFEIT TABLETS",NA,1
"RAMAN SPECTROSCOPY, FOR HAZMAT, LAW ENFORCEMENT, LIMITING EXPOSURE TO UNKNOWNS",NA,1
"RAMAN SPECTRUM OF INTACT",NA,1
"RAMAN, IN CHARACTERISING PHARMACEUTICAL TABLETS, AS GENUINE, COUNTERFEIT",NA,1
"RANDOM AMPLIFIED MICROSATELLITES",NA,1
"RANDOM FOREST",NA,1
"RANDOM SEARCH",NA,1
"RANDOMLY AMPLIFIED POLYMORPHIC DNA",NA,1
"RANKING",NA,1
"RAPD ANALYSIS",NA,2
"RAPID ASSESSMENT",NA,1
"RAPID DETECTION",NA,2
"RAPID DETECTION BY DARTÃ¢Â‚¬Â€ŒTOF-MS",NA,1
"RAPID PURIFICATION",NA,1
"RAPID RESOLUTION LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION MASS SPECTROMETRY (RRLC-ESI-MS)",NA,1
"RAPID SCREENING OF MEDICINES FOR COUNTERFEITS",NA,1
"RAPID SPME",NA,1
"RAT POISON",NA,1
"RATE CONSTANT",NA,1
"RATE OF HYDROLYSIS",NA,1
"RATIO-SPECTRA DERIVATIVE SPECTROPHOTOMETRY",NA,2
"RATIO SPECTRAL DERIVATIVE",NA,1
"RATIONAL CHOICE THEORY",NA,1
"RAW MATERIAL IDENTIFICATION AND CHARACTERIZATION",NA,1
"RAW MILK",NA,1
"RAYLEIGH FRACTIONATION",NA,1
"RBCL LOCUS",NA,1
"RCS-4",NA,1
"RD",NA,1
"RDF",NA,1
"RDNA",NA,1
"RDNA INTERNAL TRANSCRIBED SPACER (ITS)",NA,2
"REACTION ENDPOINT DETERMINATION",NA,1
"REACTION INTERMEDIATES",NA,1
"REACTIVE INTERMEDIATES",NA,1
"REACTIVE MATRIX",NA,1
"REACTIVE METABOLITES",NA,1
"REACTIVITY",NA,2
"REAGENT STORAGE",NA,1
"REAGENTS REUSE",NA,1
"REAL CHALLENGE",NA,1
"REAL CHALLENGE, EVIDENCE BY SKILLFUL, OBJECTIVE PEOPLE, SERVING CAUSE OF JUSTICE",NA,1
"REAL EXPOSURE",NA,1
"REAL SAMPLES",NA,1
"REAL TIME NEUTRON RADIOGRAPHY",NA,1
"REARRANGEMENT",NA,1
"RECEIVER GAIN",NA,1
"RECEIVER GAIN FUNCTION",NA,1
"RECEIVER OPERATING CHARACTERISTICS (ROC)",NA,1
"RECENT PAST",NA,1
"RECENT TREND OF ABUSE",NA,1
"RECOGNITION ELEMENTS",NA,1
"RECOMBINED YEAST",NA,1
"RECREATIONAL",NA,1
"RECREATIONAL SUBSTANCE USE",NA,1
"RECREATIVE DRUGS",NA,1
"RECRUITMENT METHODS",NA,1
"RED WINES",NA,1
"REDOX-RECYCLING",NA,1
"REDUCED DIMENSIONALITY",NA,1
"REDUCTIVE ELIMINATION",NA,1
"REEVALUATION OF MORPHINE",NA,1
"REFERENCE EXTRACTS",NA,1
"REFERENCE POPULATION",NA,2
"REFERENCE RAMAN SPECTRA",NA,1
"REFERENCE SUBSTANCES",NA,1
"REFINING",NA,1
"REFLECTANCE",NA,1
"REFLECTED AND TRANSMITTED THZ PULSE",NA,1
"REFRACTIVE INDEX",NA,1
"REGENERATION",NA,1
"REGIOISOMERIC FLUOROCATHINONES",NA,1
"REGIOISOMERIC METHOXYPHENIDINES",NA,1
"REGIONAL VARIATION",NA,1
"REGIOSELECTIVITY",NA,1
"REGRESSION ANALYSIS",NA,3
"REGULATORY CLEANUP STANDARD",NA,1
"REGULATORY PERSPECTIVES",NA,1
"REGULATORY REQUIREMENT IN IMPURITY PROFILE",NA,1
"REGULATORY STATUS",NA,1
"RELATED ORGANIC IMPURITIES",NA,1
"RELATED PATENTS",NA,1
"RELATED SUBSTANCES",NA,3
"RELATIVE QUANTIFICATION",NA,1
"RELATIVE RAMAN BAND INTENSITIES WITHIN SPECTRUM, IN QUANTITATIVE MEASUREMENTS",NA,1
"RELATIVE RESPONSE FACTOR",NA,1
"RELATIVE SENSITIVITY",NA,1
"RELAXATION TIMES",NA,1
"REMAINING-AMOUNT ANALYSIS",NA,1
"REMOTE ANALYSIS",NA,1
"REMOVAL",NA,1
"REMOVAL EFFICIENCY",NA,1
"REMOVAL RATES",NA,1
"REPETITIVE GENOMIC CONTENT",NA,1
"REPRESENTATIVE",NA,1
"REPRESENTATIVE DATA",NA,1
"REPRODUCTIVE STRATEGY",NA,1
"REPRODUCTIVE TISSUE",NA,1
"RESEARCH PURPOSE: DESCRIPTIVE",NA,1
"RESEARCH SYNTHESIS",NA,1
"RESEARCH TRENDS",NA,1
"RESERVOIR TYPE",NA,2
"RESIDUE LEVEL",NA,1
"RESISTANT DEPRESSION",NA,1
"RESISTIVE HEATING",NA,1
"RESOLVING AGENT",NA,1
"RESONANCE",NA,1
"RESONANCE ASSIGNMENT",NA,1
"RESONANCE EFFECTS",NA,1
"RESPIRATORY PROTECTION",NA,1
"RESPIRATORY SUPPORT",NA,1
"RESPONDENT DRIVEN SAMPLING",NA,1
"RESTRICTION POLICIES",NA,1
"RETARDATION FACTOR",NA,1
"RETENTION INDEX VARIATION",NA,1
"RETENTION MECHANISM",NA,5
"RETENTION MODELLING",NA,1
"RETENTION MODELS",NA,1
"RETENTION PARAMETERS",NA,1
"RETENTION PREDICTION",NA,2
"RETENTION TIME LOCKING GAS-CHROMATOGRAPHY MASS SPECTROMETRY",NA,1
"RETRO-ENE",NA,1
"RETROSPECTIVE PREVALENCE",NA,1
"REVERSAL OF ENANTIOMER ELUTION ORDER",NA,1
"REVERSE FLOW INJECTION METHOD",NA,1
"REVERSE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY",NA,1
"REVERSE PHASE HPLC",NA,1
"REVERSED-PHASE DISPERSIVE LIQUID-LIQUID MICROEXTRACTION",NA,1
"REVERSED-PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY",NA,1
"REVERSED-PHASE HPLC",NA,3
"REVERSED-PHASE LIQUID CHROMATOGRAPHY (RPLC)",NA,8
"REVERSED-PHASE/STRONG ANION-EXCHANGE",NA,1
"REVERSED PHASE CHROMATOGRAPHY",NA,2
"REVERSED PHASE COLUMN",NA,1
"REVERSED PHASE MODE",NA,1
"REWARD",NA,1
"RFID",NA,2
"RHEUM PALMATUM",NA,1
"RHF/STO-3G",NA,1
"RIBBONS",NA,1
"RIETVELD ANALYSIS",NA,1
"RIFAMPICIN",NA,1
"RIPENING",NA,1
"RISK BEHAVIOUR",NA,1
"RISK QUOTIENT",NA,3
"RISK TARIFF",NA,1
"RISK/BENEFIT",NA,1
"RISKS AND PRICES",NA,1
"RIVER WATER MONITORING",NA,1
"RNA-SEQ",NA,1
"RNA GEL BLOT ANALYSIS",NA,1
"RNAI",NA,1
"RO5-4864",NA,1
"ROASTING",NA,1
"ROBUST DISSOLUTION",NA,1
"ROBUSTNESS STUDY",NA,1
"ROBUSTNESS TESTING",NA,2
"ROHYPNOL ®",NA,1
"ROOT DEVELOPMENT",NA,1
"ROTAROD",NA,1
"ROTATING DISK SORPTIVE EXTRACTION",NA,1
"ROTOROD",NA,1
"ROUTE SPECIFIC IMPURITIES",NA,5
"ROUTE SPECIFIC MARKER IMPURITY",NA,1
"RP-HPLC",NA,10
"RP-HPLC COLUMN SELECTION",NA,1
"RP-LC",NA,2
"RP (IX)-C2 SUBGROUP",NA,1
"RPL16",NA,1
"RPL16-RPL14 SPACER REGION",NA,1
"RRS",NA,2
"RS,RS- AND RS,SR-ISOMERS",NA,1
"RTI-126",NA,1
"RU(BPY)3 2+",NA,1
"RU[(BPY)3]2+",NA,1
"RUBIACEAE",NA,2
"RULES",NA,1
"RURAL AREAS",NA,1
"RUTHENIUM COMPLEXES",NA,1
"RUTIN",NA,1
"RYE",NA,7
"RYE FLOUR",NA,1
"RYE PRODUCTS",NA,1
"S-CLENBUTEROL",NA,1
"S BENZYLISOQUINOLINE ALKALOID",NA,1
"S. DIVINORUN SPECIFIC PRIMER DESIGN",NA,1
"S/R-CATHINONE",NA,1
"S40503",NA,1
"SACI",NA,1
"SACRED MUSHROOMS",NA,1
"SAFE AND SECURE",NA,1
"SAFE WORK PRACTICES",NA,1
"SAFETY EVALUATION",NA,1
"SAFETY TRAINING",NA,1
"SAFFRON",NA,1
"SAFROLE BROMINATION",NA,1
"SAFROLE BROMINATION SYNTHESIS",NA,1
"SALAT",NA,1
"SALES CHANNELS",NA,1
"SALINITY",NA,1
"SALLE",NA,1
"SALMONELLA",NA,1
"SALT FORMATION OF PHARMACEUTICAL COMPOUND",NA,1
"SALT FORMERS",NA,1
"SALT STRESS",NA,1
"SALTS",NA,1
"SALVIA DIVINORUM EPLING & J√°TIVA-M.",NA,1
"SALVIA MILTIORRHIZA",NA,1
"SALVIA SPECIES",NA,2
"SALVIANOLIC ACID",NA,1
"SALVINORIN",NA,3
"SAMPLE-SAMPLE COMPARISON",NA,1
"SAMPLE ANALYSIS",NA,1
"SAMPLE CLEAN-UP",NA,1
"SAMPLE DIGESTION",NA,1
"SAMPLE DILUTION",NA,1
"SAMPLE ENRICHMENT",NA,1
"SAMPLE HANDLING",NA,1
"SAMPLE HOMOGENEITY, AND SAMPLING WITH FT-IR/ATR SPECTROSCOPY",NA,1
"SAMPLE INTRODUCTION",NA,1
"SAMPLE PREPARATION AND GC-MS OR LC-MS ANALYSIS",NA,1
"SAMPLE PRESERVATION",NA,1
"SAMPLE VOLUME OVERLOAD",NA,1
"SAMPLE/ELUENT SOLVENT MISMATCH",NA,1
"SAMPLING ERROR",NA,1
"SAMPLING METHODOLOGY",NA,1
"SAMPLING PLAN",NA,1
"SAMPLING RATE",NA,1
"SAMPLING TECHNIQUES, BULK/MACRO- AND MICRO-SAMPLE PREPARATION",NA,1
"SAN PEDRO",NA,1
"SAN PEDRO MACHO",NA,1
"SANDWICH TECHNIQUE",NA,1
"SAR",NA,2
"SARMS",NA,1
"SATURATED HYDROGEN BONDING",NA,1
"SATURATION",NA,1
"SBA-15 NANOCOMPOSITE",NA,1
"SCAFFOLD",NA,1
"SCAN MODE",NA,1
"SCANNING ELECTRON MICROSCOPY/ENERGY DISPERSIVE X-RAY SPECTROSCOPY",NA,1
"SCATTERING TECHNIQUES AND SAMPLE HANDLING REQUIREMENTS, MINIMAL",NA,1
"SCELETIUM TORTUOSUM",NA,1
"SCENT TRACING",NA,1
"SCHEDULE II DRUGS",NA,1
"SCHEELITE CAWO4",NA,1
"SCHIFF BASE COMPLEX",NA,1
"SCHIFF BASE COMPLEXES",NA,1
"SCHISANDRA CHINENSIS (TURCZ.) BAILL.",NA,1
"SCHOOL",NA,1
"SCHOOL STUDENTS",NA,1
"SCIENCE",NA,1
"SCIENCE EDUCATION",NA,1
"SCIENTIFIC FOUNDATIONS",NA,1
"SCOPING STUDIES",NA,1
"SCOPOLAMIEN",NA,1
"SCOPOLAMINE HYDROBROMIDE",NA,2
"SCOPOLIA EXTRACT",NA,1
"SCOPOLIA TANGUTICA",NA,2
"SCOPUS",NA,1
"SCOULERINE",NA,1
"SCRAPING OFF",NA,1
"SCREEN-PRINTED CARBON ELECTRODE",NA,1
"SCREEN-PRINTED SENSOR",NA,1
"SCREEN-PRINTED SPARKED ELECTRODES",NA,1
"SCREEN OF GREEN (SCROG)",NA,1
"SCREEN PRINTED ELECTRODE",NA,3
"SCREEN PRINTED ELECTRODE (SPE)",NA,1
"SCREENING AND OPTIMIZATION",NA,1
"SCREENING ASSAYS",NA,1
"SCREENING COUNTERFEIT DRUGS",NA,1
"SCREENING NMR MIXTURES",NA,1
"SCREENING PROCESS",NA,1
"SCREENING STRATEGY",NA,1
"SCREENING SYSTEM",NA,1
"SCUTELLARIA LATERIFLORA",NA,1
"SCX-MODIFIED SILICA",NA,1
"SCXRD",NA,1
"SDB-006",NA,1
"SDME",NA,1
"SE SPECIATION",NA,1
"SEARCH DOGS",NA,1
"SEARCH ENGINE",NA,1
"SEARCHABLE DATABASES",NA,1
"SEASONAL VARIATIONS",NA,1
"SEAWATER",NA,3
"SECOBARBITONE",NA,1
"SECOND-ORDER CALIBRATION",NA,1
"SECOND-YEAR UNDERGRADUATE",NA,1
"SECOND ORDER DESIGN",NA,1
"SECONDARY AND PRIMARY AMINES",NA,1
"SECONDARY ELECTROSPRAY IONIZATION",NA,1
"SECONDARY MASS SPECTRAL LIBRARIES",NA,1
"SECONDARY METABOLISM",NA,4
"SECONDARY METABOLITES",NA,2
"SECONDHAND SMOKE",NA,1
"SECRETAGOGUES",NA,1
"SECRETORY GLAND",NA,1
"SECT. STUNTZII",NA,1
"SECTION CYANOPODAE",NA,1
"SECULAR TRENDS",NA,1
"SEDATIVE-HYPNOTIC DRUG",NA,1
"SEDATIVE HYPNOTIC DRUG",NA,1
"SEDIMENT FINGERPRINTING",NA,1
"SEDIMENT PROPERTIES",NA,1
"SEDIMENT PROVENANCE",NA,1
"SEDIMENT SOURCES",NA,1
"SEE",NA,1
"SEED",NA,7
"SEED AND STRAW YIELDS",NA,1
"SEED DETECTION",NA,1
"SEED EMBRYO",NA,1
"SEED OIL",NA,1
"SEIZED COCAINE HYDROCHLORIDE",NA,1
"SEIZED COCAINE SAMPLES",NA,1
"SEIZED HEROIN",NA,2
"SEIZED HEROIN SAMPLES",NA,1
"SEIZED PRODUCTS",NA,2
"SEIZURE DATA",NA,1
"SEIZURE DRUG SUBSTANCES",NA,1
"SEIZURE SAMPLE",NA,1
"SEIZURE SAMPLES",NA,1
"SEIZURES COMPARISONS",NA,2
"SELECTED ION MONITORING",NA,1
"SELECTED REACTION MONITORING",NA,1
"SELECTIVE AMPLIFIER",NA,1
"SELECTIVE ANALYTICAL METHODOLOGIES",NA,1
"SELECTIVE DETECTION",NA,1
"SELECTIVE REMOVAL",NA,1
"SELECTIVE TWO-DIMENSIONAL LIQUID CHROMATOGRAPHY",NA,1
"SELECTIVITY DIFFERENCES",NA,1
"SELECTIVITY RECOGNITION",NA,1
"SELECTOR COVERAGE",NA,1
"SELEX",NA,1
"SELF-ORGANISING MAP",NA,1
"SELF-WEIGHTED ALTERNATING TRILINEAR DECOMPOSITION",NA,1
"SEMI-AUTOMATED PORTABLE INSTRUMENT",NA,1
"SEMI-PACKED",NA,1
"SEMICONDUCTORS",NA,1
"SEMISYNTHESIS",NA,1
"SENIOR RESIDENCES",NA,1
"SENSING KITS",NA,1
"SENSING RESPONSE",NA,1
"SENSITIVE ASSAY",NA,1
"SENSOR ARRAY",NA,1
"SENSOR BASED IN MWCNT-MIP",NA,1
"SENSORS AND ACTUATORS",NA,1
"SENSORS AND BIOSENSORS",NA,1
"SENSORY ANALYSIS",NA,1
"SENTIMENT ANALYSIS",NA,1
"SEPARATION ANALYSIS",NA,1
"SEPARATION COLUMNS",NA,1
"SEPARATION METHODS",NA,2
"SEPARATION STRATEGY",NA,1
"SEPARATION TECHNIQUE",NA,1
"SEQUENTIAL DERIVATIZATION",NA,1
"SEQUENTIAL ELECTROSPRAY",NA,1
"SEQUENTIAL INJECTION",NA,1
"SEQUENTIAL INJECTION SOLIDIFIED FLOATING ORGANIC DROP",NA,1
"SERDS",NA,1
"SERENOA REPENS",NA,1
"SERIAL CRIME ANALYSIS",NA,1
"SERIOUS GAMES",NA,1
"SEROTONERGIC PSYCHEDELICS",NA,1
"SERS PLATFORM",NA,1
"SERS, RAPID, SENSITIVE AND MOLECULARLY SPECIFIC METHODS",NA,1
"SERS, SCATTERING, ORDERS OF MAGNITUDE AND QUENCHING FLUORESCENCE",NA,1
"SERTRALINE HYDROCHLORIDE",NA,1
"SERVING CAUSE OF JUSTICE",NA,1
"SET CONDITIONS",NA,1
"SETTING: NATIONAL",NA,1
"SEWAGE-BASED EPIDEMIOLOGY",NA,5
"SEWAGE ANALYSIS",NA,4
"SEWAGE BIOMARKERS",NA,1
"SEWAGE FARM",NA,1
"SEWAGE INFLUENTS",NA,2
"SEWAGE MARKER",NA,1
"SEWAGE TREATMENT PLANTS",NA,1
"SEWAGE WATER",NA,2
"SEWAGE WATER ANALYSIS",NA,1
"SEWER EPIDEMIOLOGY",NA,1
"SEWER INFORMATION MINING",NA,1
"SEWER POROSITY",NA,1
"SEX CHROMOSOMES",NA,1
"SEX CRIMES",NA,1
"SEXUAL STIMULANTS",NA,1
"SHAMANISM",NA,2
"SHAPE",NA,1
"SHAPE-SPECIFIC SILVER NANOPARTICLES",NA,1
"SHIELDING EFFECT",NA,1
"SHITEI-YAKUBUTSU",NA,3
"SHORT CHAIN DEHYDROGENASE/REDUCTASE",NA,1
"SHORT COLUMN",NA,1
"SHORT COLUMNS",NA,1
"SHORT DAY PLANT",NA,1
"SHORT TANDEM REPEAT MULTIPLEX",NA,1
"SIBUTRAMINE ANALOGUE",NA,1
"SIBUTRAMINE HYDROCHLORIDE",NA,1
"SICHUAN",NA,1
"SIDA CORDIFOLIA",NA,1
"SIEVE ELEMENT",NA,1
"SIGMATROPIC REARRANGEMENT",NA,1
"SIGNAL PROCESSING",NA,1
"SIGNAL SUPPRESSION",NA,1
"SIGNAURE PROGRAM",NA,1
"SILENCING",NA,1
"SILICA COATED GOLD NANORODS",NA,1
"SILICA COLUMN",NA,1
"SILICA NANOPARTICLE",NA,2
"SILICON CARBIDE NANOTUBE",NA,1
"SILICONE OIL",NA,1
"SILVER COLLOID",NA,2
"SILVER FIBER",NA,1
"SILYBUM MARIANUM",NA,1
"SILYL-DERIVATIZATION",NA,1
"SILYLATION",NA,5
"SIMILARITY",NA,3
"SIMILARITY ASSESSMENT",NA,1
"SIMILARITY COEFFICIENT METHOD",NA,1
"SIMILARITY MATCHING",NA,1
"SIMPLE DETECTION",NA,1
"SIMPLE SAMPLE PREPARATION",NA,1
"SIMPLE SEQUENCE REPEATS",NA,2
"SIMPLEX",NA,1
"SIMPLEX OPTIMIZATION",NA,1
"SIMULATED GASTRIC AND INTESTINAL FLUIDS",NA,1
"SIMULATED MOVING BED",NA,1
"SIMULATION METHODS AND PROGRAMS",NA,1
"SIMULTANEOUS",NA,1
"SIMULTANEOUS ASSAY",NA,1
"SIMULTANEOUS CHIRAL ANALYSIS",NA,1
"SIMULTANEOUS DETERMINATION OF PARACETAMOL",NA,1
"SIMULTANEOUS EQUATION METHOD",NA,1
"SIMULTANEOUS ESTIMATION",NA,1
"SIMULTANEOUS QUANTIFICATION",NA,2
"SIMVASTATIN",NA,1
"SINGLE-CHAIN FV ANTIBODY",NA,1
"SINGLE-COLOR REFLECTOMETRY",NA,1
"SINGLE-CRYSTAL TRANSITION",NA,1
"SINGLE-CRYSTAL X-RAY DIFFRACTION",NA,1
"SINGLE-DROP MICROEXTRACTION (SDME)",NA,1
"SINGLE-ISOMER AMINO CYCLODEXTRINS",NA,1
"SINGLE-LABORATORY VALIDATION",NA,1
"SINGLE-MOLECULE LONG-READ ISOFORM SEQUENCING (ISOSEQ)",NA,1
"SINGLE ISOMER",NA,1
"SINGLE QUADRAPOLE MASS DETECTION",NA,1
"SINGLE RUN",NA,1
"SINGLE SHOT MULTIBOX DETECTOR (SSD)",NA,1
"SINGLET OXYGEN",NA,1
"SINOMENINE DERIVATIVES",NA,1
"SINOMENIUM ACUTUM",NA,1
"SINOMENIUM ACUTUM (THUMB.) REHD. ET WILS. MENISPERMACEAE",NA,1
"SITE-SATURATION MUTAGENESIS",NA,1
"SITUATION ASSESSMENT",NA,1
"SIZE-EXCLUSION CHROMATOGRAPHY",NA,1
"SIZE ESTIMATION",NA,1
"SIZE EXCLUSION CHROMATOGRAPHY",NA,1
"SLEEP INDUCERS",NA,1
"SLIMMERS",NA,1
"SLIMMING AIDS",NA,1
"SLIMMING HERBAL PRODUCTS",NA,1
"SLIMMING PHYTOTHERAPEUTIC FORMULATIONS",NA,1
"SLIMMING PRODUCTS",NA,2
"SLIMMING SUPPLEMENT",NA,1
"SLIMMING TEA",NA,1
"SLOW RELEASE",NA,1
"SLUDGE",NA,1
"SMALL AMOUNTS OF DRUGS HAVING PSYCHOTROPIC ACTIVITIES",NA,1
"SMALL MOLECULE-DNA INTERACTIONS",NA,1
"SMART PHONE CAMERA",NA,1
"SMART PROBE",NA,1
"SMARTDRUG",NA,1
"SMARTPHONE-BASED",NA,1
"SMARTPHONE-BASED INSTRUMENTATION",NA,1
"SMARTPHONE SENSING",NA,1
"SMARTSHOP",NA,1
"SMARTSHOPS",NA,1
"SMNPS",NA,1
"SMOKING BLENDS",NA,1
"SMOKING MIXTURES",NA,1
"SMUGGLED SAMPLE ANALYSIS",NA,1
"SNIF-NMR",NA,1
"SNPSTR HAPLOTYPE",NA,1
"SNYDER-DOLAN CLASSIFICATION SCHEME",NA,1
"SNYDER THEORY IN LSCHROM SOFTWARE",NA,1
"SOCIAL CRISIS",NA,1
"SOCIAL MASS EVENT",NA,1
"SOCIAL MEDIA",NA,10
"SOCIAL MEDIA, ALCOHOL, MARIJUANA, TWITTER, PREVENTION RESEARCH. MANUSCRIPT FORMAT: RESEARCH",NA,1
"SOCIAL NETWORKING (ONLINE)",NA,1
"SOCIAL SPAM",NA,1
"SOCIOECONOMIC CONSIDERATIONS",NA,1
"SOCIOECONOMIC STATUS",NA,1
"SODIUM ALGINATE",NA,1
"SODIUM BARBITURATE",NA,1
"SODIUM BENZOATE",NA,1
"SODIUM CHOLATE",NA,1
"SODIUM DEOXYCHOLATE",NA,2
"SODIUM DODECYL SULFATE",NA,3
"SODIUM DODECYL SULPHATE",NA,1
"SODIUM LAURYL ETHER SULFATE",NA,1
"SODIUM STARCH GLYCOLATE",NA,1
"SODIUM TETRAPHENYLBORATE",NA,1
"SODIUM THIOSULPHATE",NA,1
"SOFT INDEPENDENT CLASS ANALOGY MODEL",NA,1
"SOFT INDEPENDENT MODELLING OF CLASS ANALOGY",NA,1
"SOFT MEDICINAL FORMULATIONS",NA,1
"SOIL ENVIRONMENT",NA,1
"SOIL TESTING",NA,1
"SOL-GEL TECHNOLOGY",NA,2
"SOLÃ¢Â‚¬Â€ŒGEL",NA,1
"SOLANACEAE",NA,5
"SOLANACEAES SEEDS",NA,1
"SOLID-LIQUID EXTRACTION",NA,1
"SOLID-PHASE EXTRACTION PROTOCOL",NA,1
"SOLID-PHASE IMPRINTING",NA,1
"SOLID-STATE",NA,3
"SOLID-STATE CHARACTERIZATION",NA,1
"SOLID-STATE NMR",NA,2
"SOLID-STATE SENSOR",NA,1
"SOLID-STATE SPECTROSCOPY",NA,1
"SOLID–LIQUID EXTRACTION",NA,1
"SOLID DEPOSITION GCÃ¢Â‚¬Â€ŒIRD",NA,1
"SOLID DOSAGE FORM",NA,1
"SOLID PHASE",NA,1
"SOLID PHASE DYNAMIC EXTRACTION",NA,1
"SOLID PHASE MICROEXTRACTION-ION MOBILITY SPECTROMETRY (SPME-IMS)",NA,1
"SOLID SAMPLE ANALYSIS",NA,1
"SOLID SENSORS",NA,1
"SOLID STATE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY",NA,1
"SOLID WASTE",NA,1
"SOLUTION AND MOBILE PHASE STABILITY",NA,1
"SOLUTION NMR SPECTROSCOPY",NA,1
"SOLUTION SPECTROSCOPIC ANALYSIS",NA,1
"SOLUTION THERMODYNAMICS",NA,1
"SOLVATION",NA,1
"SOLVATION EFFECTS",NA,1
"SOLVATION PARAMETER MODEL",NA,1
"SOLVENT-FREE PROCESS",NA,1
"SOLVENT-FREE REACTION",NA,1
"SOLVENT CHEMISTRY",NA,1
"SOLVENT COMPOSITION",NA,1
"SOLVENT EFFECTS",NA,1
"SOLVENT ELIMINATION",NA,1
"SOLVENT SUPPRESSION",NA,1
"SOLVENTS RESIDUES",NA,1
"SOLVOTHERMAL METHOD",NA,1
"SOMALI",NA,1
"SOMATIC EMBRYOGENESIS",NA,3
"SOMATROPIN",NA,1
"SONOCHEMICAL METHOD",NA,1
"SOPHISTICATION",NA,1
"SORBENT TUBES",NA,1
"SOURCE RELATIONS",NA,2
"SOURCES",NA,1
"SOUTH TYROL",NA,1
"SOUTHEAST ASIA",NA,1
"SOUTHERN THAILAND",NA,1
"SOUTHWEST ASIA",NA,1
"SOXHLET",NA,1
"SP",NA,1
"SPARSE-PRINCIPAL COMPONENT ANALYSIS",NA,1
"SPARSE SAMPLING",NA,1
"SPARTEINE",NA,1
"SPATIAL ANALYSIS",NA,2
"SPATIAL DISTRIBUTION",NA,1
"SPATIAL RESOLUTION",NA,1
"SPATIALLY RESOLVED SPECTROSCOPY",NA,1
"SPATIOTEMPORAL CHANGES",NA,1
"SPATIOTEMPORAL CLUSTER ANALYSIS",NA,1
"SPD489",NA,1
"SPE CLEAN-UP",NA,2
"SPE/LC-(ESI)MS-MS",NA,1
"SPE/TLC",NA,1
"SPE/TLC PROFILING",NA,2
"SPECIALIST",NA,1
"SPECIALIZED METABOLISM",NA,1
"SPECIFIC DATABASE OF REFERENCE SPECTRA",NA,1
"SPECIFICATION",NA,1
"SPECTRA",NA,2
"SPECTRA COMPARISON",NA,1
"SPECTRA INTERPRETATION",NA,1
"SPECTRA MODELING",NA,1
"SPECTRA OF RAMAN SCATTERING",NA,1
"SPECTRAL ANALYSES",NA,1
"SPECTRAL DATA",NA,1
"SPECTRAL DATABASE",NA,1
"SPECTRAL FLUORESCENCE SIGNATURE",NA,1
"SPECTRAL FLUORESCENT SIGNATURES (SFS).",NA,1
"SPECTRAL IMAGES",NA,1
"SPECTRAL LIBRARY SEARCHING",NA,2
"SPECTRAL PATTERNS",NA,1
"SPECTRAL RESOLUTION",NA,1
"SPECTRAL SEARCH ALGORITHM",NA,1
"SPECTRO-ELECTROCHEMISTRY",NA,2
"SPECTROCHROMATOGRAM",NA,1
"SPECTROELECTROCHEMISTRY",NA,2
"SPECTROFLUORIMETRIC",NA,1
"SPECTROFLUOROMETER",NA,1
"SPECTROPHOMETRIC",NA,1
"SPECTROPHOTOMETRIC",NA,2
"SPECTROSCOPIC CHARACTERISATION",NA,1
"SPECTROSCOPIC DATA",NA,1
"SPECTRUM ANALYSIS",NA,1
"SPIKED BEVERAGE",NA,1
"SPIKED HUMAN PLASMA",NA,1
"SPIN DYNAMICS",NA,1
"SPIRANS",NA,1
"SPLS-DA",NA,1
"SPME-GC/MS",NA,1
"SPME-HPLC",NA,1
"SPME HEADSPACE",NA,1
"SPOROBOLUS POIRETII",NA,1
"SPORTS DOPING",NA,2
"SPORTS NUTRITION",NA,1
"SPP.",NA,1
"SPRAY OR JET-BASED AMBIENT IONIZATION TECHNIQUES-DESI, DESSI",NA,1
"SPRAY REAGENTS",NA,1
"SQUALANE",NA,1
"SQUARE-ROOT TIME LAW",NA,1
"SQUARE-WAVE",NA,1
"SRI-TOF-MS",NA,2
"SRM",NA,1
"SS-RTP",NA,1
"SSR",NA,1
"ST JOHN'S WORT (HYPERICUM PERFORATUM)",NA,1
"STABILITY-INDICATING ASSAY",NA,2
"STABILITY-INDICATING METHOD",NA,5
"STABILITY CONSTANT",NA,1
"STABILITY IN SLUDGE",NA,1
"STABILITY INDICTING",NA,1
"STABILITY TEST UNDER TEMPERATURE INFLUENCE",NA,1
"STABILIZATION ENERGIES",NA,1
"STABLE ISOTOPE GEOCHEMISTRY",NA,1
"STABLE ISOTOPE LABELING",NA,1
"STABLE ISOTOPE RATIO MEASUREMENTS",NA,1
"STABLE ISOTOPIC COMPOSITION",NA,1
"STABLE ISOTOPIC RATIO MASS SPECTROMETRY",NA,1
"STANDARD ADDITION CALIBRATION",NA,1
"STANDARD FREE",NA,1
"STANDARD REFERENCE MATERIAL",NA,1
"STANDARDIZED COLOR DETERMINATION",NA,1
"STANDARDIZED SOFTWARE",NA,1
"STANDARDLESS QUANTIFICATION",NA,1
"STANDARDS (OR DRUG STANDARDS)",NA,1
"STANOZOLOL",NA,2
"STANOZOLOL METABOLITE",NA,1
"STARCH",NA,1
"STARTING MATERIAL",NA,1
"STATIC SURFACE CULTURE FERMENTATION",NA,1
"STATIONARY PHASE CHARACTERIZATION",NA,1
"STATIONARY PHASES, ELECTROCHROMATOGRAPHY",NA,1
"STATIONARY WAVELET TRANSFORM",NA,1
"STATISTICAL DESIGNS",NA,1
"STATISTICAL INFERENCE",NA,1
"STATISTICAL METHODS",NA,1
"STATISTICAL PROCEDURES",NA,1
"STATISTICAL TREATMENT",NA,1
"STATISTICAL VALIDATION",NA,3
"STATUTORY LIMITS",NA,1
"STEARIC ACID",NA,1
"STEM",NA,2
"STEM ANATOMY",NA,1
"STEP THERAPY",NA,1
"STEPHANIA YUNNANENSIS LO",NA,1
"STEREOCHEMISTRY",NA,1
"STEREOCHEMISTRY ASSESSMENT",NA,1
"STEREODIVERGENT SYNTHESIS",NA,1
"STEREOGENIC CENTERS",NA,1
"STEREOISOMERS",NA,3
"STEREOLITHOGRAPHY",NA,1
"STEREOSELECTIVE ADDITION",NA,1
"STEREOSELECTIVE ANALYSIS",NA,1
"STEREOSELECTIVE BIOREDUCTION",NA,1
"STEREOSELECTIVE BIOTRANSFORMATION",NA,1
"STEREOSELECTIVE DEGRADATION",NA,1
"STEREOSELECTIVE REDUCTION",NA,1
"STEREOSELECTIVE SEPARATION",NA,1
"STEREOSELECTIVE SYNTHESIS",NA,2
"STEREUMENE B",NA,1
"STERILITY TEST",NA,1
"STERN-VOLMER PLOT",NA,1
"STEROID HORMONE DETECTION",NA,1
"STEROID HORMONES",NA,12
"STEROID ISOTOPIC STANDARDS",NA,1
"STEROID METABOLISM",NA,1
"STEROID QUANTIFICATION",NA,1
"STEROIDAL DRUGS",NA,1
"STEROIDAL ESTROGENS",NA,1
"STEROIDAL RING CONFORMATION",NA,1
"STIGMATISATION",NA,1
"STILBENES",NA,1
"STIMULANT PHENETHYLAMINE ALKALOIDS",NA,1
"STIMULANT USE",NA,1
"STIR BAR MAGNETIC SOLID PHASE EXTRACTION",NA,1
"STORAGE OF ODOR SAMPLES",NA,1
"STRAINS",NA,1
"STRAMENLACTONE",NA,1
"STRATEGY: BEHAVIOR CHANGE",NA,1
"STREAM ECOLOGY",NA,1
"STREAMS",NA,1
"STREET-GRADE ILLEGAL TABLETS",NA,1
"STREET ANALOGS",NA,1
"STREET DRUG SAMPLES",NA,2
"STREET DRUGS ANALYSIS",NA,1
"STREET LEVEL",NA,1
"STREET LIKE SYNTHESIS",NA,1
"STREETRX",NA,1
"STRESS TESTING",NA,2
"STRESSED SAMPLES",NA,1
"STRICTOSIDINE SYNTHASE",NA,1
"STRIP-BASED SENSORS",NA,1
"STRONG CATION-EXCHANGE",NA,1
"STRONG CATION EXCHANGE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (SCX-HPLC)",NA,1
"STRONG CHIRAL CATION EXCHANGER",NA,1
"STRONTIUM ISOTOPE ABUNDANCE RATIOS",NA,1
"STRUCTURAL CHARACTERISTICS",NA,1
"STRUCTURAL CHARACTERIZATION",NA,2
"STRUCTURAL CHEMICAL ANALYSER",NA,1
"STRUCTURAL DIFFERENTIATION",NA,1
"STRUCTURAL ISOMERISM",NA,1
"STRUCTURAL MODIFICATION",NA,1
"STRUCTURAL RELATIONSHIPS",NA,1
"STRUCTURE-PROPERTY RELATIONSHIPS",NA,1
"STRUCTURE-RETENTION RELATIONSHIPS",NA,1
"STRUCTURE-TOXICITY RELATIONSHIP",NA,1
"STRUCTURE DESIGN",NA,1
"STRUCTURE SOLUTION BY POWDER DIFFRACTION",NA,1
"STRUCTUREÃ¢Â‚¬Â€ŒACTIVITY RELATIONSHIP",NA,1
"STUDENT-CENTERED LEARNING",NA,1
"STUDIES OF COUNTERFEIT PHARMACEUTICALS",NA,1
"STUDY CHARACTERISTICS",NA,1
"STUDY DESIGN: CONTENT ANALYSIS",NA,1
"STUPEFACIENT DRUGS",NA,1
"STYRENE-MALEIC ACID POLYMER",NA,1
"SUB-2 ŒºM",NA,1
"SUB-2 ŒºM PARTICLES",NA,1
"SUB-2M PARTICLE C18 COLUMN",NA,1
"SUB-STANDARD MEDICINES",NA,1
"SUB-TWO ŒºM PARTICLES",NA,1
"SUBCLASS CHARACTERISTICS",NA,1
"SUBCUTANEOUS MEMBRANE",NA,1
"SUBJECTIVE RATINGS",NA,1
"SUBLINGUAL FILM",NA,1
"SUBLINGUAL TABLETS",NA,1
"SUBMARINE SEWAGE OUTFALL",NA,1
"SUBSTANCE ABUSE CB1R",NA,1
"SUBSTANCE DATABASE",NA,1
"SUBSTANCE P",NA,1
"SUBSTANDARD MEDICINES",NA,1
"SUBSTITUENT EFFECTS",NA,1
"SUBSTITUTE REFERENCE SUBSTANCE",NA,1
"SUBSTITUTED CATHINONES",NA,2
"SUBSTITUTED PHENETHYLAMINE DERIVATIVES",NA,1
"SUBSTITUTED PHENETHYLAMINES",NA,1
"SUBSTITUTED TRYPTAMINES",NA,2
"SUBTRACTIVE HYBRIDIZATION",NA,1
"SUBTROPICAL ZONE",NA,1
"SUCCINIC ACID",NA,1
"SUDAN RED",NA,1
"SUICIDAL RISK",NA,1
"SULFATED ÃŽÂ²-CYCLODEXTRIN",NA,2
"SULFATED Œ≤-CYCLODEXTRIN",NA,1
"SULFATED Œ≤-CYCLODEXTRIN (HS-Œ≤-CD) ELECTROLYTE",NA,1
"SULFITE",NA,1
"SULFOAILDENAFIL",NA,1
"SULFOBUTYLETHER ÃŽÂ²-CYCLODEXTRIN",NA,1
"SULFOCONJUGATES",NA,1
"SULFONATE ESTER",NA,1
"SULFONYLATION",NA,1
"SULPHURIC ACID",NA,1
"SUMMARY STATISTICS",NA,1
"SUPER PARTIAL LEAST SQUARES REGRESSION DISCRIMINATE ANALYSIS",NA,1
"SUPERCRITICAL CO2",NA,1
"SUPERCRITICAL CO2 EXTRACTION",NA,4
"SUPERCRITICAL FLUID",NA,1
"SUPERFICIALLY POROUS PARTICLES",NA,1
"SUPERSONIC MOLECULAR BEAMS",NA,2
"SUPPLEMENT",NA,2
"SUPPLY-CHAINS",NA,1
"SUPPLY-REDUCTION",NA,1
"SUPPLY-SIDE",NA,1
"SUPPORT FOR DRUG POLICY REFORM",NA,1
"SUPPORTED LIQUID-LIQUID EXTRACTION (SLE)",NA,1
"SUPPORTED LIQUID MEMBRANE",NA,1
"SUPRAMOLECULAR CHEMISTRY",NA,3
"SURFACE",NA,1
"SURFACE-ENHANCE RAMAN SCATTERING",NA,1
"SURFACE-ENHANCED ATR IMAGING",NA,1
"SURFACE-ENHANCED RAMAN SCATTERING (SERS)",NA,1
"SURFACE-ENHANCED RAMAN SPECTROSCOPY (SERS) SPECTRO-ELECTROCHEMISTRY",NA,1
"SURFACE-GROUNDWATER",NA,1
"SURFACE ACTIVATED CHEMICAL IONIZATION",NA,1
"SURFACE ANALYSIS",NA,2
"SURFACE COATING",NA,1
"SURFACE COLOR",NA,1
"SURFACE CONTAMINATION",NA,1
"SURFACE DESORPTION ATMOSPHERIC PRESSURE CHEMICAL IONIZATION",NA,1
"SURFACE ENHANCED RAMAN SCATTERING",NA,2
"SURFACE IONIZATION MASS SPECTROMETRY",NA,2
"SURFACE MODIFICATION",NA,3
"SURFACE MOLECULARLY IMPRINTED POLYMERS",NA,1
"SURFACE SAMPLES",NA,1
"SURFACE WATER SAMPLES",NA,1
"SURFACE WEB",NA,1
"SURFACED-ENHANCED RAMAN SPECTROSCOPY",NA,1
"SURFACTANT BEHAVIOUR",NA,1
"SURFACTANT ENHANCED LIQUID-PHASE MICROEXTRACTION",NA,1
"SURROGATE",NA,1
"SURVEILLANCE SYSTEM",NA,1
"SUSPECT MEDICINES",NA,1
"SUSTAINABILITY INNOVATION LEARNING",NA,1
"SUSTAINABLE AND HEALTHY FOOD INGREDIENTS",NA,1
"SUSTAINABLE LIVELIHOOD",NA,1
"SWCNT",NA,1
"SWEAT SAMPLES",NA,1
"SWEET ORANGES",NA,1
"SWELLABLE POLYMERS",NA,1
"SWELLING",NA,1
"SWEPT SOURCE",NA,1
"SWGDAM",NA,1
"SWIMMING POOL WATER",NA,1
"SWINE FEED",NA,1
"SWITCH SENSOR",NA,1
"SYBRÃ‚Â® GREEN I",NA,1
"SYMBOLIC BOUNDARIES",NA,1
"SYMPATHOMIMETIC DRUGS",NA,1
"SYMPATHOMIMETICS",NA,1
"SYNCHRONOUS FLUORESCENCE SPECTROSCOPY",NA,1
"SYNEPHRINE",NA,6
"SYNERGISTIC EFFECT",NA,3
"SYNTHACAINE",NA,1
"SYNTHESIS DESIGN",NA,1
"SYNTHESIS MARKERS",NA,1
"SYNTHESIS ROUTES",NA,1
"SYNTHESIS WASTE",NA,1
"SYNTHESIZED DRUGS",NA,1
"SYNTHETIC ADDITIVE",NA,1
"SYNTHETIC ADULTERANT",NA,1
"SYNTHETIC BIOLOGY",NA,3
"SYNTHETIC CANNABINOID RECEPTOR AGONISTS (SCRAS)",NA,1
"SYNTHETIC CANNABINOIDS (SCS)",NA,1
"SYNTHETIC CANNABINOIDS/CANNABIMIMETICS",NA,1
"SYNTHETIC IMPURITIES",NA,2
"SYNTHETIC OPIOID, QUALITATIVE",NA,1
"SYNTHETIC STIMULANT",NA,1
"SYNTHETIC TREND",NA,1
"SYRINGEABILITY",NA,1
"SYSTEM PEAKS",NA,1
"SYSTEM PERFORMANCE",NA,1
"SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT",NA,1
"SYSTEMATIC LITERATURE REVIEW",NA,1
"SYSTEMATIC PLANNING",NA,1
"T-BOC-MDMA",NA,1
"T-CELL SUPPRESSION",NA,1
"T6ODM",NA,1
"TABERNAEMONTANA ALBA",NA,1
"TABERNAEMONTANA ARBOREA",NA,1
"TABERNANTHE IBOGA",NA,1
"TABLET CONSTITUENTS",NA,1
"TABLET DOSAGE FORM",NA,3
"TABLET FORMULATIONS",NA,1
"TABLET STRENGTH",NA,1
"TABLETING",NA,1
"TACTICAL CRIME ANALYSIS",NA,1
"TADALAFIL ANALOGUE",NA,2
"TADALAFIL DETERMINATION",NA,1
"TADALAFIL DRUGS",NA,1
"TADALAFIL ENANTIOMERS",NA,1
"TAGETES",NA,1
"TAGGED NEUTRONS",NA,1
"TAIL IMMERSION TEST",NA,1
"TAIWAN FDA",NA,1
"TALL FESCUE",NA,1
"TALL FESCUE TOXICOSIS",NA,1
"TAMPER-RESISTANT",NA,3
"TAMPER-RESISTANT FORMULATION",NA,2
"TAMPER RESISTANCE",NA,2
"TAMPER RESISTANT DRUGS",NA,1
"TANDEM HYBRID MASS SPECTROMETRY",NA,1
"TANDEM REACTION",NA,2
"TANNIN",NA,1
"TANSHINONE",NA,1
"TAPENTADOL ABUSE LIABILITY",NA,1
"TAPENTADOL IMMEDIATE RELEASE",NA,1
"TAPENTADOL PR",NA,1
"TAQMAN REAL-TIME PCR",NA,1
"TAQMANª ASSAY",NA,1
"TAQMANÃ¢Â€ŽÂ¢ ASSAY",NA,1
"TARGET",NA,1
"TARGET-INDUCED STRAND RELEASE",NA,1
"TARGET DETECTION",NA,1
"TARGET METABOLOME",NA,1
"TARGET POPULATION AGE: YOUTH, ADULTS",NA,1
"TARGET POPULATION CIRCUMSTANCES: EDUCATION/INCOME LEVEL",NA,1
"TARGET QUANTIFICATION",NA,1
"TARGETED METHODS",NA,1
"TARTRATE",NA,1
"TASTE SENSOR",NA,1
"TAUTOMERISM",NA,1
"TD-DFT",NA,1
"TDT",NA,1
"TDZ",NA,1
"TEACHING CHEMISTRY",NA,1
"TECHNICAL HEMP",NA,1
"TEMPERATURE PROGRAM OPTIMIZATION",NA,1
"TEMPLATE",NA,1
"TEMPLATE STRIPPING METHOD",NA,1
"TEMPORAL COMPARISON",NA,1
"TEMPORARY SCHEDULING",NA,1
"TEMPRANILLO",NA,1
"TENSILE PROPERTIES",NA,1
"TENTATIVE IDENTIFICATION",NA,1
"TERAHERTZ (THZ)",NA,1
"TERAHERTZ ABSORPTION SPECTRA",NA,1
"TERAHERTZ FREQUENCY IMAGING, OR SCANNING CAPABILITY, MATERIALS IDENTIFIED SPATIALLY",NA,1
"TERAHERTZ FREQUENCY SPECTROSCOPY, ITS POTENTIAL IN SECURITY APPLICATIONS",NA,1
"TERAHERTZ TIME-DOMAIN SPECTROSCOPY",NA,1
"TERAHERTZ TIME-DOMAIN, ALL-OPTICAL, PRODUCING THZ RADIATION",NA,1
"TERAHERTZ WAVE",NA,1
"TERBUTALINE ENANTIOMERS",NA,1
"TERMINALIA CORIACEA",NA,1
"TERNARY COMPLEX OF COBALT",NA,1
"TERNARY MATRIX",NA,1
"TERPENES",NA,8
"TERPENOID",NA,6
"TERPENOID INDOLE ALKALOIDS",NA,1
"TERT-BUTOXYCARBONYL-METHAMPHETAMINE (T-BOC-MP)",NA,1
"TERT-BUTYL ALCOHOL",NA,1
"TERT-BUTYL GROUP",NA,1
"TERTIARY AMINE N-OXIDES",NA,1
"TESTOSTERONE AND PROHORMONES",NA,1
"TESTOSTERONE MISUSE",NA,1
"TESTOSTERONE PROPIONATE",NA,1
"TETRA-O-BENZYLPYROPHOSPHATE",NA,1
"TETRAHEDRAL AMORPHOUS CARBON",NA,2
"TETRAHYDRO-ÃƑÅ½Ã‚Â²-CARBOLINES",NA,1
"TETRAHYDRO-Œ≤-CARBOLINES",NA,1
"TETRAHYDROFURAN",NA,1
"TETRAHYDROFURAN VAPOURS SENSING",NA,1
"TETRAHYDROGESTRINONE",NA,2
"TETRAHYDROISOQUINOLINE",NA,1
"TETRAPTERYS MUCRONATA",NA,1
"TETRARUTHENATED PORPHYRINS",NA,1
"TETRASUBSTITUTED ALKENES",NA,1
"TETRAZOLIUM PRO-DYE",NA,1
"TETRAZOLIUM SALT",NA,1
"TEXT CLASSI-CATION",NA,1
"TEXT CLUSTERING",NA,1
"TEXTBOOKS/REFERENCE BOOKS",NA,1
"TFA",NA,1
"TFA DERIVATIVES",NA,1
"TG-FTIR",NA,1
"TG/DTG",NA,1
"THC-ACID-A",NA,1
"THCA-SYNTHASE",NA,1
"THE NORTHERN AREAS OF PAKISTAN",NA,1
"THE RAMAN SHIFT, STOKES OR ANTI-STOKES, AND UNCHANGED WAVELENGTH",NA,1
"THE TOR NETWORK",NA,1
"THEBAINE 6-O-DEMETHYLASE",NA,1
"THEBAINE O-DEMETHYLATION",NA,1
"THEBAOL",NA,1
"THEOPHYLLINE AND EPHEDRINE HYDROCHLORIDE DETERMINATION",NA,1
"THERAPEUTIC OPIATES",NA,1
"THERAPEUTIC USES",NA,1
"THERMAL ANALYSES",NA,3
"THERMAL BREAKDOWN PRODUCTS",NA,1
"THERMAL CONVERSION",NA,1
"THERMAL IMMOBILIZATION",NA,1
"THERMAL LENS SPECTROMETRY",NA,1
"THERMODYNAMIC PARAMETERS",NA,3
"THERMODYNAMIC STUDIES",NA,1
"THERMODYNAMICS",NA,4
"THERMODYNAMICS OF DIASTEREOMER SEPARATION",NA,1
"THERMOGRAPHY",NA,1
"THERMOLYSIS",NA,1
"THERMOLYTIC PRODUCTS",NA,1
"THERMOMYCES LANUGINOSUS LIPASE",NA,1
"THERMOSALIENT BEHAVIOUR",NA,1
"THERMOSPRAY",NA,1
"THIAMINE DIPHOSPHATE",NA,1
"THIENORPHINE",NA,1
"THIN-LAYER CHROMATOGRAPHY-UV DENSITOMETRY",NA,1
"THIN-LAYER CHROMATOGRAPHYÃ¢Â‚¬Â€ŒDENSITOMETRY",NA,1
"THIN FILM MICRO-EXTRACTION",NA,1
"THIOGLYCOLIC ACID DECORATED CDSE",NA,1
"THIRD-GENERATION SCS",NA,1
"THIRD-PARTY POLICING",NA,1
"THIRD DERIVATIVE",NA,1
"THREAT DETECTION",NA,1
"THREE-COMPONENT REACTION",NA,1
"THRESHING RESIDUES",NA,1
"THROUGHPUT",NA,1
"THROUGHPUT ANALYSIS",NA,1
"THYMUS ALGERIENSIS",NA,1
"THZ-TDS",NA,2
"THZ-TDS, SPECTRAL INFORMATION FOR RAMAN SPECTROSCOPY",NA,1
"THZ FREQUENCY RADIATION, SCATTERING AND ABSORPTION PHENOMENA DISCRIMINATION",NA,1
"THZ FREQUENCY RADIATION, THOUGH NON-METALLIC, NON-POLAR MATERIALS",NA,1
"THZ FREQUENCY, SENSITIVITY TO SALTS AND POLYMORPHS OF THE SAME MOLECULE",NA,1
"THZ PULSE",NA,1
"THZ SPECTRA OF PLASTIC EXPLOSIVES, SPECTRAL FEATURES OF CONSTITUENT EXPLOSIVES",NA,1
"THZ SPECTROSCOPY",NA,1
"THZ SPECTROSCOPY, CHEMICAL SPECIFICITY, PACKAGING, A STAND-OFF CONFIGURATION",NA,1
"THZ TIME-DOMAIN SPECTROSCOPY",NA,1
"TIBETAN PLATEAU",NA,1
"TILAPIA",NA,1
"TIME-OF-FLIGHT MASS SPECTROMETER",NA,1
"TIME-RESOLVED FLUORESCENT IMMUNOCHROMATOGRAPHY",NA,1
"TIME AXIS LINEARIZATION",NA,1
"TIME RESOLVED SPECTROSCOPY",NA,1
"TIME SERIES ANALYSIS",NA,2
"TIME SHIFTED MASS BALANCING",NA,1
"TIN NANORODS",NA,1
"TIO2 NANOPARTICLES",NA,1
"TIO2@CUO-N-RGO",NA,1
"TIRE PRINTS",NA,1
"TISSUE CULTURE",NA,1
"TISSUE EXPRESSION",NA,1
"TLC-DENSITOMETRY",NA,2
"TLC-IMAGE ANALYSIS",NA,1
"TLC-MS",NA,3
"TLC ANALYSIS",NA,1
"TLC DENSITOMETRY",NA,1
"TLC METHOD",NA,1
"TLC OF CANNABINOIDS",NA,1
"TLC PLATES",NA,1
"TLC PROFILE",NA,1
"TMA-2",NA,1
"TMS DERIVATIVES",NA,1
"TMS DERIVATIZATION",NA,1
"TNMT",NA,1
"TNTU",NA,1
"TOBRAMYCIN",NA,1
"TOCAINIDE",NA,1
"TOCOPHEROLS",NA,4
"TODDY",NA,1
"TODDY SAMPLE",NA,1
"TOF",NA,2
"TOFMS",NA,2
"TOLFENAMIC ACID",NA,1
"TOM KITS§",NA,1
"TOOLMARK EXAMINATION",NA,1
"TOR",NA,1
"TOR NETWORK",NA,1
"TOTAL- ŒÎ9-THC",NA,1
"TOTAL ELEMENT QUANTITATION",NA,1
"TOTAL INTERNAL REFLECTION",NA,1
"TOTAL PHENOLIC",NA,1
"TOTAL SYNTHESIS",NA,6
"TOXIC DRUGS",NA,1
"TOXIC IMPURITY",NA,1
"TOXIC INDUSTRIAL CHEMICAL",NA,1
"TOXIC INGREDIENT COMPOUNDS",NA,1
"TOXICITY PROFILING",NA,1
"TOXICODYNAMICS",NA,2
"TOXICOLOGICAL ASPECTS",NA,1
"TOXICOLOGICAL DATA",NA,1
"TOXICOLOGY AND PHARMACOLOGY",NA,1
"TOXICOLOGY MICROCRYSTAL TESTS",NA,1
"TOXICOPHORE",NA,1
"TR FLUOROIMMUNOASSAY",NA,1
"TRACE CONCENTRATION",NA,1
"TRACE DRUG ANALYSIS",NA,1
"TRACE EVIDENCE DETECTION",NA,1
"TRACE METALS",NA,2
"TRACE MICROANALYSIS",NA,1
"TRACEABLE OPIOID MATERIAL§ KITS",NA,1
"TRACING",NA,1
"TRACK AND TRACE",NA,1
"TRADE",NA,1
"TRADITIONAL",NA,1
"TRADITIONAL CALIBRATION",NA,1
"TRADITIONAL MEDICINAL PREPARATIONS",NA,1
"TRADITIONAL PREPARATION",NA,1
"TRADITIONAL USES",NA,1
"TRAIL-RESISTANCE",NA,1
"TRAINING AIDS",NA,1
"TRAMADOL-IMPRINTED POLYMER",NA,1
"TRAMADOL-RELATED MORTALITY",NA,1
"TRAMADOL CLASSIFICATION",NA,1
"TRAMADOL HCL",NA,1
"TRAMADOL HYDROCHLORIDE",NA,7
"TRAMADOL SENSING",NA,1
"TRANS- CINNAMOYLCOCAINE",NA,1
"TRANS-CINNAMOYLCOCAINE",NA,1
"TRANS-FERULOYLTYRAMINE",NA,1
"TRANS-TADALAFIL",NA,1
"TRANSCRIPT PROFILING",NA,1
"TRANSCRIPTION FACTORS",NA,3
"TRANSCRIPTOME",NA,2
"TRANSCRIPTOME DATA",NA,1
"TRANSCRIPTOMES",NA,1
"TRANSFER OF TLC METHODS TO HPTLC-DENSITOMETRY",NA,1
"TRANSFERABILITY",NA,2
"TRANSFLECTION SPECTROSCOPY",NA,1
"TRANSFORMATION",NA,3
"TRANSGENIC",NA,1
"TRANSITION METAL DICHALCOGENIDES",NA,1
"TRANSITION STATE",NA,1
"TRANSLOCATION FACTOR",NA,1
"TRANSMETALLATION",NA,1
"TRANSMISSION-MODE DESORPTION ELECTROSPRAY IONIZATION",NA,1
"TRANSMISSION RAMAN SPECTROSCOPY",NA,1
"TRANSMISSION SPECTRUM",NA,1
"TRANSMUCOSAL DELIVERY",NA,1
"TRANSPORT BEHAVIOUR",NA,1
"TRAVEL",NA,1
"TREATMENT ADMISSIONS",NA,1
"TREATMENT DEMAND",NA,1
"TRENDS IN DRUG ABUSE",NA,1
"TRIALKYLSILYLATION",NA,2
"TRIANGULATION",NA,1
"TRIAZINE",NA,2
"TRIAZOLE",NA,1
"TRIBODESORPTION",NA,1
"TRIBOLUMINESCENCE",NA,1
"TRICHLOROSILANE",NA,1
"TRICHOME",NA,3
"TRICKLING FILTER BEDS",NA,1
"TRIFLUOPERAZINE HCL",NA,1
"TRIFLUOROACETIC ANHYDRIDE (TFAA)",NA,1
"TRIFLUOROACETYLACETONE",NA,1
"TRIFLUOROMETHYLPHENYLPIPERAZINE (TFMPP)",NA,4
"TRIGLYCERIDE ANALYSIS",NA,1
"TRIPOS FORCE FIELD",NA,1
"TRIPROLIDINE",NA,2
"TRIS-PHOSPHATE BUFFER",NA,1
"TRIS(2,2-BIPYRIDYL) RUTHERNIUM(II) ELECTROCHEMILUMINESCENCE",NA,1
"TRIS(2,2Ã¢Â‚¬Â²-BIPYRIDINE)RUTHENIUM",NA,1
"TRIS(2,2ÃƑÂ¢Ã‚Â‚¬Ã‚Â²-BIPYRIDINE)RUTHENIUM(III)",NA,1
"TRISTIMULUS COLORIMETER",NA,1
"TRITERPENOID SAPONINS",NA,1
"TRITIUM",NA,2
"TRNF",NA,1
"TRNL (UAA) INTRON",NA,1
"TRNL/TRNF LOCUS",NA,1
"TROPACOCAINE",NA,2
"TROPANE",NA,1
"TROPANE ALKALOID ANALYSIS",NA,1
"TROPARIL",NA,1
"TROPICAL PLANTS",NA,1
"TROPINONE",NA,2
"TRUXILLINE",NA,2
"TRYPSIN",NA,1
"TRYPTAMINE ALKALOIDS",NA,1
"TRYPTOPHAN PATHWAY",NA,1
"TRYPTOPHAN SYNTHASE",NA,1
"TSK-GEL AMIDE 80",NA,1
"TUNABLE DIODE LASER ABSORPTION SPECTROSCOPY (TDLAS)",NA,1
"TUNABLE FILTER",NA,1
"TUNABLE INFRARED LASER",NA,1
"TURNING FREQUENCY",NA,1
"TWINS LABELING",NA,1
"TWITTER",NA,7
"TWO-DIMENSIONAL COMPREHENSIVE GAS CHROMATOGRAPHY",NA,1
"TWO-DIMENSIONAL CORRELATION SPECTROSCOPY",NA,3
"TWO-DIMENSIONAL GAS CHROMATOGRAPHY–TIME-OF-FLIGHT MASS SPECTROMETRY",NA,1
"TWO-DIMENSIONAL GEL ELECTROPHORESIS",NA,1
"TWO-DIMENSIONAL LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY",NA,1
"TWO-DIMENSIONAL NANOMATERIALS",NA,1
"TWO-DIMENSIONAL RETENTION MODELLING",NA,1
"TWO-DIMENSIONAL SEPARATION",NA,1
"TYPE I AND II ERRORS",NA,1
"TYPE XII INDOLE ALKALOIDS (_-CARBOLINES)",NA,1
"TYRAMINE",NA,2
"TYROSINASE INHIBITON",NA,1
"U-HPLCÃ¢Â‚¬Â€ŒMS/MS",NA,1
"U-OPIOIDS",NA,1
"U.S. EPA-PRIORITY HORMONES AND BISPHENOL A",NA,1
"UAE",NA,1
"UFLC-ESI-MS/MS",NA,1
"UGI REACTION",NA,1
"UHPL-QQTOF-MS",NA,1
"UHPLC-DAD",NA,1
"UHPLC-FLD",NA,1
"UHPLC-PDA/UV-MS",NA,1
"UHPLC-Q-ORBITRAP HRMS",NA,1
"UHPLC-QTOF",NA,1
"UHPLC–MS/MS",NA,2
"UHPLCÃ¢Â‚¬Â€ŒMS/MS",NA,2
"UHPSFC",NA,1
"UKRAINE",NA,1
"ULTRA-FAST LIQUID CHROMATOGRAPHY",NA,2
"ULTRA-HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY",NA,3
"ULTRA-HIGH-SPEED HPLC",NA,1
"ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED TO HIGH-RESOLUTION MASS SPECTROMETRY",NA,1
"ULTRA-HIGH PERFORMANCE SUPERCRITICAL FLUID CHROMATOGRAPHY",NA,2
"ULTRA-LOW-LEVEL MEASUREMENT",NA,1
"ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION",NA,1
"ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHYÃ¢Â‚¬Â€ŒQUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRY",NA,1
"ULTRA HIGH-PERFORMANCE LIQUID",NA,1
"ULTRA HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (UHPLC)",NA,3
"ULTRA HIGH PERFORMANCE SUPERCRITICAL FLUID CHROMATOGRAPHY",NA,1
"ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",NA,1
"ULTRA TRACE",NA,1
"ULTRAHIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",NA,1
"ULTRAHIGH PRESSURE CHROMATOGRAPHY",NA,1
"ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY",NA,1
"ULTRASONIC",NA,1
"ULTRASONIC-ASSISTED EXTRACTION",NA,1
"ULTRASOUND-ASSISTED EXTRACTION",NA,3
"ULTRAVIOLET (UV)-DERIVATIVE SPECTROPHOTOMETRY",NA,1
"ULTRAVIOLET DISINFECTION",NA,1
"UNAPPROVED/UNPERMITTED DRUG",NA,1
"UNCERTAINTY PROPAGATION",NA,1
"UNCONTROLLED DRUG",NA,1
"UNDAMAGED ANALYSIS",NA,1
"UNDECLARED DRUGS",NA,1
"UNDECLARED PHARMACEUTICAL CHEMICALS",NA,1
"UNDECLARED SYNTHETIC DRUGS",NA,1
"UNDER-REPORTING",NA,1
"UNDERGROUND WATER",NA,1
"UNEQ",NA,1
"UNIFIED CALIBRATION",NA,1
"UNIFORM DESIGN",NA,1
"UNINFORMATIVE VARIABLE ELIMINATION",NA,1
"UNINTENDED MISUSE",NA,1
"UNIQUE",NA,1
"UNIT MASS RESOLUTION MASS SPECTROMETER",NA,1
"UNITED ARAB EMIRATES",NA,1
"UNIVERSAL SCREENING",NA,1
"UNIVERSITY STUDENTS",NA,1
"UNKNOWN",NA,1
"UNKNOWN COMPOUNDS",NA,1
"UNKNOWN FORMULAS",NA,1
"UNSATURATED COMPOUNDS",NA,1
"UNTARGETED ANALYSIS",NA,1
"UNUSUAL FORM",NA,1
"UP-SCHEDULING",NA,1
"UPGMA",NA,1
"UPLC-ESI/MS/MS",NA,1
"UPLC-HRMS",NA,1
"UPLC-MS/TOF",NA,1
"UPLC-Q-TOF",NA,1
"UPLC-TQ/MS",NA,1
"UPLC-TWIM-MS",NA,1
"UPLCÃ¢Â‚¬Â€ŒMS/MS",NA,1
"URB-754",NA,1
"URBAN CITIES",NA,1
"URBAN METABOLISM METROLOGY",NA,1
"URBAN STREAMS",NA,1
"UREAS",NA,1
"URINARY ANALYSIS",NA,1
"URINARY DETECTION",NA,2
"URSOLIC ACID",NA,1
"URUGUAY",NA,2
"US FOOD AND DRUG ADMINISTRATION",NA,1
"USE IN INTELLIGENCE WORK",NA,1
"USE OF SMOKED COCAINE AND ALCOHOL",NA,1
"USP APPARATUS 3",NA,1
"UV",NA,2
"UV-SPECTROPHOTOMETER",NA,1
"UV–VISIBLE",NA,1
"UV ABSORBANCE SPECTRUM",NA,1
"UV DATA",NA,1
"UV DENSITOMETRY",NA,1
"UV DETECTION",NA,4
"UV DETECTION VALIDATION",NA,1
"UV PATTERN",NA,1
"UV SPECTROMETRY",NA,1
"UV/VIS",NA,2
"UV/VIS SPECTROPHOTOMETER",NA,1
"UV/VISIBLE DETECTION",NA,1
"UVA/UVB-PHOTODEGRADATION",NA,1
"UZUNKÃƑÂ¶PRÃƑÂ¼",NA,1
"VACCINIUM MACROCARPON AIT.",NA,1
"VACUUM-BASED IONIZATION",NA,1
"VALERIANA OFFICINALIS",NA,1
"VALIDACE",NA,1
"VALIDATED",NA,1
"VALIDATION ASSAY",NA,1
"VALIDATION OF CE METHODS",NA,1
"VAN'T HOFF",NA,1
"VAN DEEMTER",NA,1
"VANCOMYCIN",NA,2
"VANCOMYCIN CRYSTALLINE DEGRADATION PRODUCTS",NA,1
"VAPE",NA,1
"VAPOR DETECTION",NA,3
"VAPOR PHASE INFRARED SPECTROSCOPY",NA,1
"VAPOUR PRESSURE",NA,1
"VAPOUR SAMPLING",NA,1
"VARDENAFIL HYDROCHLORIDE",NA,1
"VARDENAFIL HYDROCHLORIDE (VAR)",NA,1
"VARIABILITY FACTOR",NA,1
"VARIABLE SELECTION",NA,1
"VARIABLE WAVELENGTH",NA,1
"VARIETIES",NA,1
"VARIOUS PH BUFFERS",NA,1
"VARYING BASED ON POPULARITY, COST OF GENUINE DRUGS",NA,1
"VCD SPECTROSCOPY",NA,1
"VEGETATION CONTAINING NARCOTIC SUBSTANCES",NA,1
"VEGETATIVE PROPAGATION",NA,1
"VENICE (ITALY)",NA,1
"VENTOLINE DEPOT TABLETS",NA,1
"VERIFICATION METHOD",NA,1
"VERITIES OF ILLICIT DRUGS",NA,1
"VERTICAL MARKET STRUCTURE",NA,1
"VERY SMALL-SIZED SAMPLES",NA,1
"VESICLES",NA,1
"VETERINARY DRUG RESIDUE",NA,1
"VF-PC-SERS",NA,1
"VIAGRA¨",NA,1
"VIAGRA¬Æ",NA,2
"VIAGRA1¨",NA,1
"VIAGRA1Ã‚Â®",NA,1
"VIAGRAÃ‚Â®",NA,4
"VIAGRAÃƑÂ€ŠÃ‚Â®",NA,1
"VIBRATION",NA,1
"VIBRATIONAL ANALYSIS",NA,2
"VIBRATIONAL FREQUENCY ASSIGNMENTS",NA,1
"VIBRATIONAL MODES",NA,1
"VIBRATIONAL SPECTRA",NA,2
"VIBRATIONAL SPECTROSCOPIES",NA,1
"VIBRATIONAL SPECTROSCOPY AND INSTRUMENTATION, IN FORENSIC-TYPE MEASUREMENTS",NA,1
"VIBRATIONAL SPECTROSCOPY SAMPLING TECHNIQUES",NA,1
"VIBRATIONAL SPECTROSCOPY TECHNIQUES, AND THE BASICS",NA,1
"VIBRATIONAL SPECTROSCOPY, RAMAN AND MID-IR FT-IR IN FIELDS, NARCOTICS SECTOR",NA,1
"VIBRATIONAL SPECTROSCOPY, SAMPLING TECHNIQUES",NA,1
"VICILIN-LIKE",NA,1
"VIETNAM",NA,1
"VIEW ATTENTION",NA,1
"VINCA MINOR",NA,1
"VINYLFERROCENE",NA,1
"VINYLPYRIDINE",NA,1
"VIOLURIC ACID",NA,1
"VISUAL LIMIT OF COLOR PERCEPTION",NA,1
"VITAMIN",NA,1
"VITAMIN B1",NA,1
"VITAMIN TABLET",NA,1
"VOACANGA AFRICANA",NA,1
"VOACANGINE",NA,1
"VOLATILE CONSTITUENTS",NA,1
"VOLATILE FRACTION",NA,1
"VOLATILE IMPURITIES",NA,1
"VOLATILE MARKER",NA,1
"VOLATILE OIL",NA,3
"VOLATILE SIGNATURE",NA,1
"VOLATILES ORGANIC COMPOUNDS",NA,1
"VOLATILIZATION STUDIES",NA,1
"VOLTAMMETRIC DETECTION",NA,1
"VOLTAMMETRIC DETERMINATION",NA,2
"VOLTAMMETRIC MEASUREMENT",NA,1
"VOLTAMMETRIC METHOD",NA,1
"VOLTAMMETRY OF MICROPARTICLES",NA,2
"VOLUME HOLOGRAPHIC NOTCH FILTERS",NA,1
"VORICONAZOLE",NA,1
"VORTEX-ASSISTED DISPERSIVE LIQUID–LIQUID MICROEXTRACTION",NA,1
"VORTIOXETINE",NA,2
"VR-ENVIRONMENT",NA,1
"VTXRD",NA,1
"WACKER OXIDATION",NA,1
"WASHINGTON STATE",NA,1
"WASTE PREVENTION",NA,1
"WASTEWATER AND RECEIVING WATERS",NA,1
"WASTEWATER EFFLUENTS",NA,1
"WASTEWATER TREATMENT",NA,3
"WASTEWATER TREATMENT PLANT",NA,4
"WATER",NA,8
"WATER-ALCOHOL EXTRACT",NA,1
"WATER-SOLUBLE PRODRUG",NA,1
"WATER EXTRACTION",NA,1
"WATER POLLUTION",NA,1
"WATER PURIFICATION",NA,1
"WATER PURIFICATION PLANT",NA,1
"WATER RESOURCES",NA,1
"WATER SUPPLY SOURCE",NA,1
"WATER SUPPRESSION TECHNIQUE",NA,1
"WATER TREATMENT",NA,3
"WAVELENGTH SELECTION",NA,1
"WAVELET PCA",NA,1
"WAVELET TRANSFORM",NA,1
"WD-XRF",NA,1
"WEAK CATION-EXCHANGE",NA,1
"WEAK CATIONIC MIXED-MODE POLYMERIC SORBENT",NA,1
"WEB ANALYTICS",NA,1
"WEB CONTENT MINING",NA,1
"WEB SITES",NA,2
"WEB SURVEY",NA,1
"WEBSHOPS",NA,2
"WEBSITE",NA,1
"WEIGHT-LOSS DIETARY SUPPLEMENTS",NA,1
"WEIGHT-LOSS SUPPLEMENTS",NA,1
"WEIGHT LOSS COMPOUND",NA,2
"WEIGHT LOSS PRODUCTS",NA,1
"WEIGHT LOSS SUPPLEMENT",NA,1
"WEIGHT MANAGEMENT SUPPLEMENT",NA,1
"WEIGHT REDUCING HERB",NA,1
"WEIGHTED-AVERAGE-LINKAGE DENDROGRAM",NA,1
"WEIGHTED LINEAR REGRESSION",NA,3
"WELL-ESTABLISHED WITH RAPID IDENTIFICATION",NA,1
"WELSH ONIONS (ALLIUM FISTULOSUM L.)",NA,1
"WEST INDIES",NA,1
"WESTERN HIMALAYA",NA,1
"WETNESS",NA,1
"WHEAT",NA,3
"WHIPPITS",NA,1
"WHITE NEUTRON BEAM",NA,1
"WHOLE-CELL BIOTRANSFORMATION",NA,1
"WICKERHAMOMYCES SUBPELLICULOSUS",NA,1
"WIDE AREA SURVEILLANCE",NA,1
"WILD MUSHROOMS",NA,1
"WILD POPULATIONS",NA,1
"WIPE SAMPLING",NA,1
"WITHANIA SOMNIFERA",NA,1
"WITHANOLIDES",NA,1
"WOGONIN",NA,1
"WOOD-ROTTING FUNGI",NA,1
"WOODINHABITING FUNGI",NA,1
"WORD EMBEDDINGS",NA,2
"WORK FUNCTION",NA,1
"WORKING DOGS",NA,1
"WRITING INKS",NA,1
"WRKY",NA,1
"WWTP",NA,1
"X-RAY ANALYSIS",NA,1
"X-RAY CRYSTALLOGRAPHIC ANALYSIS",NA,2
"X-RAY POWDER DIFFRACTOMETRY",NA,1
"X-RAY POWDER MICRO-DIFFRACTION",NA,1
"X-RAY SINGLE-CRYSTAL",NA,1
"XANTHAN GUM",NA,1
"XANTHINE ALKALOIDS",NA,1
"XTAMPZA ER",NA,1
"XTC TABLETS",NA,1
"XYLARIA NIGRIPES",NA,1
"XYLENOL BLUE",NA,1
"YIELD",NA,5
"YOUTUBE",NA,2
"YUNNAN",NA,1
"ZALEPLON-D5",NA,1
"ZEOLITE SILICA NANOPARTICLES",NA,1
"ZIF-8",NA,1
"ZIPEPROL",NA,1
"ZNCRFEO4",NA,1
"ZNO",NA,1
"ZNO-MWCNT NANOCOMPOSITES",NA,1
"ZOHYDRO ER",NA,1
"ZOLMITRIPTAN",NA,1
"ZOLMITRIPTAN IMPURITIES",NA,1
"ZONE ELECTROPHORESIS",NA,1
"ZOPICLONE, CHIRAL SWITCHING",NA,1
"ZORBAX COLUMNS",NA,1
"ZPC",NA,1
"ZR-BASED METAL-ORGANIC FRAMEWORK NANOSHEETS",NA,1
"ZWITTERIONIC",NA,1
"ZWITTERIONIC SELECTOR",NA,1
"ZYMARK¬Æ",NA,1
"Α-PHENYLACETOACETONITRILE",NA,1
"Β-CARBOLINES",NA,1
"Β-CYCLODEXTRIN",NA,1
"Β−CD−BR15",NA,1
"Δ⁹-TETRAHYDROCANNABINOL (THC)",NA,1
"Κ-OPIOID RECEPTOR (KOR)",NA,1
"Μ-OPIOID RECEPTOR (MOR)",NA,1
"Μ-OPIOID RECEPTOR (MOR) ACTIVATION",NA,1
"ΜPAD",NA,1
